Citrus Sinensis ID: 007429

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600----
Protein Sequence
MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Secondary Structure (PSIPRED)
cccccccccccccccHHHHHHHHccccccccHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHccccccEEEEEEEcccccccccccccccccccccccccccccccccccccHHHHHHcccccccEEEEEHHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccEEEccccccEEEccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEccccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEcccccEEccccccccccccccccccHHHHHccccccccccccccEEHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccEEEcccccccccHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcccccHHHccccHHHHHHHHHHHHHHHcccccEEEEEEEcccccccEEEEEccccccccccHHcccccccHHHHHHHHHHHHccccEEEEEEEEEccccHHHHHHHHHHHHHHHHccccccccEccccccccccccccccEEEEEEcccccHHHHHcccccccccccccccccccEEEccccccccccccccccccEEEccccEEEEEEEcccccccEEccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHEcccccEEEEccccHHHHccccccccccccccEEcccHHHHHccccccEEEcHcHHHHHHEEEHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccccccccHHHHHHHHHHHHHccccccc
Coil and Loop (DISEMBL)
MAAALECWssrastdeDMVEQVLMRTNDRSEAVSAAAetssasatgkeYSSVVQKRFQRLSRNVSEAIASLKNtlnldsaptggvgvgardqptassnskietsrkVVWGSVVRnltqlypgsqlpeRLVSNMRKhydslplsyaqagfdMKEVFLHIKLIEqasgddrpaimiqevsddeaqgsVYKLTFAcnssiswpamsgalDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAikkpkptsvklpfglcgcqeentkgrdfgeieeeeacdesfrngvensnlkiqlqmplpsssfvvsvdewqtvqsGGEEIGRwllnsdnlefidqigpnsfkgvykgkrvgieklkgcdkgnaYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKlmeggsvndLILKSRKLQTKEIIRIAIDVAEGIKFLndhgvayrdlnsQRILldrhgnvclgdMGIVTACKSvgeateyetdgyrwlapeiiagdpesvseTWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAacglrpeipkdcPQILKSLMIkcwnnspskrpqFSEIISLLLRtnnisnssnr
Flexible Loop (DISEMBL)
maaalecwssrastdedMVEQVLMRTNDRSEAVSAaaetssasatgkeyssVVQKRFQRLSRNVSEAIASLkntlnldsaptggvgvgardqptassnskietsrkvvWGSVVRnltqlypgsqlpERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKsaikkpkptsvklpfglcgcqeentkgrdfgeIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGieklkgcdkgnAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISlllrtnnisnssnr
Low Complexity Region (SEG)
MAAALECWSSRASTDEDMVEQVLMRTNDRseavsaaaetssasatGKEYSSVVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Disordered region (IsUnstruct)
*********************************************************************************************************KVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASG***PAIMIQEV****AQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAG*************************KLPFGLCGC******************************************SSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC*********************CPQILKSLMIKCWNN********SEIISLLL***********
Disordered Region (DISOPRED)
***A*E*WSSRASTDEDMVE***********************************************IASLKNTL*********************************WGSVVR**T***********LVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQE***********************************************F*****************************************GLCGCQE**T***********************************************************WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL***********
Disordered Region (DISEMBL)
*****************MVEQVLMRTN**************************QKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVG***************SRKVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Disordered Region (DISPRO)
****************D****V*****************************VVQKRFQRLSRNVSEAIASLKNTLNLD**********************IETSRKVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDES**N***NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	604	2.2.26 [Sep-21-2011]
Q55GU0	916	Probable serine/threonine	yes	no	0.387	0.255	0.347	1e-34
Q55A09	1331	Probable serine/threonine	no	no	0.415	0.188	0.315	6e-34
Q2MHE4	390	Serine/threonine-protein	no	no	0.433	0.671	0.301	2e-32
Q7TQP6	835	Serine/threonine-protein	yes	no	0.503	0.364	0.306	6e-32
Q54I36	1338	Dual specificity protein	no	no	0.412	0.186	0.301	2e-31
P18161	1155	Dual specificity protein	no	no	0.408	0.213	0.301	2e-31
Q5GIG6	834	Serine/threonine-protein	yes	no	0.417	0.302	0.323	6e-31
Q59H18	835	Serine/threonine-protein	no	no	0.412	0.298	0.319	3e-30
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.415	0.154	0.313	2e-29
Q9ESL4	802	Mitogen-activated protein	no	no	0.410	0.309	0.320	2e-28

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  148 bits (374), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 132/242 (54%), Gaps = 8/242 (3%)

Query: 353 FKGVYKGKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
           +KG+++G  V I+++K   D  N    E RK+L  L    H NI+     C    + LC 
Sbjct: 677 YKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPN-LCF 735

Query: 412 VTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ + GGS+ D L  K  K+  +   ++AI +A+G+ +L+  GV +RD+ S  +LLD H
Sbjct: 736 ITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEH 795

Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
            NV + D G+ +  KS             W++PE++ G+      T   +VY+FG+++WE
Sbjct: 796 MNVKICDFGL-SKLKSKSTEMTKSIGSPIWMSPELLMGE----DYTEKVDVYAFGIILWE 850

Query: 531 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           + TGE  Y+    VQ A+ +    LRP IP   P  L  L+  CW+  P KRP F+EI++
Sbjct: 851 LGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILN 910

Query: 591 LL 592
           LL
Sbjct: 911 LL 912

Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  146 bits (368), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 147/273 (53%), Gaps = 22/273 (8%)

Query: 336  LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGC-DKGNAYEFELRKDLLELM-T 389
            ++N  +++   +IG   F    KG +KGK V ++KL    DK      +  K  +EL+ +
Sbjct: 1067 MINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFKAEVELLGS 1126

Query: 390  CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-------KSRKLQTKEIIRIAID 442
              H N++  Y   ++    +C+V + +  G++ +LI        +S KL +  I+ IA D
Sbjct: 1127 LQHPNLVTCYGYSLNP---MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFD 1183

Query: 443  VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 502
            +A G++ L+   + +RDL S  +L+D+H N+ + D+GI          T   T    W A
Sbjct: 1184 IARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMTTIGTVA--WTA 1241

Query: 503  PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 562
            PEI+  +    S    ++VYS+ +V++E++TGE  Y    P+ A + +A+ GLRPE+P +
Sbjct: 1242 PEILRHE----SYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDN 1297

Query: 563  CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT 595
            C    K L++ CW+  P+KRP F EI + L +T
Sbjct: 1298 CDPNWKKLVVWCWSEDPNKRPSFEEITNYLTKT 1330

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  141 bits (355), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 147/289 (50%), Gaps = 27/289 (9%)

Query: 318 SVDEWQTVQSGGEEIGRWLLNSDNL----EFIDQIGPNSFKGVYKGKRVGIEKLK----G 369
           +V+ W+  +   EE   W  +   L    +F        ++G+YK + V ++ ++     
Sbjct: 65  NVETWEASKGEREE---WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHK 121

Query: 370 CDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 429
            +     E + + ++  L    H NI+QF   C  +    C++T+ M  G++   + K  
Sbjct: 122 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGNLRMYLNKKE 180

Query: 430 K--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
              L  + ++R+A+D++ G+++L+  GV +RDL S  +LL+    V + D G  T+C   
Sbjct: 181 PYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFG--TSCL-- 236

Query: 488 GEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 543
            E    E  G    YRW+APE+I   P     T   +VYSFG+V+WE+ T    +   +P
Sbjct: 237 -ETQCREAKGNMGTYRWMAPEMIKEKPY----TRKVDVYSFGIVLWELTTALLPFQGMTP 291

Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           VQAA  +A    RP +P  C   L  L+ +CW+ +PSKRP FS I+++L
Sbjct: 292 VQAAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVL 340

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3

 Score =  139 bits (350), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 101/329 (30%), Positives = 167/329 (50%), Gaps = 25/329 (7%)

Query: 278 RDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWL 336
           + +   +EE  C+E  + G + S + +    P P         E   V     E+  R+ 
Sbjct: 402 KHYKRPQEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFH 457

Query: 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMT 389
           L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  L  
Sbjct: 458 LQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQ 515

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEG 446
             H  ++QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DVA+G
Sbjct: 516 LNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKG 573

Query: 447 IKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 503
           +++L+     + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW+AP
Sbjct: 574 MEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAP 633

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           E+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I    
Sbjct: 634 EVFT---QCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIGYSI 690

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P+ + SL+I+ WN  P  RP+FSE++S L
Sbjct: 691 PKPISSLLIRGWNACPEGRPEFSEVVSKL 719

May play a role in cardiac physiology.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1

 Score =  137 bits (346), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 140/265 (52%), Gaps = 16/265 (6%)

Query: 333  GRWLLNSDNLEFIDQIGP----NSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 388
            G+  +  D +  ++++G     N F G++ G +V I+ LK     N  +F   K++  L+
Sbjct: 1048 GKKEIKFDEVAIVEKVGAGSFANVFLGIWNGYKVAIKILKNESISNDEKF--IKEVSSLI 1105

Query: 389  TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGI 447
               H N++ F   C+D     C+ T+ ++GGS+ D++ ++  KL    + ++  D++ G+
Sbjct: 1106 KSHHPNVVTFMGACID---PPCIFTEYLQGGSLYDVLHIQKIKLNPLMMYKMIHDLSLGM 1162

Query: 448  KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
            + L+   + +RDL S+ ILLD   N+ + D G+ T      + T       RW +PE+  
Sbjct: 1163 EHLHSIQMLHRDLTSKNILLDEFKNIKIADFGLATTLSD--DMTLSGITNPRWRSPELTK 1220

Query: 508  GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
            G    +      +VYSFG+V++E+ TG+  +       +A   A    RP IP DCP  L
Sbjct: 1221 G----LVYNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSL 1276

Query: 568  KSLMIKCWNNSPSKRPQFSEIISLL 592
            + L+ KCW + PS+RP F+EI++ L
Sbjct: 1277 RKLITKCWASDPSQRPSFTEILTEL 1301

Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2

 Score =  137 bits (345), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 142/275 (51%), Gaps = 28/275 (10%)

Query: 335  WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
            ++++ ++++FI ++G  +F    +G +KG  V I+KLK       ++    +++  L   
Sbjct: 846  YIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKG 905

Query: 391  GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVA 444
             H+NI+ F   C       C++T+ M GGS+ +++          K     ++++A D+A
Sbjct: 906  NHQNIVMFIGACYKP---ACIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMA 962

Query: 445  EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
             G+  L+   + +RDL SQ ILLD  GN+ + D G+       G  T   T+G     RW
Sbjct: 963  LGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTM--TNGGICNPRW 1020

Query: 501  LAPEI---IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 557
              PE+   +    E V      +VY F +V+WE++TGE  ++     QA+  +A  GLRP
Sbjct: 1021 RPPELTKNLGHYSEKV------DVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRP 1074

Query: 558  EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             IP+ C   LK L+ +CW   P+ RP F+ I++ L
Sbjct: 1075 PIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4

 Score =  136 bits (342), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 146/272 (53%), Gaps = 20/272 (7%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 386
           R+ L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  
Sbjct: 454 RFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 511

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 443
           L    H  ++QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DV
Sbjct: 512 LCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDV 569

Query: 444 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
           A+G+++L+     + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW
Sbjct: 570 AKGMEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 629

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           +APE+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I 
Sbjct: 630 MAPEVFT---QCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIG 686

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              P+ + SL+++ WN  P  RP+FSE++  L
Sbjct: 687 YSIPKPISSLLMRGWNACPEGRPEFSEVVRKL 718

May play a role in cardiac physiology.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q59H18|TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3

 Score =  134 bits (336), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 145/269 (53%), Gaps = 20/269 (7%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 386
            + L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  
Sbjct: 455 HFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 512

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 443
           L    H  ++QF   C+++     +VT+ + GGS+  L+ + ++   LQ+K II  A+DV
Sbjct: 513 LCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDV 570

Query: 444 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
           A+G+++L++    + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW
Sbjct: 571 AKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 630

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           +APE+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I 
Sbjct: 631 MAPEVFT---QCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAAADMAYHHIRPPIG 687

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEII 589
              P+ + SL+I+ WN  P  RP+FSE++
Sbjct: 688 YSIPKPISSLLIRGWNACPEGRPEFSEVV 716

May play a role in cardiac physiology.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  131 bits (329), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 135/268 (50%), Gaps = 17/268 (6%)

Query: 334  RWLLNSDNLEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
            RW++N D +    QIG  S    F G +KG  V ++K            E R ++  L  
Sbjct: 1356 RWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSE 1415

Query: 390  CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGI 447
              H NI+ F   C+ +   +C+VT+ M  G++ D +LK+   K+     +++    A GI
Sbjct: 1416 LKHSNIVTFIGACI-KKPNICIVTEYMRMGNLRD-VLKNPDIKITFANKLKLLYGAAMGI 1473

Query: 448  KFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             +L+     + +RD+    IL+D H NV + D G     +     T   T    W APE+
Sbjct: 1474 DYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNTTMTRCGTPC--WTAPEV 1531

Query: 506  IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
            I G  E   E   ++V+SFG+V+WE++TG+  +A C+ ++ ++ I   G RP IP DCP 
Sbjct: 1532 IRG--EKYCEK--ADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGG-RPIIPSDCPH 1586

Query: 566  ILKSLMIKCWNNSPSKRPQFSEIISLLL 593
                L+ KCW+    KRP  +E++  L+
Sbjct: 1587 EFAKLIKKCWHAKAHKRPTMTEVVQQLM 1614

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ESL4|MLTK_MOUSE Mitogen-activated protein kinase kinase kinase MLT OS=Mus musculus GN=Mltk PE=1 SV=1

 Score =  127 bits (320), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           D+L+F +  G  SF  VY+ K +  +K     K      ++ K+   L    H+NI+QFY
Sbjct: 14  DDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKL----LKIEKEAEILSVLSHRNIIQFY 69

Query: 400 CVCVDE-NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG-- 454
            V ++  N+G  +VT+    GS+ D I  +R  ++  + I+  A DVA+G+ +L+     
Sbjct: 70  GVILEPPNYG--IVTEYASLGSLYDYINSNRSEEMDMEHIMTWATDVAKGMHYLHMEAPV 127

Query: 455 -VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPES 512
            V +RDL S+ +++   G + + D G   A +     T     G + W+APE+I   P  
Sbjct: 128 KVIHRDLKSRNVVIAADGVLKICDFG---ASRFHNHTTHMSLVGTFPWMAPEVIQSLP-- 182

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
           VSET   + YS+G+V+WEM+T E  +     +Q A  +     R  IP  CP+    L+ 
Sbjct: 183 VSET--CDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLH 240

Query: 573 KCWNNSPSKRPQFSEIISLLLRTNNISN 600
           +CW     KRP F +IIS+L   +N +N
Sbjct: 241 QCWEADAKKRPSFKQIISILESMSNDTN 268

Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Isoform 1, but not isoform 2, phosphorylates histone H3 at 'Ser-28'.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	604
255571340	609	protein kinase, putative [Ricinus commun	0.986	0.978	0.812	0.0
225434500	592	PREDICTED: cell surface receptor daf-1 [	0.951	0.971	0.828	0.0
449450836	585	PREDICTED: probable LIM domain-containin	0.958	0.989	0.724	0.0
356553098	590	PREDICTED: mitogen-activated protein kin	0.960	0.983	0.708	0.0
297793387	604	kinase family protein [Arabidopsis lyrat	0.978	0.978	0.724	0.0
15237684	604	protein kinase family protein [Arabidops	0.978	0.978	0.713	0.0
356500890	588	PREDICTED: focal adhesion kinase 1-like	0.955	0.981	0.714	0.0
10177030	591	unnamed protein product [Arabidopsis tha	0.956	0.978	0.696	0.0
356569502	580	PREDICTED: uncharacterized protein LOC10	0.948	0.987	0.677	0.0
356537583	582	PREDICTED: uncharacterized protein LOC10	0.951	0.987	0.685	0.0

>gi|255571340|ref|XP_002526619.1| protein kinase, putative [Ricinus communis] gi|223534059|gb|EEF35778.1| protein kinase, putative [Ricinus communis]

 Score = 1025 bits (2651), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 493/607 (81%), Positives = 547/607 (90%), Gaps = 11/607 (1%)

Query: 1   MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASAT------GKEYSSVVQ 54
           MAAALECWSSRASTDEDMVEQVLMRT DRSE+     +T+S+ ++          SS +Q
Sbjct: 1   MAAALECWSSRASTDEDMVEQVLMRTQDRSESTLLHQDTTSSLSSLNPVIKDPPSSSNMQ 60

Query: 55  KRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPT----ASSNSKIETSRKVVWG 110
           KR QRLSRNVSEAIASLKN+LNLDS     V    + Q       + ++K+E+ RKVVW 
Sbjct: 61  KRLQRLSRNVSEAIASLKNSLNLDSPRGDSVLQLQQQQQQLPLQVNGSTKVESCRKVVWA 120

Query: 111 SVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRP 170
            VVRNLTQLYPGSQLPE+LVSN+RKHYDSLPLSYAQAGFDMK+VFLHIKLIEQAS D++P
Sbjct: 121 GVVRNLTQLYPGSQLPEKLVSNIRKHYDSLPLSYAQAGFDMKDVFLHIKLIEQASVDEQP 180

Query: 171 AIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVI 230
           AIMIQEVSDDE QGSV+KLTFACNS ISWPAMSGALD ASICCKKIQIFEKKGFTL V++
Sbjct: 181 AIMIQEVSDDEVQGSVFKLTFACNSLISWPAMSGALDNASICCKKIQIFEKKGFTLAVIL 240

Query: 231 LAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACD 290
           L VQAG EKSFK++IENALK+AIKKPK T+VKLPFGLCGCQEENT+GRDFGEIEE+   +
Sbjct: 241 LLVQAGHEKSFKNRIENALKNAIKKPKQTTVKLPFGLCGCQEENTRGRDFGEIEEDPN-E 299

Query: 291 ESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGP 350
            S+RNG EN N+KIQL+MPLP+SSFVVS+DEWQT+QSGG+EIG+WLLNSDNLEF+DQIGP
Sbjct: 300 LSYRNGTENLNVKIQLEMPLPTSSFVVSIDEWQTMQSGGDEIGKWLLNSDNLEFVDQIGP 359

Query: 351 NSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410
           NSFKGVYKGKRVGIEKLKGCDKGNAY+FELRKDLLELMTCGHKN+LQFY VCVDENHGLC
Sbjct: 360 NSFKGVYKGKRVGIEKLKGCDKGNAYDFELRKDLLELMTCGHKNVLQFYGVCVDENHGLC 419

Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           VVTKLMEGGSV+DL+LK++KLQTKEIIRIA+D+AEGIKF+NDHGVAYRDLN+QRILLDRH
Sbjct: 420 VVTKLMEGGSVSDLMLKNKKLQTKEIIRIAVDIAEGIKFMNDHGVAYRDLNTQRILLDRH 479

Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           GN CLGDMGIVTACKS+GEA EYETDGYRWLAPEIIAGDPESV+ETWMSNVYSFGMVIWE
Sbjct: 480 GNACLGDMGIVTACKSMGEAMEYETDGYRWLAPEIIAGDPESVTETWMSNVYSFGMVIWE 539

Query: 531 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           MVTGEAAYAACSPVQAAVGIAACGLRP+IPKDCPQILKSLM KCWNN PSKRPQFSEI+S
Sbjct: 540 MVTGEAAYAACSPVQAAVGIAACGLRPDIPKDCPQILKSLMTKCWNNCPSKRPQFSEILS 599

Query: 591 LLLRTNN 597
           +LLR +N
Sbjct: 600 ILLRFSN 606

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225434500|ref|XP_002275567.1| PREDICTED: cell surface receptor daf-1 [Vitis vinifera] gi|297745851|emb|CBI15907.3| unnamed protein product [Vitis vinifera]

 Score = 1000 bits (2586), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 492/594 (82%), Positives = 538/594 (90%), Gaps = 19/594 (3%)

Query: 1   MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
           MAAALECWSSRASTDEDMVEQVLMRT DRSE +       ++S  G + SS +QKR QRL
Sbjct: 1   MAAALECWSSRASTDEDMVEQVLMRTQDRSEGLP-----ENSSGAGVKESSAMQKRLQRL 55

Query: 61  SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
           SRNVSEAIASLKN+LNLDS          RD P     SKIE+ RK+VWG VVRNLTQLY
Sbjct: 56  SRNVSEAIASLKNSLNLDSP---------RDPPA----SKIESCRKLVWGGVVRNLTQLY 102

Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
           PGSQLPE+LVSN+RKHYDSLPLSYAQAGFDMK+VFLHI++IEQAS DD PAI+IQEVSDD
Sbjct: 103 PGSQLPEKLVSNIRKHYDSLPLSYAQAGFDMKDVFLHIRMIEQASVDDHPAILIQEVSDD 162

Query: 181 EAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKS 240
           E QGSV+KLTFACNSSISWPAMSGALD+ASICCKKIQIFEKKGFTLG+++L VQAGQEKS
Sbjct: 163 EIQGSVFKLTFACNSSISWPAMSGALDSASICCKKIQIFEKKGFTLGIILLLVQAGQEKS 222

Query: 241 FKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENS 300
           F+++IENALK AIKK KPT+VKLPFGLCGCQEENTKGR+ GEIEEE   +   RNG++NS
Sbjct: 223 FQNRIENALKFAIKKSKPTTVKLPFGLCGCQEENTKGREVGEIEEEGG-EPHHRNGIDNS 281

Query: 301 NLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK 360
           N K+QLQMPLP+SSFVVSVDEWQTVQSGGEEIG+WLLNSDNLEF+DQIGPNSFKGVYKGK
Sbjct: 282 NTKVQLQMPLPTSSFVVSVDEWQTVQSGGEEIGKWLLNSDNLEFVDQIGPNSFKGVYKGK 341

Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
           RVGIEKLKGCDKGN+YEFELRKDLLELMTCGHKNILQF+ VCVDENHGLCVVTKLMEGGS
Sbjct: 342 RVGIEKLKGCDKGNSYEFELRKDLLELMTCGHKNILQFFGVCVDENHGLCVVTKLMEGGS 401

Query: 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
           V+D+ILK++K Q KEIIRIAIDVAEGIKF+NDHGVAYRDLN+QR+LLDRHGN CLGDMGI
Sbjct: 402 VHDVILKNKKFQNKEIIRIAIDVAEGIKFMNDHGVAYRDLNTQRVLLDRHGNACLGDMGI 461

Query: 481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           VTACKSVGEA EYETDGYRWLAPEIIAGDPESV+ET MSNVYSFGMV+WEMVTGEAAY+A
Sbjct: 462 VTACKSVGEAMEYETDGYRWLAPEIIAGDPESVTETLMSNVYSFGMVLWEMVTGEAAYSA 521

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
            SPVQAAVGIAACGLRPEIPKDCPQIL+SLM KCWNN PSKRPQFSEI+S+LLR
Sbjct: 522 YSPVQAAVGIAACGLRPEIPKDCPQILRSLMTKCWNNCPSKRPQFSEILSILLR 575

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450836|ref|XP_004143168.1| PREDICTED: probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001-like [Cucumis sativus]

 Score =  902 bits (2330), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/599 (72%), Positives = 507/599 (84%), Gaps = 20/599 (3%)

Query: 1   MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
           MA ALECWSSRASTDEDMVEQVLMRT DRSE     ++  S+ A G++ SS + +R QR 
Sbjct: 1   MATALECWSSRASTDEDMVEQVLMRTQDRSEG----SKPDSSFAVGEKESSAMHRRLQRF 56

Query: 61  SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
           SRNVSEA+ASLKN+LNLDS          RD     S ++ E S+K VWG+VVRNLTQLY
Sbjct: 57  SRNVSEAVASLKNSLNLDSI---------RD----PSPTRTEGSKKAVWGTVVRNLTQLY 103

Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
           PGSQLPE+LVSN+RKHYDSLPLSYA AGFDMK+VFLHIKL+EQAS  D PAI+ QEV++ 
Sbjct: 104 PGSQLPEKLVSNIRKHYDSLPLSYALAGFDMKDVFLHIKLMEQASVYDHPAILFQEVTNR 163

Query: 181 EAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKS 240
           + Q  + K TFACNSS+SW AMSGAL+TA+I C+KIQIFEKK FTLGV++      QEK 
Sbjct: 164 DVQKPIIKFTFACNSSVSWSAMSGALETAAIRCEKIQIFEKKKFTLGVILFVNLDLQEKL 223

Query: 241 FKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENS 300
           FKS++ENALK AIKKPK T+VKLPFG CGCQE NT G+D  E EE+   + + R+G ENS
Sbjct: 224 FKSKVENALKLAIKKPKTTAVKLPFGFCGCQEGNTGGKDLRETEED-GVEPNCRSGFENS 282

Query: 301 NL--KIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
           NL   +Q++MPL +SSF V+VDEWQT+QSGG E+G+WLL+S+NLEF+DQ+GPNSFKGVYK
Sbjct: 283 NLSENLQIEMPLCTSSFAVTVDEWQTIQSGGNELGKWLLSSENLEFVDQMGPNSFKGVYK 342

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418
           G+RV IEK+KGC+KG +Y+FELRKDLLELMTCGHKNIL FY VC+DENHGLCVVTKLMEG
Sbjct: 343 GRRVAIEKIKGCEKGVSYKFELRKDLLELMTCGHKNILMFYGVCIDENHGLCVVTKLMEG 402

Query: 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
           GSV++L+LK++KLQTKEI RIAID+ EGIKF+NDHGVAYRDLN+QRILLD++GN CLGDM
Sbjct: 403 GSVHELMLKNKKLQTKEITRIAIDIVEGIKFMNDHGVAYRDLNTQRILLDKNGNACLGDM 462

Query: 479 GIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           GI+TACK++GEA EYETDGYRWLAPEIIAGDPESV+ETWMSNVYS GMVIWEMVTGEAAY
Sbjct: 463 GILTACKNLGEAMEYETDGYRWLAPEIIAGDPESVNETWMSNVYSLGMVIWEMVTGEAAY 522

Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
            A SPVQAAVGIAACGLRP++PKDC   LKSLMI+CWNN PSKRPQFSEI+SLLL +NN
Sbjct: 523 GAYSPVQAAVGIAACGLRPDVPKDCSSTLKSLMIRCWNNCPSKRPQFSEILSLLLDSNN 581

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553098|ref|XP_003544895.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Glycine max]

 Score =  884 bits (2284), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/604 (70%), Positives = 503/604 (83%), Gaps = 24/604 (3%)

Query: 1   MAAALECWSSRASTDEDM------VEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQ 54
           MAAALECWSSR +           VEQVLMRT+ RSE  +  +  ++ +      +  V 
Sbjct: 1   MAAALECWSSRTTAAAATSTDDDTVEQVLMRTHHRSEGTTTTSTPNNNNNKDPSSAIPVH 60

Query: 55  KRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVR 114
           K+ Q+L+RNVSEAIAS +N+LNLDS P               S+    +SRK+ WGSVVR
Sbjct: 61  KKLQKLTRNVSEAIASFRNSLNLDSPP---------------SSKADASSRKLAWGSVVR 105

Query: 115 NLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMI 174
           NLTQLYPGSQLPE+L+SN+RKHYDSLPLSYAQA FDMK+VFLHIKL+EQAS  D+PAI+I
Sbjct: 106 NLTQLYPGSQLPEKLMSNIRKHYDSLPLSYAQAEFDMKDVFLHIKLMEQASESDQPAILI 165

Query: 175 QEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQ 234
           QE  D E QGS  +LTFACNS ISWPAMSGALD++SICCK++QIFEKKGFTLGVV+L VQ
Sbjct: 166 QEECDYEVQGSALRLTFACNSPISWPAMSGALDSSSICCKRMQIFEKKGFTLGVVLLVVQ 225

Query: 235 AGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFR 294
           +G +K  ++++E+ALK A+K+PK  +VKLPFGLCGCQEEN+KG D  EIEEE    + +R
Sbjct: 226 SGHDKLVRTRVESALKFAMKRPKTGAVKLPFGLCGCQEENSKGGDLVEIEEE--ISDGYR 283

Query: 295 NG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF 353
               ENS  +IQLQ+PLPSSSFVVSVDEWQT++SGG+EI +WLLNSD++EF++QIGPNSF
Sbjct: 284 GKEFENSGQRIQLQVPLPSSSFVVSVDEWQTIKSGGDEIEKWLLNSDSVEFVEQIGPNSF 343

Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413
           KGVY GKRV IEKLKGCDKGN+YEFEL KDLLELMTCGH+NILQF  +CVD+NHGLCVVT
Sbjct: 344 KGVYLGKRVKIEKLKGCDKGNSYEFELHKDLLELMTCGHRNILQFCGICVDDNHGLCVVT 403

Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
           K MEGGSV+DL++K++KLQTK+I+RIA+DVAEGIKF+NDHGVAYRDLN+ RILLDRHGN 
Sbjct: 404 KFMEGGSVHDLMMKNKKLQTKDIVRIAVDVAEGIKFMNDHGVAYRDLNTPRILLDRHGNA 463

Query: 474 CLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           CLGDMGIVTACKSVGEA EYETDGYRWLAPEIIAGDPE+V+ETWMSNVYSFGMVIWEMVT
Sbjct: 464 CLGDMGIVTACKSVGEAMEYETDGYRWLAPEIIAGDPENVTETWMSNVYSFGMVIWEMVT 523

Query: 534 GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
           GE AY++ SPVQAAVGIAACGLRPEIPKDC Q LK +M KCWNN+PSKRP FSEI+++LL
Sbjct: 524 GETAYSSFSPVQAAVGIAACGLRPEIPKDCQQTLKYIMTKCWNNNPSKRPHFSEILAILL 583

Query: 594 RTNN 597
           R NN
Sbjct: 584 RPNN 587

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297793387|ref|XP_002864578.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310413|gb|EFH40837.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  882 bits (2280), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/603 (72%), Positives = 504/603 (83%), Gaps = 12/603 (1%)

Query: 1   MAAALECWSSRAST----DEDMVEQVLMRTNDRSEA-VSAAAETS----SASATGKEYSS 51
           MAAALECWSSRA      D+D+V+QVLMRT+DRSE+ +++  ETS     ++A   + SS
Sbjct: 1   MAAALECWSSRAGGGGGPDDDLVDQVLMRTHDRSESLITSLPETSLEVEGSTAGFDQSSS 60

Query: 52  VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
            +QKRFQRLSRNVSEAIASLKN+LNLDSA      VG    P A         RK+VW +
Sbjct: 61  AMQKRFQRLSRNVSEAIASLKNSLNLDSARDNQT-VGGATTPKAEVGGG-GGGRKLVWAT 118

Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
           VVRNL ++YPGSQLPE+LVSN++KHYDSLP SY+QA  DMKEVFLH+KLIEQASGDD P 
Sbjct: 119 VVRNLARMYPGSQLPEKLVSNLKKHYDSLPFSYSQADLDMKEVFLHVKLIEQASGDDNPV 178

Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
            MIQEVS +E +GSV +LTFACNSS+SW  MSGALD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSAEEPRGSVLRLTFACNSSLSWSTMSGALDSASICCKKIQIFEKKGLTLGVVLL 238

Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
             Q+GQ   FK+++ENALK A KKPKPTSVKLPFGLCGCQE+N    +     EEE+   
Sbjct: 239 LDQSGQHNFFKTRVENALKVATKKPKPTSVKLPFGLCGCQEQNGGVGE-LGGVEEESIQH 297

Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
           S R G+EN N  IQL +PL SSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP 
Sbjct: 298 SNRLGIENLNSTIQLHIPLLSSSFAVSVDEWQTIQSGGSEIGKWLLNSDSFEFGDQIGPT 357

Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
           SFKG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SFKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417

Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
           VTKLMEGGS+++L+LKS+KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKSKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477

Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
           N CLGD+GIVTACKS GEA EYETDGYRWLAPEIIAGDPE+ +ETWMSN YSFGMV+WEM
Sbjct: 478 NACLGDIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDPENTTETWMSNAYSFGMVLWEM 537

Query: 532 VTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
           VTGEAAYA+CSPVQAAVGIAACGLRP+IPK+CPQ L +LMI CWNNSPSKRP FS I + 
Sbjct: 538 VTGEAAYASCSPVQAAVGIAACGLRPDIPKECPQALGTLMINCWNNSPSKRPNFSHIHNT 597

Query: 592 LLR 594
           LLR
Sbjct: 598 LLR 600

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15237684|ref|NP_200660.1| protein kinase family protein [Arabidopsis thaliana] gi|110738981|dbj|BAF01411.1| protein kinase like protein [Arabidopsis thaliana] gi|332009679|gb|AED97062.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  875 bits (2261), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/603 (71%), Positives = 498/603 (82%), Gaps = 12/603 (1%)

Query: 1   MAAALECWSSRAS----TDEDMVEQVLMRTNDRSEAVSAAAETSSASATGK-----EYSS 51
           MAAALECWSSRA      D D+V+QVLMRT+DRSE+V  +   +S    G      + SS
Sbjct: 1   MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60

Query: 52  VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
            +QKRFQRLSRNVSEAI SLKNTLNLDSA       GA       S       RK+VW +
Sbjct: 61  AMQKRFQRLSRNVSEAIVSLKNTLNLDSARDNQSFGGAMTPKAEVSGGG--GGRKLVWAT 118

Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
           VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P 
Sbjct: 119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178

Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
            MIQEVS +E +GSV +LTFACNS +SW  MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238

Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
             Q+GQ   FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N    +     EEE+   
Sbjct: 239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGEL-GGVEEESIQH 297

Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
           S R G+EN N  IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP 
Sbjct: 298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357

Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
           S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417

Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
           VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477

Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
           N CLG++GIVTACKS GEA EYETDGYRWLAPEIIAGDPE+ +ETWMSN YSFGMV+WEM
Sbjct: 478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDPENTTETWMSNAYSFGMVLWEM 537

Query: 532 VTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
           VTGEAAYA+CSPVQAAVGIAACGLRPEIPK+CPQ+L++LMI CWNNSPSKRP FS I + 
Sbjct: 538 VTGEAAYASCSPVQAAVGIAACGLRPEIPKECPQVLRTLMINCWNNSPSKRPNFSHIHNT 597

Query: 592 LLR 594
           LLR
Sbjct: 598 LLR 600

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500890|ref|XP_003519263.1| PREDICTED: focal adhesion kinase 1-like [Glycine max]

 Score =  872 bits (2252), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/605 (71%), Positives = 508/605 (83%), Gaps = 28/605 (4%)

Query: 1   MAAALECWSSRASTDEDM------VEQVLMRTNDRSEAVSAAAETSSASATGKEYSSV-V 53
           MAAALECWSSR +T          VEQVLMRT+ RSE  +    TS+ +      S++ V
Sbjct: 1   MAAALECWSSRTTTSAAAATDDDTVEQVLMRTHHRSEGTTT---TSTHNNKDNLPSAIPV 57

Query: 54  QKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVV 113
            K+ Q+L+RNVSEAIAS +N+LNLDS P              SSN+   +SRK+ WGSVV
Sbjct: 58  HKKLQKLTRNVSEAIASFRNSLNLDSPP--------------SSNADA-SSRKLAWGSVV 102

Query: 114 RNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIM 173
           RNLTQLYPGSQLPE+L+SN+RKHYDSLPLSYAQA FDMK VFLHIKL+EQAS  D+PAI+
Sbjct: 103 RNLTQLYPGSQLPEKLMSNIRKHYDSLPLSYAQAEFDMKNVFLHIKLMEQASESDQPAIL 162

Query: 174 IQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAV 233
           IQE  D E QGS  +LTFACNS ISWPAMSGALD++SICCK++QIFEKKGFTLGVV+L V
Sbjct: 163 IQEECDGEIQGSALRLTFACNSPISWPAMSGALDSSSICCKRMQIFEKKGFTLGVVLLVV 222

Query: 234 QAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESF 293
             G +K  ++++ENALK A+KKPK  +VKLPFGLCGCQEEN+KGR+  EIEEE    + +
Sbjct: 223 LPGHDKLVRTRVENALKFAMKKPKTGAVKLPFGLCGCQEENSKGRELVEIEEETG--DGY 280

Query: 294 RNG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNS 352
           R    ENS+ +IQLQ+PLPSSSFVVSVDEWQT++SGG EI +WLLNSD++EF++QIGPNS
Sbjct: 281 RGKEFENSSQRIQLQVPLPSSSFVVSVDEWQTIKSGGNEIEKWLLNSDSVEFVEQIGPNS 340

Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412
           ++GVY GKRVGIEKLKGCDKGN+YEFEL KDLLELMTCGH+NILQF  +CVD+NHGLCVV
Sbjct: 341 YRGVYMGKRVGIEKLKGCDKGNSYEFELHKDLLELMTCGHRNILQFCGICVDDNHGLCVV 400

Query: 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
           TK MEGGSV+DL++K++KLQTK+++RIA+DVAEGIKF+NDHGVAYRDLN++ ILLD+HGN
Sbjct: 401 TKFMEGGSVHDLMMKNKKLQTKDVVRIAVDVAEGIKFMNDHGVAYRDLNTRGILLDKHGN 460

Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
            CLGDMGIVTACKSVGEA EYETDGYRWLAPEIIAGDPE+V+ETWMSNVYSFGMVIWEMV
Sbjct: 461 ACLGDMGIVTACKSVGEAMEYETDGYRWLAPEIIAGDPENVTETWMSNVYSFGMVIWEMV 520

Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           TGEAAY++ SPVQAAVGIAACGLRPEIPKDC Q LK +M KCWNN+PSKRP FSEI+++L
Sbjct: 521 TGEAAYSSFSPVQAAVGIAACGLRPEIPKDCQQTLKHIMTKCWNNTPSKRPHFSEILAIL 580

Query: 593 LRTNN 597
           LR NN
Sbjct: 581 LRPNN 585

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|10177030|dbj|BAB10268.1| unnamed protein product [Arabidopsis thaliana]

 Score =  843 bits (2177), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/603 (69%), Positives = 486/603 (80%), Gaps = 25/603 (4%)

Query: 1   MAAALECWSSRAS----TDEDMVEQVLMRTNDRSEAVSAAAETSSASATGK-----EYSS 51
           MAAALECWSSRA      D D+V+QVLMRT+DRSE+V  +   +S    G      + SS
Sbjct: 1   MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60

Query: 52  VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
            +QKRFQRLSRNVSEAI SLKNTLNLDSA       GA       S       RK+VW +
Sbjct: 61  AMQKRFQRLSRNVSEAIVSLKNTLNLDSARDNQSFGGAMTPKAEVSGGG--GGRKLVWAT 118

Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
           VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P 
Sbjct: 119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178

Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
            MIQEVS +E +GSV +LTFACNS +SW  MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238

Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
             Q+GQ   FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N    +     EEE+   
Sbjct: 239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGEL-GGVEEESIQH 297

Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
           S R G+EN N  IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP 
Sbjct: 298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357

Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
           S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417

Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
           VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477

Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
           N CLG++GIVTACKS GEA EYETDGYRWLAPE             MSN YSFGMV+WEM
Sbjct: 478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPE-------------MSNAYSFGMVLWEM 524

Query: 532 VTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
           VTGEAAYA+CSPVQAAVGIAACGLRPEIPK+CPQ+L++LMI CWNNSPSKRP FS I + 
Sbjct: 525 VTGEAAYASCSPVQAAVGIAACGLRPEIPKECPQVLRTLMINCWNNSPSKRPNFSHIHNT 584

Query: 592 LLR 594
           LLR
Sbjct: 585 LLR 587

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569502|ref|XP_003552939.1| PREDICTED: uncharacterized protein LOC100811417 [Glycine max]

 Score =  835 bits (2158), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/601 (67%), Positives = 489/601 (81%), Gaps = 28/601 (4%)

Query: 1   MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
           MAAALECWS RA+T       +LM+  ++        +T+   ++    SS+V K+ Q+L
Sbjct: 1   MAAALECWSRRATTTVHEDHALLMQRPEQ--------DTTPRDSSSSSSSSLVHKKLQKL 52

Query: 61  SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
           +RNVSEAIASLKN+LN                     +SK++  R +VW +V+RNLT LY
Sbjct: 53  TRNVSEAIASLKNSLN---------------STINVESSKLDGPRSLVWTTVLRNLTHLY 97

Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
           PGSQLPE+LV N+RKHYDSLPLSY+QAGFD+K+VFLH+KL+EQA  D++ AI+IQE  D 
Sbjct: 98  PGSQLPEKLVCNIRKHYDSLPLSYSQAGFDVKDVFLHMKLMEQALEDEQAAILIQEECDG 157

Query: 181 EAQ--GSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAG-- 236
           E Q  GSV+KLTFACNS ISWP MSGALD  SICCKKIQIFEKKGFTLG+V+L V +G  
Sbjct: 158 EIQLQGSVFKLTFACNSPISWPLMSGALDGYSICCKKIQIFEKKGFTLGIVLLLVLSGGG 217

Query: 237 QEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNG 296
           Q+K  ++++E+ALK A+K+ K   VKLPFGLCGCQEEN+KGR  GEIEE+   D    NG
Sbjct: 218 QDKLVRTRVESALKIAMKRLKTGGVKLPFGLCGCQEENSKGRGLGEIEEDGG-DAYCGNG 276

Query: 297 VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGV 356
            EN +  IQL++PLPSSSF+V +DEWQT+QSGG+EI +WLLNSD+LEF++QI PNS+KG 
Sbjct: 277 FENLSQNIQLRVPLPSSSFLVVIDEWQTIQSGGDEIEKWLLNSDSLEFVEQIAPNSYKGT 336

Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y GKRVGIEKL+GC+KGN+YEFELRKDLL LMTCGH+NI+QF  VCVD+NHGLC VTK +
Sbjct: 337 YMGKRVGIEKLRGCEKGNSYEFELRKDLLALMTCGHRNIMQFCGVCVDDNHGLCAVTKFV 396

Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           EGGSV+DL+LK++KL +K+++RIA DVAEGIKF+NDHGVAY DLN+QRILLD+HGN CLG
Sbjct: 397 EGGSVHDLMLKNKKLSSKDVVRIAADVAEGIKFMNDHGVAYGDLNTQRILLDKHGNACLG 456

Query: 477 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
           DMGIVTACKSV EA +YETDGYRWLAPEIIAGDPESV+ETWMSNVYSFGMVIWEMVTGEA
Sbjct: 457 DMGIVTACKSVREAIDYETDGYRWLAPEIIAGDPESVTETWMSNVYSFGMVIWEMVTGEA 516

Query: 537 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN 596
           AY+A SPVQAAVGIAACGLRPEIPKDCPQ LKSLM KCWNN+PSKRP FSEI+++LLR +
Sbjct: 517 AYSAFSPVQAAVGIAACGLRPEIPKDCPQTLKSLMTKCWNNTPSKRPHFSEILAILLRPS 576

Query: 597 N 597
           N
Sbjct: 577 N 577

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356537583|ref|XP_003537306.1| PREDICTED: uncharacterized protein LOC100819097 [Glycine max]

 Score =  833 bits (2152), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/601 (68%), Positives = 495/601 (82%), Gaps = 26/601 (4%)

Query: 1   MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
           MAAALECWS RA+T  D    VLM+  ++   +    ++SS        SS+V K+ Q+L
Sbjct: 1   MAAALECWSRRATTTVDEDHAVLMQPPEQDPTIPQPRDSSS--------SSIVHKKLQKL 52

Query: 61  SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
           +RNVSEAIASLKN+LN  S               +  +SK +  R +VW +V+R+L  LY
Sbjct: 53  TRNVSEAIASLKNSLNSSST-------------VSVESSKPDAPRSLVWTTVLRHLIHLY 99

Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
           PGSQLPE+LV N+RKHYDSLPLSY++AGF++K+VFLH+KL+EQA  D++ AI+IQE  DD
Sbjct: 100 PGSQLPEKLVCNIRKHYDSLPLSYSKAGFEVKDVFLHMKLMEQALEDEQAAILIQEECDD 159

Query: 181 EAQ--GSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAG-- 236
           E Q  GSV+KLTFACNS ISWPAMSGALD  SICCKKIQIFEKK FTLG+V+L V +G  
Sbjct: 160 EIQLQGSVFKLTFACNSPISWPAMSGALDAYSICCKKIQIFEKKCFTLGIVLLLVLSGGG 219

Query: 237 QEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNG 296
           Q+K  ++++E+ALK A+K+PK   VKLPFGLCGCQEEN+KGR  GEIEE+   D    NG
Sbjct: 220 QDKLVRTRVESALKIAMKRPKAGGVKLPFGLCGCQEENSKGRRLGEIEED-GWDAYCGNG 278

Query: 297 VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGV 356
            EN + KI+LQ+PLPSSSF+V VDEWQT+QSGG EI +WLLNSD+LEF++QI PNS+KG 
Sbjct: 279 FENLSQKIELQVPLPSSSFLVVVDEWQTIQSGGAEIEKWLLNSDSLEFVEQIAPNSYKGT 338

Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y GK+VGIEKL+GC+KGN+YEFELRKDLL LMTCGH+NI+QF  VCVD+NHGLCVVTK +
Sbjct: 339 YMGKKVGIEKLRGCEKGNSYEFELRKDLLALMTCGHRNIMQFCGVCVDDNHGLCVVTKFV 398

Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           EGGSV+DL+LK++KL +K+I+RIA DVAEGIKF NDHGVAYRDLN+QRILLD+HGN CLG
Sbjct: 399 EGGSVHDLMLKNKKLPSKDIVRIAADVAEGIKFKNDHGVAYRDLNTQRILLDKHGNACLG 458

Query: 477 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
           DMGIVTACK+VGEA +YETDGYRWLAPEIIAGDPESV+ETWMSNVYSFGMVIWEMVTGEA
Sbjct: 459 DMGIVTACKNVGEAMDYETDGYRWLAPEIIAGDPESVTETWMSNVYSFGMVIWEMVTGEA 518

Query: 537 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN 596
           AY+A SPVQAAVGIAACGLRPEIPKDCPQ LKSLM +CWNN+PSKRP FSEI+++LLR++
Sbjct: 519 AYSAFSPVQAAVGIAACGLRPEIPKDCPQTLKSLMTRCWNNTPSKRPNFSEILAILLRSS 578

Query: 597 N 597
           N
Sbjct: 579 N 579

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	604
TAIR|locus:2171213	604	AT5G58520 [Arabidopsis thalian	0.978	0.978	0.708	2.5e-232
TAIR|locus:2182905	583	AT5G07140 [Arabidopsis thalian	0.955	0.989	0.651	2.6e-212
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.385	0.408	0.355	8.9e-41
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.413	0.457	0.347	2.6e-40
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.481	0.506	0.335	2.6e-40
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.387	0.567	0.337	4.2e-34
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.399	0.459	0.323	5.2e-32
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.387	0.569	0.317	1.6e-31
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.413	0.272	0.332	3.8e-31
RGD|727908	835	Tnni3k "TNNI3 interacting kina	0.493	0.356	0.312	4.2e-30

TAIR|locus:2171213 AT5G58520 [Arabidopsis thaliana (taxid:3702)]

 Score = 2241 (793.9 bits), Expect = 2.5e-232, P = 2.5e-232
 Identities = 427/603 (70%), Positives = 494/603 (81%)

Query:     1 MAAALECWSSRAST----DEDMVEQVLMRTNDRXXXXXXXXXXXXXXXXGK-----EYSS 51
             MAAALECWSSRA      D D+V+QVLMRT+DR                G      + SS
Sbjct:     1 MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60

Query:    52 VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
              +QKRFQRLSRNVSEAI SLKNTLNLDSA       G    P A  +      RK+VW +
Sbjct:    61 AMQKRFQRLSRNVSEAIVSLKNTLNLDSA-RDNQSFGGAMTPKAEVSGG-GGGRKLVWAT 118

Query:   112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
             VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P 
Sbjct:   119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178

Query:   172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
              MIQEVS +E +GSV +LTFACNS +SW  MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct:   179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238

Query:   232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
               Q+GQ   FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N    + G +EEE +   
Sbjct:   239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGELGGVEEE-SIQH 297

Query:   292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
             S R G+EN N  IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP 
Sbjct:   298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357

Query:   352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
             S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct:   358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417

Query:   412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
             VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct:   418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477

Query:   472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
             N CLG++GIVTACKS GEA EYETDGYRWLAPEIIAGDPE+ +ETWMSN YSFGMV+WEM
Sbjct:   478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDPENTTETWMSNAYSFGMVLWEM 537

Query:   532 VTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
             VTGEAAYA+CSPVQAAVGIAACGLRPEIPK+CPQ+L++LMI CWNNSPSKRP FS I + 
Sbjct:   538 VTGEAAYASCSPVQAAVGIAACGLRPEIPKECPQVLRTLMINCWNNSPSKRPNFSHIHNT 597

Query:   592 LLR 594
             LLR
Sbjct:   598 LLR 600

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2182905 AT5G07140 [Arabidopsis thaliana (taxid:3702)]

 Score = 2052 (727.4 bits), Expect = 2.6e-212, P = 2.6e-212
 Identities = 388/596 (65%), Positives = 475/596 (79%)

Query:     1 MAAALECWSSRASTDEDMVEQVLMRTNDRXXXXXXXXXXXXXXXXGKEYSSVVQKRFQRL 60
             MA+ALECW++R +      +  + +                      + SS +QKRFQRL
Sbjct:     1 MASALECWTTRNAAGGCADDDFVDQV---LMSSEDRSESLTAPPPSDQTSSAMQKRFQRL 57

Query:    61 SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
              RNVS+AIASLKN+LNLDS+         RD   A++       RK+VW +VVRNL ++Y
Sbjct:    58 GRNVSDAIASLKNSLNLDSS---------RDNQNAATGG----GRKLVWATVVRNLAKMY 104

Query:   121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
             PGSQLP++LVSN+RKHYDSLPLSY+Q GFDMK+VF+HIKLIEQA GDD P  +IQEV D+
Sbjct:   105 PGSQLPDKLVSNLRKHYDSLPLSYSQTGFDMKDVFVHIKLIEQAFGDDNPVFVIQEVCDE 164

Query:   181 EA--QGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQE 238
             EA  QGSV+KLTFAC  S+ W  +SG+LD A ICCKK+QIFEKKG TLGVV+L V++GQE
Sbjct:   165 EADDQGSVFKLTFACTCSLPWSTISGSLDGALICCKKVQIFEKKGLTLGVVLLLVESGQE 224

Query:   239 KSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVE 298
             K FK ++ NAL+SA++KPK TSVKLPFGLCGC+E+N    +FG+++ E + D+ +R+ ++
Sbjct:   225 KMFKVKVVNALRSAVRKPKSTSVKLPFGLCGCEEQNAGVGEFGDVDVE-SIDQCYRHELD 283

Query:   299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
             + N +IQLQMP PSSSF VSVDEWQT+QSGG++I +WLLNSD+LEF  Q+GPNSFKGVY+
Sbjct:   284 DLNTRIQLQMPPPSSSFSVSVDEWQTIQSGGDDIRKWLLNSDDLEFSGQLGPNSFKGVYR 343

Query:   359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418
             G +V IEKLKGC+KGN+YEF +RKD LELMTCGHK+ILQFY VC+DENHGLCVVTKLM+G
Sbjct:   344 GTKVAIEKLKGCEKGNSYEFAIRKDFLELMTCGHKSILQFYGVCIDENHGLCVVTKLMQG 403

Query:   419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
             GS+ +L+LK +KLQTK I +IA+D+AEG+KF+NDHGVAYRDLN+QRILLD+  N CLGD+
Sbjct:   404 GSLRELVLKKKKLQTKLIFQIAVDIAEGMKFINDHGVAYRDLNTQRILLDKQCNACLGDL 463

Query:   479 GIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
             GIVTACKSV EA EYETDGYRWLAPEIIAGDPE   E+WMSN YSFGMV+WEMVTGE AY
Sbjct:   464 GIVTACKSVNEAMEYETDGYRWLAPEIIAGDPEKTRESWMSNAYSFGMVLWEMVTGEEAY 523

Query:   539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
              +CSPVQAAVGIAACGLRP+IPK+CPQ+LK LMIKCWN  PS R  FS+I  +LLR
Sbjct:   524 GSCSPVQAAVGIAACGLRPDIPKECPQVLKYLMIKCWNTCPSTRLNFSQIHCILLR 579

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 418 (152.2 bits), Expect = 8.9e-41, Sum P(2) = 8.9e-41
 Identities = 86/242 (35%), Positives = 144/242 (59%)

Query:   353 FKGVYKGKRVGIEKLKGCDKGNAYEF-ELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
             F+G Y  + V I+ LK  ++ NA    E  +++  +    HKN++QF   C   +  LC+
Sbjct:   307 FRGTYCSQEVAIKILKP-ERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACT-RSPNLCI 364

Query:   412 VTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
             VT+ M  GS+ D + K + + + + ++++A+DV++G+ +L+ + + +RDL +  +L+D H
Sbjct:   365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424

Query:   471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
               V + D G+       G  T  ET  YRW+APE+I   P        ++V+S+ +V+WE
Sbjct:   425 EVVKVADFGVARVQTESGVMTA-ETGTYRWMAPEVIEHKPYD----HRADVFSYAIVLWE 479

Query:   531 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             ++TGE  Y+  +P+QAAVG+   GLRP+IPK+    L  L+ KCW   P+ RP F+EII 
Sbjct:   480 LLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIE 539

Query:   591 LL 592
             +L
Sbjct:   540 ML 541

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 92/265 (34%), Positives = 152/265 (57%)

Query:   335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
             W ++   L+   ++   S+    +G Y  + V I+ LK     N    E  +++  +   
Sbjct:   279 WEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKV 338

Query:   391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 447
              HKN++QF   C   +  LC+VT+ M  GS+ D + K +   KLQT  ++++A+DVA+G+
Sbjct:   339 RHKNVVQFLGACT-RSPTLCIVTEFMARGSIYDFLHKQKCAFKLQT--LLKVALDVAKGM 395

Query:   448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
              +L+ + + +RDL +  +L+D HG V + D G+       G  T  ET  YRW+APE+I 
Sbjct:   396 SYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTA-ETGTYRWMAPEVIE 454

Query:   508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
               P +      ++V+S+ +V+WE++TG+  YA  +P+QAAVG+   GLRP+IPK     +
Sbjct:   455 HKPYNHK----ADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKV 510

Query:   568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             K L+ +CW+  P +RP F EII +L
Sbjct:   511 KGLLERCWHQDPEQRPLFEEIIEML 535

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 107/319 (33%), Positives = 171/319 (53%)

Query:   291 ESFRNGVENSNLKIQLQM---PLPSSSFVVSVDEWQT-------VQSGGEEIGRWLLNSD 340
             E  R  +E    KI+LQ    P+   SF    +  QT       + + G ++  W +N  
Sbjct:   232 ERLRISLEKEAAKIELQSQSWPM-QQSFSPEKENGQTGARTHVPIPNDGTDV--WEINLK 288

Query:   341 NLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +L+F  +I   S+  +YKG    + V I+ LK     +  E E  +++  +    HKN++
Sbjct:   289 HLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVV 348

Query:   397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDH 453
             QF   C    H LC+VT+ M GGSV D + K +   KL T  + ++AID+ +G+ +L+ +
Sbjct:   349 QFIGACTKPPH-LCIVTEFMPGGSVYDYLHKQKGVFKLPT--LFKVAIDICKGMSYLHQN 405

Query:   454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
              + +RDL +  +L+D +  V + D G+       G  T  ET  YRW+APE+I   P   
Sbjct:   406 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTA-ETGTYRWMAPEVIEHKPYDH 464

Query:   514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 573
                  ++V+S+G+V+WE++TG+  Y   +P+QAAVG+   GLRP IPK+    L  L+ +
Sbjct:   465 K----ADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLER 520

Query:   574 CWNNSPSKRPQFSEIISLL 592
              W +  ++RP FSEII  L
Sbjct:   521 LWEHDSTQRPDFSEIIEQL 539

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 374 (136.7 bits), Expect = 4.2e-34, P = 4.2e-34
 Identities = 83/246 (33%), Positives = 136/246 (55%)

Query:   353 FKGVYKGKRVGIEKLKGCD----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408
             ++G Y G+ V I+ L+  D    K  A E + ++++  L    H NI++F   C+ +   
Sbjct:   146 YRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLAFLKHPNIVRFIGACI-KPMV 204

Query:   409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
              C+VT+  +GGSV   + K  +R +  K  +  A+DVA G+ ++++    +RDL S  +L
Sbjct:   205 WCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLL 264

Query:   467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 526
             +    ++ + D G V   +   E    ET  YRW+APE+I   P     T   +VYSFG+
Sbjct:   265 ISADRSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPY----TQKVDVYSFGI 319

Query:   527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             V+WE++TG   +   + VQAA  +   G+RP +P DC  +L  +M +CW+  P  RP F+
Sbjct:   320 VLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFA 379

Query:   587 EIISLL 592
             EI++LL
Sbjct:   380 EIVNLL 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 368 (134.6 bits), Expect = 5.2e-32, P = 5.2e-32
 Identities = 85/263 (32%), Positives = 142/263 (53%)

Query:   342 LEFIDQIGPNSFKGVYKGKRVGIEKL-------KGCDKGNAYEFELRKDLLELMTCGHKN 394
             L+F   +    + G Y+ K V ++ +        GC  G   E +  K++  L    H N
Sbjct:   211 LKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGC-LGARLEKQFTKEVTLLSRLTHPN 269

Query:   395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLND 452
             +++F     D     CV+T+ +  GS+   + K  +R L  K++I  AID+A G+++++ 
Sbjct:   270 VIKFVGAYKDPPV-YCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHS 328

Query:   453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGD 509
               + +RDL  + +L+D   ++ + D GI  AC+   E  +   D    YRW+APE+I   
Sbjct:   329 RRIIHRDLKPENVLIDEEFHLKIADFGI--ACEE--EYCDMLADDPGTYRWMAPEMIKRK 384

Query:   510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
             P        ++VYSFG+V+WEMV G   Y   +P+QAA  +    +RP IP DCP  +K+
Sbjct:   385 PHGRK----ADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKA 440

Query:   570 LMIKCWNNSPSKRPQFSEIISLL 592
             L+ +CW+ +P KRP+F +I+ +L
Sbjct:   441 LIEQCWSVAPDKRPEFWQIVKVL 463

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 351 (128.6 bits), Expect = 1.6e-31, P = 1.6e-31
 Identities = 78/246 (31%), Positives = 133/246 (54%)

Query:   353 FKGVYKGKRVGIEKLK----GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408
             +KG Y G+ V I+ L+      +K    E + ++++  L    H NI++F   C  +   
Sbjct:   145 YKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVSMLANLKHPNIVRFIGAC-RKPMV 203

Query:   409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
              C+VT+  +GGSV   + +  +R +  K  ++ A+DVA G+ +++     +RDL S  +L
Sbjct:   204 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNLL 263

Query:   467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 526
             +    ++ + D G V   +   E    ET  YRW+APE+I    +  +     +VYSFG+
Sbjct:   264 ISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMI----QHRAYNQKVDVYSFGI 318

Query:   527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             V+WE++TG   +   + VQAA  +   G+RP +P DC  +L  +M +CW+ +P  RP F 
Sbjct:   319 VLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFV 378

Query:   587 EIISLL 592
             E++ LL
Sbjct:   379 EVVKLL 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 371 (135.7 bits), Expect = 3.8e-31, P = 3.8e-31
 Identities = 87/262 (33%), Positives = 141/262 (53%)

Query:   337 LNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG 391
             ++   L+   ++G  +F    KG+++G  V I+++K   D  N    E RK+L  L    
Sbjct:   657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLR 716

Query:   392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFL 450
             H NI+     C    + LC +T+ + GGS+ D +  K  K+  +   ++AI +A+G+ +L
Sbjct:   717 HPNIVLLMAACTAPPN-LCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775

Query:   451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
             +  GV +RD+ S  +LLD H NV + D G+ +  KS             W++PE++ G  
Sbjct:   776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGL-SKLKSKSTEMTKSIGSPIWMSPELLMG-- 832

Query:   511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
             E  +E    +VY+FG+++WE+ TGE  Y+    VQ A+ +    LRP IP   P  L  L
Sbjct:   833 EDYTEK--VDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHL 890

Query:   571 MIKCWNNSPSKRPQFSEIISLL 592
             +  CW+  P KRP F+EI++LL
Sbjct:   891 IQACWHQDPLKRPSFTEILNLL 912

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

RGD|727908 Tnni3k "TNNI3 interacting kinase" [Rattus norvegicus (taxid:10116)]

 Score = 361 (132.1 bits), Expect = 4.2e-30, P = 4.2e-30
 Identities = 101/323 (31%), Positives = 165/323 (51%)

Query:   284 EEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWLLNSDNL 342
             +EE  C+E  + G + S + +    P P         E   V     E+  R+ L    +
Sbjct:   408 QEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFHLQLSEI 463

Query:   343 EFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMTCGHKNI 395
             EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  L    H  +
Sbjct:   464 EFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQLNHPCV 521

Query:   396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLND 452
             +QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DVA+G+++L+ 
Sbjct:   522 VQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKGMEYLHS 579

Query:   453 --HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGD 509
                 + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW+APE+    
Sbjct:   580 LTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEVFT-- 637

Query:   510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
              +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I    P+ + S
Sbjct:   638 -QCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIGYSIPKPISS 696

Query:   570 LMIKCWNNSPSKRPQFSEIISLL 592
             L+I+ WN  P  RP+FSE++S L
Sbjct:   697 LLIRGWNACPEGRPEFSEVVSKL 719

GO:0004672 "protein kinase activity" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0031013 "troponin I binding" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00024046001 SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (592 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	604
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-31
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-22
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-15
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-06
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-04
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.001
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	0.001
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	0.002
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.002
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.003
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.003

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (414), Expect = 4e-46
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 29/269 (10%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCD------KGNAYEFELRKDLLE----LMTCG 391
           LE   ++G  +F  VYKG   G  +           K  A E E R++ LE    +    
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NI++   VC      L +VT+ M GG + D L     KL  K+++++A+ +A+G+++L
Sbjct: 60  HPNIVRLLGVCTQGEP-LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEI 505
                 +RDL ++  L+  +  V + D G+    + + E   Y   G      +W+APE 
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 506 IAGDPESV-SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           +    +   +    S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P++C
Sbjct: 176 LK---DGKFTSK--SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPENC 229

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P  L  LM++CW   P  RP FSE++  L
Sbjct: 230 PDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (403), Expect = 1e-44
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 34/271 (12%)

Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 387
           L    ++G  +F  VYKGK           V ++ LK          +  ++ L     +
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-----ASEQQIEEFLREARIM 55

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 446
               H N+++   VC +E   L +V + MEGG +   + K+R KL   +++  A+ +A G
Sbjct: 56  RKLDHPNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           +++L      +RDL ++  L+  +  V + D G+    + + +   Y   G     RW+A
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMA 171

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE +    E    T  S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P 
Sbjct: 172 PESLK---EGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPP 226

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP  L  LM++CW   P  RP FSE++ +L
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  158 bits (401), Expect = 3e-44
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 35/272 (12%)

Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 387
           L    ++G  +F  VYKG            V ++ LK          +  ++ L     +
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-----EDASEQQIEEFLREARIM 55

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAE 445
               H NI++   VC +E   L +V + M GG + D + K+R   L   +++  A+ +A 
Sbjct: 56  RKLDHPNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
           G+++L      +RDL ++  L+  +  V + D G+    + + +   Y+  G     RW+
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWM 171

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE +    E    T  S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P
Sbjct: 172 APESLK---EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKP 226

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            +CP  L  LM++CW   P  RP FSE++ +L
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  151 bits (384), Expect = 8e-42
 Identities = 78/264 (29%), Positives = 122/264 (46%), Gaps = 38/264 (14%)

Query: 353 FKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCV 403
           +KG  KGK      V ++ LK          E RKD L+    +   GH N+++   VC 
Sbjct: 12  YKGKLKGKDGKTTEVAVKTLKEDA-----SEEERKDFLKEARVMKKLGHPNVVRLLGVCT 66

Query: 404 DENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEIIRIAIDVAEGIKFLNDHG 454
           +E   L +V + MEGG + D + KSR          L  K+++  AI +A+G+++L    
Sbjct: 67  EEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGD 509
             +RDL ++  L+     V + D G+    + V +   Y          RW+APE +   
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182

Query: 510 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
             +      S+V+SFG+++WE+ T G   Y   S  +    +   G R   P+ CP  L 
Sbjct: 183 IFTS----KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELY 237

Query: 569 SLMIKCWNNSPSKRPQFSEIISLL 592
            LM+ CW   P  RP FSE++  L
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  148 bits (375), Expect = 1e-40
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 19/260 (7%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELM---TCGHKNI 395
            E + ++G  SF  VYK K  G  K+   K   K +    + +    E+       H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           ++      D++H L +V +  EGG + D + +   L   E  +IA+ +  G+++L+ +G+
Sbjct: 61  VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DG-YRWLAPEIIAGDPESV 513
            +RDL  + ILLD +G V + D G+  A K +  ++   T  G   ++APE++ G     
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGL--AKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKDCPQI--LK 568
            +    +V+S G++++E++TG+  ++  + +   Q    I    L  + PK        K
Sbjct: 178 PK---VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 569 SLMIKCWNNSPSKRPQFSEI 588
            L+ KC N  PSKRP   EI
Sbjct: 235 DLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (331), Expect = 4e-35
 Identities = 73/256 (28%), Positives = 117/256 (45%), Gaps = 52/256 (20%)

Query: 348 IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
           +G   F  VY       GK+V I+ +K  D  +  E EL +++  L    H NI++ Y V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460
             DENH L +V +  EGGS+ DL+ +   KL   EI+RI + + EG+++L+ +G+ +RDL
Sbjct: 60  FEDENH-LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 461 NSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSET 516
             + ILLD  +G V L D G+    K +               ++APE++ G       +
Sbjct: 119 KPENILLDSDNGKVKLADFGL---SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY---S 172

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
             S+++S G++++E+                                   LK L+ K   
Sbjct: 173 EKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ 199

Query: 577 NSPSKRPQFSEIISLL 592
             P KRP   EI+  L
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (332), Expect = 1e-34
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 33/263 (12%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 395
           E ++++G  SF  VY  +     K   +K   K    +   R+ +L     L    H NI
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNI 59

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           ++ Y V  DE+  L +V +  EGG + DL+ K  +L   E       +   +++L+  G+
Sbjct: 60  VRLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEIIA 507
            +RDL  + ILLD  G+V L D G+         A + +             ++APE++ 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGL---------ARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQ 565
           G     +     +++S G++++E++TG+  +     +            P  P   D   
Sbjct: 170 GKGYGKA----VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
             K L+ K     P KR    E 
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 2e-31
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 35/273 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---L 387
           W +NS  L+    IG   F     G Y+G++V ++ LK  D   A  F     L E   +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAAQAF-----LAEASVM 54

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVA 444
            T  H N++Q   V +  N  L +VT+ M  GS+ D  L+SR    +   + +  A+DV 
Sbjct: 55  TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDY-LRSRGRAVITLAQQLGFALDVC 112

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----W 500
           EG+++L +    +RDL ++ +L+       + D G+        +      D  +    W
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL-------AKEASQGQDSGKLPVKW 165

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +    E    T  S+V+SFG+++WE+ + G   Y    P++  V     G R E 
Sbjct: 166 TAPEALR---EKKFST-KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEA 220

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P+ CP  +  +M  CW   P+KRP F ++   L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 3e-29
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 57/297 (19%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDK-GNAYEFELRK 382
           W L  + +  I ++G  SF  VY+G            RV I+ +          EF    
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ---------- 432
            +++   C H  +++   V       L VV +LM  G +    L+SR+ +          
Sbjct: 61  SVMKEFNCHH--VVRLLGVVSTGQPTL-VVMELMAKGDLKSY-LRSRRPEAENNPGLGPP 116

Query: 433 -TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
             ++ I++A ++A+G+ +L      +RDL ++  ++     V +GD G+           
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI------- 169

Query: 492 EYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAA 537
            YETD Y          RW+APE       S+ +   T  S+V+SFG+V+WEM T  E  
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPE-------SLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y   S  +    +   G   ++P++CP  L  LM  CW  +P  RP F EI+S L  
Sbjct: 222 YQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (290), Expect = 7e-29
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NI+++Y     +E + L +  + + GGS++ L+ K  KL    I +    + EG+ +L
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEI 505
           + +G+ +RD+    IL+D  G V L D G     K +G+    E  G       W+APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFG---CAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-IAACGLRPEIPKDCP 564
           I G+    +    ++++S G  + EM TG+  ++      AA+  I + G  PEIP+   
Sbjct: 175 IRGEEYGRA----ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230

Query: 565 QILKSLMIKCWNNSPSKRP 583
           +  K  + KC    P KRP
Sbjct: 231 EEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (289), Expect = 9e-29
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 18/260 (6%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMT 389
           W    +      ++G   F  V++G      RV I+ LK  D     +F+  K++  L  
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQ--KEVQALKR 58

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 447
             HK+++  + VC      + ++T+LME GS+   +     + L    +I +A  VAEG+
Sbjct: 59  LRHKHLISLFAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
            +L +    +RDL ++ IL+     VC + D G+    K     +  +   Y+W APE  
Sbjct: 118 AYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           +    S      S+V+SFG++++EM T G+  Y   +           G R   P  CPQ
Sbjct: 177 SHGTFSTK----SDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQ 231

Query: 566 ILKSLMIKCWNNSPSKRPQF 585
            +  +M++CW   P  RP F
Sbjct: 232 EIYKIMLECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 4e-28
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 23/253 (9%)

Query: 354 KGVY---KGKR--VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408
           KGVY    GK   V ++ LK  +   A + E  ++   +    H  I++   VC  E   
Sbjct: 13  KGVYLMKSGKEVEVAVKTLKQ-EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE--P 69

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L +V +L   G +   + K R++   ++  +A  VA G+ +L      +RDL ++ +LL 
Sbjct: 70  LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129

Query: 469 RHGNVCLGDMGIVTACKSVGEATEY---ETDG---YRWLAPEIIAGDPESVSETWMSNVY 522
                 + D G+    +++G  ++Y    T G    +W APE I     S      S+V+
Sbjct: 130 NRHQAKISDFGM---SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK----SDVW 182

Query: 523 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 581
           S+G+ +WE  + G   Y      +  + +   G R   P++CPQ + S+M+ CW   P  
Sbjct: 183 SYGVTLWEAFSYGAKPYGEMKGAEV-IAMLESGERLPRPEECPQEIYSIMLSCWKYRPED 241

Query: 582 RPQFSEIISLLLR 594
           RP FSE+ S   R
Sbjct: 242 RPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (279), Expect = 2e-27
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 38/260 (14%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCGHKN 394
           E +++IG   F  VYK      GK V I+ +K    +K      E++  +L+   C H N
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ--ILK--KCKHPN 58

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           I+++Y     +   L +V +   GGS+ DL+   ++ L   +I  +  ++ +G+++L+ +
Sbjct: 59  IVKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLAPEII 506
           G+ +RD+ +  ILL   G V L D G+             VG  T Y      W+APE+I
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG--TPY------WMAPEVI 169

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA---ACGLRPEIPKDC 563
            G P        ++++S G+   E+  G+  Y+   P++A   IA     GLR   P+  
Sbjct: 170 NGKPYDYK----ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NPEKW 223

Query: 564 PQILKSLMIKCWNNSPSKRP 583
               K  + KC   +P KRP
Sbjct: 224 SDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 6e-27
 Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 39/272 (14%)

Query: 344 FIDQ-IGPNSFKGVYKG---------KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG- 391
            I++ IG   F  V +G           V I+ LK G       +F     L E    G 
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF-----LTEASIMGQ 61

Query: 392 --HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
             H NI++   V V ++  + ++T+ ME GS++  + ++  K    +++ +   +A G+K
Sbjct: 62  FDHPNIIRLEGV-VTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG----YRWLAP 503
           +L++    +RDL ++ IL++ +  VC + D G+    +   EAT Y T G     RW AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDS-EAT-YTTKGGKIPIRWTAP 177

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACS--PVQAAVGIAACGLRPEIP 560
           E IA    + +    S+V+SFG+V+WE M  GE  Y   S   V  AV     G R   P
Sbjct: 178 EAIAYRKFTSA----SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---GYRLPPP 230

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            DCP  L  LM+ CW    ++RP FS+I+S L
Sbjct: 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (273), Expect = 2e-26
 Identities = 67/286 (23%), Positives = 126/286 (44%), Gaps = 48/286 (16%)

Query: 340 DNLEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
            +L+FI Q+G   F  V            G++V ++ L        +  +  +++  L T
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRT 62

Query: 390 CGHKNILQFYCVCVDENHG--LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 446
             H+NI+++  VC ++  G  L ++ + +  GS+ D + + R ++  K ++  +  + +G
Sbjct: 63  LDHENIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET---DG---YRW 500
           + +L      +RDL ++ IL++    V + D G+    K + E  +Y      G     W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA---KVLPEDKDYYYVKEPGESPIFW 178

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC------ 553
            APE +     S +    S+V+SFG+ ++E+ T G+ +    SP    + +         
Sbjct: 179 YAPECLRTSKFSSA----SDVWSFGVTLYELFTYGDPS---QSPPAEFLRMIGIAQGQMI 231

Query: 554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                     G R   P  CP  +  LM  CW   P  RP F+++I
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 6e-26
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 18/260 (6%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
           W ++  +++ + ++G   F  V++G       V ++ LK    G     +   +   +  
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKK 57

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 447
             H  ++Q Y VC  E   + +VT+LM+ GS+ + +     R L+  ++I +A  VA G+
Sbjct: 58  LRHPKLIQLYAVCTLEE-PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEII 506
            +L      +RDL ++ +L+  +    + D G+    K  + EA E      +W APE  
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
             +  S+     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P  CP+
Sbjct: 177 LYNRFSIK----SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPK 231

Query: 566 ILKSLMIKCWNNSPSKRPQF 585
            L  +M+ CW   P  RP F
Sbjct: 232 ELYDIMLDCWKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 77/267 (28%), Positives = 133/267 (49%), Gaps = 21/267 (7%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           WLLN   L   + IG   F    +G Y G++V ++ +K CD   A  F     ++  +  
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK-CDV-TAQAFLEETAVMTKLH- 57

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKL-QTKEIIRIAIDVAEGIK 448
            HKN+++   V +  ++GL +V +LM  G+ VN L  + R L    ++++ ++DVAEG++
Sbjct: 58  -HKNLVRLLGVIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L    + +RDL ++ IL+   G   + D G+        + ++      +W APE +  
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKH 171

Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S      S+V+S+G+++WE+ + G A Y   S  +    +   G R E P+ CP  +
Sbjct: 172 KKFSSK----SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADV 226

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLLLR 594
             LM  CW   P KRP F ++   L +
Sbjct: 227 YVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 54/291 (18%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELM---- 388
            +  + +++IG  +   VYK      GK V I+K++           LRK   EL+    
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----------LRKQNKELIINEI 66

Query: 389 ----TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDV 443
                C H NI+ +Y   +  +  L VV + M+GGS+ D+I     ++   +I  +  +V
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYET 495
            +G+++L+   V +RD+ S  ILL + G+V L D G    +T  KS     VG  T Y  
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG--TPY-- 181

Query: 496 DGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
               W+APE+I        V      +++S G++  EM  GE  Y    P++A   I   
Sbjct: 182 ----WMAPEVIKRKDYGPKV------DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231

Query: 554 GLRPEI--PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
           G+ P +  P+      K  + KC    P KRP   E++             
Sbjct: 232 GI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  104 bits (260), Expect = 4e-25
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 21/262 (8%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 56

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 172

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP +
Sbjct: 173 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPV 227

Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  +M +CW+   + RP F ++
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  103 bits (259), Expect = 1e-24
 Identities = 82/279 (29%), Positives = 137/279 (49%), Gaps = 48/279 (17%)

Query: 348 IGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLE--LMT-CGH 392
           +G  +F  VY+G             RV ++ L+   KG A + E ++ L E  LM+   H
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KG-ATDQEKKEFLKEAHLMSNFNH 58

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIAIDVAE 445
            NI++   VC+  N    ++ +LMEGG +   +  +R        L  KE++ I +DVA+
Sbjct: 59  PNIVKLLGVCLL-NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVC-----LGDMGIVTACKSVGEATEYETDG--- 497
           G  +L      +RDL ++  L+   G        +GD G+    + + ++  Y  +G   
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---RDIYKSDYYRKEGEGL 174

Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              RW+APE ++ G       T  S+V+SFG+++WE++T G+  Y A +  +    + A 
Sbjct: 175 LPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           G R + P++CP  +  LM  CW   PS+RP F  I  +L
Sbjct: 230 G-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 68/261 (26%), Positives = 127/261 (48%), Gaps = 19/261 (7%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           L F+ ++G   F  V+ GK  G     +K   +G   E +  ++   +M   H N++Q Y
Sbjct: 6   LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
            VC  +   + +VT+ M  G + + + + + KL T+ ++ +  DV E +++L  +G  +R
Sbjct: 66  GVCT-KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESV 513
           DL ++  L+     V + D G+    + V +  +Y +        +W  PE+      S 
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLA---RYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 514 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
                S+V+SFG+++WE+ + G+  Y   S  +    ++A G R   PK  P  + ++M 
Sbjct: 181 K----SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMY 235

Query: 573 KCWNNSPSKRPQFSEIISLLL 593
            CW+  P  RP F +++S L 
Sbjct: 236 SCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (252), Expect = 7e-24
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 33/265 (12%)

Query: 348 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 394
           IG   F  V++G           V I+ LK       Y  + R+D L E    G   H N
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-----GYTEKQRQDFLSEASIMGQFSHHN 67

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLND 452
           I++   V       + ++T+ ME G++ D  L+    +  + +++ +   +A G+K+L+D
Sbjct: 68  IIRLEGVVTKFKPAM-IITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAG 508
               +RDL ++ IL++ +    + D G+    +   E T Y T G     RW APE IA 
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIA- 183

Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
                  T  S+V+SFG+V+WE+++ GE  Y   S  +    I   G R   P DCP  +
Sbjct: 184 ---YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAV 239

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             LM++CW    ++RP+F +I++LL
Sbjct: 240 YQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (251), Expect = 9e-24
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 28/266 (10%)

Query: 346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
            ++G  SF  V +G+          V ++ LK  DK +    +  K+   + +  H+N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI---AIDVAEGIKFLNDH 453
           + Y V +   H L +VT+L   GS+ D  L+   L    I  +   A+ +A G+++L   
Sbjct: 60  RLYGVVLT--HPLMMVTELAPLGSLLDR-LRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPEIIAG 508
              +RDL ++ ILL     V +GD G++ A     +   Y  + +      W APE +  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED--HYVMEEHLKVPFAWCAPESL-- 172

Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              + + +  S+V+ FG+ +WEM T GE  +A  S  Q    I   G R E P+ CPQ +
Sbjct: 173 --RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI 230

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLLL 593
            ++M++CW ++P+ RP F+ +   L 
Sbjct: 231 YNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 54/293 (18%)

Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL---LELMT- 389
            + F++++G  +F  VYKG+  G  +            K NA E +++++     ELM+ 
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSD 64

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS---------------RKLQT 433
             H NI+    VC  E    C++ + +  G +++ L+  S                 L  
Sbjct: 65  LQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
            + + IAI +A G+++L+ H   +RDL ++  L+     V + D G+            Y
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI--------Y 175

Query: 494 ETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 542
             D Y          RW+ PE I     +      S+++SFG+V+WE+ + G   Y   S
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTE----SDIWSFGVVLWEIFSYGLQPYYGFS 231

Query: 543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT 595
             +    I +  L P  P+DCP  + +LMI+CWN  P++RP+F + I   LR+
Sbjct: 232 NQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKD-IHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 80/247 (32%), Positives = 125/247 (50%), Gaps = 25/247 (10%)

Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L E    G   H NI+    V V ++  + +
Sbjct: 29  GKREIPVAIKTLKA-----GYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSKPVMI 82

Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           VT+ ME GS++  + K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +
Sbjct: 83  VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142

Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
               + D G+    +   EA  Y T G     RW APE IA    + +    S+V+S+G+
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSA----SDVWSYGI 197

Query: 527 VIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           V+WE M  GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    ++RP+F
Sbjct: 198 VMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKF 256

Query: 586 SEIISLL 592
            +I+S+L
Sbjct: 257 EQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 21/266 (7%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 394
           ++   L  + +IG   F  V+ G  +   K  +K   +G   E +  ++   +M   H  
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDH 453
           ++Q Y VC  E   +C+V + ME G ++D +   R K   + ++ + +DV EG+ +L   
Sbjct: 61  LVQLYGVCT-ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGD 509
            V +RDL ++  L+  +  V + D G+    + V +     + G     +W +PE+ +  
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT---RFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 510 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
             S      S+V+SFG+++WE+ + G+  Y   S  +    I A G R   P+   Q + 
Sbjct: 177 KYSSK----SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVY 231

Query: 569 SLMIKCWNNSPSKRPQFSEIISLLLR 594
            LM  CW   P  RP F    SLLL 
Sbjct: 232 ELMQHCWKERPEDRPSF----SLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 34/275 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAYEFELRKDLLELM 388
           W +  ++L+   ++G   F  V+ G      +V ++ LK G     A+  E +     +M
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-----IM 55

Query: 389 -TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVA 444
               H  ++Q Y VC +E   + +VT+ M  GS+ D  LKS   +KL+  +++ +A  +A
Sbjct: 56  KKLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDF-LKSGEGKKLRLPQLVDMAAQIA 113

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DGYR---- 499
           EG+ +L      +RDL ++ IL+  +    + D G+      + E  EY   +G +    
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIK 169

Query: 500 WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           W APE    G       T  S+V+SFG+++ E+VT G   Y   +  +    +   G R 
Sbjct: 170 WTAPEAANYG-----RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRM 223

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             P +CP+ L  LM++CW+  P +RP F  + S L
Sbjct: 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 96.3 bits (239), Expect = 4e-22
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 41/288 (14%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLL 385
           +N   + F++++G + F  VYKG           + V I+ LK   +G   E E + + +
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAM 60

Query: 386 ELMTCGHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 430
                 H NI+                 YC   D +  L + +   + GS +D       
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L+  + + I   +A G++FL+ H V ++DL ++ +L+    NV + D+G+    + V  A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF---REVYAA 177

Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
             Y+  G      RW++PE I     S+     S+++S+G+V+WE+ + G   Y   S  
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                I    + P  P DCP  + +LM++CWN  PS+RP+F +I S L
Sbjct: 234 DVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 44/286 (15%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLE 386
               NL+ I  +G   F  V+  K  GIE          K     K    + E R++L  
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 387 LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEI 436
                HKN+++   +C + E H   ++ +  + G +   +  ++          L TK+ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
           + +   +A G+  L++    +RDL ++  L+     V +  + +    K V     Y ++
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL---SKDV-----YNSE 171

Query: 497 GY---------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 546
            Y         RWLAPE +  D  S      S+V+SFG+++WE+ T GE  +   S  + 
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              + A  L   +P+ CP  L  LM +CW  +P  RP FSE++S L
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 9e-22
 Identities = 62/265 (23%), Positives = 120/265 (45%), Gaps = 26/265 (9%)

Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           LE I  +G  +F  VYKG            V I+ L+  +       E+  +   + +  
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 450
           H ++++   +C+       ++T+LM  G + D +   +  + ++ ++   + +A+G+ +L
Sbjct: 68  HPHVVRLLGICLSSQV--QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
            +  + +RDL ++ +L+    +V + D G +     V E  EY  +G     +W+A E I
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLDVDE-KEYHAEGGKVPIKWMALESI 183

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
                    T  S+V+S+G+ +WE++T G   Y    P      +   G R   P  C  
Sbjct: 184 ----LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTI 238

Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            +  +++KCW      RP F E+I+
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 44/295 (14%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL-- 384
            W L  D L     +G  +F  V K + VG++             K +A E +L  DL  
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVS 64

Query: 385 -LELM-TCG-HKNILQFYCVCVDENHGLCVVTKL----------------MEGGSVNDLI 425
            +E+M   G HKNI+    VC  E   L VV +                  E  S +D  
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 426 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
                L  K+++  A  VA G++FL      +RDL ++ +L+     + + D G+    +
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---R 180

Query: 486 SVGEATEYE--TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
            +     Y   T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y 
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236

Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
              PV+    +   G R E P++C Q L  LM  CW+  PS+RP F +++  L R
Sbjct: 237 GI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 28/257 (10%)

Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCD-KGNAYEFELRKDLLELM 388
           N +  D IG  +F  VYKG           K++ +EK+K    K    E +L K+L    
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL---- 56

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H NI+++       +  L ++ +  E GS+  +I K        +      V +G+ 
Sbjct: 57  --KHPNIVKYIGSIETSDS-LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEII 506
           +L++ GV +RD+ +  IL  + G V L D G+ T    V +  +    G  Y W+APE+I
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPY-WMAPEVI 171

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
                S +    S+++S G  + E++TG   Y   +P+ A   I      P +P+     
Sbjct: 172 EMSGASTA----SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPE 226

Query: 567 LKSLMIKCWNNSPSKRP 583
           LK  +++C+   P+ RP
Sbjct: 227 LKDFLMQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 42/277 (15%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           D+ E I+ IG  +   VY        ++V I+++   +K      ELRK++  +  C H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFL 450
           N++++Y   V     L +V   + GGS+ D++  S     L    I  +  +V +G+++L
Sbjct: 60  NVVKYYTSFV-VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------- 499
           + +G  +RD+ +  ILL   G+V + D G V+A             G R           
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFG-VSAS--------LADGGDRTRKVRKTFVGT 169

Query: 500 --WLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI---AAC 553
             W+APE++    E V    + ++++SFG+   E+ TG A Y+   P++  +        
Sbjct: 170 PCWMAPEVM----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225

Query: 554 GLRPEI-PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            L      K   +  + ++  C    PSKRP   E++
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.0 bits (231), Expect = 4e-21
 Identities = 67/267 (25%), Positives = 129/267 (48%), Gaps = 27/267 (10%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           ++  +L F+ ++G   F  V  GK      V I+ +K   +G+  E E  ++   +M   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLS 57

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H+ ++Q Y VC  +   + +VT+ M  G  +N L    ++ Q  +++ +  DV EG+ +L
Sbjct: 58  HEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPE 504
                 +RDL ++  L+D  G V + D G+           SVG  +++     RW  PE
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG--SKFPV---RWSPPE 171

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           ++     S      S+V++FG+++WE+ + G+  Y   +  +    ++  GLR   P   
Sbjct: 172 VLLYSKFSSK----SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLA 226

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIIS 590
            + + ++M  CW+    +RP F +++S
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 18/253 (7%)

Query: 348 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +G  SF  VY+G           K V +       +    + E    LL  +   H NI+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIV 65

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
           Q+     +E++ L +  +L+ GGS+  L+ K        I      +  G+++L+D    
Sbjct: 66  QYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 516
           +RD+    IL+D +G V L D G+         A  ++   Y W+APE+IA   +     
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIA---QQGGYG 180

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
             ++++S G  + EM TG+  ++    V A   I      P IP       K  ++KC  
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 577 NSPSKRPQFSEII 589
             PS RP  +E++
Sbjct: 241 RDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 17/264 (6%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           +N   L F+ ++G   F  V+ GK R  I+  +K  ++G   E +  ++   +M   H  
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           ++Q Y VC  +   L +VT+ ME G  +N L  +  KL    ++ +  DV EG+++L  +
Sbjct: 61  LVQLYGVCT-QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGD 509
              +RDL ++  L+   G V + D G+    + V +     + G     +W  PE+    
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 510 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
             S      S+V+SFG+++WE+ T G+  +   S  +    I+  G R   PK     + 
Sbjct: 177 KYSSK----SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVY 231

Query: 569 SLMIKCWNNSPSKRPQFSEIISLL 592
            +M  CW+  P  RP F+E++  +
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 74/282 (26%), Positives = 134/282 (47%), Gaps = 47/282 (16%)

Query: 342 LEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEF-ELRKDLLELMTC 390
           + F++++G  +F  +YKG          + V I+ LK  D  N  ++ E +++   +   
Sbjct: 7   VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS----------------RKLQT 433
            H NI+    V V +   +C++ + +  G +++ LI++S                  L  
Sbjct: 65  HHPNIVCLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
            + + IAI +A G+++L+ H   ++DL ++ IL+    +V + D+G+    + +  A  Y
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL---SREIYSADYY 180

Query: 494 ETDG-----YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 546
                     RW+ PE I+ G   S S+ W     SFG+V+WE+ + G   Y   S  + 
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIW-----SFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
              +    L P   +DCP  + SLM +CW   PS+RP+F +I
Sbjct: 236 IEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 64/257 (24%), Positives = 129/257 (50%), Gaps = 28/257 (10%)

Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV 412
           +G   G++V ++ LK    GN +  +L+K++  L    H+NI+++  +C ++  +G+ ++
Sbjct: 28  EGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
            + +  GS+ + + +++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 472 NVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
            V +GD G+  A ++  E    + D      W APE +      ++    S+V+SFG+ +
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA----SDVWSFGVTL 202

Query: 529 WEMVTGEAAYAACSP----------------VQAAVGIAACGLRPEIPKDCPQILKSLMI 572
           +E++T     +  SP                V   V +   G R   P +CP+ +  LM 
Sbjct: 203 YELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMR 260

Query: 573 KCWNNSPSKRPQFSEII 589
           KCW   PSKR  F  +I
Sbjct: 261 KCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)

Query: 340 DNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYE-FELRKDLLEL 387
           D +    ++G  +F  V+ G+            V ++ LK     +A + FE   +LL  
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---------ILKSRK-----LQT 433
               H+NI++FY VC + +    +V + ME G +N            LKS       L  
Sbjct: 65  F--QHENIVKFYGVCTEGD-PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
            ++++IA+ +A G+ +L      +RDL ++  L+     V +GD G+    + V     Y
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM---SRDV-----Y 173

Query: 494 ETDGY----------RWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
            TD Y          RW+ PE I+         T  S+V+SFG+V+WE+ T G+  +   
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVVLWEIFTYGKQPWYGL 228

Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           S  +    I   G   + P+ CP  +  +M+ CW   P +R    +I   L
Sbjct: 229 SNEEVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 75/265 (28%), Positives = 122/265 (46%), Gaps = 32/265 (12%)

Query: 345 IDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHKNILQF 398
           I QIG  SF  VY  +R    KL   K  D  N  E E    L E   L    H NI+++
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHG 454
           Y    ++   LC+V +  +GG ++  I K +K       ++I+   + +   +K+L+   
Sbjct: 65  YESFEEKGK-LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKS-VGEATEYETDGYRWLAPEII 506
           + +RD+  Q I L  +G V LGD GI       V   K+ VG  T Y    Y  L+PE+ 
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG--TPY----Y--LSPELC 175

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
              P +      S+++S G V++E+ T +  +   + ++ A+ I   G  P IP      
Sbjct: 176 QNKPYNYK----SDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSE 230

Query: 567 LKSLMIKCWNNSPSKRPQFSEIISL 591
           L++L+       P +RP  ++I+  
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 26/263 (9%)

Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHKN 394
           + + + ++G  S+  VYK KR+   +   LK  D G+  + E    + E   L +  H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFL 450
           I+ +    +D N  LC+V +    G ++  I K +K    +  +EI RI I +  G++ L
Sbjct: 61  IISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           ++  + +RDL S  ILL  +  V +GD+GI    K     T+  T  Y  +APE+  G P
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHY--MAPEVWKGRP 177

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQI 566
            S      S+++S G +++EM T    + A S       +   G  P IP    +D    
Sbjct: 178 YSYK----SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNF 232

Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
           ++S++       P  RP   +I+
Sbjct: 233 IRSMLQV----KPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 49/286 (17%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLELMT 389
           D++  +  +G  +F  VY+G   G +          K          E +   + L +  
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAID 442
             H+NI++   V  +      ++ +LM GG +   + ++R        L  K+++  A D
Sbjct: 66  FNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATE-YETDGY 498
           VA+G K+L ++   +RD+ ++  LL   G      + D G+         A + Y    Y
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM---------ARDIYRASYY 175

Query: 499 R----------WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 546
           R          W+ PE  + G   S ++ W     SFG+++WE+ + G   Y      Q 
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVW-----SFGVLLWEIFSLGYMPYP-GRTNQE 229

Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            +     G R + PK CP  +  +M  CW ++P  RP F+ I+  +
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 9e-20
 Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 26/257 (10%)

Query: 346 DQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 400
           ++IG  +F  VYKG  +   E  +K C +        RK L E   L    H NI++   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 401 VCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
           VCV +   + +V +L+ GGS +  L  K  +L  K+++++++D A G+++L      +RD
Sbjct: 60  VCVQK-QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYR-----WLAPEII-AGDPES 512
           L ++  L+  +  + + D G+        E   Y  +DG +     W APE +  G   S
Sbjct: 119 LAARNCLVGENNVLKISDFGM----SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 513 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
            S+ W     S+G+++WE  + G+  Y   S  Q    I + G R   P+ CP+ +  LM
Sbjct: 175 ESDVW-----SYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLM 228

Query: 572 IKCWNNSPSKRPQFSEI 588
           ++CW   P  RP FSEI
Sbjct: 229 LQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 16/249 (6%)

Query: 354 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409
           KG+YK K+    V ++ LK  +   A + EL ++   +    +  I++   +C  E+   
Sbjct: 13  KGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES--W 70

Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
            +V +L E G +N  + K++ +  K I  +   V+ G+K+L +    +RDL ++ +LL  
Sbjct: 71  MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT 130

Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
                + D G+  A  +     + +T G    +W APE +     S      S+V+SFG+
Sbjct: 131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK----SDVWSFGV 186

Query: 527 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           ++WE  + G+  Y      +    I + G R E P+ CP  +  LM  CW     +RP F
Sbjct: 187 LMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWTYGVDERPGF 245

Query: 586 SEIISLLLR 594
           + ++ L LR
Sbjct: 246 A-VVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H NI++   VC  +   + +V +L++GG     +  +  +L+ KE+I++  + A G+++L
Sbjct: 52  HPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPEI 505
                 +RDL ++  L+     + + D G+    +   +     T G +     W APE 
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGM---SREEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 506 IA-GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           +  G   S S+ W     SFG+++WE  + G   YA  S  Q    I   G+R   P+ C
Sbjct: 168 LNYGRYSSESDVW-----SFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELC 221

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
           P  +  LM +CW   P +RP FS +   L 
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 50/265 (18%)

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKLME 417
           G+ V ++ LK  + G       +K++  L T  H+NI+++   C ++   GL ++ + + 
Sbjct: 33  GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91

Query: 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
            GS+ D + K  KL   +++  A  + EG+ +L+     +RDL ++ +LLD    V +GD
Sbjct: 92  LGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150

Query: 478 MGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMV 527
            G+    K+V E  EY    YR          W A E +    +    ++ S+V+SFG+ 
Sbjct: 151 FGLA---KAVPEGHEY----YRVREDGDSPVFWYAVECL----KENKFSYASDVWSFGVT 199

Query: 528 IWEMVTGEAAYAACSPVQAA-------VGIAAC-------------GLRPEIPKDCPQIL 567
           ++E++T       C   Q+        +G                 G+R   PK+CPQ +
Sbjct: 200 LYELLT------HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEV 253

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             LM  CW      RP F  +I +L
Sbjct: 254 YILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 29/272 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKG-KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ + ++G   F     G Y G  +V I+ LK G     A+  E  L K L  
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-- 58

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
                H  +++ Y V   E   + ++T+ ME GS+ D  LK+    KL   ++I +A  +
Sbjct: 59  ----QHPRLVRLYAVVTQEP--IYIITEYMENGSLVDF-LKTPEGIKLTINKLIDMAAQI 111

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
           AEG+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W 
Sbjct: 112 AEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWT 170

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P
Sbjct: 171 APEAINYGTFTIK----SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRP 225

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            +CP+ L  LM  CW   P +RP F  + S+L
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKL-KGCDKGNAYEFELRK 382
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKS-------RKLQT 433
            +++  TC H  +++   V V +     VV +LM  G +   +  L+        R   T
Sbjct: 61  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117

Query: 434 -KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+            
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-------- 169

Query: 493 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           YETD YR          W+APE +    +    T  S+++SFG+V+WE+ +  E  Y   
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225

Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           S  Q    +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 226 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 36/271 (13%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHK 393
           D  E I ++G  +F  VYK +          K     +  E EL   ++E   L  C H 
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHP 62

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLND 452
           NI+  Y     EN  L ++ +  +GG+++ ++L+  +  T+  IR +   + E + FL+ 
Sbjct: 63  NIVGLYEAYFYENK-LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------ATEYETDGYRWLAPEII 506
           H V +RDL +  ILL   G+V L D G+    KS  +       T Y      W+APE++
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY------WMAPEVV 175

Query: 507 AGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-D 562
           A   E+  +    + ++++S G+ + E+   E  +   +P++  + I    L+ E P  D
Sbjct: 176 AC--ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----LKSEPPTLD 229

Query: 563 CPQI----LKSLMIKCWNNSPSKRPQFSEII 589
            P          +  C    P  RP  +E++
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 31/265 (11%)

Query: 348 IGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 394
           IG   F  V +G+          V I+ LK       Y  + R+D L E    G   H N
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-----GYTEKQRRDFLSEASIMGQFDHPN 66

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           I+    V V ++  + ++T+ ME G+++  +     +    +++ +   +A G+K+L++ 
Sbjct: 67  IIHLEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG----YRWLAPEIIAG 508
              +RDL ++ IL++ +    + D G+    +    + T   + G     RW APE IA 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA- 184

Query: 509 DPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
                  T  S+V+S+G+V+WE M  GE  Y   S  Q  +       R   P DCP  L
Sbjct: 185 ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTAL 240

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             LM+ CW    + RP+F +I+S L
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 35/259 (13%)

Query: 348 IGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFELR--KDLLELMTCGHKNILQFYCVCV 403
           +G  +F  V+KG  K      +K C +    E +++   +   L    H NI++   VC 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
            +   + +V +L+ GG     + K + +L+TK++++ A+D A G+ +L      +RDL +
Sbjct: 63  -QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----------RWLAPEIIA-GDP 510
           +  L+  +  + + D G+          +  E DG            +W APE +  G  
Sbjct: 122 RNCLVGENNVLKISDFGM----------SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 511 ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
            S S+ W     S+G+++WE  + G   Y   +  QA   +   G R   P+ CP  +  
Sbjct: 172 SSESDVW-----SYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYK 225

Query: 570 LMIKCWNNSPSKRPQFSEI 588
           +M +CW+  P  RP+FSE+
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 41/285 (14%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 433
            +++   C H  +++   V V +     V+ +LM  G +    L+S + +          
Sbjct: 61  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVQAPP 116

Query: 434 --KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
             K++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E  
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYETD 173

Query: 492 EYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 545
            Y   G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  Q
Sbjct: 174 YYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQ 229

Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
               +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 VLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 30/199 (15%)

Query: 411 VVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           V+   M+ G ++  +L SR       L  + ++R  ID+A G+++L+     +RDL ++ 
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVS 514
            +L+ +  VC+ D G+    K +     Y  D YR          WLA E +A +  +  
Sbjct: 144 CMLNENMTVCVADFGL---SKKI-----YSGDYYRQGCASKLPVKWLALESLADNVYTTH 195

Query: 515 ETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 573
               S+V++FG+ +WE++T G+  YA     +    +   G R + P DC + +  LM +
Sbjct: 196 ----SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQPPDCLEDVYELMCQ 250

Query: 574 CWNNSPSKRPQFSEIISLL 592
           CW+  P  RP F  +   L
Sbjct: 251 CWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 78/289 (26%), Positives = 137/289 (47%), Gaps = 58/289 (20%)

Query: 342 LEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L+FI Q+G  +F  V            G+ V ++KL+     +  +FE  +++  L +  
Sbjct: 6   LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQ 63

Query: 392 HKNILQFYCVCVDENH-GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 449
           H NI+++  VC       L +V + +  GS+ D + K R +L  ++++  A  + +G+++
Sbjct: 64  HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------- 499
           L      +RDL ++ IL++    V +GD G+    K + +  EY    Y+          
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLT---KVLPQDKEY----YKVREPGESPIF 176

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA--ACSP-----------VQA 546
           W APE +     SV+    S+V+SFG+V++E+ T    Y+  +CSP            Q 
Sbjct: 177 WYAPESLTESKFSVA----SDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQG 228

Query: 547 A------VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                  + +     R   P  CP  + ++M +CWNN PS+RP FSE+ 
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 20/219 (9%)

Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +L K+L       H+ I+Q+Y  C+ ++  L +  + M GGSV D +     L     
Sbjct: 54  EIQLLKNLQ------HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT 106

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATE 492
            +    + EG+++L+ + + +RD+    IL D  GNV LGD G    + T C S      
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 493 YETDGYRWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
                Y W++PE+I+G      E +   ++V+S G  + EM+T +  +A    + A   I
Sbjct: 167 VTGTPY-WMSPEVISG------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219

Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           A     P++P       ++ + + +  +  KRP   E++
Sbjct: 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L+ I ++G   F  V+ G      +V ++ LK G     ++  E ++ K L  
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-- 58

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H  ++Q Y V  +E   + +VT+ M  GS+ D +   + R L+   ++ +A  VA
Sbjct: 59  ----RHDKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGY--RWL 501
            G+ ++      +RDL S  IL+   G VC + D G+    +   E T  +   +  +W 
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIED-NEYTARQGAKFPIKWT 170

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE       ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P
Sbjct: 171 APEAALYGRFTIK----SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCP 225

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +DCP  L  LM++CW   P +RP F  + S L
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 17/201 (8%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H  I++ +     E   L +V +   GG +   + K  +   +     A ++   
Sbjct: 47  LSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA 105

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWL 501
           +++L+  G+ YRDL  + ILLD  G++ L D G+    K +            T  Y  L
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL---AKELSSEGSRTNTFCGTPEY--L 160

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           APE++ G     +  W    +S G++++EM+TG+  + A    +    I         P+
Sbjct: 161 APEVLLGKGYGKAVDW----WSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPE 214

Query: 562 DCPQILKSLMIKCWNNSPSKR 582
                 + L+       P+KR
Sbjct: 215 FLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 59/295 (20%)

Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE---LMTC 390
           NL     +G   F  V K     ++   G         K NA   ELR  L E   L   
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------------- 430
            H ++++ Y  C  ++  L ++ +  + GS+   + +SRK                    
Sbjct: 61  NHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L   ++I  A  ++ G+++L +  + +RDL ++ +L+     + + D G+    + 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL---SRD 176

Query: 487 VGEATEYETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 535
           V     YE D Y          +W+A E +         T  S+V+SFG+++WE+VT G 
Sbjct: 177 V-----YEEDSYVKRSKGRIPVKWMAIESLFDH----IYTTQSDVWSFGVLLWEIVTLGG 227

Query: 536 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             Y   +P +    +   G R E P++C + + +LM+ CW   P KRP F++I  
Sbjct: 228 NPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I   +     K++I   + VA+G+++L
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-------WLAP 503
                 +RDL ++  +LD    V + D G+    + + +   Y    +        W+A 
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLA---RDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E +    ++   T  S+V+SFG+++WE++T G   Y         V +   G R   P+ 
Sbjct: 172 ESL----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEY 226

Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           CP  L  +M+ CW+  P  RP FSE++S
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIKF 449
           H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  +++
Sbjct: 61  HPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEI 505
           L      +RDL ++  L+  +  V + D G+    + +   T     G     +W APE 
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGL---SRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
           +A +  S+     S+V++FG+++WE+ T G + Y     +     +   G R E P+ CP
Sbjct: 177 LAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCP 231

Query: 565 QILKSLMIKCWNNSPSKRPQFSEI 588
             +  LM  CW  +PS RP F+EI
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 85.6 bits (210), Expect = 8e-18
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 32/278 (11%)

Query: 341 NLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNI 395
           +   + ++G  SF  VY  +    V ++ L    +  + E E     ++++       NI
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLND 452
           ++ Y    DE   L +V + ++GGS+ DL+    +   L   E + I   +   +++L+ 
Sbjct: 61  VKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 453 HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACKSVGEATEYE--------TDGYRWLAP 503
            G+ +RD+  + ILLDR G  V L D G+       G  +           T GY   AP
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM--AP 177

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTG----EAAYAACSPVQAAVGIAACG----- 554
           E++ G   + + +  S+++S G+ ++E++TG    E    + +  Q    I         
Sbjct: 178 EVLLGLSLAYA-SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 555 --LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             L P  P+   +    L+ K     P  R   S  +S
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 28/272 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E  L K    
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---- 56

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDV 443
             T  H  +++ Y V V +   + ++T+ M  GS+ D  LKS    K+   ++I  +  +
Sbjct: 57  --TLQHDKLVRLYAV-VTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQI 112

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
           AEG+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W 
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 171

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE I       S T  S+V+SFG++++E+VT G+  Y   S       +   G R    
Sbjct: 172 APEAI----NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRM 226

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           ++CP  L  +M  CW     +RP F  + S+L
Sbjct: 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 55/286 (19%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQ 397
            EF+   G   F G  +   V ++ L+      A     R D L+    +    + NI++
Sbjct: 30  AEFL-GEGAPEFDG--QPVLVAVKMLRADVTKTA-----RNDFLKEIKIMSRLKNPNIIR 81

Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------------EIIRIAIDVA 444
              VCV ++  LC++T+ ME G +N   L  R++++               ++ +A+ +A
Sbjct: 82  LLGVCVSDD-PLCMITEYMENGDLN-QFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YR 499
            G+K+L      +RDL ++  L+  H  + + D G+    +++     Y   G      R
Sbjct: 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM---SRNLYSGDYYRIQGRAVLPIR 196

Query: 500 WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIAACG-- 554
           W+A E I+ G   + S+ W     +FG+ +WEM T   E  Y+  S  Q    I   G  
Sbjct: 197 WMAWESILLGKFTTASDVW-----AFGVTLWEMFTLCKEQPYSLLSDEQV---IENTGEF 248

Query: 555 LRPE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            R +           CP  +  LM++CW+     RP F++I   L 
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 46/227 (20%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--------KLQTKEIIRIAIDV 443
           H+NIL    VC+++     V+   M  G++   + + R         L T++++ +AI +
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNV-----------------CLGDMGIVTACKS 486
           A G+ +L+  GV ++D+ ++  ++D    V                 CLGD         
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD--------- 177

Query: 487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 545
                  E    +W+A E +     S +    S+V+SFG+++WE++T G+  Y    P +
Sbjct: 178 ------NENRPVKWMALESLVNKEYSSA----SDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            A  +   G R   P +CP  L ++M  CW   P +RP FS+++  L
Sbjct: 228 MAAYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 33/253 (13%)

Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK        +F+   +LL  +   H++I++FY VC D +  L +V + M+ G +
Sbjct: 38  VAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGD-PLIMVFEYMKHGDL 94

Query: 422 ND----------LILKSRKLQTK------EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
           N           +++  +  Q K      +++ IA  +A G+ +L      +RDL ++  
Sbjct: 95  NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154

Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSN 520
           L+  +  V +GD G+    + V     Y   G+     RW+ PE I     +      S+
Sbjct: 155 LVGANLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SD 207

Query: 521 VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           V+SFG+++WE+ T G+  +   S  +    I   G   E P+ CP+ +  +M+ CW   P
Sbjct: 208 VWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREP 266

Query: 580 SKRPQFSEIISLL 592
            +R    EI  +L
Sbjct: 267 QQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 65/264 (24%), Positives = 122/264 (46%), Gaps = 29/264 (10%)

Query: 348 IGPNSFKGVYKG-----------KRVGIEKL--KGCDKGNAYEFELRKDLLELMTCGHKN 394
           IG  SF  VY G           K+V +  +     D+  +    L +++  L    H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+Q+    +D +H L +  + + GGSV  L+      +   +      + +G+ +L++ G
Sbjct: 68  IVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEII 506
           + +RD+    IL+D  G + + D GI  + K    +   +T+G R        W+APE++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGI--SKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               +  S T  ++++S G ++ EM+TG+  +  C+ +QA   I      PEIP +    
Sbjct: 185 ----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSE 239

Query: 567 LKSLMIKCWNNSPSKRPQFSEIIS 590
               + K +    +KRP  +E++ 
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLK 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 26/165 (15%)

Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NI++ Y    V +   L VV + +EGG++ D++  +R +  ++I  + + V + + FL
Sbjct: 75  HPNIVEMYSSYLVGDE--LWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFL 131

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---------ATEYETDGYRWL 501
           +  GV +RD+ S  ILL   G V L D G    C  V +          T Y      W+
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGF---CAQVSKEVPRRKSLVGTPY------WM 182

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 546
           APE+I+  P   +E    +++S G+++ EMV GE  Y    P+QA
Sbjct: 183 APEVISRLPYG-TEV---DIWSLGIMVIEMVDGEPPYFNEPPLQA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 28/252 (11%)

Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK   +    +F+   +LL ++   H++I++FY VC  E   L +V + M  G +
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCT-EGRPLLMVFEYMRHGDL 94

Query: 422 NDL---------ILKSRKLQT------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           N           IL   +          +++ IA  +A G+ +L      +RDL ++  L
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154

Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 523
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+++S
Sbjct: 155 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDIWS 209

Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           FG+V+WE+ T G+  +   S  +A   I   G   E P+ CP  + ++M  CW   P +R
Sbjct: 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQR 268

Query: 583 PQFSEIISLLLR 594
               +I S L  
Sbjct: 269 MVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 35/219 (15%)

Query: 392 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 440
           H N+++   VC+   E+ G     V+   M+ G ++  +L SR       L T+ +++  
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 499
            D+A G+++L+     +RDL ++  +L+ + NVC+ D G+    K +     Y  D YR 
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL---SKKI-----YNGDYYRQ 170

Query: 500 ---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 549
                    W+A E +A   + V  T  S+V+SFG+ +WE+ T G+  Y      +    
Sbjct: 171 GRIAKMPVKWIAIESLA---DRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226

Query: 550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           +   G R + P DC   L SLM  CW  +P  RP F  +
Sbjct: 227 LRQ-GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 74/304 (24%), Positives = 136/304 (44%), Gaps = 42/304 (13%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           RW +  D L     +G   F  V   + +G++K K            K +A E +L   +
Sbjct: 12  RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI 71

Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                +L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 485 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
             + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 191 HHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
             PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   ++ 
Sbjct: 246 V-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI--LAL 302

Query: 601 SSNR 604
           +SN+
Sbjct: 303 TSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 75/296 (25%), Positives = 135/296 (45%), Gaps = 48/296 (16%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKD---------- 383
           +W    D L     +G   F  V + +  GI+K +  D+      ++ KD          
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRP-DQTVTVAVKMLKDNATDKDLADL 64

Query: 384 --LLELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 430
              +ELM     HKNI+    VC  E   L V+ +    G++ +  L++R+         
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEG-PLYVIVEYAAKGNLREF-LRARRPPGPDYTFD 122

Query: 431 --------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482
                   L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+  
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA- 181

Query: 483 ACKSVGEATEYE--TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEA 536
             + V +   Y+  ++G    +W+APE +    + V  T  S+V+SFG+++WE+ T G +
Sbjct: 182 --RGVHDIDYYKKTSNGRLPVKWMAPEALF---DRVY-THQSDVWSFGILMWEIFTLGGS 235

Query: 537 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            Y    PV+    +   G R + P +C   L  LM +CW+  P++RP F +++  L
Sbjct: 236 PYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 46/287 (16%)

Query: 340 DNLEFIDQIGPNSFKGVYKG--KRVG------IEKLKGCDKGNAYEFELRKDLLELMTCG 391
           ++++F D IG  +F  V +   K+ G      I+ LK     N +  +   +L  L   G
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-DFAGELEVLCKLG 60

Query: 392 -HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT---------------- 433
            H NI+     C  EN G L +  +    G++ D + KSR L+T                
Sbjct: 61  HHPNIINLLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVG 488
           +++++ A DVA G+++L++    +RDL ++ +L+  +    + D G+     V   K++G
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 547
                     RW+A E +     SV  T  S+V+SFG+++WE+V+ G   Y   +  +  
Sbjct: 179 RLP------VRWMAIESLN---YSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228

Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             +   G R E P++C   +  LM +CW + P +RP F++I   L R
Sbjct: 229 EKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGI 447
           H+NI+Q Y     EN    +  + + GGS++ L L+S+   L+  E  II     + EG+
Sbjct: 64  HRNIVQ-YLGSDSENGFFKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           K+L+D+ + +RD+    +L++ +  V  + D G       +   TE  T   +++APE+I
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA---VGIAACGLRPEIPKDC 563
              P        ++++S G  I EM TG+  +      QAA   VG+    + PEIP+  
Sbjct: 182 DKGPRGYGAP--ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--IHPEIPESL 237

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEII 589
               K+ +++C+   P KR    +++
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 36/227 (15%)

Query: 384 LLELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
           L E +T G   H NI++   V +   + + +VT+ M  G+++  + K   +L   +++ +
Sbjct: 54  LAEALTLGQFDHSNIVRLEGV-ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--------EAT 491
              +A G+K+L++ G  ++ L + ++L++               CK  G           
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-----------LVCKISGFRRLQEDKSEA 161

Query: 492 EYETDGYR----WLAPEIIA-GDPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACSPVQ 545
            Y T   +    W APE I      S S+ W     SFG+V+WE M  GE  Y   S  Q
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVW-----SFGIVMWEVMSYGERPYWDMSG-Q 215

Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +     G R   P++CP +L  LM+ CW     +RP+FS+I S+L
Sbjct: 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 72/260 (27%), Positives = 120/260 (46%), Gaps = 33/260 (12%)

Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK        +F    +LL  +   H++I++FY VCV E   L +V + M+ G +
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCV-EGDPLIMVFEYMKHGDL 94

Query: 422 N--------DLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           N        D +L +      +L   +++ IA  +A G+ +L      +RDL ++  L+ 
Sbjct: 95  NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSNVYS 523
            +  V +GD G+    + V     Y   G+     RW+ PE I         T  S+V+S
Sbjct: 155 ENLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWS 207

Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            G+V+WE+ T G+  +   S  +    I   G   + P+ CP+ +  LM+ CW   P  R
Sbjct: 208 LGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMR 266

Query: 583 PQFSEIISLLLRTNNISNSS 602
               EI SLL    N++ +S
Sbjct: 267 LNIKEIHSLL---QNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 29/272 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E  + K L  
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-- 58

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
                H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +
Sbjct: 59  ----QHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQI 111

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
           AEG+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W 
Sbjct: 112 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT 170

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P
Sbjct: 171 APEAI----NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRP 225

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           ++CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 40/294 (13%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           RW  + D L     +G   F  V   + +GI+K K  +         K +A E +L   +
Sbjct: 9   RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 68

Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 69  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127

Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                ++  K+++     VA G+++L      +RDL ++ +L+  +  + + D G+    
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 485 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
            ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 188 NNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             PV+    +   G R + P +C   L  +M  CW+  PS RP F +++  L R
Sbjct: 243 I-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 39/225 (17%)

Query: 392 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 440
           H N+++   VC +      +    V+   M+ G ++  +L SR      KL  + +++  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 499
           +D+A G+++L++    +RDL ++  +L     VC+ D G+            Y  D YR 
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL--------SKKIYSGDYYRQ 171

Query: 500 ---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA-- 547
                    W+A E +A        T  S+V++FG+ +WE+ T G+  Y     V+    
Sbjct: 172 GRIAKMPVKWIAIESLADR----VYTSKSDVWAFGVTMWEIATRGQTPYPG---VENHEI 224

Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 G R + P+DC   L  LM  CW   P  RP F+++  +L
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 46/234 (19%)

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE------------------ 435
           NI++   VCVDE+  LC++T+ ME G +N   L S  L  KE                  
Sbjct: 80  NIIRLLGVCVDED-PLCMITEYMENGDLNQF-LSSHHLDDKEENGNDAVPPAHCLPAISY 137

Query: 436 --IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
             ++ +A+ +A G+K+L+     +RDL ++  L+  +  + + D G+    +++     Y
Sbjct: 138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM---SRNLYAGDYY 194

Query: 494 ETDG-----YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWE--MVTGEAAYAACSPVQ 545
              G      RW+A E I+ G   + S+ W     +FG+ +WE  M+  E  Y   +  Q
Sbjct: 195 RIQGRAVLPIRWMAWECILMGKFTTASDVW-----AFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 546 AAVGIAACGLRPE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +  A    R +        P  CPQ L  LM++CW+    +RP FS+I + L
Sbjct: 250 V-IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 65/257 (25%), Positives = 117/257 (45%), Gaps = 29/257 (11%)

Query: 348 IGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKD---LLELMTCGHKNILQFY 399
           IG  ++  VY+GK     RV   K+   D  +    +++++   L +L      NI ++Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 400 -CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
                     L ++ +  EGGSV  L +K+  +  K I  I  +V   +K+++  GV +R
Sbjct: 69  GSYLKGPR--LWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125

Query: 459 DLNSQRILLDRHGNVCLGDMGI------VTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
           D+ +  IL+   GNV L D G+       ++ +S    T Y      W+APE+I    E 
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY------WMAPEVIT---EG 176

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLM 571
                 ++++S G+ I+EM TG   Y+     +A + I      P +  +   ++L+  +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-PPRLEDNGYSKLLREFV 235

Query: 572 IKCWNNSPSKRPQFSEI 588
             C +  P +R    E+
Sbjct: 236 AACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 72/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELR-----KDLLEL- 387
           +W L+   L     +G   F  V   + +GI+K K           L+     KDL +L 
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 388 -------MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------------- 425
                  M   HKNI+     C  ++  L V+ +    G++ + +               
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 426 -LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
            L   +L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 485 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
            ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 185 HNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
             PV+    +   G R + P +C   L  +M +CW+  PS+RP F +++  L R   +++
Sbjct: 240 I-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298

Query: 601 S 601
           +
Sbjct: 299 T 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 16/262 (6%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGH-KNILQ 397
            E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L    H +NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 398 FYCVCVDEN-----HGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFL 450
           +Y   + +N       L +V +    GSV DLI   K   L+ + I  I  ++  G+  L
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 509
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 186

Query: 510 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
             P++  + + S+++S G+   EM  G        P++A   I          K   +  
Sbjct: 187 ENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245

Query: 568 KSLMIKCWNNSPSKRPQFSEII 589
           +S +  C   + S+RP   +++
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H N++++Y V V     + +  +   GG++ +L+   R L    I    + + EG+ +L+
Sbjct: 58  HPNLVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW------LAPEI 505
            HG+ +RD+    I LD +G + LGD G   A K     T    +          +APE+
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFG--CAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           I G           +++S G V+ EM TG+  ++        +     G +P IP     
Sbjct: 175 ITGGKGKGHGRAA-DIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS--- 230

Query: 566 ILKSLMIK-----CWNNSPSKRPQFSEI 588
           +  S   K     C  + P KRP  SE+
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 14/253 (5%)

Query: 345 IDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
           + +IG  SF      K    GK+  I+++           E RK++  L    H NI+Q 
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLNDHGVA 456
           Y    +EN  L +V    EGG +   I   R +     +I+   + +   +K ++D  + 
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123

Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 516
           +RD+ SQ I L + G + LGD GI     S  E          +L+PEI    P +    
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK-- 181

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
             S++++ G V++EM T + A+ A +     + I   G  P +       L++L+ + + 
Sbjct: 182 --SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQLFK 238

Query: 577 NSPSKRPQFSEII 589
            +P  RP  + I+
Sbjct: 239 RNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 72/281 (25%), Positives = 124/281 (44%), Gaps = 33/281 (11%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK-----------LKGCDKGNAYEFELRK 382
           +W    +NL F   +G  +F  V +    G+ K           LK     ++ E E   
Sbjct: 29  KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSEREALM 86

Query: 383 DLLELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRI 439
             L++M+    H+NI+     C      L +      G  +N L  K    L  ++++  
Sbjct: 87  SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG- 497
           +  VA+G+ FL      +RDL ++ +LL  HG +  + D G+    + +   + Y   G 
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLA---RDIMNDSNYVVKGN 202

Query: 498 ----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV-GIA 551
                +W+APE I      V  T+ S+V+S+G+++WE+ + G   Y    PV +    + 
Sbjct: 203 ARLPVKWMAPESIF---NCVY-TFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLI 257

Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 24/254 (9%)

Query: 343 EFIDQIGPNSFKGVYKGKRVG---IEKLKGCDKGNAYEFELRKDLLE---LMTCGHKNIL 396
           E +++IG  SF  V+K  R     +  +K  D       E  + + E   L       I+
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 454
           ++Y     +   L +V +  E G ++ L+   R   L   ++ R  I +  G+  L+   
Sbjct: 63  RYY-ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWLAPEIIAGD 509
           + +RD+ S  + LD + NV +GD+G+    K + + T +      T  Y  L+PE+    
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVA---KLLSDNTNFANTIVGTPYY--LSPELCEDK 176

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
           P +      S+V++ G+V++E  TG+  + A +     + I   G+ P + +   Q L  
Sbjct: 177 PYNEK----SDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQ 231

Query: 570 LMIKCWNNSPSKRP 583
           L+ +C      +RP
Sbjct: 232 LIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 67/274 (24%), Positives = 127/274 (46%), Gaps = 24/274 (8%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 386
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 3   ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 445
           + +  H ++++   VC+     + +VT+LM  G + D + + +  + ++ ++   + +A+
Sbjct: 63  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 178

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           A E I         T  S+V+S+G+ IWE++T G   Y    P +    +   G R   P
Sbjct: 179 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQP 233

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             C   +  +M+KCW      RP+F E+ +   R
Sbjct: 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 392 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----------------K 434
           H NI+     C  E+ G L +  +    G++ D + KSR L+T                +
Sbjct: 55  HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVGE 489
           +++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K++G 
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172

Query: 490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV 548
                    RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  +   
Sbjct: 173 LP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222

Query: 549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            +   G R E P +C   +  LM +CW   P +RP F++I
Sbjct: 223 KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 25/242 (10%)

Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQ 397
            E ++ +G  ++  VYKG+ V   +L      +  E E  +  LE+        H+NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 398 FYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKFL 450
           +Y   + +     +  L +V +    GSV DL+  ++    KE  I  I  ++  G+  L
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 509
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 196

Query: 510 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
             P++  + + S+++S G+   EM  G        P++A            IP++ P  L
Sbjct: 197 ENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246

Query: 568 KS 569
           KS
Sbjct: 247 KS 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/198 (25%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 408 GLCV------VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460
           G+C+      VT+LM  G + D + +++ ++ +++++   + +A+G+ +L +  + +RDL
Sbjct: 76  GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDL 135

Query: 461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSET 516
            ++ +L+    +V + D G+        + TEY  DG     +W+A E I         T
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESIL----HRRFT 189

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
             S+V+S+G+ +WE++T  A      P +    +   G R   P  C   +  +M+KCW 
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM 249

Query: 577 NSPSKRPQFSEIISLLLR 594
                RP+F E++    R
Sbjct: 250 IDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 35/258 (13%)

Query: 362 VGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
           V ++ L+         +F   K++  L      NI +   VC  +   LC++ + ME G 
Sbjct: 49  VAVKVLRPDASDNAREDFL--KEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGD 105

Query: 421 VN-----------DLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
           +N            L   S+ L    ++ +A  +A G+++L      +RDL ++  L+ +
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165

Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSF 524
           +  + + D G+    +++  +  Y   G      RW+A E +     +      S+V++F
Sbjct: 166 NYTIKIADFGM---SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK----SDVWAF 218

Query: 525 GMVIWEMVT--GEAAYAACSP---VQAAVGIAACGLRPEI---PKDCPQILKSLMIKCWN 576
           G+ +WE++T   E  Y   +    ++ A        R      P +CP+ +  LM++CW 
Sbjct: 219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWR 278

Query: 577 NSPSKRPQFSEIISLLLR 594
                RP F EI   L R
Sbjct: 279 RDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 55/297 (18%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKR-----------VGIEKLK-GCDKGNAYEFELRKDLLEL 387
           +N+E++  IG  +F  V++ +            V ++ LK         +F+    L+  
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI---------------LKSRK-- 430
               H NI++   VC      +C++ + M  G +N+ +                 +RK  
Sbjct: 65  FD--HPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 431 -----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+     
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 486 SVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 542
           S    +A+E +    RW+ PE I  +      T  S+V+++G+V+WE+ + G   Y   +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Query: 543 --PVQAAV---GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
              V   V    + +C      P +CP  L +LM  CW+  PS RP F+ I  +L R
Sbjct: 238 HEEVIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 374 NAYEFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ 432
           NA E E++  LL+ +   H  I+Q+Y C+   E   L +  + M GGS+ D +     L 
Sbjct: 49  NALECEIQ--LLKNLR--HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT 104

Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVG 488
                R    + +G+ +L+ + + +RD+    IL D  GNV LGD G    I T C S G
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS-G 163

Query: 489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
              +  T    W++PE+I+G+         ++V+S    + EM+T +  +A    + A  
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRK----ADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219

Query: 549 GIAACGLRPEIPKD----CPQILKSLMI 572
            IA    +P +P      C   LK + +
Sbjct: 220 KIATQPTKPMLPDGVSDACRDFLKQIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 77.0 bits (189), Expect = 6e-15
 Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 428 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
           S  L T +++     VA G++FL      +RDL ++ +LL +   V + D G+    + +
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA---RDI 287

Query: 488 GEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
              + Y + G      +W+APE I  +      T +S+V+S+G+++WE+ + G   Y   
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDN----LYTTLSDVWSYGILLWEIFSLGGTPYPGM 343

Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF---SEIISLLL 593
                       G R   P    Q +  +M+KCWN+ P KRP F   S+I+  LL
Sbjct: 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-----------SRKLQTKEIIRIAID 442
           NI++   VC+  +  LC++T+ ME G +N  + +              +    +I +A  
Sbjct: 80  NIIRLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 497
           +A G+K+L+     +RDL ++  L+ ++  + + D G+    +++     Y   G     
Sbjct: 139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM---SRNLYSGDYYRIQGRAVLP 195

Query: 498 YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIAAC- 553
            RW++ E I+ G       T  S+V++FG+ +WE++T   E  Y+  S  Q         
Sbjct: 196 IRWMSWESILLG-----KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250

Query: 554 ---GLRPEIPKD--CPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
              G +  +PK   CP  L  LM+ CW  +  +RP F EI + LL
Sbjct: 251 RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 21/240 (8%)

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLME 417
              +   K    D     + ++ ++L    +C    I+++Y   +DE+   + +  +  E
Sbjct: 25  TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84

Query: 418 GGSVNDLI--LKSRKLQTKE--IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
           GGS++ +   +K R  +  E  + +IA  V +G+ +L+   + +RD+    ILL R G V
Sbjct: 85  GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV 144

Query: 474 CLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
            L D G+     +    T   T  Y  +APE I G P S++    S+V+S G+ + E+  
Sbjct: 145 KLCDFGVSGELVNSLAGTFTGTSFY--MAPERIQGKPYSIT----SDVWSLGLTLLEVAQ 198

Query: 534 GEAAY-AACSPVQAAVGIAACGLRPEIP--KDCPQI-------LKSLMIKCWNNSPSKRP 583
               +     P    + + +  +    P  KD P          K  + +C    P++RP
Sbjct: 199 NRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 61/272 (22%)

Query: 348 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
           IG  SF  VYK       + V I K+   ++      ++++++  L  C    I ++Y  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAI-KVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
              +   L ++ +   GGS  DL LK  KL    I  I  +V  G+++L++ G  +RD+ 
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125

Query: 462 SQRILLDRHGNVCLGDMGIV-----TACKS---VGEATEYETDGYRWLAPEIIAGDPESV 513
           +  ILL   G+V L D G+      T  K    VG  T +      W+APE+I       
Sbjct: 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVG--TPF------WMAPEVI------- 170

Query: 514 SETWMSNVYSFGMVIW-------EMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQ 565
                 + Y     IW       E+  GE   +   P++         L   IPK + P 
Sbjct: 171 ----KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--------LF-LIPKNNPPS 217

Query: 566 I--------LKSLMIKCWNNSPSKRPQFSEII 589
           +         K  +  C N  P +RP   E++
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 50/292 (17%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELM 388
           L  ++++F D IG  +F  V K +           I+++K     + +  +   +L  L 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLC 62

Query: 389 TCG-HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 433
             G H NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 63  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 434 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 485
              ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA--CS 542
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y    C+
Sbjct: 181 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 230

Query: 543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
            +   +     G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 231 ELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIE-----KLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           D+LE++ ++G  +   V K            K    +   A + ++ ++L  L  C    
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIKFL-N 451
           I+ FY    +    + +  + M+GGS+ D ILK  + +  E I  +IA+ V +G+ +L  
Sbjct: 61  IVGFYGAFYNNGD-ISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVT------ACKSVGEATEYETDGYRWLAPEI 505
            H + +RD+    IL++  G + L D G+        A   VG ++        ++APE 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS--------YMAPER 170

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC 541
           I G+  SV     S+++S G+ + E+ TG   Y   
Sbjct: 171 IQGNDYSVK----SDIWSLGLSLIELATGRFPYPPE 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      +V I+ LK G     A+  E ++ K L  
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR- 59

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVA 444
                H  ++  Y V  +E   + +VT+ M  GS+ D + +   + L+  +++ +A  +A
Sbjct: 60  -----HDKLVPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           +G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTA 171

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+VT G   Y      +    +   G R   P+
Sbjct: 172 PEAALYGRFTIK----SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQ 226

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            CP+ L  LM  CW   P +RP F  I S L
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 61

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L +  + +RDL ++ +L+    +V + D G+     +  +  EY  +G     +W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKW 177

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 178 MALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 232

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 233 PPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)

Query: 377 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
           E +L K+LL      H+ I+Q+Y C+       L +  + M GGS+ D  LKS    T+ 
Sbjct: 54  EIQLLKNLL------HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ-LKSYGALTEN 106

Query: 436 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 490
           + R     + EG+ +L+ + + +RD+    IL D  GNV LGD G    + T C S G  
Sbjct: 107 VTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-GTG 165

Query: 491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
            +  T    W++PE+I+G+         ++++S G  + EM+T +  +A    + A   I
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRK----ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 221

Query: 551 AACGLRPEIPKD----CPQILKSLMIKCWNNSPSKRPQFSEII 589
           A     P +P      C   LK + ++        RP   E++
Sbjct: 222 ATQPTNPVLPPHVSDHCRDFLKRIFVEA-----KLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 14/193 (7%)

Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC--VCVDENHGLCVVTK 414
           + GK+V ++K+    K    E  L  +++ +    H+N++  Y   +  DE   L VV +
Sbjct: 45  HTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHENVVDMYNSYLVGDE---LWVVME 99

Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
            +EGG++ D++  +R +  ++I  + + V   + +L++ GV +RD+ S  ILL   G + 
Sbjct: 100 FLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158

Query: 475 LGDMGIVT-ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           L D G      K V +        Y W+APE+I+  P         +++S G+++ EM+ 
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPY-WMAPEVISRLPYGTE----VDIWSLGIMVIEMID 213

Query: 534 GEAAYAACSPVQA 546
           GE  Y    P+QA
Sbjct: 214 GEPPYFNEPPLQA 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 39/267 (14%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           + ++++G  S+  VYK      G+ V I+ +           E+ K++  L  C    I+
Sbjct: 6   DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIV 61

Query: 397 QFY-CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           ++Y     + +  L +V +    GSV+D++ + ++ L  +EI  I     +G+++L+ + 
Sbjct: 62  KYYGSYFKNTD--LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVT------ACKSVGEATEYETDGYRWLAPEIIAG 508
             +RD+ +  ILL+  G   L D G+        A ++    T +      W+APE+I  
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF------WMAPEVIQE 173

Query: 509 DP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKDC 563
               + ++ W     S G+   EM  G+  Y+   P++A   I     +P      P+  
Sbjct: 174 IGYNNKADIW-----SLGITAIEMAEGKPPYSDIHPMRA---IFMIPNKPPPTLSDPEKW 225

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIIS 590
                  + KC    P +RP   +++ 
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 59

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 60  -----HEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 171

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 172 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 226

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 12/203 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKF 449
           H NI+++Y   +++   L +V +   GG++ + I K     L    I+   + +   +  
Sbjct: 58  HPNIIEYYENFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIA 507
           ++   + +RDL +Q ILLD+H  V  +GD GI     S  +A T   T  Y  ++PE+  
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY--ISPELCE 174

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
           G P +      S++++ G V++E+ + + A+ A +     + I +    P   +  P  L
Sbjct: 175 GKPYNQK----SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD-L 229

Query: 568 KSLMIKCWNNSPSKRPQFSEIIS 590
           + L++   N  PSKRPQ S+I++
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 10/157 (6%)

Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H+N+++ Y    V E   L V+ + ++GG++ D++ ++R L  ++I  +   V + + +L
Sbjct: 77  HQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYL 133

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETDGYRWLAPEIIAGD 509
           +  GV +RD+ S  ILL   G V L D G      K V +        Y W+APE+I+  
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEVISRT 192

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 546
           P         +++S G+++ EMV GE  Y + SPVQA
Sbjct: 193 PYGTE----VDIWSLGIMVIEMVDGEPPYFSDSPVQA 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 13/221 (5%)

Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEII 437
           E+   +L + +  H  I++   +C      L +VT+L   GS+ D + + R  L  + ++
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYE 494
              + +A+G+ +L +H + +R+L ++ ILL     V + D G+        +    +E++
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
           T   +W+A E I         T  S+V+S+G+ +WEM++ G   YA   P      +   
Sbjct: 173 TP-IKWMALESILFG----RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEK 226

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           G R   P+ C   +  +M+KCW    + RP F E+ +   R
Sbjct: 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 20/256 (7%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
            +LE +  +G  S   VYK      GK   ++K+        +  +L ++L  L +C   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESP 59

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-ND 452
            +++ Y     +   + +V + M+GGS+ DL+ K  K+    +  IA  + +G+ +L   
Sbjct: 60  YVVKCYGA-FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSVGEATEYETDGYRWLAPEIIAGDP 510
             + +RD+    +L++  G V + D GI  V         T   T  Y  ++PE I G+ 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY--MSPERIQGES 176

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPVQAAVGIAAC-GLRPEIPKD-CPQIL 567
            S +    ++++S G+ + E   G+  +     P    +  A C G  P +P +      
Sbjct: 177 YSYA----ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232

Query: 568 KSLMIKCWNNSPSKRP 583
           +  +  C    P KRP
Sbjct: 233 RDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  + Q +  C      L  V + + GG +   I +S +         A ++  G++FL+
Sbjct: 55  HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-----VGEATEYETDGYRWLAPEII 506
           + G+ YRDL    +LLD  G++ + D G+   CK      V  +T   T  Y  +APEI+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGM---CKEGILGGVTTSTFCGTPDY--IAPEIL 168

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +  P   +  W    ++ G++++EM+ G++ +
Sbjct: 169 SYQPYGPAVDW----WALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 23/203 (11%)

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
           +   H  + Q YC C      L  V + + GG +   I KSR+         A ++   +
Sbjct: 51  LARNHPFLTQLYC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL 109

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEYETDGYRWLAPEI 505
            FL+D G+ YRDL    +LLD  G+  L D G+           +T   T  Y  +APEI
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDY--IAPEI 167

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI------ 559
           +       S  W    ++ G++++EM+ G A + A    +    +    L  E+      
Sbjct: 168 LQEMLYGPSVDW----WAMGVLLYEMLCGHAPFEA----ENEDDLFEAILNDEVVYPTWL 219

Query: 560 PKDCPQILKSLMIKCWNNSPSKR 582
            +D   ILK+ M K    +P+ R
Sbjct: 220 SQDAVDILKAFMTK----NPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 377 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
           E +L K+L       H+ I+Q+Y C+       L +  + M GGSV D  LK+    T+ 
Sbjct: 54  EIQLLKNL------QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTES 106

Query: 436 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 490
           + R     + EG+ +L+ + + +RD+    IL D  GNV LGD G    + T C S G  
Sbjct: 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS-GTG 165

Query: 491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
               T    W++PE+I+G+         ++V+S G  + EM+T +  +A    + A   I
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRK----ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221

Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           A     P++P    +  +   + C       RP   E++ 
Sbjct: 222 ATQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 76  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSV 131

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT-ACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-WMAPELISR 190

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQI 566
            P         +++S G+++ EMV GE  Y    P++A   I    L P++         
Sbjct: 191 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPS 245

Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
           LK  + +     P++R   +E++
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 13/194 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  +   +C    + H L  V + + GG +   I  S +         A ++  G++FL+
Sbjct: 55  HPFLTHLFCTFQTKEH-LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 508
             G+ YRDL    +LLD+ G++ + D G+   CK    GE       G   ++APEI+ G
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGM---CKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              + S  W    +SFG++++EM+ G++ +      +    I     RP  P+   +  K
Sbjct: 171 QKYNESVDW----WSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWISKEAK 224

Query: 569 SLMIKCWNNSPSKR 582
             + K +   P+KR
Sbjct: 225 DCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 57/250 (22%), Positives = 115/250 (46%), Gaps = 12/250 (4%)

Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 69  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDS-KA 182

Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 241

Query: 580 SKRPQFSEII 589
           S RP   E++
Sbjct: 242 SFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 17/244 (6%)

Query: 354 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409
           KGVYK ++    V I+ LK  ++ +  + E+ ++   +    +  I++   VC  E   L
Sbjct: 13  KGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMIGVCEAEA--L 69

Query: 410 CVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
            +V ++  GG +N  L  K  ++    ++ +   V+ G+K+L      +RDL ++ +LL 
Sbjct: 70  MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFG 525
                 + D G+  A  +     +  + G    +W APE I     S      S+V+S+G
Sbjct: 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR----SDVWSYG 185

Query: 526 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 584
           + +WE  + G+  Y      +    I   G R + P +CP  + +LM  CW      RP 
Sbjct: 186 ITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244

Query: 585 FSEI 588
           F+++
Sbjct: 245 FAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 25/262 (9%)

Query: 347 QIGPNSFKGVYKGKRVG------IEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 395
           Q+G  +F   Y+ + V       ++++        ++    E  LRK++  +    H +I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHI 65

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           ++      +++H   +  + M GGSV+ L+ K    +   II     +  G+ +L+++ +
Sbjct: 66  IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 456 AYRDLNSQRILLDRHGN-VCLGDMG----IVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
            +RD+    +L+D  G  + + D G    +       GE          ++APE++ G+ 
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAA---CSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S     +V+S G VI EM T +  + A    + +     IA+    P IP+     L
Sbjct: 185 YGRS----CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 568 KSLMIKCWNNSPSKRPQFSEII 589
           + + ++C    P  RP   E++
Sbjct: 241 RDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 28/258 (10%)

Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  VYKG     K V   K+   ++      ++++++  L  C    I ++Y
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL LK   L+   I  I  ++ +G+ +L+     +RD
Sbjct: 69  GSYL-KGTKLWIIMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL   G+V L D G+                   W+APE+I    +  +  + +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----KQSAYDFKA 182

Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL--------KSLM 571
           +++S G+   E+  GE   +   P++             IPK+ P  L        K  +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSKPFKEFV 233

Query: 572 IKCWNNSPSKRPQFSEII 589
             C N  P  RP   E++
Sbjct: 234 EACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 37/228 (16%)

Query: 379 ELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK 434
            +RK +L     +  C    I+ FY   ++EN+ +C+  + M+ GS++ +  K   +  +
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVE 103

Query: 435 EIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI------VTACKSV 487
            + +IA+ V EG+ +L N H + +RD+    IL++  G + L D G+        A   V
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 547
           G +T        +++PE I G   +V     S+V+S G+ I E+  G+  +A  S +   
Sbjct: 164 GTST--------YMSPERIQGGKYTVK----SDVWSLGISIIELALGKFPFAF-SNIDDD 210

Query: 548 VGIAACGL-----------RPEIPK-DCPQILKSLMIKCWNNSPSKRP 583
                 G+            P +P  D P+ L+  +  C    P++RP
Sbjct: 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 25/225 (11%)

Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E E  KDL       H NI+Q Y         L +  + + GGS+   +    + + + +
Sbjct: 58  EIETLKDL------DHLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                 V EG+ +L+  G+ +RDL +  +L+D  G   + D GI      +     Y+ D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI-----YDND 165

Query: 497 GYR-------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
                     W+APE+I    +  S     +++S G V+ EM  G   ++    + A   
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAK--VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223

Query: 550 IAACGLRPEIPKDCPQILKS----LMIKCWNNSPSKRPQFSEIIS 590
           +      P IP D    L       +  C+  +P  RP   E++ 
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 53/286 (18%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLKGCDKGN-AYEFELRKDLLELMT 389
           +   E ++ IG  ++  VYK +         + I  +   ++     E+ + +       
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY----- 59

Query: 390 CGHKNILQFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKL--QTKE--IIRIA 440
             H NI  FY   + +N       L +V +L  GGSV DL+   RK   + KE  I  I 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-- 498
            +   G+ +L+++ V +RD+  Q ILL ++  V L D G+     S    T    + +  
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TLGRRNTFIG 175

Query: 499 --RWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
              W+APE+IA D E    ++   S+V+S G+   E+  G+       P++A        
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------ 228

Query: 555 LRPEIPKDCPQILKS----------LMIKCWNNSPSKRPQFSEIIS 590
              +IP++ P  LKS           + +C   +  +RP   E++ 
Sbjct: 229 ---KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 9/133 (6%)

Query: 409 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           LC+V  LM GG +   I  +  R L+ + +I  +  +  GI  L+   + YRD+  + +L
Sbjct: 68  LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127

Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
           LD  GN  L D+G+    K     T+   T+GY  +APEI+  +P S    W    ++ G
Sbjct: 128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY--MAPEILKEEPYSYPVDW----FAMG 181

Query: 526 MVIWEMVTGEAAY 538
             I+EMV G   +
Sbjct: 182 CSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 17/170 (10%)

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGE 489
           L T++++  +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +  
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIRN 266

Query: 490 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
            + Y   G      +W+APE I      V  T+ S+V+S+G+++WE+ + G + Y    P
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIF---NCVY-TFESDVWSYGILLWEIFSLGSSPYPGM-P 321

Query: 544 VQAAV-GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           V +    +   G R   P+  P  +  +M  CW+  P KRP F +I+ L+
Sbjct: 322 VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 449
           H NI+ +Y   +D+N  L +  +   GG++ D I++ +    +E  ++     +   + +
Sbjct: 58  HPNIIAYYNHFMDDN-TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSVGEATEYETDGYRWLAPEIIA 507
           ++  G+ +RD+ +  I L + G + LGD GI  +   +     T   T  Y  ++PE+  
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYY--MSPELCQ 174

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
           G    V   + S++++ G V++E++T +  + A +P+   V I      P         L
Sbjct: 175 G----VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSEL 229

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLLL 593
            SL+       P KRP   E++   L
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 78/280 (27%), Positives = 116/280 (41%), Gaps = 47/280 (16%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLL--------ELMTCG 391
           E ++ IG  SF  V K +R    K+   K  D GN  E E  K  L        EL    
Sbjct: 3   EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELK--- 57

Query: 392 HKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEG 446
           H NI+++Y   +D  N  L +V +  EGG +  LI K +K    ++ + I RI   +   
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 447 IK-----FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--------VTACKSVGEATEY 493
           +          + V +RDL    I LD + NV LGD G+          A   VG  T Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG--TPY 175

Query: 494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
                 +++PE +            S+++S G +I+E+      + A + +Q A  I   
Sbjct: 176 ------YMSPEQLNHMSYDEK----SDIWSLGCLIYELCALSPPFTARNQLQLASKIKE- 224

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
           G    IP      L  ++    N  P KRP   E++ L L
Sbjct: 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF----YCVCV 403
           +G   F  V   +     K+  C K +    + RK   E M    K IL+     + V +
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58

Query: 404 ----DENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
               +    LC+V  LM GG +   I  +          I  A  +  G++ L+   + Y
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSET 516
           RDL  + +LLD HGNV + D+G+    K   +      T GY  +APE++ G+    S  
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY--MAPEVLQGEVYDFSVD 176

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAA 540
           W    ++ G  ++EM+ G + +  
Sbjct: 177 W----FALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 64/257 (24%), Positives = 115/257 (44%), Gaps = 30/257 (11%)

Query: 351 NSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405
           + ++GVY         V ++  K C   +  E  L++  + +    H +I++   V  + 
Sbjct: 21  DVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI-MRQFDHPHIVKLIGVITEN 79

Query: 406 NHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
                 V  +ME   + +L   L+  K  L    +I  +  ++  + +L      +RD+ 
Sbjct: 80  P-----VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134

Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDP-ESVSET 516
           ++ +L+     V LGD G+    + + + + Y+    +    W+APE I      S S+ 
Sbjct: 135 ARNVLVSSPDCVKLGDFGL---SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191

Query: 517 WMSNVYSFGMVIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 575
           WM     FG+ +WE ++ G   +         +G    G R  +P +CP  L SLM KCW
Sbjct: 192 WM-----FGVCMWEILMLGVKPFQGV-KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW 245

Query: 576 NNSPSKRPQFSEIISLL 592
              PSKRP+F+E+ + L
Sbjct: 246 AYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 25/263 (9%)

Query: 341 NLEFIDQIGPNSFKGVY--KGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMT 389
             E I +IG  SF  +Y  K K          + + K+   +K  +     +K+++ L  
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-----KKEVILLAK 55

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGI 447
             H NI+ F+     EN  L +V +  +GG +   I + R +   E  I+   + ++ G+
Sbjct: 56  MKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           K ++D  + +RD+ SQ I L ++G V  LGD GI        E          +L+PEI 
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
              P +      ++++S G V++E+ T +  +   +  Q  + I      P I  +  + 
Sbjct: 175 QNRPYNNK----TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP-ISPNFSRD 229

Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
           L+SL+ + +  SP  RP  + I+
Sbjct: 230 LRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 23/230 (10%)

Query: 339 SDNLEFIDQIGPNSFKGVYK--GKRVG-------IEKLKGCDKGNAYEFELRKDLLELMT 389
           +D  E I+ IG  ++  VYK   K+ G       ++ +   D+    E E   ++L+ + 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIEAEYNILQSLP 76

Query: 390 CGHKNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAI 441
             H N+++FY +    +      L +V +L  GGSV +L+    +  ++L    I  I  
Sbjct: 77  -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
               G++ L+++ + +RD+    ILL   G V L D G+     S             W+
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195

Query: 502 APEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
           APE+IA + +   S     +V+S G+   E+  G+       PV+    I
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 49/222 (22%), Positives = 99/222 (44%), Gaps = 20/222 (9%)

Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME---GGSVNDLILKSRKLQTKE 435
           +L++++  L +  H NI+Q+   C+D+      ++  ME   GGS++ ++ +   L    
Sbjct: 48  KLQEEVDLLKSLKHVNIVQYLGTCLDD----NTISIFMEFVPGGSISSILNRFGPLPEPV 103

Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
             +    + +G+ +L+++ V +RD+    ++L  +G + L D G       VG      +
Sbjct: 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG-LHGTHS 162

Query: 496 DGYR-------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
           +  +       W+APE+I            S+++S G  ++EM TG+   A+   + A  
Sbjct: 163 NMLKSMHGTPYWMAPEVI----NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218

Query: 549 GIAA-CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            I A  GL P +P          +  C      +RP   +++
Sbjct: 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 13/168 (7%)

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  +++I  +  VA G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 227

Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G + Y      
Sbjct: 228 PDYVRKGSARLPLKWMAPESIF---DKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQIN 283

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P++    +  +M+ CW   P +RP FS ++ +L
Sbjct: 284 EEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  +++I  +  VA+G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 232

Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 288

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 54/243 (22%), Positives = 110/243 (45%), Gaps = 12/243 (4%)

Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV 411
           +KG++  K V I   K   KG+    ++ ++ ++ +      NIL+ Y   +D    L  
Sbjct: 37  YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96

Query: 412 VTKLME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILL 467
           ++ ++E    G + +++ K + L  K  + +AID  +G+  L  +    Y++L S   L+
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE-TWMSNVYSFGM 526
             +  + +   G+     S           Y   + +++    +  SE T   ++YS G+
Sbjct: 157 TENYKLKIICHGLEKIL-SSPPFKNVNFMVYF--SYKMLN---DIFSEYTIKDDIYSLGV 210

Query: 527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
           V+WE+ TG+  +   +  +    I       ++P DCP  +K ++  C ++   KRP   
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Query: 587 EII 589
           EI+
Sbjct: 271 EIL 273

Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 26/180 (14%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           E I +IG  ++  VYK      G+ V I+ +K  + G+ +E  +++++  L  C H NI+
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFE-IIQQEISMLKECRHPNIV 63

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGV 455
            ++   +     L +V +   GGS+ D+   +R  L   +I  +  +  +G+ +L++ G 
Sbjct: 64  AYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEIIA 507
            +RD+    ILL   G+V L D G+   +TA  +     +G  T Y      W+APE+ A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG--TPY------WMAPEVAA 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 54/250 (21%), Positives = 113/250 (45%), Gaps = 12/250 (4%)

Query: 345 IDQIGPNSFKGVYKG---KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG   +   +  +K  D   A +   ++++++  L  C    + ++Y
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L++      +I  +  ++ +G+ +L+     +RD
Sbjct: 69  GSYL-KGTKLWIIMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL   G+V L D G+                   W+APE+I    +S  ++  +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDS-KA 182

Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE   +   P++    I      P +  +  +  K  +  C N  P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDP 241

Query: 580 SKRPQFSEII 589
           S RP   E++
Sbjct: 242 SFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 38/277 (13%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
           SD  E I+ IG  ++  V+K      G +  ++ L      +  E E   ++L+ ++  H
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALS-DH 74

Query: 393 KNILQFYCVCV--DENHG--LCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVA- 444
            N+++FY +    D  +G  L +V +L  GGSV DL+   LK  +   + II   +  A 
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
            G++ L+ +   +RD+    ILL   G V L D G+     S             W+APE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 505 IIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           +IA + + +  T+    +V+S G+   E+  G+   A   P++A           +IP++
Sbjct: 195 VIACE-QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF---------KIPRN 244

Query: 563 CPQILKS----------LMIKCWNNSPSKRPQFSEII 589
            P  L             + KC      KRP  S+++
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 13/194 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  +   YC    + + L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 55  HPFLTHLYCTFQTKEN-LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 508
             G+ YRDL    ILLD  G++ + D G+   CK   +G+A      G   ++APEI+ G
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              + S  W    +SFG++++EM+ G++ +      +    I      P  P+   +  K
Sbjct: 171 QKYNTSVDW----WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224

Query: 569 SLMIKCWNNSPSKR 582
            +++K +   P +R
Sbjct: 225 DILVKLFVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 33/212 (15%)

Query: 392 HKNILQF---YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           H NI+ +   Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++
Sbjct: 75  HPNIVNYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALE 129

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLA 502
           FL+ + V +RD+ S  ILL   G+V L D G           +S    T Y      W+A
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY------WMA 183

Query: 503 PEII---AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           PE++   A  P+        +++S G++  EMV GE  Y   +P++A   IA  G  PE+
Sbjct: 184 PEVVTRKAYGPK-------VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL 235

Query: 560 --PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
             P+    I +  + +C      KR    E++
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 16/175 (9%)

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  +++I  +  VA G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 226

Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G + Y      
Sbjct: 227 PDYVRKGDARLPLKWMAPESIF---DKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQID 282

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS---EIISLLLRTN 596
           +        G R   P+     + S+M+ CW+N+P  RP FS   EI+  LL+ N
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 13/182 (7%)

Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E    + LI +S  L   +++  +  VA G++FL      +RDL ++ +L+     V + 
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281

Query: 477 DMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
           D G+    + +   + Y + G      +W+APE I  +      T +S+V+SFG+++WE+
Sbjct: 282 DFGLA---RDIMRDSNYISKGSTFLPLKWMAPESIFNN----LYTTLSDVWSFGILLWEI 334

Query: 532 VT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
            T G   Y      +        G R   P      +  +M KCW      RP FS+++ 
Sbjct: 335 FTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394

Query: 591 LL 592
           L+
Sbjct: 395 LV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 67/291 (23%), Positives = 132/291 (45%), Gaps = 26/291 (8%)

Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE 386
           E + R L  ++  E I ++G  +F  VYK K      L   K  +  +  E EL   ++E
Sbjct: 2   EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVE 59

Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 442
              L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  I   
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWL 501
           + E +++L+   + +RDL +  +LL   G++ L D G+     K++     +    Y W+
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-WM 177

Query: 502 APEIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
           APE++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA    + E
Sbjct: 178 APEVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KSE 231

Query: 559 IPK-DCPQI----LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
            P    P       +  +    +  P  RP  ++++     ++  SN   R
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 65/289 (22%), Positives = 128/289 (44%), Gaps = 54/289 (18%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMT 389
            N +   +IG   F  VYK      G+ V ++K++  +  +A   + R+D L+    L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAE 445
             H N++++    ++ N  L +V +L + G ++ +I   +K    +  + I +  + +  
Sbjct: 59  LDHPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKS-VGEATEYETDG 497
            ++ ++   + +RD+    + +   G V LGD+G+        TA  S VG  T Y    
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG--TPY---- 171

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT------GEAA--YAACSPVQAAVG 549
             +++PE I  +       + S+++S G +++EM        G+    Y+ C        
Sbjct: 172 --YMSPERIHEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------ 219

Query: 550 IAACGLRPEIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           I  C   P +P D   + L+ L+ +C N  P KRP  S ++ +    + 
Sbjct: 220 IEKCDYPP-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 61/275 (22%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDK------GNAYEFELRKDLLELMTC 390
           D+ +F   IG  SF  V   K     K   +K  DK            ++ K++L  +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH  I++ Y    DE + L  V +    G +   I K   L  K     A ++   +++L
Sbjct: 60  GHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-------------KSVGEATEYETDG 497
           +  G+ +RDL  + ILLD+  ++ + D G  TA               +    ++ E + 
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG--TAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 498 YR---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
            R         +++PE++   P   S    S++++ G +I++M+TG+  +   +      
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKS----SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232

Query: 549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 583
            I         P + P   K L+ K     P  R 
Sbjct: 233 KILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 61/262 (23%), Positives = 111/262 (42%), Gaps = 37/262 (14%)

Query: 341 NLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
           ++++ + +G  +   VYK      +R+   K+   D     + ++  +L  L  C    I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           + FY     EN  + + T+ M+GGS++      RK+    + RIA+ V +G+ +L    +
Sbjct: 62  IGFYGAFFVENR-ISICTEFMDGGSLD----VYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE 515
            +RD+    +L++  G V L D G+ T   +    T   T+ Y  +APE I+G+   +  
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAY--MAPERISGEQYGI-- 172

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE------IPKDCP----- 564
              S+V+S G+   E+  G   Y      Q         L P       + +D P     
Sbjct: 173 --HSDVWSLGISFMELALGRFPYPQIQKNQ-------GSLMPLQLLQCIVDEDPPVLPVG 223

Query: 565 ---QILKSLMIKCWNNSPSKRP 583
              +     + +C    P +RP
Sbjct: 224 QFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 15/174 (8%)

Query: 428 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKS 486
           S  L   +++R +  VA+G+ FL      +RD+ ++ +LL   G V  + D G+    + 
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLA---RD 261

Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G++ Y  
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
                    +   G +   P   P  + S+M  CWN  P++RP FS+I  L+ R
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 63.3 bits (155), Expect = 6e-11
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 22/154 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAIDVAEGI 447
           H NI++   V   E   L +V +  +     DL   L  R   L    I  I   +  G+
Sbjct: 57  HPNIVKLLDVIHTERK-LYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEI 505
            + + H + +RDL  Q IL++R G + L D G+  A          E  T  YR  APEI
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEI 169

Query: 506 IAGDPE---SVSETWMSNVYSFGMVIWEMVTGEA 536
           + G      +V      +++S G +  EM+TG+ 
Sbjct: 170 LLGSKHYSTAV------DIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 55/261 (21%), Positives = 121/261 (46%), Gaps = 17/261 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKN 394
           ++ E I +IG  ++  VYK + V   +L        + G  +   ++++++ +  C H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+ ++   +  +  L +  +   GGS+ D+   +  L   +I  ++ +  +G+ +L+  G
Sbjct: 68  IVAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
             +RD+    ILL  +G+V L D G+   +TA  ++ +   +    Y W+APE+ A + +
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPY-WMAPEVAAVERK 183

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL- 570
                 + ++++ G+   E+   +       P++A   +     +P   KD  +   S  
Sbjct: 184 G-GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242

Query: 571 -MIK-CWNNSPSKRPQFSEII 589
             +K     +P KRP   +++
Sbjct: 243 HFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 44/213 (20%)

Query: 345 IDQIGPNSFKGVYK------GKRVGIEKLK-----GCDKGNAYEFELRKDLLELMTCGHK 393
           + +IG  ++  VYK      G+ V I+K+K           A   E+ K L EL    H 
Sbjct: 4   LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EI-KLLKEL---NHP 58

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLND 452
           NI++   V   +   L +V + M+   +  LI   ++   + +I+     + +G+ F + 
Sbjct: 59  NIIKLLDVFRHKGD-LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAG 508
           HG+ +RDL  + +L++  G + L D G+    +S G      T  Y   RW  APE++ G
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGL---ARSFGSPVRPYTH-YVVTRWYRAPELLLG 172

Query: 509 DPESVSETWMSNVYSFGMVIW-------EMVTG 534
           D            YS  + IW       E+++ 
Sbjct: 173 D----------KGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRK---LQTKEIIRIAIDVAEG 446
           H NI+ +      E+  L +V    EGG   DL   LK +K   L   +++   + +A  
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           +++L++  + +RDL +Q + L R   + +GD+GI    ++  +          +++PE+ 
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
           +  P +    + S+V++ G  ++EM T + A+ A   + + V     G  P +PKD    
Sbjct: 175 SNKPYN----YKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPPMPKDYSPE 229

Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
           L  L+    +  P KRP    I+
Sbjct: 230 LGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 5/153 (3%)

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
           +   H  +   +C C      L  V + + GG +   I +SRK         A +V   +
Sbjct: 51  LAAKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
            FL+ HGV YRDL    ILLD  G+  L D G+       G  T        ++APEI+ 
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
                 S  W    ++ G++++EM+ G+  + A
Sbjct: 170 ELEYGPSVDW----WALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 4/137 (2%)

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL+  G+ YRDL 
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128

Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW---- 184

Query: 522 YSFGMVIWEMVTGEAAY 538
           ++FG++++EM+ G+A +
Sbjct: 185 WAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 14/186 (7%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +RD+ S  ILL 
Sbjct: 92  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 525
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 203

Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 583
           ++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +  + +C +    KR 
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262

Query: 584 QFSEII 589
              E++
Sbjct: 263 SAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 14/186 (7%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +RD+ S  +LL 
Sbjct: 91  LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 525
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 202

Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 583
           ++  EMV GE  Y   +P++A   IA  G  PE+  P+    I +  + +C      KR 
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRG 261

Query: 584 QFSEII 589
              E++
Sbjct: 262 SAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L +V + + GG +   + + RKL  +     A ++   + FL++ G+ YRDL 
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123

Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW---- 179

Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 69/231 (29%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----------- 391
           E I QIG  ++  VYK +     +L            L+K  +E    G           
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGEL----------VALKKIRMENEKEGFPITAIREIKL 51

Query: 392 -----HKNILQFYCVCVDENHGLC-VVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAI 441
                H NI++   +   +  G   +V + M+    +DL  +L S   K    +I     
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMK 107

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---- 497
            + EG+++L+ +G+ +RD+    IL++  G + L D G+         A  Y        
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL---------ARPYTKRNSADY 158

Query: 498 --------YRWLAPEIIAG----DPESVSETWMSNVYSFGMVIWEMVTGEA 536
                   YR   PE++ G     PE        +++S G ++ E+  G+ 
Sbjct: 159 TNRVITLWYR--PPELLLGATRYGPE-------VDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 21/150 (14%)

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLNDH 453
             YC    + H L  V + + GG   DL+   +     ++ R     AE   G++FL+  
Sbjct: 60  HLYCTFQTKEH-LFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGE---ATEYETDGYRWLAPEIIAG 508
           G+ YRDL    ++LDR G++ + D G+   CK    G+   +T   T  Y  +APEI+ G
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDY--IAPEILQG 170

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
              + S  W    +SFG++++EM+ G++ +
Sbjct: 171 LKYTFSVDW----WSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 60/264 (22%), Positives = 118/264 (44%), Gaps = 18/264 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           D +E +D++G  ++  VYK      G  + +++++  +   +   ++  +L  L      
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSP 59

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFL 450
            I+ FY     E   + +  + M+ GS++ L       +      + RI   V +G+KFL
Sbjct: 60  YIVDFYGAFFIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 451 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
             +H + +RD+    +L++ +G V L D G+     +    T      Y  +APE I   
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSY--MAPERIKSG 176

Query: 510 PESVSETW--MSNVYSFGMVIWEMVTGEAAYA--ACSPVQAAVGIAACGLRPEIPKDCPQ 565
             + + T+   S+V+S G+ I EM  G   Y     + + A +     G  P +P     
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 566 ILKSLMIKCWNNSPSKRPQFSEII 589
             +  + KC N  P++RP +++++
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 66/264 (25%), Positives = 104/264 (39%), Gaps = 45/264 (17%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELM----TCGHK 393
           D+ EFI  +G  SF     G RV + + K    G  Y  + L K  +++L         K
Sbjct: 1   DDFEFIKTLGTGSF-----G-RVMLVRHK--GSGKYYALKILSKAKIVKLKQVEHVLNEK 52

Query: 394 NILQ-----FYCVCVD---ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     F         ++  L +V + + GG +   + KS +         A  V  
Sbjct: 53  RILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL 112

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYETDGY 498
            +++L+   + YRDL  + +LLD  G + + D G     K V   T       EY     
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF---AKRVKGRTYTLCGTPEY----- 164

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
             LAPEII       +  W    ++ G++I+EM+ G   +   +P+Q    I    +R  
Sbjct: 165 --LAPEIILSKGYGKAVDW----WALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-- 216

Query: 559 IPKDCPQILKSLMIKCWNNSPSKR 582
            P       K L+        +KR
Sbjct: 217 FPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  V + + GG +   I +  K +  + +  A +++ G+ FL+  G+ YRDL    ++LD
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
             G++ + D G+       G  T        ++APEIIA  P   S  W    +++G+++
Sbjct: 136 SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW----WAYGVLL 191

Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G+  +      +    I    +     + K+   I K LM K     PSKR
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK----HPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 47/206 (22%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGI 447
           H  I++F+   + E    C++T+  EG  ++  + +     + L   ++    I +  G+
Sbjct: 61  HPAIVKFHASFL-ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRWLAPE 504
            +++   + +RDL ++ I L ++  + +GD G+  +   +G    AT +    Y +++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGV--SRLLMGSCDLATTFTGTPY-YMSPE 175

Query: 505 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
            +     +S S+ W     S G +++EM     A+   + +   + I   G  P +P+  
Sbjct: 176 ALKHQGYDSKSDIW-----SLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETY 229

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEII 589
            + L S+M    N  PS RP  +EI+
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 7/215 (3%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE---LMTCGHKNILQF 398
           E I ++G  +F  VYK +      L          E EL   ++E   L +C H NI++ 
Sbjct: 8   EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67

Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
                 EN+ L ++ +   GG+V+ ++L+  R L   +I  +     E + +L+++ + +
Sbjct: 68  LDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD-PESVSET 516
           RDL +  IL    G++ L D G+        +  +       W+APE++  +  +     
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
           + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 58/274 (21%), Positives = 120/274 (43%), Gaps = 38/274 (13%)

Query: 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 390
           N     +IG   F  VY+      G  V ++K++  D  +A   + R D ++    L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQL 59

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEG 446
            H N++++Y   +++N  L +V +L + G ++ +I     + R +  K + +  + +   
Sbjct: 60  NHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           ++ ++   V +RD+    + +   G V LGD+G+     S   A         +++PE I
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAA--------YAACSPVQAAVGIAACGLRPE 558
             +       + S+++S G +++EM   ++         Y+ C  ++       C   P 
Sbjct: 179 HEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDY-PP 227

Query: 559 IPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISL 591
           +P D   + L+ L+  C N  P KRP  + +  +
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 8e-10
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 123

Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 179

Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 344 FIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLL---ELMTCG--HKNIL- 396
           F+  +G  SF  V   +R G ++L        Y  + L+KD++   + + C    K +L 
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDEL--------YAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 397 ---------QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
                    Q +  C      L  V + + GG +   I +  K +    +  A ++A G+
Sbjct: 56  LPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPE 504
            FL+  G+ YRDL    ++LD  G++ + D G+   CK    G  T     G   ++APE
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCGTPDYIAPE 171

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           IIA  P   S  W    ++FG++++EM+ G+  +
Sbjct: 172 IIAYQPYGKSVDW----WAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.2 bits (144), Expect = 9e-10
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID-VAE 445
           L  C H  I++ Y    D+ + + ++ +   GG +   IL+ R L  +   R  I  V  
Sbjct: 47  LEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVL 104

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYE---TDGYRWL 501
             ++L++ G+ YRDL  + +LLD +G V L D G   A K   G+ T +    T  Y  +
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG--FAKKLKSGQKT-WTFCGTPEY--V 159

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APEII       S  +    +S G++++E++TG
Sbjct: 160 APEIILNKGYDFSVDY----WSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L VV + + GGS+ D++ ++  +   +I  +  +  + + FL+ + V +RD+ S  ILL 
Sbjct: 91  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 525
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 202

Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 583
           ++  EMV GE  Y   +P++A   IA  G  PE+  P+    + +  + +C      +R 
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRG 261

Query: 584 QFSEII 589
              E++
Sbjct: 262 SAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 24/220 (10%)

Query: 381 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKE-IIR 438
           RK+ + L    H NI+ F      + H L +V +  +GG +   I   R KL  ++ I++
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG--------IVTACKSVGEA 490
             + +  G++ +++  V +RD+ S+ I L ++G V LGD G           AC  VG  
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG-- 162

Query: 491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
           T Y      ++ PEI     E++     S+++S G +++E+ T +  + A S     + +
Sbjct: 163 TPY------YVPPEIW----ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212

Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                +P +P      L+SL+ + +  +P  RP  + I+S
Sbjct: 213 CQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 53/265 (20%), Positives = 119/265 (44%), Gaps = 25/265 (9%)

Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 395
           + E I ++G  ++  VYK + +   +L        + G+ +   +++++  +  C H NI
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNI 68

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           + ++   +     L +  +   GGS+ D+   +  L   +I  +  +  +G+ +L+  G 
Sbjct: 69  VAYFGSYLSREK-LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
            +RD+    ILL  +G+V L D G+   +TA  ++ +   +    Y W+APE+ A +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPY-WMAPEVAAVEKNG 184

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ------- 565
                + ++++ G+   E+   +       P++A   ++    +P   KD  +       
Sbjct: 185 -GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243

Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            +K  + K    +P KRP    +++
Sbjct: 244 FVKISLTK----NPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 52/215 (24%)

Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE----LMTCGHKNILQFYCVC 402
           +G  SF     GK   + K+ G D G  Y  + L+K  L+    + T   ++IL      
Sbjct: 4   LGQGSF-----GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL------ 52

Query: 403 VDENHGLCV--------------VTKLMEGGSVNDLILKSRK--LQTKEIIRIAI-DVAE 445
            + NH   V              +   + GG   DL  +  K  + T+E ++  + ++A 
Sbjct: 53  AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------R 499
            +  L+  G+ YRDL  + ILLD  G++ L D G+    K   E+ ++E   Y       
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL---SK---ESIDHEKKAYSFCGTVE 163

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           ++APE++     + S  W    +SFG++++EM+TG
Sbjct: 164 YMAPEVVNRRGHTQSADW----WSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 26/174 (14%)

Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N ++ Y
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-Y 80

Query: 400 CVCVDENHGLCVVTKLMEG--GSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVA 456
             C    H   +V   ME   GS +D++   +K LQ  EI  I     +G+ +L+ H   
Sbjct: 81  KGCYLREHTAWLV---MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 457 YRDLNSQRILLDRHGNVCLGDMG---IVTACKS-VGEATEYETDGYRWLAPEII 506
           +RD+ +  ILL   G V L D G   +V+   S VG  T Y      W+APE+I
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVG--TPY------WMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 17/146 (11%)

Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAI-DVAEGIKFLNDH 453
           +Y    +EN  + +V  L+ GG   DL   + +  K  ++E ++  I ++   +++L+  
Sbjct: 66  WYSFQDEEN--MYLVVDLLLGG---DLRYHLSQKVKF-SEEQVKFWICEIVLALEYLHSK 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPES 512
           G+ +RD+    ILLD  G+V + D  I T        T    T GY  +APE++     S
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY--MAPEVLCRQGYS 177

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAY 538
           V+  W    +S G+  +E + G+  Y
Sbjct: 178 VAVDW----WSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 23/139 (16%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  +  LM GG ++  + +       E+   A ++  G++ +++  V YRDL    ILLD
Sbjct: 72  LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 131

Query: 469 RHGNVCLGDMGIVTACK--------SVGEATEYETDGYRWLAPEIIA-GDPESVSETWMS 519
            HG+V + D+G+  AC         SVG      T GY  +APE++  G     S  W  
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVG------THGY--MAPEVLQKGVAYDSSADW-- 179

Query: 520 NVYSFGMVIWEMVTGEAAY 538
             +S G ++++++ G + +
Sbjct: 180 --FSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 43/185 (23%), Positives = 82/185 (44%), Gaps = 17/185 (9%)

Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNIL-----QF---YCVCVDENHGLCVVTKLME 417
           K+  C +      + RK   E M    K IL     QF        +    LC+V  +M 
Sbjct: 26  KMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83

Query: 418 GGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
           GG +   I  + +   + +  +  A ++  G++ L+     YRDL  + ILLD +G++ +
Sbjct: 84  GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRI 143

Query: 476 GDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
            D+G+       GE+         ++APE++     ++S  +    +  G +I+EM+ G+
Sbjct: 144 SDLGLAVKIPE-GESIRGRVGTVGYMAPEVLNNQRYTLSPDY----WGLGCLIYEMIEGQ 198

Query: 536 AAYAA 540
           + +  
Sbjct: 199 SPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC +  LM GG ++  + +      KE+   A ++  G++ +++  V YRDL    ILLD
Sbjct: 72  LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 527
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW----FSLGCM 185

Query: 528 IWEMVTGEAAY 538
           +++++ G + +
Sbjct: 186 LFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 44/183 (24%), Positives = 84/183 (45%), Gaps = 17/183 (9%)

Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ----FYCVCV----DENHGLCVVTKLME 417
           K+  C K      + RK   E M    K IL+     + V +    +    LC+V  LM 
Sbjct: 26  KMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83

Query: 418 GGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
           GG +   I  +     +    +  A ++  G++ L+   + YRDL  + ILLD HG++ +
Sbjct: 84  GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRI 143

Query: 476 GDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
            D+G+       G+  +       ++APE++  +  + S  W    ++ G +++EM+ G+
Sbjct: 144 SDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALGCLLYEMIAGQ 198

Query: 536 AAY 538
           + +
Sbjct: 199 SPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 29/184 (15%)

Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
           R +   +I+ I   V   I++L+++ + +RD+ ++ I ++  G+VCLGD G   AC  V 
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG--AACFPVD 234

Query: 489 -EATEYETDGYRWL------APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY--- 538
             A +Y    Y W       APE++A DP   +     +++S G+V++EM T   +    
Sbjct: 235 INANKY----YGWAGTIATNAPELLARDPYGPA----VDIWSAGIVLFEMATCHDSLFEK 286

Query: 539 ----AAC-SPVQAAVGIAACGLRP-EIPKDCPQILKSLMIKCWNNS---PSKRPQFSEII 589
                 C S  Q  + I   G  P E P D    L  + I     S   P  RP ++ + 
Sbjct: 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346

Query: 590 SLLL 593
            L +
Sbjct: 347 ELPI 350

Length = 391

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 29/222 (13%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL-----QTKEIIRIAIDVAEG 446
           H N+LQ    C+ E+    +V +    G + + +  +R +     Q   + R+A +VA G
Sbjct: 54  HPNVLQCLGQCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWL 501
           + +L+     + DL  +   L    +V +GD G+    +       Y T        RWL
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL-ALEQY--PEDYYITKDCHAVPLRWL 169

Query: 502 APEII---AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           APE++     D     +T  SN++S G+ +WE+ T  +  Y   S  Q    +       
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQVVREQ 226

Query: 558 EIPKDCPQILKSL-------MIKCWNNSPSKRPQFSEIISLL 592
           +I    PQ+           M  CW   P  RP   E+  LL
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIK 448
            H  ++  +     E+H +C V +   GG   DL++   +        +  A  V  G++
Sbjct: 60  RHPFLVNLFACFQTEDH-VCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQ 115

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS---VGEATEYETDGYRWLAPEI 505
           +L+++ + YRDL    +LLD  G V + D G+   CK     G+ T        +LAPE+
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +     + +  W    +  G++I+EM+ GE+ +
Sbjct: 173 LTETSYTRAVDW----WGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKF 449
           HK+I+  Y VCV +   + +V + +E G + DL +  KS  L T    ++A  +A  + +
Sbjct: 63  HKHIVLLYGVCVRDVENI-MVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 450 LNDHGVAYRDLNSQRILLDRHG--NVC-----LGDMGIVTACKSVGEATEYETDGYRWLA 502
           L D  + + ++ ++ ILL R G    C     L D GI     S  E  E       W+A
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER----IPWIA 176

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE +    +S + +  ++ +SFG  +WE+   GE      +  +              P 
Sbjct: 177 PECVE---DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ-CMLVTP- 231

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEII 589
            C + L  LM  C N  P++RP F  I+
Sbjct: 232 SCKE-LADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 387 LMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDV 443
           LM+   HK++++ Y VCV + + +  V + ++ G + D+ L   K  +     + +A  +
Sbjct: 54  LMSQLSHKHLVKLYGVCVRDENIM--VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQL 110

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGN-------VCLGDMGIVTACKSVGEATEYETD 496
           A  + +L D  + + ++  + IL+ R+G        + L D GI     S     E   +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR----EERVE 166

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
              W+APE I       S T  ++ +SFG  + E+ + GE   +  S  +          
Sbjct: 167 RIPWIAPECIRNG--QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            P    DC ++   L+ +CW   P+KRP F  I+  L
Sbjct: 225 LPMP--DCAELAN-LINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 34/132 (25%), Positives = 66/132 (50%), Gaps = 7/132 (5%)

Query: 409 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           LC+V  LM GG +   I  + +     +  +  A ++  G++ L+   + YRDL  + IL
Sbjct: 75  LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134

Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 526
           LD +G++ + D+G+       GE          ++APE++  +  + S  W    +  G 
Sbjct: 135 LDDYGHIRISDLGLAVEIPE-GETIRGRVGTVGYMAPEVVKNERYTFSPDW----WGLGC 189

Query: 527 VIWEMVTGEAAY 538
           +I+EM+ G++ +
Sbjct: 190 LIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 31/199 (15%)

Query: 344 FIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
            + +IG  +F  V K      GK   I+ +K   K       LR+         H NIL+
Sbjct: 3   ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 398 FYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 454
              V  D   G L +V +LM+  ++ +LI K RK  L  K +      + + +  ++ +G
Sbjct: 63  LIEVLFDRKTGRLALVFELMDM-NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV---GEATEY-ETDGYRWLAPEIIAGDP 510
           + +RD+  + IL+     + L D G   +C+ +      TEY  T  YR  APE +  D 
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFG---SCRGIYSKPPYTEYISTRWYR--APECLLTD- 173

Query: 511 ESVSETWMSNVYSFGMVIW 529
                      Y   M IW
Sbjct: 174 ---------GYYGPKMDIW 183

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 35/148 (23%), Positives = 70/148 (47%), Gaps = 8/148 (5%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H  I++ +    D+   L ++ + + GG +   +  S +      +  A ++   
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRF-LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA 113

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           +++L+   + YRDL  + ILLD+ G++ L D G     K + + T        +LAPE+I
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVI 170

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTG 534
                + +  W    ++ G++I+EM+ G
Sbjct: 171 QSKGHNKAVDW----WALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L +V + + GG    LI     L      +   +V  G++ L+  G+ +RD+  + +L+D
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ L D G+       G   +       +LAPE I G    V +  MS+ +S G VI
Sbjct: 132 QTGHLKLTDFGL----SRNGLENKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVI 183

Query: 529 WEMVTGEAAYAACSP 543
           +E + G   + A +P
Sbjct: 184 FEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 58/278 (20%)

Query: 346 DQIGPNSFKGVYKGKR--VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY---- 399
           + +G  +F  ++KG R  VG       D G  ++ E+   LL+++   H+N  + +    
Sbjct: 1   ESLGQGTFTKIFKGIRREVG-------DYGELHKTEV---LLKVLDKSHRNYSESFFEAA 50

Query: 400 -----------------CVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIA 440
                            CVC DE+    +V + ++ GS+ D  LK  K  +     + +A
Sbjct: 51  SMMSQLSHKHLVLNYGVCVCGDES---IMVQEYVKFGSL-DTYLKKNKNLINISWKLEVA 106

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VCLGDMGIVTACKSVGEATE 492
             +A  + FL D G+ + ++ ++ +LL R  +        + L D GI           E
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KE 162

Query: 493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIA 551
              +   W+ PE I  +P+++S    ++ +SFG  +WE+ +G +   +A    +      
Sbjct: 163 ILLERIPWVPPECIE-NPQNLS--LAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE 219

Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
               R ++P      L +L+ +C +  P  RP F  II
Sbjct: 220 D---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 6/182 (3%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  V   + GG +   + + R          A ++A  + +L+   + YRDL  + ILLD
Sbjct: 71  LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
             G+V L D G+     +  + T        +LAPE+I   P   +  W    +  G V+
Sbjct: 131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW----WCLGAVL 186

Query: 529 WEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
           +EM+ G   +      +    I      LRP        IL+ L+ K        +  F 
Sbjct: 187 YEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246

Query: 587 EI 588
           EI
Sbjct: 247 EI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)

Query: 343 EFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYE--FELR--KDLLELMTCGH 392
           + I Q+G  +F  VY  +       V I+K+K   K  ++E    LR  K L +L    H
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLN--EH 57

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ--TKEIIR-IAIDVAEGIKF 449
            NI++   V  + +  L  V + MEG ++  L+ K RK +  ++ +IR I   + +G+  
Sbjct: 58  PNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLM-KDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 506
           ++ HG  +RDL  + +L+     V + D G+    +S    T+Y  T  YR  APEI+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR--APEIL 170

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 17/183 (9%)

Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ----FYCVCV----DENHGLCVVTKLME 417
           K+  C K      + RK   E M    K IL+     + V +    +    LC+V  +M 
Sbjct: 26  KMYACKKLEKKRIKKRKG--EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83

Query: 418 GGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
           GG +   I  + +     +  I  A ++  G++ L    + YRDL  + ILLD  G++ +
Sbjct: 84  GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRI 143

Query: 476 GDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
            D+G+       GE          ++APE+I  +  + S  W    +  G +I+EM+ G+
Sbjct: 144 SDLGLAVQIPE-GETVRGRVGTVGYMAPEVINNEKYTFSPDW----WGLGCLIYEMIQGQ 198

Query: 536 AAY 538
           + +
Sbjct: 199 SPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 29/229 (12%)

Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
            +   W L+  + E  + +G  SF       RV I K KG  +  A +   ++++L+   
Sbjct: 10  PDTSSWKLS--DFEMGETLGTGSFG------RVRIAKHKGTGEYYAIKCLKKREILKMKQ 61

Query: 387 ----------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
                     LM   H  I+   C   DEN  +  + + + GG +   + K+ +      
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDENR-VYFLLEFVVGGELFTHLRKAGRFPNDVA 120

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++    ++L+   + YRDL  + +LLD  G+V + D G     K V + T     
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCG 177

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
              +LAPE+I       +  W    ++ G++++E + G   +   +P +
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDW----WTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 393 KNILQ----------FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
           ++IL           +Y     +N  L +V + + GG   DL  +L++     +++ RI 
Sbjct: 44  RDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGG---DLASLLENVGSLDEDVARIY 98

Query: 441 I-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD-----MGIVTACKSVGEATEYE 494
           I ++   +++L+ +G+ +RDL    IL+D +G++ L D     +G+V    ++ +  + +
Sbjct: 99  IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 495 -----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
                T  Y  +APE+I G   S +  W    +S G +++E + G   +   +P +    
Sbjct: 159 KRIVGTPDY--IAPEVILGQGHSKTVDW----WSLGCILYEFLVGIPPFHGETPEEIFQN 212

Query: 550 IAACGLRPEIPKDC--PQILKSLMIKCWNNSPSKRPQFSEI 588
           I     + E P+D         L+ K     P KR     I
Sbjct: 213 I--LNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 13/192 (6%)

Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N +Q Y
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-Y 80

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
             C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +RD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  + 
Sbjct: 141 VKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKV- 195

Query: 520 NVYSFGMVIWEM 531
           +V+S G+   E+
Sbjct: 196 DVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 37/256 (14%)

Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN- 406
           IG  +F  VY+ ++    ++      +  E   +K++    T G +NIL      +DE+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH--TIGERNILV--RTLLDESP 56

Query: 407 ------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLN 451
                         L +VT  M GG +   + K  +       R    +AE    ++ L+
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLH 113

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
            + + YRDL  + ILLD  G++ L D G+  A  +  + T        +LAPE++    +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL---D 170

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-----PQI 566
               T   + +S G++++EM  G + + A    Q    IA   +R   PK+       Q 
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--FPKNVLSDEGRQF 228

Query: 567 LKSLMIKCWNNSPSKR 582
           +K L+    N +P  R
Sbjct: 229 VKGLL----NRNPQHR 240

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 498
           A +VA  I +L+   + YRDL  + ILLD  G+V L D G+   CK  G   E  T  + 
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GVEPEETTSTFC 157

Query: 499 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
               +LAPE++  +P   +  W    +  G V++EM+ G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDW----WCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 16/140 (11%)

Query: 409 LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           LC+V  +M GG +   I    +                +  G++ L+   + YRDL  + 
Sbjct: 68  LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSN 520
           +LLD  GNV + D+G+    K      + +T GY     ++APE++ G+    S  +   
Sbjct: 128 VLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY--- 180

Query: 521 VYSFGMVIWEMVTGEAAYAA 540
            ++ G+ ++EM+     + A
Sbjct: 181 -FALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 15/255 (5%)

Query: 344 FID--QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKN 394
           F+   +IG  SF  VY        + V ++K+    K    +++ + K++  L    H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
            ++ Y  C  + H   +V +   G + + L +  + LQ  EI  I     +G+ +L+ H 
Sbjct: 83  TIE-YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RD+ +  ILL   G V L D G   +      A  +    Y W+APE+I    E   
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG---SASKSSPANSFVGTPY-WMAPEVILAMDEGQY 197

Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 574
           +  + +V+S G+   E+   +      + + A   IA          +     +  +  C
Sbjct: 198 DGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256

Query: 575 WNNSPSKRPQFSEII 589
               P +RP  +E++
Sbjct: 257 LQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 13/250 (5%)

Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N ++ Y
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE-Y 90

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
             C    H   +V +   G + + L +  + LQ  EI  I     +G+ +L+ H + +RD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  ILL   G V L D G   +      A  +    Y W+APE+I    E   +  + 
Sbjct: 151 IKAGNILLTEPGQVKLADFG---SASIASPANSFVGTPY-WMAPEVILAMDEGQYDGKV- 205

Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +V+S G+   E+   +      + + A   IA          +     ++ +  C    P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 580 SKRPQFSEII 589
             RP   E++
Sbjct: 266 QDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 14/107 (13%)

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  ++ I I   + E + +L+  G+ +RD+ ++ I LD   N  LGD G   ACK   +A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKL--DA 237

Query: 491 TEYETDGYRWL------APEIIAGDPESVSETWMSNVYSFGMVIWEM 531
                  Y W       +PE++A DP        ++++S G+V++EM
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAK----TDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 38/201 (18%)

Query: 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
           ++DL      L    + +    +  GI+F + H + +RD+  + IL+ + G V L D G 
Sbjct: 87  LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 146

Query: 481 VTACKSVGEA-TEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                + GE  T+Y  T  YR  APE++ GD +        ++++ G ++ EM+TGE  +
Sbjct: 147 ARTLAAPGEVYTDYVATRWYR--APELLVGDTKYGRAV---DIWAVGCLVTEMLTGEPLF 201

Query: 539 AACSPVQAAVGIAAC-------------------GLR-PEI----------PKDCPQILK 568
              S +     I  C                   G+R PE+          PK    +L 
Sbjct: 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL- 260

Query: 569 SLMIKCWNNSPSKRPQFSEII 589
            L  +C    P  RP  S+++
Sbjct: 261 DLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 35/137 (25%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + FL++ G+ YRDL 
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123

Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 179

Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 38/179 (21%), Positives = 83/179 (46%), Gaps = 9/179 (5%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L ++   + GG +   + +  + + +E+   + ++   ++ L+  G+ YRD+  + ILLD
Sbjct: 80  LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPESVSET--WMSNVYSFG 525
            +G+V L D G+            Y   G   ++AP+I+ G      +   W    +S G
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW----WSMG 195

Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
           ++++E++TG + +       +   I+   L+  P  P++   + K ++ +     P KR
Sbjct: 196 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 47/204 (23%), Positives = 96/204 (47%), Gaps = 13/204 (6%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        +   KL   +   A   ++ ++L  L  C 
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 62  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+          +   T  Y  ++PE + G  
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY--MSPERLQGTH 178

Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 179 YSVQ----SDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 30/192 (15%)

Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIA 440
           ++L  L  C    I+ FY     +   + +  + M+GGS+ D +LK   ++    + +I+
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSL-DQVLKKAGRIPENILGKIS 105

Query: 441 IDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI------VTACKSVGEATEY 493
           I V  G+ +L + H + +RD+    IL++  G + L D G+        A   VG     
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----- 160

Query: 494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG--------EAAYAACSPVQ 545
            T  Y  ++PE + G   +V     S+++S G+ + EM  G             A     
Sbjct: 161 -TRSY--MSPERLQGTHYTVQ----SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213

Query: 546 AAVGIAACGLRP 557
            + G A    RP
Sbjct: 214 VSEGEAKESHRP 225

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 14/151 (9%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGI 447
           H NILQ    CV E     +V +  E G +   +       R  Q   + R+A ++A G+
Sbjct: 54  HPNILQCLGQCV-EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGY---RWLAP 503
             ++ H   + DL  +   L     V +GD GI  +  K   +  E E D     RWLAP
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE--DYIETEDDKCVPLRWLAP 170

Query: 504 EIIA---GDPESVSETWMSNVYSFGMVIWEM 531
           E++    G   +  +T  SNV++ G+ +WE+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 30/111 (27%), Positives = 58/111 (52%), Gaps = 16/111 (14%)

Query: 427 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTA 483
           + R L   ++  +A  +   I +++  G+ +RD+ ++ +L++   ++CLGD G       
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312

Query: 484 CKSV----GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
             S     G A   +T+     APE++AGDP + S     +++S G+VI+E
Sbjct: 313 SWSTPFHYGIAGTVDTN-----APEVLAGDPYTPS----VDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 14/155 (9%)

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 498
           A ++A  + +L+   + YRDL  + ILLD  G+V L D G+   CK  G      T  + 
Sbjct: 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GIEHSKTTSTFC 157

Query: 499 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI--AAC 553
               +LAPE++   P   +  W    +  G V++EM+ G   + +    +    I     
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDW----WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            L+P I      +L+ L+ K        +  F EI
Sbjct: 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 46/252 (18%)

Query: 372 KGNAYEFELRKDLLELM---TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 428
           + +A   E  K L E     +  H N+LQ    C +    L V    ME   + DL    
Sbjct: 31  RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV----MEFCPLGDLKGYL 86

Query: 429 RKLQTKEII--------RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
           R  +  E++        R+A ++A G+  L+ +   + DL  +  LL     V +GD G+
Sbjct: 87  RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146

Query: 481 VTACKSVGEATEYETDGY----------RWLAPEI---IAGDPESVSETWMSNVYSFGMV 527
            +  K       Y+ D Y          RW+APE+   + G+   V +T  SNV+S G+ 
Sbjct: 147 -SHNK-------YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198

Query: 528 IWEMVT-GEAAYAACSPVQA-AVGIAACGLRPEIPKDCPQILKS-----LMIKCWNNSPS 580
           IWE+   G   Y   S  Q     +    L+  +PK   ++  S     +M  CW   P 
Sbjct: 199 IWELFELGSQPYRHLSDEQVLTYTVREQQLK--LPKPRLKLPLSDRWYEVMQFCW-LQPE 255

Query: 581 KRPQFSEIISLL 592
           +RP   E+  LL
Sbjct: 256 QRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 44/208 (21%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V K        +   KL   +   A   ++ ++L  L  C 
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ +++++  + + +++I V  G+ +L 
Sbjct: 62  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLAPEII 506
           + H + +RD+    IL++  G + L D G+       G+  +   + +     +++PE +
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGV------SGQLIDSMANSFVGTRSYMSPERL 174

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTG 534
            G   SV     S+++S G+ + E+  G
Sbjct: 175 QGTHYSVQ----SDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 28/172 (16%)

Query: 426 LKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
           L  R+  T+  +R+ I ++   +  L+  G+ YRD+  + ILLD  G+V L D G+    
Sbjct: 96  LYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGL---S 152

Query: 485 KSVGEATEYETDGY----RWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTGEAAY 538
           K      E     +     ++APE+I G      +   W    +S G++ +E++TG    
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW----WSLGVLTFELLTG---- 204

Query: 539 AACSPV--------QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
              SP         Q+ +       +P  PK      +  + K     P KR
Sbjct: 205 --ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 6/151 (3%)

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
           A ++A  + +L+   + YRDL  + ILLD  G++ L D G+          T        
Sbjct: 102 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI--AACGLRP 557
           +LAPE++   P   +  W    +  G V++EM+ G   + + +  +    I      L+P
Sbjct: 162 YLAPEVLHKQPYDRTVDW----WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 217

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            I      +L+ L+ K        +  F EI
Sbjct: 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 427 KSRKLQTKEII--RIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIV-T 482
             + L   E I  +IA+ + + +++L+    V +RD+    +L++R+G V L D GI   
Sbjct: 94  YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC- 541
              SV +  +     Y  +APE I  +         S+V+S G+ + E+ TG   Y +  
Sbjct: 154 LVDSVAKTIDAGCKPY--MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211

Query: 542 SPVQAAVGIAACGLRPEIPKD--CPQILKSLMIKCWNNSPSKRPQFSEI 588
           +P Q    +      P++P +   P+  +  + KC   +  +RP + E+
Sbjct: 212 TPFQQLKQVVE-EPSPQLPAEKFSPEF-QDFVNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 39/219 (17%)

Query: 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELM 388
           N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L    
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL---- 56

Query: 389 TCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIAI 441
              H NI++   V   EN    V       + K M+   ++ + L   K    +++    
Sbjct: 57  --NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL---- 110

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYR 499
              +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E  T  YR
Sbjct: 111 ---QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
             APEI+ G       +   +++S G +  EMVT  A +
Sbjct: 168 --APEILLG---CKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 53/227 (23%)

Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
           N + ++++G  ++  VYKG           K + ++  +G       E  L K+L     
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL----- 55

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA----- 444
             H+NI++ + V   EN  L +V + M+     DL    +K      +R A+D       
Sbjct: 56  -KHENIVRLHDVIHTENK-LMLVFEYMD----KDL----KKYMDTHGVRGALDPNTVKSF 105

Query: 445 -----EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-----ATEYE 494
                +GI F +++ V +RDL  Q +L+++ G + L D G+    ++ G      + E  
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV 162

Query: 495 TDGYRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYA 539
           T  YR  AP+++ G     S T+ +  +++S G ++ EM+TG   + 
Sbjct: 163 TLWYR--APDVLLG-----SRTYSTSIDIWSVGCIMAEMITGRPLFP 202

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGH 392
           D  E +++IG  ++  VYK      GK V ++K +   D+       LR+  L  M    
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 393 KNILQFYCV-CVDENHG---LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVA 444
             I++   V  V+E +G   L +V + ++      +        R L  K I      + 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACK-SVGEAT-EYETDGYRWL 501
           +G+   + HGV +RDL  Q +L+D+   +  + D+G+  A    V   T E  T  YR  
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR-- 178

Query: 502 APEIIAGDPESVSETWMSNV--YSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
           APE++ G     S  + + V  +S G +  EM   +  +   S +Q  + I
Sbjct: 179 APEVLLG-----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 50.7 bits (122), Expect = 9e-07
 Identities = 35/202 (17%), Positives = 84/202 (41%), Gaps = 17/202 (8%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           + + +IG  +   V+K      G+ V ++K+           +  +++  L  C H  ++
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 397 QFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDH 453
           +   V     HG   V  +ME     +++++    + L   ++      + +G+ +++ +
Sbjct: 63  KLLDV---FPHGSGFVL-VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPES 512
           G+ +RDL    +L+   G + + D G+                  RW  APE++ G  + 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 513 VSETWMSNVYSFGMVIWEMVTG 534
                  ++++ G +  E++ G
Sbjct: 179 DPGV---DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 9e-07
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 16/159 (10%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 449
           H NIL +    +  +  L VV+ LM  GS  DL+         E  I  I  DV   + +
Sbjct: 58  HPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---------TEYETDGYRW 500
           ++  G  +R + +  ILL   G V L   G+  +   +             +       W
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 539
           L+PE++  + +  +E   S++YS G+   E+  G   + 
Sbjct: 175 LSPEVLQQNLQGYNEK--SDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 39/273 (14%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK----GNAYEFELRKDL--LELMTCGH- 392
           ++LE + +IG  +   VYK +      +    +    GN  E   ++ L  L+++   H 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHD 72

Query: 393 -KNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
              I++ Y     D +  +C+  +LM   +  D +LK  +    E I  ++ + + + + 
Sbjct: 73  CPYIVKCYGYFITDSDVFICM--ELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128

Query: 449 FLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGEATEYETDGYRW 500
           +L + HGV +RD+    ILLD  GNV L D GI           +S G A         +
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--------Y 180

Query: 501 LAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
           +APE I  DP   +  +   ++V+S G+ + E+ TG+  Y  C      +        P 
Sbjct: 181 MAPERI--DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238

Query: 559 IP--KDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           +P  +       S +  C      KRP++ E++
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 51/265 (19%), Positives = 112/265 (42%), Gaps = 30/265 (11%)

Query: 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 390
           N +   +IG   F  VY+       K V ++K++  +  +A   + R+D ++    L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA---KARQDCVKEIDLLKQL 59

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEG 446
            H N++++    +++N  L +V +L + G ++ +I     + R +  + + +  + +   
Sbjct: 60  NHPNVIKYLDSFIEDNE-LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           ++ ++   V +RD+    + +   G V LGD+G+       G     +T     L     
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSSKTTAAHSLVGTPY 171

Query: 507 AGDPESVSE---TWMSNVYSFGMVIWEMVTGEAAYAA--CSPVQAAVGIAACGLRPEIPK 561
              PE + E    + S+++S G +++EM   ++ +     +       I  C   P   +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE 231

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFS 586
              + L+ L+  C    P +RP   
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 25/155 (16%)

Query: 424 LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 480
           L  +SR L   + + I   + EG+++L+   + +RD+ ++ I ++    VC+GD+G    
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Query: 481 -VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV------- 532
            V A   +G A   ET+     APE++A D  +      ++++S G+V++EM+       
Sbjct: 207 PVVAPAFLGLAGTVETN-----APEVLARDKYNSK----ADIWSAGIVLFEMLAYPSTIF 257

Query: 533 ----TGEAAYAACSPVQAAVGIAACGLRP-EIPKD 562
               +    Y           I+   + P E P+D
Sbjct: 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292

Length = 357

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 54/274 (19%), Positives = 110/274 (40%), Gaps = 29/274 (10%)

Query: 341 NLEFIDQIGPNSFKGVYK-GKRVGIEKLKGCDKGNAYEFELRKDLLE--------LMTCG 391
               ++ +G  +F  VYK  K+   + L    + N +     KD  E        +    
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 392 -------HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRK--LQTKEIIRIA 440
                  H NI+++Y   + EN  L +V  L+EG  + +    LK +K     + I  I 
Sbjct: 61  IIKEQLRHPNIVRYYKTFL-ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 441 IDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
           + +   +++L+ +  + +RDL    I+L     V + D G+    K              
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTIL 178

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           +  PEI+  +P        ++V++FG ++++M T +  + + + +  A  I      P +
Sbjct: 179 YSCPEIVKNEP----YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-L 233

Query: 560 PKDCPQILKSLMIK-CWNNSPSKRPQFSEIISLL 592
           P+       + +I  C       RP   ++ +++
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 11/119 (9%)

Query: 422 NDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG-- 479
           N+L    R +    I +I     + + F + H   +RD+  + IL+ + G + L D G  
Sbjct: 88  NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147

Query: 480 -IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
            I+T      + T+Y  T  YR  APE++ GD +        +V++ G V  E++TG+ 
Sbjct: 148 RILTG--PGDDYTDYVATRWYR--APELLVGDTQYGPPV---DVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 6/133 (4%)

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           L+   V YRDL  + ILLD  G++ L D G+        + T        +LAPE++ G 
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
             + +  W    ++ G++++EM+TG   +   +  +    I    LR   P    +  K 
Sbjct: 169 GYTKAVDW----WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKD 222

Query: 570 LMIKCWNNSPSKR 582
           L+I   +  P++R
Sbjct: 223 LLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 48.7 bits (117), Expect = 3e-06
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 46/211 (21%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYE----FELR--KDLLELMTC 390
           E   ++G  ++  VYK      G+ V I+K+K  ++  A +      LR  K L EL   
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-- 60

Query: 391 GHKNILQFYCV-CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL-----QTKEIIRIAID 442
            H NI+    V     N  + +V + ME     DL  ++K + +       K  + + + 
Sbjct: 61  -HPNIIGLLDVFGHKSN--INLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTL- 112

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRW 500
              G+++L+ + + +RDL    +L+   G + L D G+  +  S      ++  T  YR 
Sbjct: 113 --RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEM 531
            APE++ G          +  Y  G+ +W +
Sbjct: 170 -APELLFG----------ARHYGVGVDMWSV 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 4/94 (4%)

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           ++ L+  G+ YRDL  + ILLD  G+V L D G+       G  T        ++APEI+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
                  +  W    +S G ++++M+TG   + A
Sbjct: 173 MRSGHGKAVDW----WSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIK 448
           ++Q +C   D+ + L +V + M GG + +L+       K  K  T E++ +A+D      
Sbjct: 105 VVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDA----- 157

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEI 505
            ++  G+ +RD+    +LLD+HG++ L D G        G     T   T  Y  ++PE+
Sbjct: 158 -IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY--ISPEV 214

Query: 506 I---AGDPESVSET-WMSNVYSFGMVIWEMVTGEAAYAACSPV 544
           +    GD     E  W    +S G+ ++EM+ G+  + A S V
Sbjct: 215 LKSQGGDGYYGRECDW----WSVGVFLFEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 21/209 (10%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +  E +  +G  ++  V K +       V I+K K  +     +    +++  L    H+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+        +   L +V + +E   +  L      L    +      + + I + + H
Sbjct: 61  NIVNLKEAFRRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEY-ETDGYRWLAPEIIAGDP 510
            + +RD+  + IL+   G + L D G   A   +     T+Y  T  YR  APE++ GD 
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR--APELLVGDT 177

Query: 511 E---SVSETWMSNVYSFGMVIWEMVTGEA 536
                V      +V++ G ++ E++ GE 
Sbjct: 178 NYGKPV------DVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 12/156 (7%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKF 449
           H NI+ +    + +N  L VVT  M  GS  DLI       +    I  I   V + + +
Sbjct: 58  HPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDY 116

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-------CKSVGEATEYETDGYRWLA 502
           ++  G  +R + +  IL+   G V L  +    +        + V +  +Y      WL+
Sbjct: 117 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           PE++  + +       S++YS G+   E+  G   +
Sbjct: 177 PEVLQQNLQGYDAK--SDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 8/145 (5%)

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
           ++   ++ L+  G+ YRD+  + ILLD  G+V L D G+     S  +   Y   G   +
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 501 LAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYA--ACSPVQAAVGIAACGLRP 557
           +APEII G      +  W    +S G++I+E++TG + +        Q+ V        P
Sbjct: 173 MAPEIIRGKGGHGKAVDW----WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKR 582
             P       + L+ K     P KR
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 24/161 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+NI+    + +     +  VT+L+      DL  +L SR L+ + I      +  G+K+
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAG 508
           ++  GV +RDL    IL++ + ++ + D G+        + T Y  T  YR  APEI+  
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYR--APEIML- 178

Query: 509 DPESVSETWMS-----NVYSFGMVIWEMVTGEAAYAACSPV 544
                  TW       +++S G +  EM+ G+  +     V
Sbjct: 179 -------TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 43/197 (21%), Positives = 89/197 (45%), Gaps = 33/197 (16%)

Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413
           +G  K +R+  +++K   +       L  ++L L    H+NIL+   +   E +   +  
Sbjct: 187 QGKPKCERLIAKRVKAGSRAAIQ---LENEILALGRLNHENILKIEEILRSEANTYMITQ 243

Query: 414 K-------LMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           K        M          K R L  QT+ I++    +   +++++D  + +RD+  + 
Sbjct: 244 KYDFDLYSFMYDE---AFDWKDRPLLKQTRAIMK---QLLCAVEYIHDKKLIHRDIKLEN 297

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL------APEIIAGDPESVSETWM 518
           I L+  G + LGD G     +   EA +Y      W+      +PEI+AGD        +
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYG-----WVGTVATNSPEILAGD----GYCEI 348

Query: 519 SNVYSFGMVIWEMVTGE 535
           ++++S G+++ +M++ +
Sbjct: 349 TDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 30/133 (22%), Positives = 63/133 (47%), Gaps = 10/133 (7%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V + + GG +   + + R            ++   + +L+   + YRDL  + ++LD
Sbjct: 70  LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD 129

Query: 469 RHGNVCLGDMGIVTACKS-VGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
           + G++ + D G+   CK  + +A   +T      +LAPE++  +    +  W    +  G
Sbjct: 130 KDGHIKITDFGL---CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLG 182

Query: 526 MVIWEMVTGEAAY 538
           +V++EM+ G   +
Sbjct: 183 VVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 47/218 (21%)

Query: 345 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +D++G  ++  VYKG           K + +E  +G       E  L KDL       H 
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 64

Query: 394 NILQFYCVCVDENHGLCVVTKLME----------GGSVNDLILKSRKLQTKEIIRIAIDV 443
           NI+  + + +     L +V + ++          G S+N   + + KL   +++R     
Sbjct: 65  NIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGNSIN---MHNVKLFLFQLLR----- 115

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 500
             G+ + +   V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  YR 
Sbjct: 116 --GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYR- 171

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
             P+I+ G  +  ++    +++  G + +EM TG   +
Sbjct: 172 -PPDILLGSTDYSTQI---DMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 37/159 (23%)

Query: 409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQRI 465
           LC+V     GG +  L L+ +  K  ++E+ R  A +V   +++L+  G+ YRDL  + I
Sbjct: 76  LCLVMDYCPGGELFRL-LQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134

Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEY--------------------ETDGYR------ 499
           LL   G++ L D  +                                 E   +R      
Sbjct: 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVG 194

Query: 500 ---WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
              ++APE+I+GD    +  W    ++ G++++EM+ G 
Sbjct: 195 TEEYIAPEVISGDGHGSAVDW----WTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 50/243 (20%)

Query: 330 EEIGRWLLNSDNLEFIDQIGPNSF-----------KGVYKGKRVG-IEKLKGCDKGNAYE 377
           E+I +  + +++ + I  IG  +F           K VY  K +   E +K  D  +A+ 
Sbjct: 33  EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD--SAFF 90

Query: 378 FELRKDLLELMTCGHKN---ILQFYCVCVDENHGLCVVTKLMEGGS-VN-----DLILKS 428
           +E R    ++M   H N   I+Q +    D+ + L +V + M GG  VN     D+  K 
Sbjct: 91  WEER----DIM--AHANSEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPEKW 143

Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
            +  T E++ +A+D       ++  G  +RD+    +LLD+ G++ L D G      + G
Sbjct: 144 ARFYTAEVV-LALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196

Query: 489 EA---TEYETDGYRWLAPEII---AGDPESVSET-WMSNVYSFGMVIWEMVTGEAAYAAC 541
                T   T  Y  ++PE++    GD     E  W    +S G+ ++EM+ G+  + A 
Sbjct: 197 MVRCDTAVGTPDY--ISPEVLKSQGGDGYYGRECDW----WSVGVFLYEMLVGDTPFYAD 250

Query: 542 SPV 544
           S V
Sbjct: 251 SLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 345 IDQIGPNSFKGVYKGKR------VGIEKLK------GCDKGNAYEFELRKDLLELMTCGH 392
           I++IG  ++  VYKG+       V ++K++      G       E  L K+L       H
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL------QH 58

Query: 393 KNILQFYCVCVDENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
            NI+    V + E+    +   L M+     D + K + +  + +      + +GI F +
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGD 509
              V +RDL  Q +L+D  G + L D G+  A         +E  T  YR  APE++ G 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR--APEVLLGS 176

Query: 510 PESVSETWMSNVYSFGMVIWEMVT 533
           P   +     +++S G +  EM T
Sbjct: 177 PRYSTPV---DIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 31/129 (24%), Positives = 61/129 (47%), Gaps = 10/129 (7%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 70  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 129

Query: 469 RHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAGDPESVSETWMSNVYSFG 525
           + G++ + D G+   CK      AT     G   +LAPE++  +    +  W    +  G
Sbjct: 130 KDGHIKITDFGL---CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLG 182

Query: 526 MVIWEMVTG 534
           +V++EM+ G
Sbjct: 183 VVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 34/202 (16%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI+            L  V + + G ++ +++     L   E  R+ + V + +   +
Sbjct: 37  HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAH 96

Query: 452 DHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEA--------TEY-ETDGYR 499
           + G+ +RDL  Q I++ + G   +  + D GI T    V +A        TE   T  Y 
Sbjct: 97  NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY- 155

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA----------YAACSPVQAAVG 549
             APE + G+P     T  S++Y++G++  E +TG+            Y   SPV  ++ 
Sbjct: 156 -CAPEQLRGEP----VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP 210

Query: 550 IAACG------LRPEIPKDCPQ 565
               G      LR  + KD  Q
Sbjct: 211 PWIAGHPLGQVLRKALNKDPRQ 232

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 34/275 (12%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELM---T 389
           +++L+ + +IG  +F  V K      G  + +++++        +  L  DL  +M    
Sbjct: 3   AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSD 61

Query: 390 CGHKNILQFYCVCVDENHGLC-VVTKLMEGGSVNDLILKSRKLQTKEII------RIAID 442
           C    I++FY     E  G C +  +LM+     D   K      K +I      +IA+ 
Sbjct: 62  C--PYIVKFYGALFRE--GDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 443 VAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-W 500
             + + +L  +  + +RD+    ILLDR+GN+ L D GI  + + V    +    G R +
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSIAKTRDAGCRPY 173

Query: 501 LAPEIIAGDPESVSETWM-SNVYSFGMVIWEMVTGEAAYAACSPV----QAAVGIAACGL 555
           +APE I  DP +     + S+V+S G+ ++E+ TG+  Y   + V       V      L
Sbjct: 174 MAPERI--DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                ++      + +  C     SKRP++ E++ 
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 29/130 (22%), Positives = 58/130 (44%), Gaps = 4/130 (3%)

Query: 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
            +  LC V +   GG +   + + R            ++   + +L+   V YRDL  + 
Sbjct: 66  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 524
           ++LD+ G++ + D G+     S G   +       +LAPE++  +    +  W    +  
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGL 181

Query: 525 GMVIWEMVTG 534
           G+V++EM+ G
Sbjct: 182 GVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 44.9 bits (107), Expect = 7e-05
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 35/170 (20%)

Query: 391 GHKNILQFYCVCVDENH-GLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGI 447
            H NI++   V   EN   + +V + ME     DL  ++++  L+      I   + + +
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYME----TDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y---RW 500
           K+++   V +RDL    ILL+    V L D G+    +S+ E  E   +     Y   RW
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL---ARSLSELEENPENPVLTDYVATRW 177

Query: 501 L-APEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEAAYAACS 542
             APEI+ G          S  Y+ G+ +W       EM+ G+  +   S
Sbjct: 178 YRAPEILLG----------STRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 24/217 (11%)

Query: 340 DNLEFIDQIGPNSFKGV----YKGKR---VGIEKLKGC----DKGNAYEFELRKDLLELM 388
           ++  FI  +G  SF  V    YK +    V I++ +       K   + F  RK L  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI- 88

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H   +  Y    DE++ L +V + + GG     + ++++         A  +    +
Sbjct: 89  --NHPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIA 507
           +L    + YRDL  + +LLD+ G + + D G       V +   Y   G   ++APEI+ 
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA----KVVDTRTYTLCGTPEYIAPEILL 201

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
                 +  W    ++ G+ I+E++ G   + A  P+
Sbjct: 202 NVGHGKAADW----WTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 16/156 (10%)

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
           M C HK I       V E+  + +V +  EGG +   I K   +  + + R A ++   +
Sbjct: 47  MVCLHKYI-------VSED-SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL 98

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
             L+  G+  RDLN   ILLD  G++ L           V ++ + E     + APE+  
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFS---RWSEVEDSCDGEAVENMYCAPEVGG 155

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 543
              E+ +  W    +S G +++E++TG+     C P
Sbjct: 156 ISEETEACDW----WSLGAILFELLTGK-TLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 44/218 (20%)

Query: 340 DNLEFIDQIGPNSFKGVYKGK-RVGIE-------KLKGCDKG----NAYEFELRKDLLEL 387
           D  E +++IG  ++  VYK + RV  E       +L+  D+G       E  L K++   
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM--- 58

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE------IIRIAI 441
               H NI++   V   E     V   L       DL LK     + +      +I+  +
Sbjct: 59  ---QHGNIVRLQDVVHSEKRLYLVFEYL-------DLDLKKHMDSSPDFAKNPRLIKTYL 108

Query: 442 -DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYE--TDG 497
             +  GI + + H V +RDL  Q +L+DR  N   L D G+  A         +E  T  
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168

Query: 498 YRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVT 533
           YR  APEI+ G     S  + +  +++S G +  EMV 
Sbjct: 169 YR--APEILLG-----SRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 33/98 (33%), Positives = 44/98 (44%), Gaps = 21/98 (21%)

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLA 502
           +GI + + H V +RDL  Q +L+DR G + L D G+  A         +E  T  YR  A
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR--A 167

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 533
           PEI+ G          S  YS  + IW       EMV 
Sbjct: 168 PEILLG----------SRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 51/240 (21%)

Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----KNIL--------- 396
           S K + +G    +  ++  D G+ Y  + LRK D+LE    GH    ++IL         
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 397 -QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
             FY     +   L ++ + + GG +  L++K   L  +E      +    I  ++  G 
Sbjct: 65  KMFYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------------- 498
            +RD+    +LLD  G+V L D G+ T  K       Y    +                 
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 499 -------RWLAPEIIAGDPESVS-ETWMSNVY-------SFGMVIWEMVTGEAAYAACSP 543
                  R LA   + G P+ ++ E +M   Y       S G++++EM+ G   + + +P
Sbjct: 183 ETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.7 bits (104), Expect = 1e-04
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)

Query: 387 LMTCGHKNILQ-FYCVCVDENHGLCVVTKLM---EGGSVNDLILKSRKLQTKEIIRIAID 442
           LM   + N ++ +Y V   + H L     +M   + G + DL+ K  KL   E+ +I   
Sbjct: 64  LMKD-NPNFIKLYYSVTTLKGHVL-----IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
           + E +  L+ H + + D+  + +L DR    + L D G+   CK +G  + Y  DG   +
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL---CKIIGTPSCY--DGTLDY 172

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
            +PE I G    VS  W    ++ G++ +E++TG+
Sbjct: 173 FSPEKIKGHNYDVSFDW----WAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 55/249 (22%)

Query: 340 DNLEFIDQIGPNSFKGVY------KGKRVGIEKLKGCD---KGNAYEFELRKDLLELMTC 390
           D+ E I  IG  +F  V+       G+   ++ L+  D   +         +D+L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL--ADA 58

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQ-TKEIIRIAIDVAE--- 445
               I++ Y    DE H L +V + M GG   DL+ L  RK    +E  R  I  AE   
Sbjct: 59  DSPWIVKLYYSFQDEEH-LYLVMEYMPGG---DLMNLLIRKDVFPEETARFYI--AELVL 112

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR------ 499
            +  ++  G  +RD+    IL+D  G++ L D G+        +   Y  D +       
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 500 -----------------------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
                                  ++APE++ G P  +   W    +S G++++EM+ G  
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW----WSLGVILYEMLYGFP 228

Query: 537 AYAACSPVQ 545
            + + +  +
Sbjct: 229 PFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 35/162 (21%)

Query: 392 HKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR-IAIDVA 444
           H+NI+           ++ + + +VT+LME     DL  ++KS +  T + I+     + 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQIL 113

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETDGYR 499
            G+K+L+   V +RDL    IL++ + ++ + D G    +       G  TEY  T  YR
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTG 534
             APE++            S+ Y+  + IW       E++T 
Sbjct: 174 --APELLL----------SSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 30/201 (14%)

Query: 407 HGLCV-------VTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAY 457
           HG+CV       V + +E G + D+ L+  K +      I +A  +A  + +L D  + +
Sbjct: 82  HGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH 140

Query: 458 RDLNSQRILLDRHG-------NVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGD 509
            ++ ++ ILL R G        + L D G+  TA      + E   +   W+APE +   
Sbjct: 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL-----SREERVERIPWIAPECV--- 192

Query: 510 PESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
           P   S +  ++ +SFG  + E+   GE      +P +           PE    C + L 
Sbjct: 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE--PSCKE-LA 249

Query: 569 SLMIKCWNNSPSKRPQFSEII 589
           +L+ +C    P++RP F  I+
Sbjct: 250 TLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 45/194 (23%), Positives = 88/194 (45%), Gaps = 31/194 (15%)

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101

Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 102 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 159

Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 160 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIML--------NWMHYNQTVDIWSV 204

Query: 525 GMVIWEMVTGEAAY 538
           G ++ E++TG   +
Sbjct: 205 GCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 19/217 (8%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLELMTCG 391
           +D+ E ++++G  S+  VYKGK     KL          ++G  +       LL+ +   
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-- 61

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI+  + + +     L +V + +       +      L  + +      +  G+ +++
Sbjct: 62  HANIVLLHDI-IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAG 508
              + +RDL  Q +L+   G + L D G+  A KSV   T   E  T  YR   P+++ G
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYR--PPDVLLG 177

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
             E  +     +++  G +  EM+ G AA+     +Q
Sbjct: 178 STEYST---CLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 70  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129

Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 185

Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 186 MYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 45/217 (20%)

Query: 345 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           ++++G  ++  V+KG           K + +E  +G       E  L KDL       H 
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 64

Query: 394 NILQFYCVCVDENHGLCVVTKLMEG---------GSVNDLILKSRKLQTKEIIRIAIDVA 444
           NI+  + + V  +  L +V + ++          G++  + + + K+   +I+R      
Sbjct: 65  NIVTLHDI-VHTDKSLTLVFEYLDKDLKQYMDDCGNI--MSMHNVKIFLYQILR------ 115

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWL 501
            G+ + +   V +RDL  Q +L++  G + L D G+  A KSV   T   E  T  YR  
Sbjct: 116 -GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYR-- 171

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
            P+++ G  E  ++    +++  G + +EM +G   +
Sbjct: 172 PPDVLLGSSEYSTQI---DMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQ 463
           +   L +V +   GG +  L+ +      +++ +  + ++   I  ++  G  +RD+  +
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131

Query: 464 RILLDRHGNVCLGDMG---IVTACKSVGEATEYETDGYRWLAPEI---IAGDPES---VS 514
            +L+DR G++ L D G    +TA K V       T  Y  +APE+   + GD +    V 
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY--IAPEVLTTMNGDGKGTYGVE 189

Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAA 540
             W    +S G++ +EM+ G + +  
Sbjct: 190 CDW----WSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           E    IG  +F  V+       GKRV ++K+    +       + ++L  L    H N+L
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 397 QFYCVC----VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
               +     +D    + VVT+LM+   ++ +I+  + L +  +      +  G+K+L+ 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEA-TEYETDGYRWLAPEI 505
            G+ +RD+    +L++ +  + + D G+        +     E  T+Y    YR  APEI
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY----YR--APEI 175

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
           + G     S     +++S G +  E++     + A SP+Q
Sbjct: 176 LMGSRHYTSAV---DIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 26/134 (19%)

Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +VT LM G  +N+ I+K +KL    I  +   +  G+K+++  G+ +RDL    I ++  
Sbjct: 97  LVTHLM-GADLNN-IVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 154

Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGY---RW-LAPEIIAGDPESVSETWMS-----NV 521
             + + D G+          T+ E  GY   RW  APEI+          WM      ++
Sbjct: 155 CELKILDFGL-------ARHTDDEMTGYVATRWYRAPEIML--------NWMHYNQTVDI 199

Query: 522 YSFGMVIWEMVTGE 535
           +S G ++ E++TG+
Sbjct: 200 WSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 53/285 (18%)

Query: 343 EFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKD---LLELMTCGH 392
           E + +IG  ++  V+K       G+ V +++++             ++   L  L T  H
Sbjct: 4   ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 393 KNILQFYCVCV----DENHGLCVVTKLMEGGSVNDLILKSRK-----LQTKEIIRIAIDV 443
            N+++ + VC     D    L +V + ++     DL     K     + T+ I  +   +
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
             G+ FL+ H V +RDL  Q IL+   G + L D G+     S   A         + AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAP 178

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--------------------P 543
           E++       S     +++S G +  EM   +  +   S                    P
Sbjct: 179 EVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 544 VQAAVGIAACGLRPEIP-----KDCPQILKSLMIKCWNNSPSKRP 583
              A+   A   +   P      D  ++ K L++KC   +P+KR 
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 45/194 (23%), Positives = 84/194 (43%), Gaps = 31/194 (15%)

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G +V I+KL    +   +     ++L  L    H+N++    V      +D  H   +V 
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99

Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
             M  G+    ++K  KL    I  +   + +G+K+++  G+ +RDL    + ++    +
Sbjct: 100 PFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL 157

Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APE+I          WM      +++S 
Sbjct: 158 KILDFGL-------ARQTDSEMTGYVVTRWYRAPEVIL--------NWMHYTQTVDIWSV 202

Query: 525 GMVIWEMVTGEAAY 538
           G ++ EM+TG+  +
Sbjct: 203 GCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 26/137 (18%)

Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +VT LM G  +N+ I+K +KL  + +  +   +  G+K+++  G+ +RDL    + ++  
Sbjct: 97  LVTNLM-GADLNN-IVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154

Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NV 521
             + + D G+           + E  GY   RW  APEI+          WM      ++
Sbjct: 155 CELRILDFGL-------ARQADDEMTGYVATRWYRAPEIML--------NWMHYNQTVDI 199

Query: 522 YSFGMVIWEMVTGEAAY 538
           +S G ++ E++ G+A +
Sbjct: 200 WSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 66/302 (21%), Positives = 125/302 (41%), Gaps = 42/302 (13%)

Query: 302 LKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK--- 358
           L + L +P PSSS   S     +  SG        L+   LE +++IG  +   VYK   
Sbjct: 41  LAVPLPLPPPSSS---SSSSSSSSASGSAPSAAKSLS--ELERVNRIGSGAGGTVYKVIH 95

Query: 359 ---GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ---FYCVCVDENHGLCVV 412
              G+   ++ + G +  +    ++ +++  L    H N+++    +    D N  + V+
Sbjct: 96  RPTGRLYALKVIYG-NHEDTVRRQICREIEILRDVNHPNVVKCHDMF----DHNGEIQVL 150

Query: 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
            + M+GGS+      +     + +  +A  +  GI +L+   + +RD+    +L++   N
Sbjct: 151 LEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN 206

Query: 473 VCLGDMGI-------VTACK-SVGEATEYETDGYRWLAPEIIAGD-PESVSETWMSNVYS 523
           V + D G+       +  C  SVG      T  Y  ++PE I  D      + +  +++S
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSVG------TIAY--MSPERINTDLNHGAYDGYAGDIWS 258

Query: 524 FGMVIWEMVTGEAAYAACSPVQ-AAVGIAAC-GLRPEIPKDCPQILKSLMIKCWNNSPSK 581
            G+ I E   G   +        A++  A C    PE P    +  +  +  C    P+K
Sbjct: 259 LGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAK 318

Query: 582 RP 583
           R 
Sbjct: 319 RW 320

Length = 353

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 29/209 (13%)

Query: 345 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +D++G  ++  V+KG           K + +E  +G       E  L K+L       H 
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------KHA 63

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLND 452
           NI+  + + +     L +V + ++   +   +     L +   ++I +  +  G+ + + 
Sbjct: 64  NIVTLHDI-IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAGD 509
             + +RDL  Q +L++  G + L D G+  A KSV   T   E  T  YR   P+++ G 
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYR--PPDVLLGS 178

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAY 538
            E  +   M  V   G +++EM TG   +
Sbjct: 179 TEYSTPIDMWGV---GCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 18/135 (13%)

Query: 416 ME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
           ME   GG    L+     L          ++ E +  L++ G  +RDL  +  L+D  G+
Sbjct: 80  MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH 139

Query: 473 VCLGDMG----IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + L D G    IVT   SV  + +Y       +APE++ G     +  +    +S G ++
Sbjct: 140 IKLTDFGLSKGIVTYANSVVGSPDY-------MAPEVLRGKGYDFTVDY----WSLGCML 188

Query: 529 WEMVTGEAAYAACSP 543
           +E + G   ++  +P
Sbjct: 189 YEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 37/164 (22%)

Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
             E +++IG  ++  V+K            KRV ++     D        LR+  L L  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICL-LKE 55

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLME----------GGSVNDLILKSRKLQTKEIIRI 439
             HKNI++ Y V +  +  L +V +  +           G ++  I+KS   Q       
Sbjct: 56  LKHKNIVRLYDV-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ------- 107

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
              + +G+ F + H V +RDL  Q +L++++G + L D G+  A
Sbjct: 108 ---LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLA 502
           G+ +++   + +RDL  Q +L+   G + L D G+  A KS+   T   E  T  YR   
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYR--P 171

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
           P+++ G  +  S     +++  G +  EM+ G+ A+   S V
Sbjct: 172 PDVLLGATDYSSAL---DIWGAGCIFIEMLQGQPAFPGVSDV 210

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 59/252 (23%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----K 393
           D+ E +  IG  +F  V    R+  +K    D G+ Y  + LRK D+LE     H    +
Sbjct: 1   DDFESLKVIGRGAFGEV----RLVQKK----DTGHIYAMKILRKADMLEKEQVAHIRAER 52

Query: 394 NIL----------QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
           +IL           FY     +   L ++ + + GG +  L++K   L  +       + 
Sbjct: 53  DILVEADGAWVVKMFYSF--QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---------- 493
              I  ++  G  +RD+    +LLD  G+V L D G+ T  K       Y          
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 494 ------------ET--DGYRWLAPEIIAGDPESVS-ETWMSNVY-------SFGMVIWEM 531
                       ET     R LA   + G P+ ++ E +M   Y       S G++++EM
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 532 VTGEAAYAACSP 543
           + G   + + +P
Sbjct: 230 LIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 19/188 (10%)

Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
           +LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 106 ELMDA---NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162

Query: 474 CLGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWE 530
            + D G+  TAC +        T  YR  APE+I G    E+V      +++S G ++ E
Sbjct: 163 KILDFGLARTACTNFMMTPYVVTRYYR--APEVILGMGYKENV------DIWSVGCIMGE 214

Query: 531 MVTGEAAY 538
           +V G   +
Sbjct: 215 LVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 19/187 (10%)

Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

Query: 475 LGDMGIV-TACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM 531
           + D G+  TA  S        T  YR  APE+I   G  E+V      +++S G ++ EM
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENV------DIWSVGCIMGEM 218

Query: 532 VTGEAAY 538
           + G   +
Sbjct: 219 IKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 55/230 (23%)

Query: 348 IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---------- 391
           +G  ++  V K      GK V I+K+K  +       ++ KD   +  CG          
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIE----ISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 392 ------HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR-IAID 442
                 H+NI+    V V+ +  + +V  +M      DL  ++  +   T+  ++ I + 
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDF-INLVMDIMAS----DLKKVVDRKIRLTESQVKCILLQ 127

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 499
           +  G+  L+     +RDL+   I ++  G   + D G+             ++ ET   R
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 500 ----------WL-APEIIAGDPESVSETWMSNV--YSFGMVIWEMVTGEA 536
                     W  APE++ G     +E +   V  +S G +  E++TG+ 
Sbjct: 188 EEMTSKVVTLWYRAPELLMG-----AEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	604
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PRK10345	210	hypothetical protein; Provisional	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
smart00090	237	RIO RIO-like kinase.	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.26
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.2
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.91
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
KOG3087	229	consensus Serine/threonine protein kinase [General	98.67
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.55
PRK09902	216	hypothetical protein; Provisional	98.48
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.44
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.04
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.03
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.94
PF01636	239	APH: Phosphotransferase enzyme family This family	97.81
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.8
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.79
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.73
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.63
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.28
PLN02876	822	acyl-CoA dehydrogenase	97.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.02
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.0
PRK10593	297	hypothetical protein; Provisional	96.45
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.32
KOG2270	520	consensus Serine/threonine protein kinase involved	96.14
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.13
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.95
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.68
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.68
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.41
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.01
PRK05231	319	homoserine kinase; Provisional	94.9
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.46
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.22
PLN02756	418	S-methyl-5-thioribose kinase	93.48
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	93.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.86
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	91.13
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	90.55
PRK12396	409	5-methylribose kinase; Reviewed	90.11
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	89.96
KOG1236	565	consensus Predicted unusual protein kinase [Genera	89.89
PTZ00384	383	choline kinase; Provisional	88.8
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	88.09
PRK10271	188	thiK thiamine kinase; Provisional	86.88
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	84.45
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	84.03
PLN02236	344	choline kinase	82.87
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	82.43
KOG2269	531	consensus Serine/threonine protein kinase [Signal	81.78
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	80.56

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-50  Score=425.96  Aligned_cols=264  Identities=38%  Similarity=0.671  Sum_probs=237.7

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe----EE-EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KR-VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG----k~-VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|.++.+++.+.+.||+|+||+||+|    .. ||+|++...+........+.+|+.+|.+++|||||+|+|+|.++..
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            467788888899999999999999985    45 9999998766555556789999999999999999999999998873


Q ss_pred             cEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeccCCCCceEEcCCC-cEEEEecCCccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILLDRHG-NVCLGDMGIVTA  483 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~g-IVHrDLKp~NILld~~g-~vKL~DFGla~~  483 (604)
                      .++|||||+++|+|.+++.+  .+.++...++.++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            49999999999999999976  568999999999999999999999999 99999999999999998 999999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      ............||+.|||||++.+.  ...++.|+||||||+++|||+||+.||....+.+....++..+.++.+|..|
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            66543444557899999999999965  3456778999999999999999999999999988888899999999999999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++.+..||..||..||..||+|.+|+..|..+...
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999987653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-49  Score=425.29  Aligned_cols=259  Identities=26%  Similarity=0.493  Sum_probs=228.4

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .++|+++.+.+.++++||+|.||.||.|.     .||+|.++..   ......+.+|+.+|++|+|+|||+++|+|..++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            47899999999999999999999999985     6999999843   333456779999999999999999999999877


Q ss_pred             CcEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                       ++|||||||+.|+|.++|+.  +..+...+.+.++.|||.||+||+++++|||||.++||||++++.+||+|||||+..
T Consensus       275 -piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  275 -PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             -ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence             49999999999999999975  457999999999999999999999999999999999999999999999999999955


Q ss_pred             ccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          485 KSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       485 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .++.. .......++.|+|||.+....++.    |||||||||+||||+| |+.||++.+..+.+ ..+..|+|++.|..
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~----kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSS----KSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-ELLERGYRLPRPEG  428 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCccc----ccceeehhhhHHHHhccCCCCCCCCCHHHHH-HHHhccCcCCCCCC
Confidence            44322 222334578999999999876554    5999999999999999 99999998877765 55778999999999


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ||++++++|..||..+|++||||+.+...|.++....
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            9999999999999999999999999999998887644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=397.40  Aligned_cols=251  Identities=20%  Similarity=0.396  Sum_probs=222.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++++.++.||+|+.|+|||+      +.+|+|.+. .........++.+|+.+++.++|||||.|||.|.++...++
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            55578899999999999999994      678999995 44556677889999999999999999999999998873499


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+||||++|||++++...+++++..+..++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++.+.+.  
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999999888899999999999999999999995 89999999999999999999999999999877654  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHHcCCCCCCCCC-c
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-----SPVQAAVGIAACGLRPEIPKD-C  563 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~-----s~~~~~~~i~~~~~r~~~p~~-~  563 (604)
                      ......||..|||||.+.+..|+..    +||||||++++|+.+|+.||...     ...+.+.. +..+.+|.+|.. +
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~----sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~-Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVK----SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA-IVDEPPPRLPEGEF  307 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcc----cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-HhcCCCCCCCcccC
Confidence            4566789999999999999977765    99999999999999999999874     33344333 445678888987 9


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +++++++|..||++||.+||++.|++.|=+-.
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence            99999999999999999999999999986644

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-46  Score=408.35  Aligned_cols=248  Identities=22%  Similarity=0.358  Sum_probs=227.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+|+..+.||+|||..||.+      ..||+|.+.+... .......+.+||.+.++|+|||||+++++|.+.++ +|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n-VYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN-VYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc-eEEE
Confidence            56899999999999999984      5799999865332 22345668999999999999999999999999887 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      +|+|..|+|..++++.+.+++.+++.++.||+.||.|||+++|||||||..|+|++++.+|||+|||||..+..+.+...
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999999988878888


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ..+|||.|.|||++...+++..    +||||+||+||-|+.|++||...+-.+.+..|....+.  +|..++.+.++||.
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfE----vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFE----VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHLSAEAKDLIR  250 (592)
T ss_pred             eecCCCcccChhHhccCCCCCc----hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--cccccCHHHHHHHH
Confidence            8899999999999998888876    99999999999999999999998888888888877665  67799999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|+.||.+|||+++|+.+=..
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             HHhcCCcccCCCHHHHhcCHhh
Confidence            9999999999999999998665

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-46  Score=386.56  Aligned_cols=255  Identities=17%  Similarity=0.210  Sum_probs=216.4

Q ss_pred             cCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-----HHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-----YEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-----~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..+.|.+.+.||+|+||.|-+      |+.||||++........     ....+++|+.+|++|+|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            347889999999999999987      57999999975443221     2334689999999999999999999998887


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC---CcEEEEecCCccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTA  483 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~---g~vKL~DFGla~~  483 (604)
                      . .|+||||++||.|.+.+-.++.+.+..-..++.|++.|+.|||++||+||||||+|||++.+   ..+||+|||+|+.
T Consensus       250 s-~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 S-SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             c-eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            6 89999999999999999899999999999999999999999999999999999999999876   7899999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHcCCCC--CCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRP--EIP  560 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~-~~~~i~~~~~r~--~~p  560 (604)
                      .. ....+...+|||.|.|||++.+...... ..+.|+||+||+||-+++|.+||.+..... ....|..+.+..  ..-
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~-~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEYY-PSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeecc-cchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            66 3445677899999999999998766543 347899999999999999999999765544 444555544332  222


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..++++..+||.+||..||++|||++|+++|-|.-
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            45789999999999999999999999999988754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-45  Score=376.93  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=219.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++++.||+|+||.||..      +.+|+|.+++...... .......|..+|.+++||+||+++-.|++..+ +
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k-L  100 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK-L  100 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe-E
Confidence            44589999999999999999984      5688888875543333 34568899999999999999999999998886 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+|+||+.||.|...|.+.+.|++..+..++.+|+.||.|||++|||||||||+|||||.+|+++|+|||+++.....+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987777777


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      .+...+||+.|||||++.+.+++..    +|.||+|+++|||++|.+||...+.......+.... .+..|...+.+.++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~----vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKA----VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARD  255 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcc----cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHH
Confidence            7778899999999999999877765    999999999999999999999988888777777653 34556668999999


Q ss_pred             HHHHhhhcCCCCCC----CHHHHHHH
Q 007429          570 LMIKCWNNSPSKRP----QFSEIISL  591 (604)
Q Consensus       570 LI~kCL~~dP~kRP----T~~ELL~~  591 (604)
                      ++.+.+..||++|.    .+.+|-+|
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhcC
Confidence            99999999999995    46665544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-45  Score=409.23  Aligned_cols=264  Identities=28%  Similarity=0.500  Sum_probs=227.3

Q ss_pred             ccccceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEE
Q 007429          330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF  398 (604)
Q Consensus       330 ~~i~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl  398 (604)
                      ...+..++...++++.++||+|+||.||+|           ..||||.++.. .......+|++|+..+..++|||||+|
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            345667889999999999999999999996           37999999843 344467789999999999999999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhc----------CC----CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------RK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------~~----l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      +|+|.+++. +|+|+|||..|+|.++|+.+          ..    ++..+.+.++.||+.||+||-++.+|||||.++|
T Consensus       555 lGVC~~~~P-~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  555 LGVCREGDP-LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             EEEEccCCe-eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            999998875 99999999999999999522          12    7889999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  541 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~  541 (604)
                      +||+++..|||+|||+++..=....  ......-+++|||||.|..++++    .+||||||||+|||+++ |..||.+.
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT----teSDVWs~GVvLWEIFsyG~QPy~gl  709 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT----TESDVWSFGVVLWEIFSYGKQPYYGL  709 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc----chhhhhhhhhhhhhhhccccCccccc
Confidence            9999999999999999875422111  11122346899999999987655    45999999999999999 99999999


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ++.+.+.-+..+.. ...|++||.+++.||..||+.+|.+||+|+||-..|......++
T Consensus       710 Sn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  710 SNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             chHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            99988876666555 88999999999999999999999999999999999998876553

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-44  Score=375.03  Aligned_cols=259  Identities=24%  Similarity=0.445  Sum_probs=215.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  401 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~  401 (604)
                      .|.+..++|++.+.||+|+||.||+|.           .||+|.++.. ........+.+|+.++..+ +|||||+++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            377888999999999999999999873           5899988743 2223345688999999998 89999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc-----------------------------------------------------
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------------------------------------  428 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~-----------------------------------------------------  428 (604)
                      |...+..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            987665689999999999999998542                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCC
Q 007429          429 ---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDG  497 (604)
Q Consensus       429 ---------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt  497 (604)
                               ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     2367788899999999999999999999999999999999999999999999875432211  11223456


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhh
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  576 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~  576 (604)
                      +.|+|||++.+..++    .++|||||||++|||++ |..||......+........+..+..|..+++.+.+++.+||+
T Consensus       240 ~~y~aPE~~~~~~~~----~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         240 LKWMAPESIFDKVYT----TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             ccccCcHHhhcCCCC----cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            789999999776544    45999999999999997 9999987655454555555666666788899999999999999


Q ss_pred             cCCCCCCCHHHHHHHHHHhhC
Q 007429          577 NSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       577 ~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .||.+|||+.+|++.|.++..
T Consensus       316 ~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         316 GDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=376.56  Aligned_cols=247  Identities=23%  Similarity=0.396  Sum_probs=214.2

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+|.+.++||+|+||+||+|+      .||||.+....-......-+..||.+|+.++|||||.+++++.+++. +|+||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~-i~lVM   88 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF-IYLVM   88 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe-EEEEE
Confidence            678899999999999999974      79999997554344455668899999999999999999999998886 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC------CcEEEEecCCccccccC
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------GNVCLGDMGIVTACKSV  487 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~------g~vKL~DFGla~~~~~~  487 (604)
                      |||.||+|.++|.+.+.+++..+..++.||+.||++||+++||||||||.||||+..      -.+||+|||+|+.+.. 
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-  167 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-
Confidence            999999999999988899999999999999999999999999999999999999875      4589999999998764 


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~  566 (604)
                      +......+|+|.|||||++....|+.    |+|+||+|+++|+|++|+.||...++.+....+..... .+.++..++..
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdA----KADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDA----KADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccc----hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence            33455668999999999998776554    59999999999999999999999999888876665544 34456667788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +.+|+...+..+|.+|.++.+-..+-
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhh
Confidence            88999999999999999988776553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-46  Score=370.93  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=214.6

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEE-EEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC-VCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g-~~~~~~~~l~L  411 (604)
                      ..+|+++++||+|+||.||+      |+.+|.|+++-.............|+.+|+.|+|||||++++ .+.+++.-++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            36789999999999999999      467899998854444445667889999999999999999999 44444444899


Q ss_pred             EEecccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          412 VTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLND--HG--VAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       412 VmEy~~gGSL~dlL~----~~~~l~~~~il~ia~qIa~gL~YLHs--~g--IVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      |||||.+|+|..+++    ..+.+++..+++++.|+|.||.++|+  .+  |+||||||.||+|+.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999984    24579999999999999999999999  55  99999999999999999999999999999


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC-CC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-KD  562 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p-~~  562 (604)
                      +...........|||-||+||.+.+.+|+++    |||||+||++|||+.-.+||.+.+-.+.-.+|..+. -+++| ..
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k----SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p~~~  252 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFK----SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLPDEH  252 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcc----hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCcHHH
Confidence            8877666777899999999999999887765    999999999999999999999986666655555554 44566 67


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+..+..||..|+..||+.||+...++..+..
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            89999999999999999999996555555444

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=388.96  Aligned_cols=263  Identities=29%  Similarity=0.526  Sum_probs=231.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE---------E-EEEEEeecCC-CCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------R-VGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk---------~-VAIKklk~~~-~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ..|++.+++..+.++||+|+||.||+|+         . ||+|..+... .......++.+|.++++.++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4799999999999999999999999973         2 7888887522 344456678999999999999999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      +..+.. ++||||+|+||+|.++|.+.+ .++..+.+.++.+.+.||+|||++++|||||.++|||++.++.+||+|||+
T Consensus       230 a~~~~P-l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  230 AVLEEP-LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EcCCCc-cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            998875 999999999999999998776 599999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ++.............-+.+|+|||.+....++    .++|||||||++||+++ |..||.+....+....+...+++...
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s----~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~  384 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFS----FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI  384 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccc----cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence            76654221112233467899999999877544    45999999999999999 88999999999999899899999999


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      |...|.++..++.+||..+|++||+|.++.+.|..+....+
T Consensus       385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999999999876554

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=371.17  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=215.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-cEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-~l~LV  412 (604)
                      .++...+.||+|+||.||++      ...|||.+.......  ...+.+|+.+|.+++|||||+++|....... .++|.
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            45678899999999999984      568999987552222  4558899999999999999999997443332 48999


Q ss_pred             EecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccccccC---
Q 007429          413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSV---  487 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~~~---  487 (604)
                      |||+++|||.+++.+.+ .+++..+..+..||++||.|||++|||||||||+|||++. ++.+||+|||+++.....   
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999998766 8999999999999999999999999999999999999999 799999999998776631   


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~-~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      ........||+.|||||++.......   .++|||||||++.||+||..||.. .........+......|.+|..++.+
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~---~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVAR---RESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCC---ccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence            12234467999999999998622211   248999999999999999999998 56677777777777778999999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .++++.+|+..||++|||+++++.|..-..+.
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999999999999999999998876544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=385.81  Aligned_cols=263  Identities=28%  Similarity=0.521  Sum_probs=223.5

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk---~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      ...|.|..+++.+...||+|.||+||+|+   .||||++.........-..|++|+..+++.+|.||+-|+|+|..+.  
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc--
Confidence            47899999999999999999999999998   5999999987777766677999999999999999999999998765  


Q ss_pred             EEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc--
Q 007429          409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--  485 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~--  485 (604)
                      +.||+.+|+|-+|+.+|.-. .+|+....+.|+.||+.||.|||.++|||||||..||++.++++|||+||||+....  
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            58999999999999999543 489999999999999999999999999999999999999999999999999975432  


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CC---CCCC
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RP---EIPK  561 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~---~~p~  561 (604)
                      ..........|...|||||+++.+. ...++..+|||||||++|||++|..||......+.++ .+-.|+ .+   ..-.
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd-~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-mVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQD-DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-MVGRGYLMPDLSKIRS  619 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcc-cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-EecccccCccchhhhc
Confidence            2222344556888999999998543 4456777999999999999999999999555555443 333332 22   2345


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +|+.++++|+..||.+++++||.|.+|+..|..+...
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            7899999999999999999999999999988887663

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=371.68  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=220.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCG-HKNILQFYCVCVDENH  407 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~---~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~  407 (604)
                      ..+.|++.+.||+|+||.|+.|      ..||+|.+......   ......+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3478899999999999999986      57999976543111   133556779999999998 9999999999998887


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~~  486 (604)
                       +|+||||+.||+|.+++.+.+++.+..+..++.|++.|++|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus        95 -~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   95 -IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             -EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence             99999999999999999888899999999999999999999999999999999999999999 9999999999887643


Q ss_pred             CCCcccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc-c
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-P  564 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~-s  564 (604)
                      ........+|++.|+|||++.+.. |+..   ++||||+||+||.|++|..||...+.......+...  +..+|..+ +
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~---~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S  248 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGK---AADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLS  248 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCc---hhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCC
Confidence            334566778999999999999877 6643   589999999999999999999997777766665443  45688888 9


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ++++.|+.+|+..||.+|+++.+|+.+=|...
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999998877765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=385.03  Aligned_cols=250  Identities=26%  Similarity=0.535  Sum_probs=225.7

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      -.-|++..+.+.-++-||+|+.|.||.|+    .||||+++..         -+.+|.-|++|+|+||+.|.|+|....-
T Consensus       116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence            35699998999999999999999999974    7999998632         1367788999999999999999987764


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|||||||..|-|+++|+..+.++...+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-++..++.
T Consensus       187 -yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  187 -YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             -eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence             8999999999999999988889999999999999999999999999999999999999999999999999998877655


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                       ..+....||..|||||+|+.++.+.+    +||||||||||||+||..||.+......++.+-.+.+..+.|..||+.+
T Consensus       266 -STkMSFaGTVaWMAPEvIrnePcsEK----VDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  266 -STKMSFAGTVAWMAPEVIRNEPCSEK----VDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             -hhhhhhhhhHhhhCHHHhhcCCcccc----cceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence             33445689999999999999887765    9999999999999999999999888888877777778888999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +-||++||...|..||+|.+|+.||.-+.
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999997653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=371.91  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=214.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      -...+|.+++.||.|+|++|+++      +.+|||++.+...-.+ ...-+.+|-..|..| +||.||+||-.|+|+.. 
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s-  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES-  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc-
Confidence            34689999999999999999996      5688888753221111 112244555667777 89999999999999886 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+|+||+++|+|.++|.+-+.|++...+.++.+|+.||+|||++|||||||||+|||+|++|++||.|||-|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998765322


Q ss_pred             Cc-------------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC
Q 007429          489 EA-------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       489 ~~-------------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      ..             ....+||..|.+||.+.....+..    +|+|+|||++|.|+.|.+||.+.++.-.+.+|+...+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~----sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS----SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc----cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            11             133679999999999998766655    9999999999999999999999998888888887644


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                        .+|+++++.+.+||.+.|..||.+|++..+|.+|...
T Consensus       305 --~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  305 --EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             --cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence              5899999999999999999999999999999988644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=348.94  Aligned_cols=235  Identities=21%  Similarity=0.333  Sum_probs=211.9

Q ss_pred             cCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..++|++++.||.|+||.|.+      |..+|+|.+...+.-.. ...+..+|..+|+.+.||+++++++.|.+..+ +|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~-ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN-LY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe-EE
Confidence            447899999999999999998      45789999875543332 23447789999999999999999999998886 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||||++||.|..++++.++|++..++.++.||+.||+|||+.+|++|||||+|||||.+|++||.|||+|+....   .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987654   2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      +...+|||.|+|||++...++...    +|.|||||++|||+.|.+||...++.+...+|+....  .+|..+++++++|
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynka----vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdL  271 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKA----VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDL  271 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcc----hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHH
Confidence            666799999999999998877765    8999999999999999999999999998888887644  5899999999999


Q ss_pred             HHHhhhcCCCCC
Q 007429          571 MIKCWNNSPSKR  582 (604)
Q Consensus       571 I~kCL~~dP~kR  582 (604)
                      +.+.++.|-.+|
T Consensus       272 l~~LL~vD~t~R  283 (355)
T KOG0616|consen  272 LKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHhhhhHhh
Confidence            999999999999

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=397.87  Aligned_cols=256  Identities=27%  Similarity=0.529  Sum_probs=220.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      +..+..++.+.||+|+||.||.|.           .||||.++... ......+|.+|..+|..++|||||+++|+|.+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            446788999999999999999974           48999998543 344567799999999999999999999999996


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      .. .+|++|||.||+|..+|++.       ..++...++.++.|||.|+.||+++++|||||.++||||+....|||+||
T Consensus       768 ~~-~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  768 GP-PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CC-cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            65 78999999999999999765       25889999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCC-cccc-cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCC
Q 007429          479 GIVTACKSVGE-ATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       479 Gla~~~~~~~~-~~~~-~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      |+|+..-.... .... ..-+.+|||||.+....    ++.|||||||||+|||++| |..||++.++.+...-....+ 
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i----FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-  921 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI----FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-  921 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcc----cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence            99984332211 1111 13457899999998754    4556999999999999999 999999999888776666665 


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      |...|..||..++++|.+||+.+|++||+|..|++.+..+.+..
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            99999999999999999999999999999999999888876643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=359.79  Aligned_cols=259  Identities=24%  Similarity=0.406  Sum_probs=219.2

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+|.++.++|++.+.||.|.-++||+|      ..||||++...+... .-..+++|+..++.++||||++++..|..+.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            578889999999999999999999986      589999998554433 3466899999999999999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      . +|+||.||.+||+.+++...  ..+++..+..+..++++||.|||.+|.||||||+.||||+++|.|||+|||....+
T Consensus        98 ~-LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   98 E-LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             e-eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            5 99999999999999999643  25999999999999999999999999999999999999999999999999997655


Q ss_pred             ccCCCcc----cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---
Q 007429          485 KSVGEAT----EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---  557 (604)
Q Consensus       485 ~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---  557 (604)
                      ...+...    ....||++|||||++.....  .|+.|+||||||++..||.+|+.||....+.+.+...+.+..+-   
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~--GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH--GYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhccc--CccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            5544333    34479999999999764432  45667999999999999999999999999998877655543321   


Q ss_pred             -C----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 -E----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 -~----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                       .    ....++..++.++..||.+||.+|||+++++++-+.-
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk  297 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK  297 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence             1    1124567899999999999999999999999986654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-41  Score=347.16  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=213.7

Q ss_pred             ecCCCeEEe--eeeeccCceEEEEe----EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEc--CC-
Q 007429          337 LNSDNLEFI--DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVD--EN-  406 (604)
Q Consensus       337 i~~~~y~i~--~~LG~G~FG~VykG----k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~--~~-  406 (604)
                      ++.++++..  ..||+|++|.||+|    +.||+|.++....... ....+.+|+.++.+++|||||+++|++.+  +. 
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            344445444  57999999999996    5899999875433322 23457799999999999999999999976  32 


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ..+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            34899999999999999998777899999999999999999999984 99999999999999999999999999987543


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ..   .....+++.|+|||.+.+..  ..++.++|||||||++|||++|..||...+..+....+...+.++..|..+++
T Consensus       175 ~~---~~~~~~~~~y~aPE~~~~~~--~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (283)
T PHA02988        175 SP---PFKNVNFMVYFSYKMLNDIF--SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL  249 (283)
T ss_pred             cc---cccccCcccccCHHHhhhcc--ccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence            32   22346788999999987521  13455799999999999999999999988877776666667777788888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+.++|.+||+.||.+|||+.+++..|...-
T Consensus       250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999998764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-41  Score=362.63  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=216.0

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEE
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY  399 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~  399 (604)
                      .+.|.+..++|++.+.||+|+||.||++.           .||+|.++.... ......+.+|+.++..+ +|+|||+++
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            35788888999999999999999999864           699999975432 22344578899999998 899999999


Q ss_pred             EEEEcCCCcEEEEEecccCCCHHHHHHhc---------------------------------------------------
Q 007429          400 CVCVDENHGLCVVTKLMEGGSVNDLILKS---------------------------------------------------  428 (604)
Q Consensus       400 g~~~~~~~~l~LVmEy~~gGSL~dlL~~~---------------------------------------------------  428 (604)
                      ++|...+. +++||||+++|+|.+++...                                                   
T Consensus       109 ~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         109 GACTHGGP-VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eEecCCCC-eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            99988775 99999999999999998432                                                   


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          429 -------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       429 -------------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                                         .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                               1367888999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          490 A--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       490 ~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .  .....+++.|+|||++.+..++    .++|||||||++|||++ |..||...............+.++..|...+++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYT----VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE  343 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCC----ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence            1  1122345679999999766544    45999999999999997 999998876655566666666777777788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +.+++.+||+.||.+||++.++++.|.++.
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=372.37  Aligned_cols=245  Identities=22%  Similarity=0.379  Sum_probs=221.0

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|.+.+.||+|+||.||||+      .||+|.+.+.......-..+++|+++++.++|||||.++++|....+ +|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~-~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH-LWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-EEEEe
Confidence            578889999999999999974      69999998777776666779999999999999999999999998886 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+.| +|..+|...+.++++.+..++.+++.||.|||+.+|+|||+||.|||++.+|++|+||||+|+....+......
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            99988 99999999999999999999999999999999999999999999999999999999999999988766555666


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..|||.|||||...+.+|+..    +|+||+||++||+++|++||...+-.+.+..|...  +...|...+..+.++++.
T Consensus       160 ikGtPlYmAPElv~e~pyd~~----sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHT----SDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             ccCcccccCHHHHcCCCccch----hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHHH
Confidence            689999999999999988776    99999999999999999999987776666656553  444667889999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHH
Q 007429          574 CWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L  592 (604)
                      .+.+||.+|.+..+++.|-
T Consensus       234 LL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             HhhcChhhcccHHHHhcCh
Confidence            9999999999999998763

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-41  Score=361.70  Aligned_cols=257  Identities=24%  Similarity=0.443  Sum_probs=214.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      .+|.+..++|++.+.||+|+||.||+++           .||+|.++... .......+.+|+.++..+ +|||||++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            4677888899999999999999999864           68999887433 223345678899999999 8999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC---------------------------------------------------
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------  429 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~---------------------------------------------------  429 (604)
                      +|.+... .++||||+++|+|.+++...+                                                   
T Consensus       107 ~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         107 ACTVGGP-TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeccCCc-ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            9988775 899999999999999985321                                                   


Q ss_pred             ------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          430 ------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       430 ------------------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                                              .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                    36788899999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  .....+++.|+|||.+.+..++    .++|||||||++|||++ |..||............+..+.++..|..
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYT----FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC  341 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCC----CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence            32211  1122345679999999876554    45999999999999998 89999887666666666776767777777


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+.++++|+.+||+.||++||++.+|++.|++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            889999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=365.40  Aligned_cols=255  Identities=20%  Similarity=0.309  Sum_probs=215.7

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchH-HHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAY-EFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~-~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..+..++|++++.||+|+||.||+      |..+|+|++++....... -..++.|-.+|....+|+||++|-.|++..
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            3456779999999999999999998      467999999865432221 234677778888889999999999999888


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      + +||||||++||++..+|.+.+.|+++.+..++.+++.|++-||+.|+|||||||+|+|||..||+||+||||+.....
T Consensus       215 ~-LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  215 Y-LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             e-eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            6 999999999999999998889999999999999999999999999999999999999999999999999999754321


Q ss_pred             C---------------------CCcc--------------------------cccCCCCcccccccccCCCCCCCCCcch
Q 007429          487 V---------------------GEAT--------------------------EYETDGYRWLAPEIIAGDPESVSETWMS  519 (604)
Q Consensus       487 ~---------------------~~~~--------------------------~~~~gt~~Y~APE~l~~~~~s~~~t~kS  519 (604)
                      .                     .+..                          ....|||.|||||++.+.+|...    +
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~----c  369 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE----C  369 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc----c
Confidence            0                     0000                          01258999999999999887765    9


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHH
Q 007429          520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLLR  594 (604)
Q Consensus       520 DVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT---~~ELL~~L~~  594 (604)
                      |.||||||+|||+.|.+||.+.++.+...+|+.......+|.  .++++..+||.+|+. ||++|.-   +.||.+|-+.
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF  448 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence            999999999999999999999999999888887665555665  467999999999999 9999964   8888776543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=369.37  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=218.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ..|.-..+||+|+.|.||.+      +.||||++....+..  ..-+.+|+.+|+..+|+|||.+++.+...+. +|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-LWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDE-LWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccce-eEEEE
Confidence            56788899999999999974      579999997654443  3457899999999999999999999887765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||+||+|.|++.. ..+++.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+.........
T Consensus       350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999999844 45999999999999999999999999999999999999999999999999999888776666777


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s~~l~~LI~  572 (604)
                      ..|||.|||||++....|.++    .||||||++++||+.|++||-..++...++.|...+.+ ...++.+++.+++++.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~K----VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             ccCCCCccchhhhhhcccCcc----ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            899999999999998776654    99999999999999999999999999999888877643 3557889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +||..|+.+|+++.|||+|=
T Consensus       505 ~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             HHhhcchhcCCCHHHHhcCh
Confidence            99999999999999999873

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=347.80  Aligned_cols=246  Identities=20%  Similarity=0.309  Sum_probs=209.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+....... .....+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF-LYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe-EEEE
Confidence            47899999999999999985      579999986432211 223457889999999999999999999887765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......   ..
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            999999999999987788999999999999999999999999999999999999999999999999998765432   22


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...|++.|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..+++.+.++|.
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~  230 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHN----KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIK  230 (291)
T ss_pred             cccCChhhcCHHHHcCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHH
Confidence            34689999999999876554    4599999999999999999999988776666555543  45577788999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQ-----FSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT-----~~ELL~~L~~~  595 (604)
                      +||+.||.+||+     +.++++|-|..
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            999999999995     99999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-42  Score=347.21  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=208.6

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|+.+.++|+|+||.|||      |+.||||++...........-..+||.+|++++|+|+|.++++|..... +++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk-lhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK-LHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce-eEEEe
Confidence            5688899999999999998      6799999998665555555557899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+. ++-+.|.+ ...++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+...++...
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            99988 54444443 34789999999999999999999999999999999999999999999999999998886666666


Q ss_pred             ccCCCCcccccccccCC-CCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-----------------
Q 007429          493 YETDGYRWLAPEIIAGD-PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  554 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~-~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-----------------  554 (604)
                      ....|-+|.|||.+.|. .|..    .+||||+||++.||++|.+.|++.++.+.++.|...-                 
T Consensus       160 DYVATRWYRaPELLvGDtqYG~----pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGK----PVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCC----cccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            66789999999999884 3443    4899999999999999999999999988887655431                 


Q ss_pred             --CCCCCC----------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          555 --LRPEIP----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       555 --~r~~~p----------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                        .+.+-|          ++.+..+.+++.+|+..||++|++-++++.|=
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~  285 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP  285 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence              111111          23456789999999999999999999998763

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-40  Score=335.64  Aligned_cols=252  Identities=26%  Similarity=0.474  Sum_probs=208.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ++.++|++.+.||+|+||.||+|.         .||+|.++... .......+.+|+..+..++||||++++|++...+.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            345789999999999999999863         68888887532 22334567899999999999999999999987765


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus        81 -~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 -MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             -cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence             99999999999999998654 4789999999999999999999999999999999999999999999999998654322


Q ss_pred             CCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          487 VGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       487 ~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ... ......++..|+|||.+.+..++    .++|||||||++||+++ |..||...+..+....+ ..+.+++.|..++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFS----SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCP  234 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCcc----chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCC
Confidence            111 11122345789999998776544    45999999999999875 99999887776654443 4455666788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=366.15  Aligned_cols=251  Identities=21%  Similarity=0.299  Sum_probs=212.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|.++++||.|+||.||+|      ..||||+++..... ..+---.+|+..|++|+ |||||++.+++.+.+..+|+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            478899999999999999995      57999999865433 33444679999999998 99999999999988856999


Q ss_pred             EEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||||+. +|+++++ +++.|++..+..|+.||+.||+|+|.+|+.||||||+||||.....+||+|||+|+...+....
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            9999977 9999996 4568999999999999999999999999999999999999999999999999999988765544


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-------------
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------------  557 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-------------  557 (604)
                      +. ...|-+|.|||++....   .|+.+.|+||+|||++|+++-++.|++.+..+.+++|..--..|             
T Consensus       167 Te-YVSTRWYRAPEvLLrs~---~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  167 TE-YVSTRWYRAPEVLLRSG---YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             ch-hhhcccccchHHhhhcc---ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            43 46788999999997654   34556999999999999999999999999988887764321111             


Q ss_pred             ------C---------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ------E---------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ------~---------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                            +         +...++.+..++|.+|++.||.+|||+.+++++--..
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence                  0         1134789999999999999999999999999875443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-41  Score=369.21  Aligned_cols=245  Identities=20%  Similarity=0.368  Sum_probs=217.8

Q ss_pred             EEeeeeeccCceEEEE------eEEEEEEEeecCC-CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~-~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      ++++.||.|+.|.|-+      |+.+|||.+.... ........+++||.+|+-+.||||+++|+++.+..+ +|+|.||
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~-lylvlEy   93 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH-LYLVLEY   93 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce-EEEEEEe
Confidence            7789999999999987      6789999997652 222234568899999999999999999999988876 9999999


Q ss_pred             ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccC
Q 007429          416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET  495 (604)
Q Consensus       416 ~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~  495 (604)
                      ++||-|.+++.+.+++++.++.+++.||+.|+.|+|..+|+||||||+|+|||..+++||+|||+|... ..+..-...+
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gklLeTSC  172 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGKLLETSC  172 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCCccccccC
Confidence            999999999999999999999999999999999999999999999999999999999999999998643 3344456678


Q ss_pred             CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       496 gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      |.|.|.|||++.|.+|...   ++||||.|||||-|+||+.||.+.+....+.++..+.+  .+|..++++.++|+++|+
T Consensus       173 GSPHYA~PEIV~G~pYdG~---~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml  247 (786)
T KOG0588|consen  173 GSPHYAAPEIVSGRPYDGR---PSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISSEAQDLLRRML  247 (786)
T ss_pred             CCcccCCchhhcCCCCCCC---ccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCHHHHHHHHHHh
Confidence            9999999999999998765   58999999999999999999998888777776666544  467999999999999999


Q ss_pred             hcCCCCCCCHHHHHHHHHH
Q 007429          576 NNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       576 ~~dP~kRPT~~ELL~~L~~  594 (604)
                      ..||++|.|..||++|-+=
T Consensus       248 ~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  248 DVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             ccCccccccHHHHhhCchh
Confidence            9999999999999998763

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-41  Score=352.56  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=209.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++.+.||+|+||.||++      +.+|+|.++...... .....+.+|+.++..++||||+++++++.+++. +|+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR-VYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE-EEE
Confidence            478999999999999999985      469999987432111 123457889999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   .
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---T  172 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---c
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998765432   2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....|++.|+|||++.+..++    .++|||||||++|||++|..||.+.++.+....+...  +..+|..++..+.++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  246 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHG----KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLV  246 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCC----CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHH
Confidence            234689999999999877654    3599999999999999999999987776665555433  4567788899999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHHHHHH
Q 007429          572 IKCWNNSPSKRPQ-----FSEIISLLLR  594 (604)
Q Consensus       572 ~kCL~~dP~kRPT-----~~ELL~~L~~  594 (604)
                      .+||+.||.+||+     +.+++.|-+.
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f  274 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYF  274 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence            9999999999997     7999887543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.8e-41  Score=352.26  Aligned_cols=241  Identities=19%  Similarity=0.266  Sum_probs=203.5

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +.||+|+||.||++      +.+|+|.++..... ......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR-LCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE-EEEEEeCCCC
Confidence            36999999999985      57999998743221 2223456789999999999999999999988775 9999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      |+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875443333344557899


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcC
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  578 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~d  578 (604)
                      .|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|.+||+.|
T Consensus       160 ~y~aPE~~~~~~~~----~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         160 EYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             cccChhhhcCCCCC----ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence            99999999876554    4599999999999999999999887666555444433  45678889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHHH
Q 007429          579 PSKRP-----QFSEIISLLL  593 (604)
Q Consensus       579 P~kRP-----T~~ELL~~L~  593 (604)
                      |++||     ++.++++|-+
T Consensus       234 P~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             HHHcCCCCCCCHHHHHcCCC
Confidence            99999     8999988744

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-40  Score=341.21  Aligned_cols=250  Identities=25%  Similarity=0.449  Sum_probs=200.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCce
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI  395 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnI  395 (604)
                      ..++|++.+.||+|+||.||++.                      .||+|.+.... .......+.+|+.++.+++||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence            45788999999999999999864                      58999887432 23334568899999999999999


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCce
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------------KLQTKEIIRIAIDVAEGIKFLNDHGVA  456 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~-------------------~l~~~~il~ia~qIa~gL~YLHs~gIV  456 (604)
                      +++++++.+.+. .++||||+++|+|.+++....                   .+++..++.++.||+.||.|||++||+
T Consensus        82 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          82 IRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eEEEEEEecCCc-eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999988765 899999999999999985421                   356788899999999999999999999


Q ss_pred             eccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-
Q 007429          457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-  533 (604)
Q Consensus       457 HrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-  533 (604)
                      ||||||+|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..++    .++||||||+++|||++ 
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT----TASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC----chhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999875433211  11223457789999998766543    45999999999999986 


Q ss_pred             -CCCCCCCCChHHHHHHHHH---c---CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          534 -GEAAYAACSPVQAAVGIAA---C---GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       534 -G~~Pf~~~s~~~~~~~i~~---~---~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                       +..||...+..+.......   .   ......|..+++.+.++|.+||+.||.+|||+.+|.+.|.
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             6788887666554432221   1   1122345678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-40  Score=358.48  Aligned_cols=259  Identities=24%  Similarity=0.454  Sum_probs=217.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g  400 (604)
                      ++|.+..++|++++.||+|+||.||+|.           .||+|+++... .......+.+|+.++..++ |||||++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            6899999999999999999999999875           48999986432 2333456889999999995 999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhc----------------------------------------------------
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKS----------------------------------------------------  428 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------------------------------------------  428 (604)
                      +|.+... +|+||||+++|+|.+++.++                                                    
T Consensus       109 ~~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         109 ACTKSGP-IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEccCCc-eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            9987765 99999999999999988532                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          429 --------------------------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       429 --------------------------------------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                                                                  ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        136778889999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  541 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~  541 (604)
                      ||++.++.+||+|||+++.......  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||...
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT----TLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC----chhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999999876543221  11223456789999999776544    45999999999999997 99999876


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ............+.++..+..++.++.+++.+||+.||++||++.+|.+.|.++..
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            65555555666666777788899999999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=367.00  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=223.1

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      ..+.+..+.+.+.++||.|.||.||+|.          .||||..+..... .....|..|..+++.++|||||+++|+|
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence            4577778888889999999999999873          5889988864333 3356689999999999999999999999


Q ss_pred             EcCCCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          403 VDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       403 ~~~~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .+.  ++|||||+++.|.|..+|..++ .++...+..++.||+.||.|||++++|||||..+|||+.+...|||+|||++
T Consensus       461 ~e~--P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  461 VEQ--PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ecc--ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence            876  4899999999999999997654 7999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          482 TACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       482 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      +...+.... .....-++.|||||.+....+    +.+||||.|||.+||++. |..||.+..+.+.+. .+.+|.|++.
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrF----TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeRlP~  613 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRF----TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGERLPC  613 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcc----cchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCCCCC
Confidence            887654322 233345789999999987654    445999999999999987 999999877766543 4567889999


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      |++||+.++.||.+||+.+|.+||+|.+|...|.++...
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999988763

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=351.31  Aligned_cols=259  Identities=24%  Similarity=0.445  Sum_probs=214.5

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  401 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~  401 (604)
                      +|.+..++|++.+.||+|+||.||+|           +.||+|+++... .......+.+|+..+.++ +|+||++++++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            47788899999999999999999986           469999887432 223334577899999998 89999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc-----------------------------------------------------
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------------------------------------  428 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~-----------------------------------------------------  428 (604)
                      |...+..++++|||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            987766689999999999999998532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCCC
Q 007429          429 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGY  498 (604)
Q Consensus       429 --------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~  498 (604)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ......++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2578889999999999999999999999999999999999999999999999876533221  112234567


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      .|+|||++.+..++    .++|||||||++|||++ |..||......+........+.++..|..+++++.+++.+||+.
T Consensus       240 ~y~aPE~~~~~~~~----~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         240 KWMAPESIFDKVYT----TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             cccCcHHhcCCCCC----ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            89999999876544    45999999999999998 99999875554445455555566667778899999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhhC
Q 007429          578 SPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       578 dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +|++||++.||+++|.++..
T Consensus       316 ~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         316 NPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-41  Score=359.68  Aligned_cols=261  Identities=22%  Similarity=0.370  Sum_probs=218.6

Q ss_pred             Cccccce-eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          329 GEEIGRW-LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       329 ~~~i~~~-~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ++.+..| ....+.|+.+++||+|.||.||++      +.||+|+++........-.-..+||.+|++|+||||+++.+.
T Consensus       105 ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  105 GEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             ccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence            4445555 345678999999999999999995      579999998766555566667899999999999999999999


Q ss_pred             EEcC-CCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecC
Q 007429          402 CVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       402 ~~~~-~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                      ..+. ...+|+|+|||+. +|..++.... +|++.++.-|+.|++.||+|+|++||+|||||.+|||||.+|.+||+|||
T Consensus       185 vt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  185 VTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccc
Confidence            9987 3459999999988 9999886543 89999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          480 IVTACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       480 la~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      ||+.+...... ....+-|.+|.|||.+.|..   .|+...|+||.||||.||++|++.|.+.+..+.+..|......|.
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t---~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGAT---SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCc---ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence            99976554332 34446789999999999874   355669999999999999999999999999888877665432221


Q ss_pred             --------CC-------------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          559 --------IP-------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       559 --------~p-------------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                              +|                   ..+++...+|+..+|..||.+|.|+.+++..=.
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence                    11                   246778899999999999999999999987533

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=357.89  Aligned_cols=258  Identities=18%  Similarity=0.264  Sum_probs=212.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC------------CchHHHHHHHHHHHHHhCCCCceeEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK------------GNAYEFELRKDLLELMTCGHKNILQFYC  400 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~------------~~~~~~~~~~Ei~~L~~L~HpnIVkl~g  400 (604)
                      .++|++++.||+|.||.|-++      +.+|||++.+...            ........++||.+|++|.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            478999999999999999985      6899999854321            1112246889999999999999999999


Q ss_pred             EEEcCC-CcEEEEEecccCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          401 VCVDEN-HGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       401 ~~~~~~-~~l~LVmEy~~gGSL~dlL~~~~~-l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      +..+.. ..+|||+|||..|.+...- .... +.+.+++.++.+++.||+|||.+|||||||||+|+||+++|+|||+||
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence            997764 4599999999998876542 3334 899999999999999999999999999999999999999999999999


Q ss_pred             CCccccccC-----CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc
Q 007429          479 GIVTACKSV-----GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       479 Gla~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~  553 (604)
                      |.+......     ...-....|||.|+|||.+.++........+.||||+||+||.|+.|..||.+....+...+|+..
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND  334 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence            998655221     112234679999999999987543233345689999999999999999999998888888888876


Q ss_pred             CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       554 ~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ...-+..+.+.+++++||.++|++||++|.+..+|..|.|....
T Consensus       335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            44433333478999999999999999999999999999887654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.9e-40  Score=335.78  Aligned_cols=250  Identities=27%  Similarity=0.524  Sum_probs=208.0

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..++|++.+.||+|+||.||+|.           .+++|.++... .......+.+|+..+..++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            34688999999999999999863           58888886432 2233456789999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  470 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~  470 (604)
                      . .+++|||+++|+|.+++...                ..+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus        82 ~-~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          82 P-TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             c-eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            5 89999999999999998653                357888999999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 007429          471 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  547 (604)
Q Consensus       471 g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~  547 (604)
                      +.+||+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||.+.+..+..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT----TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc----hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999875432211  12233457889999998766544    45999999999999998 99999887776654


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .. +..+..+..|..++.++.+|+.+||+.||.+||++.+|+++|..
T Consensus       237 ~~-i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EM-IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH-HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            43 44455566788999999999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-40  Score=351.52  Aligned_cols=250  Identities=20%  Similarity=0.261  Sum_probs=211.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-------~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +.+..++|++.+.||+|+||.||+|+       .||+|.+...... ......+.+|+.++..++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            44566899999999999999999863       6899988643221 122345778999999999999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       105 ~-~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 Y-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             E-EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            5 999999999999999998888899999999999999999999999999999999999999999999999999876542


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .   .....||+.|+|||++.+..++    .++|||||||++|||++|..||...++......+...  ...+|..+++.
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~  254 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLNVGHG----KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNN  254 (340)
T ss_pred             C---cceecCChhhcCHHHHhCCCCC----ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHH
Confidence            2   2345689999999999876554    3599999999999999999999987776655555543  34567888999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      +.++|.+||+.||.+|+     ++.++++|-+.
T Consensus       255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence            99999999999999995     89999988553

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-40  Score=340.57  Aligned_cols=255  Identities=22%  Similarity=0.436  Sum_probs=211.7

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeEE----------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk~----------VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +...+|++.+.||+|+||.||+|+.          |++|.++.. .......++.+|+.++..++||||++++|+|....
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            4567899999999999999999752          888988643 22334456788999999999999999999998653


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++|+||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 --~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          83 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             --ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence              67999999999999998654 368899999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcc--cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ......  ....++..|+|||.+.+..++    .++|||||||++|||++ |..||.+....+ ...+...+.+...+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~----~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  235 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYT----HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPI  235 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCC----chhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCC
Confidence            332211  112345689999999776544    45999999999999998 999998766554 3445556666667788


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ++..+..++.+||..+|.+||++.+++..|.++.+..
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=360.95  Aligned_cols=282  Identities=24%  Similarity=0.444  Sum_probs=236.2

Q ss_pred             cccccccCCCCCCccccccchhhhcCCCccccceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCch
Q 007429          302 LKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNA  375 (604)
Q Consensus       302 ~~~~l~~P~psss~~~~~~~~~~~~~~~~~i~~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~  375 (604)
                      .-.++-+|.|......    ..   .-.+..++|+.+..++...++||.|.||.||.|.      .||||.++.   ...
T Consensus       236 LittLhYPApK~nKpt----vy---gvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtM  305 (1157)
T KOG4278|consen  236 LITTLHYPAPKKNKPT----VY---GVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTM  305 (1157)
T ss_pred             eeEeeeccCccCCCCc----ee---eecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cch
Confidence            3346777877654322    11   1122337899999999999999999999999984      589999873   334


Q ss_pred             HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhc
Q 007429          376 YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDH  453 (604)
Q Consensus       376 ~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~  453 (604)
                      .-.+|.+|..+|+.++|||+|+++|+|..+.. +|||+|||..|+|.++|++..  .++.-.++.++.||..||+||..+
T Consensus       306 eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk  384 (1157)
T KOG4278|consen  306 EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK  384 (1157)
T ss_pred             hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh
Confidence            45678999999999999999999999998875 999999999999999997543  577888899999999999999999


Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHH
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV  532 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELl  532 (604)
                      ++|||||.++|||+.++..||++|||+++.+..+... ...-.-++.|.|||.+....++.    |+|||+|||+|||+.
T Consensus       385 nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSi----KSDVWAFGVLLWEIA  460 (1157)
T KOG4278|consen  385 NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI----KSDVWAFGVLLWEIA  460 (1157)
T ss_pred             hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCccccccccccc----chhhHHHHHHHHHHH
Confidence            9999999999999999999999999999877643221 11223468999999998776655    599999999999999


Q ss_pred             c-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          533 T-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       533 T-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      | |..||++....+ ++.++..++++..|+.||+.++.||+.||+.+|.+||+|.||-..++.+...+
T Consensus       461 TYGMsPYPGidlSq-VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  461 TYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             hcCCCCCCCccHHH-HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            8 899999866544 56788999999999999999999999999999999999999999998876544

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.9e-40  Score=335.95  Aligned_cols=247  Identities=16%  Similarity=0.226  Sum_probs=199.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.+|+|+++...........+.+|+.++..++||||+++++++...+. +++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-LYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE-EEEEE
Confidence            46899999999999999985      468999987654444444567889999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-ccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~  492 (604)
                      ||++++.+..+......+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            9999987776654455799999999999999999999999999999999999999999999999999876543221 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------------  556 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------------  556 (604)
                      ...+++.|+|||++.+..++    .++|||||||++|||++|++||...+..+....+......                
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~----~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYG----KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccCCcHHHcCCCCC----CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            34688999999999876544    4599999999999999999999887655443332211000                


Q ss_pred             -CC-------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          557 -PE-------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       557 -~~-------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                       ..             ....++..+.++|.+||+.||++|||++++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             00             112367889999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=346.99  Aligned_cols=247  Identities=16%  Similarity=0.260  Sum_probs=206.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||+|      +.||+|.++..... ......+.+|+.++..++||||+++++++.+.+. .|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE-EEEE
Confidence            46899999999999999986      47999998743221 1223457789999999999999999999987775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ...
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            99999999999998777899999999999999999999999999999999999999999999999999875543   233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC------CCccHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP------KDCPQI  566 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p------~~~s~~  566 (604)
                      ...|++.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+.........|      ..++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~----~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYD----FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             CcccCccccChhHhcCCCCC----CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence            45689999999999877544    45999999999999999999999877766555444322222122      146899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +.++|.+||..+|.+||++.+++++-+.
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~  260 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNHPFF  260 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence            9999999999999999999999988553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-39  Score=337.25  Aligned_cols=262  Identities=24%  Similarity=0.473  Sum_probs=215.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      .+|.+..++|.+.+.||+|+||.||+++             .+++|.++... .......+..|+..+..+ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            5788888999999999999999999864             48888887432 222334577899999988 79999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++++...+. .|+||||+++|+|.+++...+                .+++..++.++.||+.||+|||++|++||||||
T Consensus        90 ~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          90 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            999987775 899999999999999996432                478889999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +||+++.++.+||+|||+++........  .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY----THQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC----CcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999998755432111  112234568999999976644    345999999999999998 889997


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      ..... ..........+...|..++.++.+++.+||..+|.+||++.++++.|.++....+.
T Consensus       245 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         245 GVPVE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             cCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence            75544 34444555666677888999999999999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.3e-40  Score=346.10  Aligned_cols=260  Identities=24%  Similarity=0.436  Sum_probs=213.4

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  401 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~  401 (604)
                      +|.+..++|++.+.||+|+||.||+|           +.||+|.++... .......+.+|+.++..+ +||||++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            47888899999999999999999986           468999987432 223344578899999999 78999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc-----------------------------------------------------
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------------------------------------  428 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~-----------------------------------------------------  428 (604)
                      +...+..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            987766689999999999999998532                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--ccc
Q 007429          429 --------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATE  492 (604)
Q Consensus       429 --------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~  492 (604)
                                    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          1367778889999999999999999999999999999999999999999999876432221  111


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ...+++.|+|||.+.+..++    .++||||||+++|+|++ |..||...............+.++..|..+++.+.+++
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYT----IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  315 (343)
T ss_pred             CCCCCcceECcHHhcCCCCC----chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            22346779999998766544    45999999999999997 99999876554445555556666667777889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..||+.||.+||++.+|+++|..+.+.
T Consensus       316 ~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-39  Score=342.00  Aligned_cols=251  Identities=18%  Similarity=0.331  Sum_probs=204.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++|++++.||+|+||.||++      ..+|+|.+... ........+.+|+.++..++||||+++++++.+.+. ++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EE
Confidence            45689999999999999999985      46888888743 223344568899999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999999998777899999999999999999999986 6999999999999999999999999998755332  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH--------------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--------------------  549 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~--------------------  549 (604)
                      ......+++.|+|||.+.+..++    .++|||||||++|||++|+.||......+....                    
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~----~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYS----VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCC----chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            22334688999999999876544    459999999999999999999976444322110                    


Q ss_pred             -------------------------HHHcCCCCCCC-CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          550 -------------------------IAACGLRPEIP-KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       550 -------------------------i~~~~~r~~~p-~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                               ......++..+ ..+++++.+||.+||+.||++|||+++|++|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                     01111122222 24678999999999999999999999999997754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-40  Score=346.10  Aligned_cols=241  Identities=17%  Similarity=0.277  Sum_probs=202.0

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +.||+|+||.||++      +.||+|.++.... .......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE-EEEEEeCCCC
Confidence            46899999999985      5799999874321 11223446788999999999999999999987775 9999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      |+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|++
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99999988777899999999999999999999999999999999999999999999999999765433322333456899


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcC
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  578 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~d  578 (604)
                      .|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|.+||+.|
T Consensus       160 ~y~aPE~~~~~~~~----~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         160 EYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CcCCcccccCCCCC----chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence            99999999876554    4599999999999999999999887776655555443  34577889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHHH
Q 007429          579 PSKRP-----QFSEIISLLL  593 (604)
Q Consensus       579 P~kRP-----T~~ELL~~L~  593 (604)
                      |.+||     ++.+++++-+
T Consensus       234 P~~R~~~~~~~~~~~l~h~~  253 (323)
T cd05595         234 PKQRLGGGPSDAKEVMEHRF  253 (323)
T ss_pred             HHHhCCCCCCCHHHHHcCCC
Confidence            99998     8999988743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-40  Score=334.00  Aligned_cols=243  Identities=31%  Similarity=0.587  Sum_probs=199.1

Q ss_pred             EEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++.+.||.|.||.||+|          ..|+||.++. .........+.+|+..+.+++||||++++|++...+. .++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccc-cccc
Confidence            57889999999999995          4578999964 2333346678999999999999999999999996665 8999


Q ss_pred             EecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-
Q 007429          413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-  489 (604)
                      |||+++|+|.++|...  ..+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........ 
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999765  5799999999999999999999999999999999999999999999999999876522211 


Q ss_pred             -cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          490 -ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       490 -~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                       ..........|+|||.+.+..    ++.++||||||+++|||++ |..||...+..+....+ ..+.++..+..++..+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~----~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGE----YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDI  234 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSE----ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHH
T ss_pred             cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHH
Confidence             122334667899999997664    4567999999999999999 78999988776655555 6667777888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .++|.+||+.||.+||++.+|++.|
T Consensus       235 ~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  235 YSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhcC
Confidence            9999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=344.09  Aligned_cols=239  Identities=19%  Similarity=0.274  Sum_probs=200.6

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++||||+++++++.+.+. +|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK-LYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe-EEEEEcCCCCCc
Confidence            699999999985      4699999874321 12233456789999999999999999999987765 999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcc
Q 007429          421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  500 (604)
Q Consensus       421 L~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y  500 (604)
                      |.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            99999877789999999999999999999999999999999999999999999999999987543333333445689999


Q ss_pred             cccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCC
Q 007429          501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS  580 (604)
Q Consensus       501 ~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~  580 (604)
                      +|||.+.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++.+.++|.+||+.||.
T Consensus       160 ~aPE~~~~~~~~----~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         160 LAPELLLGHGYT----KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CCHHHHcCCCCC----CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            999999876554    4599999999999999999999987776665555443  4567788999999999999999999


Q ss_pred             CCCC---HHHHHHHHH
Q 007429          581 KRPQ---FSEIISLLL  593 (604)
Q Consensus       581 kRPT---~~ELL~~L~  593 (604)
                      +||+   +.+++.|-+
T Consensus       234 ~R~~~~~~~e~l~hp~  249 (312)
T cd05585         234 RRLGYNGAQEIKNHPF  249 (312)
T ss_pred             HcCCCCCHHHHHcCCC
Confidence            9975   678777643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=349.10  Aligned_cols=249  Identities=20%  Similarity=0.325  Sum_probs=208.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|+++...... .....+..|+.++..++||||+++++++.+.+. +|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH-LYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe-EEEE
Confidence            46899999999999999985      579999987533221 234457789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC----
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG----  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~----  488 (604)
                      |||+++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9999999999999777789999999999999999999999999999999999999999999999999987654432    


Q ss_pred             -------------------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 007429          489 -------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP  543 (604)
Q Consensus       489 -------------------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~  543 (604)
                                               .......||+.|+|||++.+..++    .++|||||||++|||++|..||...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG----LECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC----CceeeEecchhhhhhccCCCCCCCCCH
Confidence                                     122334689999999999877544    459999999999999999999998887


Q ss_pred             HHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHH
Q 007429          544 VQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ-FSEIISLLLR  594 (604)
Q Consensus       544 ~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT-~~ELL~~L~~  594 (604)
                      ......+........+|.  .+++++.++|.+|+. ||.+||+ +.+++++-+.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            766666655222233333  369999999999997 9999999 9999998543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=360.14  Aligned_cols=245  Identities=24%  Similarity=0.404  Sum_probs=216.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ..|..++.||+|+||.||+|      +.||+|.+.... .......+++|+.+|..++++||.++||.+..... ++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-LWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-HHHHH
Confidence            45677799999999999996      579999997543 33345568899999999999999999999998776 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||.||++.+++..+..+.+..+.-++.++..||.|||.++.+|||||+.|||+..+|.+||+|||.+............
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99999999999977777799999999999999999999999999999999999999999999999999888776666677


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..|||.|||||++.+..|+.    |+||||||++.+||.+|.+||....++..++.|-. ..+|.+..++++.++++|..
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~----KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDT----KADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             ccccccccchhhhccccccc----hhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccccccCHHHHHHHHH
Confidence            89999999999999766554    59999999999999999999999999776655443 44566677899999999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 007429          574 CWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~  591 (604)
                      ||++||+.||++.++++|
T Consensus       246 CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HhhcCcccCcCHHHHhhh
Confidence            999999999999999987

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.7e-40  Score=352.40  Aligned_cols=260  Identities=18%  Similarity=0.250  Sum_probs=214.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ..+.+..++|++.+.||+|+||.||++      +.+|+|.+....... .....+.+|+.++..++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            445567789999999999999999985      479999986432211 1223467889999999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      +. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         116 KY-LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            75 9999999999999998854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--C
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  562 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~  562 (604)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||...+.......+........+|.  .
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE  273 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence            3322 223456899999999997654444456679999999999999999999998887766666665444445555  5


Q ss_pred             ccHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLR  594 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~k--RPT~~ELL~~L~~  594 (604)
                      ++.++.++|.+||..+|.+  ||++++++.|-+.
T Consensus       274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             CCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            7899999999999999988  9999999988654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=330.18  Aligned_cols=252  Identities=26%  Similarity=0.463  Sum_probs=205.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      |.+..++|++.+.||+|+||.||+|           ..+++|++.... ......++.+|+.++..++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            5667789999999999999999975           358888875432 2233456788999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  473 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~----------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~v  473 (604)
                      +... .++||||+++|+|.+++.+.+          .++...+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus        80 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          80 QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCCC-eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence            7665 899999999999999985422          35677889999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      +|+|||+++........  .....+++.|+|||.+.+..++    .++|||||||++|||++ |..||...+.......+
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT----TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC----chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999998654322111  1122346789999999865544    45999999999999999 78999877665544433


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                       .....+..+..++..+.+++.+||+.||.+|||+.|++++|.
T Consensus       235 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 -MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             334445667888999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.6e-40  Score=343.38  Aligned_cols=242  Identities=19%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             eeeeeccCceEEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          345 IDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       345 ~~~LG~G~FG~VykG---------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++.||+|+||.||++         +.+|+|.++....  .......+..|+.++..++||||+++++++.+++. +|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK-LYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe-EEEEE
Confidence            367999999999975         4599999874321  11223456789999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++|+|.+++.+.+.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999999987788899999999999999999999999999999999999999999999999998754433333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..|++.|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..+++.+.++|.+
T Consensus       160 ~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  233 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHG----KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKK  233 (323)
T ss_pred             cCCCccccChhhccCCCCC----CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence            5689999999999876544    4599999999999999999999987776655555443  456788889999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHHHHH
Q 007429          574 CWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       574 CL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      ||+.||++||     ++.+++.+-+
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCC
Confidence            9999999999     8999988754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-39  Score=326.17  Aligned_cols=251  Identities=24%  Similarity=0.463  Sum_probs=209.5

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+..++|+++++||+|+||.||+|.     .+++|.+....   .....+.+|+.++..++|+||+++++.+.+.+. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP-I   76 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-c
Confidence            66778999999999999999999964     58888876422   234567889999999999999999999887765 8


Q ss_pred             EEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++|+|.+++.+  ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999999999854  346888999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ... .....++..|+|||.+.+..++    .++|||||||++|+|++ |..||...........+ ..+.+.+.+..++.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFT----IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPD  231 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCC----hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence            211 1222356789999998766544    35999999999999998 99999887666554443 34455556677899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+++.+||..+|++||+++++.+.|++
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-40  Score=345.54  Aligned_cols=241  Identities=18%  Similarity=0.257  Sum_probs=202.4

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR-LCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE-EEEEEeCCCC
Confidence            36899999999984      57999998753221 2233457788999999999999999999987775 9999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      |+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99999987777899999999999999999999999999999999999999999999999999875433323334456899


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcC
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  578 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~d  578 (604)
                      .|+|||.+.+..++    .++|||||||++|||++|..||...+..+....+..  ....+|..+++++.++|.+||..|
T Consensus       160 ~y~aPE~~~~~~~~----~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         160 EYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             CccChhhhcCCCCC----ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCC
Confidence            99999999876554    359999999999999999999988776655444333  344578889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHHH
Q 007429          579 PSKRP-----QFSEIISLLL  593 (604)
Q Consensus       579 P~kRP-----T~~ELL~~L~  593 (604)
                      |.+||     ++.++++|-+
T Consensus       234 P~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             HHHcCCCCCCCHHHHhcCCC
Confidence            99997     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=349.00  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=206.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++||||+++++++.+... +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY-LYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe-EEEE
Confidence            47899999999999999985      57999999753221 1223457789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||+++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........   
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999998777899999999999999999999999999999999999999999999999999865432110   


Q ss_pred             -----------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC
Q 007429          490 -----------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG  534 (604)
Q Consensus       490 -----------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG  534 (604)
                                                         ......||+.|+|||++.+..++    .++|||||||++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~il~el~~G  235 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN----KECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC----CeeeeecchhHHHHhhcC
Confidence                                               00123589999999999876554    459999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCC---HHHHHHHHH
Q 007429          535 EAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  593 (604)
Q Consensus       535 ~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT---~~ELL~~L~  593 (604)
                      ..||...++.+....+........+|.  .+++.+.++|.+|+. +|.+|++   +.+++.|-+
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~  298 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF  298 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence            999998888777666665444444444  468999999999996 9999998   999988754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.7e-40  Score=347.59  Aligned_cols=247  Identities=19%  Similarity=0.297  Sum_probs=202.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++.+.+... +|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~-~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN-LYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe-EEEE
Confidence            47899999999999999985      57999998743221 1223457788999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999865432110   


Q ss_pred             --------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 007429          490 --------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA  537 (604)
Q Consensus       490 --------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~P  537 (604)
                                                      ......||+.|+|||++.+..++.    ++|||||||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~----~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK----LCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC----chhhhhhHHHHHHHHhCCCC
Confidence                                            011236899999999998765543    59999999999999999999


Q ss_pred             CCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 007429          538 YAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWN--NSPSKRPQFSEIISL  591 (604)
Q Consensus       538 f~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~--~dP~kRPT~~ELL~~  591 (604)
                      |...++.+....+........+|.  .+++++.++|.+++.  .++..||+++||++|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            998887776666665444444554  367899999988543  344457999999988

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=325.33  Aligned_cols=251  Identities=27%  Similarity=0.493  Sum_probs=208.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      ..++|++.+.||+|+||.||+|.         .|++|.++.. ........+.+|+..+..++||||+++++++.+.+. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP-   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc-
Confidence            45789999999999999999874         5788887643 233344567889999999999999999999987765 


Q ss_pred             EEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            89999999999999998654 47899999999999999999999999999999999999999999999999998776421


Q ss_pred             CC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          488 GE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       488 ~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ..  ......+++.|+|||.+.+..++    .++||||||+++|+|++ |..||......+....+ ....+.+.+..++
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~----~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFT----SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCP  234 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCc----cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCC
Confidence            11  11223346789999999866544    45999999999999998 99999877665544433 3445556677889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +.+.+++.+||+.+|++||++.+++++|..+
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-39  Score=333.56  Aligned_cols=247  Identities=18%  Similarity=0.274  Sum_probs=201.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. +++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~-~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-EEEEE
Confidence            3788999999999999985      57999988643322 1223456789999999999999999999987775 99999


Q ss_pred             ecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  158 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV  158 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence            99999999988753  3368999999999999999999999999999999999999999999999999987653321 22


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHcCCCCCCCCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ---AAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~---~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      ....|++.|+|||++.+..++    .++|||||||++|||++|..||.......   ...... ......++..+++.+.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~----~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~  233 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYT----FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAK  233 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCC----cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCccCCHHHH
Confidence            334689999999999876554    45999999999999999999998754322   111111 2334456778899999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQ-----FSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT-----~~ELL~~L~~  594 (604)
                      +|+.+||+.||.+||+     +++++++-+.
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence            9999999999999997     8999987553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=327.85  Aligned_cols=252  Identities=27%  Similarity=0.474  Sum_probs=208.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      |.+..++|++.+.||+|+||.||+|.           .+++|.+.... .......+.+|+..+..++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            56778899999999999999999853           58888875332 2233446778999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  473 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~----------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~v  473 (604)
                      .... .++||||+++|+|.+++....          .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+
T Consensus        80 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          80 TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCC-cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence            8765 899999999999999985321          36788899999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      ||+|||+++.......  ......++..|+|||.+.+...+    .++|||||||++||+++ |..||...+..+....+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT----TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC----cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            9999999875543221  12233457789999998765444    45999999999999998 99999887766655444


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      . .+..+..|..++..+.+++.+||+.+|++|||+.+++..|.
T Consensus       235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 I-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            4 55566778889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-39  Score=325.12  Aligned_cols=241  Identities=26%  Similarity=0.450  Sum_probs=201.9

Q ss_pred             eeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          347 QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       347 ~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +||+|+||.||+|        +.+++|.++..........++.+|+.++..++||||+++++++..+  ..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE--SWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CcEEEEecCCC
Confidence            5899999999985        5689998875544444556688999999999999999999998643  37899999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc---ccccC
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYET  495 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~~  495 (604)
                      |+|.+++.+...+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||++.........   .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999977778999999999999999999999999999999999999999999999999998765433221   11223


Q ss_pred             CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       496 gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      +++.|+|||.+....++    .++|||||||++|||++ |..||......+.. ..+..+..+..|..+++++.++|.+|
T Consensus       160 ~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~  234 (257)
T cd05116         160 WPVKWYAPECMNYYKFS----SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCccccCHhHhccCCcC----chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            45789999998765433    45999999999999998 99999887665544 34455566778889999999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHH
Q 007429          575 WNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~~  594 (604)
                      |+.||.+||++.+|...|.+
T Consensus       235 ~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         235 WTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             hccCchhCcCHHHHHHHHhc
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.4e-40  Score=349.81  Aligned_cols=249  Identities=17%  Similarity=0.278  Sum_probs=204.1

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .|++++.||+|+||.||++      +.+|+|++...... ......+.+|+.++..++|||||++++++.+.+. +|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE-EEEEE
Confidence            5889999999999999986      47999999753322 2233457889999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC----
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----  489 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~----  489 (604)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999998778899999999999999999999999999999999999999999999999999753211000    


Q ss_pred             -------------------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHH
Q 007429          490 -------------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM  526 (604)
Q Consensus       490 -------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGv  526 (604)
                                                                 ......||+.|+|||.+.+..++    .++|||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~----~~~DiwSlG~  236 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT----QLCDWWSVGV  236 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC----Cccceeehhh
Confidence                                                       01123689999999999876554    3599999999


Q ss_pred             HHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHH--hhhcCCCCCCCHHHHHHHHHH
Q 007429          527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIK--CWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       527 vLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~k--CL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|||++|..||...++.+....+........+|.  .+++++.++|.+  |+..+|..||++.+++.|-+.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f  308 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF  308 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence            99999999999998777666555554333344443  578999999998  556677779999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=360.22  Aligned_cols=242  Identities=21%  Similarity=0.347  Sum_probs=211.1

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHH-HHHHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYE-FELRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~-~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      .+..++|.+++.||+|+||.|+++      +.+|||.+++...-...+ .....|..++... +||+++.++..|+.+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            567799999999999999999985      579999998766544333 2344454444433 79999999999999887


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|+||||+.||++..+ ...+.|++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++.....
T Consensus       444 -l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 -LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             -EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence             9999999999994433 35578999999999999999999999999999999999999999999999999999987767


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      +..+...+|||.|||||++.+..|+..    +|.|||||+||||+.|..||.+.+..+....|+..  .+.+|..++.+.
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~a----VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea  595 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRA----VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEA  595 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccch----hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHH
Confidence            777888899999999999999987765    89999999999999999999999998888888765  556899999999


Q ss_pred             HHHHHHhhhcCCCCCCCH
Q 007429          568 KSLMIKCWNNSPSKRPQF  585 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~  585 (604)
                      .+||++++.++|++|.-.
T Consensus       596 ~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhccCcccccCC
Confidence            999999999999999765

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5e-39  Score=326.91  Aligned_cols=256  Identities=22%  Similarity=0.438  Sum_probs=211.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|+          .||+|.++... .......+.+|+..+..++||||+++++++....
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            456889999999999999999975          37899887432 3334556788999999999999999999997543


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++++||+++|+|.+++..+ ..+++..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...
T Consensus        83 --~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          83 --VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             --cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence              67999999999999998653 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||........ ...+..+..+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  235 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRF----THQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQPPI  235 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCC----CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCcc
Confidence            32221  112234678999999976654    445999999999999998 9999987655443 344555556666778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ++..+.+++.+||..||++||++.++++.|.++...++
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            89999999999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=323.59  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=211.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch---HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~---~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+........   ....+.+|+..+.+++||||+++++++.++.. ++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET-LS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe-EE
Confidence            56889999999999999985      5789998864332211   22457889999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +|+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999987778999999999999999999999999999999999999999999999999998655332111


Q ss_pred             c---cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          491 T---EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       491 ~---~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      .   ....++..|+|||.+.+..+    +.++||||||+++|||++|+.||...+..............+.+|..++..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGY----GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccCCCcCccccCcceeccCCC----CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            1   23456788999999987653    3459999999999999999999988777766666666666777888899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .++|.+||..+|.+|||+.+++.+.+
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            99999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-39  Score=340.48  Aligned_cols=244  Identities=22%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCCcEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g~~~~~~~~l~LV  412 (604)
                      +|++++.||+|+||.||+|      +.+|+|.+..... .......+..|+.++..++| ++|+++++++.+.+. +|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE-EEEE
Confidence            5889999999999999986      3699999874321 11223446678888888866 568888888877765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999998777899999999999999999999999999999999999999999999999999865433333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+..  ....+|..+++++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~----~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~  233 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICK  233 (324)
T ss_pred             eecCCccccChhhhcCCCCC----cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence            45689999999999876554    359999999999999999999998777666655543  345678889999999999


Q ss_pred             HhhhcCCCCCCCH-----HHHHHH
Q 007429          573 KCWNNSPSKRPQF-----SEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~-----~ELL~~  591 (604)
                      +||..||.+|++.     .+++++
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcC
Confidence            9999999999986     677765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.9e-39  Score=324.95  Aligned_cols=252  Identities=25%  Similarity=0.466  Sum_probs=210.4

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      |.+...+|.+.+.||+|+||.||+|      +.+++|.+...   ......+.+|+..+..++|+||+++++++..+.. 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   76 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   76 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC-
Confidence            5566788999999999999999985      47899988632   2224457889999999999999999999987765 


Q ss_pred             EEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      +++||||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            89999999999999998643  3689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcc-cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          487 VGEAT-EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       487 ~~~~~-~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ..... .....++.|+|||.+.+..++    .++|||||||++|||++ |..||......+. ......+.++..+..++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  231 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFS----IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKGYRMERPEGCP  231 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCC----chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCC
Confidence            22111 112235679999998776544    35999999999999998 9999987665443 34455566777888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..+.+++.+||+.||++||++.++++.|..+
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-39  Score=322.96  Aligned_cols=251  Identities=25%  Similarity=0.483  Sum_probs=209.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |++..++|++.+.||+|+||.||+|     +.|++|.++....   ....+.+|+..+.+++||||+++++++...+. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-I   76 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCC-e
Confidence            5677789999999999999999985     4689998864322   24557889999999999999999999887765 8


Q ss_pred             EEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999999986543  6899999999999999999999999999999999999999999999999998766532


Q ss_pred             CCcc-cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GEAT-EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~~~-~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .... .....+..|+|||.+.+..++    .++||||||+++|||++ |+.||.+.+.......+ ....+...+..++.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFS----IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPK  231 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCC----chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCH
Confidence            2111 111234579999998766543    45999999999999999 99999887766555444 34455566778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-39  Score=338.83  Aligned_cols=251  Identities=17%  Similarity=0.204  Sum_probs=197.4

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l~  410 (604)
                      +|++.+.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++....    ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4889999999999999985      47999998744333333456789999999999999999999986543    2379


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-  489 (604)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            9999995 59999987777899999999999999999999999999999999999999999999999999875432211 


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH---------------
Q 007429          490 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA---------------  552 (604)
Q Consensus       490 --~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~---------------  552 (604)
                        ......+++.|+|||++.+..  ..++.++|||||||++|||++|.+||.+.+.......+..               
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccc--cccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence              112346889999999986521  1234569999999999999999999987654332211110               


Q ss_pred             -----------cCCCCCC---CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          553 -----------CGLRPEI---PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       553 -----------~~~r~~~---p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                 ......+   ...+++.+.+++.+||+.||++|||++|++++=+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence                       0000011   12457889999999999999999999999998654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.8e-39  Score=327.69  Aligned_cols=250  Identities=26%  Similarity=0.504  Sum_probs=205.3

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..++|++.+.||+|+||.||+|.          .+++|.++... .......+.+|+.++..++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            34788999999999999999974          58888887432 22333567889999999999999999999987765


Q ss_pred             cEEEEEecccCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  470 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~  470 (604)
                       .|+||||+++++|.+++...                 ..+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus        82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          82 -VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             -eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence             89999999999999998422                 247888899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 007429          471 GNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  547 (604)
Q Consensus       471 g~vKL~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~  547 (604)
                      +.+||+|||+++......  .......++..|+|||.+.+..++    .++|||||||++|||++ |..||.+.++... 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-  235 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS----SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-  235 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC----chhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence            999999999987653321  112223456789999999766543    45999999999999998 9999987665443 


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ...+.....+..+..+++.+.+++.+||+.||.+||++.+|+++|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            34444455556788899999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-39  Score=333.16  Aligned_cols=247  Identities=15%  Similarity=0.241  Sum_probs=199.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||.|+||.||+|      +.||+|.++..... .....+.+|+.++..++||||+++++++.+++. .++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERC-LTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence            467999999999999999986      47999998643322 223456789999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999975 999988654 357899999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------  557 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------------  557 (604)
                      ....+++.|+|||.+.+..   .++.++||||+||++|||++|..||.+.+..+....+......+              
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGST---EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cCceecccccChHHhcCCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            3446789999999987532   23456999999999999999999998877665554333211100              


Q ss_pred             ---CC-----------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 ---EI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 ---~~-----------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                         .+           ...++++..+++.+||..||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               01           12457889999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=343.63  Aligned_cols=254  Identities=17%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|++++.||+|+||.||++      +.|++|.+.... .......+.+|+.++..++|+||+++++++.+.+. +++
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l  149 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-IQV  149 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe-EEE
Confidence            4477889999999999999985      579999986432 23344568899999999999999999999987765 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++|+|.+.    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            9999999998653    345677888999999999999999999999999999999999999999999987665433333


Q ss_pred             cccCCCCcccccccccCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHcCCCCCCCCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s-~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~--~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      ....|+..|+|||.+...... ...+.++|||||||++|||++|+.||......  ............+..+..++.++.
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            445789999999998643221 12234699999999999999999999743322  222222233445566778899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++|.+||+.||++||++.|+++|-+-...
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            99999999999999999999998665543

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4e-39  Score=324.19  Aligned_cols=251  Identities=19%  Similarity=0.369  Sum_probs=204.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||+|      +.+++|.+...... ......+.+|+..++.++||||+++++++.+.+. .++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE-LNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe-EEEE
Confidence            57899999999999999986      57899988653332 2234457889999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +||+++|+|.+++..    ...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999998842    3358899999999999999999999999999999999999999999999999987655433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .......+++.|+|||.+.+...+    .++|+||||+++|||++|..||.....  ......+.....++..+..++..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~----~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYN----FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCC----chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            323344678899999999766543    459999999999999999999975432  23333323223333334567889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +.++|.+||+.+|++||++.++++.+.++
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            99999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-39  Score=322.73  Aligned_cols=246  Identities=26%  Similarity=0.497  Sum_probs=203.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.++|++.+.||+|+||.||+++     .+++|.+....   .....+.+|+..++.++||||+++++++.+... .++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~iv   77 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-LYIV   77 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC-EEEE
Confidence            34678999999999999999863     67888775332   224567889999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-  490 (604)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999998643 46899999999999999999999999999999999999999999999999998754332211 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      .....++..|+|||.+.+..++    .++||||||+++|||++ |..||...+..+....+.. +.++..|...+..+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~----~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~  232 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYS----SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYE  232 (256)
T ss_pred             cCCCCCchhhCChhhcccCccc----hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence            1122345679999999766544    45999999999999999 9999988776665554443 4455567778899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ++.+||+.+|.+||++.++++.|
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=368.75  Aligned_cols=260  Identities=27%  Similarity=0.454  Sum_probs=226.2

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+|+...+.|.+.||.|.||.||+|+         .||||.++.-. .......|..|..+|-++.||||++|.|+....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            35788889999999999999999973         69999998543 333456689999999999999999999999876


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      +. ++||+|||++|+|+.+|+.+ +.|+..++..+++.|+.||.||-+.++|||||.++|||++.+-..|++|||+++.+
T Consensus       703 ~P-vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  703 KP-VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             ce-eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence            64 99999999999999999754 57999999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcccccC---CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          485 KSVGEATEYET---DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       485 ~~~~~~~~~~~---gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      .++........   -+++|.|||.|...++    +.+||||||||+|||.++ |+.||-+.++.+.+.. +..++|.+.|
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKF----TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpP  856 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKF----TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPP  856 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhccc----CchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCC
Confidence            66553322222   3579999999987654    445999999999999887 9999999988877655 5568999999


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      .+||..+.+||..||++|-.+||.|.+|+.+|.++...+++
T Consensus       857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            99999999999999999999999999999999998665543

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-39  Score=340.18  Aligned_cols=244  Identities=20%  Similarity=0.318  Sum_probs=200.8

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHH---HhCCCCceeEEEEEEEcCCCcEEE
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLEL---MTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L---~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      |++++.||+|+||.||++      +.||+|.++..... ......+.+|+.++   ..++||||+++++++.+.+. .|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~-~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH-VCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE-EEE
Confidence            678999999999999985      57999999743211 11223455565544   45789999999999987775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++|+|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        80 v~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          80 VMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999998874 4579999999999999999999999999999999999999999999999999986544333334


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....|++.|+|||.+.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++.+.++|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  232 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYT----RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIM  232 (324)
T ss_pred             cccccCccccCHhHhcCCCCC----cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence            455789999999999876544    4599999999999999999999987777666555543  3457788999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHHHHH
Q 007429          572 IKCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       572 ~kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      .+||+.||.+||     ++.+++++-+
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence            999999999999     6888887653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-40  Score=344.33  Aligned_cols=239  Identities=20%  Similarity=0.315  Sum_probs=201.6

Q ss_pred             eeeeccCceEEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykG---------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +.||+|+||.||++         +.+|+|.++...........+.+|+.++.+++||||+++++++.+++. +|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE-EEEEEcCC
Confidence            57999999999963         568999987543332334456789999999999999999999988775 99999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCC
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      ++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999977778999999999999999999999999999999999999999999999999998765443333344568


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  576 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~  576 (604)
                      ++.|+|||.+.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++.+.++|.+||+
T Consensus       161 ~~~y~aPE~~~~~~~~----~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         161 TVEYMAPEVVNRRGHT----QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             ChhhcCHHHHcCCCCC----CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            9999999999876544    4599999999999999999999987776666555443  345677889999999999999


Q ss_pred             cCCCCCCC-----HHHHHHH
Q 007429          577 NSPSKRPQ-----FSEIISL  591 (604)
Q Consensus       577 ~dP~kRPT-----~~ELL~~  591 (604)
                      .||.+||+     ..+++.+
T Consensus       235 ~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         235 RNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             cCHhHcCCCCCCCHHHHhCC
Confidence            99999999     5666655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.7e-39  Score=330.23  Aligned_cols=246  Identities=21%  Similarity=0.338  Sum_probs=194.7

Q ss_pred             CCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEc----C
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVD----E  405 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~----~  405 (604)
                      ++|++++.||+|+||.||++       +.||+|.++...........+.+|+.++..+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999985       4589998875433333333455666666554   79999999999862    2


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ...+++||||++ ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            334899999997 5999988543  3589999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC------
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------  557 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~------  557 (604)
                      .... .......+++.|+|||.+.+..++    .++|||||||++|||++|.+||.+.+..+.+..+......+      
T Consensus       160 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         160 YSFQ-MALTSVVVTLWYRAPEVLLQSSYA----TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             ccCC-cccccccccccccChHHHhCCCCC----CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            5432 223344688999999999766544    35999999999999999999999877766655544321100      


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                         .+...+++.+.+++.+||+.||++|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                               0113467889999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-39  Score=327.75  Aligned_cols=250  Identities=18%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             CCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++++.||+|+||.||+|+      .+++|++.....  .....+.+|+..+..++||||+++++++..++. +++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~-~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK-LWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE-EEEE
Confidence            3678999999999999999964      589998864322  223457789999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999987777899999999999999999999999999999999999999999999999999876543322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC---CCCccHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILKS  569 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~---p~~~s~~l~~  569 (604)
                      ...+++.|+|||.+.+... ..++.++|||||||++|||++|..||....+......+......+..   +..++..+.+
T Consensus       165 ~~~~~~~y~~PE~~~~~~~-~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKN-GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             ccccCccccCHhHcccccC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            4467889999999854322 12345699999999999999999999766555444333333333222   2346789999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +|.+||..+|++||++++|+++|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCC
Confidence            99999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.7e-39  Score=349.41  Aligned_cols=258  Identities=23%  Similarity=0.442  Sum_probs=216.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g  400 (604)
                      ..|.+..++|.+.+.||+|+||.||+|+           .||+|+++.... ......+.+|+.++..+. |||||++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            4688999999999999999999999875           699999975332 222345788999999997 999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC---------------------------------------------------
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------  429 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~---------------------------------------------------  429 (604)
                      +|...+. +++||||+++|+|.+++.+++                                                   
T Consensus       109 ~~~~~~~-~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         109 ACTKGGP-IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEccCCC-cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9988775 999999999999999985431                                                   


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          430 -----------------------------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       430 -----------------------------------------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                                                                     .+++..++.++.||+.||+|||+.+++||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           256667888999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||.
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT----TLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC----cHhHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999875432211  11223467889999999766543    45999999999999998 899998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .....+.....+..+.++..|..++.++.+|+.+||..+|.+||++.+|+..|.++.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            877666666667777777888889999999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.9e-39  Score=320.04  Aligned_cols=245  Identities=22%  Similarity=0.377  Sum_probs=208.5

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|.+.+.||+|+||.||++      +.+++|.+............+.+|+..++.++||||+++++++.+.+. .++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-LNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE-EEEEEE
Confidence            5788999999999999986      568999887544444556678899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999998653  4789999999999999999999999999999999999999999999999999876654433334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||++.+..++    .++|+|||||++|+|++|..||...+.......+. .+..+.++..++..+.+++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYN----EKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             ccccCccccCHHHhcCCCCC----CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHH
Confidence            44678899999999876544    45999999999999999999998877655544443 34455677788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~  591 (604)
                      +||+.+|++||++.+++++
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHccCCcccCcCHHHHhhC
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-39  Score=334.34  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||+|+||.||+|      +.+|+|.++..... .....+.+|+.+++.++||||+++++++.+... .++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe-EEEE
Confidence            478999999999999999986      46899998744322 223456789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+. ++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            99996 5888877543 468999999999999999999999999999999999999999999999999986544332223


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHcCCCC-------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAACGLRP-------------  557 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~-~~~i~~~~~r~-------------  557 (604)
                      ....+++.|+|||++.+..   .++.++||||+||++|||++|..||.+...... +..+......+             
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGST---EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             CCCcccCCCCChHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            3456789999999986542   234469999999999999999999987544322 22211100000             


Q ss_pred             --------CCCC---------CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 --------EIPK---------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 --------~~p~---------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                              ..+.         ..++.+.+++.+||+.||.+|||+.++++|=+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence                    0011         2346788999999999999999999999876653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-40  Score=348.81  Aligned_cols=249  Identities=16%  Similarity=0.229  Sum_probs=203.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|.+++.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++|||||++++++.+... +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY-LYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe-eEEE
Confidence            47899999999999999985      57999998643211 1223457789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999863211000   


Q ss_pred             --------------------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHH
Q 007429          490 --------------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG  525 (604)
Q Consensus       490 --------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlG  525 (604)
                                                                  ......||+.|+|||++.+..++    .++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG  235 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG----QECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC----CceeeEecc
Confidence                                                        00013589999999999876554    359999999


Q ss_pred             HHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCC---CCHHHHHHHHHH
Q 007429          526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKR---PQFSEIISLLLR  594 (604)
Q Consensus       526 vvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kR---PT~~ELL~~L~~  594 (604)
                      |++|||++|..||...+..+....+........+|.  .++.++.++|.+|+. +|.+|   +++.+++.|-+.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            999999999999998777666555554433444554  478999999999997 66665   699999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-39  Score=327.51  Aligned_cols=249  Identities=26%  Similarity=0.481  Sum_probs=206.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..++|.+.+.||+|+||.||+|.           .+++|.++.... ......+.+|+.++..++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            34678999999999999999863           588998864322 223456889999999999999999999998876


Q ss_pred             CcEEEEEecccCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS--------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  472 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~--------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~  472 (604)
                      . .++||||+++|+|.+++...              ..+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          82 P-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             C-eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            5 99999999999999998643              24788899999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 007429          473 VCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG  549 (604)
Q Consensus       473 vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~  549 (604)
                      +||+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||...+..+....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT----TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc----hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999865432211  12233456789999999876544    45999999999999998 9999987776655544


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       550 i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +. .+.....+..++..+.+++.+||+.||++||++.|+++.|.
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            44 44445567788999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.6e-40  Score=343.38  Aligned_cols=241  Identities=18%  Similarity=0.267  Sum_probs=201.3

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +.||+|+||.||++      +.+|+|.++..... ......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-LCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE-EEEEEeCCCC
Confidence            36899999999974      57999998753221 1223456778888999999999999999987775 9999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      |+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            9999998777789999999999999999999997 799999999999999999999999999986543333333445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++.    ++|||||||++|||++|..||...+.......+..  ....+|..+++++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~~----~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         160 PEYLAPEVLEDNDYGR----AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             cccCCHHHHccCCCCC----ccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhhc
Confidence            9999999998765543    59999999999999999999988776655544433  24457788999999999999999


Q ss_pred             CCCCCC-----CHHHHHHHHH
Q 007429          578 SPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       578 dP~kRP-----T~~ELL~~L~  593 (604)
                      ||.+|+     ++.++++|-+
T Consensus       234 dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcCCC
Confidence            999996     8999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-39  Score=339.03  Aligned_cols=244  Identities=21%  Similarity=0.289  Sum_probs=202.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +|++++.||+|+||.||++      +.+|+|.+...... .........|..++..+ +|++|+++++++.+.+. +|+|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR-LYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE-EEEE
Confidence            5789999999999999986      47999998753221 11223345566666665 68999999999887765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999997777899999999999999999999999999999999999999999999999999875443333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..++.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  233 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK  233 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCC----CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHH
Confidence            45689999999999877654    4599999999999999999999988777666655543  44577889999999999


Q ss_pred             HhhhcCCCCCCCH-----HHHHHH
Q 007429          573 KCWNNSPSKRPQF-----SEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~-----~ELL~~  591 (604)
                      +|++.||.+|++.     .+++++
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcC
Confidence            9999999999984     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.4e-39  Score=330.89  Aligned_cols=260  Identities=23%  Similarity=0.467  Sum_probs=214.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      .+|.+..++|.+.+.||+|+||.||+++             .+++|.+... ........+.+|+..+..+ +||||+++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence            4677888999999999999999999874             4788877632 2223345678999999998 89999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++++..... .++||||+++|+|.+++.+.                ..++...+..++.||+.||.|||++|++||||||
T Consensus        87 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          87 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             eEEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999987765 89999999999999998643                2467788999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +||+++.++.+||+|||+++........  .....+++.|+|||++.+..++    .++||||||+++|+|++ |..||.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT----HQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC----chhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999998766432221  2223456789999999765443    45999999999999998 889998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..+..+.. .....+.+...+..++..+.+++.+||..+|.+||++.++++.|.++....
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         242 GIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             cCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            76665544 344555666678889999999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.7e-39  Score=331.91  Aligned_cols=256  Identities=24%  Similarity=0.467  Sum_probs=214.1

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  401 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~  401 (604)
                      .|.+..++|++.+.||+|+||.||++.           .+|+|.++.... ......+.+|+.++.++ +||||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            566777899999999999999999863           588888764322 22344678999999999 89999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecC
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                      +...+. .++||||+++|+|.+++....  .+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||
T Consensus       108 ~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         108 CTIGGP-ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EecCCc-eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence            987775 899999999999999986533  38999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCC
Q 007429          480 IVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR  556 (604)
Q Consensus       480 la~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r  556 (604)
                      ++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||...............+.+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT----FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCC----cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            9876543221  11223456789999999766543    45999999999999998 99999887766666666666666


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +..+...++.+.+++.+||..+|++||++.+++..|.++
T Consensus       263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            666777889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.3e-39  Score=326.92  Aligned_cols=254  Identities=25%  Similarity=0.444  Sum_probs=207.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeEE----------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk~----------VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|..          +++|.+... .......++..|+..+..++||||+++++++... 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-
Confidence            4457889999999999999999753          677776532 2222334567788888999999999999988543 


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       ..++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence             37899999999999999965 3578999999999999999999999999999999999999999999999999987553


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ....  ......++..|+|||.+.+..++    .++|||||||++|||++ |..||.+..+.. ...+...+.++..+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~----~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  235 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYT----HQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQI  235 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcC----chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCC
Confidence            3221  12233466789999999766544    45999999999999998 999998766544 3344556666667778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++..+..++.+||..||.+||++.|+++.|..+.+.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            899999999999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-39  Score=325.07  Aligned_cols=251  Identities=27%  Similarity=0.498  Sum_probs=210.7

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +....+|++++.||.|+||.||+|     +.+++|.+.....  .....+..|+..+..++|+||+++++++.+... .+
T Consensus         2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   78 (261)
T cd05148           2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-VY   78 (261)
T ss_pred             cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCC-eE
Confidence            344567899999999999999986     4588888864332  224457889999999999999999999988775 89


Q ss_pred             EEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +||||+++|+|.+++.+  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999999964  3468999999999999999999999999999999999999999999999999987654432


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      .......+++.|+|||.+.+..++    .++||||||+++|+|++ |..||...+..+....+. .+.++..+..+++.+
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~----~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFS----TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEI  233 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCC----chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHH
Confidence            222333456789999998766544    35999999999999998 899998877666555444 556667788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .++|.+||..||.+|||+.+|++.|..
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-39  Score=339.11  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             CeEEeeeeeccCceEEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +|++++.||+|+||.||++         +.+|+|.+.....  .......+..|+.++..+ +|+||+++++++..++. 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK-   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence            5889999999999999974         4689999864321  112234567888889988 58999999999887765 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +++||||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            89999999999999999877789999999999999999999999999999999999999999999999999987643322


Q ss_pred             C-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHcCCCCCCCCCcc
Q 007429          489 E-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       489 ~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s---~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      . ......||+.|+|||.+.+..   .++.++|||||||++|||++|..||....   ........ .....+.+|..++
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKG---GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-ILKCDPPFPSFIG  235 (332)
T ss_pred             CCccccccCCccccCHHHhcCCC---CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCC
Confidence            2 223346899999999997643   12345899999999999999999997432   22222221 2234566778899


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +.+.+++.+||+.||++||     ++.+++++-+
T Consensus       236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            9999999999999999999     7889988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-40  Score=342.25  Aligned_cols=252  Identities=14%  Similarity=0.208  Sum_probs=206.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++|+||+++++++.+.+. .|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN-LYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe-EEEE
Confidence            47899999999999999984      5799999975432 12233457788888899999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-  490 (604)
                      |||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999999765 57999999999999999999999999999999999999999999999999998765433221 


Q ss_pred             ccccCCCCcccccccccCCCC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--CccHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQI  566 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~--s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~  566 (604)
                      .....+|+.|+|||++.....  ...++.++|||||||++|||++|..||...+.......+........+|.  .+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            233468999999999874321  12345569999999999999999999998777666665554433333343  57899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +.+|+.+||. +|.+||++.+++.|-+
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence            9999999997 9999999999998744

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-39  Score=347.48  Aligned_cols=261  Identities=18%  Similarity=0.276  Sum_probs=213.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+..+..++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            345566789999999999999999985      47999998643221 12234467888899999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         116 KY-LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            75 9999999999999999854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--C
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  562 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~  562 (604)
                      .... ......||+.|+|||++.+......++.++||||+||++|||++|..||...+.......+........+|.  .
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence            3322 223456899999999998765433455679999999999999999999998887777666666554555555  4


Q ss_pred             ccHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~k--RPT~~ELL~~L~~~  595 (604)
                      ++..+++++..|+..++.+  |+++.++++|-+..
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            6899999999999865543  89999999996653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-38  Score=326.96  Aligned_cols=254  Identities=26%  Similarity=0.470  Sum_probs=210.0

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +.++|.+.+.||+|+||.||++.           .+++|.+...  .......+.+|+..+.+++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            44789999999999999999864           3778877532  2233456889999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcE
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR-------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  473 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~-------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~v  473 (604)
                      . .++||||+++++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus        81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          81 P-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             c-cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            5 899999999999999986432             48999999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      ||+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||...........+
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT----TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999875432211  11223356789999999766544    45999999999999998 99999887766655544


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      . .+.....+..++..+.+++.+||+.||.+|||+.++++.|.++...+
T Consensus       236 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         236 T-QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             H-cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            4 34445567778999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=342.64  Aligned_cols=246  Identities=19%  Similarity=0.344  Sum_probs=217.7

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      -+|++.+.||+|.||.|-+      |+.||||.+++...... .-..+++||.+|..|+||||+.+|++|...+. +.||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-Iviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-IVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce-EEEE
Confidence            5789999999999999987      68899999986654443 34568999999999999999999999988776 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||..+|.|+|++.+.+.+++..+..|+.||..|+.|+|.++++|||||.+|||+|.++++||+|||++..+.+. ..-.
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQ  210 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHH
Confidence            999999999999999999999999999999999999999999999999999999999999999999998766543 2344


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ..+|+|.|.+||++.|.+|...   ..|-|||||+||.|+.|.+||.+......+..|..+.++.+-   .|....-||+
T Consensus       211 TFCGSPLYASPEIvNG~PY~GP---EVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIR  284 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGP---EVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIR  284 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCC---ccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHH
Confidence            5689999999999999988755   389999999999999999999998888888888877776432   2456888999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .||..||++|-|..+|..|-|
T Consensus       285 wmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHhcCcccchhHHHHhhhhe
Confidence            999999999999999999876

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-38  Score=326.58  Aligned_cols=256  Identities=24%  Similarity=0.450  Sum_probs=208.1

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      |.+..++|++.+.||+|+||.||+|.           .||+|.+.... .......+.+|+..+..++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            67788999999999999999999863           57888876332 2233445778999999999999999999988


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  473 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~----------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~v  473 (604)
                      +... .++||||+++|+|.+++.+.          ..++...+..++.||+.||.|||+++|+||||||+||+++.++.+
T Consensus        80 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          80 KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCCC-cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            7765 89999999999999999542          134567889999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      +|+|||+++........  .....++..|+|||.+.+..++    .++|||||||++|||++ |..||......+....+
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~----~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT----TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCC----hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999998754332211  1122346779999998766443    45999999999999998 78999876665544333


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                       ..+.....+..+++.+.+++.+||+.||.+||++.++++.|.+...
T Consensus       235 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         235 -MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence             3344556677889999999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.6e-40  Score=348.24  Aligned_cols=248  Identities=18%  Similarity=0.303  Sum_probs=202.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++.+.+++. +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE-EEEE
Confidence            36899999999999999985      57999998643211 1123457789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........   
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            99999999999998777899999999999999999999999999999999999999999999999999753210000   


Q ss_pred             ----------------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHH
Q 007429          490 ----------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  529 (604)
Q Consensus       490 ----------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLy  529 (604)
                                                              ......||+.|+|||++.+..++.    ++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlGvily  235 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ----LCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCc----ceeeeeccceee
Confidence                                                    001235899999999998776543    599999999999


Q ss_pred             HHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHHHHHHHhhhcCCCCCC---CHHHHHHHHH
Q 007429          530 EMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILKSLMIKCWNNSPSKRP---QFSEIISLLL  593 (604)
Q Consensus       530 ELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~~LI~kCL~~dP~kRP---T~~ELL~~L~  593 (604)
                      ||++|..||...++.+....+........+|  ..+++++.++|.+|+ .+|.+|+   ++.+++.|-+
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            9999999999887766555544433333333  367899999999976 5999999   9999998854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=319.79  Aligned_cols=248  Identities=27%  Similarity=0.485  Sum_probs=209.9

Q ss_pred             eeecCCCeEEeeeeeccCceEEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      |.+..++|++.+.||.|+||.||+    |+.|++|.++....   ...++.+|+.++..++|+||+++++++.+... .+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   76 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP-LY   76 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC-eE
Confidence            455678899999999999999997    46899999975432   35568899999999999999999999987654 89


Q ss_pred             EEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999996554  68999999999999999999999999999999999999999999999999987653221


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                         .....+..|+|||.+....++    .++||||||+++|||++ |..||...+..... .....+.+...+..+++.+
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~----~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFS----TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHVEKGYRMEAPEGCPPEV  228 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCC----cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhcCCCCCCccCCCHHH
Confidence               123345679999998765443    45999999999999997 99999887655543 3344455667778889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+++.+||..+|.+||++.++++.|.+
T Consensus       229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         229 YKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-39  Score=339.50  Aligned_cols=241  Identities=22%  Similarity=0.292  Sum_probs=199.4

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.||+|.++.... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-LFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE-EEEEEcCCC
Confidence            36899999999985      4699999874321 111223455677777665 79999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            99999999888889999999999999999999999999999999999999999999999999987543333334455789


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||.+.+..++.    ++|||||||++|||++|..||...+..+....+..  .....|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~~----~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         160 PDYIAPEILQEMLYGP----SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             ccccCHHHHcCCCCCC----ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccc
Confidence            9999999998765543    49999999999999999999998877766555543  24456778899999999999999


Q ss_pred             CCCCCCCH------HHHHHHHH
Q 007429          578 SPSKRPQF------SEIISLLL  593 (604)
Q Consensus       578 dP~kRPT~------~ELL~~L~  593 (604)
                      ||.+||++      ++++.|-+
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCC
Confidence            99999998      77777644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-40  Score=352.18  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=223.6

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|+.++++|+|+||.++.      .+.+++|++..............+|+.++.++.|||||.+++.|..++..++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            47899999999999999997      358999999877666666667889999999999999999999999888669999


Q ss_pred             EecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |+||+||+|.+.+.+.  ..|+++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||+|||+|+........
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            9999999999999643  47999999999999999999999999999999999999999999999999999988876555


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....|||.||+||.+.+.+|..+    +|||||||++|||++-+++|...+....+.++.... -.++|...+.+++.+
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~K----SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEK----SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL  237 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCcc----CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence            666789999999999998876654    999999999999999999999988888877777655 456889999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~  591 (604)
                      |..|+..+|..||++.+++.+
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhC
Confidence            999999999999999999987

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.2e-39  Score=325.02  Aligned_cols=251  Identities=19%  Similarity=0.260  Sum_probs=214.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|..++.||+|.||.||+|      +.||||+++.............+||..|+.++|+||+.++++|.+... +-||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-LSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-eEEEE
Confidence            56788899999999999995      689999998776665666778999999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||++. +|+..++.. ..++..++..++.++++|++|||++.|+||||||.|+||+++|.+||+|||+++.+........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99987 999999644 4799999999999999999999999999999999999999999999999999998887666666


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---C-----------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---E-----------  558 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~-----------  558 (604)
                      ....|-.|.|||.+.|.+   .|+...|+||.||++.||+-|.+-|.+.++.+.+..+...-..|   .           
T Consensus       160 ~~V~TRWYRAPELLfGsr---~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSR---QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cceeeeeccChHHhccch---hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            667889999999998764   34445899999999999999999999988887776554432111   0           


Q ss_pred             ------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          559 ------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       559 ------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                  +...++.+..+|+.++|..||.+|+++.|++++=..-
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence                        1124567789999999999999999999999875543

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-38  Score=326.57  Aligned_cols=251  Identities=24%  Similarity=0.479  Sum_probs=206.4

Q ss_pred             CeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +|++.+.||+|+||.||+|.           .+++|.+.... .......+.+|+..+..++||||+++++.+...+. .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-L   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-c
Confidence            46888999999999999974           36777775332 22334567889999999999999999999987765 8


Q ss_pred             EEEEecccCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCce
Q 007429          410 CVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI  465 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~------------------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NI  465 (604)
                      ++||||+.+|+|.+++...                        ..+++..++.++.|++.||.|||+++++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999998532                        2477889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q 007429          466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS  542 (604)
Q Consensus       466 Lld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s  542 (604)
                      |+++++.+||+|||+++.......  ......++..|+|||.+.+..++    .++||||||+++|||++ |..||.+..
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~----~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT----TQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc----hHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999875432221  12223456789999998765443    45999999999999998 999998766


Q ss_pred             hHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       543 ~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +... ............+..++.++.+++.+||+.+|.+||++.++++.|+++...
T Consensus       235 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         235 PERL-FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            5553 444555566677888999999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-40  Score=325.29  Aligned_cols=257  Identities=18%  Similarity=0.319  Sum_probs=223.5

Q ss_pred             ccccceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       330 ~~i~~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      .....|.+  ++|++++.||+|.||.||.|+      .||+|.+.+... ....+.++++|+.+-..|+||||+++|++|
T Consensus        14 ~~~~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   14 RATKTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             ccccccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            33455644  899999999999999999975      699999864332 122456789999999999999999999999


Q ss_pred             EcCCCcEEEEEecccCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          403 VDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       403 ~~~~~~l~LVmEy~~gGSL~dlL~--~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      .++.. +|+++||.+.|+|+..|.  +..++++.....++.|++.||.|+|.++||||||||+|+|++..|.+||+|||-
T Consensus        92 hd~~r-iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw  170 (281)
T KOG0580|consen   92 HDSKR-IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW  170 (281)
T ss_pred             eccce-eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence            99886 999999999999999997  556899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      +....  .......+||..|.+||+..+..++..    .|+|++|+++||++.|.+||...+..+....|...  +..+|
T Consensus       171 sV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~----Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p  242 (281)
T KOG0580|consen  171 SVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKF----VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFP  242 (281)
T ss_pred             eeecC--CCCceeeecccccCCHhhcCCCCccch----hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCC
Confidence            75543  334566789999999999998877655    89999999999999999999998877777777664  45578


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ..++.+.+++|.+|+.++|.+|.+..|++.|-|-..+
T Consensus       243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999999999876543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.2e-39  Score=337.00  Aligned_cols=253  Identities=19%  Similarity=0.353  Sum_probs=204.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++|++.+.||+|+||.||++      ..+++|.+... ........+.+|+.+++.++||||++++++|.+.+. ++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE-EE
Confidence            45689999999999999999985      46788887643 223344568899999999999999999999998775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999999999999998777899999999999999999999985 7999999999999999999999999998654322  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH---------------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---------------------  548 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~---------------------  548 (604)
                      ......+++.|+|||.+.+..++    .++|||||||++|||++|..||..........                     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~----~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYS----VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            12334688999999999876544    45999999999999999999997644322211                     


Q ss_pred             ----------------------HHHHcCCCCCCCC-CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          549 ----------------------GIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       549 ----------------------~i~~~~~r~~~p~-~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                                            ........+..+. ..+.++++||.+||+.||++|||+.|++.+-+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                  0111112222222 357889999999999999999999999998776543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.3e-39  Score=321.28  Aligned_cols=248  Identities=25%  Similarity=0.497  Sum_probs=207.2

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      |.++.++|++.+.||+|+||.||++    ..+++|.++...    ....+.+|+..++.++|+|++++++++...+...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            5677789999999999999999985    568888876322    23457889999999999999999998766655589


Q ss_pred             EEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +||||+++++|.+++....  .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999986543  48899999999999999999999999999999999999999999999999976543321


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                         .....+..|+|||++.+..+    +.++|||||||++|||++ |+.||......+... ....+..+..+..+++.+
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGCPPVV  228 (256)
T ss_pred             ---CCCccceeecCHHHHccCCC----CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhcCCCCCCCCCCCHHH
Confidence               22234567999999876544    345999999999999997 999998766554433 344456667778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+++.+||..+|++|||+.++++.|..
T Consensus       229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         229 YDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.1e-39  Score=326.83  Aligned_cols=257  Identities=28%  Similarity=0.497  Sum_probs=212.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||++.           .+++|.+.... .......+.+|+..+..+ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3677888999999999999999999874           57888876432 223335578899999998 8999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILK----------------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~----------------~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      ++...+. .++||||+++|+|.+++..                ...+++..++.++.||+.||.|||+++|+||||||+|
T Consensus        84 ~~~~~~~-~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          84 VCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEcCCCC-eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            9987765 8999999999999999853                2358899999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  541 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~  541 (604)
                      ||++.++.+||+|||+++........  .....+++.|+|||.+.+..++    .++|||||||++|||++ |..||...
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT----HQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC----cccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999998765432211  1122345779999998765444    45999999999999998 99999887


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ...+.. .....+..+..+..++..+.+++.+||..||.+|||+.++++.|..+.
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         239 PVEELF-KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            665544 344455566778888999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-39  Score=346.51  Aligned_cols=247  Identities=18%  Similarity=0.311  Sum_probs=202.4

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|||||++++.+.+.+. +|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~-~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-LYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-EEEEE
Confidence            5899999999999999996      46899998743221 1223457889999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC----
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----  489 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~----  489 (604)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999997777899999999999999999999999999999999999999999999999999753211000    


Q ss_pred             -------------------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHH
Q 007429          490 -------------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM  526 (604)
Q Consensus       490 -------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGv  526 (604)
                                                                 ......||+.|+|||++.+..++    .++|||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~----~~~DiwSlGv  236 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT----QLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC----CeeeEEechH
Confidence                                                       01123588999999999877654    3599999999


Q ss_pred             HHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHHHHHHHhhhcCCCCCCC---HHHHHHHHH
Q 007429          527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  593 (604)
Q Consensus       527 vLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~~LI~kCL~~dP~kRPT---~~ELL~~L~  593 (604)
                      ++|||++|..||...++.+....+.........|  ..+++++.++|.+++ .+|.+|++   +.+++.|-+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  307 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF  307 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence            9999999999999888777666665544444444  357889999998876 59999997   999888743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-39  Score=337.94  Aligned_cols=239  Identities=22%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.||+|.++..... .........|..++.. .+||||+++++++...+. +|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH-LFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            36999999999986      36999998753211 1112233455555554 489999999999987765 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            99999999777789999999999999999999999999999999999999999999999999987654333334455789


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||.+.+..++    .++|||||||++|||++|..||.+.+..+....+.  ...+.+|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         160 PDYIAPEILKGQKYN----ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             ccccCHHHHcCCCCC----CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999876544    45999999999999999999999877766555443  345667888999999999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 007429          578 SPSKRPQFS-EIISL  591 (604)
Q Consensus       578 dP~kRPT~~-ELL~~  591 (604)
                      ||.+||++. +++.+
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05592         234 DPTKRLGVDGDIRQH  248 (316)
T ss_pred             CHHHcCCChHHHHcC
Confidence            999999875 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-38  Score=326.18  Aligned_cols=253  Identities=25%  Similarity=0.450  Sum_probs=208.7

Q ss_pred             CCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      .++|.+.+.||+|+||.||+|+           .+++|.+....  ......+.+|+..+.+++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4678999999999999999875           37777775322  2233567899999999999999999999987765


Q ss_pred             cEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                       .++||||+++++|.+++..+.                .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus        82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          82 -LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             -eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence             899999999999999986432                378899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .++|+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||...+..+...
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT----TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999865433221  12233456789999999876544    45999999999999999 999998877665544


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      . ...+..+..+..++..+.+++.+||+.+|.+||++.++++.|.++.+..
T Consensus       237 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         237 C-ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             H-HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            3 3444455567778999999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.6e-39  Score=328.20  Aligned_cols=250  Identities=26%  Similarity=0.491  Sum_probs=205.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..+|++.+.||+|+||.||+|           +.||+|.++... .......+.+|+.++..++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            3466888999999999999996           458999987432 2233455788999999999999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  470 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~  470 (604)
                      . .++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus        82 ~-~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          82 P-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             c-eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            5 89999999999999998421                247888899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 007429          471 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  547 (604)
Q Consensus       471 g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~  547 (604)
                      +.+||+|||+++.......  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||.+....+..
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS----IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC----cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999876533221  11223456789999999766544    35999999999999998 88999887766554


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .. +..+.....+.+++..+.+++.+||+.+|.+||++.+|+..|..
T Consensus       237 ~~-i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EM-IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HH-HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            44 43444556788899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-38  Score=320.89  Aligned_cols=246  Identities=25%  Similarity=0.497  Sum_probs=204.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.++|++++.||+|+||.||+|+     .+|+|.++....   ....+.+|+..+..++||||+++++++.+... .++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP-IYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC-cEEE
Confidence            34678999999999999999975     488998864322   23557889999999999999999999987665 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+.+|+|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999998654 368999999999999999999999999999999999999999999999999987554322111


Q ss_pred             -cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          492 -EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       492 -~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                       ....++..|+|||.+.+..++    .++|||||||++|+|++ |..||...+.......+ ..+.++..+...+..+.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~----~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFS----SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-SQGLRLYRPHLASEKVYA  232 (256)
T ss_pred             cCCCccChhhCCHHHHhcCccc----chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-hcCCCCCCCCCCCHHHHH
Confidence             122345679999999765443    45999999999999998 99999877765544444 344555567778899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ++.+||..+|.+||++.+|+..|
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHhh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.2e-39  Score=345.51  Aligned_cols=261  Identities=18%  Similarity=0.252  Sum_probs=211.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ....+..++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            345567789999999999999999985      46899998642211 11233467888888999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         116 RY-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            65 9999999999999999854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CC
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  562 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~  562 (604)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||...+.......+........+|  ..
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            3322 22345689999999999865443345667999999999999999999999887776666666544334444  36


Q ss_pred             ccHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~k--RPT~~ELL~~L~~~  595 (604)
                      ++..++++|..|+..++.+  ||++.++++|.+..
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence            8899999999999844433  78999999987653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-38  Score=320.14  Aligned_cols=250  Identities=27%  Similarity=0.480  Sum_probs=208.0

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+..++|++++.||+|+||.||++     +.+++|.+.....   ....+.+|+..+++++|+||+++++++.. +. .
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EP-I   75 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CC-c
Confidence            5677789999999999999999985     5799999874332   23467889999999999999999998754 33 8


Q ss_pred             EEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+.+++|.+++..  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999999999854  336899999999999999999999999999999999999999999999999998765422


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .. ......+++.|+|||.+.+..++    .++||||||+++|||++ |..||...+..+... ....+.+...+..++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~----~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  230 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFT----IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLERGYRMPRPDNCPE  230 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcC----cccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHcCCCCCCCCCCCH
Confidence            21 12223456789999999766544    35999999999999999 999998776655443 3444556677788899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+++.+||+.+|++||++++++..|..
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            99999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.5e-39  Score=337.87  Aligned_cols=241  Identities=23%  Similarity=0.253  Sum_probs=200.1

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||+|      +.+|+|.++..... ......+..|..++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-LFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe-EEEEEeCCC
Confidence            36899999999986      46999998743211 12223355677777654 89999999999988775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            99999999887889999999999999999999999999999999999999999999999999987544333334445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..+++++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         160 PDYIAPEILQELEYG----PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             ccccCHHHHcCCCCC----CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcc
Confidence            999999999876544    4599999999999999999999988877766655543  3446777899999999999999


Q ss_pred             CCCCCC-------CHHHHHHHHH
Q 007429          578 SPSKRP-------QFSEIISLLL  593 (604)
Q Consensus       578 dP~kRP-------T~~ELL~~L~  593 (604)
                      ||.+||       ++.+++++-+
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCc
Confidence            999999       8889988754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-38  Score=329.93  Aligned_cols=258  Identities=24%  Similarity=0.483  Sum_probs=212.1

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      ..|.+..++|.+.+.||+|+||.||+++             .+++|.++... .......+.+|+.++..+ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            3677888999999999999999999874             48888876432 233344578899999888 69999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++++.+.+. .++||||+++|+|.+++...                ..+++..+..++.||+.||.|||++|++||||||
T Consensus        84 ~~~~~~~~~-~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  162 (314)
T cd05099          84 LGVCTQEGP-LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA  162 (314)
T ss_pred             EEEEccCCc-eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999987765 89999999999999998542                2478889999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||+++........  .....+++.|+|||.+.+..++    .++|||||||++|||++ |..||.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT----HQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC----ccchhhHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998765432111  1122344679999999765443    45999999999999999 899998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ..+..+... ....+.....+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         239 GIPVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCHHHHHH-HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            766655443 444455566788899999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-38  Score=320.60  Aligned_cols=248  Identities=24%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             EEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----CcE
Q 007429          343 EFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGL  409 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~~l  409 (604)
                      .+.+.||+|+||.||+|+        .+|+|.++...........+.+|+..+..++|+||+++++++....     ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            466889999999999974        5888888754333334456788999999999999999999885421     236


Q ss_pred             EEEEecccCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          410 CVVTKLMEGGSVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~------~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ++||||+++|+|.+++..      ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            899999999999998732      12478999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          484 CKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       484 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ......  ......+++.|+|||.+.+..++    .++|||||||++|||++ |..||......+.... ...+..+..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~----~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~  236 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYT----TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLKQP  236 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcC----hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence            543221  11223456789999999866544    45999999999999999 8999987666554433 4444455667


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..++..+.+++.+||+.||++|||+.+|++.|.++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            78899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=318.99  Aligned_cols=249  Identities=24%  Similarity=0.461  Sum_probs=204.1

Q ss_pred             eEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          342 LEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      |.+.+.||+|+||.||+|.         .+|+|+++...........+.+|+..+..++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4678899999999999863         58999987544333344568899999999999999999998865432     


Q ss_pred             cEEEEEecccCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      ..++||||+++|+|..++...      ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            268999999999999988432      26889999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          482 TACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       482 ~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      +........  ......+..|+|||.+.+..++    .++|||||||++|||++ |..||......+... ....+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~----~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~  235 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT----SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-YLRHGNRLK  235 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCC----cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCC
Confidence            765432211  1222346789999998766544    45999999999999999 899998776655543 344455666


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .|..++..+.+++.+||+.||.+||++.++++.|.++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7888999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.5e-39  Score=335.90  Aligned_cols=240  Identities=20%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.||+|.++..... .........|..++.. ++||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH-LFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE-EEEEECCCC
Confidence            46999999999985      47999998743211 1122334566666654 489999999999988775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            99999999777789999999999999999999999999999999999999999999999999986543222333445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+..  ..+.+|..++.++.++|.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         160 PDYIAPEILQGLKYT----FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFER  233 (316)
T ss_pred             cCccCHHHHcCCCCC----cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999876554    359999999999999999999988776655544433  34567778899999999999999


Q ss_pred             CCCCCCCH-HHHHHHH
Q 007429          578 SPSKRPQF-SEIISLL  592 (604)
Q Consensus       578 dP~kRPT~-~ELL~~L  592 (604)
                      ||.+||++ ++++.|-
T Consensus       234 dP~~R~~~~~~~~~h~  249 (316)
T cd05620         234 DPTRRLGVVGNIRGHP  249 (316)
T ss_pred             CHHHcCCChHHHHcCC
Confidence            99999997 5676553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-38  Score=325.43  Aligned_cols=260  Identities=19%  Similarity=0.352  Sum_probs=211.8

Q ss_pred             cccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       331 ~i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      ++++|....+.|++++.||.|+||.||+|      +.+++|.+...  .......+.+|+..+..++|+||+++++.+..
T Consensus         3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (292)
T cd06644           3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW   80 (292)
T ss_pred             hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence            45677777889999999999999999985      46888888643  22334557789999999999999999999987


Q ss_pred             CCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ++. .++||||+++++|..++.+ ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~-~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          81 DGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             CCe-EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            775 9999999999999988754 45789999999999999999999999999999999999999999999999999765


Q ss_pred             cccCCCcccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPK  561 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~  561 (604)
                      ............+++.|+|||.+.+... ...++.++|||||||++|||++|..||...++......+..... ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T cd06644         160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS  239 (292)
T ss_pred             ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence            4333233344567889999999864332 22345679999999999999999999988776655544433222 123456


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .++.++.++|.+||..+|++||++.+++++-+
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            78899999999999999999999999998754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-38  Score=326.09  Aligned_cols=253  Identities=25%  Similarity=0.466  Sum_probs=206.3

Q ss_pred             CCeEEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++|++.+.||+|+||.||+|.        .+++|.++.. ........+.+|+..+.++ +||||+++++++..... .+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY-LY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-ce
Confidence            688999999999999999873        3677777632 2222344578899999898 79999999999987765 89


Q ss_pred             EEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEE
Q 007429          411 VVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vK  474 (604)
                      +||||+++|+|.+++.+..                .+++..++.++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999986432                478889999999999999999999999999999999999999999


Q ss_pred             EEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHc
Q 007429          475 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       475 L~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~  553 (604)
                      |+|||++...... ........+..|+|||.+.+..++    .++|||||||++|||++ |..||...........+ ..
T Consensus       160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~----~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~-~~  233 (297)
T cd05089         160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYT----TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ  233 (297)
T ss_pred             ECCcCCCccccce-eccCCCCcCccccCchhhccCCCC----chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hc
Confidence            9999997543211 111122335679999998766544    45999999999999997 99999887766554443 34


Q ss_pred             CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       554 ~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      +..+..+..++..+.+++.+||+.+|.+||++.+++..|..+.+..+
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            45666778899999999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.7e-39  Score=337.59  Aligned_cols=242  Identities=20%  Similarity=0.331  Sum_probs=196.9

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.++...... .....+.+|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~-~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-LFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-EEEEEeCCC
Confidence            36899999999985      479999997543222 2234467888888887 79999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            99999998777889999999999999999999999999999999999999999999999999986533333333445789


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--------PVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s--------~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||....        .......... .....+|..++..+.+
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~  234 (329)
T cd05588         160 PNYIAPEILRGEDYG----FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASS  234 (329)
T ss_pred             ccccCHHHHcCCCCC----CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHH
Confidence            999999999876554    35999999999999999999996311        1222222222 2345578889999999


Q ss_pred             HHHHhhhcCCCCCCC------HHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQ------FSEIISLLL  593 (604)
Q Consensus       570 LI~kCL~~dP~kRPT------~~ELL~~L~  593 (604)
                      +|.+||+.||.+||+      +.++++|-+
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPF  264 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence            999999999999997      788887644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-38  Score=331.76  Aligned_cols=260  Identities=23%  Similarity=0.468  Sum_probs=214.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      .+|++...+|++.+.||+|+||.||+++             .+++|.++.. ........+.+|+.++.++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            4788888999999999999999999874             4788877632 2223345678899999998 89999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      +++|.+.+. +++||||+++|+|.+++.+.                ..++...+..++.||+.||.|||++|++||||||
T Consensus        84 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          84 LGACTQDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eEEEccCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            999987765 89999999999999998642                2467788999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||+++........  .....++..|+|||++.+..++    .++|||||||++|||++ |..||.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT----HQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC----chhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999998765432211  1122345679999999776544    45999999999999998 889998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..+..+.. .....+..+..+..++..+.+++.+||+.+|.+||++.++++.|..+....
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         239 GIPVEELF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             CCCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            76655544 344455666677888999999999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.9e-39  Score=335.56  Aligned_cols=240  Identities=20%  Similarity=0.289  Sum_probs=199.3

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.++..... ......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR-LFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            46999999999985      47999998743211 12233456777777766 79999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.............|+
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            99999998877789999999999999999999999999999999999999999999999999986533333333444689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||.+.+..++.    ++|||||||++|+|++|..||...+.......+...  ...+|..++..+.++|.+||..
T Consensus       160 ~~y~aPE~~~~~~~~~----~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         160 PDYIAPEILSYQPYGP----AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             ccccCHHHhcCCCCCc----chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccC
Confidence            9999999998766543    599999999999999999999887766655544432  4456778899999999999999


Q ss_pred             CCCCCCCH-----HHHHHHH
Q 007429          578 SPSKRPQF-----SEIISLL  592 (604)
Q Consensus       578 dP~kRPT~-----~ELL~~L  592 (604)
                      ||.+||++     .+++++-
T Consensus       234 dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCC
Confidence            99999999     8888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.5e-38  Score=315.60  Aligned_cols=252  Identities=20%  Similarity=0.378  Sum_probs=206.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||+|      +.+++|.++...... .....+.+|+.++.+++|+||+++++++.+.+. .++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~-~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE-LNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence            57899999999999999985      568999886433222 234568899999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++|+|.+++..    ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999998853    2358999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHcCCCCCCCC-CccHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPK-DCPQI  566 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-~~~~~~~i~~~~~r~~~p~-~~s~~  566 (604)
                      .......+++.|+|||.+.+..++    .++|||||||++|+|++|..||.... ...........+..+..|. .++..
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYN----FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cccceecCCccccCHHHhccCCCC----chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            333344678889999998766544    45999999999999999999996543 2222222233333444554 78889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +.++|.+||..+|++||++.+|++.|.++.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=357.23  Aligned_cols=252  Identities=26%  Similarity=0.481  Sum_probs=218.3

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .-+|..+++.+.++||+|.||.|++|.         .||||.++.... ......|.+|+..|.+|+|+|+|++||++.+
T Consensus       104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l-~~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL-NAIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc-chhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            456777888999999999999999973         699999985443 3355679999999999999999999999987


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .  .+.+|||+++.|||.+.|.+.  ..|....+-.|+.||+.||.||.++++|||||.++|+|+.....|||+||||.+
T Consensus       183 q--p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 Q--PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             c--hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence            4  478999999999999999762  367888899999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccc---ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          483 ACKSVGEATE---YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       483 ~~~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      .+..+.+...   ...-++.|+|||.++...++.    +||||+|||++|||+| |+.||.+....+.+..+- .+.+.+
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSh----aSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLp  335 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSH----ASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLP  335 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccc----cchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCC
Confidence            8776544321   123467899999999876554    5999999999999999 899999999988877666 788889


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .|+.|+++++++|..||+.+|.+||||..|.+.+-
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            99999999999999999999999999999985443

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=352.88  Aligned_cols=249  Identities=17%  Similarity=0.263  Sum_probs=207.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      .++|++.+.||+|+||.||++      +.||+|.+............+.+|+..+..++|+||+++++.+.....     
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            478999999999999999985      479999987554444445567889999999999999999887754321     


Q ss_pred             --cEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          408 --GLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       408 --~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                        .+++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls  190 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS  190 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence              26899999999999999853    246899999999999999999999999999999999999999999999999998


Q ss_pred             cccccC--CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          482 TACKSV--GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       482 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      +.....  ........||+.|+|||.+.+..++    .++|||||||++|||++|..||...+..+....+.. +....+
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s----~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~  265 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS----KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPL  265 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCC
Confidence            765432  1123345689999999999876544    459999999999999999999998776665554443 344567


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      |..+++++.+++.+||+.||.+||++.+++.+-
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            888999999999999999999999999998863

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.1e-39  Score=341.80  Aligned_cols=248  Identities=19%  Similarity=0.310  Sum_probs=203.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+..|+.++..++||||+++++.+.+.+. +|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN-LYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence            47899999999999999984      57999998743221 2223457788999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........   
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999764422100   


Q ss_pred             --------------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 007429          490 --------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA  537 (604)
Q Consensus       490 --------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~P  537 (604)
                                                      ......||+.|+|||++.+..++.    ++|||||||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~----~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK----LCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC----cceeccccceeeecccCCCC
Confidence                                            011236899999999998776554    49999999999999999999


Q ss_pred             CCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCC---HHHHHHHHH
Q 007429          538 YAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  593 (604)
Q Consensus       538 f~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT---~~ELL~~L~  593 (604)
                      |...++......+........+|.  .+++++.++|.+++ .||.+|++   +.+++.|-+
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            998887776666554333344444  36789999999976 49999984   788888744

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.7e-38  Score=318.46  Aligned_cols=252  Identities=24%  Similarity=0.447  Sum_probs=207.5

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+...+|++.++||+|+||.||+|+     .|++|+++....   ....+.+|+..+..++||||+++++++.+ .. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~   75 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-I   75 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CC-c
Confidence            55667889999999999999999974     588998874332   23457889999999999999999998743 33 7


Q ss_pred             EEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++|+|.+++.+.  ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            8999999999999999653  35789999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ... .....++..|+|||.+.+..++    .++||||||+++|||++ |..||......+....+ ..+.+...+..++.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFT----IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPE  230 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCC----chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-hcCCCCCCccccCH
Confidence            211 1223456779999998766544    45999999999999999 89999887666554443 33444555677899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+.+++.+||+.+|.+||++.++++.|+...
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.3e-38  Score=314.47  Aligned_cols=246  Identities=22%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|++++.||+|+||.||++      +.+++|++............+.+|+..+++++|+|++++++.+...+..+|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999975      4699999875443333445678899999999999999999988655544899999


Q ss_pred             cccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++++|.+++..  ...+++.++..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            9999999999865  34689999999999999999999999999999999999999999999999999876644333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+..++    .++||||||+++|+|++|..||...+.......+. .+..+..+...++.+.+++.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYN----YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             cccCCcCccChhHhcCCCCC----chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHH
Confidence            45678899999999876544    35999999999999999999998766655444443 34445567788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~  591 (604)
                      +||+.||.+||++.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHhccCcccCCCHHHHhcC
Confidence            9999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.6e-38  Score=316.69  Aligned_cols=244  Identities=22%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||.|+||.||++      +.+++|.++.... ......+.+|+.++..++|+||+++++.+.+.+. +|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH-LYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence            5789999999999999985      5789998864332 2334567789999999999999999999988775 999999


Q ss_pred             cccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            9999999998854  34689999999999999999999999999999999999999999999999999876654333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+..+    +.++|+||||+++|+|++|..||...+.......+. .+.....|..++..+.++|.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~----~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPY----NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             cccCCccccCHHHHccCCc----CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHH
Confidence            4568889999999876644    345999999999999999999998876655544443 34455577788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~  591 (604)
                      +||+.||.+||++.+|+..
T Consensus       234 ~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         234 QMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhCCcccCCCHHHHhhc
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-39  Score=336.15  Aligned_cols=240  Identities=20%  Similarity=0.260  Sum_probs=195.6

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.||+|.+...... ......+..|.. .+..++||||+++++++.+.+. .|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~-~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK-LYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-EEEEEcCCC
Confidence            36999999999985      46999998643211 112233445544 4567899999999999987765 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            99999999877889999999999999999999999999999999999999999999999999986543333333445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...++..+++.+.++|.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         160 PEYLAPEVLRKQPYD----RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             hhhcChhhhcCCCCC----ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence            999999999876544    4599999999999999999999987776655555443  3446667899999999999999


Q ss_pred             CCCCCCCH----HHHHHHH
Q 007429          578 SPSKRPQF----SEIISLL  592 (604)
Q Consensus       578 dP~kRPT~----~ELL~~L  592 (604)
                      ||.+||++    .+++.+-
T Consensus       234 ~p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         234 DRTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             CHHhCCCCCCCHHHHHcCC
Confidence            99999987    5666553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-38  Score=319.21  Aligned_cols=251  Identities=28%  Similarity=0.494  Sum_probs=206.6

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      +..+|++.+.||+|+||.||+|.         .+++|.++... .......+.+|+..+..++||||+++++++.+.+. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP-   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-
Confidence            34678999999999999999874         47888876432 23334568889999999999999999999987765 


Q ss_pred             EEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .|+||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            89999999999999998654 46899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCccc---ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          488 GEATE---YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       488 ~~~~~---~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .....   ...++..|+|||.+.+..++    .++|+||||+++||+++ |..||......+....+ ..+.+.+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~----~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFT----SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDC  234 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccC----chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH-hCCCcCCCCCCC
Confidence            22111   11235679999999765444    45999999999999886 99999887665544443 344556667788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++.+.+++.+||+.+|.+||++.++++.|..+
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-38  Score=333.90  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +|++.+.||+|+||.||++      +.||+|.+...... ......+..|+.++..+. |++|+++++++.+.+. +|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR-LYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE-EEEE
Confidence            4788999999999999985      47999998743211 112234566777777765 5778889888877765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|+|||++.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..++.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~----~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~  233 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYG----KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICK  233 (323)
T ss_pred             CccCCccccCHHHHcCCCCC----CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHH
Confidence            45689999999999876544    4599999999999999999999988777666655543  34577888999999999


Q ss_pred             HhhhcCCCCCCCH-----HHHHHH
Q 007429          573 KCWNNSPSKRPQF-----SEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~-----~ELL~~  591 (604)
                      +||+.+|.+|++.     .++++|
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcC
Confidence            9999999999984     566555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.7e-38  Score=323.31  Aligned_cols=250  Identities=24%  Similarity=0.439  Sum_probs=202.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCce
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI  395 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnI  395 (604)
                      ...+|++++.||+|+||.||++.                      .+++|.+.... .......+.+|+.++..++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            34688999999999999999853                      37888886432 22344568899999999999999


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~-----------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      +++++++..+.. .++||||+++++|.+++.+..           .+++..++.++.|++.||.|||++|++||||||+|
T Consensus        82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          82 ARLLGVCTVDPP-LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEEecCCC-cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999988765 899999999999999996654           68999999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAA  540 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT--G~~Pf~~  540 (604)
                      |+++.++.++|+|||+++.......  ......+++.|+|||.+.+..++    .++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT----TKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC----ccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999865433211  12233456789999998765443    45999999999999998  7888987


Q ss_pred             CChHHHHHHHHHc------CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          541 CSPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       541 ~s~~~~~~~i~~~------~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .+..+.+......      ......+..++.++.+++.+||+.||.+||++.+|+..|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            6665544433321      1112345567899999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-38  Score=322.40  Aligned_cols=248  Identities=25%  Similarity=0.451  Sum_probs=204.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..++|.+.++||+|+||.||+++           .+++|.+...  .......+.+|+..+..++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            44788999999999999999863           5777877532  2334456889999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR---------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~---------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      . .++||||+++|+|.+++....               .+++..++.++.||+.||+|||++|++||||||+|||+++++
T Consensus        81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          81 P-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             c-eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            5 899999999999999986532               478899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .+||+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|||++ |.+||..........
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT----TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC----chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            999999999865432211  11222346789999999876544    45999999999999998 999998777665554


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .+. .+.....+..+++.+.+++.+||+.||.+||++.+|++.|.
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            443 34455667789999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.2e-39  Score=333.81  Aligned_cols=239  Identities=22%  Similarity=0.336  Sum_probs=195.1

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||+|      +.||+|.++..... .........|..++.. ++||||+++++++.+.+. +++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-LFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-EEEEEeCCC
Confidence            46999999999986      46999998753211 1122334556666665 599999999999988775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            99999999777789999999999999999999999999999999999999999999999999986543222223345689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  .+.+|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         160 PDYIAPEILLGQKYN----TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             ccccCHHHHcCCCCC----chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhcc
Confidence            999999999876544    4599999999999999999999987766655444332  3456777899999999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 007429          578 SPSKRPQFS-EIISL  591 (604)
Q Consensus       578 dP~kRPT~~-ELL~~  591 (604)
                      ||.+||++. +++.+
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05619         234 EPERRLGVKGDIRQH  248 (316)
T ss_pred             CHhhcCCChHHHHcC
Confidence            999999996 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.8e-39  Score=336.20  Aligned_cols=241  Identities=19%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.++...... .....+..|+.++..+ +||||+++++++.+.+. .|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE-EEEEEeCCC
Confidence            46999999999985      479999997543222 2334467788777765 89999999999988775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            99999998777889999999999999999999999999999999999999999999999999986543333333445789


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------ChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------SPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~--------s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      +.|+|||++.+..++.    ++|||||||++|||++|..||...        ........... .....+|..++..+.+
T Consensus       160 ~~y~aPE~~~~~~~~~----~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~  234 (329)
T cd05618         160 PNYIAPEILRGEDYGF----SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAAS  234 (329)
T ss_pred             ccccCHHHHcCCCCCC----ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHH
Confidence            9999999998765543    599999999999999999999521        11222222222 3345678889999999


Q ss_pred             HHHHhhhcCCCCCCC------HHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQ------FSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT------~~ELL~~L  592 (604)
                      +|.+||+.||.+||+      +.++++|-
T Consensus       235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05618         235 VLKSFLNKDPKERLGCHPQTGFADIQGHP  263 (329)
T ss_pred             HHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence            999999999999998      57887763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-38  Score=327.82  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=205.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      ..++|++.+.||+|+||.||+|.        .+++|.++... .......+.+|+.++.++ +|+||+++++++.+.+. 
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~-   82 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-   82 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC-
Confidence            44789999999999999999974        35677665322 223345678899999998 89999999999987775 


Q ss_pred             EEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  472 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~  472 (604)
                      .|+||||+++|+|.+++.+.+                .+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            899999999999999986432                4788999999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 007429          473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA  551 (604)
Q Consensus       473 vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~  551 (604)
                      +||+|||++...... ........++.|+|||.+.+..+    +.++|||||||++|||+| |..||...+..+... ..
T Consensus       163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~  236 (303)
T cd05088         163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY----TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KL  236 (303)
T ss_pred             EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCC----cccccchhhhhHHHHHHhcCCCCcccCChHHHHH-HH
Confidence            999999997532211 11122234667999999876543    345999999999999998 999998766554433 33


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       552 ~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..+.+...+..+++.+.+++.+||+.+|.+||++.+++..|.++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            444555667778899999999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-38  Score=348.86  Aligned_cols=244  Identities=18%  Similarity=0.250  Sum_probs=203.4

Q ss_pred             CCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ..|.+.+.||+|+||.||++       ..|++|.+....  ......+.+|+..+..++|||||++++++...+. +|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK-LLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE-EEEE
Confidence            34899999999999999985       357777664322  2233457789999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999988743    3368999999999999999999999999999999999999999999999999987654322


Q ss_pred             C--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 E--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 ~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .  ......||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+... .....|..++..
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~  298 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYS----KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSG  298 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCC----cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHH
Confidence            1  12334689999999999876544    4599999999999999999999887776666555544 334567788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.++|.+||..||++||++.+++.+
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhC
Confidence            9999999999999999999999865

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.8e-38  Score=317.76  Aligned_cols=250  Identities=26%  Similarity=0.490  Sum_probs=207.1

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+..++|++.+.||+|+||.||++.     .+++|.+......   ...+.+|+.++++++|+||+++++++.. .. .
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~   75 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EP-I   75 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CC-c
Confidence            55677899999999999999999864     5888988753322   3457899999999999999999998854 33 7


Q ss_pred             EEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++++||||||+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            8999999999999998643  36899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ... .....++..|+|||.+.+..++    .++||||||+++|||++ |..||...+..+....+ ..+.+++.+...+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFT----IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPI  230 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCc----chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCH
Confidence            211 1122345679999998765443    45999999999999999 89999887766555444 34556667888899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+.+++.+||..+|.+|||+.++.+.|.+
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-38  Score=317.01  Aligned_cols=241  Identities=24%  Similarity=0.436  Sum_probs=199.2

Q ss_pred             eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          347 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       347 ~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      .||+|+||.||+|.        .|++|.+.... .......+.+|+.++.+++||||+++++++...  ..++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~--~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--ALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC--CeEEEEEeCCC
Confidence            48999999999863        48888886432 233345688999999999999999999998543  38999999999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc---cccc
Q 007429          419 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYE  494 (604)
Q Consensus       419 GSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~---~~~~  494 (604)
                      |+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.........   ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999864 447899999999999999999999999999999999999999999999999998754432211   1112


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      .+++.|+|||.+.+..++    .++|||||||++||+++ |..||......... ..+..+.++..|..+++++.++|.+
T Consensus       159 ~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05115         159 KWPLKWYAPECINFRKFS----SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKD  233 (257)
T ss_pred             CCCcccCCHHHHccCCCC----chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            235789999998766544    45999999999999996 99999887766544 4445566777888999999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ||..+|++||++.+|.+.|...
T Consensus       234 c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         234 CWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HcCCChhhCcCHHHHHHHHhhh
Confidence            9999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=316.90  Aligned_cols=245  Identities=26%  Similarity=0.496  Sum_probs=202.9

Q ss_pred             CCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ..+|++.+.||+|+||.||+|+     .+++|.+.....   ....+.+|+.++..++||||+++++++...+. .++||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP-IFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-eEEEE
Confidence            4578899999999999999864     588888753222   23457789999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc-
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~-  491 (604)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++......... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999998653 468999999999999999999999999999999999999999999999999986554321111 


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....++..|+|||.+.+..++    .++||||||+++|||++ |..||...++.+.... ...+.+...|..++..+.++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~----~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  233 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFS----SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTEVYTI  233 (256)
T ss_pred             CCCCCCccccCHHHhccCCCC----chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCCHHHHHH
Confidence            112234579999999876544    45999999999999999 8999987766555443 44455667778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +.+||..+|.+|||+.++++.|
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHh
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.9e-38  Score=320.41  Aligned_cols=249  Identities=24%  Similarity=0.488  Sum_probs=202.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..++|.+.+.||+|+||.||+|.           .|++|.+... ........+.+|+..+..++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34678999999999999999864           3677766532 22333456788999999999999999999998777


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEE
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLG  476 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~-------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~  476 (604)
                      . .++||||+++++|.+++...+       .+++..++.++.||+.||+|||+++++||||||+||+++.++   .+||+
T Consensus        83 ~-~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          83 P-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             C-cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            5 889999999999999986543       488999999999999999999999999999999999998765   59999


Q ss_pred             ecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHc
Q 007429          477 DMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       477 DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~  553 (604)
                      |||+++........  ......++.|+|||++.+..+    +.++|||||||++|||++ |..||...+..... ..+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF----TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTG  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc----CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHc
Confidence            99998765322111  111223467999999976554    445999999999999997 99999887665543 34444


Q ss_pred             CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       554 ~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ..+...|..++..+.+++.+||+.+|++||++.+++++|.
T Consensus       237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            5566778889999999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=315.57  Aligned_cols=249  Identities=21%  Similarity=0.404  Sum_probs=206.7

Q ss_pred             CCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||.|+||.||++.      .+++|.+......  ....+.+|+.+++.++||||+++++++.+.+. +|++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK-LWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE-EEEE
Confidence            3789999999999999999864      5889988754332  34567899999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++..........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence            9999999999998765 689999999999999999999999999999999999999999999999999987655433233


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC---CCCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE---IPKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~---~p~~~s~~l~  568 (604)
                      ....++..|+|||.+.+... ..++.++||||||+++|||++|..||...++.............+.   .+...+.++.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             ccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            44567888999999876521 2334569999999999999999999998777666555554433332   2344578899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +++.+||..+|.+|||+.+++.+
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-38  Score=319.69  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=199.9

Q ss_pred             CeEEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcE
Q 007429          341 NLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  409 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l  409 (604)
                      .|++++.||+|+||.||++          +.|++|.++... .......+.+|+..+..++||||+++++++.... ..+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            4589999999999999763          468999887432 2233456778999999999999999999987543 348


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      ++||||+++|+|.+++.+ ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            999999999999999854 4699999999999999999999999999999999999999999999999999876543221


Q ss_pred             c---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--------------HHHHHHHH
Q 007429          490 A---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--------------QAAVGIAA  552 (604)
Q Consensus       490 ~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~--------------~~~~~i~~  552 (604)
                      .   .....++..|+|||.+.+...+    .++||||||+++|||++|..||......              ........
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~----~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFS----YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCC----cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            1   1222355679999998765443    4599999999999999999998643211              11111222


Q ss_pred             cCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       553 ~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .....+.+..++..+.+++.+||+.+|++|||+.+++..|..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            33444567788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=314.82  Aligned_cols=242  Identities=27%  Similarity=0.472  Sum_probs=201.1

Q ss_pred             eeeeccCceEEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykG---------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      ++||+|+||.||+|         ..+++|.+...... .....+.+|+..+..+.|+|||++++++...  ..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE--PLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC--ceEEEEEeC
Confidence            46999999999986         36888888744332 3456688999999999999999999987643  378999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc---c
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE---Y  493 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~---~  493 (604)
                      ++|+|.+++.+...+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||+++..........   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9999999998777899999999999999999999999999999999999999999999999999876543322111   1


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ..++..|+|||.+.+..++    .++|||||||++|||++ |..||...+..+.. .......+...|..++..+.++|.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         158 GRWPLKWYAPECINYGKFS----SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             ccccccccCHHHhcCCCCC----ccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHH
Confidence            1234679999998766544    45999999999999998 99999887665543 334445566778889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||..+|.+||++.++++.|...
T Consensus       233 ~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         233 SCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHhcCChhhCcCHHHHHHHHHhc
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-38  Score=318.78  Aligned_cols=255  Identities=24%  Similarity=0.472  Sum_probs=209.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++.+.||+|+||.||+|.          .|++|.++.. ........+.+|+..+..++|+||+++++++...+
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            455889999999999999999863          4677777633 23334456788999999999999999999988765


Q ss_pred             CcEEEEEecccCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS--------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~--------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      ...++++||+++|+|.+++...        ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            5588999999999999998543        35889999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCC
Q 007429          479 GIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       479 Gla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      |+++........  .....++..|+|||.+.+..+    +.++|||||||++||+++ |+.||...++.+.. .....+.
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~----~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY----SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGY  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC----CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCC
Confidence            998755322111  112245677999999976543    456999999999999999 99999887665543 3444555


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +...+..+++.+.+++.+||..||++|||+.+++..|.++..
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            666677789999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.7e-39  Score=334.78  Aligned_cols=240  Identities=20%  Similarity=0.268  Sum_probs=194.9

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.+...... ......+..|.. .+..++||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~-~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-LYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-EEEEEeCCC
Confidence            36999999999986      46899998743211 112233444444 4567899999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+...+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            99999999877788999999999999999999999999999999999999999999999999987543333334445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...++..++..+.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         160 PEYLAPEVLHKQPYD----RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             ccccCHHHHcCCCCC----CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHccc
Confidence            999999999876554    3599999999999999999999987776665555443  3345667899999999999999


Q ss_pred             CCCCCCCHH----HHHHHH
Q 007429          578 SPSKRPQFS----EIISLL  592 (604)
Q Consensus       578 dP~kRPT~~----ELL~~L  592 (604)
                      ||.+||+..    +++++.
T Consensus       234 ~p~~R~~~~~~~~~i~~~~  252 (325)
T cd05602         234 DRTKRLGAKDDFMEIKNHI  252 (325)
T ss_pred             CHHHCCCCCCCHHHHhcCc
Confidence            999999876    455444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.1e-38  Score=315.77  Aligned_cols=252  Identities=27%  Similarity=0.481  Sum_probs=207.2

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +..++|+..+.||+|+||.||+|.         .+++|.++... .......+..|+..+..++|+||+++++++.+.+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            345788999999999999999874         57888876432 22334567889999999999999999999987775


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        81 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 -AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence             89999999999999998653 5789999999999999999999999999999999999999999999999999865543


Q ss_pred             CCCccc---ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          487 VGEATE---YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       487 ~~~~~~---~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ......   ....++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+....+. .+.+.+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~  234 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKF----TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMD  234 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCc----ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCC
Confidence            221111   1123457999999876543    345999999999999997 999998776665544443 4455566778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=324.51  Aligned_cols=249  Identities=17%  Similarity=0.279  Sum_probs=201.7

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .|++.+.||+|+||.||++      +.||+|++....... .....+.+|+.+++.++||||+++++.+.+.+. +++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-EEEEE
Confidence            4788999999999999985      479999986433221 223446789999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+++++||||||+||++++++.++|+|||++....... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI  158 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence            999999999887543  468999999999999999999999999999999999999999999999999987653222 22


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH--HcCCCCCCCCCccHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA--ACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~--~~~~r~~~p~~~s~~l~~  569 (604)
                      ....|++.|+|||.+.+..++    .++||||+||++|||++|..||.+.........+.  .......++..++..+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~----~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYT----FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS  234 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCC----ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence            334688999999999766544    45899999999999999999998755432221111  122344567778999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHHHHHHh
Q 007429          570 LMIKCWNNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       570 LI~kCL~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      ++.+||..||.+||     ++++++.+-+..
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             HHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            99999999999999     899998875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5e-38  Score=314.04  Aligned_cols=241  Identities=25%  Similarity=0.488  Sum_probs=197.3

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCC
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG  419 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gG  419 (604)
                      +.||+|+||.||+|      +.+++|.+... ........+.+|+..+..++||||+++++++..... .++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC-eEEEEeeccCC
Confidence            36899999999986      45889987632 223344568899999999999999999999988775 89999999999


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc--cccCC
Q 007429          420 SVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETD  496 (604)
Q Consensus       420 SL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~g  496 (604)
                      +|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........  .....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999998654 368999999999999999999999999999999999999999999999999986543221111  11123


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      +..|+|||.+.+..+    +.++|||||||++|||++ |..||...+...... ......+...+..++..+.+++.+||
T Consensus       159 ~~~y~aPE~~~~~~~----~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         159 PVKWTAPEALNYGRY----SSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-AIEQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             ceeecCchhhcCCCC----ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCCCCcccCCHHHHHHHHHHc
Confidence            456999999876654    345999999999999998 999998766654433 33344556678888999999999999


Q ss_pred             hcCCCCCCCHHHHHHHHH
Q 007429          576 NNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       576 ~~dP~kRPT~~ELL~~L~  593 (604)
                      ..+|++||++.++++.|.
T Consensus       234 ~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         234 EYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCChhhCcCHHHHHHHHh
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.5e-38  Score=318.22  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=203.0

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC-----C
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~-----~  407 (604)
                      +.|++.+.||+|+||.||+|.      .+++|.+....   .....+..|+..+..+ +|+||+++++++....     .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            567888999999999999864      68999886433   2245677888888887 7999999999987532     2


Q ss_pred             cEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            378999999999999998653  468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ..........+++.|+|||++.+... ...++.++|||||||++|||++|..||....+............+...+..++
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence            33333344568889999999864321 22345579999999999999999999987766655544444444444456788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+.+++.+||..+|.+|||+.+++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            999999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=341.65  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=198.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+++|.--..||+|+||.||+|     ..||||++.......  ..+|.+|+.++.+++|||+|+++|||.+.+...+||
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            4477777889999999999996     479999887544332  455999999999999999999999999877337899


Q ss_pred             EecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          413 TKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~g---IVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      +||+++|+|.++|....  .++|..+++|+.++|.||+|||+..   ||||||||+|||+|+++.+||+|||+++.....
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999996443  8999999999999999999999853   999999999999999999999999999654431


Q ss_pred             CCccccc-CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHHHHcC-----C
Q 007429          488 GEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS------PVQAAVGIAACG-----L  555 (604)
Q Consensus       488 ~~~~~~~-~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s------~~~~~~~i~~~~-----~  555 (604)
                      ....... .||..|+|||++..+.    .+.|+|||||||++.||+||+.|.....      -.++....+..+     .
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~----lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii  306 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGK----LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV  306 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCC----cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence            1111222 7999999999997643    3456999999999999999998876432      122222222221     1


Q ss_pred             CCCCC-CCcc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          556 RPEIP-KDCP-----QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       556 r~~~p-~~~s-----~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+.+. ...+     ..+..+...|++.+|.+||++.++++.|..+..
T Consensus       307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            22222 2222     336677788999999999999999999966554

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-38  Score=313.26  Aligned_cols=246  Identities=20%  Similarity=0.346  Sum_probs=207.8

Q ss_pred             CeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++++.||.|+||.||.      |+.+++|.+............+.+|+.++++++|+||+++++++.+.+. +++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT-LLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe-EEEEEE
Confidence            589999999999998886      4578999887544444445567899999999999999999999988765 999999


Q ss_pred             cccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999654  4689999999999999999999999999999999999999999999999999876544332333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+...+    .++||||||+++|||++|..||...+..+....+..... ...+..++.++.+++.
T Consensus       160 ~~~~~~~y~ape~~~~~~~~----~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  234 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYN----FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-TPVVSVYSSELISLVH  234 (256)
T ss_pred             ccCCCccccCHhhcCCCCCC----CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHH
Confidence            45688999999998765443    459999999999999999999988777666655554433 3455778899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +||..+|.+||++.++++++
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHcccCcccCCCHHHHhhCc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-38  Score=313.68  Aligned_cols=251  Identities=27%  Similarity=0.512  Sum_probs=209.4

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+..++|++.+.||+|+||.||++     +.+++|.+.....   ....+.+|+..++.++|+||+++++++.+... .
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-I   76 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-e
Confidence            5677899999999999999999986     3588998874322   24567899999999999999999999887665 8


Q ss_pred             EEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++++|.+++...  ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999999998653  36899999999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .. .......+..|+|||.+.+...+    .++||||||+++|+|++ |+.||...+.......+ ..+.+...+..++.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFT----IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPE  231 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcC----chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence            11 11122345679999999866544    45999999999999998 99999887666555444 34556667778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+++.+||..+|.+||+++++...|+.
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=317.44  Aligned_cols=255  Identities=23%  Similarity=0.444  Sum_probs=210.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++.+.||+|+||.||+|.          .+++|.+.... .......+.+|+..+.+++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            445788999999999999999975          47888776432 23344567899999999999999999999987 3


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       ..++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          82 -QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             -ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence             489999999999999998654 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcc--cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ......  ....+++.|+|||.+....++    .++|+||||+++||+++ |..||......+... .+..+.....|..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~  235 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYT----HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-LLEKGERLPQPPI  235 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcC----chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHhCCCCCCCCCC
Confidence            322211  112235679999998765443    45999999999999998 999998877655443 3444555666778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ++..+.+++.+||..+|.+||++.++++.|.++.+..
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            8999999999999999999999999999999986654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.7e-38  Score=316.53  Aligned_cols=250  Identities=26%  Similarity=0.468  Sum_probs=205.4

Q ss_pred             CCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..+|++.+.||+|+||.||+|.         .|++|.++.. ........+..|+..+..++||||+++++++.+... .
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP-V   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc-e
Confidence            3578999999999999999864         3899988643 223334568899999999999999999999987765 8


Q ss_pred             EEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      ++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999999864 3468999999999999999999999999999999999999999999999999976544322


Q ss_pred             Ccccc---cC--CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          489 EATEY---ET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       489 ~~~~~---~~--gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....   ..  .+..|+|||.+.+..++    .++|||||||++|||++ |..||...+.......+ ....+.+.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~  235 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT----SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMD  235 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCccc----chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCccc
Confidence            11111   11  23579999999766544    45999999999999886 99999887666554444 34455566778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++..+.+++.+||..+|.+||++.+|+..|..+
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.1e-38  Score=314.28  Aligned_cols=246  Identities=25%  Similarity=0.455  Sum_probs=196.8

Q ss_pred             eeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +.||+|+||.||+|.         .+++|.+.... .......+.+|+..++.++||||+++++++...+...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            368999999999864         57888875322 22234457788899999999999999998875554578999999


Q ss_pred             cCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC----cc
Q 007429          417 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----AT  491 (604)
Q Consensus       417 ~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~----~~  491 (604)
                      .+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.......    ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            999999998653 3567788899999999999999999999999999999999999999999999865432211    11


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....+++.|+|||.+.+..+    +.++|||||||++|||++ |.+||...+...... ....+..+..+..+++.+.++
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             ccCcCCccccChhHhccCcc----chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCCCCCcCCHHHHHH
Confidence            12245678999999876544    345999999999999999 567777666554443 334445556677789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+||..+|++||++.+++..|.++.+
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-38  Score=318.50  Aligned_cols=251  Identities=21%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+....... .....+.+|+.+++.++|+||+++++++.+.+. .++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe-EEEE
Confidence            56788999999999999985      478999886543322 233467889999999999999999999988775 8999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998853    3468999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHcCCCCCCCCCccHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~--~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .......++..|+|||.+.+...+    .++|+||||+++|+|++|..||......  .....+.....++..+..+++.
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~----~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYN----FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCcc----chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            333344688899999999766543    4599999999999999999999754332  2222222222233334567899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +.+++.+||..||.+|||+.+|++.+.+.
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            99999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-38  Score=324.07  Aligned_cols=242  Identities=19%  Similarity=0.288  Sum_probs=194.1

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||+|+||.||++      +.+|+|++........ ....+..|+.+++.++|+||+++++++..... +|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD-LCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe-EEEEEeCCCCCC
Confidence            699999999984      5799999864322211 22346788999999999999999999887765 999999999999


Q ss_pred             HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCC
Q 007429          421 VNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       421 L~dlL~----~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      |.+++.    .+..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++..............|
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            998773    2346899999999999999999999999999999999999999999999999998765543333334568


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH--cCCCCCCCCCccHHHHHHHHHh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~--~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      ++.|+|||.+.+..++    .++|||||||++|||++|..||..............  ......++..+++.+.+++.+|
T Consensus       160 ~~~y~aPE~~~~~~~~----~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         160 TPGFMAPELLQGEEYD----FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             CcCccCHHHhcCCCCC----ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            8999999999876554    459999999999999999999986433211111111  1223456778899999999999


Q ss_pred             hhcCCCCCC-----CHHHHHHHHHH
Q 007429          575 WNNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       575 L~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      |+.||++||     +++++++|-+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhh
Confidence            999999999     77899987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-38  Score=323.17  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=200.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE--------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK--------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ  397 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk--------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVk  397 (604)
                      ..++|++.+.||+|+||.||+++                    .|++|.++.. ........+.+|+..+.+++|+||++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            44788999999999999999853                    4888888643 22333456889999999999999999


Q ss_pred             EEEEEEcCCCcEEEEEecccCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCce
Q 007429          398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI  465 (604)
Q Consensus       398 l~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NI  465 (604)
                      +++++...+. .++||||+++++|.+++....            .+++..++.++.|++.||.|||++|++||||||+||
T Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          82 LLGVCVSDDP-LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEEcCCCc-cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999987765 899999999999999985321            367888999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCCC
Q 007429          466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAAC  541 (604)
Q Consensus       466 Lld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT--G~~Pf~~~  541 (604)
                      +++.++.+||+|||++........  ......+++.|+|||.+.+..++    .++|||||||++|+|++  |..||...
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT----TASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC----chhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999865432211  11222346789999998766543    45999999999999998  67888876


Q ss_pred             ChHHHHHHHHH------cCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          542 SPVQAAVGIAA------CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       542 s~~~~~~~i~~------~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +..+....+..      .......+..+++.+.+|+.+||+.||++||++++|++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            66554433221      11122345667899999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-37  Score=313.80  Aligned_cols=250  Identities=25%  Similarity=0.462  Sum_probs=205.5

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |++..++|++.+.||+|+||.||++.     .+++|.+....   .....+.+|+.++..++|+|++++++++.. +. .
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EP-I   75 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC-c
Confidence            45666789999999999999999864     58888876432   223457789999999999999999998754 33 7


Q ss_pred             EEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            8999999999999998643  35789999999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .. ......++..|+|||.+.+...    +.++||||||+++|||++ |..||.+..+.+.... ...+..+..+...+.
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~----~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRF----TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VERGYRMPCPQGCPE  230 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCc----ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCcccCH
Confidence            21 1122245678999998876544    345999999999999999 9999988776655443 344556667778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+.+++.+||..||.+||++.++++.|.+
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=311.01  Aligned_cols=241  Identities=31%  Similarity=0.548  Sum_probs=203.1

Q ss_pred             eeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +.||+|+||.||++.         .+++|.+....... ....+.+|+..+..++|+||+++++++.+... .++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-LYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCc-eEEEEEec
Confidence            468999999999853         46788887543332 35668899999999999999999999988654 99999999


Q ss_pred             cCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          417 EGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       417 ~gGSL~dlL~~~---------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ++++|.+++...         ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999764         67999999999999999999999999999999999999999999999999998776543


Q ss_pred             C--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          488 G--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       488 ~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .  .......+++.|+|||.+....+    +.++||||+|+++|||++ |..||......+....+. .+.+...|..++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF----TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCP  233 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc----chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCC
Confidence            2  22233456788999999877643    445999999999999999 699999876665544444 456677888899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +++.+++.+||..+|.+||++.+++++|.
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         234 DELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9e-39  Score=333.35  Aligned_cols=241  Identities=21%  Similarity=0.266  Sum_probs=195.0

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.+..... .......+..|+. ++..++||||+++++++.+.+. .|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~-~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK-LYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            36999999999986      4689999864321 1112233445544 4677899999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+.+.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            99999988777789999999999999999999999999999999999999999999999999986543322333445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||.+.+..++    .++|||||||++|||++|..||...+.......+..  .+..+|...+..+.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         160 PEYLAPEVLRKEPYD----RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             cccCCHHHhcCCCCC----CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999876554    359999999999999999999988776655554443  24567778899999999999999


Q ss_pred             CCCCCCCH----HHHHHHHH
Q 007429          578 SPSKRPQF----SEIISLLL  593 (604)
Q Consensus       578 dP~kRPT~----~ELL~~L~  593 (604)
                      ||.+||+.    .+++++.+
T Consensus       234 ~p~~R~~~~~~~~~~~~~~~  253 (321)
T cd05603         234 DQRRRLGAKADFLEIKNHVF  253 (321)
T ss_pred             CHhhcCCCCCCHHHHhCCCC
Confidence            99999875    46665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.6e-38  Score=318.29  Aligned_cols=246  Identities=20%  Similarity=0.276  Sum_probs=197.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++++.||+|+||.||+|      ..+++|+++...........+.+|+.++..++||||+++++++.+++. .|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR-LYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-EEEEEe
Confidence            5789999999999999996      469999987543333334567889999999999999999999988775 899999


Q ss_pred             cccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          415 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       415 y~~gGSL~dlL~~~---~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |++ ++|.+++...   ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5898887532   468999999999999999999999999999999999999999999999999987554332222


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------  555 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----------------  555 (604)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|++||...+.......+.....                
T Consensus       159 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSP---RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             cCCcccccccChHHhcCCC---CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            3345688899999886542   234569999999999999999999987665443332221100                


Q ss_pred             C-----------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 R-----------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 r-----------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +           ......+++++.++|.+||..||.+|||+.+|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0           01123468899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.8e-38  Score=321.21  Aligned_cols=251  Identities=25%  Similarity=0.453  Sum_probs=200.3

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCce
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI  395 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnI  395 (604)
                      ..++|++.+.||+|+||.||+++                      .+++|.+.... .......+.+|+..+..++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            34679999999999999999752                      57888886432 22334568899999999999999


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~-----------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      +++++++.+.+. .++||||+++|+|.+++....           .+++..+..++.||+.||+|||++|++||||||+|
T Consensus        82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          82 IRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             ceEEEEEecCCc-cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999988775 899999999999999986432           36677899999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAA  540 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT--G~~Pf~~  540 (604)
                      ||++.++.++|+|||+++.......  ......+++.|+|||...+..++    .++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~----~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT----TASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc----chhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999875433211  11122345789999988766544    45999999999999998  7899987


Q ss_pred             CChHHHHHHHHH------cCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          541 CSPVQAAVGIAA------CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       541 ~s~~~~~~~i~~------~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+..+.......      .....+.+..+++.+.+++.+||+.||.+||++.+|++.|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            666554332211      111223456788999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7e-38  Score=331.92  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=195.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----Cc
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~~  408 (604)
                      ++|++.+.||+|+||.||++      +.+|+|++............+.+|+.+++.++||||+++++++....     ..
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            78999999999999999985      57999998754444444556789999999999999999999986543     23


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF  177 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence            7999999976 6666653  358889999999999999999999999999999999999999999999999986543221


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--------------
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--------------  554 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--------------  554 (604)
                       ......+|+.|+|||.+.+..++.    ++|||||||++|+|++|..||.+.+.......+....              
T Consensus       178 -~~~~~~~t~~y~aPE~~~~~~~~~----~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         178 -MMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             -cCCCCcccCCCCCchhccCCCCCc----chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence             223346789999999998765543    5999999999999999999998765433222111100              


Q ss_pred             ------CCCC--------------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          555 ------LRPE--------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       555 ------~r~~--------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                            .++.                    .+...++.++++|.+||..||.+|||+.|++.|-+-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                  0000                    1112457789999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.1e-38  Score=314.44  Aligned_cols=246  Identities=21%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             CeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      +|++.+.||.|+||.||+|.     .+++|.+.......    .....+.+|+..+..++|+||+++++++.+.+. .++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-ISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe-EEE
Confidence            36788899999999999864     58999886433221    122457889999999999999999999988765 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC---
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---  488 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~---  488 (604)
                      |+||+++++|.+++.+...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999777789999999999999999999999999999999999999999999999999986543211   


Q ss_pred             ---CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-CCCCCCCCCcc
Q 007429          489 ---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GLRPEIPKDCP  564 (604)
Q Consensus       489 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-~~r~~~p~~~s  564 (604)
                         .......++..|+|||.+.+..++    .++|||||||++|+|++|..||...+.......+... ...+..+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~----~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYG----RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCc----chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence               111233578899999999876544    4599999999999999999999876655544433333 34456778889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .++.++|++||+.+|.+||++.+++.+
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.3e-38  Score=314.63  Aligned_cols=244  Identities=23%  Similarity=0.430  Sum_probs=203.3

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-------HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-------~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      |.+.+.||.|+||.||+|      +.+++|.+........       ....+.+|+.++..++||||+++++++.+... 
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   80 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH-   80 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc-
Confidence            567789999999999986      4689998864432211       12457789999999999999999999988775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .++||||+++++|.+++.+.+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            89999999999999999877789999999999999999999999999999999999999999999999999987664221


Q ss_pred             C------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          489 E------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       489 ~------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .      ......++..|+|||.+.+..++    .++|+|||||++|+|++|..||...+.......+.. ...+..|..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~----~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~  235 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT----RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSN  235 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCC----chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcc
Confidence            1      11223477889999999766543    459999999999999999999988766555444333 456677888


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ++..+.++|.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            99999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-37  Score=316.72  Aligned_cols=251  Identities=26%  Similarity=0.466  Sum_probs=199.9

Q ss_pred             CCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~  407 (604)
                      ..+|++++.||+|+||.||++.          .+++|.+....  ......+.+|+.++..++||||+++++++...+ .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4688999999999999999853          68999886432  223456789999999999999999999886443 3


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      .+++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            489999999999999998654 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---------------HHHH
Q 007429          487 VGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------------QAAV  548 (604)
Q Consensus       487 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---------------~~~~  548 (604)
                      ....   .....++..|+|||.+.+..++    .++|||||||++|||++|..|+......               ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFS----VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcC----hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            2211   1112234569999999766543    4599999999999999987765432111               1112


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .......+...+..++..+.+++.+||+.+|++|||+.+|++.|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            23334445556678899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-37  Score=313.99  Aligned_cols=254  Identities=23%  Similarity=0.436  Sum_probs=208.7

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +..++|.+.+.||.|+||.||+|.         .+++|...... .......+.+|+..+..++||||+++++++.+.. 
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-   80 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP-   80 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCC-
Confidence            455778999999999999999974         36777775332 2333456888999999999999999999987543 


Q ss_pred             cEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus        81 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 -VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             -cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence             689999999999999996543 689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          487 VGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       487 ~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .... .....+++.|+|||.+....++    .++||||||+++||+++ |..||...+..+.... ...+.+...+..++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFT----SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLPMPPNCP  234 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCC----chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCCCCCCCC
Confidence            3211 1122345679999998765443    45999999999999986 9999988776555433 34455666788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..+.++|.+||..+|.+|||+.++++.|..+.+.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-37  Score=315.32  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=191.1

Q ss_pred             eeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||+|+        .+++|.++.... ......+.+|+..++.++||||+++++++.+... .++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP-YLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC-cEEEEECCC
Confidence            368999999999974        578888764432 2334567889999999999999999999987765 899999999


Q ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--c
Q 007429          418 GGSVNDLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A  490 (604)
Q Consensus       418 gGSL~dlL~~~~-----~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~  490 (604)
                      +|+|.+++...+     ..++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999985422     456778889999999999999999999999999999999999999999999864332211  1


Q ss_pred             ccccCCCCcccccccccCCCCC---CCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcC-C---CCCCCCC
Q 007429          491 TEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG-L---RPEIPKD  562 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s---~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~-~---r~~~p~~  562 (604)
                      .....+++.|+|||.+.+....   ..++.++|+||||+++|||++ |..||....+.+......... .   .+.....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223467889999998643221   134567999999999999996 999998776655443333221 1   1222335


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +++.+.++|..|| .+|++|||+++|+..|.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            6788999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-38  Score=336.67  Aligned_cols=251  Identities=20%  Similarity=0.289  Sum_probs=201.4

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l~  410 (604)
                      +|++++.||+|+||.||++      +.||+|++............+.+|+.++..++|+||+++++++...+    ..+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999985      57999998654333334456789999999999999999999998765    2489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-C
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-~  489 (604)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... .
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            9999997 4898888777789999999999999999999999999999999999999999999999999987543321 1


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-----------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA-----------------  552 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~-----------------  552 (604)
                      ......+++.|+|||.+.+..   .++.++|||||||++|||++|+.||...++.+....+..                 
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSR---HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCC---CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            122335788899999987643   234469999999999999999999988766544433221                 


Q ss_pred             ------cCCCC-------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          553 ------CGLRP-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       553 ------~~~r~-------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                            ....+       ......++++.++|.+||+.||.+|||+.|++.+-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence                  11111       12345678899999999999999999999999986643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-38  Score=331.35  Aligned_cols=241  Identities=20%  Similarity=0.302  Sum_probs=196.4

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.++...... .....+.+|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-EEEEEeCCC
Confidence            36999999999985      479999997543222 2234467888888777 69999999999887765 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            99999998777789999999999999999999999999999999999999999999999999987543333334455789


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC------ChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC------SPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~------s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      +.|+|||.+.+..++    .++|||||||++|||++|..||...      ...+....... ..+..+|..++..+.+++
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         160 PNYIAPEILRGEEYG----FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             cccCCHHHHCCCCCC----chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHH
Confidence            999999999876554    3599999999999999999999632      22233333333 234457888899999999


Q ss_pred             HHhhhcCCCCCCC------HHHHHHHH
Q 007429          572 IKCWNNSPSKRPQ------FSEIISLL  592 (604)
Q Consensus       572 ~kCL~~dP~kRPT------~~ELL~~L  592 (604)
                      .+||..||.+||+      +.++++|-
T Consensus       235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         235 KGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            9999999999997      56887764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.9e-38  Score=312.18  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=207.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||++      +.+++|.+...........++.+|+..+++++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN-LYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe-EEEEEe
Confidence            4789999999999999984      579999987543333445578899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            99999999988653  3578999999999999999999999999999999999999999999999999876544333333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+...+    .++|+|||||++|+|++|..||......+....+.. +..+..+..++..+.++|.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~----~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYN----NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hccCCccccCHHHhCCCCCC----CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHH
Confidence            34578889999998766443    459999999999999999999988776666555543 4455667888999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~  591 (604)
                      +||+.+|++||++.+++.+
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHhhCChhhCcCHHHHhhC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.9e-39  Score=318.97  Aligned_cols=246  Identities=25%  Similarity=0.448  Sum_probs=199.7

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      |++++.||+|+||.||++      +.+++|.+..............+|+..+..++||||+++++++.+... .++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY-LYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE-EEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc-ccccccc
Confidence            789999999999999995      579999998654443333344568899999999999999999998765 8999999


Q ss_pred             ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccC
Q 007429          416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET  495 (604)
Q Consensus       416 ~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~  495 (604)
                      +++++|.+++.+...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..............
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998778899999999999999999999999999999999999999999999999999865433333445567


Q ss_pred             CCCccccccccc-CCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHcCCCC--CCCCCccHHHHH
Q 007429          496 DGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA---VGIAACGLRP--EIPKDCPQILKS  569 (604)
Q Consensus       496 gt~~Y~APE~l~-~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~---~~i~~~~~r~--~~p~~~s~~l~~  569 (604)
                      +++.|+|||.+. +.    ..+.++||||+|+++|+|++|..||.........   ..........  ......+..+.+
T Consensus       160 ~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGK----KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSGGGSCHHHHTTTS----SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            889999999987 33    3345699999999999999999999987332222   2222111111  111223489999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +|.+||+.||++||++.+++++=
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             HHHHHccCChhHCcCHHHHhcCC
Confidence            99999999999999999998763

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-37  Score=315.13  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=191.0

Q ss_pred             eeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      ++||+|+||.||+|.        .+++|.+... ........+.+|+..+..++|+||+++++.+.+... .++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~-~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP-YLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc-eEEEEEeCC
Confidence            368999999999974        4566665432 223334557789999999999999999999987765 899999999


Q ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--c
Q 007429          418 GGSVNDLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A  490 (604)
Q Consensus       418 gGSL~dlL~~~~-----~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~  490 (604)
                      +|+|.+++...+     ..++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999986533     246778899999999999999999999999999999999999999999999764322111  1


Q ss_pred             ccccCCCCcccccccccCCCC---CCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCC----CCCCCCC
Q 007429          491 TEYETDGYRWLAPEIIAGDPE---SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL----RPEIPKD  562 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~---s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~----r~~~p~~  562 (604)
                      .....+++.|+|||++.....   ....+.++|||||||++|||++ |..||....+.+..........    .+..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            122345677999999864321   2234567999999999999999 8899988776665554444332    2334557


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +++.+..++..|| .||++||++++|++.|
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            8899999999999 5999999999999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.4e-38  Score=316.02  Aligned_cols=250  Identities=26%  Similarity=0.468  Sum_probs=204.5

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..++|+++..||+|+||.||+|+           .+++|.+.... .......+.+|+.++.+++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            34788999999999999999875           47777775332 2223456889999999999999999999997766


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEe
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR---------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD  477 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~---------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~D  477 (604)
                      . .++||||+++|+|.+++....         .+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|
T Consensus        82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          82 P-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             c-ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            5 899999999999999996544         689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCC-CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCC
Q 007429          478 MGIVTACKSVG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       478 FGla~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      ||++....... .......++..|+|||.+.+...+    .++||||||+++|+|++ |..||...........+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~  236 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS----TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL  236 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCC----chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence            99975432211 111222456779999998765443    45999999999999998 8899987666665555544444


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ....+..++..+.+++.+||..+|.+||++.+++..|.
T Consensus       237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            44556778999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-37  Score=316.59  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=200.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||+|      +.+++|.+............+.+|+.+++.++|+||+++++++..... .++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-LHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE-EEEEE
Confidence            47899999999999999985      579999886443333334456789999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99999999888766667999999999999999999999999999999999999999999999999998766543322333


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------------  555 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------------  555 (604)
                      ..++..|+|||.+.+..   .++.++||||||+++|||++|..||.+.+..+....+.....                  
T Consensus       160 ~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         160 YVATRWYRAPELLVGDT---QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cccccccCCHHHHhCCC---CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            45778899999987532   234469999999999999999999988766554433321100                  


Q ss_pred             -CCCC----------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          556 -RPEI----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       556 -r~~~----------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                       ..+.          ....+..+.+++.+||+.+|++||++.|++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence             0000          124578899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=330.04  Aligned_cols=253  Identities=20%  Similarity=0.269  Sum_probs=202.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.+++. +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN-LYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe-EEEE
Confidence            47899999999999999985      47999998642211 1223446788888899999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-c
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~  490 (604)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999965 45799999999999999999999999999999999999999999999999999866543322 2


Q ss_pred             ccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC---CCccHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP---KDCPQI  566 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p---~~~s~~  566 (604)
                      .....||+.|+|||++.+... ...++.++|||||||++|||++|..||...+..+....+........++   ..++..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            233468999999999874221 1223456999999999999999999999877766665555433333333   347899


Q ss_pred             HHHHHHHhhhcCCC--CCCCHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPS--KRPQFSEIISLLL  593 (604)
Q Consensus       567 l~~LI~kCL~~dP~--kRPT~~ELL~~L~  593 (604)
                      ++++|.+|+..++.  .||++.+++.|-+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            99999998865443  4889999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-38  Score=317.85  Aligned_cols=248  Identities=19%  Similarity=0.382  Sum_probs=202.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.+++|.++....  .....+.+|+.++..++||||+++++++...+. .++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~-~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK-LWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-EEEEE
Confidence            57888999999999999985      5789998874422  222346788999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++............
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence            99999999999987778999999999999999999999999999999999999999999999999998765443333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC---CCCccHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILKSL  570 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~---p~~~s~~l~~L  570 (604)
                      ..+++.|+|||.+..... ..++.++|||||||++|+|++|..||....+.............+..   ...++..+.++
T Consensus       166 ~~~~~~y~aPE~~~~~~~-~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         166 FIGTPYWMAPEVAAVERK-GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             ccCcccccChhhhccccC-CCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            568899999999752211 12345699999999999999999999876655544443333333221   12467889999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.+||+.+|++||++++|+++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHccCCchhCcCHHHHhcC
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-37  Score=309.81  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=206.3

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LVm  413 (604)
                      +|++++.||.|+||.||++      +.+++|.+............+..|+..++.++|+||+++++++... +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5789999999999999985      5689998875544444556688899999999999999999988654 34479999


Q ss_pred             ecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          414 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLN-----DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       414 Ey~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLH-----s~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999999854    357899999999999999999999     899999999999999999999999999998776


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ...........+++.|+|||.+.+...    +.++|+||||+++|+|++|..||...+.... ......+..+.++..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSY----DEKSDIWSLGCLIYELCALSPPFTARNQLQL-ASKIKEGKFRRIPYRYS  235 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCC----CchhHHHHHHHHHHHHHHCCCcccCcCHHHH-HHHHhcCCCCCCccccC
Confidence            544332334467889999999977653    3459999999999999999999988764443 33444455556788889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+.+++.+||+.+|.+||++.+|+++
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8e-38  Score=323.82  Aligned_cols=252  Identities=14%  Similarity=0.240  Sum_probs=201.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|.+++.||+|+||.||+|      +.+|+|.++..... .....+.+|+.++..++||||+++++++..++. .++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS-LTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe-EEEE
Confidence            377999999999999999986      46899998754322 223346789999999999999999999987775 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999976 888887544 458899999999999999999999999999999999999999999999999987544333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-----------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  554 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-----------------  554 (604)
                      ....+++.|+|||.+.+..   .++.++|||||||++|||++|..||...+..+....+...-                 
T Consensus       162 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSS---EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccCCHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            3446788999999987542   23456999999999999999999998776554433322110                 


Q ss_pred             ----CCC-------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          555 ----LRP-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       555 ----~r~-------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                          .+.       .....+++++.++|.+||..||.+|||+.|++.+-+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence                000       011246788999999999999999999999999877653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-38  Score=332.43  Aligned_cols=239  Identities=20%  Similarity=0.257  Sum_probs=194.5

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||+|+||.||++      +.+|+|.+..... .......+..|.. +++.++||||+++++++...+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~-~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK-LYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE-EEEEEcCCC
Confidence            46899999999985      4799999864321 1122334455554 3566899999999999987775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            99999998877889999999999999999999999999999999999999999999999999986543333333445689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|+|||++.+..++.    ++|||||||++|||++|..||...+..+....+...  ....+...+..+.+++.+|++.
T Consensus       160 ~~y~aPE~~~~~~~~~----~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         160 PEYLAPEVIRKQPYDN----TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             hhhCCHHHHcCCCCCC----cCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhcc
Confidence            9999999998765543    599999999999999999999987776665555443  3345567889999999999999


Q ss_pred             CCCCCCCHH----HHHHH
Q 007429          578 SPSKRPQFS----EIISL  591 (604)
Q Consensus       578 dP~kRPT~~----ELL~~  591 (604)
                      +|.+||++.    +++++
T Consensus       234 ~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         234 DRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             CHHhcCCCCCCHHHHhcC
Confidence            999999874    55554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=326.02  Aligned_cols=252  Identities=19%  Similarity=0.275  Sum_probs=214.3

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~LV  412 (604)
                      ++|+.+..|++|+||.||+|+      .||+|+++...........-.+||.+|.+++|||||.+..+....+ +.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            678899999999999999974      7999999876655555556789999999999999999999887553 459999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+. +|..++..- .+|...++.-++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+.+.....
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            999988 999998643 489999999999999999999999999999999999999999999999999999998776666


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------  557 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------------  557 (604)
                      ....-|..|.|||.+.|.+   .|+...|+||+|||+.||+++.+.|.+.+..+.+..|...-..|              
T Consensus       235 T~lVVTLWYRaPELLLG~~---tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAK---TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             cceEEEeeecCHHHhcCCc---ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            6667899999999999864   45556999999999999999999999988887777665432111              


Q ss_pred             ---------------CCCCC-ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ---------------EIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ---------------~~p~~-~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                     .++.. .++.-.+|+..++..||.+|.|+++.++|=+..
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                           11111 457788999999999999999999999886554

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.9e-38  Score=317.63  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=201.9

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEc----C
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVD----E  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~----~  405 (604)
                      ...++|++.+.||+|+||.||++      +.+++|.+....   .....+..|+.++..+ +||||+++++++..    .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            34588999999999999999985      568899875321   2234567888888888 79999999998853    2


Q ss_pred             CCcEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      +...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            2348999999999999998742    346889999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-CCCCC
Q 007429          482 TACKSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEI  559 (604)
Q Consensus       482 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-~r~~~  559 (604)
                      ..............+++.|+|||.+.... ....++.++|||||||++|||++|..||....+........... .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            76544333333446889999999986432 12234567999999999999999999998776655443332221 12223


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      |..++..+.++|.+||+.||++||++.|++++.+
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            5567889999999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-37  Score=314.52  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc---hHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~---~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l  409 (604)
                      .+|++.+.||+|+||.||++      +.+++|++.......   .....+.+|+.++..++||||+++++++.+. ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999985      478999886443222   2234578899999999999999999998764 3447


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-  488 (604)
                      ++++||+++++|.+++.+...+++...+.++.|++.||.|||+++++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            8999999999999999777789999999999999999999999999999999999999999999999999987543211 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                        .......++..|+|||.+.+..++    .++|||||||++|||++|..||..................+.+|..+++.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYG----RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCC----chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence              111234578899999999766444    45999999999999999999998877666666555555567778888899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +..++ .||..+|++||+++||++|
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhcC
Confidence            99999 6888999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-37  Score=312.37  Aligned_cols=246  Identities=27%  Similarity=0.521  Sum_probs=205.2

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      |.+..++|++.+.||+|+||.||+|    +.+++|.++...    ....+.+|+..+..++||||+++++++..+.  .+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~   74 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG--LY   74 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--cE
Confidence            5666788999999999999999985    578899886321    2346788999999999999999999987543  78


Q ss_pred             EEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +||||+++++|.+++....  .+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999999986433  5889999999999999999999999999999999999999999999999998654321 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                        ......+..|+|||.+.+..++    .++|+|||||++|||++ |..||...+..+... ....+.++..+..++..+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~----~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  226 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFS----SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-CVEKGYRMEPPEGCPADV  226 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcC----chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-HHhCCCCCCCCCcCCHHH
Confidence              1222345679999998765443    45999999999999997 999998877655443 344556666677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+++.+||+.+|.+||++.+++..|.+
T Consensus       227 ~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         227 YVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-37  Score=310.84  Aligned_cols=241  Identities=29%  Similarity=0.514  Sum_probs=202.6

Q ss_pred             eeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +.||+|+||.||+|.         .+++|.+...... .....+.+|+..+++++||||+++++++.+ . ..++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-PLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-eEEEEEEec
Confidence            368999999999864         4788888754332 445678899999999999999999999987 4 489999999


Q ss_pred             cCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc---c
Q 007429          417 EGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---T  491 (604)
Q Consensus       417 ~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~---~  491 (604)
                      ++|+|.+++.+..  .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.........   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999986543  6899999999999999999999999999999999999999999999999998765432211   1


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....++..|+|||.+.+..++    .++|||||||++|||++ |..||...+..+....+.........+..+|..+.++
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~----~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFS----HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cCCCCCceecCHHHhcccCcC----chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence            223467789999998766544    45999999999999998 9999988777776666555555566677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +.+||+.+|++||++.++++.|.
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhc
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.1e-37  Score=310.57  Aligned_cols=250  Identities=25%  Similarity=0.462  Sum_probs=206.7

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      |.+..++|++.+.||+|+||.||++.     .+++|.+...   ......+.+|+.+++.++|+||+++++.+.+ . ..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-~~   75 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-PI   75 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-Ce
Confidence            67788999999999999999999874     4888877632   2234567889999999999999999999877 4 37


Q ss_pred             EEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      +++|||+++|+|.+++.+  ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999999999965  336788899999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .. ......++..|+|||.+.+..++    .++|+|||||++|++++ |..||...+...... ....+...+.+...+.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~----~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  230 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFT----IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-ALERGYRMPRPENCPE  230 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcC----ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhCCCCCCCcccCCH
Confidence            21 11222356779999999765443    45999999999999998 999998866655443 3344555566778889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+.+++.+||..+|.+||++.++++.|..
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-37  Score=319.70  Aligned_cols=248  Identities=21%  Similarity=0.376  Sum_probs=205.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+|++++.||+|+||.||+|      +.+++|.+......  ....+.+|+.++..++|+||+++++.+..... .|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~-~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE-EEEee
Confidence            67899999999999999986      47899988754332  23557789999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++............
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            99999999999843 46899999999999999999999999999999999999999999999999997654433222334


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      ..+++.|+|||.+.+...+    .++|||||||++|+|++|..||....+......+..... ....+..++..+.++|.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~----~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYG----PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             ccCCccccCHHHHcCCCCC----ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            4688899999998866544    359999999999999999999988776554444333322 22345678899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||..+|.+||++.+++.+-+..
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~  274 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLK  274 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhh
Confidence            99999999999999999975543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-37  Score=321.11  Aligned_cols=255  Identities=24%  Similarity=0.464  Sum_probs=207.9

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|+..+.||+|+||.||+|.          .+++|.+.... .......+.+|+.++..++||||++++|+|....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence            455788999999999999999974          46888776432 2333446788999999999999999999997643


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++++||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus        83 --~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          83 --IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             --ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence              578999999999999986543 68999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  .....++..|+|||.+.+..+    +.++|||||||++|||++ |..||.+..... .......+.....+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  235 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKF----THQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPI  235 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCC----ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCC
Confidence            32221  122234678999999876554    345999999999999997 999998765443 3444555556666777


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ++..+..++.+||..+|++||++.+++..|..+....
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            8999999999999999999999999999999875443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-37  Score=317.56  Aligned_cols=251  Identities=26%  Similarity=0.498  Sum_probs=203.9

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ++.++|++.+.||+|+||.||++           ..+++|.+.... .......+.+|+..+..++||||+++++++.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34578999999999999999985           357888876332 233345688899999999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSR----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  463 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~----------------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~  463 (604)
                      .. .++||||+++|+|.+++....                      .+++..++.++.||+.||.|||+++++||||||+
T Consensus        81 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          81 KP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             Cc-cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            65 899999999999999985321                      3678889999999999999999999999999999


Q ss_pred             ceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 007429          464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA  540 (604)
Q Consensus       464 NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~  540 (604)
                      ||+++.++.++|+|||++........  .......++.|+|||.+.+..++    .++|||||||++|||++ |..||.+
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT----TESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC----chhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999765432211  11222345679999998766544    45999999999999998 8889987


Q ss_pred             CChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       541 ~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+..+....+. .+.....+..++..+.+++.+||+.+|.+||++.|+++.|++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            77665554433 344445677889999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-37  Score=311.70  Aligned_cols=248  Identities=22%  Similarity=0.365  Sum_probs=204.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc---hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~---~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l  409 (604)
                      .+|++.+.||+|+||.||+|      +.|++|.+.......   .....+.+|+..+..++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999985      579999886432221   22345788999999999999999999887643 347


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-  488 (604)
                      ++||||+++++|.+++.+...+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999999776778999999999999999999999999999999999999999999999999986543211 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                        .......++..|+|||.+.+...+    .++|||||||++|||++|..||..................+..|...+..
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYG----RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCC----cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence              112234578899999998765443    45999999999999999999998876666655555555556677788889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +.+++.+||. +|.+||++++|+.+-
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            9999999995 999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.5e-38  Score=317.99  Aligned_cols=254  Identities=20%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|++.+.||.|+||.||+|      ..+++|.+....  ......+.+|+.+++.++||||+++++++...+. .++||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE-EEEEE
Confidence            34678899999999999996      456777775322  2234457789999999999999999999988765 89999


Q ss_pred             ecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            99999999998754 45789999999999999999999999999999999999999999999999999866543333334


Q ss_pred             ccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSL  570 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~L  570 (604)
                      ...+++.|+|||.+.... ....++.++|||||||++|||++|..||...++.+....+..... ....|..++..+.++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            456888999999985321 112344569999999999999999999998777666555544322 233466788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      |.+||+.||.+||++.+++.+-+...
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEec
Confidence            99999999999999999998766443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-38  Score=317.80  Aligned_cols=255  Identities=23%  Similarity=0.401  Sum_probs=209.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||.|+||.||++      ..+++|.+....  ......+..|+.++..++||||+++++++.+... .|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENK-LWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe-EEEE
Confidence            467899999999999999986      468899886432  2233457789999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999998653 479999999999999999999999999999999999999999999999999976554433334


Q ss_pred             cccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKS  569 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~  569 (604)
                      ....+++.|+|||.+..... ...++.++||||||+++|||++|..||...........+..... ....+..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            44568889999999864322 12245569999999999999999999988776665554443322 12345678899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +|.+||+.+|.+||++.+++++-+-..
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999866543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6e-38  Score=329.32  Aligned_cols=253  Identities=20%  Similarity=0.251  Sum_probs=203.2

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||+++      .+|+|.+...... ......+..|+.++..++|+||+++++++.+.+. +|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN-LYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE-EEEE
Confidence            478999999999999999864      6899988642211 1122346778888888999999999999987775 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-c
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~  490 (604)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999976 45789999999999999999999999999999999999999999999999999865433222 2


Q ss_pred             ccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC---CCccHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP---KDCPQI  566 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p---~~~s~~  566 (604)
                      .....||+.|+|||++.+... ...++.++|||||||++|||++|+.||...+..+....+.....+..+|   ..++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            233568999999999864211 1234556999999999999999999999888777776666554443444   357899


Q ss_pred             HHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSK--RPQFSEIISLLL  593 (604)
Q Consensus       567 l~~LI~kCL~~dP~k--RPT~~ELL~~L~  593 (604)
                      +.+++.+|+..++.+  |+++.++++|-+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence            999999988655444  789999998843

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=313.06  Aligned_cols=242  Identities=26%  Similarity=0.457  Sum_probs=195.8

Q ss_pred             eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          347 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       347 ~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      .||+|+||.||+|+        .+++|.++.. ........+.+|+..+.++ +||||+++++++...+. .++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC-ceEEEEeCC
Confidence            58999999999974        3577777632 2223344678899999998 89999999999988775 899999999


Q ss_pred             CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          418 GGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       418 gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      +|+|.+++...+                .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999986432                4788999999999999999999999999999999999999999999999997


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          482 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       482 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ...... ........+..|+|||.+.+..++    .++|||||||++|||++ |..||...+...... ....+.+...+
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~----~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~~~  233 (270)
T cd05047         160 RGQEVY-VKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGYRLEKP  233 (270)
T ss_pred             cccchh-hhccCCCCccccCChHHHccCCCC----chhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-HHhCCCCCCCC
Confidence            532211 111122335679999998765443    45999999999999997 999998766554433 33444555677


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ..++.++.+++.+||..||.+|||+.+++..|.++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         234 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            788899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=327.88  Aligned_cols=249  Identities=19%  Similarity=0.255  Sum_probs=206.0

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----CCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE----NHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~----~~~l  409 (604)
                      ..|..++.||+|+||.|..      |+.||||++...-.......+..+|+..|+.++|+||+.+++++..+    -..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4556689999999999997      57899999986666666778899999999999999999999998762    2449


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC--
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV--  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~--  487 (604)
                      |+|+|+|+. +|...++.+..++..++..+++||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+.....  
T Consensus       102 YiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  102 YLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             EEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            999999955 99999977777999999999999999999999999999999999999999999999999999887643  


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc--------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--------------  553 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~--------------  553 (604)
                      .........|-+|.|||.+...   ..|+...||||+||++.||++|++.|.+.+....+..+...              
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~---~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNS---SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             ccchhcceeeeeecCHHHHhcc---ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            1122334568889999998643   34556699999999999999999999987665544433221              


Q ss_pred             ----------CCCCCC-----CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          554 ----------GLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       554 ----------~~r~~~-----p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                ...+..     -++.++...+|+.+||..||.+|+|++|.++|-
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence                      111211     136778999999999999999999999999873

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.2e-38  Score=329.33  Aligned_cols=253  Identities=20%  Similarity=0.256  Sum_probs=203.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. .|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~-~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY-LYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence            57899999999999999985      46899998642211 1223346778888888999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-c
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~  490 (604)
                      |||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999976 45789999999999999999999999999999999999999999999999999876543322 1


Q ss_pred             ccccCCCCcccccccccCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC---CccHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK---DCPQI  566 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s-~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~---~~s~~  566 (604)
                      .....|++.|+|||++.+.... ..++.++|||||||++|||++|..||...+..+....+.....+..+|.   +++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2234689999999998753211 1234569999999999999999999998777776666665444444443   46899


Q ss_pred             HHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSK--RPQFSEIISLLL  593 (604)
Q Consensus       567 l~~LI~kCL~~dP~k--RPT~~ELL~~L~  593 (604)
                      +.+++.+|+..++.+  |+++.++++|-+
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence            999999999866544  568999988754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-37  Score=308.45  Aligned_cols=245  Identities=25%  Similarity=0.433  Sum_probs=206.7

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~---~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      |+..+.||+|+||.||+|      +.+++|.+......   ......+.+|+..+..++|+||+++++++.+... .++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv   80 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN-LYIF   80 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe-EEEE
Confidence            567788999999999985      47899988643321   2234568899999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      +||+++++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            9999999999999777779999999999999999999999999999999999999999999999999976654332 223


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+....   .++.++|+||||+++|+|++|..||....+......+......+.++..+++.+.+++.
T Consensus       160 ~~~~~~~y~~pe~~~~~~---~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQG---GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL  236 (258)
T ss_pred             ccCCCcceeCHHHhcCCC---CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence            445788899999987543   23456999999999999999999998877666666555545566778888999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~  591 (604)
                      +||+.+|.+||++.+++.+
T Consensus       237 ~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         237 KCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHhhcCcccCcCHHHHhcC
Confidence            9999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-37  Score=328.41  Aligned_cols=248  Identities=19%  Similarity=0.227  Sum_probs=195.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++.+.||+|+||.||++      +.+|+|++............+.+|+.+++.++||||+++++++....     .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            378999999999999999984      57999998755444444556778999999999999999999986432     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ..|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            37999999976 6777664  35889999999999999999999999999999999999999999999999998764432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  555 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------  555 (604)
                      . ......+|+.|+|||.+.+..++    .++|||||||++|+|++|..||.+.........+...-.            
T Consensus       173 ~-~~~~~~~t~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         173 F-MMTPYVVTRYYRAPEVILGMGYK----ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             c-ccCCccccCCccCHHHHcCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            1 22334678999999999876544    459999999999999999999987665443322211000            


Q ss_pred             --------C--------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          556 --------R--------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       556 --------r--------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                              .                    ...+...+..++++|.+||..||.+|||+.|+++|-+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                    0                    00112235678999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.1e-37  Score=317.65  Aligned_cols=248  Identities=21%  Similarity=0.370  Sum_probs=207.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+|++++.||.|+||.||+|      +.|++|.+......  ....+.+|+..+..++||||+++++++...+. .++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDE-LFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCce-EEEEE
Confidence            57899999999999999985      57999998754322  24557889999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999998854 46899999999999999999999999999999999999999999999999997765443332334


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      ..+++.|+|||.+.+..++    .++|||||||++|+|++|..||...++......+..... ....+..+++.+.++|.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~----~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYG----PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             cCCCccccCcchhcCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            4678899999998766544    459999999999999999999998777665554443332 22356678899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||..||.+||++.+++.+=+..
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhh
Confidence            99999999999999999876553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.1e-38  Score=342.05  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=195.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE------  405 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~------  405 (604)
                      ..++|++++.||+|+||.||+|      +.||+|++....      ....+|+.++..++|||||++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3468999999999999999985      479999886322      1234789999999999999999887532      


Q ss_pred             -CCcEEEEEecccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecC
Q 007429          406 -NHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMG  479 (604)
Q Consensus       406 -~~~l~LVmEy~~gGSL~dlL~----~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFG  479 (604)
                       ...+++||||+++ +|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             1236799999986 7877664    345789999999999999999999999999999999999999665 69999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----  555 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----  555 (604)
                      +++....... .....+|+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+..+.+..+.....    
T Consensus       217 la~~~~~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR-SVSYICSRFYRAPELMLGAT---NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC-cccCCCCcCccCHHHhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9876543222 22346789999999987542   234569999999999999999999998776655544432110    


Q ss_pred             -----------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 -----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 -----------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                             +..+|...++++.+||.+||..||.+|||+.|++.|-+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence                                   0123456788999999999999999999999999887753

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-37  Score=315.82  Aligned_cols=246  Identities=18%  Similarity=0.264  Sum_probs=191.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh---CCCCceeEEEEEEEcC----CC
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE----NH  407 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~---L~HpnIVkl~g~~~~~----~~  407 (604)
                      +|++.+.||+|+||.||++      +.+|+|.++...........+.+|+.++..   ++||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4789999999999999996      468999887543332223334566666554   4799999999998643    23


Q ss_pred             cEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .+++||||+++ +|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            37999999985 898888543  358999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC---C------
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL---R------  556 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~---r------  556 (604)
                      ... ......+++.|+|||++.+..++    .++|||||||++|||++|.+||......+....+.....   .      
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~----~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         160 CQM-ALTPVVVTLWYRAPEVLLQSTYA----TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             Ccc-cCCCccccccccCchHhhCCCCC----CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            321 12234578899999999776544    459999999999999999999987766554433332100   0      


Q ss_pred             ---------C-------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          557 ---------P-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       557 ---------~-------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                               +       ...+.++..+.+++.+||+.||.+|||+.+++.|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                     0       01235678899999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.7e-37  Score=308.50  Aligned_cols=249  Identities=24%  Similarity=0.436  Sum_probs=205.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|.+.+.||+|+||.||+|      +.+++|.++...........+..|+.++..++|+||+++++++...+. .++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE-EEEEEe
Confidence            4788999999999999996      468999987654443455678899999999999999999999877665 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc--
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE--  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~--  492 (604)
                      |+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999997777789999999999999999999999999999999999999999999999999876544322211  


Q ss_pred             --ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc--cHHHH
Q 007429          493 --YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC--PQILK  568 (604)
Q Consensus       493 --~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~--s~~l~  568 (604)
                        ...+++.|+|||.+.+.. ....+.++||||||+++|++++|..||...............+..+.+|...  ++.+.
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK  238 (264)
T ss_pred             ccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence              245788999999997654 1124556999999999999999999998654333333333334555566554  89999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +++.+||+.+|.+||++.+++.+
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhcC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=354.59  Aligned_cols=257  Identities=26%  Similarity=0.510  Sum_probs=221.9

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY  399 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~  399 (604)
                      .|++..+++.+.+.||+|.||.|++|.             .||||.++..... .....+..|+..|..+ .|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            799999999999999999999999863             5889998855444 5566789999999987 699999999


Q ss_pred             EEEEcCCCcEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q 007429          400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  463 (604)
Q Consensus       400 g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~  463 (604)
                      |+|..... +++|+||+..|+|.++++..+                .++...++.++.||+.||+||++.++|||||.++
T Consensus       369 G~~t~~~~-~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  369 GACTQDGP-LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeccCCc-eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            99998554 999999999999999996544                3889999999999999999999999999999999


Q ss_pred             ceEEcCCCcEEEEecCCccccccCCCcc-cccC--CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          464 RILLDRHGNVCLGDMGIVTACKSVGEAT-EYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       464 NILld~~g~vKL~DFGla~~~~~~~~~~-~~~~--gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      |||+..+..+||+|||+++......... ....  -+..|||||.+....    ++.+||||||||+||||+| |..||+
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~----ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV----FTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc----ccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999998644332221 2222  356799999998754    4556999999999999999 999999


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +......+...+..|.++..|..|+++++++|+.||..+|++||+|.++.+.+....
T Consensus       524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            876455556788899999999999999999999999999999999999999999854

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=318.72  Aligned_cols=253  Identities=20%  Similarity=0.385  Sum_probs=211.4

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      ++..+.++++++..||.|+.|.|++      |..+|||.+.+... .++..++..++.++... ..|+||+++|+|..+.
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            4556677889999999999999998      56899999986543 33456678888876654 4799999999999887


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      . ++|.||.|.- .++.++.+- +++++..+-++...++.||.||.+ ++|+|||+||+|||+|+.|++||||||++.++
T Consensus       165 d-V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  165 D-VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             h-HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            6 8999999955 777777553 479999999999999999999975 58999999999999999999999999998877


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--C
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  562 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~  562 (604)
                      .+.. ......|.+.|||||.+.... ..+|+.++||||||++++||.||..||.++...-.....+.+..+|.+|.  .
T Consensus       243 vdSk-AhtrsAGC~~YMaPERidp~~-~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  243 VDSK-AHTRSAGCAAYMAPERIDPPD-KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             eccc-ccccccCCccccCccccCCCC-CCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence            6543 345567899999999998664 45778899999999999999999999999765544444444566666665  3


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +++.+.+++..||.+|+.+||.+.++++|
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            79999999999999999999999999986

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-37  Score=315.25  Aligned_cols=252  Identities=25%  Similarity=0.465  Sum_probs=201.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NH  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~  407 (604)
                      .+.|++++.||+|+||.||.+          +.+++|.++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            356789999999999999974          468999986432 233345688999999999999999999999876 24


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      ..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            489999999999999998654 3689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------------ChHHHHHH
Q 007429          487 VGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------SPVQAAVG  549 (604)
Q Consensus       487 ~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~--------------s~~~~~~~  549 (604)
                      ...   ......++..|+|||.+.+..++    .++|||||||++|||+++..|+...              ........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~----~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFY----IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCC----ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            221   11223456779999998765443    4599999999999999987664321              11112222


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       550 i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ....+.+.+.+..++..+.+++.+||+.||.+||++.++++.|..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            3334445556778899999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-37  Score=312.96  Aligned_cols=252  Identities=24%  Similarity=0.461  Sum_probs=204.5

Q ss_pred             CCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~  407 (604)
                      .++|++.+.||+|+||.||+++          .+++|.+...... .....+.+|+..++.++|+||+++++++.... .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4678899999999999999864          6899998754332 34566889999999999999999999987632 2


Q ss_pred             cEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            3899999999999999996544 689999999999999999999999999999999999999999999999999876653


Q ss_pred             CCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--------------HHHHHH
Q 007429          487 VGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--------------VQAAVG  549 (604)
Q Consensus       487 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--------------~~~~~~  549 (604)
                      ....   .....++..|+|||.+.+...+    .++||||||+++|||++|..|+.....              ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~----~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFS----SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCC----cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            2211   1112345669999998766443    459999999999999999999865322              122233


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       550 i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ......+...+..++.++.+++.+||..+|.+||++.+|+++|..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            4444455556678889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.5e-37  Score=305.75  Aligned_cols=241  Identities=25%  Similarity=0.502  Sum_probs=198.5

Q ss_pred             eeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          346 DQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       346 ~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      +.||+|+||.||+|.     .+++|.+... ........+.+|+..+..++||||+++++++..... .++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-IYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-cEEEEECCCCCc
Confidence            368999999999964     5888887643 233344567889999999999999999999987775 899999999999


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-cccccCCCC
Q 007429          421 VNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGY  498 (604)
Q Consensus       421 L~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~gt~  498 (604)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......+++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            99998643 4688999999999999999999999999999999999999999999999999865432211 112223456


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      .|+|||++.+..+    +.++||||||+++|++++ |..||........... ...+.+...+..++..+.+++.+||..
T Consensus       159 ~y~aPE~~~~~~~----~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         159 KWTAPEALNYGRY----SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             cccCHHHhccCCC----CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHccc
Confidence            7999999876543    345999999999999998 9999988766554443 344556667788999999999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 007429          578 SPSKRPQFSEIISLLL  593 (604)
Q Consensus       578 dP~kRPT~~ELL~~L~  593 (604)
                      +|.+||++.++++.|.
T Consensus       234 ~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         234 KPENRPKFSELQKELA  249 (250)
T ss_pred             CcccCCCHHHHHHHhc
Confidence            9999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-37  Score=316.99  Aligned_cols=235  Identities=22%  Similarity=0.313  Sum_probs=185.8

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||+|+||.||++      +.+|+|.+....... .....+..|+.++..++||||+++++++.+... +|+||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH-LCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe-EEEEEecCCCCC
Confidence            699999999984      579999886432211 123345668889999999999999999987765 999999999999


Q ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          421 VNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       421 L~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      |.+++...  ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ......+++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence            99887543  358899999999999999999999999999999999999999999999999987654322 223446889


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV----QAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~----~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      .|+|||++.+..++    .++|||||||++|||++|..||......    +....... .........+++++.+++.+|
T Consensus       159 ~y~aPE~~~~~~~~----~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~  233 (277)
T cd05607         159 GYMAPEILKEEPYS----YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEVKFEHQNFTEESKDICRLF  233 (277)
T ss_pred             CccCHHHHccCCCC----CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-cccccccccCCHHHHHHHHHH
Confidence            99999999876544    4599999999999999999999864332    12122221 111122346789999999999


Q ss_pred             hhcCCCCCCCHHHHH
Q 007429          575 WNNSPSKRPQFSEII  589 (604)
Q Consensus       575 L~~dP~kRPT~~ELL  589 (604)
                      |+.||.+||++.|++
T Consensus       234 L~~~P~~R~~~~~~~  248 (277)
T cd05607         234 LAKKPEDRLGSREKN  248 (277)
T ss_pred             hccCHhhCCCCccch
Confidence            999999999995544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=335.09  Aligned_cols=245  Identities=19%  Similarity=0.287  Sum_probs=193.3

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +...+|++++.||+|+||.||++      +.||+|....        ..+.+|+.++..++|||||++++++..... .+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKF-TC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe-eE
Confidence            44578999999999999999985      5788886532        235689999999999999999999987765 89


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-C
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-~  489 (604)
                      +|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999995 6899988777789999999999999999999999999999999999999999999999999986533221 1


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHHc-C-------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-------PVQAAVGIAAC-G-------  554 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-------~~~~~~~i~~~-~-------  554 (604)
                      ......||+.|+|||++.+..++    .++|||||||++|||++|..||....       ....+..+... +       
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYG----PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCC----cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            22334689999999999876544    45999999999999999998764321       11111111110 0       


Q ss_pred             ------------------CC-C-CCC-----CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          555 ------------------LR-P-EIP-----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       555 ------------------~r-~-~~p-----~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                        .. + ..+     ...+.++.+||.+||+.||.+|||+.|++++-+..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                              00 0 000     12466899999999999999999999999887754

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-37  Score=317.25  Aligned_cols=248  Identities=18%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .|++.+.||+|+||.||++      +.+|+|.+........ ....+.+|+.++..++|+||+++++.+.+.+. +|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-EEEEE
Confidence            3678899999999999984      5799999865432222 23446789999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....... ..
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI  158 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence            999999999988533  368999999999999999999999999999999999999999999999999986543222 12


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHcCCCCCCCCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      ....|++.|+|||.+.+..++    .++|||||||++|+|++|..||......   ....... .......+..+++++.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~----~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYT----FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDAR  233 (285)
T ss_pred             cCCCCCccccChHHHcCCCCC----CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHH
Confidence            234688999999999876554    3599999999999999999999864321   1111111 2223456777899999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHHHHHHh
Q 007429          569 SLMIKCWNNSPSKRPQ-----FSEIISLLLRT  595 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT-----~~ELL~~L~~~  595 (604)
                      +++.+||+.||.+|||     +.|+++|-+..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            9999999999999999     89999976653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=312.39  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=208.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||+|      +.+++|.+.... .......+.+|+.+++.++|+||+++++++.+... +++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK-LWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe-EEEEE
Confidence            46788999999999999985      478999886432 22334557889999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++..+ ++++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++...........
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999998654 7899999999999999999999999999999999999999999999999998776544333444


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC-ccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD-CPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~-~s~~l~~LI~  572 (604)
                      ..+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...++......+. ....+..+.. ++.++.+++.
T Consensus       158 ~~~~~~y~~PE~~~~~~~----~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGY----DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccCCccccChhhhccCCC----CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHH
Confidence            567888999999987653    445999999999999999999998776655544333 3344555555 8899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +||..+|++||++.+++.+-+-..
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcC
Confidence            999999999999999998766544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-37  Score=315.93  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=206.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+...... ......+.+|+..+.+++||||+++++++.+.+. .++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN-LYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe-EEEE
Confidence            47899999999999999975      57999988643221 1234557889999999999999999999988775 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++......   ..
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            999999999999987788999999999999999999999999999999999999999999999999998765433   33


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+...+    .++||||||+++|+|++|..||...........+.  .....+|..+++.+++++.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~  230 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCccccChhhhcCCCCC----ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHH
Confidence            44688899999998766443    45899999999999999999998877655444444  3345678888999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHHHHH
Q 007429          573 KCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       573 kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +||+.||.+||     ++.+++.+-+
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcc
Confidence            99999999999     8888887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=320.54  Aligned_cols=250  Identities=19%  Similarity=0.262  Sum_probs=214.1

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+.|++.+.||+|.|+.||+      |+.+++|.+.........-.++.+|+.+-..|+|||||++.+.+.++.. .|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~-~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce-eEEE
Confidence            47889999999999999996      4555555554332222234568899999999999999999999887776 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC---CcEEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~---g~vKL~DFGla~~~~~~~~  489 (604)
                      +|+|.|++|..-+..+..+++..+..++.||+++|.|+|.+||||||+||+|+|+-+.   .-+||+|||++.... .+.
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~  167 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE  167 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence            9999999998766555678899999999999999999999999999999999999544   359999999998887 555


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQIL  567 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l  567 (604)
                      ......|||.|||||+++..+++..    +|||+-||+||-|+.|.+||.+.+.......|+...+..+-  -+.++++.
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kp----vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKP----VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCc----chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            5666789999999999999988876    89999999999999999999998888888888888766443  35688999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|+++||..||.+|+|+.|.++|-|-
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi  270 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWI  270 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchh
Confidence            999999999999999999999988663

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4e-37  Score=319.16  Aligned_cols=249  Identities=19%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      ..+++|.+... .......++.+|+.++..++||||+++++++.+++. +++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE-ISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE-EEEEe
Confidence            46899999999999999985      46788887643 223334567889999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++......  ...
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  156 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  156 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence            999999999999877889999999999999999999997 59999999999999999999999999997654322  123


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH----------------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI----------------------  550 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i----------------------  550 (604)
                      ...+++.|+|||.+.+..++    .++|||||||++|+|++|..||...+........                      
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~----~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYT----VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cCCCCcCccChhHhcCCCCC----ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence            34678899999998765443    4599999999999999999999754432211110                      


Q ss_pred             -------------HHcCCCCCCCC-CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          551 -------------AACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       551 -------------~~~~~r~~~p~-~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                   .....++..|. .++.++.+++.+||..+|++||++.+++.+.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                         11111222222 36788999999999999999999999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-37  Score=314.67  Aligned_cols=249  Identities=23%  Similarity=0.383  Sum_probs=199.6

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC-----CC
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE-----NH  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~-----~~  407 (604)
                      +.|++.+.||.|+||.||+|+      .+++|.+....   .....+..|+.++.++ +|+||+++++++...     ..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            577889999999999999864      68888875432   2334577888888887 799999999998632     23


Q ss_pred             cEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ..|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            489999999999999998643  358888999999999999999999999999999999999999999999999976554


Q ss_pred             cCCCcccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ..........+++.|+|||.+.... ....++.++|||||||++|||++|..||....+......+.........+..++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence            3222333456888999999986321 122345579999999999999999999987766555544443333333445688


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+.++|.+||..||.+||++.||+++
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.9e-37  Score=313.07  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=202.5

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~----~  407 (604)
                      .++|++.+.||+|+||.||++      +.+++|.+....   .....+.+|+.++.++ +||||+++++++...+    .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            478999999999999999984      578899886422   2345567888888888 8999999999987543    2


Q ss_pred             cEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..++||||+++|+|.+++..    ...+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            47999999999999998752    35789999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPK  561 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~  561 (604)
                      ............++..|+|||.+.... ....++.++|||||||++|||++|+.||....+......+..... ....+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            544333333456788999999986542 222345679999999999999999999988776665554443322 122355


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+..+.++|.+||+.+|++||++.+|+.+
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            677889999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.5e-37  Score=314.19  Aligned_cols=247  Identities=21%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.+++|.+... ........+.+|+.++.+++||||+++++.+...+. .++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-ISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE-EEEEE
Confidence            46788999999999999986      57899988643 223344568889999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++......  ....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence            99999999754    35788899999999999999999999999999999999999999999999998655432  2234


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH------HHHHHHHHcCCCCCC-CCCccHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV------QAAVGIAACGLRPEI-PKDCPQI  566 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~------~~~~~i~~~~~r~~~-p~~~s~~  566 (604)
                      ..++..|+|||.+.+..++    .++|||||||++|+|++|..||......      ............+.. ....+++
T Consensus       153 ~~~~~~y~aPE~~~~~~~~----~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         153 YVGTNAYMAPERISGEQYG----IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             CCCChhhcCceeecCCCCC----CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            4688899999999876544    4599999999999999999999653211      111112222222333 2346789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +.++|.+||+.+|.+||++++++++-+.....
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            99999999999999999999999987765443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-37  Score=308.72  Aligned_cols=244  Identities=22%  Similarity=0.406  Sum_probs=203.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||.|+||.||+|      +.+++|.+.....    ...+.+|+..++.++|+||+++++.+.+... .|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTD-LWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCc-EEEE
Confidence            478999999999999999986      4688888864321    4568899999999999999999999988765 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence            999999999999864 4578999999999999999999999999999999999999999999999999987665433333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-CCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-~r~~~p~~~s~~l~~L  570 (604)
                      ....++..|+|||++.+..+    +.++||||||+++|+|++|..||....+......+.... .....+..++..+.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~----~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGY----NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccccCCccccCHHHHhcCCC----CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence            44557889999999877644    445999999999999999999998766654443322211 1122345678899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.+||+.||++||++.+++.+
T Consensus       233 i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcC
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-37  Score=327.60  Aligned_cols=248  Identities=19%  Similarity=0.233  Sum_probs=197.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++.+.||+|+||.||++      +.+|+|++............+.+|+.++..++||||+++++++....     .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            378999999999999999985      56999998754444444556778999999999999999999886432     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  179 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence            37999999976 7877764  34788999999999999999999999999999999999999999999999998754332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------  556 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-----------  556 (604)
                      . ......+++.|+|||++.+..++    .++|||||||++|||++|..||...+.......++..-..           
T Consensus       180 ~-~~~~~~~t~~y~aPE~~~~~~~~----~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         180 F-MMTPYVVTRYYRAPEVILGMGYK----ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             C-cccCCcccCCcCCHHHHhCCCCC----chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            1 22334688999999999876544    4599999999999999999999887665544433321100           


Q ss_pred             ---------CC--------------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          557 ---------PE--------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       557 ---------~~--------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                               +.                    .....+..+.++|.+||..||.+|||+.++++|-+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                     00                    011124578999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.9e-37  Score=306.50  Aligned_cols=247  Identities=21%  Similarity=0.429  Sum_probs=208.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||++      +.+++|++...... .....+.+|+..+..++|+||+++++++...+. .++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE-ISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe-EEEEE
Confidence            46889999999999999985      56899988754332 445668899999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999777889999999999999999999999 9999999999999999999999999999876654433333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHcCCCCCCCCC-ccHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKD-CPQILKS  569 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s--~~~~~~~i~~~~~r~~~p~~-~s~~l~~  569 (604)
                      ...++..|+|||.+.+..+    +.++|+||||+++|+|++|..||....  ..............+..+.. ++..+.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~----~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         159 TFVGTVTYMSPERIQGESY----SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             ceeecccccCHhhhCCCCC----CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            4467888999999877643    345999999999999999999998764  33333333334455566666 8999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ++.+||..+|++||++.+++++=
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCH
Confidence            99999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.9e-37  Score=305.63  Aligned_cols=246  Identities=26%  Similarity=0.521  Sum_probs=202.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +..+|++.+.||.|+||.||++     ..+++|.+.....   ....+.+|+.++..++||||+++++++..... .++|
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v   77 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-ICLV   77 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc-eEEE
Confidence            4568899999999999999985     4678888763322   23457889999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-  490 (604)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998653 46899999999999999999999999999999999999999999999999998654332111 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      .....++..|+|||.+.+..++    .++||||||+++|||++ |..||...........+ ..+.+...|...+..+.+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~----~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYS----SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYE  232 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcC----hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-hCCCCCCCCCCCCHHHHH
Confidence            1122345789999998765443    45999999999999998 99999876665544433 344455556678899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ++.+||+.+|++||++.++++.|
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhh
Confidence            99999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=309.38  Aligned_cols=250  Identities=26%  Similarity=0.430  Sum_probs=202.9

Q ss_pred             CCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-----  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~-----  406 (604)
                      .++|++.+.||.|+||.||+|.      .+++|.+....   .....+.+|+.+++++ +|+||+++++++....     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            3789999999999999999964      58888876432   2345678999999998 7999999999997543     


Q ss_pred             CcEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ...++||||+++++|.+++..    +..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            237999999999999999854    3478999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCC
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIP  560 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p  560 (604)
                      .............+++.|+|||.+..... ...++.++|||||||++|+|++|..||...........+....... ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP  241 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence            65443333344568889999999865322 2334567999999999999999999998766665555544432211 223


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+++.+.++|.+||..||.+|||+.+++.+
T Consensus       242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         242 ENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            3478899999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.9e-37  Score=311.01  Aligned_cols=254  Identities=20%  Similarity=0.373  Sum_probs=199.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~-L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.||+|.++.... ...+.++..|+.. ++.++||||+++++++..++. .|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD-VWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-EEEE
Confidence            47899999999999999994      5799999875322 2233445556664 555799999999999987775 9999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      |||++ |+|.+++..    ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 588888743    23689999999999999999999997 9999999999999999999999999998765332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHcCCCCCCC-CCccH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIP-KDCPQ  565 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-~~~~~~~i~~~~~r~~~p-~~~s~  565 (604)
                      . ......++..|+|||.+.+......++.++|+|||||++|+|++|..||.... ..+...... .+..+.+| ..++.
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (283)
T cd06617         158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSP  235 (283)
T ss_pred             c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCH
Confidence            1 12234578889999998764332344567999999999999999999997533 333333333 33344444 35789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++.++|.+||..+|.+||++.+++.+-+.....
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            999999999999999999999999977665543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.3e-37  Score=309.63  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=189.8

Q ss_pred             eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          347 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       347 ~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +||+|+||.||+|+        .+++|.+.... .......+.+|+..+..++||||+++++.|.+... .|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP-YLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc-cEEEEecCCC
Confidence            68999999999975        24455554322 22344568888888999999999999999987765 8999999999


Q ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC--Cccc
Q 007429          419 GSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EATE  492 (604)
Q Consensus       419 GSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~  492 (604)
                      |+|.+++.+.    ..++...+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++.......  ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            9999998643    246677888999999999999999999999999999999999999999999975422111  1122


Q ss_pred             ccCCCCcccccccccCCC---CCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcC----CCCCCCCCcc
Q 007429          493 YETDGYRWLAPEIIAGDP---ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG----LRPEIPKDCP  564 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~---~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~----~r~~~p~~~s  564 (604)
                      ...++..|+|||++....   .....+.++|||||||++|||++ |..||...++.+....+....    .++.++..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            345778899999985422   12234567999999999999997 678898777665555444332    2344555678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +.+.+++..|| .+|++||++.+|++.|.
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            89999999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-37  Score=316.55  Aligned_cols=250  Identities=16%  Similarity=0.237  Sum_probs=199.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||+|      +.|++|.++..... .....+.+|+..+..++||||+++++++..++. .++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~-~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCe-EEEEE
Confidence            78999999999999999986      46899988644322 223456789999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++ +|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++...........
T Consensus        84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            99974 998888643 4689999999999999999999999999999999999999999999999999865443322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-----------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-----------------  555 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-----------------  555 (604)
                      ...+++.|+|||.+.+..   .++.++|||||||++|||++|.+||...+..+....+.....                 
T Consensus       163 ~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         163 NEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             ccceeecccCcHHHhCCC---CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            345688999999987542   234569999999999999999999988766544332221100                 


Q ss_pred             CCC-----------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 RPE-----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 r~~-----------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ...           ....+++.+++||.+||..||.+|||+.|++.+-|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            000           1134678899999999999999999999999886654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-37  Score=315.38  Aligned_cols=253  Identities=22%  Similarity=0.382  Sum_probs=205.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.+++|.++... .......+.+|+..+..++|+||+++++.+...+. .++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA-VYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe-EEEEE
Confidence            46889999999999999985      578999886432 22233567889999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          414 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~---~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      ||+++++|..++...   ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999988653   378999999999999999999997 59999999999999999999999999998654322  


Q ss_pred             cccccCCCCcccccccccCCCC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH--HHHcCCCCCCCCCccH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--IAACGLRPEIPKDCPQ  565 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~--s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~--i~~~~~r~~~p~~~s~  565 (604)
                      ......+++.|+|||.+.+...  ...++.++|+|||||++|+|++|..||...........  ....+..+.++..+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            2233457888999999865432  12235579999999999999999999976544332221  2233445667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ++.++|.+||..+|.+||++.+++.+-+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~  267 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK  267 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence            9999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-37  Score=314.27  Aligned_cols=246  Identities=17%  Similarity=0.266  Sum_probs=199.4

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      |+..+.||+|+||.||++      +.+|+|.+........ ....+.+|+.++..++|+||+.+++.+.+++. .++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA-LCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-EEEEEE
Confidence            677889999999999985      5799999865332221 23346789999999999999999999987765 999999


Q ss_pred             cccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence            9999999988854  3369999999999999999999999999999999999999999999999999986543221 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH--cCCCCCCCCCccHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~--~~~r~~~p~~~s~~l~~L  570 (604)
                      ...|+..|+|||.+.+..++    .++|+|||||++|||++|..||...........+..  ......++..++..+.+|
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~----~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYT----LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CCCCCcCccChHHhcCCCCC----cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            34688999999999876544    358999999999999999999987655433222221  222345667788999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQ-----FSEIISLLL  593 (604)
Q Consensus       571 I~kCL~~dP~kRPT-----~~ELL~~L~  593 (604)
                      +..||+.||.+||+     +.+++.+-+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPF  263 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChh
Confidence            99999999999999     888888743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-37  Score=313.97  Aligned_cols=233  Identities=22%  Similarity=0.406  Sum_probs=185.4

Q ss_pred             eeeccCceEEEEeE------------------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCcee
Q 007429          347 QIGPNSFKGVYKGK------------------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL  396 (604)
Q Consensus       347 ~LG~G~FG~VykGk------------------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIV  396 (604)
                      .||+|+||.||+|.                              .|++|.+....  ......+.+|+..+..++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            58999999999874                              36777775321  22334567788888899999999


Q ss_pred             EEEEEEEcCCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----
Q 007429          397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----  471 (604)
Q Consensus       397 kl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----  471 (604)
                      +++++|.+... .++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+    
T Consensus        80 ~~~~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          80 FVHGVCVRGSE-NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eEEEEEEeCCc-eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99999988775 8999999999999999865 45789999999999999999999999999999999999998654    


Q ss_pred             ---cEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHH
Q 007429          472 ---NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAA  547 (604)
Q Consensus       472 ---~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELl-TG~~Pf~~~s~~~~~  547 (604)
                         .+|++|||++.....    .....++..|+|||.+.+..   .++.++|||||||++|||+ +|..||....+.+..
T Consensus       159 ~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~---~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGN---SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             ccceeeecCCcccccccc----ccccccCCcccCchhhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence               389999998654322    12235678899999886531   2345699999999999985 699999876654432


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      . ....  ....|...++.+.++|.+||+.+|++||++.+|++.|
T Consensus       232 ~-~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 R-FYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             H-HHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            2 2222  2234555667899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=329.62  Aligned_cols=241  Identities=21%  Similarity=0.264  Sum_probs=192.6

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      ||+|+||.||++      +.||+|.+....... ........|..++..+   +||||+++++++.+... +|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~-~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD-LYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-EEEEEcCCC
Confidence            799999999985      579999986422111 1122334455555543   79999999999988775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            99999999877889999999999999999999999999999999999999999999999999987543333334455689


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC-CccHHHHHHHHHhhh
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWN  576 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~-~~s~~l~~LI~kCL~  576 (604)
                      +.|+|||++.+..   .++.++|||||||++|||++|..||...+..+....+.....  .+|. .+++++.+++.+||.
T Consensus       160 ~~y~aPE~~~~~~---~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L~  234 (330)
T cd05586         160 TEYLAPEVLLDEK---GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLLN  234 (330)
T ss_pred             ccccCHHHHcCCC---CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcC
Confidence            9999999987543   133459999999999999999999988776665555444332  2333 468999999999999


Q ss_pred             cCCCCCC----CHHHHHHHHHH
Q 007429          577 NSPSKRP----QFSEIISLLLR  594 (604)
Q Consensus       577 ~dP~kRP----T~~ELL~~L~~  594 (604)
                      .||.+||    ++.++++|-+.
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~  256 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFF  256 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccc
Confidence            9999998    68888886543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.4e-37  Score=312.08  Aligned_cols=251  Identities=21%  Similarity=0.397  Sum_probs=208.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ..|+.++.||.|+||.||+|      ..+++|.+..... ......+.+|+..+..++|+||+++++++.+... .++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK-LWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEEE
Confidence            35678889999999999986      4689998874322 2334567889999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999999854 56899999999999999999999999999999999999999999999999998765443323333


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..++..|+|||.+.+...    +.++|+|||||++|||++|..||....+......+ .....+.++..++..+.+++.+
T Consensus       161 ~~~~~~y~apE~~~~~~~----~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAY----DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             ccCcccccCHhHhccCCC----ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHH
Confidence            457888999999876543    44699999999999999999999887765544332 3344566677788999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          574 CWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ||+.+|.+||++.+++.+-+.....
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         236 CLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HcccCcccCcCHHHHHhChHhhhcc
Confidence            9999999999999999987765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=338.63  Aligned_cols=255  Identities=25%  Similarity=0.430  Sum_probs=211.9

Q ss_pred             eecCCCeEEeeeeeccCceEEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++..+.+.+.++||+|.||.|.+     +..||+|+++... .......|.+|+++|.+|+|||||.++|+|..++. +|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-ic  611 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-LC  611 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-hH
Confidence            46678899999999999999998     3789999998543 33446789999999999999999999999998875 99


Q ss_pred             EEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||+++|+|.+++.++.  .+......+++.||+.||+||.+.++|||||.++|||++.++++||+|||+++.+-...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999999998764  33556677899999999999999999999999999999999999999999987543221


Q ss_pred             C--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHH---HcCCC---CC
Q 007429          489 E--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIA---ACGLR---PE  558 (604)
Q Consensus       489 ~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT--G~~Pf~~~s~~~~~~~i~---~~~~r---~~  558 (604)
                      .  .......+++|||||.+.-++    ++.+||||+||+++||+++  ...||+..+..+.....-   ..+.+   +.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgk----FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGK----FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhcc----ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            1  112234578999999998664    4556999999999999876  789999888776654322   11111   24


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .|.-||..++++|..||..|-++||+|+++..+|.+..
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            67889999999999999999999999999999998753

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9e-37  Score=304.31  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||++      +.+++|.+............+.+|+..++.++||||+++++.+...+. .++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA-LMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE-EEEEEe
Confidence            5889999999999999984      468999987554444455678899999999999999999999887665 899999


Q ss_pred             cccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCCcc
Q 007429          415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       415 y~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~~~  491 (604)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .+||+|||++........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~  158 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A  158 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence            99999999999653  3589999999999999999999999999999999999998654 589999999876543322 2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+...    +.++||||||+++|+|++|..||...+.......+.. .....++..+++.+.+++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li  233 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPY----NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLI  233 (256)
T ss_pred             cccccCCcccCchhccCCCC----CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHH
Confidence            23457889999999976543    3459999999999999999999988766555444443 334556778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 007429          572 IKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .+||..+|.+|||+.+++.+
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHccCChhhCCCHHHHhhC
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=331.03  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=217.6

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~  410 (604)
                      .+.|++.+.||+|.||.||+      |+.+|+|.+.+...... ....+.+|+.+|..+. |||||.+++++.+... ++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~-~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS-VY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe-EE
Confidence            36789999999999999998      56899999976543322 3456899999999998 9999999999998885 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC----CcEEEEecCCcccccc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKS  486 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~----g~vKL~DFGla~~~~~  486 (604)
                      +|||++.||.|.+.+.+. .+++..+..++.||+.++.|||+.||+||||||+|+|+...    +.+|++|||++.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999998655 49999999999999999999999999999999999999644    4799999999988776


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCcc
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCP  564 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s  564 (604)
                       +......+||+.|+|||++...+++..    +||||+||++|.|++|.+||.+.+.......+....+.-.  .-..++
T Consensus       192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~----~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  192 -GERLHTIVGTPEYVAPEVLGGRPYGDE----VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             -CceEeeecCCccccCchhhcCCCCCcc----cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence             556677899999999999998776655    8999999999999999999999998888887777665332  224568


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..++++|..++..||.+|+|+.++++|-|-.
T Consensus       267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            9999999999999999999999999997743

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-37  Score=314.52  Aligned_cols=248  Identities=21%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+............+.+|+..+..++||||+++++++.+++. .++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-LYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe-EEEEE
Confidence            46899999999999999995      468999876543333344567789999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.++......+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999999988766667999999999999999999999999999999999999999999999999998765443333333


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------------  555 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------------  555 (604)
                      ..++..|+|||++.+..   .++.++||||||+++|||++|.+||......+....+.....                  
T Consensus       160 ~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         160 YVATRWYRAPELLVGDT---KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             ccceeeccCcHHhcccc---ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            45788999999986532   234569999999999999999999987665443332221100                  


Q ss_pred             --CC---------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 --RP---------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 --r~---------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                        .+         ..+..++..+.+++.+||..+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              00         0123567889999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.1e-37  Score=306.02  Aligned_cols=246  Identities=26%  Similarity=0.482  Sum_probs=203.1

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||+|.      .+++|.+....... ....+.+|+..++.++|+||+++++.+...+. .++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE-LWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE-EEEEE
Confidence            478999999999999999864      68899886433322 45568899999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~---~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |++++++|.+++...   ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999653   35899999999999999999999999999999999999999999999999998665543222


Q ss_pred             ----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC-----C
Q 007429          491 ----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-----K  561 (604)
Q Consensus       491 ----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p-----~  561 (604)
                          .....+++.|+|||++....   ..+.++|+|||||++|+|++|..||...++.+......... .+.++     .
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~---~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVH---GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYK  234 (267)
T ss_pred             cccccccccCChhhcChHHHcccc---CcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccc
Confidence                12335788999999987651   23456999999999999999999998877766555544432 22222     2


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .+++.+.+++.+||..||++||++.+|+.+
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            567899999999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-37  Score=315.20  Aligned_cols=250  Identities=22%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|++++.||+|+||.||++      +.+++|.+.... .......+.+|+.++..++||||+++++++...+. .++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE-EEE
Confidence            3468899999999999999984      568898876432 23345668899999999999999999999998865 899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+++++|.+++.+.+.+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++......  .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence            99999999999998777789999999999999999999997 69999999999999999999999999997654322  1


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHHHHcCCCCCC
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-----------QAAVGIAACGLRPEI  559 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~-----------~~~~~i~~~~~r~~~  559 (604)
                      .....++..|+|||++.+...+    .++|+|||||++|+|++|..||......           .....+.. ...+.+
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~----~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  233 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYT----VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRL  233 (284)
T ss_pred             cCccccCcccCCHHHHccCCCC----ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCC
Confidence            2234688999999998766443    4599999999999999999999864432           11222222 223333


Q ss_pred             CCC-ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 PKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p~~-~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +.. ++..+.+++.+||..||.+||++.|++++.+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            333 7889999999999999999999999999865543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.5e-37  Score=318.00  Aligned_cols=247  Identities=21%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+|.+++.||.|+||.||++      +.|++|.+......  ....+.+|+.++..++|+||+++++++...+. .++||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE-EEEee
Confidence            67899999999999999985      57999998743322  23457789999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            99999999999844 46889999999999999999999999999999999999999999999999998765433322334


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      ..+++.|+|||.+.+..++    .++|+|||||++|+|++|..||...++......+...+. ....|..++..+.+++.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~----~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYG----PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             ccCCccccCHHHHcCCCCC----cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            4678899999999876544    459999999999999999999987665444333333222 22346678899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||..+|.+||++.+++.+=+.
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~  272 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFL  272 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchh
Confidence            9999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-37  Score=309.56  Aligned_cols=234  Identities=23%  Similarity=0.399  Sum_probs=184.7

Q ss_pred             eeeeccCceEEEEeE------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          346 DQIGPNSFKGVYKGK------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       346 ~~LG~G~FG~VykGk------------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +.||+|+||.||+|.                  .|++|.+....  ......+.+|+..+..++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999985                  47777765322  2233456788888999999999999999987765


Q ss_pred             cEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc-------EEEEecC
Q 007429          408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-------VCLGDMG  479 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~-------vKL~DFG  479 (604)
                       .++||||+++|+|..++.+ ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.       ++++|||
T Consensus        79 -~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          79 -NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             -CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence             7899999999999998864 357899999999999999999999999999999999999987664       8999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELl-TG~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      ++.....    .....++..|+|||.+....   .++.++|||||||++|||+ +|..||......+.. ......  ..
T Consensus       158 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~--~~  227 (262)
T cd05077         158 IPITVLS----RQECVERIPWIAPECVEDSK---NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ--CM  227 (262)
T ss_pred             CCccccC----cccccccccccChhhhcCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC--cc
Confidence            9765432    12335678899999886332   2344699999999999997 588998765543322 122221  12


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .....++++.+||.+||+.||.+||++.+|+++|
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            2333467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.2e-37  Score=321.61  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             Eeeeeecc--CceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          344 FIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       344 i~~~LG~G--~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      +++.||+|  +|++||++      +.||+|.+............+.+|+.+++.++||||++++++|..++. .++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-LWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE-EEEEEec
Confidence            56789999  68899984      579999987544334444567789999999999999999999988775 9999999


Q ss_pred             ccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC----
Q 007429          416 MEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----  489 (604)
Q Consensus       416 ~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~----  489 (604)
                      +++|+|.+++..+  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++++|||........+.    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999998643  4589999999999999999999999999999999999999999999999987543322111    


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------
Q 007429          490 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  556 (604)
Q Consensus       490 ---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------  556 (604)
                         ...+..++..|+|||++.+...  .++.++|||||||++|||++|..||.................+          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQ--GYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccceecccChHHhhcccC--CCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence               1123346678999999975321  2345699999999999999999999865544333222211100          


Q ss_pred             ----------------------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 ----------------------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 ----------------------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                                        ......+++.+.+++.+||+.||++|||+.+++++-+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                                              001123467899999999999999999999999876653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.5e-38  Score=324.00  Aligned_cols=241  Identities=24%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l~  410 (604)
                      .|+-.+.+|+|+||.||+|      +.||||+.......      -.+|+.+|+.+.|||||++.-+|....    -.+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4677899999999999997      58999999754432      236788888999999999988876442    1367


Q ss_pred             EEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCccccc
Q 007429          411 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACK  485 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~  485 (604)
                      +||||++. +|.++++.    +.+++.-.+.-+..||++||.|||++||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            89999988 99999863    5688999999999999999999999999999999999999987 889999999999887


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------  557 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------  557 (604)
                      .......+.+ |-.|.|||.+.|..   .|+++.||||.||++.||+-|++-|++.+..+.+..|+..-..|        
T Consensus       178 ~~epniSYic-SRyYRaPELifga~---~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  178 KGEPNISYIC-SRYYRAPELIFGAT---EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             cCCCceeEEE-eccccCHHHHcCcc---ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            7666555554 44599999998864   46678999999999999999999999998887776655431111        


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                         .+....+++..+++.+++..+|.+|.++.|++.|=
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence                               13346789999999999999999999999998763

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-36  Score=306.92  Aligned_cols=250  Identities=23%  Similarity=0.420  Sum_probs=200.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++.+++.....||+|+||.||+|.      .+++|.+....  ......+.+|+.++..++|+||+++++++...+. .+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF-FK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE-EE
Confidence            444555666789999999999974      58888876432  2234567899999999999999999999988765 89


Q ss_pred             EEEecccCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCcccccc
Q 007429          411 VVTKLMEGGSVNDLILKS-RKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKS  486 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~-~~l--~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~~  486 (604)
                      +|+||+++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. .+.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999998653 345  78889999999999999999999999999999999976 67899999999865543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCCCCCCCCccH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .........+++.|+|||.+.+...  .++.++||||||+++|+|++|..||..... .............+.+|..+++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPR--GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             CCCccccCCCCccccChhhhccccc--cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence            3333334457889999999865432  234469999999999999999999976433 2222223333445667888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ++.+++.+||+.+|.+|||+.+++.+
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            99999999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.6e-37  Score=314.18  Aligned_cols=248  Identities=17%  Similarity=0.256  Sum_probs=194.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||++      +.+++|.++...........+.+|+..+..++||||+++++++.+... .++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK-LTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc-eEEEEe
Confidence            4789999999999999985      578999887543333333456789999999999999999999987775 999999


Q ss_pred             cccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |+++ +|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 88887754 457999999999999999999999999999999999999999999999999998765433222333


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHHcCC-----------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGL-----------------  555 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~-~s~~~~~~~i~~~~~-----------------  555 (604)
                      ..+++.|+|||.+.+..   .++.++|||||||++|||++|..||.. .+..+....+.....                 
T Consensus       159 ~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         159 EVVTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CccccCCcChHHHhCCc---ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            45678899999987643   234469999999999999999888643 333332222211000                 


Q ss_pred             -CC---------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          556 -RP---------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       556 -r~---------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                       .+         .....+++++.++|.+||+.||.+|||+.+++.+-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence             00         112346788999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=310.40  Aligned_cols=248  Identities=19%  Similarity=0.296  Sum_probs=200.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||+|      +.|++|.++...........+.+|+..++.++|+||+++++++.+.+. .++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-LYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE-EEEEE
Confidence            36899999999999999995      478999887544444445668899999999999999999999988665 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-ccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~  492 (604)
                      ||++++.+..++.+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            9999977777666656799999999999999999999999999999999999999999999999999876654332 222


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC------------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG------------------  554 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~------------------  554 (604)
                      ...++..|+|||++.+..   .++.++||||||+++|+|++|..||...+.......+....                  
T Consensus       160 ~~~~~~~~~~PE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         160 DYVATRWYRAPELLVGDT---NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             CcccccCCcCCchhcCCC---CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            345678899999997652   23456999999999999999999998766554433322110                  


Q ss_pred             ---CC---------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          555 ---LR---------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       555 ---~r---------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                         ..         ..++..++.++.++|.+||..+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence               00         01233458889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-37  Score=313.50  Aligned_cols=248  Identities=20%  Similarity=0.299  Sum_probs=199.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~LV  412 (604)
                      ++|++.+.||.|+||.||+|      +.+++|.++...........+.+|+..++.++||||+++++++...+ ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57899999999999999995      46899998755444333445678999999999999999999988762 349999


Q ss_pred             EecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++ +|.+++.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            999975 9999886543 58999999999999999999999999999999999999999999999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-----------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  554 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-----------------  554 (604)
                      ....+++.|+|||.+.+...   .+.++|+||||+++|||++|..||...+.......+...-                 
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             ccccccccccCchhhcCCcc---ccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            34457888999999875432   3456999999999999999999998776655443322110                 


Q ss_pred             ------------CCCCCCCC-ccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          555 ------------LRPEIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       555 ------------~r~~~p~~-~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                  ....++.. +++.+.++|.+||+.||++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                        01112333 57889999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=325.15  Aligned_cols=265  Identities=19%  Similarity=0.315  Sum_probs=215.5

Q ss_pred             chhhhcCCCccccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCC
Q 007429          321 EWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHK  393 (604)
Q Consensus       321 ~~~~~~~~~~~i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~Hp  393 (604)
                      .|..++.... ...-.+..++|++++.||.|.-|+||++      ...|+|.+.+.... .....+.+.|-.+|..++||
T Consensus        59 ~w~a~~~~~~-~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHP  137 (459)
T KOG0610|consen   59 RWEAISSIRN-SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHP  137 (459)
T ss_pred             hhhhhccccc-cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCC
Confidence            4444443221 2344567789999999999999999985      47899998654322 11233456677788999999


Q ss_pred             ceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       394 nIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      .++.+|+.|..++. .|+|||||+||+|..++++  ++.|++..++.++.+|+.||+|||-.|||+|||||+||||-++|
T Consensus       138 FlPTLYa~fet~~~-~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG  216 (459)
T KOG0610|consen  138 FLPTLYASFETDKY-SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG  216 (459)
T ss_pred             ccchhhheeeccce-eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC
Confidence            99999999998886 9999999999999999864  35799999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCC---------------------------------C-----------------------cccccC
Q 007429          472 NVCLGDMGIVTACKSVG---------------------------------E-----------------------ATEYET  495 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~---------------------------------~-----------------------~~~~~~  495 (604)
                      +|.|+||.|+.......                                 .                       .....+
T Consensus       217 HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFV  296 (459)
T KOG0610|consen  217 HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFV  296 (459)
T ss_pred             cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccc
Confidence            99999999964331100                                 0                       001124


Q ss_pred             CCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       496 gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      ||-.|+|||+|.|.+....    +|.|+|||++|||+.|..||.+.+..+.+..++.....-+-....+..+++||++.|
T Consensus       297 GThEYlAPEvI~G~GHgsA----VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  297 GTHEYLAPEVIRGEGHGSA----VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cccccccceeeecCCCCch----hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            7889999999999988766    899999999999999999999999999999988765543333356789999999999


Q ss_pred             hcCCCCCCC----HHHHHHH
Q 007429          576 NNSPSKRPQ----FSEIISL  591 (604)
Q Consensus       576 ~~dP~kRPT----~~ELL~~  591 (604)
                      .+||.+|..    +.||.+|
T Consensus       373 vKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ccChhhhhccccchHHhhcC
Confidence            999999998    7777765

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-37  Score=309.43  Aligned_cols=247  Identities=21%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||++      +.+++|.+..... .....++.+|+..++.++||||+++++++...+. .++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD-ISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE-EEEEE
Confidence            46788899999999999985      4689998875432 3445668899999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999999999765 688999999999999999999999 9999999999999999999999999999765533211  


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHcCCCCCCCCC-ccHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIPKD-CPQI  566 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s----~~~~~~~i~~~~~r~~~p~~-~s~~  566 (604)
                      ....++..|+|||.+.+..+    +.++||||||+++|+|++|..||....    ..............+..+.. ++.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~----~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDY----SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD  232 (265)
T ss_pred             hcccCChhccCHHHHcCCCC----CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            12567889999999977644    345999999999999999999997642    11122222333444555555 8899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +.++|.+||..||++|||+.+++.+-+.
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence            9999999999999999999999988665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-37  Score=313.40  Aligned_cols=247  Identities=22%  Similarity=0.405  Sum_probs=204.1

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|+..+.||+|+||.||+|      +.|++|.+..... ......+.+|+..+..++||||+++++++...+. .|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK-LWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc-eEEEEE
Confidence            4566788999999999996      4688988764322 2334568899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++. ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999999884 4568999999999999999999999999999999999999999999999999987654433223334


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      .++..|+|||.+.+..+    +.++|||||||++|||++|..||....+...... ......+..+..++..+.+++.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         162 VGTPFWMAPEVIKQSAY----DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             cCcccccCHHHhCcCCC----chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhcCCCCCCCcccCHHHHHHHHHH
Confidence            57888999999986644    3459999999999999999999987665544433 333445556677889999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHh
Q 007429          575 WNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~~~  595 (604)
                      |+.+|++||++.+++.+-+-.
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         237 LNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             ccCCcccCcCHHHHHHhHHHH
Confidence            999999999999999976643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-36  Score=302.17  Aligned_cols=243  Identities=29%  Similarity=0.540  Sum_probs=200.9

Q ss_pred             EEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++.+.||.|+||.||++          ..+++|.++.... ......+..|+..+..++|+||+++++++.+.+. .+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP-LMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe-eEEE
Confidence            56788999999999985          5688998864322 2245678899999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          413 TKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~--l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+++++|.+++.....  +++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999999865443  999999999999999999999999999999999999999999999999998765433111


Q ss_pred             cc-ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          491 TE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       491 ~~-~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      .. ...+++.|+|||.+.+..++    .++||||+|+++|+|++ |..||...+....... ...+..+..+..++.++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~----~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFT----SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYRLPKPENCPPEIY  234 (258)
T ss_pred             ccccCCCcccccChHHhccCCCC----cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHH
Confidence            11 22367889999998655443    45999999999999998 8899987666555444 344456667777899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +++.+||..||.+|||+.++++.|
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHhhC
Confidence            999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=301.76  Aligned_cols=241  Identities=27%  Similarity=0.526  Sum_probs=198.4

Q ss_pred             eeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       346 ~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      +.||.|+||.||++     +.|++|.+...... .....+.+|+.+++.++|+||+++++++.+... .++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-IYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC-eEEEEEcCCCCc
Confidence            46899999999985     56899988754332 345568899999999999999999999988775 899999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc--cccCCC
Q 007429          421 VNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETDG  497 (604)
Q Consensus       421 L~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~--~~~~gt  497 (604)
                      |.+++.+ ...++...+..++.+++.||.|||+++++||||||+||+++.++.+||+|||++..........  .....+
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9999854 3468899999999999999999999999999999999999999999999999986543211111  112235


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhh
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  576 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~  576 (604)
                      ..|+|||.+.+..++    .++|+|||||++|||++ |..||........... .....+...|..++..+.+++.+||.
T Consensus       159 ~~y~~PE~~~~~~~~----~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         159 IKWTAPEALNYGRYT----SESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-IESGYRMPAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             eccCChHhhccCCCC----cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-HhcCCCCCCCccCCHHHHHHHHHHhc
Confidence            679999998766543    45999999999999999 8999988766554433 33445566778889999999999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 007429          577 NSPSKRPQFSEIISLLL  593 (604)
Q Consensus       577 ~dP~kRPT~~ELL~~L~  593 (604)
                      .+|.+||++.|+++.|.
T Consensus       234 ~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         234 YDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cChhhCcCHHHHHHHhh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=314.66  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=203.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+....... .....+..|+..+..++|+||+++++.+.+... .|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY-LCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE-EEEE
Confidence            47899999999999999985      578999987543332 234557889999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+.+++|.+++.+.  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999998643  47899999999999999999999999999999999999999999999999997654322110


Q ss_pred             -----------------------------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 007429          491 -----------------------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC  541 (604)
Q Consensus       491 -----------------------------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~  541 (604)
                                                   .....|+..|+|||.+.+..+    +.++||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~----~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH----GSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC----CchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                         112256788999999986654    34599999999999999999999887


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCC----HHHHHHHHH
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ----FSEIISLLL  593 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT----~~ELL~~L~  593 (604)
                      +.......+.............+..+.+++.+||..||++||+    +.+++.+=+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~  291 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF  291 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence            7766665555433332222336899999999999999999999    888888744

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-37  Score=324.62  Aligned_cols=249  Identities=18%  Similarity=0.278  Sum_probs=197.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++++.||+|+||.||++      +.||+|++............+.+|+.+++.++||||+++++++....     .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            378999999999999999986      47999998754333333455778999999999999999999886432     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ..|++++++ +++|.+++ +...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  171 (343)
T cd07878          94 EVYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE  171 (343)
T ss_pred             cEEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence            378999988 67998877 4557999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  555 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------  555 (604)
                         .....+++.|+|||++.+..   .++.++|||||||++|+|++|..||...+..+.+..+.....            
T Consensus       172 ---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         172 ---MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             ---cCCccccccccCchHhcCCc---cCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence               23346889999999987632   234469999999999999999999987655443332221100            


Q ss_pred             ---------CCCC--------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 ---------RPEI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 ---------r~~~--------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                               .+..        ....++.+.+++.+||..||.+|||+.|++.|-+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                     0011        123466789999999999999999999999986654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-36  Score=312.81  Aligned_cols=248  Identities=17%  Similarity=0.287  Sum_probs=199.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.|++|.+...... ......+.+|+.+++.++||||+++++.+..++. +++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH-LCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE-EEEE
Confidence            46899999999999999985      57999988643321 1223457788999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.......   
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999999997777899999999999999999999999999999999999999999999999999763211000   


Q ss_pred             ------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-
Q 007429          490 ------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-  556 (604)
Q Consensus       490 ------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-  556 (604)
                                  ......++..|+|||.+.+..++    .++|+|||||++|||++|..||.+.++.+....+...... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG----KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                        01123467889999998765544    4599999999999999999999887776655555443322 


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCH---HHHHHHH
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQF---SEIISLL  592 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~---~ELL~~L  592 (604)
                      +..+..++..+.++|.+||+.||++||++   .+++++-
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            22233678999999999999999999995   5555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-37  Score=309.76  Aligned_cols=234  Identities=24%  Similarity=0.421  Sum_probs=187.2

Q ss_pred             eeeeccCceEEEEeEE-------------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          346 DQIGPNSFKGVYKGKR-------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       346 ~~LG~G~FG~VykGk~-------------VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.||+|+||.||+|..             +++|.+....  ......+..|+..+..++||||+++++++..... .++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-cEEE
Confidence            3689999999999754             5566654221  2233456788888999999999999999988765 8899


Q ss_pred             EecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc--------EEEEecCCccc
Q 007429          413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VCLGDMGIVTA  483 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~--------vKL~DFGla~~  483 (604)
                      |||+++|+|.+++..++ .+++..++.++.||+.||+|||++||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999996544 6899999999999999999999999999999999999987765        69999999754


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ...    .....+++.|+|||.+.+..   .++.++|||||||++|||++| ..||...++..... ...  .+..+|..
T Consensus       158 ~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~  227 (258)
T cd05078         158 VLP----KEILLERIPWVPPECIENPQ---NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAP  227 (258)
T ss_pred             cCC----chhccccCCccCchhccCCC---CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCC
Confidence            432    23345778899999987532   234459999999999999998 57776655543322 222  24456777


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .+.++.+++.+||+.||.+|||+.+|++.|
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-36  Score=306.40  Aligned_cols=249  Identities=20%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC--c------hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG--N------AYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~--~------~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +|.+.+.||.|+||.||+|      +.+++|.++.....  .      .....+..|+..+..++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999986      46899987532111  0      11234678899999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . .++||||+++++|.+++.+...+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~-~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 Y-LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             c-eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            5 899999999999999997777899999999999999999999999999999999999999999999999999865433


Q ss_pred             CCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC---
Q 007429          487 VGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK---  561 (604)
Q Consensus       487 ~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~---  561 (604)
                      ...  ......++..|+|||.+....  ..++.++|+||||+++|++++|..||...........+......+.++.   
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            211  122335788999999987654  1234569999999999999999999987666555544443433433333   


Q ss_pred             -CccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          562 -DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       562 -~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                       .++..+.++|.+||..+|.+||++.+++++-
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence             4588999999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=339.85  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=211.0

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchH-HHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAY-EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~-~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      |.-++.||.|+||.||.+      ..||||++....+.... -..+.+|+..|.+++|||+|.+.|+|..+.. .|+|||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-aWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-AWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-HHHHHH
Confidence            556789999999999986      47999999766554443 3458999999999999999999999887665 899999


Q ss_pred             cccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||-| |-.|++.-+ +++.+..+..|+.+.+.||.|||+++.||||||+.|||+++.|.|||+|||.|.....    ...
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----Ans  181 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANS  181 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhc
Confidence            9955 999988543 5799999999999999999999999999999999999999999999999999866543    456


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..|||.|||||+|.-.... .|+-|+||||||+++.||...++|+.+.+.+..++-|..+..+.-....++..+.+++..
T Consensus       182 FvGTPywMAPEVILAMDEG-qYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheecccc-ccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence            7899999999998743322 344469999999999999999999999999999988887654433345689999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHhh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ||++-|.+|||.+++++|-.-.+
T Consensus       261 CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHhhCcccCCcHHHHhhcchhcc
Confidence            99999999999999998865443

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-36  Score=304.87  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=199.7

Q ss_pred             eEEeeeeeccCceEEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          342 LEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      |.+.+.||+|+||.||+|         +.+++|.+...........++.+|+..+..++||||+++++++.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            467788999999999975         468999987544333445567889999999999999999998865421     


Q ss_pred             cEEEEEecccCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      ..++++||+.+|+|.+++...      ..++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            147889999999999887421      24788999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          482 TACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       482 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      +.......  ......+++.|++||.+....++    .++|||||||++|||++ |..||...........+. ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~----~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~  235 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYT----THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLK  235 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccc----hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence            76543211  11222356789999998766544    35999999999999999 899998766554433333 334445


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+..++..+.+++.+||+.+|++||++.+++..|..+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            5667889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-37  Score=319.38  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=205.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCC----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENH----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hpn-IVkl~g~~~~~~~----  407 (604)
                      ...|+.+++||+|+||.||+|      +.||+|+++.............+|+.++..++|+| ||.+++++...+.    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            356788889999999999996      57999999865443223344679999999999999 9999999998773    


Q ss_pred             -cEEEEEecccCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          408 -GLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       408 -~l~LVmEy~~gGSL~dlL~~~~----~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                       .+++|+||+.. +|..++....    .++...+..++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             59999999977 9999996543    57788999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  557 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----  557 (604)
                      ...-.........+|..|.|||++.+...   |+...||||+||++.||+++++.|.+.+..+.+..|...-..|     
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~---Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTS---YSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCc---CCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            76544444555578888999999998743   2334899999999999999999999998887777665432211     


Q ss_pred             -----------CCC-----C-------CccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 -----------EIP-----K-------DCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 -----------~~p-----~-------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                 .++     .       ...+...+++.+|++.+|.+|.|+..++.|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                       111     1       122478899999999999999999999998

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-36  Score=303.54  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||+|      ..+++|.+............+.+|+.+++.++|+||+++++.+.+... .++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR-LFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe-EEEEEe
Confidence            4788999999999999985      468999886543333344567899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc-EEEEecCCccccccCCCcc
Q 007429          415 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       415 y~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~-vKL~DFGla~~~~~~~~~~  491 (604)
                      |+++++|.+++.+..  .+++..+..++.|++.||.|||+.+++|+||||+||++++++. +||+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999986533  5789999999999999999999999999999999999998864 6999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+..+    +.++|+||||+++|||++|..||...+..+....+.. +.....+..++..+.+++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPY----NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             cccCCCccccCHHHHcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHH
Confidence            34468889999999876543    3459999999999999999999987766665544443 334455667789999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHH
Q 007429          572 IKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .+||..+|++|||+.+++++-
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCC
Confidence            999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-36  Score=309.39  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++++.||.|+||.||+|      +.+++|++............+.+|+..+.+++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc-EEEEee
Confidence            4789999999999999986      468999886543333334567889999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+. ++|.+++..  ...+++..+..++.||+.||+|||+++++|+||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 589888854  34689999999999999999999999999999999999999999999999999865543322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  557 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---------------  557 (604)
                      ...+++.|+|||.+.+...   .+.++||||||+++|||+||..||...+.......+......+               
T Consensus       159 ~~~~~~~y~aPE~~~~~~~---~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccCCeEEecCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            3456788999998875432   3446999999999999999999998766554443332211110               


Q ss_pred             ------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 ------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                  .....+++++.++|.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                        0123467889999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=343.19  Aligned_cols=256  Identities=21%  Similarity=0.409  Sum_probs=216.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEeEEE------EEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk~V------AIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..+.|+|+..||.|+||.||++...      |-|.+..  +....-..+.-||.+|..+.||+||++++.|+.++. ++|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-Lwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-LWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-eEE
Confidence            3456688999999999999997532      3344432  222333457789999999999999999999988886 999


Q ss_pred             EEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ..|||.||.++.++.. .+.+++.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+.........
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999999998854 568999999999999999999999999999999999999999999999999997655544455


Q ss_pred             ccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p~~~s~~l~  568 (604)
                      .....|||.|||||+..... -+.+|++++||||||++|.||..+.+|....+++..+..+.....+. -.|..++..+.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            66778999999999887543 23456788999999999999999999999999999998888765432 34788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +++.+||.+||..||++.+|++|-+-.+
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            9999999999999999999999876543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-36  Score=311.45  Aligned_cols=251  Identities=19%  Similarity=0.252  Sum_probs=200.8

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~---~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      +|++.+.||+|+||.||+|      +.|++|.++.....   ......+..|+..++.++|+||+++++++.+.+. .++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN-INL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE-EEE
Confidence            4788899999999999996      47999999755433   2334556789999999999999999999988665 999


Q ss_pred             EEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99999 889999997655 7999999999999999999999999999999999999999999999999998766544333


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--------------
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--------------  556 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--------------  556 (604)
                      .....+++.|+|||.+.+..   .++.++|||||||++|||++|.+||...++......+......              
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGAR---HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccceeeeCHHHHhCCC---CCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            33445678899999885432   2345699999999999999998888776654433332211000              


Q ss_pred             -------CC-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          557 -------PE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       557 -------~~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                             +.     .....+..+.++|.+||..||.+|||+.+++.+=+..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                   00     11345688999999999999999999999999855443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=306.73  Aligned_cols=250  Identities=22%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCCcEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~---HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .|++.+.||.|+||.||+|      +.+++|.+.... ......++.+|+.++..++   |||++++++++.+... .|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~-~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR-LWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE-EEE
Confidence            4678889999999999986      458999886432 2233445778888888886   9999999999987665 899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999999854 478999999999999999999999999999999999999999999999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC-ccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD-CPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~-~s~~l~~L  570 (604)
                      ....++..|+|||.+.+..   .++.++|||||||++|+|++|..||...........+. ....+.++.. ++.++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         159 STFVGTPYWMAPEVITEGK---YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             ccccCCcceeCHHHhccCC---ccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHH
Confidence            4446888999999886532   23446999999999999999999998766554433222 2233344443 78899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+||+.||++||++.+++.+-+....
T Consensus       235 i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         235 VAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            999999999999999999998776544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-36  Score=306.15  Aligned_cols=246  Identities=22%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +|+..+.||+|+||.||++      +.+++|.+.......    .....+.+|+..+.+++|+||+++++++.+.+. .+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH-FN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-EE
Confidence            3677889999999999985      469999886433211    134568899999999999999999999987775 89


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~  489 (604)
                      +|+||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999998777899999999999999999999999999999999999998776 599999999876543211


Q ss_pred             c----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCCCCCCC
Q 007429          490 A----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       490 ~----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~~~p~~  562 (604)
                      .    .....++..|+|||.+.+..++    .++||||+|+++|+|++|..||.....   ......+......+..|..
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~----~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYG----RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCC----cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            1    1233578899999998765443    459999999999999999999975432   2333333334455667778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .++.+.+++.+||..+|.+||++.+++++
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            89999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=334.78  Aligned_cols=248  Identities=15%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC------CCCceeEEEEEEEcC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVDE  405 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L------~HpnIVkl~g~~~~~  405 (604)
                      ..++|++++.||+|+||.||++      +.||||+++....   .......|+.++..+      +|.+++++++++..+
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            4578999999999999999996      4699999964321   223344555555554      455699999999876


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCC-------------
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHG-------------  471 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g-------------  471 (604)
                      ...+|+|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            65589999998 66999998777889999999999999999999998 5999999999999998766             


Q ss_pred             ---cEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 007429          472 ---NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ---~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~  548 (604)
                         .+||+|||++....   .......||+.|+|||++.+..++    .++|||||||++|||++|++||...+..+.+.
T Consensus       283 ~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~----~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWM----YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             CCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCC----cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence               49999999865322   123345789999999999877554    45999999999999999999998776654433


Q ss_pred             HHHHcCC-------------------------CCCC-C--------------CCccHHHHHHHHHhhhcCCCCCCCHHHH
Q 007429          549 GIAACGL-------------------------RPEI-P--------------KDCPQILKSLMIKCWNNSPSKRPQFSEI  588 (604)
Q Consensus       549 ~i~~~~~-------------------------r~~~-p--------------~~~s~~l~~LI~kCL~~dP~kRPT~~EL  588 (604)
                      .+.....                         ++.. +              ....+.+.+||.+||..||.+|||+.|+
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            2221100                         0000 0              0013557899999999999999999999


Q ss_pred             HHHHHHhh
Q 007429          589 ISLLLRTN  596 (604)
Q Consensus       589 L~~L~~~~  596 (604)
                      ++|=+...
T Consensus       436 L~Hp~~~~  443 (467)
T PTZ00284        436 TTHPYVLK  443 (467)
T ss_pred             hcCccccc
Confidence            99876553

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=298.51  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=209.3

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||++      +.+++|.+............+.+|+..+.+++|+|++++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS-LYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE-EEEEEe
Confidence            4788999999999999985      479999997655433445678899999999999999999999987764 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999777789999999999999999999999999999999999999999999999999987765443333345


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      .++..|+|||...+...    +.++||||+|+++|+|++|..||....+......... ...+.++..+++.+.+++.+|
T Consensus       160 ~~~~~y~~pe~~~~~~~----~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         160 VGTPYWMAPEVIEMSGA----STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             ccchhhcCHhhhcCCCC----CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHH
Confidence            67889999999876543    3459999999999999999999987776555555443 445567788899999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 007429          575 WNNSPSKRPQFSEIISL  591 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~  591 (604)
                      |..+|++||++.+++.+
T Consensus       235 l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         235 FQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HhCChhhCcCHHHHhcC
Confidence            99999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-36  Score=305.90  Aligned_cols=241  Identities=29%  Similarity=0.547  Sum_probs=195.2

Q ss_pred             eeeeccCceEEEEeE------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          346 DQIGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       346 ~~LG~G~FG~VykGk------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.||+|+||.||+|+            .+++|.+... ........+.+|+..+..++||||+++++++..... .++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-QYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC-eEEEE
Confidence            358999999999874            4677776532 222334567889999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-----cEEEEecCCc
Q 007429          414 KLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-----NVCLGDMGIV  481 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-----~vKL~DFGla  481 (604)
                      ||+++++|.+++.+.       ..+++..++.++.||+.||.|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998532       2478899999999999999999999999999999999999888     8999999998


Q ss_pred             cccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          482 TACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       482 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      ........  ......++..|+|||.+.+...+    .++|||||||++|||++ |..||...+..+.... +..+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~  233 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT----TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-VTAGGRLQ  233 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcc----cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-HhcCCccC
Confidence            65432211  11122356789999999876544    45999999999999998 9999987766554433 33445556


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .+..+|..+.+++.+||..+|.+||++.++++.|.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            67788999999999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-36  Score=302.87  Aligned_cols=233  Identities=24%  Similarity=0.423  Sum_probs=185.3

Q ss_pred             eeeeccCceEEEEeEE----------------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          346 DQIGPNSFKGVYKGKR----------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       346 ~~LG~G~FG~VykGk~----------------VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +.||+|+||.||+|..                +++|.+....   .....+.+|+.+++.++||||+++++++.. .. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-N   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-c
Confidence            3689999999998743                5556554322   114567889999999999999999999987 43 7


Q ss_pred             EEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-------cEEEEecCCc
Q 007429          410 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-------NVCLGDMGIV  481 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-------~vKL~DFGla  481 (604)
                      ++||||+++|+|.+++.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            89999999999999997655 789999999999999999999999999999999999999888       8999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          482 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       482 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      .....    .....++..|+|||.+.+..  ..++.++||||||+++|||++ |..||...+....... ......  .+
T Consensus       156 ~~~~~----~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~~~~~--~~  226 (259)
T cd05037         156 ITVLS----REERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHR--LP  226 (259)
T ss_pred             ccccc----ccccccCCCccChhhhcCCC--CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-HhcCCC--CC
Confidence            76443    22345667899999987652  223456999999999999999 6888877654332222 222222  22


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ......+.+++.+||..+|.+||++.++++.|
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            22347899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=302.90  Aligned_cols=247  Identities=21%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~---~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l  409 (604)
                      .+|++.+.||+|+||.||+|      +.+++|.+.....   .......+.+|+..+..++|+||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999996      4689998753221   1223356788999999999999999999987653 347


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-  488 (604)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++...... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            8999999999999998776778999999999999999999999999999999999999999999999999987653211 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                        .......++..|+|||.+.+...+    .++|+|||||++|+|++|..||...........+.....++.+|..+++.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYG----RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCC----ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence              111233578899999999876443    45999999999999999999999877777666666666667788999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.+++.+||. +|.+||+..+++.|
T Consensus       238 ~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         238 CRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHHHHHhc-CcccCccHHHHhcC
Confidence            9999999999 57999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-36  Score=303.19  Aligned_cols=242  Identities=20%  Similarity=0.296  Sum_probs=203.9

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||.|+||.||++      +.+++|.+...... ......+.+|+.++..++||||+++++.+.+.+. .++||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc-cEEEEecCCCCc
Confidence            699999999985      46899998654322 2345668899999999999999999999987775 899999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcc
Q 007429          421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  500 (604)
Q Consensus       421 L~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y  500 (604)
                      |.+++.+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......+++.|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            99999777789999999999999999999999999999999999999999999999999987654332 22334678899


Q ss_pred             cccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcC
Q 007429          501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  578 (604)
Q Consensus       501 ~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s--~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~d  578 (604)
                      +|||.+.+..++    .++|+||||+++|+|++|..||....  +......+........+|..+++.+.++|.+||+.+
T Consensus       159 ~~PE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         159 VAPEIILNKGYD----FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             cChhHhcCCCCC----ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            999998765443    45999999999999999999998766  555555555445566778888999999999999999


Q ss_pred             CCCCCC-----HHHHHHHHHHh
Q 007429          579 PSKRPQ-----FSEIISLLLRT  595 (604)
Q Consensus       579 P~kRPT-----~~ELL~~L~~~  595 (604)
                      |.+||+     +.|++++-+.-
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhh
Confidence            999999     99999977654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-36  Score=305.42  Aligned_cols=247  Identities=23%  Similarity=0.415  Sum_probs=204.5

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      -|++++.||+|+||.||+|      +.+|+|.+..... ......+.+|+..+.+++||||+++++++...+. .++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe-EEEEEE
Confidence            4678889999999999986      4689998764322 2334567889999999999999999999987775 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999999885 3468999999999999999999999999999999999999999999999999986654332223334


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      .++..|+|||.+.+...    +.++|+|||||++|+|++|..||...........+ .....+.++..++.++.+++.+|
T Consensus       162 ~~~~~y~~PE~~~~~~~----~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         162 VGTPFWMAPEVIKQSAY----DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             cCCccccChhhhccCCC----CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccCHHHHHHHHHH
Confidence            67888999999876543    34599999999999999999999876665544433 33445567778899999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHh
Q 007429          575 WNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~~~  595 (604)
                      |..+|.+||++.+++.+-+..
T Consensus       237 l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         237 LNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             ccCChhhCcCHHHHHhCHHHh
Confidence            999999999999999975443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.6e-37  Score=307.01  Aligned_cols=244  Identities=18%  Similarity=0.266  Sum_probs=202.9

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +|++.+.||.|+||.||++      +.+++|.+....... .....+.+|+..+.+++||||+++++.+.+... .++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN-MYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe-EEEEE
Confidence            4889999999999999985      578999887543222 234568889999999999999999999877665 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+.+++|.+++.....+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ....
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            999999999999776789999999999999999999999999999999999999999999999999976654322 2234


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ..++..|+|||.+.+...    +.++|+||||+++|+|++|..||...+.  ......... ...+..|..++..+.++|
T Consensus       159 ~~~~~~y~~PE~~~~~~~----~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGY----SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAI  233 (258)
T ss_pred             cCCChhhcCHHHHcccCC----CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHH
Confidence            457888999999987653    3459999999999999999999987664  333322222 245667888899999999


Q ss_pred             HHhhhcCCCCCCCH--HHHHHH
Q 007429          572 IKCWNNSPSKRPQF--SEIISL  591 (604)
Q Consensus       572 ~kCL~~dP~kRPT~--~ELL~~  591 (604)
                      .+||+.||.+||++  .+++.+
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcC
Confidence            99999999999999  777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.7e-36  Score=298.22  Aligned_cols=245  Identities=24%  Similarity=0.440  Sum_probs=208.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||.|+||.||++      +.+++|.+............+.+|+..++.++|+|++++++.+..... .++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK-LCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE-EEEEEE
Confidence            5788999999999999984      578999987654444455678899999999999999999999987764 899999


Q ss_pred             cccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          415 LMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       415 y~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |+++++|.+++.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999998653    67999999999999999999999999999999999999999999999999998766544323


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....+++.|+|||.+.+..++    .++|+||+|+++|+|++|..||...+..+...... ....+.+|..++..+.++
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~----~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYN----YKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNL  234 (258)
T ss_pred             ecceeeeecccChhHhccCCCC----ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHH
Confidence            3444678889999998766543    45999999999999999999998877655554444 334556777889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.+||..+|++||++.+++.+
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=325.73  Aligned_cols=243  Identities=21%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +-|.++++||+|+||.||+      |..+|||++...    ..-.++.+|+.++.++..|+||++||.+..... ++|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeeh
Confidence            3467889999999999998      789999998632    224568899999999999999999999887766 99999


Q ss_pred             ecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||..|++.|+++ +++.+.+..+..++.+.+.||+|||..+-||||||+.|||++.+|++||+|||.+..+.+.-....
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            9999999999985 567899999999999999999999999999999999999999999999999999988776555566


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSL  570 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l~~L  570 (604)
                      ...|||.|||||++..-+|.    .++||||||++..||..|++||....+...++-+-. ..+|.+  |+.++.++.++
T Consensus       188 TVIGTPFWMAPEVI~EIGY~----~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYD----TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             ccccCcccccHHHHHHhccc----hhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHH
Confidence            77899999999999877654    459999999999999999999999999877654333 233333  66788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +++||-++|++|-|+.++++|-
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhh
Confidence            9999999999999999998874

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.5e-36  Score=304.59  Aligned_cols=248  Identities=16%  Similarity=0.267  Sum_probs=200.8

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||.|+||.||+|      +.+++|++............+.+|+..+..++||||+++++++.+... .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG-FVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe-eEEEec
Confidence            4789999999999999985      479999987654434445668899999999999999999999988765 899999


Q ss_pred             cccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-ccc
Q 007429          415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~  492 (604)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999999854 45789999999999999999999999999999999999999999999999999876544321 123


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  557 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---------------  557 (604)
                      ...++..|+|||.+.+..   .++.++||||+|+++|||++|.+||...++......+...-..+               
T Consensus       159 ~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         159 HQVATRWYRAPELLYGAR---KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccCcccccCceeeeccc---cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            346788999999986543   23456999999999999999998888766554443332211000               


Q ss_pred             -------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          558 -------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       558 -------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                                   ....+.+..+.+++.+||..+|.+||++++++.|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence                         011345788999999999999999999999998743

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=351.18  Aligned_cols=253  Identities=17%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~  410 (604)
                      ..++|++++.||.|+||.||++      ..+++|.+............+..|+.++..++|||||+++++|.+.. ..+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3478999999999999999986      46889988755444445566889999999999999999999986543 4589


Q ss_pred             EEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CceeccCCCCceEEcC----------
Q 007429          411 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-------GVAYRDLNSQRILLDR----------  469 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~-------gIVHrDLKp~NILld~----------  469 (604)
                      |||||+++|+|.++|..    ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999999854    24799999999999999999999984       5999999999999964          


Q ss_pred             -------CCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 007429          470 -------HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS  542 (604)
Q Consensus       470 -------~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s  542 (604)
                             .+.+||+|||++....... ......||+.|+|||++.+...  .++.++|||||||+||||++|..||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~--~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETK--SYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCC--CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   2358999999987654322 2234468999999999865432  23456999999999999999999998766


Q ss_pred             hHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       543 ~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ....+...+......+ ....+..+.+||..||..+|.+||++.+++.+-+-
T Consensus       248 ~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        248 NFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             cHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6555555444433222 23568999999999999999999999999975443

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5e-36  Score=310.12  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=202.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.|++.+.||+|+||.||+|      +.|++|.+....... .....+.+|+..+..++||||++++++|.+.+. .++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT-AWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe-EEEE
Confidence            56888999999999999985      578999886443322 233467899999999999999999999988775 8999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++......    
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            999974 77777643 457899999999999999999999999999999999999999999999999997654322    


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+... ..++.++||||||+++|||++|..||...+.......+.........+..++..+.++|
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~-~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             CCccCCccccCceeeeccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence            23457788999998853221 22445699999999999999999999887766655544433322223445788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+||..+|.+||++.+|+.+.+....
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcChhhccc
Confidence            99999999999999999998776543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.4e-36  Score=295.30  Aligned_cols=248  Identities=26%  Similarity=0.458  Sum_probs=207.8

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~LVm  413 (604)
                      +|.+.+.||+|+||.||+|      +.+++|.+............+.+|+..+.+++|+||+++++.+.+.. ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4678899999999999996      46899988755443344566889999999999999999999998761 3489999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--cc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~  491 (604)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            9999999999997777899999999999999999999999999999999999999999999999999876654432  13


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....++..|+|||.+.+...    +.++||||||+++|+|++|..||.... .......+......+.+|..++..+.++
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         161 GSVRGTPYWMAPEVIRGEEY----GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cCCCCCccccCHhhhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            44567889999999877653    445999999999999999999998765 3333333333345566788889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +.+||+.+|.+||++.+++.+-
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhhCC
Confidence            9999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.1e-36  Score=303.06  Aligned_cols=247  Identities=16%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             CeEEeeeeeccCceEEEEe-------EEEEEEEeecCCC--------CchHHHHHHHHHHHHHh-CCCCceeEEEEEEEc
Q 007429          341 NLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDK--------GNAYEFELRKDLLELMT-CGHKNILQFYCVCVD  404 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~--------~~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~  404 (604)
                      +|++.+.||+|+||.||+|       +.+++|.+.....        ......++..|+..+.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4778899999999999985       4588888753221        11122345677777765 799999999999988


Q ss_pred             CCCcEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecC
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                      .+. .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||
T Consensus        81 ~~~-~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 NDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CCe-EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence            775 9999999999999998742    3468999999999999999999996 689999999999999999999999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ++....... ......++..|+|||.+.+..+    +.++||||||+++|||++|..||...........+......+..
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~----~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd08528         160 LAKQKQPES-KLTSVVGTILYSCPEIVKNEPY----GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP  234 (269)
T ss_pred             ceeeccccc-ccccccCcccCcChhhhcCCCC----chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence            987654432 2334567889999999986544    44599999999999999999999876665555444444444333


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ...+++.+.++|.+||+.||++||++.|+..++.
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            3467899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.8e-36  Score=306.05  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=207.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|++.+.||.|+||.||+|      ..+++|.+.....   ....+.+|+..+..++|+||+++++.+..... .++|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE-LWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE-EEEEE
Confidence            66888999999999999995      4689999875433   34567889999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999997665 899999999999999999999999999999999999999999999999999765543322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCCCCccHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILKSLM  571 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p~~~s~~l~~LI  571 (604)
                      ...+++.|+|||.+.+..++    .++|||||||++|+|++|..||....+......+....... ..+..++..+.++|
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~----~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYG----PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             cccCCcccCCHhHhcCCCCC----CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            44578889999998766543    45999999999999999999999877765555444433322 22334889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+||+.+|.+||++.+++.+-+...
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-36  Score=324.43  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..+|++++.||+|+||.||++        +.|++|.+...       ....+|+.+++.++|||||++++++..... +|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST-VC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE-EE
Confidence            467999999999999999985        45778877532       124579999999999999999999987765 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-  489 (604)
                      +|||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999996 58999886677899999999999999999999999999999999999999999999999999876543222 


Q ss_pred             -cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHc------------
Q 007429          490 -ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAAC------------  553 (604)
Q Consensus       490 -~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~------------  553 (604)
                       ......||+.|+|||++.+..++.    ++|||||||++|||++|..||.+...   ...+..+...            
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~----~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCA----KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCc----hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence             122346899999999998765543    59999999999999999999975432   1222221110            


Q ss_pred             -------------CCCCCC--C-----CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          554 -------------GLRPEI--P-----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       554 -------------~~r~~~--p-----~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                   ..++..  |     ..++.++.++|.+||..||.+||++.|++.+-+...
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                         011111  1     134667899999999999999999999999876643

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2e-36  Score=308.83  Aligned_cols=252  Identities=22%  Similarity=0.366  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|+..+.||+|+||.||++      +.+++|.+...... .....+.+|+..+.++. |+||+++++++..++. .++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-CWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc-EEE
Confidence            357778899999999999984      57999998743322 34556788999998885 9999999999987765 889


Q ss_pred             EEecccCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          412 VTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       412 VmEy~~gGSL~dlL~-----~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      +|||+.. +|.++..     ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999865 6655432     235799999999999999999999975 99999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHcCCCCCC----C
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEI----P  560 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~-~~~~~i~~~~~r~~~----p  560 (604)
                      ... ......+++.|+|||.+.+.. ...++.++|||||||++|||++|..||...... +....+. .+..+.+    +
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (288)
T cd06616         160 DSI-AKTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE  236 (288)
T ss_pred             cCC-ccccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence            322 123346788899999987652 123455699999999999999999999875532 2222222 2222222    2


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ..++.++.++|.+||+.+|++|||+.+|+.+-+...
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            347899999999999999999999999999866543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=325.97  Aligned_cols=247  Identities=20%  Similarity=0.369  Sum_probs=219.1

Q ss_pred             CCeEEeeeeeccCceEEE------EeEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vy------kGk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .=|.+.+.||+|.|..|-      .|..||||++.+.+-......++.+|++.|+-++|||||++|++...... +|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK-lyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK-LYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce-EEEEE
Confidence            447788999999998764      48899999998877777777889999999999999999999999876665 99999


Q ss_pred             ecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-CCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |+-.+|+|+|||.++. .+.++...++++||+.|+.|+|+..+|||||||+|+.+. .-|.|||.|||++..+.. +..-
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-G~kL  175 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-GKKL  175 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-cchh
Confidence            9999999999997764 799999999999999999999999999999999998775 568999999999866543 3445


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ...+|+..|-|||++.|..|+.+   +.||||||||||.|++|.+||...+..+.+.-|+.+.+.  .|..++.+.++||
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAP---AVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--vPshvS~eCrdLI  250 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAP---AVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--VPSHVSKECRDLI  250 (864)
T ss_pred             hcccchhhccCchhhhcCccCCc---chhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--CchhhhHHHHHHH
Confidence            66789999999999999988754   589999999999999999999999998888888877654  8899999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHH
Q 007429          572 IKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ..||..||.+|.+.+||..+-|
T Consensus       251 ~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  251 QSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             HHHHhcCchhhccHHHHhcccc
Confidence            9999999999999999988765

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-35  Score=292.71  Aligned_cols=242  Identities=26%  Similarity=0.535  Sum_probs=202.3

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||+|+||.||++      +.+++|++.....  .....+.+|+..+..++|+||+++++.+..... .++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE-LWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEEEe
Confidence            4788899999999999985      4688998875433  244568899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence            99999999998665 5799999999999999999999999999999999999999999999999999876554322 344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC--ccHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--CPQILKSLM  571 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~--~s~~l~~LI  571 (604)
                      ..++..|+|||.+.+...    +.++||||||+++|+|++|..||...+.......... ...+..+..  ++..+.+++
T Consensus       157 ~~~~~~~~~PE~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i  231 (253)
T cd05122         157 MVGTPYWMAPEVINGKPY----DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL  231 (253)
T ss_pred             eecCCcccCHHHHcCCCC----CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence            567889999999976653    4459999999999999999999988766555544443 233333333  388999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 007429          572 IKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .+||+.||.+|||+.+++.+
T Consensus       232 ~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         232 KKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHccCChhhCCCHHHHhcC
Confidence            99999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.2e-36  Score=305.12  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=191.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|.+.+.||+|+||.||+|      +.+++|.+..... ......+.+|+..+..++|+||+++++++.+... .|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe-EEEE
Confidence            368899999999999999985      4799999864432 2223456789999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++.........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 577776643 3467888899999999999999999999999999999999999999999999987544333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHc-C---------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAAC-G---------------  554 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~-~~~i~~~-~---------------  554 (604)
                      ....+++.|+|||.+.+..   .++.++|||||||++|||++|..||........ +..+... +               
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGAT---DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCccccccccCCceeecCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            3445788999999987532   133458999999999999999999986554322 1111110 0               


Q ss_pred             CCCC-----CC---------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          555 LRPE-----IP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       555 ~r~~-----~p---------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+.     .+         -..+..+.+++.+|+..||.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000     00         0125688999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.6e-36  Score=307.32  Aligned_cols=260  Identities=20%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      .|.++.++|++.+.||+|+||.||+|      +.+++|.++..... .....+.+|+..+..+ +|+||+++++++.+..
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            46677799999999999999999984      57899998754322 2234455666655555 5999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      . .|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus        88 ~-~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          88 D-VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             e-EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            5 9999999854 88887754 4578999999999999999999997 59999999999999999999999999998665


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHcCCCCCCC--C
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEIP--K  561 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~-~~~~~i~~~~~r~~~p--~  561 (604)
                      ..... .....+++.|+|||.+.+.......+.++||||||+++|+|++|..||...... +....+.. ...+..+  .
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPPNE  243 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CCCCCCCCCC
Confidence            43222 223357788999999976653344566799999999999999999999764443 33333332 2233333  3


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .++.++.+++.+||..||.+||++.+++.+-+.....
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            4789999999999999999999999999998766543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-36  Score=309.98  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=202.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||+|      +.+++|.+.....  .....+.+|+.+++.++||||+++++++...+. .|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDE-LWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc-EEEEE
Confidence            67899999999999999986      4689998863322  224557889999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            99999999999854 45889999999999999999999999999999999999999999999999997655443333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s~~l~~LI~  572 (604)
                      ..+++.|+|||.+.+..+    +.++||||||+++|++++|..||...++......+...+.. ...+...+..+.++|.
T Consensus       175 ~~~~~~y~~PE~~~~~~~----~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccCChhhcCchhhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            468889999999876544    34599999999999999999999876665443333322211 1234456789999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||+.+|.+||++.+++.|-+..
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHh
Confidence            99999999999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.3e-36  Score=304.47  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=195.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCC----c
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH----G  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~----~  408 (604)
                      ++|++.+.||+|+||.||+|      +.|++|.+............+.+|+.++..+ +||||+++++++.....    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999995      5799998765433332345577899999998 46999999999876542    2


Q ss_pred             EEEEEecccCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCcc
Q 007429          409 LCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVT  482 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~-----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~  482 (604)
                      .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7999999986 898887532     35799999999999999999999999999999999999998 8899999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  557 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----  557 (604)
                      .............+++.|+|||.+.+..   .++.++||||||+++|+|++|..||...++......+...-..+     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGST---HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            5543322223335678899999886532   23456999999999999999999998877665554433211000     


Q ss_pred             ---------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 ---------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 ---------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                           ...+.+++.+.++|.+||..||.+||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                                 0113467889999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=304.39  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      |++.+.||.|++|.||+|      +.+++|++............+.+|+..+..++||||+++++++.+.+. .|+||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK-LYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCe-EEEEEec
Confidence            567889999999999985      468999887543333333457789999999999999999999987765 9999999


Q ss_pred             ccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          416 MEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       416 ~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ++ ++|.+++....  .+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++............
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 59999986554  7899999999999999999999999999999999999999999999999998655433222233


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-----------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------------  556 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-----------------  556 (604)
                      ..+++.|+|||++.+..   .++.++||||||+++|+|++|.+||...+.......+......                 
T Consensus       159 ~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         159 EVVTLWYRAPEILLGSR---QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cccccCCCCCceeecCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            35678899999886542   1234699999999999999999999877665544433221100                 


Q ss_pred             ----------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          557 ----------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       557 ----------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                ......++..+.+++.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                      01134567889999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.3e-36  Score=308.39  Aligned_cols=253  Identities=17%  Similarity=0.267  Sum_probs=202.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~L  411 (604)
                      .++|++.+.||.|+||.||+|      +.||+|.++...........+.+|+.++..++|+||+++++++.+.. ..+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            478999999999999999986      46999998754333333344568999999999999999999997653 34899


Q ss_pred             EEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9999975 89888865 357899999999999999999999999999999999999999999999999998766543222


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-------------
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------------  557 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-------------  557 (604)
                      .....+++.|+|||.+.+..   .++.++|||||||++|||++|.+||...++.+....+......+             
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCT---TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCcccccccccChhhhcCCC---CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            23334577899999987532   23456999999999999999999999877766655444311000             


Q ss_pred             ----CCC-----------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ----EIP-----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ----~~p-----------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                          ..+           ...++.+.++|.+||..||.+|||+++++.|-+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                000           12478889999999999999999999999987764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=340.92  Aligned_cols=259  Identities=18%  Similarity=0.298  Sum_probs=209.4

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEE-EcC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVC-VDE  405 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~-~~~  405 (604)
                      ...+..-++++.+.|.+|||+.||.+      ..+|+|++...+  ...-..+.+||.+|+.| +|+|||.|++.. ...
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d--e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND--EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC--HHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            34677778899999999999999983      689999998653  33344578999999999 599999999932 211


Q ss_pred             ---C--CcEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCcEEEE
Q 007429          406 ---N--HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLG  476 (604)
Q Consensus       406 ---~--~~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~vKL~  476 (604)
                         +  ..++|.||||.||+|-|++..  ...|++.++++|++|+|+|+.+||..+  |||||||-+||||+.+|+.|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence               1  347899999999999999963  346999999999999999999999987  9999999999999999999999


Q ss_pred             ecCCccccccCCCc---------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 007429          477 DMGIVTACKSVGEA---------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  547 (604)
Q Consensus       477 DFGla~~~~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~  547 (604)
                      |||.+.........         ......|+.|.|||+|.-.. ....+.|+|||+|||+||-|+....||+.....   
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-GLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            99998654322211         11123689999999986322 123456799999999999999999999875443   


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                       +|+...+..+-.+.++..+.+||+.||+.||.+||++.+++..+..+.+..
T Consensus       265 -aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 -AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             -eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence             345555554444678999999999999999999999999999999998754

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-35  Score=345.18  Aligned_cols=253  Identities=20%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||+|      +.||+|++...... .....++.+|+.++..++||||+++++++.+.+. .++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~-lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP-VYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE-EEEE
Confidence            57899999999999999985      57999998743322 2234568899999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          413 TKLMEGGSVNDLILKS-----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-----------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      |||++||+|.+++...           ..++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998531           13456678899999999999999999999999999999999999999999998


Q ss_pred             cccccCC------------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh
Q 007429          482 TACKSVG------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP  543 (604)
Q Consensus       482 ~~~~~~~------------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~  543 (604)
                      .......                  .......||+.|+|||.+.+..++    .++|||||||++|||+||..||.....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S----~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS----ESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC----cHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            7652110                  001123589999999999876544    459999999999999999999987554


Q ss_pred             HHHHHHHHHcCC-CCCCCCCccHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhhC
Q 007429          544 VQAAVGIAACGL-RPEIPKDCPQILKSLMIKCWNNSPSKRP-QFSEIISLLLRTNN  597 (604)
Q Consensus       544 ~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~kCL~~dP~kRP-T~~ELL~~L~~~~~  597 (604)
                      ............ .......+|+.+.+++.+||+.||.+|| +++++++.|.....
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            333222111111 1111246789999999999999999996 57777777776644

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-35  Score=304.93  Aligned_cols=245  Identities=25%  Similarity=0.420  Sum_probs=200.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|...+.||+|+||.||++      +.+++|++....  ......+.+|+.++..++||||+++++++...+. .++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~-~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-LWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe-EEEEEe
Confidence            3455678999999999986      468999886432  2234457889999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999865 678999999999999999999999999999999999999999999999999876544332223334


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHHHHHHH
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMI  572 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l~~LI~  572 (604)
                      .+++.|+|||.+.+..++    .++|||||||++|||++|..||...++......+... ..+..  +..++..+.++|.
T Consensus       176 ~~~~~y~aPE~~~~~~~~----~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         176 VGTPYWMAPEVISRLPYG----TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cCCccccCHHHhcCCCCC----CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence            588899999998766543    4599999999999999999999887766555444332 22222  3347899999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||+.+|.+||++.+++++-+.
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~  272 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFL  272 (285)
T ss_pred             HHcccChhhCcCHHHHccCccc
Confidence            9999999999999999986443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-37  Score=306.59  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=211.6

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCC------CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK------GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~------~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      ..|+-.+.||.|..+.|-+      |+..|+|++.....      .........+|+.+|+++ +||||+++.+++..+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4567778899999888875      67888888753221      111233467889999986 8999999999998887


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +++|+|+|+.|.|.|+|...-.++++...+++.|+.+|++|||.++||||||||+|||++++.++||+|||++..+..
T Consensus        97 F-~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 F-VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             h-hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            6 899999999999999998777899999999999999999999999999999999999999999999999999988764


Q ss_pred             CCCcccccCCCCcccccccccCCC--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CC
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  562 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~--~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~  562 (604)
                      . ..-...+|||+|+|||.+...-  ..+.|+...|+||.||+||.|+.|.+||......-.+.-|+.+.+.-.-|  .+
T Consensus       176 G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  176 G-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             c-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            3 4455679999999999987542  23455566999999999999999999998766666666666666654444  36


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++..+++||.+||+.||.+|.|++|++.|-+.
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            78999999999999999999999999998776

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.6e-36  Score=311.05  Aligned_cols=246  Identities=24%  Similarity=0.414  Sum_probs=199.5

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|.....||.|+||.||++      ..+++|.+....  ......+.+|+..+..++|+||+++++.+...+. .++|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe-EEEEEe
Confidence            3445677999999999985      478999886432  2234457899999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++. ...+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||++.............
T Consensus       100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999999874 4568999999999999999999999999999999999999999999999999986544332223334


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHHHHHHH
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMI  572 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l~~LI~  572 (604)
                      .+++.|+|||.+.+..++    .++||||||+++|||++|..||...........+. ....+..  ....+..+.+++.
T Consensus       179 ~~~~~y~aPE~~~~~~~~----~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         179 VGTPYWMAPEVISRLPYG----TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             ecCccccCHHHHccCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCccccccccCHHHHHHHH
Confidence            678899999998765443    45999999999999999999998776655443332 2222222  2356789999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||..||.+|||+.+++++-+..
T Consensus       254 ~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         254 LMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             HHccCChhHCcCHHHHhhChhhh
Confidence            99999999999999999985554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=314.82  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=219.0

Q ss_pred             eeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      -.+..++|.+++.||+|.||.|.+      |+.+|+|++++.-.-.. +-.....|-++|...+||.+..+.-.|+..+.
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            345678999999999999999997      56899999876443322 22346678888999999999999877877765


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|+||||+.||.|..+|.+.+.+++...+.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.....
T Consensus       243 -lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 -LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             -EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999887777


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      +..+...+|||.|+|||++....|...    .|.|.+||++|||++|+.||.+.........|+...  ..+|..++++.
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgra----VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed--~kFPr~ls~eA  395 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRA----VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED--LKFPRTLSPEA  395 (516)
T ss_pred             cceeccccCChhhcCchhhccccccce----eehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh--ccCCccCCHHH
Confidence            888888999999999999998776655    899999999999999999999987777666666654  45899999999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +.|+...|.+||.+|.     .+.||.++=.
T Consensus       396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~F  426 (516)
T KOG0690|consen  396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF  426 (516)
T ss_pred             HHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence            9999999999999995     3667766543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=303.41  Aligned_cols=248  Identities=17%  Similarity=0.274  Sum_probs=191.9

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||+|+||.||+|      +.+++|.+...... .....+.+|+.+++.++|+||+++++++.+.+. .++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKT-LTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCe-EEEE
Confidence            378999999999999999985      56999998643322 222345689999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+.+ +|.+++.+. ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++.........
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999985 999988653 468999999999999999999999999999999999999999999999999976543222222


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHcCC---------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGL---------------  555 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-~~~~~~~i~~~~~---------------  555 (604)
                      ....+++.|+|||.+.+..   .++.++||||+|+++|+|++|..||.... ..+....+.....               
T Consensus       161 ~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGST---EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccCCcHHhhcCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            2334678899999887532   13446999999999999999999997654 2222211111000               


Q ss_pred             ------CC-------CCCCCcc--HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          556 ------RP-------EIPKDCP--QILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       556 ------r~-------~~p~~~s--~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                            +.       ......+  ..+.+++.+||+.+|.+||++.+++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence                  00       0001233  7788999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.3e-36  Score=310.19  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|+....||+|+||.||++      +.+++|.+.....  .....+.+|+..+..++||||+++++.+...+. .++|||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCe-EEEEEe
Confidence            3445567999999999985      4699999864332  234457789999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++++|.+++. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus        99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            999999999774 4568999999999999999999999999999999999999999999999999986554433333445


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHHH
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~k  573 (604)
                      .+++.|+|||.+.+..++    .++|||||||++|||++|..||....+......+..... ....+..++..+.++|.+
T Consensus       178 ~~~~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         178 VGTPYWMAPEVISRTPYG----TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             ecCccccCHHHHccCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            688999999999766543    459999999999999999999987766555443332211 112344678899999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ||+.+|.+||++.+++.+-+..
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhc
Confidence            9999999999999999975544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-35  Score=301.04  Aligned_cols=248  Identities=21%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~LV  412 (604)
                      ++|++.+.||.|+||.||++      +.+++|.+..... ......+.+|+..+..++||||++++++|.+.. ..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            46899999999999999985      4689998874332 234566889999999999999999999987553 348999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988742    3468899999999999999999999999999999999999999999999999976543221


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHHHHcCCCCCCC---
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-----SPVQAAVGIAACGLRPEIP---  560 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~-----s~~~~~~~i~~~~~r~~~p---  560 (604)
                        .....++..|+|||.+.+..++    .++|||||||++|+|++|..||...     ...+.... ......+.++   
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~----~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  232 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYS----ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEP  232 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCC----chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCC
Confidence              1233567889999998766544    4599999999999999999999865     22222222 2221222222   


Q ss_pred             ---CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 ---KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ---~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                         ...++.+.+++.+||..+|++|||+.|++.+-+-.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence               23467899999999999999999999999987763

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-35  Score=307.28  Aligned_cols=239  Identities=18%  Similarity=0.264  Sum_probs=180.1

Q ss_pred             eeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEEEec
Q 007429          345 IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKL  415 (604)
Q Consensus       345 ~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LVmEy  415 (604)
                      .++||+|+||.||+|+        .+|+|.+.....    ...+.+|+.++..++||||+++++++... +..+|+||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            4679999999999974        588998864322    23467899999999999999999998654 3348999999


Q ss_pred             ccCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----cCCCcEEEEecCCcc
Q 007429          416 MEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT  482 (604)
Q Consensus       416 ~~gGSL~dlL~~~---------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----d~~g~vKL~DFGla~  482 (604)
                      +.+ +|.+++...         ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            965 888887421         248899999999999999999999999999999999999    456789999999987


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHHH
Q 007429          483 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------VQAAVGI  550 (604)
Q Consensus       483 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---------~~~~~~i  550 (604)
                      .......   ......+|+.|+|||++.+..   .++.++||||+||++|||++|.+||.....         ......+
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCC---CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            6543221   122346789999999997643   234459999999999999999999964321         1111111


Q ss_pred             HHc-CCC----------------------CC-------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          551 AAC-GLR----------------------PE-------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       551 ~~~-~~r----------------------~~-------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ... +.+                      ..             .....+..+.++|.+||+.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            110 000                      00             001224568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.2e-35  Score=302.32  Aligned_cols=250  Identities=21%  Similarity=0.271  Sum_probs=196.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||.|+||.||+|      +.+++|.+............+.+|+..++.++||||+++++++.+... .|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-LYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe-EEEEE
Confidence            57899999999999999996      469999886443332333457789999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++ +|.+++....  .+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.........
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            99965 8888775433  3678888999999999999999999999999999999985 557999999998654432222


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-------------
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------------  557 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-------------  557 (604)
                      .....+++.|+|||.+.+..   .++.++|||||||++|+|+||..||...+..+....+......+             
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSR---HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccCceeecccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            23345678899999986532   23456999999999999999999998876655554433211000             


Q ss_pred             ------C--------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 ------E--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 ------~--------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                            .        .....++++.+++.+|++.+|++||++.+++.+=+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~  287 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF  287 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence                  0        123467889999999999999999999999987543

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-35  Score=306.39  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=206.6

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ..|...+.||+|+||.||+++      .+++|.+...... ......+.+|+..++.++|||++++++++.++.. .++|
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  103 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT-AWLV  103 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-EEEE
Confidence            347788999999999999864      6899988644322 2233467889999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++.....    .
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence            999975 88777743 45789999999999999999999999999999999999999999999999999764432    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+..... ...+.++|||||||++|||++|..||...........+.........+..+++.+.+++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             ccccCCccccChhhhhcCCC-CCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence            23467888999999853211 12345699999999999999999999887776666666665554444566789999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .+||+.+|.+||++.+++++++......
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999988765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-35  Score=295.08  Aligned_cols=243  Identities=25%  Similarity=0.411  Sum_probs=204.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||.|+||.||++      +.+++|.+............+.+|+..++.++|+||+++++++.+... .++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK-LCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE-EEEEeh
Confidence            4789999999999999985      478999987544333445567789999999999999999999987765 899999


Q ss_pred             cccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          415 LMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       415 y~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++......  .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            9999999999854    346899999999999999999999999999999999999999999999999998765543  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....+++.|+|||.+.+..++    .++|+||||+++|+|++|..||...+.......+ ..+..+..+..++.++.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~----~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  232 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYS----YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNF  232 (256)
T ss_pred             cccccCCccccCHHHHCCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCchhhCHHHHHH
Confidence            2334578899999999766544    3599999999999999999999887765544433 3344455667889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +.+||..+|.+||++.+++.+
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcC
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-35  Score=299.45  Aligned_cols=245  Identities=19%  Similarity=0.323  Sum_probs=194.9

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|++.+.||.|+||.||+|      +.+++|.++..... .....+.+|+..+..++|+||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENK-LMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-EEEEEe
Confidence            5889999999999999985      46899998754322 223446689999999999999999999998776 899999


Q ss_pred             cccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          415 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       415 y~~gGSL~dlL~~~---~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |+++ +|.+++...   ..+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++..........
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 898887543   368999999999999999999999999999999999999999999999999986554332222


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC----------------C
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG----------------L  555 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~----------------~  555 (604)
                      ....+++.|++||.+.+..   .++.++|||||||++|+|++|..||...+..+....+....                .
T Consensus       158 ~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSR---TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccChHHhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            3345678899999886542   23456999999999999999999998766554433322110                0


Q ss_pred             CCC-----------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 RPE-----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 r~~-----------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ...           +.+.+++.+.+++.+||+.||.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            001           112457789999999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-35  Score=303.04  Aligned_cols=242  Identities=21%  Similarity=0.307  Sum_probs=189.7

Q ss_pred             eeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHH---HHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          347 QIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       347 ~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~---L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      .||+|+||.||++      +.+|+|.+........ ......++...   +...+||||+.+++++..++. .++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK-LCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe-EEEEEecC
Confidence            3899999999984      5789998865432222 12222333332   333479999999999987765 89999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCC
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      ++|+|.+++...+.+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++......  ......+
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  157 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence            99999999987778999999999999999999999999999999999999999999999999998654332  1233468


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      ++.|+|||.+....   .++.++|||||||++|||++|..||.....  .... ..........+|..++.++.++|.+|
T Consensus       158 ~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         158 THGYMAPEVLQKGT---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCccCHHHhcCCC---CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHHhhcCCcCCccccCHHHHHHHHHH
Confidence            89999999986421   233459999999999999999999975432  1222 12222345567788999999999999


Q ss_pred             hhcCCCCCC-----CHHHHHHHHHHh
Q 007429          575 WNNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       575 L~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      |..||.+||     ++.++++|-+..
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            999999999     699999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=305.29  Aligned_cols=251  Identities=12%  Similarity=0.156  Sum_probs=183.0

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHH---------HHHHHHHHHHhCCCCceeEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF---------ELRKDLLELMTCGHKNILQF  398 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~---------~~~~Ei~~L~~L~HpnIVkl  398 (604)
                      +..++|++.+.||+|+||.||+|+         .+++|...........+.         ....++..+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            344789999999999999999974         234443222111111111         11122233456799999999


Q ss_pred             EEEEEcCCC---cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEE
Q 007429          399 YCVCVDENH---GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL  475 (604)
Q Consensus       399 ~g~~~~~~~---~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL  475 (604)
                      ++.+.....   ..+++++++.. ++.+++......++..+..++.|++.||.|||+++|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            997765432   24678888754 77777765556788889999999999999999999999999999999999999999


Q ss_pred             EecCCccccccCCC-------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 007429          476 GDMGIVTACKSVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV  548 (604)
Q Consensus       476 ~DFGla~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~  548 (604)
                      +|||+++.......       ......||+.|+|||.+.+..++    .++|||||||++|||++|..||...+......
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~----~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT----RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC----cHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999876543221       12234689999999999876554    45999999999999999999998763322111


Q ss_pred             H-----HHHcCC-CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          549 G-----IAACGL-RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       549 ~-----i~~~~~-r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .     ....-. ....+..+++.+.+++..||..+|++||++.+|++.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1     111101 1112456789999999999999999999999999876

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.6e-35  Score=298.32  Aligned_cols=242  Identities=19%  Similarity=0.235  Sum_probs=189.6

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC--CCcEEEE
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE--NHGLCVV  412 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~--~~~l~LV  412 (604)
                      |++++.||+|+||.||+|      +.+++|.++...... ......+|+..+.++ +|+||+++++++.+.  +. +++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR-LALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc-EEEE
Confidence            578899999999999996      468999887543222 223345788888887 499999999999876  54 8999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++ +|.+.+.. ...+++..+..++.||+.||+|||+.|++||||+|+||+++. +.+||+|||++........ .
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~  155 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-Y  155 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-c
Confidence            999975 88887754 347899999999999999999999999999999999999999 9999999999876543322 1


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------  555 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----------------  555 (604)
                      ....++..|+|||.+....   ..+.++|||||||++|||++|..||...+..+....+.....                
T Consensus       156 ~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCC---CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            2235788899999875432   234469999999999999999999987766544333221100                


Q ss_pred             CCCC-----------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 RPEI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 r~~~-----------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ...+           ...++..+.++|.+||..+|.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0011           12467899999999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.5e-36  Score=301.09  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ++|++.+.||+|+||.||++      +.+++|.+..... .......+.+|+.++..++ |+||+++++++.+.+. .++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN-LYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce-EEE
Confidence            47899999999999999985      4689998864322 2223455778888999998 9999999999887665 899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC---
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---  488 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~---  488 (604)
                      ||||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99999999999999877789999999999999999999999999999999999999999999999999976554322   


Q ss_pred             -----------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 007429          489 -----------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA  551 (604)
Q Consensus       489 -----------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~  551 (604)
                                       .......++..|+|||.+.+...    +.++|+||||+++|++++|..||...+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~----~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA----GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCC----ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence                             11122346788999999876543    345999999999999999999999877655544444


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCH----HHHHHHH
Q 007429          552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF----SEIISLL  592 (604)
Q Consensus       552 ~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~----~ELL~~L  592 (604)
                        .....+|..+++.+.+++.+||+.+|.+||++    .+++.+-
T Consensus       236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence              23445777889999999999999999999999    8888763

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-35  Score=296.70  Aligned_cols=237  Identities=19%  Similarity=0.304  Sum_probs=194.5

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||.|+||.||++      +.+++|.+...... ......+.+|+..+.+++||||+++++.+..... .|+||||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN-LYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE-EEEEEecCCCCc
Confidence            689999999984      56899988644321 1234557888999999999999999999877665 899999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--------ccc
Q 007429          421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--------ATE  492 (604)
Q Consensus       421 L~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--------~~~  492 (604)
                      |.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            999997767899999999999999999999999999999999999999999999999999765433211        223


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc--cHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC--PQILKSL  570 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~--s~~l~~L  570 (604)
                      ...++..|+|||.+.+...    +.++||||||+++|++++|..||......+....+....  ...|..+  +..+.++
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~----~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGH----SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDL  233 (265)
T ss_pred             CcccCccccCHHHhcCCCC----CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHH
Confidence            3456788999999876653    345999999999999999999998877776655554432  3344444  8999999


Q ss_pred             HHHhhhcCCCCCCCH---HHHHHH
Q 007429          571 MIKCWNNSPSKRPQF---SEIISL  591 (604)
Q Consensus       571 I~kCL~~dP~kRPT~---~ELL~~  591 (604)
                      +.+||+.+|.+|||+   .+++++
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcC
Confidence            999999999999999   666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-35  Score=300.53  Aligned_cols=240  Identities=22%  Similarity=0.334  Sum_probs=192.7

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||+|+||.||++      +.+++|.+...... ......+..|+.++..++||||+++++++...+. .|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD-LCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe-EEEEEecCCCCc
Confidence            699999999984      57999988643221 1223345689999999999999999999987765 899999999999


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          421 VNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       421 L~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      |.+++.+..  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......++.
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  158 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP  158 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence            999986554  7899999999999999999999999999999999999999999999999998655431 2223345678


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      .|+|||.+.+..+    +.++||||||+++|+|++|..||.....   ...+.. .........+..+++.+.++|.+||
T Consensus       159 ~y~~PE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         159 GYMAPEVLQGEVY----DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-RTLEMAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             CcCCHHHhcCCCC----CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-ccccccccCCccCCHHHHHHHHHHc
Confidence            8999999876653    3459999999999999999999976543   121111 1122344567778999999999999


Q ss_pred             hcCCCCCC-----CHHHHHHHHHH
Q 007429          576 NNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       576 ~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      +.||.+||     ++.+++.|-+.
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             cCChhHccCCCcccHHHHHhChhh
Confidence            99999999     77778876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.7e-35  Score=311.46  Aligned_cols=248  Identities=19%  Similarity=0.240  Sum_probs=195.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++++.||+|+||.||++      +.+++|.+............+.+|+.++..++|+||+++++++....     .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            378999999999999999985      57999998644333334455778999999999999999999986442     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ..|+||||+.+ +|.+.+...  ++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            37999999965 888887543  899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  555 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------  555 (604)
                      .. .....++..|+|||.+.+..++    .++|||||||++|+|++|..||...+.......+...-.            
T Consensus       172 ~~-~~~~~~~~~y~aPE~~~~~~~~----~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         172 FM-MTPYVVTRYYRAPEVILGMGYK----ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CC-CCCCcccccccCHHHHhCCCCC----CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            21 2233578889999999876554    359999999999999999999987654433322211000            


Q ss_pred             --------CCC--------------C-------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          556 --------RPE--------------I-------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       556 --------r~~--------------~-------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                              ++.              +       +...+..+.++|.+||+.||.+|||+.|++.+=+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                    000              0       11345678999999999999999999999988654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=294.84  Aligned_cols=240  Identities=23%  Similarity=0.310  Sum_probs=191.0

Q ss_pred             eeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~-L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +.||.|+||.||++      +.+++|.+........ ....+..|... ....+|+||+++++++...+. .|+||||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY-LYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-EEEEEeccC
Confidence            56899999999985      4799998864322111 11223344333 344589999999999987665 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      +++|.+++.....+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||++.....    .....++
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence            999999997777899999999999999999999999999999999999999999999999999765432    2234578


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC--CCCCCCCccHHHHHHHHHhh
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--RPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~--r~~~p~~~s~~l~~LI~kCL  575 (604)
                      +.|+|||.+.+..+    +.++||||||+++|+|++|..||...+.......+.....  ....+..+++.+.+++.+||
T Consensus       157 ~~y~~pe~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         157 PDYLAPETILGVGD----DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             cCccChhhhcCCCC----cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            88999999887643    3469999999999999999999988776665544443322  23344568899999999999


Q ss_pred             hcCCCCCCCH---HHHHHHHHH
Q 007429          576 NNSPSKRPQF---SEIISLLLR  594 (604)
Q Consensus       576 ~~dP~kRPT~---~ELL~~L~~  594 (604)
                      +.+|++||++   .|++.+-+.
T Consensus       233 ~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         233 CMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             cCCHHHccCCCcHHHHHcChHh
Confidence            9999999954   677776554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-35  Score=300.21  Aligned_cols=250  Identities=18%  Similarity=0.276  Sum_probs=193.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      .++|++.+.||+|+||.||++      +.+++|.+............+.+|+..+++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            367899999999999999985      579999887544333334456689999999999999999999876532     


Q ss_pred             --cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          408 --GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       408 --~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                        ..++||||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              35999999975 888877543 37899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--CCC-
Q 007429          485 KSVGEA----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRP-  557 (604)
Q Consensus       485 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--~r~-  557 (604)
                      ......    .....++..|+|||.+.+..   .++.++||||||+++|||++|..||...+.......+....  .++ 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGER---DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCc---ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            432211    12234678899999886543   12346999999999999999999998766543322211110  000 


Q ss_pred             --------------CCC-------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 --------------EIP-------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 --------------~~p-------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                    ..+             ...+..+.++|.+||..||.+|||+++++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence                          001             11346778999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-35  Score=310.76  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=197.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l  409 (604)
                      ++|.+.+.||+|+||.||++      +.|++|.+............+.+|+.++..++|+||+++++++....    ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57899999999999999985      47999998754333333455678999999999999999999886543    237


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+|+||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++........
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            99999996 59999987777899999999999999999999999999999999999999999999999999876544322


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc----------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC----------------  553 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~----------------  553 (604)
                      ......++..|+|||.+.....   .+.++|||||||++|+|++|..||.+.+.......+...                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLNCSE---YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             cccccccccCccChHHHhcCCC---CCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            2333457888999998865321   344599999999999999999999765433222111100                


Q ss_pred             --------C--CCC---CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          554 --------G--LRP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       554 --------~--~r~---~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                              .  .++   ...+.+++.+.++|.+||+.+|.+|||+.+++.+-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~  293 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY  293 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence                    0  000   112457889999999999999999999999999833

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-35  Score=314.74  Aligned_cols=242  Identities=20%  Similarity=0.283  Sum_probs=185.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +...+|++++.||+|+||.||+|+      .|++|.....        ....|+.++..++||||+++++++.+... .+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-TC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCe-eE
Confidence            344679999999999999999964      5788864321        12468888999999999999999988775 89


Q ss_pred             EEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~  211 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P  211 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence            9999995 588888754 457999999999999999999999999999999999999999999999999998643322 1


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC-CCCChH---------HHHHHHHHc-CC-CC
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPV---------QAAVGIAAC-GL-RP  557 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf-~~~s~~---------~~~~~i~~~-~~-r~  557 (604)
                      ......||+.|+|||++.+..++    .++|||||||++|||+++..|+ ......         ..+..+... +. +.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYN----SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             ccccccccccccCCeecCCCCCC----chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            22334688999999999876544    4599999999999999855444 321110         111111110 11 11


Q ss_pred             CCC------------------------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          558 EIP------------------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       558 ~~p------------------------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .++                              .+++..+..+|.+||+.||.+|||+.|+++|=+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~  353 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM  353 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence            111                              134566778999999999999999999998754

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=331.66  Aligned_cols=240  Identities=22%  Similarity=0.444  Sum_probs=204.6

Q ss_pred             eeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          347 QIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       347 ~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      .||+|.||+||.|+      ++|||-+...  ....-.-+..||..-++|+|.|||+++|.|..++. +-|.||-++|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf-~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF-FKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-EEEEeecCCCCc
Confidence            69999999999985      6888888532  22333447889999999999999999999987775 889999999999


Q ss_pred             HHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccccccCCCcccccCC
Q 007429          421 VNDLILK-SRKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       421 L~dlL~~-~~~l--~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      |.++|+. =+++  ++.++..+..||++||.|||++.|||||||-+|+||+. .|.+||+|||-++++......+....|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            9999953 2466  78899999999999999999999999999999999975 578999999999888776677788899


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~-s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      |..|||||+|..++-  .|..++|||||||++.||.||++||... ++....+++-.-...|++|..++.+.+.+|.+|+
T Consensus       739 TLQYMAPEvIDqG~R--GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPR--GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             chhhhChHhhccCCc--CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            999999999987643  3455699999999999999999999865 4555555544445678899999999999999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 007429          576 NNSPSKRPQFSEIISL  591 (604)
Q Consensus       576 ~~dP~kRPT~~ELL~~  591 (604)
                      ..||.+||++.+++..
T Consensus       817 epd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CCCcccCccHHHhccC
Confidence            9999999999999864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.7e-35  Score=302.03  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC------
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN------  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~------  406 (604)
                      .++|++.+.||.|+||.||+|      +.|++|.++...........+.+|+..++.++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            478899999999999999996      46899998754433333455678999999999999999999987654      


Q ss_pred             ---CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          407 ---HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       407 ---~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                         ..+++|+||+++ +|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence               248999999987 777776543 478999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----
Q 007429          483 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----  557 (604)
Q Consensus       483 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----  557 (604)
                      ....... ......++..|+|||.+.+..   ..+.++|||||||++|||++|++||...+.......+......+    
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            6543321 112234577899999886432   22446999999999999999999998766554443332211000    


Q ss_pred             ------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 ------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 ------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                              .....++..+.+++.+||..||.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                                    0122468899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=356.63  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=212.2

Q ss_pred             EEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +-...||.|.||.||.      |...|+|-++..+.....-..+.+|+.+|..++|||+|++||+=.+.+. ++|.||||
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-v~IFMEyC 1316 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-VYIFMEYC 1316 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-HHHHHHHh
Confidence            5577899999999997      5678889887665553334457889999999999999999999887765 88999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc----cc
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA----TE  492 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~----~~  492 (604)
                      .+|+|.+++..++-.++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|.........    ..
T Consensus      1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            99999999977777788888889999999999999999999999999999999999999999999877654321    23


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|||||++.+...... .-+.||||+|||+.||+||+.||......-.+.--+..+..|++|..++++-++++.
T Consensus      1397 ~~~GT~~YMAPEvit~t~~kG~-~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGH-GGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred             hhcCCchhcCchhhcccccCCC-CcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHH
Confidence            4479999999999987542222 235899999999999999999999887776666667778999999999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .||..||++|-++.||+++-
T Consensus      1476 ~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HHHhcCchhhhHHHHHHHhh
Confidence            99999999999998888764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-35  Score=296.32  Aligned_cols=244  Identities=20%  Similarity=0.359  Sum_probs=198.0

Q ss_pred             CeEEeeeeeccCceEEEEeE------EEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~---~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      +|.+.+.||+|+||.||+++      .+++|.++....   ......++..|+.++..++||||+++++++.+... .++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-FCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc-eEE
Confidence            47889999999999999864      244555543221   22234456778889999999999999999987765 899


Q ss_pred             EEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          412 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            9999999999998853    346899999999999999999999999999999999999975 66999999998765444


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      ........+++.|+|||.+.+..++    .++|+||||+++|+|++|..||...........+. .+..+..+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~----~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYD----SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQL  233 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCC----chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHH
Confidence            3334445678899999998765443    35999999999999999999998766655444433 345556677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .++|.+||..+|++||++.+++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhhC
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-35  Score=301.85  Aligned_cols=239  Identities=19%  Similarity=0.285  Sum_probs=179.1

Q ss_pred             eeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEEEec
Q 007429          345 IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKL  415 (604)
Q Consensus       345 ~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LVmEy  415 (604)
                      ..+||+|+||.||+|+        .+|+|.+.....    ...+.+|+.++..++||||+++++++... +..+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            3579999999999964        588888864322    23467899999999999999999998653 3448999999


Q ss_pred             ccCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----cCCCcEEEEecCCcc
Q 007429          416 MEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT  482 (604)
Q Consensus       416 ~~gGSL~dlL~~~---------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----d~~g~vKL~DFGla~  482 (604)
                      +++ +|.+++...         ..+++..+..++.||+.||.|||+++|+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            875 888776421         247889999999999999999999999999999999999    566789999999987


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHH
Q 007429          483 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------QAAVGI  550 (604)
Q Consensus       483 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---------~~~~~i  550 (604)
                      .......   ......+|+.|+|||.+.+..   .++.++|||||||++|||+||.+||......         .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCC---ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            6543221   122335788999999987542   2345699999999999999999999643211         000000


Q ss_pred             HHc-CC-----------CC------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          551 AAC-GL-----------RP------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       551 ~~~-~~-----------r~------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ... +.           .+                        ......+..+.+|+.+||..||.+|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            000 00           00                        0011234568899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-35  Score=299.26  Aligned_cols=249  Identities=18%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             CeEEeeeeeccCceEEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +|++.+.||.|+||.||++         +.+|+|.++....  .......+.+|+.++..+ +|+||+++++.+..+.. 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK-   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe-
Confidence            4788999999999999964         4589999874322  122335577899999998 68999999999887664 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .|+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            89999999999999999877789999999999999999999999999999999999999999999999999987654322


Q ss_pred             C-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCCCCCCCcc
Q 007429          489 E-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       489 ~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      . ......++..|+|||.+.+...  ..+.++||||||+++|+|++|..||.....   ......... ...+.+|..++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDG--GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMS  236 (290)
T ss_pred             ccccccccCCcccCChhhccCCCC--CCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCC
Confidence            1 1223457889999999875321  123458999999999999999999974322   122222222 22445677889


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +.+.+++.+||+.||.+||     +..+++.+-+
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~  270 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF  270 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence            9999999999999999997     7888887633

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-35  Score=307.00  Aligned_cols=250  Identities=18%  Similarity=0.254  Sum_probs=202.9

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l~  410 (604)
                      +|++.+.||.|+||.||++      +.+++|++............+.+|+..++.++|+||+++++++....    ..+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5789999999999999985      47899998754433344566889999999999999999999998764    3489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC--
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~--  488 (604)
                      +||||+++ +|.+++.+...+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......  
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999985 899998777789999999999999999999999999999999999999999999999999987665432  


Q ss_pred             -CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          489 -EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       489 -~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                       .......++..|+|||.+.+..   ..+.++|+||||+++|+|++|.+||...+..+....+......+          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSS---RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             cccccccccccCcCCceeeeccc---CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence             1223345688899999998762   23445999999999999999999998877655444333311100          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                         ......+..+.++|.+||+.+|.+||++.+++.+-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence                               0123467889999999999999999999999998544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-35  Score=294.02  Aligned_cols=247  Identities=18%  Similarity=0.292  Sum_probs=196.1

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LVmE  414 (604)
                      |++.+.||.|+||.||+|      +.+++|.+............+.+|+.++..++|+|++++++++.+. ....++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            578899999999999995      5789999986542333345677899999999999999999999877 234999999


Q ss_pred             cccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-ccc
Q 007429          415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~  492 (604)
                      |+++ +|.+++... ..+++..++.++.||+.||+|||++|++|+||+|+||++++++.+||+|||++........ ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9975 899888654 5799999999999999999999999999999999999999999999999999876654321 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  557 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---------------  557 (604)
                      ...++..|+|||.+.+..   .++.++||||||+++|||++|..||...+.......+......+               
T Consensus       160 ~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         160 NRVITLWYRPPELLLGAT---RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccCCceeeEccc---cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            334677899999876532   23456999999999999999999998776654443332211000               


Q ss_pred             --------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 --------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 --------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                    .+...+++.+.+++.+||..+|.+||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence                          01112378899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=308.24  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=208.8

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~~~  406 (604)
                      -|.+..++++-++.||.|+||+|+|      |+..|||+++.... ..+..+++.|....++ -+.||||+|||++..++
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            4778889999999999999999998      89999999985433 4456678888887665 47899999999999988


Q ss_pred             CcEEEEEecccCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          407 HGLCVVTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~-----~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      . .||+||+|.- ||+.+-.     +...+++..+..+..-.+.||.||.. ..|||||+||+|||++..|.+||||||+
T Consensus       137 d-cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  137 D-CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             c-eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence            7 8899999965 8776543     34579999999999999999999975 5899999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC-
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-  559 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~-  559 (604)
                      +..+.+. .......|...|||||.+.....  .++.+|||||||++|||+.||..||..++..-.....+..+.+|.+ 
T Consensus       215 cGqLv~S-iAkT~daGCrpYmAPERi~p~~~--gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  215 CGQLVDS-IAKTVDAGCRPYMAPERIDPSDK--GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             hHhHHHH-HHhhhccCCccccChhccCCccC--CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            8765432 23445578888999999986543  5778899999999999999999999998775544455555555543 


Q ss_pred             -CC---CccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          560 -PK---DCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       560 -p~---~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                       +.   +.+..+..+|..|+.+|-.+||.+.+++++
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             33   367889999999999999999999998764

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-35  Score=323.72  Aligned_cols=243  Identities=22%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             CeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-C-----CceeEEEEEEEcCCCc
Q 007429          341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-H-----KNILQFYCVCVDENHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-H-----pnIVkl~g~~~~~~~~  408 (604)
                      +|++.+.||+|+||.|.+      ++.||||++++..   ....+...|+.+|..|+ |     -|+|+++++|...++ 
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H-  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH-  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc-
Confidence            789999999999999998      4689999998542   33455678888888885 3     589999999999887 


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC--cEEEEecCCcccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG--NVCLGDMGIVTAC  484 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g--~vKL~DFGla~~~  484 (604)
                      +|||+|++.. +|+++|+.++  .|+...++.|+.||+.||.+||+.||||+||||+||||...+  .|||+|||.+...
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999966 9999997665  688999999999999999999999999999999999997654  5999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-CCC------
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRP------  557 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-~r~------  557 (604)
                      ...   ......+-.|.|||+|.|.+|+..    .||||||||+.||++|.+.|.+.+..+.+..|+..- .++      
T Consensus       342 ~q~---vytYiQSRfYRAPEVILGlpY~~~----IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  342 SQR---VYTYIQSRFYRAPEVILGLPYDTA----IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             CCc---ceeeeeccccccchhhccCCCCCc----cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            432   224456677999999999988765    899999999999999999999988877665443211 000      


Q ss_pred             -------------------------------------------CCCC-----------CccHHHHHHHHHhhhcCCCCCC
Q 007429          558 -------------------------------------------EIPK-----------DCPQILKSLMIKCWNNSPSKRP  583 (604)
Q Consensus       558 -------------------------------------------~~p~-----------~~s~~l~~LI~kCL~~dP~kRP  583 (604)
                                                                 ..|.           .-...+.+++.+|++.||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                       0120           1124578999999999999999


Q ss_pred             CHHHHHHHHHHh
Q 007429          584 QFSEIISLLLRT  595 (604)
Q Consensus       584 T~~ELL~~L~~~  595 (604)
                      |+.+.++|=+--
T Consensus       495 tp~qal~Hpfl~  506 (586)
T KOG0667|consen  495 TPAQALNHPFLT  506 (586)
T ss_pred             CHHHHhcCcccc
Confidence            999999986543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-35  Score=307.82  Aligned_cols=252  Identities=18%  Similarity=0.250  Sum_probs=199.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---CCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---~~~l~  410 (604)
                      ++|++.+.||.|+||.||+|      +.|++|++............+.+|+.++..++||||+++++++...   ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            78899999999999999985      5799999875433333445577899999999999999999987643   23489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||||+. |+|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999996 599999877778999999999999999999999999999999999999999999999999998765432211


Q ss_pred             ----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-------------
Q 007429          491 ----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-------------  553 (604)
Q Consensus       491 ----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-------------  553 (604)
                          .....++..|+|||.+.+..   .++.++|||||||++|||++|+.||...+.......+...             
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLP---EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CCcccccccccccccChHHhcCCc---ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence                12235788899999986532   2345699999999999999999999876543322211110             


Q ss_pred             -----------CCCCCC-----CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          554 -----------GLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       554 -----------~~r~~~-----p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                 ......     ....++.+.++|.+||+.+|.+||++.+++.+-+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                       111111     134688999999999999999999999999987764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-34  Score=296.38  Aligned_cols=243  Identities=19%  Similarity=0.270  Sum_probs=190.2

Q ss_pred             eeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHH---HHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          347 QIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDL---LELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       347 ~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei---~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      .||+|+||.||++      +.||+|.+....... ........|.   ..+....||||+++++++.+.+. .++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK-LSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE-EEEEEecC
Confidence            3899999999974      579999886432221 1112222332   33444689999999999987765 89999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCC
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      +||+|.+++.+...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......  ......|
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~  157 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence            99999999877778999999999999999999999999999999999999999999999999998654332  1233468


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHcCCCCCCCCCccHHHHHHHHHhh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRPEIPKDCPQILKSLMIKCW  575 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~-~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL  575 (604)
                      +..|+|||.+.+..   .++.++||||+||++|||++|..||....... ...........+.+|..++..+.+++.+||
T Consensus       158 ~~~y~aPE~~~~~~---~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence            89999999987432   13345899999999999999999998653211 111112233456677788999999999999


Q ss_pred             hcCCCCCC-----CHHHHHHHHHHh
Q 007429          576 NNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       576 ~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      ..+|.+||     ++.+++++-+..
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCcccc
Confidence            99999999     999999875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.3e-35  Score=302.32  Aligned_cols=250  Identities=19%  Similarity=0.293  Sum_probs=195.4

Q ss_pred             EEeeeeeccCceEEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          343 EFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      .+.+.+|.|+++.||+    |+.+|+|++............+.+|+..+..++|+||+++++++.+.+. .+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~-~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE-LYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe-EEEEEeccCC
Confidence            4555667777887887    5689999997653444455678999999999999999999999987775 8999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-------
Q 007429          419 GSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-------  489 (604)
Q Consensus       419 GSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-------  489 (604)
                      |+|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999998653  4688999999999999999999999999999999999999999999999998765433221       


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------------  556 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-------------  556 (604)
                      ......++..|+|||.+.+...  .++.++|||||||++|||++|..||..................             
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQ--GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            1122346678999999875421  2345699999999999999999999876554433322211100             


Q ss_pred             -------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 -------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 -------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                         ...+..++.++.+++.+||..||++|||+++++++-+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                               011123346788999999999999999999999987754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=331.53  Aligned_cols=250  Identities=26%  Similarity=0.457  Sum_probs=215.2

Q ss_pred             CCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ...+..+.||+|+||+||+|-          +||||.+... .......++..|+..|.+++|||+++++|+|....  +
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~  772 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--L  772 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--H
Confidence            345567899999999999973          6889988743 34445667899999999999999999999998764  6


Q ss_pred             EEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .||++|+++|+|.|+++.++ .+.....+.|+.||++||.|||++++|||||.++|+|+.+-.++||.|||+++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            79999999999999997655 79999999999999999999999999999999999999999999999999998776554


Q ss_pred             Cccccc--CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          489 EATEYE--TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       489 ~~~~~~--~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ......  .-.+.|||-|.+....+..    ++|||||||++||++| |..||.+.... .+...+..+.|...|+.|+-
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~th----qSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTH----QSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCc----hhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccH
Confidence            433222  3457899999998765544    5999999999999999 99999886554 45667888889999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +++.+|.+||..|+..||+|+++...+.+...
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            99999999999999999999999999887654

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.3e-35  Score=300.21  Aligned_cols=244  Identities=24%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             EEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      .....||+|+||.||++      +.+++|++....  ......+.+|+..++.++|+||+++++.+...+. .++||||+
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~   99 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVMEFL   99 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE-EEEEEecC
Confidence            33467999999999985      579999875322  2345568889999999999999999999988775 89999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCC
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  496 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~g  496 (604)
                      ++++|.+++. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..............+
T Consensus       100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            9999999874 456899999999999999999999999999999999999999999999999997655433222334567


Q ss_pred             CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCccHHHHHHHHHh
Q 007429          497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILKSLMIKC  574 (604)
Q Consensus       497 t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s~~l~~LI~kC  574 (604)
                      ++.|+|||.+.+..++    .++|+||||+++|+|++|..||...........+ ....+..  ....+++.+.+++.+|
T Consensus       179 ~~~y~~pE~~~~~~~~----~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         179 TPYWMAPELISRLPYG----PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             CccccCHHHhcCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCcccCCcccCCHHHHHHHHHH
Confidence            8899999998765544    4599999999999999999999876655443332 2222222  2345788999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHh
Q 007429          575 WNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~~~  595 (604)
                      |+.+|.+||++.+++.+=+..
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~  274 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLA  274 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHh
Confidence            999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-35  Score=321.01  Aligned_cols=242  Identities=20%  Similarity=0.273  Sum_probs=188.1

Q ss_pred             CCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ...|.+.+.||+|+||.||++.      .|++|....        ..+.+|+.++.+++|+|||++++++...+. .++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~-~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGL-TCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEEE
Confidence            3578999999999999999964      588885431        124689999999999999999999987775 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-  490 (604)
                      ||++. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........ 
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99995 5898888543 47999999999999999999999999999999999999999999999999998765332211 


Q ss_pred             -ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHHc-CCC-CCCC
Q 007429          491 -TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-------PVQAAVGIAAC-GLR-PEIP  560 (604)
Q Consensus       491 -~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-------~~~~~~~i~~~-~~r-~~~p  560 (604)
                       .....||+.|+|||++.+..++    .++|||||||++|||++|..|+....       ....+..++.. +.. ..++
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~----~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYT----PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCC----chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence             1234689999999999876544    45999999999999999876543211       11222222221 110 0011


Q ss_pred             -------------------------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          561 -------------------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       561 -------------------------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                                     ...+..+.+||.+||+.||.+|||+.|++++-+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence                                           0234578999999999999999999999998554

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-35  Score=295.38  Aligned_cols=245  Identities=20%  Similarity=0.301  Sum_probs=197.4

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      |++.+.||.|++|.||++      +.+++|.+............+.+|+..++.++|+||+++++++.+... .++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD-LYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC-EEEEEec
Confidence            567789999999999995      468999887554443445667889999999999999999999987765 9999999


Q ss_pred             ccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          416 MEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       416 ~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      +++ +|.+++.. ...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||.+.............
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            976 88888755 3588999999999999999999999999999999999999999999999999987665433222234


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----------------
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----------------  557 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----------------  557 (604)
                      .++..|+|||.+.+..   ..+.++|+||||+++|+|++|..||...+..+....+......+                 
T Consensus       159 ~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         159 VVTRWYRAPELLLGDK---GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCcccccCcHHHhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            5778899999987541   24456999999999999999999998776655443332211000                 


Q ss_pred             -----------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 -----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 -----------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                 ...+.++.++.++|.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                       1123467889999999999999999999999876

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-34  Score=295.16  Aligned_cols=238  Identities=18%  Similarity=0.265  Sum_probs=186.3

Q ss_pred             CCeEEeeee--eccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFIDQI--GPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~~~L--G~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ++|++.+.+  |+|+||.||++      +.+++|.+.......   .+  .++..+. .+||||+++++.+...+. .++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e--~~~~~~~-~~h~~iv~~~~~~~~~~~-~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IE--PMVHQLM-KDNPNFIKLYYSVTTLKG-HVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hh--HHHHHHh-hcCCCEEEEEEEEecCCe-eEE
Confidence            455666655  99999999985      468888876432111   11  1111111 279999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+++|+|.+++..+..+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......   
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            999999999999997777899999999999999999999999999999999999999998 9999999997655422   


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH-HH-HcCCCCCCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-IA-ACGLRPEIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~-i~-~~~~r~~~p~~~s~~l~  568 (604)
                       ....++..|+|||.+.+..++    .++||||||+++|||++|..||........... .. ........+..+++.+.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~----~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYD----VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN  238 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCC----chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence             234578899999999876554    359999999999999999999985443221111 11 11233455667899999


Q ss_pred             HHHHHhhhcCCCCCCC-HHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQ-FSEIISLL  592 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT-~~ELL~~L  592 (604)
                      ++|.+||+.+|.+||+ ++++++|=
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCC
Confidence            9999999999999996 69998763

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.7e-35  Score=306.44  Aligned_cols=247  Identities=21%  Similarity=0.287  Sum_probs=194.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC-CcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-HGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~-~~l~L  411 (604)
                      ++|++.+.||+|+||.||+|      +.+++|++............+.+|+..+.++ +||||++++++|...+ ...|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            67889999999999999985      5689998864332223334567899999999 9999999999987543 34899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  489 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--  489 (604)
                      ||||+++ +|.+++.+. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  
T Consensus        87 v~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          87 VFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             Eeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            9999975 999988654 788999999999999999999999999999999999999999999999999875543221  


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------
Q 007429          490 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  556 (604)
Q Consensus       490 ---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------  556 (604)
                         ......+++.|+|||.+.+..   ..+.++||||||+++|+|++|..||....+......+......          
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLGST---RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             cCcchhcccccccccCceeeeccc---cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence               122335788999999886532   2334699999999999999999999876554433222111100          


Q ss_pred             -------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          557 -------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       557 -------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                         ......++.++.++|.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                               01123468899999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-35  Score=323.30  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=219.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ...|.+++.||+|.|+.|..+      ..||||.+....-.......+.+|+.+|..++|||||+++.+...+.. +|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~-lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT-LYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce-eEEE
Confidence            367899999999999999985      589999997655555455568999999999999999999999988876 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+.+|.+++++.++++..+..+..++.|+.+|++|||+++|||||||++||||+.+.++||+|||++..+... ....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~lq  212 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LMLQ  212 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-cccc
Confidence            999999999999999998888999999999999999999999999999999999999999999999999887743 3455


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ..+|++.|.|||...+..+...   .+|+||+|+++|-|+.|..||.+.+-.......+...++  +|-.++.+..++|+
T Consensus       213 t~cgsppyAaPEl~~g~~y~gp---e~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLr  287 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGP---EVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLR  287 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCc---ceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHH
Confidence            6689999999999999886654   589999999999999999999987766555555555555  55566778999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +++-.+|.+|++.++|.++-|.-.
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccch
Confidence            999999999999999999887643

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-36  Score=326.74  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             eEEeeeeeccCceEEEEeE------EEEE--EEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEEE
Q 007429          342 LEFIDQIGPNSFKGVYKGK------RVGI--EKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  412 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk------~VAI--Kklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~LV  412 (604)
                      .++-..||+|+|.+||+|-      .||=  +++....+......++..|+.+|+.|+|||||+||.++.+.. ..+-+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            3566789999999999963      2331  112222233333467899999999999999999999998765 447899


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CceeccCCCCceEEcCC-CcEEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--GVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~--gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~~~~~  489 (604)
                      +|++..|+|..|+++.++++...+..|+.||++||.|||++  .|||||||-+||+|+.+ |.|||+|+|||+.......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            99999999999999999999999999999999999999998  59999999999999754 7899999999987654332


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC-ccHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD-CPQILK  568 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~-~s~~l~  568 (604)
                        ....|||.|||||.+. ..    |+...||||||+.+.||+|+.+||..+.....+++.+..|..|.-... -.++++
T Consensus       202 --ksvIGTPEFMAPEmYE-E~----YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  202 --KSVIGTPEFMAPEMYE-EN----YNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             --ceeccCccccChHHHh-hh----cchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence              2368999999999987 33    444599999999999999999999999988888888888877654333 368999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+|.+|+.. .++|||+.|||.+-....
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            999999999 899999999998755443

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=304.02  Aligned_cols=252  Identities=18%  Similarity=0.269  Sum_probs=197.6

Q ss_pred             CCeE-EeeeeeccCceEEEEe------EEEEEEEeecCCCCch------------HHHHHHHHHHHHHhCCCCceeEEEE
Q 007429          340 DNLE-FIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------------YEFELRKDLLELMTCGHKNILQFYC  400 (604)
Q Consensus       340 ~~y~-i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~------------~~~~~~~Ei~~L~~L~HpnIVkl~g  400 (604)
                      ++|. +.+.||.|+||.||++      +.|++|+++.......            ....+.+|+..+..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 4577999999999996      4689998864432210            1224678999999999999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      ++...+. .++||||+. |+|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus        88 ~~~~~~~-~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDF-INLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCc-EEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            9987775 899999997 59999987777899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC--------------CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 007429          481 VTACKSV--------------GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA  546 (604)
Q Consensus       481 a~~~~~~--------------~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~  546 (604)
                      +......              ........+++.|+|||.+.+..   .++.++|||||||++|||++|..||...+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8655411              11112234577899999987543   234569999999999999999999998776554


Q ss_pred             HHHHHHcCCCC--------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          547 AVGIAACGLRP--------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       547 ~~~i~~~~~r~--------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ...+......+                          .....++..+.+++.+||+.+|++||++++++.+-+...
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            44332211000                          011345788999999999999999999999999877643

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.2e-35  Score=304.46  Aligned_cols=248  Identities=21%  Similarity=0.325  Sum_probs=192.0

Q ss_pred             eeeecc--CceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          346 DQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       346 ~~LG~G--~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      ..||+|  +||.||++      +.||+|.+............+.+|+.++..++||||++++++|..... .++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-LWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc-eEEEEeccc
Confidence            356666  99999984      579999987544444444567888988888999999999999988775 899999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc-----
Q 007429          418 GGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-----  490 (604)
Q Consensus       418 gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~-----  490 (604)
                      +++|.+++.+.  ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++++|||.+.........     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999998653  35899999999999999999999999999999999999999999999999864332221111     


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-------------
Q 007429          491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-------------  555 (604)
Q Consensus       491 --~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-------------  555 (604)
                        .....++..|+|||++.+...  .++.++|||||||++|||++|..||.................             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLY--GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccCccCccChhhhcCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence              112234567999999976432  234569999999999999999999987655443332221110             


Q ss_pred             --------------------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          556 --------------------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       556 --------------------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                                      +...+..+++.+.++|++||..||++|||+++++++-+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                            01112346678999999999999999999999998877543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=298.92  Aligned_cols=247  Identities=19%  Similarity=0.250  Sum_probs=188.3

Q ss_pred             CeEEeeeeeccCceEEEEeE--------EEEEEEeecCC-CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~-~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~  410 (604)
                      .|++.+.||+|+||.||+|.        .+|+|.+.... ........+.+|+.++..++||||+++++++.+.+ ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47889999999999999864        58999987532 11222345678999999999999999999998772 3489


Q ss_pred             EEEecccCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC----CCcEEEEecCCc
Q 007429          411 VVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----HGNVCLGDMGIV  481 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~-----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~----~g~vKL~DFGla  481 (604)
                      +||||+++ +|.+++...     ..+++..+..++.||+.||.|||+++++||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777776422     26889999999999999999999999999999999999999    999999999998


Q ss_pred             cccccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH---------HHHH
Q 007429          482 TACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ---------AAVG  549 (604)
Q Consensus       482 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~---------~~~~  549 (604)
                      ........   ......+++.|+|||.+.+..   .++.++|||||||++|+|++|.+||.......         ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            76543222   122235678899999886542   23446999999999999999999997543221         0000


Q ss_pred             HHH------------------------cCCCCCCC-----------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          550 IAA------------------------CGLRPEIP-----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       550 i~~------------------------~~~r~~~p-----------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      +..                        ......++           ...+..+.+++.+||+.||++|||+.|++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000                        00111111           1456789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-34  Score=296.25  Aligned_cols=248  Identities=18%  Similarity=0.302  Sum_probs=195.4

Q ss_pred             CeEEeeeeeccCceEEEEe---------EEEEEEEeecCCCC--chHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~~--~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +|++.+.||+|+||.||++         +.+++|.++.....  ......+.+|+.++.++ +||||+++++.+..... 
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~-   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK-   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE-
Confidence            4788999999999999975         35889988743221  12234577899999998 69999999999877665 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .++||||+++|+|.+++.+...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            89999999999999998777789999999999999999999999999999999999999999999999999976644322


Q ss_pred             Cc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCCCCCCCcc
Q 007429          489 EA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       489 ~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .. .....++..|+|||.+.+...  ..+.++||||||+++|||++|..||.....   ......... ...+..|..++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSG--GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMS  236 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCC--CCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccC
Confidence            11 222357889999999876531  123459999999999999999999964322   122211121 23445677788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ..+.+++.+||+.||++|||+.++...|
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            9999999999999999999966554433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-34  Score=298.45  Aligned_cols=245  Identities=22%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             eEEeeeeeccCceEEEEeE------EEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      |...+.||+|+||.||+|+      .+++|++....... .....+.+|+..+..++|||++++++++.+... .|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT-AWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEEEEe
Confidence            5667889999999999964      68999886443322 233457789999999999999999999988765 899999


Q ss_pred             cccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.....    ...
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~  176 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS  176 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCC
Confidence            9965 78777754 45789999999999999999999999999999999999999999999999999754321    233


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..++..|+|||.+..... ..++.++|||||||++|+|++|..||...+.......+............++..+.+++.+
T Consensus       177 ~~~~~~y~aPE~~~~~~~-~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         177 FVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             ccccccccChhhccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            467888999999853211 1234569999999999999999999988777666665554443333445677889999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHH
Q 007429          574 CWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~  593 (604)
                      ||+.+|.+||++.+++.+-+
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         256 CLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             HccCChhhCcCHHHHhcCcc
Confidence            99999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-34  Score=299.66  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.|...+.||.|+||.||+|+      .+++|.+..... .......+.+|+..++.++|+|++++++++..... .++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe-eEEE
Confidence            446778899999999999864      588998864322 22233457789999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+. |+|.+++.. ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++.....    .
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence            99997 588877643 45689999999999999999999999999999999999999999999999999765432    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+... ...+.++|||||||++|+|++|..||...........+.........+..++..+.++|
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (308)
T ss_pred             ccccCCccccCHHHHhhccc-CCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence            23457889999999853211 12345699999999999999999999877665555554444333333456888999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+||..+|.+||++.+++.+.+....
T Consensus       248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         248 DSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHhhCCcccCCCHHHHhhCcccccc
Confidence            99999999999999999998776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=304.15  Aligned_cols=247  Identities=19%  Similarity=0.291  Sum_probs=191.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l  409 (604)
                      ++|++.+.||+|+||.||+|      +.|++|.+.... .......+.+|+.++..++|+||+++++++....    ..+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            68999999999999999986      479999986432 2233455778999999999999999999876543    237


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+|+||+.+ +|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            999999975 888877 445799999999999999999999999999999999999999999999999999876543221


Q ss_pred             c---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH--------------
Q 007429          490 A---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--------------  552 (604)
Q Consensus       490 ~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~--------------  552 (604)
                      .   .....+++.|+|||.+.+..   .++.++|||||||++|+|++|+.||...........+..              
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSK---GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            1   12235788899999875432   234469999999999999999999976543322211110              


Q ss_pred             -c---------CCCCC-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          553 -C---------GLRPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       553 -~---------~~r~~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                       .         .....     .....++++.++|.+||+.+|.+|||+.+++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp  293 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP  293 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence             0         00000     1124567899999999999999999999999983

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=287.58  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=198.1

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ||.|+||.||++      +.+++|.+....... .....+..|+.++..++|+||+++++.+..+.. .++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe-eEEEEecCCCCc
Confidence            699999999984      578999886543222 234467888999999999999999999887765 899999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcc
Q 007429          421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  500 (604)
Q Consensus       421 L~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y  500 (604)
                      |.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            99999777789999999999999999999999999999999999999999999999999987655433334455678899


Q ss_pred             cccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCC
Q 007429          501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS  580 (604)
Q Consensus       501 ~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~  580 (604)
                      +|||.+.+...+    .++|+||||+++|++++|..||...........+..  ....+|...+..+.+++.+||..||+
T Consensus       160 ~~Pe~~~~~~~~----~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         160 LAPEVLLGKGYG----KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             cChHHhCCCCCC----chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            999998766533    359999999999999999999987665444444333  45567888899999999999999999


Q ss_pred             CCCCH---HHHHHH
Q 007429          581 KRPQF---SEIISL  591 (604)
Q Consensus       581 kRPT~---~ELL~~  591 (604)
                      +||++   ++++.+
T Consensus       234 ~R~~~~~~~~l~~~  247 (250)
T cd05123         234 KRLGSGGAEEIKAH  247 (250)
T ss_pred             hCCCcccHHHHHhC
Confidence            99999   676654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-34  Score=297.56  Aligned_cols=249  Identities=20%  Similarity=0.315  Sum_probs=192.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      .++|++.+.||+|+||.||+|      +.+++|.+............+.+|+..++.++||||+++++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            378999999999999999985      468999886543333233456789999999999999999998865433     


Q ss_pred             --cEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          408 --GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       408 --~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                        .+++||||+.+ +|...+.. ...+++..+..++.||+.||.|||++|++|+||||+||++++++.+||+|||++...
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              27999999976 77776654 447999999999999999999999999999999999999999999999999998755


Q ss_pred             ccCCCcc-----------cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc
Q 007429          485 KSVGEAT-----------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       485 ~~~~~~~-----------~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~  553 (604)
                      .......           ....+++.|+|||.+.+..   .++.++|||||||++|||++|.+||...+.......+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER---RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCC---ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            4322111           1124577899999886542   2344699999999999999999999877665544333221


Q ss_pred             CCCC---------------------CCC-------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          554 GLRP---------------------EIP-------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       554 ~~r~---------------------~~p-------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ...+                     ..+       ...++.+.+++.+||+.||.+|||+.+++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1100                     001       2334678899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-35  Score=315.77  Aligned_cols=256  Identities=21%  Similarity=0.293  Sum_probs=205.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      ....+....|+++++||+||-+.||+.     ..+|+|++.........-..+.+|+..|.+| +|.+||++|+|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            345678889999999999999999994     4688888775555555566789999999998 7899999999988877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l-~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . +|+||||-+- +|..+|.+.... +.-.+..+..|++.|+.++|.+||||.||||.|+|+- .|.+||+|||+|....
T Consensus       434 ~-lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  434 Y-LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             e-EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            6 9999997644 999999765543 3347788999999999999999999999999999986 6889999999998776


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCC-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHcCC
Q 007429          486 SVGE--ATEYETDGYRWLAPEIIAGDPES-------VSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGL  555 (604)
Q Consensus       486 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s-------~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~-~~~~~i~~~~~  555 (604)
                      .+..  .....+||+.||+||.+.....+       .+...+|||||+||+||+|+.|+.||...... ..+..|..-+.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            5432  34566899999999998754333       22345799999999999999999999876543 33334443334


Q ss_pred             CCCCCCCcc-HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 RPEIPKDCP-QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 r~~~p~~~s-~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..++|..-+ .++.++|+.||+.||.+||+..|+|.+
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            445555433 349999999999999999999999976

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-34  Score=302.97  Aligned_cols=249  Identities=18%  Similarity=0.265  Sum_probs=198.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      .++|++++.||+|+||.||++      +.||+|.+............+.+|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            477999999999999999985      579999986443333344567899999999999999999999876532     


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ..++||||+ +++|.+++. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  171 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE  171 (343)
T ss_pred             eEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence            258999999 679998874 457899999999999999999999999999999999999999999999999998754322


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                         .....+++.|+|||.+.+..   ..+.++|+|||||++|+|++|..||...+.......+.......          
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNWM---HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             ---ccccccCCcccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence               22345688899999986532   23456999999999999999999998766544433322211100          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                         .....+++.+.++|.+|+..||.+|||+.+++.+-+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~  302 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE  302 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence                               11245678899999999999999999999999765543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-35  Score=324.11  Aligned_cols=251  Identities=19%  Similarity=0.279  Sum_probs=184.9

Q ss_pred             CCCeEEeeeeeccCceEEEEeEEE-------EEEE---------------eecCCCCchHHHHHHHHHHHHHhCCCCcee
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGKRV-------GIEK---------------LKGCDKGNAYEFELRKDLLELMTCGHKNIL  396 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk~V-------AIKk---------------lk~~~~~~~~~~~~~~Ei~~L~~L~HpnIV  396 (604)
                      .++|++++.||+|+||.||++...       ++|.               .+...........+.+|+.++..++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            368999999999999999986421       1110               011111222344578999999999999999


Q ss_pred             EEEEEEEcCCCcEEEEEecccCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       397 kl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~-----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      ++++++.+.+. .|+|++++.+ +|.+++...     .......+..++.||+.||.|||++|||||||||+|||++.++
T Consensus       227 ~l~~~~~~~~~-~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        227 KIEEILRSEAN-TYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cEeEEEEECCe-eEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            99999988776 8999999955 777776432     1234567788999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCC-CCCCC--ChHHHH
Q 007429          472 NVCLGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA-AYAAC--SPVQAA  547 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~-Pf~~~--s~~~~~  547 (604)
                      .+||+|||+++........ .....||+.|+|||++.+..++    .++|||||||++|||++|.. ||...  .+...+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC----EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC----cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999998766543222 2234689999999999876544    45999999999999999875 44332  222222


Q ss_pred             HHHHHcCC--CCCC----------------------------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          548 VGIAACGL--RPEI----------------------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       548 ~~i~~~~~--r~~~----------------------------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..++....  ...+                            ...++..+.++|.+||+.||.+|||+.|++.+-+..
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            22221100  0000                            013456778889999999999999999999986653

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.5e-34  Score=299.36  Aligned_cols=249  Identities=20%  Similarity=0.245  Sum_probs=195.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|++++.||.|+||.||++      +.+++|++............+.+|+.++..++||||+++++++.......++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4578999999999999999985      4689998864333333445677899999999999999999999775545899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+ +++|.+++. ...+++..+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++......   .
T Consensus        88 v~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~  162 (328)
T cd07856          88 VTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---M  162 (328)
T ss_pred             Eeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---c
Confidence            99999 558988874 456888889999999999999999999999999999999999999999999998654321   2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-------------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA-------------------  552 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~-------------------  552 (604)
                      ....++..|+|||.+.+..   .++.++|||||||++|+|++|..||...........+..                   
T Consensus       163 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQ---KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             CCCcccccccCceeeeccC---CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence            2335678899999876522   234569999999999999999999987654322111110                   


Q ss_pred             -----cCCCCC-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          553 -----CGLRPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       553 -----~~~r~~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                           ......     ....+++.+.++|.+||+.+|++||++.+++.+=+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence                 000111     113467899999999999999999999999987443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=291.20  Aligned_cols=243  Identities=21%  Similarity=0.301  Sum_probs=191.9

Q ss_pred             eEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      |++.+.||.|+||.||+|.      .+++|++...... .......+|+..+++++ |+||+++++++.+.+. .++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~-~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE-LYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc-EEEEEe
Confidence            5788999999999999864      5899988643322 22334567888899998 9999999999988665 899999


Q ss_pred             cccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          415 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       415 y~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |+ +|+|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence            99 779999886554  789999999999999999999999999999999999999999999999999876543222 22


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  557 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---------------  557 (604)
                      ...++..|+|||.+....   .++.++|+||||+++|||++|.+||...+..+....+......+               
T Consensus       157 ~~~~~~~~~aPE~~~~~~---~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CCCCcccccCceeeecCc---CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            345788899999886432   23446999999999999999999998766554443322110000               


Q ss_pred             -------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 -------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 -------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                   ......+..+.+++.+||+.+|.+||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence                         0011236789999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=289.44  Aligned_cols=244  Identities=19%  Similarity=0.249  Sum_probs=190.6

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCC----c
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENH----G  408 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~----~  408 (604)
                      |++.+.||.|+||.||+|      +.+++|.++...........+.+|+.++..+   +|+||+++++++.+.+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            578899999999999986      4689999875433333334455676665554   69999999999986542    3


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      ++++|||+.+ +|.+++.+..  .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            8899999975 8999886533  589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  556 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------  556 (604)
                      ... .....+++.|+|||.+.+...+    .++|+|||||++|||++|.+||...+..+....+......          
T Consensus       160 ~~~-~~~~~~~~~~~~PE~~~~~~~~----~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         160 EMA-LTSVVVTLWYRAPEVLLQSSYA----TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             Ccc-cccccccccccChHHhccCCCC----CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            321 2223467889999999776544    4599999999999999999999887766555444321100          


Q ss_pred             --------CC-------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          557 --------PE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       557 --------~~-------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                              ..       .....++.+.+++.+||+.||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                    00       011345778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=292.91  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=202.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---  405 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---  405 (604)
                      ..++.++|.+.++||+|||+-||.++      .+|+|++.-..  ........+|+..-++++||||++++++...+   
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34778999999999999999999854      78899987433  33455678999999999999999998876533   


Q ss_pred             -CCcEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCcEEEEec
Q 007429          406 -NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       406 -~~~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~vKL~DF  478 (604)
                       .+..||+++|...|||.+.+..    +..+++.+++.++.+||+||++||+..  +.||||||.|||+++.+.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence             3458999999999999999853    336999999999999999999999998  999999999999999999999999


Q ss_pred             CCccccccC----CCc-----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 007429          479 GIVTACKSV----GEA-----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG  549 (604)
Q Consensus       479 Gla~~~~~~----~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~  549 (604)
                      |.++...-.    .+.     ......|..|.|||.+.-...+ ..+.++|||||||++|+|+.|..||...-....-..
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~-ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC-TITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc-ccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            997654211    000     1112357889999988765444 356789999999999999999999974211100001


Q ss_pred             HHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          550 IAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       550 i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .........+|.  .+++.+.++|..|++.||.+||+..+++.++..+.
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111122222332  37899999999999999999999999999998753

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=290.54  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      |++.+.||+|+||.||+|      +.+++|.+............+..|+..++.++|+||+++++++.+.+. .++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK-LYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc-eEEEecC
Confidence            567789999999999984      578999987654333334556789999999999999999999987765 9999999


Q ss_pred             ccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          416 MEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       416 ~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      +++ +|.+++.+. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            985 999999765 579999999999999999999999999999999999999999999999999987654433222333


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----------------C--
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------R--  556 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----------------r--  556 (604)
                      .++..|+|||.+.+..   .++.++|||||||++|||++|..||...+.......+.....                .  
T Consensus       159 ~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         159 VVTLWYRAPEILLGSK---HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             ccCcCcCChHHhcCCc---CCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            4567899999987551   234459999999999999999999987665544333221100                0  


Q ss_pred             -C--------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          557 -P--------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       557 -~--------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                       +        ...+..+..+.+++.+||..||++||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             0        0011346789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=307.22  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=206.3

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHH-HHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFE-LRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~-~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      .+...+|.++..||+|+||.|.++.      .+|||++++.-.-...+.+ ...|-++|.-. +-|.+++++..|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            5677899999999999999999864      5889988754322211111 12233333332 56889999988877765


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|+||||+.||+|-..+..-+++.+..+..++.+|+.||-+||++|||+||||.+||+++.+|++||+|||+++.-...
T Consensus       425 -LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 -LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             -eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999877666


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      +..+...+|||.|+|||++..++|...    +|.|||||+||||+.|.+||.+....+....|...  ...+|..++.+.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgks----vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--nvsyPKslSkEA  577 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKS----VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--NVSYPKSLSKEA  577 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccc----hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--cCcCcccccHHH
Confidence            777788899999999999999988876    89999999999999999999998888888777754  456899999999


Q ss_pred             HHHHHHhhhcCCCCCCC
Q 007429          568 KSLMIKCWNNSPSKRPQ  584 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT  584 (604)
                      ..+....+.+.|.+|.-
T Consensus       578 v~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  578 VAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHHhhcCCccccC
Confidence            99999999999999953

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-34  Score=299.94  Aligned_cols=249  Identities=16%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++.+.||+|+||.||+|      +.||+|++............+.+|+.++.+++||||+++++++....     .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            378999999999999999985      57999998754333333455778999999999999999999886432     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      ..|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus        96 ~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-  172 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  172 (345)
T ss_pred             cEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence            368888887 779998874 44689999999999999999999999999999999999999999999999999865432 


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  555 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------  555 (604)
                        ......++..|+|||.+.+..   .++.++|||||||++|||++|..||...........+.....            
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             --cccccccCCCccCHHHHhCcc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence              223346788899999886521   234469999999999999999999987655443332221100            


Q ss_pred             ------------CCC-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 ------------RPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 ------------r~~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                  .+.     .....++++.++|.+|+..||.+||++.+++.+-+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence                        000     1123578899999999999999999999999987654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=342.48  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=220.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ....+..++|++++.||+|+||.|...      +.+|.|++.+.... ......|..|-.+|..-+.+-||.++-.|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            445567899999999999999999974      46788887653222 11233466666677777789999999999998


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ++ +|+||||++||+|-.++.+..++++++++.|+..|+.||.-||+.|+|||||||+|||||..||+||+|||.+-.+.
T Consensus       148 ~~-LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  148 RY-LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             cc-eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            87 99999999999999999887799999999999999999999999999999999999999999999999999987777


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--C
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K  561 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s-~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~  561 (604)
                      .++. .+...+|||.|.+||++...... ..|...+|.||+||++|||+.|..||...+-.+.+-+|+.-.....+|  .
T Consensus       227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~  306 (1317)
T KOG0612|consen  227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET  306 (1317)
T ss_pred             CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence            5543 45667899999999999754333 455666999999999999999999999999988888888765566677  4


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT---~~ELL~~L~~~~~~  598 (604)
                      ++|++.++||.+.+. +|+.|..   ++++..|..+....
T Consensus       307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            689999999998665 5778887   99999887765443

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-34  Score=300.99  Aligned_cols=253  Identities=17%  Similarity=0.260  Sum_probs=196.7

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-  406 (604)
                      -|.+ .++|.+.+.||+|+||.||+|      +.+++|++............+.+|+.++..++||||+++++++.... 
T Consensus        10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            3555 368999999999999999985      46999998754333333445778999999999999999999987543 


Q ss_pred             ----CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          407 ----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       407 ----~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                          ...++|+||+.. +|..++  ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence                236899999965 777764  3468999999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-------
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-------  555 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-------  555 (604)
                      ....   ......+++.|+|||.+.+..   .++.++|||||||++|||++|+.||...+.......+.....       
T Consensus       166 ~~~~---~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         166 HADA---EMTGYVVTRWYRAPEVILNWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCCC---CCCCceeeecccChhhhcCcc---ccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            5432   122335678899999987532   234469999999999999999999987665444433222100       


Q ss_pred             --------------CCCC--------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHhh
Q 007429          556 --------------RPEI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL--LLRTN  596 (604)
Q Consensus       556 --------------r~~~--------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~--L~~~~  596 (604)
                                    .+..        ....++.+.++|.+||+.||.+||++.+++.+  ++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                          0001        12456789999999999999999999999977  54443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=311.35  Aligned_cols=245  Identities=20%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             eeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +.+..+.|...+.||+|+||.||-      |+.+|.|++.+... ...-+....+|-.+|..++.++||.+--+|.+.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            456667889999999999999997      44555565532211 11123335677788899999999999877877776


Q ss_pred             cEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       +|+||..|+||+|..+|...+  .|++..++.++.+|+-||++||..+||+|||||+|||+|++|+++|+|+|+|..+.
T Consensus       260 -LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  260 -LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             -eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence             999999999999998885443  79999999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH--HHHcCCCCCCCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--IAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~--i~~~~~r~~~p~~~  563 (604)
                      .... .....||.+|||||++.++.|+..    .|.||+||++|||+.|+.||...........  .........+|+.+
T Consensus       339 ~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s----~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF  413 (591)
T KOG0986|consen  339 EGKP-IRGRVGTVGYMAPEVLQNEVYDFS----PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF  413 (591)
T ss_pred             CCCc-cccccCcccccCHHHHcCCcccCC----ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence            5443 333489999999999999887766    7999999999999999999986544322211  12223455688999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQF  585 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~  585 (604)
                      +++.++|.+..|++||++|.-.
T Consensus       414 S~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccC
Confidence            9999999999999999999643

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-34  Score=302.57  Aligned_cols=248  Identities=19%  Similarity=0.294  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----  407 (604)
                      .++|++.+.||+|+||.||+|      +.+++|++............+.+|+.+++.++||||+++++++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            468999999999999999986      478999886433233334557789999999999999999987764432     


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence            389999999 5699998854 57999999999999999999999999999999999999999999999999998765332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                         .....++..|+|||.+.+..   ..+.++|||||||++|||++|..||...........+......+          
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence               23345788899999986532   23456999999999999999999998766654443332211000          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                         ......++.+.++|.+||..+|.+|||+.+|+.+-+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence                               0112457889999999999999999999999987443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-33  Score=295.51  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=192.4

Q ss_pred             CeEEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC---CCc
Q 007429          341 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE---NHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~---~~~  408 (604)
                      +|++.+.||+|+||.||+++        .+|+|++............+.+|+.++..+ +||||+++++.+...   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47889999999999999853        689998864333333345577899999888 699999999875432   233


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +++++||+. ++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            789999986 5999998777789999999999999999999999999999999999999999999999999987654322


Q ss_pred             C----cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-----------
Q 007429          489 E----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-----------  553 (604)
Q Consensus       489 ~----~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-----------  553 (604)
                      .    ......+++.|+|||.+.+..   .++.++|+|||||++|+|++|.+||...+.......++..           
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQ---SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            1    112235788999999876531   2345699999999999999999999875543322211110           


Q ss_pred             ---------------CCCCC---CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          554 ---------------GLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       554 ---------------~~r~~---~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                                     .....   ....++..+.+++.+||+.||.+|||+.+++.+=+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~  294 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY  294 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence                           00011   12245788999999999999999999999987754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.9e-34  Score=299.28  Aligned_cols=248  Identities=16%  Similarity=0.210  Sum_probs=193.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  406 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-------  406 (604)
                      .+|++.+.||.|+||.||+|      +.|++|++.....  .....+.+|+.+++.++||||+++++++....       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            68999999999999999985      5799999875443  23355778999999999999999998776542       


Q ss_pred             ------CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecC
Q 007429          407 ------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMG  479 (604)
Q Consensus       407 ------~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFG  479 (604)
                            ...|+||||+++ +|.+++. ...+++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                  137899999974 9988874 446899999999999999999999999999999999999974 5578999999


Q ss_pred             CccccccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--
Q 007429          480 IVTACKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--  554 (604)
Q Consensus       480 la~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--  554 (604)
                      ++.........   .....++..|+|||.+.+..   .++.++|||||||++|+|++|..||...++......+....  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCcc---ccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            98765332111   12234678899999875432   23456999999999999999999998766554443322210  


Q ss_pred             ---------------------CCCC-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          555 ---------------------LRPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       555 ---------------------~r~~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                           ....     ....++.++.++|.+||..||.+|||+.+++.+=+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence                                 0110     123467889999999999999999999999987544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.9e-35  Score=335.20  Aligned_cols=244  Identities=23%  Similarity=0.393  Sum_probs=190.6

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc---------
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD---------  404 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~---------  404 (604)
                      .+|+.++.||+||||.|||      |+.+|||++.... .......+.+|+..|.+|+|||||++|..+.+         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            6788899999999999999      5689999998654 44455678999999999999999999964432         


Q ss_pred             --------------------------------------------------------------------------------
Q 007429          405 --------------------------------------------------------------------------------  404 (604)
Q Consensus       405 --------------------------------------------------------------------------------  404 (604)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------CC-------CcEEEEEecccCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcC
Q 007429          405 ----------------------EN-------HGLCVVTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHG  454 (604)
Q Consensus       405 ----------------------~~-------~~l~LVmEy~~gGSL~dlL~~~~~l-~~~~il~ia~qIa~gL~YLHs~g  454 (604)
                                            +.       ..+||.||||+.-+|.+++.++... .....++++.+|+.||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  00       2379999999998888888666544 57889999999999999999999


Q ss_pred             ceeccCCCCceEEcCCCcEEEEecCCccccc----c--------------CCCcccccCCCCcccccccccCCCCCCCCC
Q 007429          455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACK----S--------------VGEATEYETDGYRWLAPEIIAGDPESVSET  516 (604)
Q Consensus       455 IVHrDLKp~NILld~~g~vKL~DFGla~~~~----~--------------~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t  516 (604)
                      ||||||||.||++++++.|||+|||+|+...    .              .........||..|+|||.+.+..- ..|+
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~-~~Yn  796 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS-NKYN  796 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc-cccc
Confidence            9999999999999999999999999987621    0              0001233468999999999987643 4677


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC------CccHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 007429          517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK------DCPQILKSLMIKCWNNSPSKRPQFSEIIS  590 (604)
Q Consensus       517 ~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~  590 (604)
                      .|+|+||+|||++||+.   ||........+...+.   .+.+|.      +--+.-..+|+.++++||++|||+.|+|.
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            88999999999999986   5654322222222222   233332      22356789999999999999999999986


Q ss_pred             H
Q 007429          591 L  591 (604)
Q Consensus       591 ~  591 (604)
                      .
T Consensus       871 s  871 (1351)
T KOG1035|consen  871 S  871 (1351)
T ss_pred             c
Confidence            4

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=279.56  Aligned_cols=222  Identities=22%  Similarity=0.364  Sum_probs=186.3

Q ss_pred             eeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      +.+..+++.-+..||+|+||.|-+      |...|+|.+.. ........++.+|+.+.++. .+|++|.|||...++..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~-tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA-TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh-hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            677889999999999999998865      78999999984 34566677788999887764 78999999999998887


Q ss_pred             cEEEEEecccCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          408 GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL----~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                       ++|.||.|.- ||..+-    .++..+++..+-+++..|++||+|||++ .+||||+||+||||+.+|++||||||++.
T Consensus       120 -vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 -VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             -EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence             9999999966 887664    4566899999999999999999999987 89999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHcCCCCCCCC
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~-s~~~~~~~i~~~~~r~~~p~  561 (604)
                      .+.+. .......|.-.|||||.+..+.....|+.||||||||++++||.+++.||... ++.+.+.+++. ...|.+|.
T Consensus       198 ~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe-ep~P~Lp~  275 (282)
T KOG0984|consen  198 YLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE-EPSPQLPA  275 (282)
T ss_pred             eehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc-CCCCCCcc
Confidence            66543 23444578888999999998877778889999999999999999999999975 56666655554 44455554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7e-33  Score=318.35  Aligned_cols=142  Identities=22%  Similarity=0.397  Sum_probs=126.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|.+++.||+|+||.||+|      +.||+|+++...... .....+..|+..+..++||||+++++++..... +|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN-VYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE-EEEE
Confidence            68899999999999999985      579999987543222 233567888899999999999999999887775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999777789999999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=316.16  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=210.1

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC----CCc
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE----NHG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~----~~~  408 (604)
                      +-++|++.||.|.+|.||+++      ..|+|++... ..  .+.+++.|..+|+.+ .|||++.+||++.-.    ++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-ED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-cc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            566899999999999999853      5667776532 22  234455666666665 899999999998743    234


Q ss_pred             EEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      +|||||||.|||.-|+++.  ..++.+..+..|+..++.||.+||...++|||||-.|||++.+|.|||+|||++.....
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            9999999999999999953  55899999999999999999999999999999999999999999999999999988877


Q ss_pred             CCCcccccCCCCcccccccccCC-CCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCCCCcc
Q 007429          487 VGEATEYETDGYRWLAPEIIAGD-PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCP  564 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p~~~s  564 (604)
                      .........|||.|||||++... .....++.++|+||||++..||-.|.+|+....+...++.|..+..+. ..|...+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs  255 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS  255 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence            76677788999999999999754 345566778999999999999999999999999998887766543221 2367889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ..+.++|..||.+|..+||+..++++|
T Consensus       256 ~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  256 KKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             HHHHHHHHHHHhhccccCcchhhhccC
Confidence            999999999999999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=310.72  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=224.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----E--EEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----R--VGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----~--VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ...+++++..||-|+||.|-+.+    .  .|+|.+++...- ...+..+..|-.+|+.++.|+||++|..|.+..+ +|
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky-vY  496 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY-VY  496 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh-hh
Confidence            44678889999999999998743    2  566766544322 2234567888899999999999999999998886 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +.||-|-||.|+..|++.+.|+..+...++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+...... .
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-K  575 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999887654 4


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      +...+|||.|.|||++...+.+..    +|.||||+++|||++|.+||.+.+++.....|+.+-....+|..++....+|
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~a----vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRA----VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             eeeecCCcccccchhhhccCcchh----hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence            566799999999999998877765    8999999999999999999999999999988888877788999999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHHHHHHhhCc
Q 007429          571 MIKCWNNSPSKRPQ-----FSEIISLLLRTNNI  598 (604)
Q Consensus       571 I~kCL~~dP~kRPT-----~~ELL~~L~~~~~~  598 (604)
                      |++....+|.+|.-     ..+|-+|-|.....
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            99999999999976     78899998876543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5e-33  Score=277.62  Aligned_cols=220  Identities=20%  Similarity=0.268  Sum_probs=176.3

Q ss_pred             cCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHH
Q 007429          351 NSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL  424 (604)
Q Consensus       351 G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dl  424 (604)
                      |.||.||++      +.+++|.+....       ...+|...+....||||+++++++.+.+. .++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDS-VFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCe-EEEEEecCCCCCHHHH
Confidence            889999984      579999986432       12234444555679999999999987765 8999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccc
Q 007429          425 ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE  504 (604)
Q Consensus       425 L~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE  504 (604)
                      +.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||++......   .....++..|+|||
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence            977778999999999999999999999999999999999999999999999999987554332   22234567799999


Q ss_pred             cccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCC
Q 007429          505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ  584 (604)
Q Consensus       505 ~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT  584 (604)
                      .+.+..++    .++||||+|+++|||++|..|+......      ........+|..+++.++++|.+||+.||.+||+
T Consensus       153 ~~~~~~~~----~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         153 VGGISEET----EACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             ccCCCCCC----chhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence            98765544    4599999999999999999887643211      1112233467778899999999999999999999


Q ss_pred             H-----HHHHHH
Q 007429          585 F-----SEIISL  591 (604)
Q Consensus       585 ~-----~ELL~~  591 (604)
                      +     ++++.|
T Consensus       223 ~~~~~~~~~~~h  234 (237)
T cd05576         223 AGVAGVEDIKSH  234 (237)
T ss_pred             CCccchHHHHcC
Confidence            6     666543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-32  Score=324.39  Aligned_cols=239  Identities=20%  Similarity=0.320  Sum_probs=183.1

Q ss_pred             eEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      +...+.||+|+||.||+|+      .||+|++......      ...|+..+.+++|||||+++|+|.+++. .|+||||
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~-~~lv~Ey  764 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKG-AYLIHEY  764 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCC-CEEEEeC
Confidence            4556789999999999974      6899988643321      1245778889999999999999988775 8999999


Q ss_pred             ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN---DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       416 ~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLH---s~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      +++|+|.+++.   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......    ..
T Consensus       765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~  836 (968)
T PLN00113        765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DT  836 (968)
T ss_pred             CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CC
Confidence            99999999984   3889999999999999999999   6699999999999999999888875 665433221    11


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHc-----CCCCCC---
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-----VQAAVGIAAC-----GLRPEI---  559 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-----~~~~~~i~~~-----~~r~~~---  559 (604)
                      ...+++.|+|||++.+..++    .++|||||||++|||+||+.||.....     .+........     ..++..   
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~----~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        837 KCFISSAYVAPETRETKDIT----EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             CccccccccCcccccCCCCC----cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence            23578899999998876544    459999999999999999999853211     1111100000     001111   


Q ss_pred             ---CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          560 ---PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       560 ---p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                         +.....++.+++.+||+.||++||++.|+++.|+.+...+
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence               1122346788999999999999999999999999987644

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-33  Score=291.62  Aligned_cols=254  Identities=18%  Similarity=0.295  Sum_probs=206.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCC-----CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~-----~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      -.++|-++..||+|+|+.||++      +.||+|+-...+     +...+.....+|-.+-+.|.||.||++|++|.-+.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3467888999999999999995      678888754322     22223345678888889999999999999998777


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CceeccCCCCceEEc---CCCcEEEEecCCc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--GVAYRDLNSQRILLD---RHGNVCLGDMGIV  481 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~--gIVHrDLKp~NILld---~~g~vKL~DFGla  481 (604)
                      +.+|-|+|||+|.+|+.+|+.++.+++..++.|+.||+.||.||.+.  .|||-||||.|||+-   ..|.+||.|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            77999999999999999999999999999999999999999999976  699999999999995   3577999999999


Q ss_pred             cccccCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH--HHH
Q 007429          482 TACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--IAA  552 (604)
Q Consensus       482 ~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~--i~~  552 (604)
                      +.+.+....       +....||++|++||.+.-....++.+.|+||||+||++|.++.|+.||+.....+.+..  .+.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            887654332       34456999999999988776777888899999999999999999999987544433321  111


Q ss_pred             cCCCCCCC--CCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          553 CGLRPEIP--KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       553 ~~~r~~~p--~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ......+|  +-++++.+.+|++||++.-++|....++..+
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            22223344  3478999999999999999999998887643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=2.4e-31  Score=259.55  Aligned_cols=233  Identities=26%  Similarity=0.392  Sum_probs=189.6

Q ss_pred             CceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHH
Q 007429          352 SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI  425 (604)
Q Consensus       352 ~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL  425 (604)
                      +||.||+|      +.+++|.+........ ...+.+|+..+..++|+||+++++.+..... .++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDK-LYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCE-EEEEEeCCCCCCHHHHH
Confidence            47888874      5689998874433221 4668899999999999999999999987664 89999999999999998


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCccccccc
Q 007429          426 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI  505 (604)
Q Consensus       426 ~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~  505 (604)
                      .....++...+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....... ......+++.|++||.
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            766568999999999999999999999999999999999999999999999999987655432 2334467888999999


Q ss_pred             ccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC--ccHHHHHHHHHhhhcCCCCCC
Q 007429          506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--CPQILKSLMIKCWNNSPSKRP  583 (604)
Q Consensus       506 l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~--~s~~l~~LI~kCL~~dP~kRP  583 (604)
                      +.+...+    .++||||||+++|+|++|..||.....................+..  ++.++.+++.+||..+|++||
T Consensus       158 ~~~~~~~----~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      158 LLGKGYG----KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HccCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            8755443    3599999999999999999999874444444444443333322222  889999999999999999999


Q ss_pred             CHHHHHHH
Q 007429          584 QFSEIISL  591 (604)
Q Consensus       584 T~~ELL~~  591 (604)
                      ++.+++++
T Consensus       234 ~~~~~~~~  241 (244)
T smart00220      234 TAEEALQH  241 (244)
T ss_pred             CHHHHhhC
Confidence            99999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=299.11  Aligned_cols=238  Identities=21%  Similarity=0.311  Sum_probs=195.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHH-hCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~-~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .+.|++...+|.|+|+.|-.+      +..++|++......      ..+|+.++. .-+||||+++.+++.+..+ +|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~-~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKE-IYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCce-eee
Confidence            578899999999999999874      45678888654221      234443333 3489999999999988876 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE-cCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl-d~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||++.|+-|.+.+...+.+. ..+..|+++|+.|+.|||++|+|||||||+|||+ ++.|+++|+|||.++.....   
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            999999998888776555444 7788899999999999999999999999999999 69999999999998776543   


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....+-|..|.|||++...+++..    +|+||||++||+|++|+.||........+   ......+.+...+|.+.++|
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~a----cD~WSLGvlLy~ML~G~tp~~~~P~~~ei---~~~i~~~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEA----CDWWSLGVLLYEMLTGRTLFAAHPAGIEI---HTRIQMPKFSECVSDEAKDL  542 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcc----hhhHHHHHHHHHHHhCCCccccCCchHHH---HHhhcCCccccccCHHHHHH
Confidence            334456788999999997766554    99999999999999999999876655333   33334555668899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +++||+.||.+||++.++..+=|.
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999998877

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-32  Score=282.01  Aligned_cols=258  Identities=21%  Similarity=0.381  Sum_probs=208.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeEEEEEE-----------EeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIE-----------KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk~VAIK-----------klk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ....+...+++....+-+|.||.||.|.+..-|           .++... ....-..+..|-..+..+.|||+....++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            345566778899999999999999999655433           333211 11111235566666777899999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcE
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS--------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  473 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~--------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~v  473 (604)
                      +.++...-++++.++.-|+|..+|.-.        +.++..++..++.|++.||+|||++||||.||.++|++||+.-.+
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence            988765567889999999999999621        246777889999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      ||+|=.+++.+-.....  ......+..||+||.+....++..    +|||||||+||||+| |+.||...+|.+... .
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa----sDvWsfGVllWELmtlg~~PyaeIDPfEm~~-y  510 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA----SDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-Y  510 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch----hhhHHHHHHHHHHHhcCCCCccccCHHHHHH-H
Confidence            99999988755332111  122235678999999998877765    999999999999999 999999988877654 4


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +..|+|...|-+||+++..+|.-||+..|++||+|.++..-|.+..
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            6678999999999999999999999999999999999999887654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=8.5e-33  Score=280.57  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=198.4

Q ss_pred             CCeEEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..|+.++.||+|.||.||++          +.+|||+++.............+|+..++.++|||||.+..++...+..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57899999999999999996          25789999876555555556789999999999999999999998866569


Q ss_pred             EEEEecccCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC----CcEEEEecCC
Q 007429          410 CVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGI  480 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~-----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~----g~vKL~DFGl  480 (604)
                      ++++||.+. +|..+|.-     .+.++...+..++.||+.|+.|||++=|+||||||.|||+..+    |.|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999988 99998842     2468999999999999999999999999999999999999887    8999999999


Q ss_pred             ccccccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHH
Q 007429          481 VTACKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------VQAAV  548 (604)
Q Consensus       481 a~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---------~~~~~  548 (604)
                      ++.+.+.-..   ......|+.|.|||.+.|...   |+.+.||||+||++.||+|-.+.|.+...         .+.+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h---YT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH---YTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhccccc---ccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9877654322   122346889999999998753   55679999999999999998888864221         11222


Q ss_pred             HHHHc-CCCC--------CCC--------------------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          549 GIAAC-GLRP--------EIP--------------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       549 ~i~~~-~~r~--------~~p--------------------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .|... +.+.        .+|                          ..-++...+|+.++|+.||.+|.|+++.+++.-
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            22211 1100        011                          112344789999999999999999999998865


Q ss_pred             Hh
Q 007429          594 RT  595 (604)
Q Consensus       594 ~~  595 (604)
                      +.
T Consensus       340 F~  341 (438)
T KOG0666|consen  340 FT  341 (438)
T ss_pred             cc
Confidence            44

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.1e-32  Score=284.04  Aligned_cols=257  Identities=25%  Similarity=0.482  Sum_probs=197.9

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~---~~l~LV  412 (604)
                      +++.+++.||+|.||.||+|    ..||||++...+...   ...+.||..-..|+|+||+.|++.=..++   ..++||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            67899999999999999985    579999998554221   11234454444579999999997754333   238999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----c---CceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-----H---GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-----~---gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ++|.+.|||+|+|.+ ..++....++++..++.||+|||-     +   .|.|||||..|||+.++|...|+|+|||...
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            999999999999965 679999999999999999999994     2   4999999999999999999999999998766


Q ss_pred             ccCCC----cccccCCCCcccccccccCCCCCCCC--CcchhHHHHHHHHHHHHc----------CCCCCCCCCh-----
Q 007429          485 KSVGE----ATEYETDGYRWLAPEIIAGDPESVSE--TWMSNVYSFGMVIWEMVT----------GEAAYAACSP-----  543 (604)
Q Consensus       485 ~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~~~--t~kSDVWSlGvvLyELlT----------G~~Pf~~~s~-----  543 (604)
                      .....    ......||-+|||||++...-...-+  -..+||||||.++||+.-          ..+||.+.-+     
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            54422    24556799999999999753211111  135899999999999874          2678875322     


Q ss_pred             HHHHHHHHHcCCCCCCCCCcc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          544 VQAAVGIAACGLRPEIPKDCP-----QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       544 ~~~~~~i~~~~~r~~~p~~~s-----~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .+...-+-....+|.+|....     ..+.+||+.||..||.-|.|+--|.+.|.++.+..+
T Consensus       447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e  508 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE  508 (513)
T ss_pred             HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence            222222334567787776432     457889999999999999999999999999987543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=277.16  Aligned_cols=243  Identities=17%  Similarity=0.282  Sum_probs=192.9

Q ss_pred             CCeEEe-eeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHH-HhCCCCceeEEEEEEEcC---CCc
Q 007429          340 DNLEFI-DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLEL-MTCGHKNILQFYCVCVDE---NHG  408 (604)
Q Consensus       340 ~~y~i~-~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L-~~L~HpnIVkl~g~~~~~---~~~  408 (604)
                      ++|.+- ..||-|--|.|..      |+++|+|.+....       ..++|+..- +.-.|||||.+++++...   ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            566665 5899999999875      5678888886432       235666543 334899999999998643   345


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~  483 (604)
                      +.+|||+|+||.|...+..++  .|++.++..|+.||+.|+.|||+.+|.||||||+|+|...   +..+||+|||+|+.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            889999999999999997655  5999999999999999999999999999999999999965   44699999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHcCCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~----~~~~~~i~~~~~r~~~  559 (604)
                      .... ......+-||.|.|||++..++|+..    +|+||+||++|-|+.|.+||.....    ......|....+.-+-
T Consensus       214 t~~~-~~L~TPc~TPyYvaPevlg~eKydks----cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  214 TQEP-GDLMTPCFTPYYVAPEVLGPEKYDKS----CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             cCCC-ccccCCcccccccCHHHhCchhcCCC----CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            5532 23445577899999999998877665    8999999999999999999986432    2233444544443222


Q ss_pred             CC--CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          560 PK--DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       560 p~--~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      |+  .++++.+++|+.+|..+|++|.|+++++++-|-
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            22  468899999999999999999999999988663

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=285.02  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=201.9

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---Cc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HG  408 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~---~~  408 (604)
                      +.+.+.+++.+.||+|.||.||||    +.||||++....+   ..+..+++|..+-.+.|+||++|+++-....   ..
T Consensus       206 l~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  206 LLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             cccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            445677889999999999999997    5899999974332   2334455566666789999999998754332   24


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------cCceeccCCCCceEEcCCCcEEEEecC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND---------HGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs---------~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                      .+||++|.+.|||.++| +...+++....+++..+++||+|||+         ..|+|||||.+||||-.++...|+|||
T Consensus       283 ywLVt~fh~kGsL~dyL-~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYL-KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeEEeeeccCCcHHHHH-HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            78999999999999999 45579999999999999999999996         259999999999999999999999999


Q ss_pred             CccccccCCC--cccccCCCCcccccccccCCCCCC--CCCcchhHHHHHHHHHHHHcCC------------CCCC---C
Q 007429          480 IVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTGE------------AAYA---A  540 (604)
Q Consensus       480 la~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~--~~t~kSDVWSlGvvLyELlTG~------------~Pf~---~  540 (604)
                      +|..+.....  ......||.+|||||++.+.-.-.  ..-.+.||||+|.|||||++..            .||.   +
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9987654322  233468999999999998653211  1113579999999999999742            2333   1


Q ss_pred             C--ChHHHHHHHHHcCCCCCCCCCc-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          541 C--SPVQAAVGIAACGLRPEIPKDC-----PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       541 ~--s~~~~~~~i~~~~~r~~~p~~~-----s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .  +-.+.....+....||.+|...     ...+.+.+..||+.||+-|.|+.=+.+.++.+....+
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            1  1123333456667788888643     3568999999999999999999999999888876554

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=291.13  Aligned_cols=242  Identities=18%  Similarity=0.274  Sum_probs=202.0

Q ss_pred             eeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCC
Q 007429          346 DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG  419 (604)
Q Consensus       346 ~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gG  419 (604)
                      +.||+|.||+||-      |+.||||.+.+.+.....+.+++.|+.+|..+.||.||.+.-.|...+. +|+|||-+.| 
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-vFVVMEKl~G-  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-VFVVMEKLHG-  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-EEEEehhhcc-
Confidence            6799999999996      5789999998877777777889999999999999999999988988776 9999999966 


Q ss_pred             CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEEecCCccccccCCCccccc
Q 007429          420 SVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       420 SL~dlL~--~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      +..+.|.  ..+++++.....++.||+.||.|||-++|+|.||||+|||+.+..   .+||||||+|+.+..... ....
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-RrsV  726 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRSV  726 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhhh
Confidence            5555553  345899999999999999999999999999999999999997664   599999999998765433 3455


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  574 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kC  574 (604)
                      .|||.|+|||++...+|...    -|+||+||++|.-++|..||....+...........+++..=..++++..+||...
T Consensus       727 VGTPAYLaPEVLrnkGyNrS----LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRS----LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             cCCccccCHHHHhhcccccc----ccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            89999999999999888766    79999999999999999999875443322222222333333346789999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHH
Q 007429          575 WNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~~  594 (604)
                      |+..-.+|-+.+..+.|.|-
T Consensus       803 LqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             HHHHHHHhcchHhhccchhh
Confidence            99999999999999988764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=272.27  Aligned_cols=245  Identities=18%  Similarity=0.298  Sum_probs=205.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchH-HHHHHHHHHHHHh-CCCCceeEEEEEEEc
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAY-EFELRKDLLELMT-CGHKNILQFYCVCVD  404 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~-~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~  404 (604)
                      ..|.+...+|.++..||+|+|..|..+      +.+|+|++++.-....+ ...++.|-.+... -+||.+|-+...|+.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            468888999999999999999999875      35777777654322221 1224444444443 489999999988888


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      +.. +++|.||++||+|--.+.+.++++++.++.+..+|+.||.|||++|||+||||..|+|||..|++||.|+|+++..
T Consensus       323 esr-lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cce-EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            775 9999999999999998888899999999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC-------CChHHHHHHHHHcCCCC
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-------CSPVQAAVGIAACGLRP  557 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~-------~s~~~~~~~i~~~~~r~  557 (604)
                      -..++.+...+|||.|.|||++++..|.+.    .|.|++||+++||+.|+.||..       .+.++.++.++. ....
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfs----vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ekqi  476 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFS----VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EKQI  476 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCce----ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hhcc
Confidence            777888888999999999999999988776    8999999999999999999962       233444444433 2344


Q ss_pred             CCCCCccHHHHHHHHHhhhcCCCCCC
Q 007429          558 EIPKDCPQILKSLMIKCWNNSPSKRP  583 (604)
Q Consensus       558 ~~p~~~s~~l~~LI~kCL~~dP~kRP  583 (604)
                      .+|..++-....+++.-|.+||.+|.
T Consensus       477 riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cccceeehhhHHHHHHhhcCCcHHhc
Confidence            58888888899999999999999985

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=295.75  Aligned_cols=250  Identities=19%  Similarity=0.297  Sum_probs=190.6

Q ss_pred             EEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----CcEEE
Q 007429          343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCV  411 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~~l~L  411 (604)
                      ..-+.||+|+||.||+|      +.||||.++..... ......-+|+.+|++++|+|||+++++=.+..     ..-.+
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhccc-chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44577999999999985      58999999864422 23445679999999999999999998754432     12469


Q ss_pred             EEecccCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--CC--cEEEEecCCcccc
Q 007429          412 VTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HG--NVCLGDMGIVTAC  484 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~---~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--~g--~vKL~DFGla~~~  484 (604)
                      |||||.||||+..|.+   ...|++..++.+..+++.||.|||++|||||||||.||++-.  +|  ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            9999999999999964   347999999999999999999999999999999999999943  33  3799999999988


Q ss_pred             ccCCCcccccCCCCcccccccccC-CCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHcC-----
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAG-DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACG-----  554 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~----~~~~~~i~~~~-----  554 (604)
                      .++. ......||..|++||.... ..|+..    +|.|||||++|++.||..||.....    .+..+.+....     
T Consensus       175 ~d~s-~~~S~vGT~~YLhPel~E~q~~y~~t----VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  175 DDNS-LFTSLVGTEEYLHPELYERQKKYTAT----VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             CCCC-eeeeecCchhhcChHHHhhccCcCce----eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            7665 4556689999999999985 444433    8999999999999999999974322    22333333221     


Q ss_pred             --------------CCCCCCCCccHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHhhCc
Q 007429          555 --------------LRPEIPKDCPQI----LKSLMIKCWNNSPSKRP--QFSEIISLLLRTNNI  598 (604)
Q Consensus       555 --------------~r~~~p~~~s~~----l~~LI~kCL~~dP~kRP--T~~ELL~~L~~~~~~  598 (604)
                                    ...++|-..++.    +...+..++.-+|.+|=  .+.+....+..+.+.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence                          111233344433    44566667788899988  788888777777654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.4e-31  Score=288.33  Aligned_cols=246  Identities=19%  Similarity=0.296  Sum_probs=192.7

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeEEEEE------EEeecCCCCchH-HHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI------EKLKGCDKGNAY-EFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk~VAI------Kklk~~~~~~~~-~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      +.|-..+..-|..++.||-|+||.|.++++|..      |.+++.+.-... -..++.|-.+|..-..+-||+||-.|.+
T Consensus       621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            455556677799999999999999999876654      444433322111 1235666777888889999999999998


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ++. +|+||+|++||++-.+|-+-+-|.+..++.++.++..|+++.|..|+|||||||+|||||.+|+|||.||||++.+
T Consensus       701 kdn-LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  701 KDN-LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             CCc-eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence            886 9999999999999999988888999999999999999999999999999999999999999999999999998655


Q ss_pred             ccCCCcc------------------------------------------cccCCCCcccccccccCCCCCCCCCcchhHH
Q 007429          485 KSVGEAT------------------------------------------EYETDGYRWLAPEIIAGDPESVSETWMSNVY  522 (604)
Q Consensus       485 ~~~~~~~------------------------------------------~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVW  522 (604)
                      .+.....                                          ....||+.|+|||++...++...    +|.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~----cdww  855 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL----CDWW  855 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc----chhh
Confidence            3211100                                          11248999999999987766544    9999


Q ss_pred             HHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--CCCCCCCCccHHHHHHHHHhhhcCCCCCC
Q 007429          523 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPKDCPQILKSLMIKCWNNSPSKRP  583 (604)
Q Consensus       523 SlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--~r~~~p~~~s~~l~~LI~kCL~~dP~kRP  583 (604)
                      |.|||||||+.|++||-..++.+.-.+++...  +......+++++..++|.+... +++.|.
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            99999999999999999888776555444332  2333446788999998887432 344553

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=252.67  Aligned_cols=247  Identities=18%  Similarity=0.278  Sum_probs=201.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +|...++||+|.||+||+|      +.||+|.++..+..........+||-+|+.+.|.|||+++++...++. +-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk-ltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce-eEEeHH
Confidence            4566789999999999996      479999998766555555667899999999999999999999988775 899999


Q ss_pred             cccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||.. +|..+... ++.++...+..++.|+++||.|+|+++++||||||.|.||+.+|.+|++|||+++.+.-.-.-...
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            9976 88888753 568999999999999999999999999999999999999999999999999999877644333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCC---------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP---------------  557 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~---------------  557 (604)
                      ...|..|.+|.++.|...   ++...|+||-||++.|+.. |++.|++..-.+.+..|...-..+               
T Consensus       161 evvtlwyrppdvlfgakl---y~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeeeeeccCcceeeeeeh---hccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            567889999999998754   3334899999999999987 888898877666665554321111               


Q ss_pred             ---CCC---------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 ---EIP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 ---~~p---------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                         .+|         +.....-++++++.+.-+|..|.++++.+++-
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence               111         12234467899999999999999999998764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=272.25  Aligned_cols=244  Identities=20%  Similarity=0.347  Sum_probs=196.6

Q ss_pred             eeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          346 DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       346 ~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      +.||+|+|+.|-.      |+.+|||++.+.  ......++.+|+.++..+ .|+||++++++|.++.. +|+|||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-FYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-EEEEEecccC
Confidence            4799999999875      678999999653  455677889999999887 79999999999998876 9999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCccccccCCCc-----
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEA-----  490 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~~~~~~~~-----  490 (604)
                      |.|...|.+++.|++.++.++..+|+.||.|||.+||.||||||+|||..+..+   |||+||.+....+.....     
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            999999999999999999999999999999999999999999999999976554   899999986544332221     


Q ss_pred             --ccccCCCCcccccccccC-CCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--------------HHHHHHHHHc
Q 007429          491 --TEYETDGYRWLAPEIIAG-DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--------------VQAAVGIAAC  553 (604)
Q Consensus       491 --~~~~~gt~~Y~APE~l~~-~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--------------~~~~~~i~~~  553 (604)
                        -..++|+..|||||+..- -.....|+.++|.||||||+|-|+.|.+||.+.-.              ...++.-+..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence              123357778999997642 11233567789999999999999999999974211              2233333333


Q ss_pred             CCCCCCCC----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          554 GLRPEIPK----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       554 ~~r~~~p~----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      + .-++|+    .++.+.++++...+-.|+.+|.++.+++.+-|
T Consensus       321 G-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  321 G-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             c-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence            3 234664    47899999999999999999999999988654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.3e-30  Score=292.05  Aligned_cols=253  Identities=14%  Similarity=0.113  Sum_probs=166.9

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE---
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV---  401 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~---  401 (604)
                      +.+..++|++.+.||+|+||.||+|          ..||+|++.....   .+......   +....+.+++.++..   
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~---l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNER---VRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHH---HHhhchhhHHHHHHhhhc
Confidence            4456789999999999999999986          4688998763221   11111111   112122222222211   


Q ss_pred             -EE-cCCCcEEEEEecccCCCHHHHHHhcC-C-------------------CCHHHHHHHHHHHHHHHHHHHhcCceecc
Q 007429          402 -CV-DENHGLCVVTKLMEGGSVNDLILKSR-K-------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRD  459 (604)
Q Consensus       402 -~~-~~~~~l~LVmEy~~gGSL~dlL~~~~-~-------------------l~~~~il~ia~qIa~gL~YLHs~gIVHrD  459 (604)
                       .. .....+++|+||+++++|.+++.... .                   .....+..++.||+.||.|||+++|+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence             11 22334899999999999999985432 1                   11334667999999999999999999999


Q ss_pred             CCCCceEEcC-CCcEEEEecCCccccccCC-CcccccCCCCcccccccccCCCCCC------------------CCCcch
Q 007429          460 LNSQRILLDR-HGNVCLGDMGIVTACKSVG-EATEYETDGYRWLAPEIIAGDPESV------------------SETWMS  519 (604)
Q Consensus       460 LKp~NILld~-~g~vKL~DFGla~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~------------------~~t~kS  519 (604)
                      |||+|||++. ++.+||+|||+++...... .......+++.|+|||.+.......                  .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999987553321 1223446789999999765332221                  123457


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-CC---------CCCCC----------CCccHHHHHHHHHhhhcCC
Q 007429          520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GL---------RPEIP----------KDCPQILKSLMIKCWNNSP  579 (604)
Q Consensus       520 DVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-~~---------r~~~p----------~~~s~~l~~LI~kCL~~dP  579 (604)
                      |||||||++|||+++..|+..  ........+.. +.         .+..+          ........+||.+||+.||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766442  22111111111 10         00000          1112345589999999999


Q ss_pred             CCCCCHHHHHHHHHHh
Q 007429          580 SKRPQFSEIISLLLRT  595 (604)
Q Consensus       580 ~kRPT~~ELL~~L~~~  595 (604)
                      .+|||+.++++|=+..
T Consensus       439 ~kR~ta~e~L~Hpff~  454 (566)
T PLN03225        439 RQRISAKAALAHPYFD  454 (566)
T ss_pred             ccCCCHHHHhCCcCcC
Confidence            9999999999986543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=276.93  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--Cc----eeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KN----ILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H--pn----IVkl~g~~~~~~  406 (604)
                      ..+|++++.+|+|.||.|-.      +..||+|+++...+   +.....-|+.+|.++.+  |+    +|++.++|.-.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            57899999999999999987      46899999986543   33445678888888732  33    788888887777


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---------------
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---------------  469 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---------------  469 (604)
                      + +|||+|.+ |-|++++|..+.  +++..+++.+++|++.++.|||+.+++|-||||+|||+-+               
T Consensus       165 h-iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  165 H-ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             c-eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            6 99999998 559999997654  7999999999999999999999999999999999999932               


Q ss_pred             -----CCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 007429          470 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  544 (604)
Q Consensus       470 -----~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~  544 (604)
                           +..|+|+|||.|+.....   ......|-.|.|||++.+.+++.+    +||||+||||+|++||...|....+.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~p----CDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQP----CDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCc----cCceeeeeEEEEeeccceecccCCcH
Confidence                 235899999998764432   345578899999999999988876    99999999999999999999987654


Q ss_pred             HHHHHHHHc--CC------------------CCCCCC-------------------------CccHHHHHHHHHhhhcCC
Q 007429          545 QAAVGIAAC--GL------------------RPEIPK-------------------------DCPQILKSLMIKCWNNSP  579 (604)
Q Consensus       545 ~~~~~i~~~--~~------------------r~~~p~-------------------------~~s~~l~~LI~kCL~~dP  579 (604)
                      +.+ .++..  +.                  +..+|.                         .....+.+||++||..||
T Consensus       316 EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  316 EHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            432 11110  00                  111111                         112358899999999999


Q ss_pred             CCCCCHHHHHHHHHHhhC
Q 007429          580 SKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       580 ~kRPT~~ELL~~L~~~~~  597 (604)
                      .+|+|+.|++.|-.....
T Consensus       395 ~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccHHHHhcCHHhhcC
Confidence            999999999998766543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6.9e-30  Score=283.56  Aligned_cols=259  Identities=15%  Similarity=0.153  Sum_probs=182.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------------------EEEEEEeecCCCCchH------------HHHHHH
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAY------------EFELRK  382 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------------------~VAIKklk~~~~~~~~------------~~~~~~  382 (604)
                      +..++|++.++||+|+||.||+|.                      .||||++.........            ......
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            367899999999999999999873                      5899998643221111            011234


Q ss_pred             HHHHHHhCCCCce-----eEEEEEEEcC-------CCcEEEEEecccCCCHHHHHHhc----------------------
Q 007429          383 DLLELMTCGHKNI-----LQFYCVCVDE-------NHGLCVVTKLMEGGSVNDLILKS----------------------  428 (604)
Q Consensus       383 Ei~~L~~L~HpnI-----Vkl~g~~~~~-------~~~l~LVmEy~~gGSL~dlL~~~----------------------  428 (604)
                      |+..+.+++|.++     ++++++|...       ....++|+||+++|+|.+++...                      
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            5566666666554     6777777532       22379999999999999988531                      


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-cccccCCCCccccccc
Q 007429          429 --RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGYRWLAPEI  505 (604)
Q Consensus       429 --~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~~~~~gt~~Y~APE~  505 (604)
                        ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ ......+++.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence              1235667888999999999999999999999999999999999999999999865432211 1222345789999999


Q ss_pred             ccCCCCCCC------------------CCcchhHHHHHHHHHHHHcCCC-CCCCCChHHH----------HHH-HHHcCC
Q 007429          506 IAGDPESVS------------------ETWMSNVYSFGMVIWEMVTGEA-AYAACSPVQA----------AVG-IAACGL  555 (604)
Q Consensus       506 l~~~~~s~~------------------~t~kSDVWSlGvvLyELlTG~~-Pf~~~s~~~~----------~~~-i~~~~~  555 (604)
                      +........                  ...+.||||+||++|+|++|.. ||........          .+. ......
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            864322111                  1123699999999999999875 7753221110          001 111112


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCC---CCCCCHHHHHHHHHHh
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSP---SKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP---~kRPT~~ELL~~L~~~  595 (604)
                      .......+++...+++.+++..+|   .+|+|+.|+++|-+..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            222334578899999999999766   6899999999987653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-31  Score=266.30  Aligned_cols=260  Identities=18%  Similarity=0.288  Sum_probs=202.8

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-  406 (604)
                      ++......|+-..+||+|.||.||+      |+.||+|++-.......+.....+|+.+|..|.|+|++.++++|.... 
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3445567788889999999999998      467888876533333333445679999999999999999998886432 


Q ss_pred             ------CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecC
Q 007429          407 ------HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       407 ------~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                            ..+|+||.+|+. +|..+|... .+++..++.+++.++..||.|+|...|+|||+||+|+||+.+|.+||+|||
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                  238999999988 999998544 489999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCC--c--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-
Q 007429          480 IVTACKSVGE--A--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-  554 (604)
Q Consensus       480 la~~~~~~~~--~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-  554 (604)
                      +++.+.....  .  ......|..|.+||.+.|.+.   ++...|||+-||++.||+||.+-+.+.+..+.+..|-... 
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~---yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE---YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccc---cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            9976643221  1  122245889999999998753   3345899999999999999999998877766655432211 


Q ss_pred             -CC------------------CCCCC-------------CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          555 -LR------------------PEIPK-------------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       555 -~r------------------~~~p~-------------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                       ..                  +++|.             .-.++..+|+.+++..||.+||++++++.|-+....
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence             00                  11221             113467899999999999999999999999876543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-31  Score=264.23  Aligned_cols=250  Identities=21%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             CeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcEE
Q 007429          341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  410 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l~  410 (604)
                      +++--+.||.|+||.||.      |++|++|++......-.....+.+|+.+|...+|.|++..++.....+    ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344456799999999995      899999999876665566778899999999999999999998876543    2368


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-C
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-~  489 (604)
                      +++|+|.. +|..++.....++.+.+.-+.+||++||.|||+.+|+||||||.|.|++++..+||||||+++.-.... .
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            89999976 999988888899999999999999999999999999999999999999999999999999987644322 2


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-----------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA-----------------  552 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~-----------------  552 (604)
                      .+.....|..|.|||++.|.+.   |+.+.||||+||++.|++..+..|...++.+.+.-|..                 
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRh---Ys~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARR---YTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchh---hcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            3444456778999999998753   34468999999999999999999998888765543321                 


Q ss_pred             ------cCCCC-CC--------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          553 ------CGLRP-EI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       553 ------~~~r~-~~--------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                            .+.++ .+        +..-..+...++.+++..||.+|.+.++.+.++..
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence                  11111 11        11223456678888999999999999998877643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=282.77  Aligned_cols=249  Identities=19%  Similarity=0.395  Sum_probs=212.6

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|+++..+|+|+||.|||+      +..|+|.++......  -.-++.|+.+++.++|||||.++|.+..... ++|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcC-cEE
Confidence            4588999999999999999995      467888887543222  2346789999999999999999999987765 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      +||||.||+|.+.-.-.+.+++.++...+++...||+|||++|-+|||||-.|||+++.|.+|++|||.+..+...-...
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            99999999999987667789999999999999999999999999999999999999999999999999987666554556


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC---CCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~---p~~~s~~l~  568 (604)
                      ....||+.|||||+..-++. ..+..++|||++|+...|+-.-.+|-....+.+.++-+.+.++.++-   +...++.+.
T Consensus       170 ksfiGtpywmapEvaaverk-ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERK-GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hcccCCccccchhHHHHHhc-ccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            66789999999998753322 23456799999999999999999998888999988887777777654   345788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIIS  590 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~  590 (604)
                      ++++.|+.++|.+||+++.++.
T Consensus       249 ~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHhcCCCccCCChhhhee
Confidence            9999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=7.7e-28  Score=227.88  Aligned_cols=207  Identities=34%  Similarity=0.564  Sum_probs=174.5

Q ss_pred             eeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCH
Q 007429          348 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV  421 (604)
Q Consensus       348 LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL  421 (604)
                      ||+|++|.||++      +.+++|.+....... ....+.+|+..+..+.|++|+++++++..... .++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH-LYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe-EEEEEecCCCCcH
Confidence            689999999985      468888887543321 34568899999999999999999999987654 8999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccccccCCCcccccCCCCc
Q 007429          422 NDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYR  499 (604)
Q Consensus       422 ~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~gt~~  499 (604)
                      .+++... ..++...+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9998655 47899999999999999999999999999999999999999 899999999998765443222333456788


Q ss_pred             ccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCC
Q 007429          500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP  579 (604)
Q Consensus       500 Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP  579 (604)
                      |++||.+...   ...+.++|+|++|+++++|                                 ..+.+++.+|++.+|
T Consensus       159 ~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         159 YMAPEVLLGK---GYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             ccChhHhccc---CCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence            9999998765   1233458999999999999                                 678999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 007429          580 SKRPQFSEIISLL  592 (604)
Q Consensus       580 ~kRPT~~ELL~~L  592 (604)
                      .+||++.++++++
T Consensus       203 ~~R~~~~~l~~~~  215 (215)
T cd00180         203 EKRPSAKEILEHL  215 (215)
T ss_pred             ccCcCHHHHhhCC
Confidence            9999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=8.9e-29  Score=264.22  Aligned_cols=243  Identities=22%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC------CCceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG------HKNILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~------HpnIVkl~g~~~~~~  406 (604)
                      -.+|.+....|+|-|+.|..      |..||||++....   .....=.+|+.+|.+|+      --|+++|+..|...+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            36899999999999999997      4689999998543   33445578999999883      358999999998888


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCcc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVT  482 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~  482 (604)
                      + +|||+|.+.- +|.++|.+-+   .|....+..|+.|+..||..|...||+|.||||.|||+++.. .+||||||.|.
T Consensus       508 H-LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  508 H-LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             e-eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            7 9999999855 9999997644   578889999999999999999999999999999999998765 47999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC------
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------  556 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r------  556 (604)
                      ....+. .+.|. .+-.|.|||+|.|.+|+..    .|+||+||+||||+||+..|++.++.+++...+.....      
T Consensus       586 ~~~ene-itPYL-VSRFYRaPEIiLG~~yd~~----iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  586 FASENE-ITPYL-VSRFYRAPEIILGLPYDYP----IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccc-ccHHH-HHHhccCcceeecCcccCC----ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            665432 22232 2346999999999987765    89999999999999999999998877665432211100      


Q ss_pred             -------------------------------------C------------CCCCC---ccHHHHHHHHHhhhcCCCCCCC
Q 007429          557 -------------------------------------P------------EIPKD---CPQILKSLMIKCWNNSPSKRPQ  584 (604)
Q Consensus       557 -------------------------------------~------------~~p~~---~s~~l~~LI~kCL~~dP~kRPT  584 (604)
                                                           |            .+|.+   .-..+.+|+.+|+..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                                                 0            01211   1245889999999999999999


Q ss_pred             HHHHHHHH
Q 007429          585 FSEIISLL  592 (604)
Q Consensus       585 ~~ELL~~L  592 (604)
                      ..+.|.|-
T Consensus       740 ~nqAL~Hp  747 (752)
T KOG0670|consen  740 VNQALKHP  747 (752)
T ss_pred             HHHHhcCC
Confidence            99999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-28  Score=248.99  Aligned_cols=244  Identities=21%  Similarity=0.274  Sum_probs=192.4

Q ss_pred             CCCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      ..+|.-++.+|.|.- .|..      ++.|++|++...........+..+|+..+..++|+||++++.+|.-..     .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999987 3432      689999998776555556677889999999999999999999987443     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+|+|||||.. +|...+.  -.++-..+..+..|++.|+.|||+.||+||||||+||++..++.+||.|||+++.....
T Consensus        95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence            37999999976 9988875  45778889999999999999999999999999999999999999999999998765433


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC------------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  555 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~------------  555 (604)
                       -.......|-.|.|||++.+..+...    +||||+||++.||++|...|.+....+...++...-.            
T Consensus       172 -~~mtpyVvtRyyrapevil~~~~ke~----vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILGMGYKEN----VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             -cccCchhheeeccCchheeccCCccc----chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence             22333456677999999998875544    8999999999999999999987655443333221110            


Q ss_pred             --------CC---------CCCC-----------CccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 --------RP---------EIPK-----------DCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 --------r~---------~~p~-----------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                              ++         .+|.           .-...+++++.+||-.||++|.+..++|+|
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                    00         0111           123458899999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=7.6e-27  Score=226.76  Aligned_cols=212  Identities=23%  Similarity=0.340  Sum_probs=172.1

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      |.+.+.||.|++|.||++      +.+++|.+...... .....+.+|+..+..++|+|++++++++..... .++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP-LYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc-eEEEEec
Confidence            467889999999999986      56889988743322 234567889999999999999999999887665 8999999


Q ss_pred             ccCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-Ccccc
Q 007429          416 MEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEY  493 (604)
Q Consensus       416 ~~gGSL~dlL~~~~~-l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-~~~~~  493 (604)
                      +++++|.+++..... +++..+..++.+++.++.|||+++++|+||+|.||+++.++.++|+|||++....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999976665 8999999999999999999999999999999999999999999999999987654432 12233


Q ss_pred             cCCCCccccccccc-CCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHHcCCCCCC
Q 007429          494 ETDGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       494 ~~gt~~Y~APE~l~-~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~-~s~~~~~~~i~~~~~r~~~  559 (604)
                      ..++..|++||.+. ...    ++.++|||+||+++++|++|+.||.. ..+.......+..+..+..
T Consensus       159 ~~~~~~~~~pe~~~~~~~----~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKG----YGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW  222 (225)
T ss_pred             eeccCCcCCHhHhcCCCC----CCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence            45678899999984 332    33469999999999999999999977 5666566655555544433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=274.58  Aligned_cols=234  Identities=21%  Similarity=0.339  Sum_probs=177.5

Q ss_pred             eeeeeccCceE-EEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEecccC
Q 007429          345 IDQIGPNSFKG-VYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG  418 (604)
Q Consensus       345 ~~~LG~G~FG~-Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~g  418 (604)
                      .+.+|.|+-|+ ||+    |+.||||.+-..     ...-..+|+..|+.. .|||||++|+.=.+... +||+.|+|..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-~YIalELC~~  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-LYIALELCAC  587 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCce-EEEEehHhhh
Confidence            35678887654 344    689999998632     223467999988876 89999999988776666 9999999977


Q ss_pred             CCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CC--cEEEEecCCccccccCCC
Q 007429          419 GSVNDLILKS-RK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HG--NVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       419 GSL~dlL~~~-~~---l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g--~vKL~DFGla~~~~~~~~  489 (604)
                       +|.+++... ..   ......+....|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.......
T Consensus       588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence             999999653 21   111345778899999999999999999999999999976   34  589999999987764332


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC-CCcc
Q 007429          490 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP-KDCP  564 (604)
Q Consensus       490 ---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p-~~~s  564 (604)
                         ......||.+|+|||++.......    .+||||+||++|+.++ |..||+..-..+  ..|+........- ..-.
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~----avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d  740 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQ----AVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPD  740 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCc----ccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCch
Confidence               233446899999999998775443    4899999999999998 589998744333  2344443332211 1111


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .+..+||.+|+..+|..||++.+++.|
T Consensus       741 ~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  741 CEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            289999999999999999999999876

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=2.5e-27  Score=232.59  Aligned_cols=246  Identities=16%  Similarity=0.265  Sum_probs=190.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC-CcE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGL  409 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~-~~l  409 (604)
                      ..++|++++++|+|.|+.||.|.      .+.||.++..+     ...+.+|+.+|..|. ||||++++++..++. ..-
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            45899999999999999999984      67888888544     466899999999984 999999999998775 225


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~  488 (604)
                      .+|+||+.+.+...+.   ..++.-.+..++.+++.||.|+|+.||+|||+||.|++||... .++|+|+|+|.......
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            6899999887776654   4578888999999999999999999999999999999998754 59999999987765433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC-CCChHHHHHHHHHc--------------
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA-ACSPVQAAVGIAAC--------------  553 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~-~~s~~~~~~~i~~~--------------  553 (604)
                      + ......+--|-.||.+..-.   .++..-|+|||||++..|+..+-||- +.++.+.+..|..-              
T Consensus       188 e-YnVRVASRyfKGPELLVdy~---~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  188 E-YNVRVASRYFKGPELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             e-eeeeeehhhcCCchheeech---hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            2 22223344577899886543   23444799999999999999888875 44444444443321              


Q ss_pred             -CCCCC----------------CCC----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          554 -GLRPE----------------IPK----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       554 -~~r~~----------------~p~----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                       .+.+.                ++.    -.+++..+++.+.|..|-.+|||+.|.+.|-...
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence             01110                111    1358899999999999999999999999886543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=257.91  Aligned_cols=196  Identities=21%  Similarity=0.309  Sum_probs=166.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch---HHH---HHHHHHHHHHhCC---CCceeEEEEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEF---ELRKDLLELMTCG---HKNILQFYCVCV  403 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~---~~~---~~~~Ei~~L~~L~---HpnIVkl~g~~~  403 (604)
                      ..+|..++.+|.|+||.|+.+      ..|.||.+.+.+.-..   .+.   .+-.||.+|.+++   |+||++++++|.
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356899999999999999986      3577777764432111   011   2567899999986   999999999999


Q ss_pred             cCCCcEEEEEeccc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          404 DENHGLCVVTKLME-GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       404 ~~~~~l~LVmEy~~-gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ++++ .||+||-.. |-+|.++|.....+++..+..++.||+.|+++||++||||||||-+|+.++.+|.+||+|||.+.
T Consensus       640 ddd~-yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  640 DDDY-YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             cCCe-eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            8886 899999865 56899999888899999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  540 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~  540 (604)
                      ..++.+  -....||..|.|||++.|.+|-.++   -|||++|++||.++..+.||.+
T Consensus       719 ~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~---qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 YTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKP---QDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhcCCC--cceeeeeccccchhhhCCCccCCCc---chhhhhhheeeEEEeccCCCcC
Confidence            665433  3456799999999999999887653   6999999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.6e-26  Score=218.14  Aligned_cols=163  Identities=20%  Similarity=0.291  Sum_probs=129.2

Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          419 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       419 GSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      |||.+++.. .+.+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++......     ...|+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            699999975 446999999999999999999999998      999999999999999  9998765432     12578


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC------CCCCccH--HHHH
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE------IPKDCPQ--ILKS  569 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~------~p~~~s~--~l~~  569 (604)
                      +.|||||++.+..++    .++|||||||++|||++|..||....................      .+...+.  .+.+
T Consensus        68 ~~y~aPE~~~~~~~~----~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       68 PYFMAPEVIQGQSYT----EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             ccccChHHhcCCCCc----chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            999999999877654    459999999999999999999976544332222222222221      1222333  6999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +|.+||..+|.+||++.+++.+++.....
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            99999999999999999999999887543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-26  Score=240.53  Aligned_cols=129  Identities=22%  Similarity=0.375  Sum_probs=107.7

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC--------CCCceeEEEEE
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC--------GHKNILQFYCV  401 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L--------~HpnIVkl~g~  401 (604)
                      .+...+|.++++||-|.|++||++      +.||+|+.+..   ..+......||.+|.++        ...+||+|++.
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            356689999999999999999995      68999999853   34455567888888875        22569999999


Q ss_pred             EEcCC---CcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEc
Q 007429          402 CVDEN---HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLD  468 (604)
Q Consensus       402 ~~~~~---~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld  468 (604)
                      |...+   ..+|+|+|++ |.+|-.+|.+.  +.++...+.+|+.||+.||.|||.+ ||||-||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            97653   4499999999 55999988654  4799999999999999999999965 999999999999993

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.4e-26  Score=271.02  Aligned_cols=198  Identities=14%  Similarity=0.189  Sum_probs=140.3

Q ss_pred             CCC-CceeEEEEEEEc------CCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q 007429          390 CGH-KNILQFYCVCVD------ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN  461 (604)
Q Consensus       390 L~H-pnIVkl~g~~~~------~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLK  461 (604)
                      ++| +||+.++++|..      ....+++++||+ +++|.++|.. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 577788887721      112367788987 5599999964 3469999999999999999999999999999999


Q ss_pred             CCceEEcCC-------------------CcEEEEecCCccccccCCC----------------cccccCCCCcccccccc
Q 007429          462 SQRILLDRH-------------------GNVCLGDMGIVTACKSVGE----------------ATEYETDGYRWLAPEII  506 (604)
Q Consensus       462 p~NILld~~-------------------g~vKL~DFGla~~~~~~~~----------------~~~~~~gt~~Y~APE~l  506 (604)
                      |+||||+..                   +.+||+|||+++.......                ......+|+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   4456666666543211000                00113478889999999


Q ss_pred             cCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHH
Q 007429          507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS  586 (604)
Q Consensus       507 ~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~  586 (604)
                      .+..++    .++|||||||+||||++|.+|+.....  ....+.....++.... ..+....++.+||..+|.+||++.
T Consensus       188 ~~~~~~----~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        188 NGSSSN----CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             ccCCCC----chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChH
Confidence            877654    459999999999999999888754221  1111221111222122 245567899999999999999999


Q ss_pred             HHHHHHHHh
Q 007429          587 EIISLLLRT  595 (604)
Q Consensus       587 ELL~~L~~~  595 (604)
                      |++++-+..
T Consensus       261 eil~h~~~~  269 (793)
T PLN00181        261 ELLQSEFIN  269 (793)
T ss_pred             HHhhchhhh
Confidence            999876643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=224.51  Aligned_cols=240  Identities=15%  Similarity=0.235  Sum_probs=177.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.|.+.+.||+|.||.+-++      ..+++|.+...   .....++.+|..---.| .|.||+.-|++.........++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            77899999999999999986      36778877643   23345677777643334 6899999887655444447789


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--CCcEEEEecCCccccccCCCc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||++.|+|..-+.. ..+.+....+++.|+++|++|||++++||||||.+||||..  ..+|||||||+.+..+..   
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t---  176 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT---  176 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence            999999999987744 35778888999999999999999999999999999999943  347999999997654432   


Q ss_pred             ccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHcCCCCCCCCC---c
Q 007429          491 TEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKD---C  563 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---~~~~~i~~~~~r~~~p~~---~  563 (604)
                      ..+..-+..|.+||.+..... .......+|+|.||+++|.++||.+||......   -..+.....+..+..|..   +
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence            333344667899997753211 112233489999999999999999999853322   122222334445555654   5


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFS  586 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~  586 (604)
                      ++.+..+.++-+..+|++|=...
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~  279 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIW  279 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhH
Confidence            78899999999999999993333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-23  Score=220.10  Aligned_cols=251  Identities=15%  Similarity=0.197  Sum_probs=190.5

Q ss_pred             CeEEeeeeeccCceEEEEeE-------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC----CCceeEEEEEEE-cCCCc
Q 007429          341 NLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQFYCVCV-DENHG  408 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk-------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~----HpnIVkl~g~~~-~~~~~  408 (604)
                      +|.+.+.||+|+||.||++.       .+|+|...........  .+..|..++..+.    -+++..+++... .+.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~-   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF-   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce-
Confidence            78999999999999999975       4667766543222211  4566777777765    268888888884 4444 


Q ss_pred             EEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-----CcEEEEecCCc
Q 007429          409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-----GNVCLGDMGIV  481 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-----g~vKL~DFGla  481 (604)
                      -|+||+++ |.||.++....  +.++..++++++.|++.+|++||+.|++||||||.|++++..     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            78999988 66999987433  589999999999999999999999999999999999999865     46999999999


Q ss_pred             c--ccc-cCCC------c-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 007429          482 T--ACK-SVGE------A-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA  551 (604)
Q Consensus       482 ~--~~~-~~~~------~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~  551 (604)
                      +  ... ..+.      . .....||.+|.++....+...+..    .|+||++.++.|++.|..||.............
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~----DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR----DDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc----hhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            8  322 1111      1 223459999999999988766654    899999999999999999998765432222222


Q ss_pred             HcCCCCC---CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          552 ACGLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       552 ~~~~r~~---~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .......   .....+.++..++..+-..+...+|.+..+...|.......
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            2111111   33456678888888888899999999999999998876654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=5e-23  Score=203.87  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=194.4

Q ss_pred             eEEeeeeeccCceEEEEeEE---EEEEEeecCCCCch-HHHHHHHHHHHHHhCCCC-ceeEEEEEEEcCCCcEEEEEecc
Q 007429          342 LEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNA-YEFELRKDLLELMTCGHK-NILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk~---VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~Hp-nIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      |.+.+.||.|+||.||++..   +++|.+........ ....+.+|+..+..+.|+ +|+++++.+..... .+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-LYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-EEEEEecC
Confidence            67889999999999999864   58888875544443 456688999999999888 79999999966554 79999999


Q ss_pred             cCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCC---
Q 007429          417 EGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       417 ~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~---  489 (604)
                      .++++.+++....   .++......++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++........   
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999998776554   789999999999999999999999999999999999999998 799999999875443322   


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCC----CC
Q 007429          490 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRP----EI  559 (604)
Q Consensus       490 ---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~----~~  559 (604)
                         ......++..|++||.+.+.. ........|+||+|++++++++|..||.....   .............+    ..
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL  239 (384)
T ss_pred             ccccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc
Confidence               234557899999999998731 01122348999999999999999999887653   33333333332222    12


Q ss_pred             CCCc----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          560 PKDC----PQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       560 p~~~----s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ....    ...+.+++..|+..+|..|.+..+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            2222    2578999999999999999998887765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=4e-24  Score=225.16  Aligned_cols=242  Identities=21%  Similarity=0.348  Sum_probs=183.5

Q ss_pred             CCeEEeeeeeccCceEEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..|..+++||.|.|++||++         +.||+|.+......    ..+..|+..|..+ .+.||+++.+.+..++. .
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~-v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ-V  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCe-e
Confidence            67889999999999999974         57999999765433    3477888888887 78999999998877665 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCccccccC-
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSV-  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~~~-  487 (604)
                      .+|+||++...-.++..   .++...+..++..+..||.++|.+|||||||||.|+|.+.. ++-.|.|||+|...... 
T Consensus       111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999988888873   46788899999999999999999999999999999999865 56889999998621000 


Q ss_pred             -----------------CC------------cc--------------cccCCCCcccccccccCCCCCCCCCcchhHHHH
Q 007429          488 -----------------GE------------AT--------------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSF  524 (604)
Q Consensus       488 -----------------~~------------~~--------------~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSl  524 (604)
                                       +.            ..              ....||++|.|||++..-+.   -+.++||||.
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~---QttaiDiws~  264 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR---QTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC---cCCccceeec
Confidence                             00            00              01138999999999975432   2446899999


Q ss_pred             HHHHHHHHcCCCCCCCCCh-HHHHHHH------------HHcCCC---------C-------------------------
Q 007429          525 GMVIWEMVTGEAAYAACSP-VQAAVGI------------AACGLR---------P-------------------------  557 (604)
Q Consensus       525 GvvLyELlTG~~Pf~~~s~-~~~~~~i------------~~~~~r---------~-------------------------  557 (604)
                      ||++..+++++.||..... ...+..+            .....+         +                         
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            9999999999999964322 1111100            000000         0                         


Q ss_pred             ---CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 ---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 ---~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                         ...+..+..+.+++.+|++.||.+|.|+++.|+|-
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence               00112345789999999999999999999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=217.67  Aligned_cols=250  Identities=23%  Similarity=0.462  Sum_probs=203.3

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++..++.++-+|.+...|..|+|+    .+..|++............|..|.-.|+-+.||||+.++|.|..+.+ +.++
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~i  265 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVII  265 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEe
Confidence            344566777788888889999875    46667766544444444557778878888899999999999998876 8899


Q ss_pred             EecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC-c-eeccCCCCceEEcCCCcEEEE--ecCCcccccc
Q 007429          413 TKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG-V-AYRDLNSQRILLDRHGNVCLG--DMGIVTACKS  486 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~g-I-VHrDLKp~NILld~~g~vKL~--DFGla~~~~~  486 (604)
                      ..||+.|||+.+|....  ..+..++.+++.+|++||.|||+.. + .---|....++||++-+++|+  |--++.    
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----  341 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee----
Confidence            99999999999996543  5678899999999999999999863 3 344789999999999887764  322211    


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                         ......-.|.||+||.+...+.+.. -..+|+|||++++||+.|.+.||...++.+.-.++...+++..+|+.++..
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n-~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h  417 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLN-IRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH  417 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcc-hhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence               1112234688999999987665433 235899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +..||.-|+..||.+||.|+.|+-.|++.
T Consensus       418 m~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  418 MNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            99999999999999999999999998875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-21  Score=199.94  Aligned_cols=251  Identities=17%  Similarity=0.257  Sum_probs=196.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      -+|.++++||+|+||..+.|      +.||||.-.......    +++.|-+..+.| ..+.|...|-+..+..+ -.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~-NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKY-NILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccch-hhhh
Confidence            57899999999999999987      589999865433333    344555555554 46889888855544444 5699


Q ss_pred             EecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-----cEEEEecCCcccccc
Q 007429          413 TKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-----NVCLGDMGIVTACKS  486 (604)
Q Consensus       413 mEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-----~vKL~DFGla~~~~~  486 (604)
                      +|++ |.||.|+.. ..++|+.+++..++.|++.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+...+
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 679999985 456899999999999999999999999999999999999997654     489999999998765


Q ss_pred             CCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHHHHcCCC
Q 007429          487 VGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC---SPVQAAVGIAACGLR  556 (604)
Q Consensus       487 ~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~---s~~~~~~~i~~~~~r  556 (604)
                      ....       .....||.+||+-....|...+..    .|+-|+|-++.+.+-|..||.+.   +..+...+|-.....
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR----DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR----DDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhh----hhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            4432       223469999999999888766654    89999999999999999999864   344444444332221


Q ss_pred             C---CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          557 P---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       557 ~---~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .   .+..++|.++..-|+-.=..+-.+-|.++-+...+.++....+
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            1   2456788999999998889999999999999998888765443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-21  Score=193.86  Aligned_cols=254  Identities=17%  Similarity=0.227  Sum_probs=193.7

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g~~~~~~~~l  409 (604)
                      +-...|.++++||+|+||.+|.|      ..||||.-.......    ++..|..+...|++ ..|..+..+..+..+ -
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~y-n   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDY-N   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccccc-c
Confidence            44578999999999999999984      689999876543332    34556566666654 566666666666555 6


Q ss_pred             EEEEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC---CcEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~---g~vKL~DFGla~~~~  485 (604)
                      .+||+++ |.||.+++. ..+.++..+++.++-|++.-++|+|.+++|||||||+|+|..-+   ..+.++|||+++...
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            6999998 779999985 56789999999999999999999999999999999999999654   358899999998776


Q ss_pred             cCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHcCC
Q 007429          486 SVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGL  555 (604)
Q Consensus       486 ~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---~~~~~i~~~~~  555 (604)
                      +....       .....||.+|.+-....+...+.    +.|+-|+|.+|..+--|..||.+....   +....|.....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR----RDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR----RDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhh----hhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            54332       23346899998887776654444    479999999999999999999975443   23333333222


Q ss_pred             ---CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          556 ---RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       556 ---r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                         ...+...+|.++.-.+.-|-..--++-|++.-|-..+.-+....|
T Consensus       242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence               223457789999999999999999999999888777766655443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=210.09  Aligned_cols=159  Identities=13%  Similarity=0.107  Sum_probs=122.1

Q ss_pred             CCCeEEeeeeeccCceEEEEeE-------EEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeE-EEEEEEcCCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQ-FYCVCVDENH  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk-------~VAIKklk~~~~---~~~~~~~~~~Ei~~L~~L~HpnIVk-l~g~~~~~~~  407 (604)
                      .++|.+.+.||+|+||.||+|.       .+|||++.....   .......+.+|+.+|..++|+||+. ++++    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4779999999999999999873       468988753211   1223455889999999999999985 4432    22


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDL-Kp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .|+||||++|++|... ..   ..   ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+++....
T Consensus        93 -~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         93 -DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             -cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence             7899999999999732 11   11   1467889999999999999999999 99999999999999999999886654


Q ss_pred             CCCcc--------cccCCCCcccccccccCC
Q 007429          487 VGEAT--------EYETDGYRWLAPEIIAGD  509 (604)
Q Consensus       487 ~~~~~--------~~~~gt~~Y~APE~l~~~  509 (604)
                      .+...        ....+++.|+|||.+...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            33111        233567889999988643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.1e-22  Score=230.45  Aligned_cols=248  Identities=16%  Similarity=0.246  Sum_probs=184.0

Q ss_pred             EEeeeeeccCceEEEEeEE------EEEEEee----cCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          343 EFIDQIGPNSFKGVYKGKR------VGIEKLK----GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykGk~------VAIKklk----~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .....+|.|++|.|+....      .+.|...    ...........+..|+.+-.++.|+|++..+..+.+... ..-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence            4567899999997776432      2222222    111111122224556666667899999888777766553 4445


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc--
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~--  490 (604)
                      ||||++ +|..++.....+....+--++.|++.|+.|||+.|+.|||||++|+++..+|.+||+|||.+.......+.  
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            999999 99999987778999999999999999999999999999999999999999999999999997655443332  


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHcCC------CCCCCC
Q 007429          491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGL------RPEIPK  561 (604)
Q Consensus       491 --~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~-~i~~~~~------r~~~p~  561 (604)
                        .....|+-.|+|||++.+..|.+.+   .||||.|++++.|++|+.||......+..+ .....+.      .-.+-.
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~---vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRA---VDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcch---hhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence              2334678889999999999888764   799999999999999999998544332211 1111110      111223


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+|.+.+.+|.++|+.||.+|.|+++|++.=|..
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            5678899999999999999999999999876654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=5.3e-21  Score=200.10  Aligned_cols=196  Identities=22%  Similarity=0.321  Sum_probs=147.8

Q ss_pred             CCCceeEEEEEEEc--------------------------CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 007429          391 GHKNILQFYCVCVD--------------------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA  444 (604)
Q Consensus       391 ~HpnIVkl~g~~~~--------------------------~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa  444 (604)
                      +|||||++.++|.+                          ++..+|+||.-++. +|.+++- .+..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-~~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-TRHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-cCCCchHHHHHHHHHHH
Confidence            79999999988765                          22348999998876 9999983 34567777888999999


Q ss_pred             HHHHHHHhcCceeccCCCCceEE--cCCC--cEEEEecCCccccccCCCcc------cccCCCCcccccccccCCCCC--
Q 007429          445 EGIKFLNDHGVAYRDLNSQRILL--DRHG--NVCLGDMGIVTACKSVGEAT------EYETDGYRWLAPEIIAGDPES--  512 (604)
Q Consensus       445 ~gL~YLHs~gIVHrDLKp~NILl--d~~g--~vKL~DFGla~~~~~~~~~~------~~~~gt~~Y~APE~l~~~~~s--  512 (604)
                      +|+.|||.+||.|||+|.+||||  ++++  .+.|+|||.+-..+..+-..      ....|.-.-||||+..-.+-.  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999  3344  37899999975544322211      122356778999987633211  


Q ss_pred             CCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHH
Q 007429          513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI  588 (604)
Q Consensus       513 ~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~EL  588 (604)
                      .-.-.|+|.|+.|.+.||+++...||........-........-|.+|+.||+.+++++...|+.||++|++..=.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence            1112368999999999999999999987433322222233444677899999999999999999999999986543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-21  Score=214.79  Aligned_cols=221  Identities=20%  Similarity=0.357  Sum_probs=176.4

Q ss_pred             eeccCceEEEE---------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEEEEeccc
Q 007429          348 IGPNSFKGVYK---------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       348 LG~G~FG~Vyk---------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +|.|+||.|+.         |.-.+.|.++..............|-.++..++ ||++|++.-.++.+.. ++++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-l~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-LYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-hhHhhhhcc
Confidence            68999999996         344566665443222211113334445555554 9999999988887775 999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      ||.|...+.+...+++.....+...++.+++++|+.+++|||+|++||+++.+|++++.|||+++.......    .+||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGT  156 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccc
Confidence            999999887777888999999999999999999999999999999999999999999999999876544322    2899


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      +.|||||++++.  ..    ..|.||||++++||+||..||..    +....|...  .+..|...+...++++..++..
T Consensus       157 ~eymApEI~~gh--~~----a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  157 YEYRAPEIINGH--LS----AADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFKR  224 (612)
T ss_pred             hhhhhhHhhhcc--CC----cccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhh
Confidence            999999999833  22    27999999999999999999988    333444432  4567888999999999999999


Q ss_pred             CCCCCCCH
Q 007429          578 SPSKRPQF  585 (604)
Q Consensus       578 dP~kRPT~  585 (604)
                      +|.+|.-.
T Consensus       225 ~p~nrLg~  232 (612)
T KOG0603|consen  225 NPENRLGA  232 (612)
T ss_pred             CHHHHhcc
Confidence            99999654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-20  Score=203.34  Aligned_cols=211  Identities=26%  Similarity=0.431  Sum_probs=164.9

Q ss_pred             HhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCc-eeccCCCCce
Q 007429          388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGV-AYRDLNSQRI  465 (604)
Q Consensus       388 ~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gI-VHrDLKp~NI  465 (604)
                      +.+.|.|+.+|+|.+.+... +++|.+||..|+|.|.+.. ...+++.....++.+|+.||+|||...| .|+.|++.|+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~-~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPE-MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccchhhhhhheeeEecCCc-eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45789999999999999865 8999999999999999965 3478888888999999999999998765 9999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCC---CCcchhHHHHHHHHHHHHcCCCCCCC
Q 007429          466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVS---ETWMSNVYSFGMVIWEMVTGEAAYAA  540 (604)
Q Consensus       466 Lld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~---~t~kSDVWSlGvvLyELlTG~~Pf~~  540 (604)
                      +++....+||+|||+.........  ......-...|.|||.+.+......   .+.+.||||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999655432111  1111112356999999987543332   45678999999999999999999985


Q ss_pred             C----ChHHHHHHHHHcCC---CCCCC-C-CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          541 C----SPVQAAVGIAACGL---RPEIP-K-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       541 ~----s~~~~~~~i~~~~~---r~~~p-~-~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .    .+.+.+..+...+.   +|.+. . .+++++..++.+||..+|.+||+++.+-..+..++...
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            2    23334444333132   33332 1 45668999999999999999999999999999887754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4e-20  Score=181.12  Aligned_cols=137  Identities=15%  Similarity=0.107  Sum_probs=104.5

Q ss_pred             eeeeeccCceEEEEe-----EEEEEEEeecCCCCchH------------------------HHHHHHHHHHHHhCCCCce
Q 007429          345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAY------------------------EFELRKDLLELMTCGHKNI  395 (604)
Q Consensus       345 ~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~------------------------~~~~~~Ei~~L~~L~HpnI  395 (604)
                      .+.||+|+||.||+|     +.||+|+++........                        .....+|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999985     58999999754221111                        1123458888888877665


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCCCCceEEcCCCcEE
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL-Hs~gIVHrDLKp~NILld~~g~vK  474 (604)
                      .....+.. ..  .+|||||++|+++...+.....++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~-~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILL-KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEe-cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            43332221 22  379999999988776544556889999999999999999999 799999999999999998 57899


Q ss_pred             EEecCCccccc
Q 007429          475 LGDMGIVTACK  485 (604)
Q Consensus       475 L~DFGla~~~~  485 (604)
                      |+|||++....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.7e-19  Score=172.88  Aligned_cols=137  Identities=15%  Similarity=0.123  Sum_probs=105.9

Q ss_pred             eeeeeccCceEEEEe-----EEEEEEEeecCCCCch------------------------HHHHHHHHHHHHHhCCCCce
Q 007429          345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA------------------------YEFELRKDLLELMTCGHKNI  395 (604)
Q Consensus       345 ~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~------------------------~~~~~~~Ei~~L~~L~HpnI  395 (604)
                      .+.||+|+||.||+|     +.||+|.++.......                        ....+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999985     5899999875422100                        01224578888888888887


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEE
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vK  474 (604)
                      .....+....   .++||||++|+++.........++......++.|++.+|.|||+ +||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          82 PVPEPILLKK---NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCceEEEecC---CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            5444333322   37999999998655443344567888999999999999999999 9999999999999999 89999


Q ss_pred             EEecCCccccc
Q 007429          475 LGDMGIVTACK  485 (604)
Q Consensus       475 L~DFGla~~~~  485 (604)
                      |+|||++....
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=5.4e-19  Score=175.42  Aligned_cols=183  Identities=11%  Similarity=0.059  Sum_probs=131.7

Q ss_pred             EeeeeeccCceEEEEeE----EEEEEEeecCCCC--chHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEEEEecc
Q 007429          344 FIDQIGPNSFKGVYKGK----RVGIEKLKGCDKG--NAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       344 i~~~LG~G~FG~VykGk----~VAIKklk~~~~~--~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      +...|++|+||+||...    ++..+.+......  ......+.+|+.+|.+|+ |++|++++++    + ..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEEEeee
Confidence            45679999999999843    4444444422211  011124789999999995 5889999886    2 268999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccC-CCCceEEcCCCcEEEEecCCccccccCCCc-----
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKSVGEA-----  490 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDL-Kp~NILld~~g~vKL~DFGla~~~~~~~~~-----  490 (604)
                      .|.+|...+..      . ...++.|++.+|.++|++||+|||| ||.|||++.+|.++|+|||++.........     
T Consensus        81 ~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         81 AGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             cCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            99999765321      1 1357789999999999999999999 799999999999999999999765543321     


Q ss_pred             --------ccccCCCCcccccccccCCCCCCCCC-cchhHHHHHHHHHHHHcCCCCCCCC
Q 007429          491 --------TEYETDGYRWLAPEIIAGDPESVSET-WMSNVYSFGMVIWEMVTGEAAYAAC  541 (604)
Q Consensus       491 --------~~~~~gt~~Y~APE~l~~~~~s~~~t-~kSDVWSlGvvLyELlTG~~Pf~~~  541 (604)
                              ......++.|+.|+...-...   .+ .+.+.++.|+-+|.++|+..|+-+.
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~---~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKR---TSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhcc---chhHHHHHHHhcchHHHHHhccCCcccc
Confidence                    112235777888876543311   11 2357778999999999999887553

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=8.9e-19  Score=176.43  Aligned_cols=169  Identities=11%  Similarity=0.098  Sum_probs=125.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHH-H------HHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYE-F------ELRKDLLELMTCGHKNILQFYCVCVDEN-  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~-~------~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-  406 (604)
                      ..+|++++.||.|+||.||..    ..+++|.+.......... .      .+++|+..+.++.|++|....+++.... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            478999999999999999984    469999987543332211 1      1578888899999999999998866442 


Q ss_pred             ------CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          407 ------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       407 ------~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                            ...++||||++|.+|.++.    .+++.    ...+|+.+|..+|+.|++|||+||+||+++.+| ++|+|||.
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence                  2378999999999998874    23332    355899999999999999999999999999988 99999998


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHH
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV  532 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELl  532 (604)
                      ......... ...           ......+.    .++|+|+||+++.-..
T Consensus       181 ~~~~~e~~a-~d~-----------~vler~y~----~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKA-KDR-----------IDLERHYG----IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhh-HHH-----------HHHHhHhc----ccccccceeEeehHHH
Confidence            654422111 110           22222222    3489999999877654

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=4e-18  Score=169.86  Aligned_cols=131  Identities=13%  Similarity=0.167  Sum_probs=100.8

Q ss_pred             eeeeeccCceEEEEeEE---EEEEEeecCCCCchHHHHHHHHHHHHHhC-----CCCceeEEEEEEEcCC--CcEE-EEE
Q 007429          345 IDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMTC-----GHKNILQFYCVCVDEN--HGLC-VVT  413 (604)
Q Consensus       345 ~~~LG~G~FG~VykGk~---VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-----~HpnIVkl~g~~~~~~--~~l~-LVm  413 (604)
                      ...||+|+||.||....   .+||++.....  .....+.+|+..+..+     .||||++++|++.++.  ..++ +||
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEECCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            35799999999997322   25676654322  2345689999999998     6799999999998874  2233 789


Q ss_pred             ec--ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCceeccCCCCceEEcCC----CcEEEEecCC
Q 007429          414 KL--MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI-KFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGI  480 (604)
Q Consensus       414 Ey--~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL-~YLHs~gIVHrDLKp~NILld~~----g~vKL~DFGl  480 (604)
                      ||  +.+|+|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||++..    +.++|+||+-
T Consensus        85 e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             cCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            99  5589999999653 46655  35677888777 99999999999999999999743    3799999544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=1.5e-18  Score=179.67  Aligned_cols=232  Identities=16%  Similarity=0.253  Sum_probs=142.8

Q ss_pred             CeEEeeeeeccCceEEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCC----------CCceeEEEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCG----------HKNILQFYCVCV  403 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~----------HpnIVkl~g~~~  403 (604)
                      .+.....||.|+|+.||.      |+.+++|.......... ...++++|......+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            457788999999999998      46889998765443222 3344555554333321          212222222222


Q ss_pred             cC------------C-C---cEEEEEecccCCCHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhcCceeccC
Q 007429          404 DE------------N-H---GLCVVTKLMEGGSVNDLIL---KSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDL  460 (604)
Q Consensus       404 ~~------------~-~---~l~LVmEy~~gGSL~dlL~---~~~~----l~~~~il~ia~qIa~gL~YLHs~gIVHrDL  460 (604)
                      -.            . .   +.+++|+-+.+ +|.+++.   ....    +.....+.+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            11            0 1   24678887754 9988863   2221    223344566789999999999999999999


Q ss_pred             CCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCC----CCCCCCcchhHHHHHHHHHHHHcCCC
Q 007429          461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP----ESVSETWMSNVYSFGMVIWEMVTGEA  536 (604)
Q Consensus       461 Kp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~s~~~t~kSDVWSlGvvLyELlTG~~  536 (604)
                      +|+|++++.+|.++|+||+.....+..   ......+..|.+||......    ....++.+.|.|++|+++|.|.+|..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999999987655432   11134456789999764321    22334567899999999999999999


Q ss_pred             CCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCC
Q 007429          537 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR  582 (604)
Q Consensus       537 Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kR  582 (604)
                      ||....+......    .+.  ...++|+.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~--~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFS--RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence            9986544321110    111  222788999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=1.4e-18  Score=199.31  Aligned_cols=245  Identities=18%  Similarity=0.211  Sum_probs=171.0

Q ss_pred             CeEEeeeeeccCceEEEEeE----EEEEEEeecCCCCchH--HHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAY--EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~--~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      ++...+.||++.|=.|.+++    .|.||.+.+.+.....  ..+..+++. ....+|||++++.-+-..+.. .|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA-AylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA-AYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH-HHHHHH
Confidence            67889999999999999864    3778887655432221  223334444 445689999999877555443 789999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc--c-cCCCcc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC--K-SVGEAT  491 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~--~-~~~~~~  491 (604)
                      |+.. +|+|.|..+.-+...+..-|+.|++.||.-+|..||+|+|||.+||||++=+=+.|+||..-++.  . +++..-
T Consensus       102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            9976 99999966666777777888999999999999999999999999999998777999999775432  1 111112


Q ss_pred             cccC----CCCcccccccccCCC-------CCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHc-CCCCC
Q 007429          492 EYET----DGYRWLAPEIIAGDP-------ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC-GLRPE  558 (604)
Q Consensus       492 ~~~~----gt~~Y~APE~l~~~~-------~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~-~~r~~  558 (604)
                      .+..    ...+|.|||.+....       .....+.+-||||+||++.||++ |++||.-..    +.+-... ...++
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNADDPE  256 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCccCHH
Confidence            2222    235799999876422       11113345799999999999988 889885210    0000000 00000


Q ss_pred             -C-CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          559 -I-PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       559 -~-p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                       . -.--+..++.++..|++.||++|.++++.|+..
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             0 000123689999999999999999999998863

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.1e-17  Score=188.12  Aligned_cols=242  Identities=16%  Similarity=0.207  Sum_probs=169.7

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEEEEEEEc
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVD  404 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~---HpnIVkl~g~~~~  404 (604)
                      ...++..+.|.|-+.||+|+||.||+|     +.||+|.-+....   +++-+..++  +.+|+   -+-|..+.....-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~--~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQV--MERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHH--HHhhchhhhcchHHHHHHHcc
Confidence            346677889999999999999999984     6899998764332   222222222  12222   1223333322222


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-------CCcEEEEe
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-------HGNVCLGD  477 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-------~g~vKL~D  477 (604)
                      .+. -++|+||.+.|+|.+++...+.+++..+..+++|++.-+++||.++|||+||||+|+||..       .--++|+|
T Consensus       766 ~~~-S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  766 QNA-SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             CCc-ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            232 5699999999999999987788999999999999999999999999999999999999943       23499999


Q ss_pred             cCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC
Q 007429          478 MGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       478 FGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      ||.+-.+.-..+.  -....+|-.+-++|+..|.+++..    .|.|.|+.++|.|+.|++-       +     ...+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq----~DyfGlAa~~h~mLFG~y~-------q-----~~~g~  908 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ----IDYFGLAATVHVMLFGKYM-------E-----VKNGS  908 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchh----hhhHHHHHHHHHHHHHHHH-------H-----hcCCc
Confidence            9997655433222  233457888999999998876655    9999999999999998641       1     22222


Q ss_pred             CCC----CCCCcc-HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          556 RPE----IPKDCP-QILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       556 r~~----~p~~~s-~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .-.    ++.... ....+++..+|..|-..=|...+|...+..+.
T Consensus       909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence            211    222222 22346666677766666677777777776654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=2.4e-17  Score=189.33  Aligned_cols=201  Identities=20%  Similarity=0.330  Sum_probs=145.3

Q ss_pred             CCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +++|+.++.|-.|+||.||..+      ++|+ ++.+             .-.+++     ||..+-    +.   -++|
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNk-------------q~lilR-----nilt~a----~n---pfvv  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINK-------------QNLILR-----NILTFA----GN---PFVV  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccc-------------cchhhh-----cccccc----CC---ccee
Confidence            4788999999999999999864      3444 2211             111111     122221    11   2233


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC---
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~---  489 (604)
                            |+-..+++.-++++.+.        +.+++|||+.||+|||+||+|.+|..-|++|+.|||+.+...-...   
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                  45555565445555443        7899999999999999999999999999999999999754321100   


Q ss_pred             ------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-CC
Q 007429          490 ------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LR  556 (604)
Q Consensus       490 ------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-~r  556 (604)
                                  .....+|||.|.|||++...+|...    +|.|++|+++||.+-|+.||.+.++++.+-..+... .-
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp----vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP----VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCC----ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                        1123368999999999998888876    899999999999999999999999988765544321 11


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCC
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRP  583 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRP  583 (604)
                      ++-.+..+++.++++.+.|.++|..|-
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            222455789999999999999999994

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=9.8e-17  Score=157.34  Aligned_cols=132  Identities=17%  Similarity=0.233  Sum_probs=106.4

Q ss_pred             eeeeccCceEEEEe----EEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEec
Q 007429          346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       346 ~~LG~G~FG~VykG----k~VAIKklk~~~~~~~------~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      +.||+|++|.||+|    ..+++|+.........      ....+.+|+..+..+.|++|+....++.+... .++||||
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEEEE
Confidence            57899999999997    5788887653322111      12346788888989999988777666665554 7899999


Q ss_pred             ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       416 ~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ++|++|.+++.....    ....++.+++.+|.+||++|++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999854322    7788999999999999999999999999999999 78999999998643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=2.2e-16  Score=153.65  Aligned_cols=128  Identities=16%  Similarity=0.211  Sum_probs=99.8

Q ss_pred             eeeccCceEEEEeE----EEEEEEeecCCCCc-h-----HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          347 QIGPNSFKGVYKGK----RVGIEKLKGCDKGN-A-----YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       347 ~LG~G~FG~VykGk----~VAIKklk~~~~~~-~-----~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      .||+|+||.||+|.    .+++|......... .     ...++.+|+..+..+.|+++.....++...+. .++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEEEE
Confidence            38999999999976    88888865322111 1     12446789999988888765544444444443 68999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      +|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998754321       7889999999999999999999999999999 89999999999754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.3e-16  Score=161.80  Aligned_cols=139  Identities=15%  Similarity=0.128  Sum_probs=107.6

Q ss_pred             CCeEEeeeeeccCceEEEEeE-------EEEEEEeecCCCCc-------------------h---HHHHHHHHHHHHHhC
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGN-------------------A---YEFELRKDLLELMTC  390 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk-------~VAIKklk~~~~~~-------------------~---~~~~~~~Ei~~L~~L  390 (604)
                      ..|.+.+.||+|+||.||+|.       .||+|.++......                   .   ....+.+|+..+..+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999974       79999987532110                   0   112356788888888


Q ss_pred             CC--CceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeccCCCCceEE
Q 007429          391 GH--KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILL  467 (604)
Q Consensus       391 ~H--pnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g-IVHrDLKp~NILl  467 (604)
                      .+  ..+.+++++   ..  .++||||++|++|.........+.......++.||+.+|.|||++| ++||||||+||++
T Consensus       108 ~~~~i~~p~~~~~---~~--~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 YEAGVPVPKPIAW---RR--NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HhcCCCCCeeeEe---cC--ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            65  334455543   22  4799999999888776544445666777899999999999999999 9999999999999


Q ss_pred             cCCCcEEEEecCCcccc
Q 007429          468 DRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       468 d~~g~vKL~DFGla~~~  484 (604)
                      + ++.++|+|||.+...
T Consensus       183 ~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             E-CCCEEEEEChhhhcc
Confidence            9 889999999997643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=3.1e-17  Score=177.80  Aligned_cols=171  Identities=21%  Similarity=0.374  Sum_probs=128.8

Q ss_pred             cEEEEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ++||.|++|...+|.++|.+.+   ..+....+.++.|++.|++|   ++.+|||+||.||+...+..+||+|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            3889999999999999996443   46777889999999999999   99999999999999999999999999998766


Q ss_pred             ccCC------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC-CCC
Q 007429          485 KSVG------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRP  557 (604)
Q Consensus       485 ~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~-~r~  557 (604)
                      ....      .......||..||+||.+.+..|+.+    +||||||++++|+++   +|............+..+ +++
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k----vdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~  479 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK----VDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPP  479 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh----cchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCCh
Confidence            5443      12344579999999999999876654    999999999999997   122211111112222222 222


Q ss_pred             CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHH
Q 007429          558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEII  589 (604)
Q Consensus       558 ~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL  589 (604)
                      .+-.+. +.-+.++.+++...|.+||++.+..
T Consensus       480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  480 EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             HHhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence            222222 4567899999999999999655543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=5.1e-16  Score=174.69  Aligned_cols=131  Identities=17%  Similarity=0.163  Sum_probs=104.6

Q ss_pred             EEeeeeeccCceEEEEe----EEEEEEEeecCC-CCc-----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          343 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCD-KGN-----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG----k~VAIKklk~~~-~~~-----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ...+.||+|+||.||+|    ..+++|+..... ...     .....+.+|+..+..++|++++..+.++.+... .++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE-KTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-CEEE
Confidence            45789999999999995    344454432111 111     122457889999999999999888777776554 7899


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      |||++|++|.+++.        ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999874        346789999999999999999999999999999 578899999999754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=6.6e-16  Score=151.17  Aligned_cols=133  Identities=17%  Similarity=0.161  Sum_probs=101.8

Q ss_pred             eEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCc--------------------hHHHHHHHHHHHHHhCCCC--c
Q 007429          342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN--------------------AYEFELRKDLLELMTCGHK--N  394 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~--------------------~~~~~~~~Ei~~L~~L~Hp--n  394 (604)
                      |.+.+.||+|+||.||++     +.|+||.+.......                    ........|+..+..+.|+  +
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            667789999999999984     579999876432110                    0112256777778888776  4


Q ss_pred             eeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEE
Q 007429          395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       395 IVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vK  474 (604)
                      ++..++.    . ..++||||++|++|.++...      .....++.+++.++.++|+.|++||||||+||+++.++.++
T Consensus        97 v~~~~~~----~-~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          97 VPKPIDW----N-RHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCceeec----C-CceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            5555542    2 25899999999999876421      34567889999999999999999999999999999999999


Q ss_pred             EEecCCccccc
Q 007429          475 LGDMGIVTACK  485 (604)
Q Consensus       475 L~DFGla~~~~  485 (604)
                      |+|||++....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.5e-16  Score=180.70  Aligned_cols=252  Identities=18%  Similarity=0.223  Sum_probs=191.5

Q ss_pred             CCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..|.+.+.||+|+|+.|-..       ..+++|.+............+..|..+-..+. |+|++.+++...+... .++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~-~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS-YLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-ccc
Confidence            45677888999999999863       24666666544434444455566766666665 9999999999887775 789


Q ss_pred             EEecccCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCceEEcCCC-cEEEEecCCcccccc-
Q 007429          412 VTKLMEGGSVNDLI-LKSR-KLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKS-  486 (604)
Q Consensus       412 VmEy~~gGSL~dlL-~~~~-~l~~~~il~ia~qIa~gL~YLH-s~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~-  486 (604)
                      +++|..|+++.+.+ .... ..+......++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999888 4444 5677788899999999999999 99999999999999999999 999999999887665 


Q ss_pred             CCC--cccccCC-CCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHcCC--CCCCC
Q 007429          487 VGE--ATEYETD-GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGL--RPEIP  560 (604)
Q Consensus       487 ~~~--~~~~~~g-t~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~-~i~~~~~--r~~~p  560 (604)
                      .+.  ......| ++.|+|||...+..+...   ..|+||.|+++.-+++|..||.........+ .......  .....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~---~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGP---SVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCC---CcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            222  2334467 999999999987533322   3799999999999999999998644333221 1111111  12334


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ...+....+++.+++..+|..|.+.+++...-+-.
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~  290 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS  290 (601)
T ss_pred             ccCChhhhhcccccccCCchhcccccccccccccc
Confidence            56778899999999999999999999887654443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=3.7e-14  Score=143.93  Aligned_cols=131  Identities=17%  Similarity=0.138  Sum_probs=96.5

Q ss_pred             ee-ccCceEEEE----eEEEEEEEeecCCC-----------CchHHHHHHHHHHHHHhCCCCce--eEEEEEEEcCCCc-
Q 007429          348 IG-PNSFKGVYK----GKRVGIEKLKGCDK-----------GNAYEFELRKDLLELMTCGHKNI--LQFYCVCVDENHG-  408 (604)
Q Consensus       348 LG-~G~FG~Vyk----Gk~VAIKklk~~~~-----------~~~~~~~~~~Ei~~L~~L~HpnI--Vkl~g~~~~~~~~-  408 (604)
                      || .|+.|+||.    +..+++|.+.....           .......+.+|+..+..+.|++|  +..+++....... 
T Consensus        39 lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~  118 (239)
T PRK01723         39 VGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLF  118 (239)
T ss_pred             eecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcc
Confidence            44 555555555    56788887753110           01223457889999999988774  6777765443321 


Q ss_pred             --EEEEEecccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          409 --LCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       409 --l~LVmEy~~g-GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                        .++|||+++| .+|.+++.. ..++...    +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.+..
T Consensus       119 ~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        119 YRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             eeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence              3599999997 699998754 3455543    56899999999999999999999999999999999999998654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.7e-14  Score=138.90  Aligned_cols=134  Identities=17%  Similarity=0.162  Sum_probs=92.4

Q ss_pred             eeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHH----------------------HHHHHHHHHHhCCCC--ce
Q 007429          345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEF----------------------ELRKDLLELMTCGHK--NI  395 (604)
Q Consensus       345 ~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~----------------------~~~~Ei~~L~~L~Hp--nI  395 (604)
                      .+.||+|+||.||++     +.|++|.++..........                      ....|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999984     6799998875322111111                      013445555554333  35


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEE
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vK  474 (604)
                      .+.++..     ..++||||++++++........... ..+..++.+++.++.++|. ++|+||||||+||+++ ++.++
T Consensus        82 ~~~~~~~-----~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          82 PKPIDLN-----RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CceEecC-----CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence            5555432     2589999999954432111111111 6678899999999999999 9999999999999999 89999


Q ss_pred             EEecCCccccc
Q 007429          475 LGDMGIVTACK  485 (604)
Q Consensus       475 L~DFGla~~~~  485 (604)
                      |+|||.+....
T Consensus       155 liDfg~a~~~~  165 (187)
T cd05119         155 IIDVPQAVEID  165 (187)
T ss_pred             EEECccccccc
Confidence            99999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=5.5e-14  Score=127.34  Aligned_cols=128  Identities=15%  Similarity=0.114  Sum_probs=104.2

Q ss_pred             EeeeeeccCceEEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCCCcEEEEEeccc
Q 007429          344 FIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTKLME  417 (604)
Q Consensus       344 i~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H--pnIVkl~g~~~~~~~~l~LVmEy~~  417 (604)
                      +++.||.|.++.||++.    .+++|.......    ...+.+|+..+..++|  .++++++++....+. .+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGW-SYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-cEEEEEecC
Confidence            35779999999999864    678887754322    3457788888888866  589999888766554 899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       418 gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~---gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ++.+..+       +......++.+++.+|.+||..   +++|+||+|+||+++..+.++++|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9777654       5566677889999999999985   799999999999999989999999998653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=9.4e-13  Score=145.26  Aligned_cols=243  Identities=17%  Similarity=0.182  Sum_probs=179.3

Q ss_pred             CCCeEEeeeeec--cCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          339 SDNLEFIDQIGP--NSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       339 ~~~y~i~~~LG~--G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      ...+.+.+.+|.  |.+|.||.+        ..+++|+-+...........-.+++...+++ .|+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345667889999  999999984        4678888554444333333344666655555 68999998888877765


Q ss_pred             cEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHH----HHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCc
Q 007429          408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAE----GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIV  481 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~----gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla  481 (604)
                       +|+-+|++. .+|..+... ...++...++....+...    ||.++|+.+++|-|+||.||++..+ ...+++|||+.
T Consensus       193 -lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  193 -LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             -ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence             899999996 588877643 345888889999999999    9999999999999999999999999 78999999998


Q ss_pred             cccccCCCccccc-----CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHcC
Q 007429          482 TACKSVGEATEYE-----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--SPVQAAVGIAACG  554 (604)
Q Consensus       482 ~~~~~~~~~~~~~-----~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~--s~~~~~~~i~~~~  554 (604)
                      ..+.+........     .+...|++||...+..     +..+|+|++|.++.+..++-.+....  +....+....   
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-----~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---  342 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-----TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---  342 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcccc-----chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence            8776654333222     5677899999998652     23489999999999988865544322  1111111000   


Q ss_pred             CCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       555 ~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      .+.++....+.++...+.++++.+|-.|+++..+.++
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            2334445556778889999999999999999887654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.26  E-value=3.1e-12  Score=147.81  Aligned_cols=247  Identities=17%  Similarity=0.219  Sum_probs=175.1

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +....+.+.+++-+-+|+|+.++..+      ..+++.......-.. .....+.+-.++....+|.++...--+... .
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r-s  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR-S  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC-C
Confidence            44556788888889999999999743      223333221111000 001111111222223456666654443222 3


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc--
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~--  485 (604)
                      ++++|++|+.+++|...|......+..-...++..+..+++|||+..++|||++|.|+|+..+|+.++.|||......  
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            489999999999999998776667777778888899999999999999999999999999999999999998432111  


Q ss_pred             ----cCC-------------------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCC
Q 007429          486 ----SVG-------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA  536 (604)
Q Consensus       486 ----~~~-------------------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~  536 (604)
                          ...                         .......+|+.|.+||...+......    +|.|++|++++|.++|.+
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~----ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA----ADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc----chhhhhhhhhhhhhcCCC
Confidence                000                         00112247899999999998876655    799999999999999999


Q ss_pred             CCCCCChHHHHHHHHHcCCC-CCCCCCccHHHHHHHHHhhhcCCCCCCCHH
Q 007429          537 AYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIKCWNNSPSKRPQFS  586 (604)
Q Consensus       537 Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~  586 (604)
                      ||...++.+....+...... +.-+...+.+.++++...+..+|.+|..+.
T Consensus      1034 p~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999888877665544322 233556789999999999999999997765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.25  E-value=3.4e-11  Score=132.66  Aligned_cols=137  Identities=18%  Similarity=0.221  Sum_probs=90.5

Q ss_pred             eeeeccCceEEEEe-----EEEEEEEeecCCCCch--------------------------------H------HHHHHH
Q 007429          346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA--------------------------------Y------EFELRK  382 (604)
Q Consensus       346 ~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~--------------------------------~------~~~~~~  382 (604)
                      +.||+|++|.||+|     +.||||+.+..-....                                .      +..+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999985     5799999764211000                                0      011233


Q ss_pred             HHHHHHhC----CCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCce
Q 007429          383 DLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAE-GIKFLNDHGVA  456 (604)
Q Consensus       383 Ei~~L~~L----~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~-gL~YLHs~gIV  456 (604)
                      |...+.++    .|.+-|.+-.++.+-....++||||++|++|.++.... ...+   ...++..++. .+..+|..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence            33333332    33333333333332222368999999999999876422 1222   2345555555 46889999999


Q ss_pred             eccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          457 YRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       457 HrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      |+|++|.||+++.+|.++++|||++....
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=6.8e-12  Score=138.53  Aligned_cols=247  Identities=16%  Similarity=0.148  Sum_probs=172.2

Q ss_pred             cCCCeEEeeeeeccCceEEEE-------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~Vyk-------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l  409 (604)
                      ...+|..+..||.|.|+.|++       +..+++|-+.........+..-..|+.+...+ .|.|++.++..+...++ .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence            345788999999999999997       34566666654333333233234455444443 68899998877766665 7


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~~~~  488 (604)
                      |+-.|||.++++...+.-...+++...+++..|++.++.++|+..++|+|+||+||++..+ +.-+++|||..+.+..  
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence            8999999999988766444468888999999999999999999999999999999999886 7789999999765321  


Q ss_pred             CcccccCCCCcccc-cccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          489 EATEYETDGYRWLA-PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       489 ~~~~~~~gt~~Y~A-PE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                       ........-+++| +|++.....   +..+.|++|||..+.|..++.+--......    ..+..+..+..+.. ...+
T Consensus       420 -~~~~~~~~~r~~p~~~~~~e~~~---~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~~~~p~~~~~-~~~~  490 (524)
T KOG0601|consen  420 -SSGVFHHIDRLYPIAEILLEDYP---HLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRSGDTPNLPGL-KLQL  490 (524)
T ss_pred             -ecccccccccccccchhhccccc---cccccccccccccccccccCcccCcccccc----eeeecccccCCCch-HHhh
Confidence             1112223344553 555543322   223589999999999999976422221111    11223333334443 3778


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ..+...+...++..||.+.++..+.....
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhhh
Confidence            88888899999999999999887765543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=1.8e-11  Score=126.72  Aligned_cols=198  Identities=20%  Similarity=0.309  Sum_probs=136.5

Q ss_pred             HHHHhCCCCceeEEEEEEEcCC----CcEEEEEecccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhc--C
Q 007429          385 LELMTCGHKNILQFYCVCVDEN----HGLCVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDH--G  454 (604)
Q Consensus       385 ~~L~~L~HpnIVkl~g~~~~~~----~~l~LVmEy~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~--g  454 (604)
                      ..|..+-|-|||+++.|+.+..    ....+++||+..|+|..+|++-    ..+......+|+-||..||.|||+.  .
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3455668999999999987653    2478899999999999999642    3678888999999999999999987  5


Q ss_pred             ceeccCCCCceEEcCCCcEEEEecCC--ccccccC--CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHH
Q 007429          455 VAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSV--GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE  530 (604)
Q Consensus       455 IVHrDLKp~NILld~~g~vKL~DFGl--a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyE  530 (604)
                      |+|+++.-+-|++..+|.+||+----  ....-..  ...+....+-+.|.+||.=.-...    +-.+|||+||....|
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~----~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT----TGASDIYKFGMCALE  274 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc----ccchhhhhhhHHHHH
Confidence            99999999999999999999752111  0000000  011233346678999986443222    234899999999999


Q ss_pred             HHcCCCCCCC-CChH--HHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          531 MVTGEAAYAA-CSPV--QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       531 LlTG~~Pf~~-~s~~--~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      |..+..--.. .+..  +.....+..+..       ...-+.++.+|++-.|..||++.+++.|..
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCce
Confidence            9887653221 1111  111111111111       122356889999999999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.20  E-value=6.5e-11  Score=111.65  Aligned_cols=123  Identities=15%  Similarity=0.126  Sum_probs=88.2

Q ss_pred             eeeeeccCceEEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCCcEEEEEecccCC
Q 007429          345 IDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLCVVTKLMEGG  419 (604)
Q Consensus       345 ~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hpn-IVkl~g~~~~~~~~l~LVmEy~~gG  419 (604)
                      ++.|+.|.++.||+    |..+++|.......   ....+.+|+..+..+.+.+ +.+++....  .. -++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~-~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ET-GVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC-CeEEEEecCCC
Confidence            46788999999997    46788888753321   1223467777777765444 345554432  22 46999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV-----AYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       420 SL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gI-----VHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ++.+.     ...   ......+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~-----~~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-----DFS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc-----ccc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87643     111   12346789999999999885     9999999999999 6789999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=4.3e-10  Score=125.85  Aligned_cols=162  Identities=19%  Similarity=0.290  Sum_probs=120.5

Q ss_pred             eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHH
Q 007429          359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR  438 (604)
Q Consensus       359 Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~  438 (604)
                      |..|.|...+....  .......+-+..|+.++||||+++++.+..++. +|||+|-+.  -|..++.+.   ....+.-
T Consensus        37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~-~ylvTErV~--Pl~~~lk~l---~~~~v~~  108 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT-LYLVTERVR--PLETVLKEL---GKEEVCL  108 (690)
T ss_pred             CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCc-eEEEeeccc--cHHHHHHHh---HHHHHHH
Confidence            45677777764433  333446777888999999999999999887775 999999874  366666432   2555566


Q ss_pred             HHHHHHHHHHHHH-hcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCc
Q 007429          439 IAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW  517 (604)
Q Consensus       439 ia~qIa~gL~YLH-s~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~  517 (604)
                      -+.||+.||.||| ..+++|++|.-..|+++..|..||++|.++...............-..|..|+.+....      +
T Consensus       109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~------~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE------W  182 (690)
T ss_pred             HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc------c
Confidence            6889999999997 67899999999999999999999999998755443332122222233467777765433      3


Q ss_pred             chhHHHHHHHHHHHHcC
Q 007429          518 MSNVYSFGMVIWEMVTG  534 (604)
Q Consensus       518 kSDVWSlGvvLyELlTG  534 (604)
                      ..|.|.|||++||++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            36999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=7.6e-10  Score=124.39  Aligned_cols=137  Identities=18%  Similarity=0.176  Sum_probs=86.6

Q ss_pred             CCeEEeeeeeccCceEEEE------eEEEEEEEeecCCCC--------------------------------chHHHH--
Q 007429          340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKG--------------------------------NAYEFE--  379 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk------Gk~VAIKklk~~~~~--------------------------------~~~~~~--  379 (604)
                      .+|+. +.||+|++|.||+      |+.||||..+..-..                                .+....  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            44555 7899999999997      468999998643100                                011112  


Q ss_pred             ----HHHHHHHHHhC----CCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 007429          380 ----LRKDLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSR----KLQTKEIIRIAIDVAE  445 (604)
Q Consensus       380 ----~~~Ei~~L~~L----~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL--~~~~----~l~~~~il~ia~qIa~  445 (604)
                          +.+|...+.++    .+.+.+.+-.++.+-....+|||||+.|+.+.++-  ...+    .+....+..++.||  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                33333333332    34443443333333222357999999999998753  2222    23333333344444  


Q ss_pred             HHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCcccc
Q 007429          446 GIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTAC  484 (604)
Q Consensus       446 gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~  484 (604)
                           ...|++|+|+||.||+++.+|    .++++|||++...
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 468999999999999999988    9999999997554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.10  E-value=8.7e-10  Score=108.99  Aligned_cols=99  Identities=18%  Similarity=0.199  Sum_probs=74.4

Q ss_pred             HHHHHHHHhCC--CCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcee
Q 007429          381 RKDLLELMTCG--HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAY  457 (604)
Q Consensus       381 ~~Ei~~L~~L~--HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL-Hs~gIVH  457 (604)
                      ++|+..|.++.  .-++.+.+++   .+  -+|||||+.++.+..-..+...++......+..+++.+|.+| |+.|+||
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~---~~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH  148 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL---KK--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH  148 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe---cC--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            48888888863  2566677754   22  469999998754432222333455666778889999999999 8999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      +||++.|||++ ++.+.|+|||.+....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999997 5789999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=8.4e-09  Score=100.36  Aligned_cols=125  Identities=17%  Similarity=0.192  Sum_probs=86.0

Q ss_pred             eeeccCceEEEEeEEE---EEEEeecCC--CCchH-----HHHHHHHHHHHHhCCC--CceeEEEEEEEcCCCcEEEEEe
Q 007429          347 QIGPNSFKGVYKGKRV---GIEKLKGCD--KGNAY-----EFELRKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       347 ~LG~G~FG~VykGk~V---AIKklk~~~--~~~~~-----~~~~~~Ei~~L~~L~H--pnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .+++|+-+.+|.+...   +|.|.+..+  -.+..     ..+..+|..++.++.-  -+++.++.+  +... ..|+||
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~-~~I~me   79 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDN-GLIVME   79 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCC-CEEEEE
Confidence            4678888888875322   333332221  11111     2335677777776533  344444443  4443 569999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      |.+|..|.+++...       ...++..|-.-+.-||..||||+||.++||+++.++ +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            99999999988655       255667788888899999999999999999998655 9999999964

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.85  E-value=1.1e-08  Score=99.99  Aligned_cols=135  Identities=16%  Similarity=0.188  Sum_probs=97.3

Q ss_pred             eeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCC--CcEEEEEecc
Q 007429          346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDEN--HGLCVVTKLM  416 (604)
Q Consensus       346 ~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H--pnIVkl~g~~~~~~--~~l~LVmEy~  416 (604)
                      +.||.|.++.||+.     +.+.+|........ .....+..|...+..+.+  .++.+++.+.....  ...++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999983     56777776543221 123356788888887755  44677777665432  1358999999


Q ss_pred             cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 007429          417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND--------------------------------------------  452 (604)
Q Consensus       417 ~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs--------------------------------------------  452 (604)
                      +|.++.+.+.. ..+++.....++.+++.+|.+||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888775422 356777777777888888888873                                            


Q ss_pred             ------------cCceeccCCCCceEEcC--CCcEEEEecCCcc
Q 007429          453 ------------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVT  482 (604)
Q Consensus       453 ------------~gIVHrDLKp~NILld~--~g~vKL~DFGla~  482 (604)
                                  ..++|+|++|.||+++.  ++.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        23699999999999998  5678999999864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.2e-07  Score=98.14  Aligned_cols=103  Identities=11%  Similarity=0.065  Sum_probs=75.4

Q ss_pred             HHHHHHHHHhCCC--CceeEEEEEEEcC----CCcEEEEEecccCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 007429          380 LRKDLLELMTCGH--KNILQFYCVCVDE----NHGLCVVTKLMEGG-SVNDLILK--SRKLQTKEIIRIAIDVAEGIKFL  450 (604)
Q Consensus       380 ~~~Ei~~L~~L~H--pnIVkl~g~~~~~----~~~l~LVmEy~~gG-SL~dlL~~--~~~l~~~~il~ia~qIa~gL~YL  450 (604)
                      ..+|...+..|..  -.++..+++....    ...-+||||++++- +|.+++..  ....+......++.+++..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            5577766665522  2222333333221    12368999999886 89998853  23456677788999999999999


Q ss_pred             HhcCceeccCCCCceEEcC-------CCcEEEEecCCcc
Q 007429          451 NDHGVAYRDLNSQRILLDR-------HGNVCLGDMGIVT  482 (604)
Q Consensus       451 Hs~gIVHrDLKp~NILld~-------~g~vKL~DFGla~  482 (604)
                      |.+||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999999999999999975       4679999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=2e-07  Score=100.06  Aligned_cols=248  Identities=15%  Similarity=0.221  Sum_probs=157.5

Q ss_pred             EeeeeeccCceEEEE-eE--EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeE--------EEEEEEcCCCcEEE
Q 007429          344 FIDQIGPNSFKGVYK-GK--RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQ--------FYCVCVDENHGLCV  411 (604)
Q Consensus       344 i~~~LG~G~FG~Vyk-Gk--~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVk--------l~g~~~~~~~~l~L  411 (604)
                      ....||+|+-+.+|. |.  .-.-|++......  ...+   .+..|... .||-+-.        ++|-  +....+.+
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecchhhchhheeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEE
Confidence            456799999999997 22  2223444432221  1222   22223332 4443322        1111  11112567


Q ss_pred             EEecccCC-CHHHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          412 VTKLMEGG-SVNDLIL---KS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       412 VmEy~~gG-SL~dlL~---~~---~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      .|..++|. -+.+++.   +.   ..+.+..+++.+..++.+.+-||++|.+-+|++++|+|+++++.|.|.|=.... .
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq-i  166 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ-I  166 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee-e
Confidence            78877764 2333332   11   247889999999999999999999999999999999999999999999754422 2


Q ss_pred             ccCCCcccccCCCCccccccccc-CCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCC-------ChHHHHHH------
Q 007429          485 KSVGEATEYETDGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAAC-------SPVQAAVG------  549 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~~-------s~~~~~~~------  549 (604)
                      ..++.......|.+.|++||... +......-+...|.|.+|+++++++.| +.||.+.       ++.+....      
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            34444456667889999999765 221222223348999999999999875 9999752       22221110      


Q ss_pred             -H-HHcCCCC---CCC-CCccHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHhhCcc
Q 007429          550 -I-AACGLRP---EIP-KDCPQILKSLMIKCWNN--SPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       550 -i-~~~~~r~---~~p-~~~s~~l~~LI~kCL~~--dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                       - ...++++   .+| .-+++.+..+..+|++.  ++.-|||++..+..|..+....
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence             0 1111111   122 23578999999999974  4678999999999888776543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.67  E-value=1.6e-07  Score=91.38  Aligned_cols=139  Identities=20%  Similarity=0.266  Sum_probs=91.6

Q ss_pred             EeeeeeccCceEEEEe----EEEEEEEeec--CCC---C-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          344 FIDQIGPNSFKGVYKG----KRVGIEKLKG--CDK---G-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       344 i~~~LG~G~FG~VykG----k~VAIKklk~--~~~---~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+..|-+|+-+.|+++    +..-||.-..  -..   . .....+..+|...|.++.--.|.--.-++.+... -+|+|
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeEEE
Confidence            3456778998988885    3434443211  011   1 1123446778888877533333222223444443 57999


Q ss_pred             ecccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCccc
Q 007429          414 KLMEG-GSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTA  483 (604)
Q Consensus       414 Ey~~g-GSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~  483 (604)
                      ||++| .++.+++...-  .....-...++..|-+.+.-||..+|||+||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 57888885432  2233334788999999999999999999999999999977664   58999999643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.56  E-value=2.5e-08  Score=112.33  Aligned_cols=145  Identities=22%  Similarity=0.336  Sum_probs=100.9

Q ss_pred             HHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccccCCCc--cc-------ccCCCCcccccccccCCCC
Q 007429          442 DVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TE-------YETDGYRWLAPEIIAGDPE  511 (604)
Q Consensus       442 qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~-------~~~gt~~Y~APE~l~~~~~  511 (604)
                      +++.||.|+|.. ++||++|.|++|.++..|..||+.|+++.........  ..       .......|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            344999999965 8999999999999999999999999986543331111  01       1112357999999987433


Q ss_pred             CCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCh--HHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHH
Q 007429          512 SVSETWMSNVYSFGMVIWEMVTGE-AAYAACSP--VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI  588 (604)
Q Consensus       512 s~~~t~kSDVWSlGvvLyELlTG~-~Pf~~~s~--~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~EL  588 (604)
                          +.++|+||+||++|-++.|. .-+.....  .........+......+.++|+++++-+.+++..++.-||++.++
T Consensus       187 ----~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  187 ----TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ----cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence                33599999999999999544 43332211  111111111112223557889999999999999999999987776


Q ss_pred             HH
Q 007429          589 IS  590 (604)
Q Consensus       589 L~  590 (604)
                      ..
T Consensus       263 ~~  264 (700)
T KOG2137|consen  263 LS  264 (700)
T ss_pred             hc
Confidence            54

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.55  E-value=8.8e-07  Score=87.90  Aligned_cols=105  Identities=18%  Similarity=0.197  Sum_probs=79.5

Q ss_pred             HHHHHHHHHHhCC--CCceeEEEEEEEcCC---CcEEEEEecccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 007429          379 ELRKDLLELMTCG--HKNILQFYCVCVDEN---HGLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND  452 (604)
Q Consensus       379 ~~~~Ei~~L~~L~--HpnIVkl~g~~~~~~---~~l~LVmEy~~gG-SL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs  452 (604)
                      ...+|...+..|.  .-.+++.+++.....   ...++|||++++. +|.+++......+......++.+++..+.-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            4556666555542  223444455544322   2358999999884 799998664457777888999999999999999


Q ss_pred             cCceeccCCCCceEEcCCC---cEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHG---NVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g---~vKL~DFGla~~  483 (604)
                      +||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=2.7e-06  Score=85.09  Aligned_cols=135  Identities=13%  Similarity=0.059  Sum_probs=94.0

Q ss_pred             eccCceEEEE----eEEEEEEEeecCCCC----chHHHHHHHHHHHHHhCCC--CceeEEE--EEEEcC-CCcEEEEEec
Q 007429          349 GPNSFKGVYK----GKRVGIEKLKGCDKG----NAYEFELRKDLLELMTCGH--KNILQFY--CVCVDE-NHGLCVVTKL  415 (604)
Q Consensus       349 G~G~FG~Vyk----Gk~VAIKklk~~~~~----~~~~~~~~~Ei~~L~~L~H--pnIVkl~--g~~~~~-~~~l~LVmEy  415 (604)
                      |+||.+.|+.    |+.+-+|.-...-..    +.-+..+.+|+..|..|..  -.+++..  +.-... ....+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            5689999987    566777764311100    1124457788888777622  2244443  211111 2336899996


Q ss_pred             ccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc--EEEEecCCccc
Q 007429          416 MEG-GSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTA  483 (604)
Q Consensus       416 ~~g-GSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~--vKL~DFGla~~  483 (604)
                      ++| -+|.+++...  .+.+......++.+|+..+.-||+.|+.|+|+.+.|||++.+|.  ++++||.-++.
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            653 5899887543  24577777899999999999999999999999999999987777  99999976543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.44  E-value=8.1e-06  Score=89.86  Aligned_cols=203  Identities=13%  Similarity=0.194  Sum_probs=139.2

Q ss_pred             eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---CCcEEEEEecccC-CCHHHHHHh-------
Q 007429          359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVVTKLMEG-GSVNDLILK-------  427 (604)
Q Consensus       359 Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---~~~l~LVmEy~~g-GSL~dlL~~-------  427 (604)
                      |..+.+|++...+....  -....-+..++++.|+|||+|.+++...   +..+++|++|.++ ++|.++.-.       
T Consensus       301 G~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~  378 (655)
T KOG3741|consen  301 GNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR  378 (655)
T ss_pred             CceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence            67888888843222111  1112345667889999999999998733   2358999999885 578876521       


Q ss_pred             --------cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCc
Q 007429          428 --------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR  499 (604)
Q Consensus       428 --------~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~  499 (604)
                              +.+.++..+|.++.|+..||.++|+.|+.-+-|.+.+||++.+-+++|+.-|+.-....+.       +   
T Consensus       379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------~---  448 (655)
T KOG3741|consen  379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------T---  448 (655)
T ss_pred             cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------C---
Confidence                    2247789999999999999999999999999999999999988888888777632222111       0   


Q ss_pred             ccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcC
Q 007429          500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA-YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  578 (604)
Q Consensus       500 Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~P-f~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~d  578 (604)
                          |-+.+.       .+-|.=.||.++..|.||..- +...........        .+....+.++++++.-....+
T Consensus       449 ----~~le~~-------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v~yl~s~~  509 (655)
T KOG3741|consen  449 ----EPLESQ-------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVVEYLESLN  509 (655)
T ss_pred             ----cchhHH-------hhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHHHHHHhcC
Confidence                112111       135888999999999998542 222222222111        123445678888888888888


Q ss_pred             CCCCCCHHHHHHHHH
Q 007429          579 PSKRPQFSEIISLLL  593 (604)
Q Consensus       579 P~kRPT~~ELL~~L~  593 (604)
                      +.+ -+..+++.++-
T Consensus       510 ~~~-ksI~~llp~~~  523 (655)
T KOG3741|consen  510 FRE-KSIQDLLPMIG  523 (655)
T ss_pred             ccc-ccHHHHHHHHH
Confidence            876 67778777654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.37  E-value=1.3e-06  Score=85.98  Aligned_cols=100  Identities=20%  Similarity=0.197  Sum_probs=66.3

Q ss_pred             HHHHHHHHHHHhCCCC--ceeEEEEEEEcCCCcEEEEEeccc--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHh
Q 007429          378 FELRKDLLELMTCGHK--NILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF-LND  452 (604)
Q Consensus       378 ~~~~~Ei~~L~~L~Hp--nIVkl~g~~~~~~~~l~LVmEy~~--gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~Y-LHs  452 (604)
                      ...++|...|..+..-  ++.+.+++-   +  -+|||||++  |..+..+...  .++......++.+++..+.. +|.
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~---~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN---R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE---T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe---C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh
Confidence            3477899999998654  567776542   2  359999999  6555554321  12244456677778886666 579


Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .|++|+||.+.|||++.+ .+.|+|||.+....
T Consensus       126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             cCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            999999999999999977 89999999875543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.18  E-value=1.3e-07  Score=105.72  Aligned_cols=185  Identities=15%  Similarity=0.087  Sum_probs=136.7

Q ss_pred             eEEeeeeeccCceEEEEeEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCCcEEEEEecccCC-
Q 007429          342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLCVVTKLMEGG-  419 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hpn-IVkl~g~~~~~~~~l~LVmEy~~gG-  419 (604)
                      +...+.+++|+++.++|.+..|-|.+........  ....-++..|.+++||| .+..++-+..+.. .+++++++.++ 
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~-~~i~~~i~s~~r  320 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY-LWIPMRICSTGR  320 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccc-cchhhhhhcCCc
Confidence            4667788999999999999888888763332222  34556777789999999 7777777766555 88999999987 


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCC
Q 007429          420 SVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  498 (604)
Q Consensus       420 SL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~  498 (604)
                      +....... .-.+..-+...++..-.++++|||+..-+|+|    ||+..+ +..|.+||+....+.... ......+++
T Consensus       321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~  394 (829)
T KOG0576|consen  321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTP  394 (829)
T ss_pred             cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCC
Confidence            33322211 11344555666777888999999998779999    877764 779999999976554332 344557899


Q ss_pred             cccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 007429          499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA  539 (604)
Q Consensus       499 ~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~  539 (604)
                      .|+|||+.....+...    .|+|++|+-..++--|.+|-.
T Consensus       395 ~~~~pev~~~~~~~~~----p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  395 EPLAPEVIQENTIDGC----PDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCchhhcccccccC----CCccCCCcchhhcCCCCCCCC
Confidence            9999999987766554    799999998888887877754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.10  E-value=1.3e-05  Score=82.67  Aligned_cols=129  Identities=17%  Similarity=0.198  Sum_probs=89.1

Q ss_pred             EEeeeeeccCceEEEE-----eEEEEEEEeecCC------------------CC--chHHHHHHHHHHHHHhCCCC--ce
Q 007429          343 EFIDQIGPNSFKGVYK-----GKRVGIEKLKGCD------------------KG--NAYEFELRKDLLELMTCGHK--NI  395 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~------------------~~--~~~~~~~~~Ei~~L~~L~Hp--nI  395 (604)
                      .+..+||-|--+.||.     |.++++|.-+.-.                  ..  .......++|...|..|.-.  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4678999999999998     4678888632110                  11  11223467888888887544  67


Q ss_pred             eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEE
Q 007429          396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL  475 (604)
Q Consensus       396 Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL  475 (604)
                      .+.+++-   .  -.+||||.+|--|...-     ++....-.++..|+.-+.-+-..||||+|+.+=||+++.+|.+.+
T Consensus       174 P~P~~~n---R--HaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         174 PKPIAWN---R--HAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCccccc---c--ceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            7766542   2  46999999996665432     133334444455555555555899999999999999999999999


Q ss_pred             EecCCc
Q 007429          476 GDMGIV  481 (604)
Q Consensus       476 ~DFGla  481 (604)
                      +||--+
T Consensus       244 IDwPQ~  249 (304)
T COG0478         244 IDWPQA  249 (304)
T ss_pred             EeCccc
Confidence            999654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.04  E-value=4.9e-05  Score=76.77  Aligned_cols=131  Identities=11%  Similarity=0.076  Sum_probs=77.0

Q ss_pred             eeeeccCceEEEE--eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcCCCcEEEEEecccCCC-
Q 007429          346 DQIGPNSFKGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK--NILQFYCVCVDENHGLCVVTKLMEGGS-  420 (604)
Q Consensus       346 ~~LG~G~FG~Vyk--Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hp--nIVkl~g~~~~~~~~l~LVmEy~~gGS-  420 (604)
                      ..||+|..+.||+  |....+|......    ....+.+|...+..+..-  .+.+.+++..+.+. ..+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTHKTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-LGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEecCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-eeeeeeecCCccc
Confidence            4689999999998  4555556654211    233467888887776432  34666777655554 778999999963 


Q ss_pred             HHHH--------------HHh-----cC----CCCHHH-HHHHHHH----------HHH-HHHHHH----hcCceeccCC
Q 007429          421 VNDL--------------ILK-----SR----KLQTKE-IIRIAID----------VAE-GIKFLN----DHGVAYRDLN  461 (604)
Q Consensus       421 L~dl--------------L~~-----~~----~l~~~~-il~ia~q----------Ia~-gL~YLH----s~gIVHrDLK  461 (604)
                      +...              +.+     +.    ..+... ...+..+          +.. ...+|.    ...++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2111              100     00    011100 0111000          111 122222    1247899999


Q ss_pred             CCceEEcCCCcEEEEecCCcc
Q 007429          462 SQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       462 p~NILld~~g~vKL~DFGla~  482 (604)
                      |.||+++.++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.03  E-value=6.2e-05  Score=75.84  Aligned_cols=134  Identities=17%  Similarity=0.215  Sum_probs=81.6

Q ss_pred             CCeEEeeeeeccCceEEEE----eEEEEEEEeecCCCCchHH----------HHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          340 DNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYE----------FELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~----------~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+|.+++.+-......|.+    |+...+|..+....-....          ..+...+..+...+-.....++-+..-.
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            5677777777766666665    5666666655322111111          1111222222222333333333333221


Q ss_pred             C----CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          406 N----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       406 ~----~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .    ...++||||++|..|.++.    .+++    .+...|..++.-||+.|+.|+|..|.|++++.++ ++++||+..
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             eccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccc
Confidence            1    2256899999998887653    2333    2345677889999999999999999999999555 999999875


Q ss_pred             c
Q 007429          482 T  482 (604)
Q Consensus       482 ~  482 (604)
                      +
T Consensus       182 ~  182 (229)
T PF06176_consen  182 R  182 (229)
T ss_pred             c
Confidence            4

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.94  E-value=8.3e-05  Score=75.92  Aligned_cols=137  Identities=18%  Similarity=0.188  Sum_probs=92.7

Q ss_pred             EEeeeeeccCceEEEE-----eEEEEEEEeecCCCCch----------------------HHHHHHHHHHHHHhC--CCC
Q 007429          343 EFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNA----------------------YEFELRKDLLELMTC--GHK  393 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~~~~~----------------------~~~~~~~Ei~~L~~L--~Hp  393 (604)
                      .+...|.+|--+.||+     +..+|+|+.+.......                      ......+|+..|.++  -+-
T Consensus        51 ~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          51 ELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            3455888999999999     46899999764321100                      011245677777765  344


Q ss_pred             ceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCc
Q 007429          394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGN  472 (604)
Q Consensus       394 nIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~  472 (604)
                      .+.+-+++..     -.|||||++...+-.-..+.-.+.......+..++++.|.-|-. .++||+||..=|||+. ++.
T Consensus       131 rvP~Pi~~~~-----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         131 RVPEPIAFRN-----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             CCCCceeecC-----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence            5566665531     35999999764211101112233444677788899999988866 8999999999999999 899


Q ss_pred             EEEEecCCccccc
Q 007429          473 VCLGDMGIVTACK  485 (604)
Q Consensus       473 vKL~DFGla~~~~  485 (604)
                      +.|+|||-+....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999875543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.81  E-value=0.00028  Score=68.97  Aligned_cols=134  Identities=13%  Similarity=0.131  Sum_probs=75.0

Q ss_pred             eeeeeccCceEEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCC--CcEEEEEecc
Q 007429          345 IDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDEN--HGLCVVTKLM  416 (604)
Q Consensus       345 ~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H--pnIVkl~g~~~~~~--~~l~LVmEy~  416 (604)
                      ++.|+.|..+.||+..    .+.+|.....    .....+.+|...+..+..  ..+.+++.......  ...+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999843    6777776432    334556777777666522  24566776543332  2268999999


Q ss_pred             cCCCHHH----------------HHH---hc--C--CCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 007429          417 EGGSVND----------------LIL---KS--R--KLQTKE---------IIRI------------AIDVAE-GIKFLN  451 (604)
Q Consensus       417 ~gGSL~d----------------lL~---~~--~--~l~~~~---------il~i------------a~qIa~-gL~YLH  451 (604)
                      +|..+..                .+.   ..  .  .+....         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                111   01  0  001000         0000            111222 233333


Q ss_pred             -------hcCceeccCCCCceEEc-CCCcEEEEecCCcc
Q 007429          452 -------DHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT  482 (604)
Q Consensus       452 -------s~gIVHrDLKp~NILld-~~g~vKL~DFGla~  482 (604)
                             ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                   24599999999999999 66777899998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.80  E-value=0.00053  Score=68.32  Aligned_cols=136  Identities=16%  Similarity=0.253  Sum_probs=94.0

Q ss_pred             CCccccceeecCCCeEEeeeeeccCc-eEEEE----eEEEEEEEeecCCCCc-------------------hHHHHHHHH
Q 007429          328 GGEEIGRWLLNSDNLEFIDQIGPNSF-KGVYK----GKRVGIEKLKGCDKGN-------------------AYEFELRKD  383 (604)
Q Consensus       328 ~~~~i~~~~i~~~~y~i~~~LG~G~F-G~Vyk----Gk~VAIKklk~~~~~~-------------------~~~~~~~~E  383 (604)
                      .++.+.++.....++++++.||.|.- |.||+    |+.+|+|..+......                   ....-+..|
T Consensus        25 ~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E  104 (207)
T PF13095_consen   25 PGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE  104 (207)
T ss_pred             CCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence            45667777776689999999999999 99998    6789999943211000                   111235566


Q ss_pred             HHHHHh---CCCCce--eEEEEEEEcCC-----------------CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHH
Q 007429          384 LLELMT---CGHKNI--LQFYCVCVDEN-----------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI  441 (604)
Q Consensus       384 i~~L~~---L~HpnI--Vkl~g~~~~~~-----------------~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~  441 (604)
                      .+...+   +++.++  |+++||..-..                 ....||.||++...         .+....    +.
T Consensus       105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~  171 (207)
T PF13095_consen  105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IP  171 (207)
T ss_pred             HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HH
Confidence            665444   455666  99999984220                 11467888776633         233333    35


Q ss_pred             HHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       442 qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      +|.+-|..+|..||+-+|+++.|..   +  -||+|||.+
T Consensus       172 ~~~~dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  172 QMLRDLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence            6777788899999999999999976   2  389999863

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.79  E-value=0.00011  Score=87.42  Aligned_cols=203  Identities=13%  Similarity=0.196  Sum_probs=145.8

Q ss_pred             HHHHHHHHHHhCCCCceeEEEEEEEcCCC-c--EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 007429          379 ELRKDLLELMTCGHKNILQFYCVCVDENH-G--LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV  455 (604)
Q Consensus       379 ~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-~--l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gI  455 (604)
                      ..+.|+..+..+.|+|++.+++|-..... +  +.+..+++.+.++...+..-..++....+.+..++..||.|+|+...
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            35567777888899999999988765532 1  23445889999999988777789999999999999999999999977


Q ss_pred             eeccCCCC---ceEEcCCCcEEEE--ecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHH
Q 007429          456 AYRDLNSQ---RILLDRHGNVCLG--DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE  530 (604)
Q Consensus       456 VHrDLKp~---NILld~~g~vKL~--DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyE  530 (604)
                      .|.-+..+   +-..+..+.+.++  ||+......+... ......+..|.+||..........  .+.|+|.+|....-
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~--r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKS--RLTDLWCLGLLLLQ  384 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhh--hhhHHHHHHHHHhh
Confidence            77777666   5556677777777  9988776654332 222233455778888776654433  34799999999999


Q ss_pred             HHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          531 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       531 LlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +..|..+-.....       .    ..-.+..+..+..+...+|+..++++|++..+++.+...-
T Consensus       385 ~~~~~~i~~~~~~-------~----~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  385 LSQGEDISEKSAV-------P----VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             hhhcCcccccccc-------h----hhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            9886543111000       0    0112223333788899999999999999999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.79  E-value=0.00042  Score=68.86  Aligned_cols=126  Identities=21%  Similarity=0.315  Sum_probs=86.4

Q ss_pred             eeeeccCceEEEEe---EEEEEEEeecCC--------------CCchHHHHHHHHHHHHHhCC------CCceeEEEEEE
Q 007429          346 DQIGPNSFKGVYKG---KRVGIEKLKGCD--------------KGNAYEFELRKDLLELMTCG------HKNILQFYCVC  402 (604)
Q Consensus       346 ~~LG~G~FG~VykG---k~VAIKklk~~~--------------~~~~~~~~~~~Ei~~L~~L~------HpnIVkl~g~~  402 (604)
                      ..||+|+.-.||.-   ....||..+...              .......+..+|+.....+.      +.+|.+++|+.
T Consensus         7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v   86 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV   86 (199)
T ss_pred             cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence            45899999999972   355666665433              01112344566666555444      88999999999


Q ss_pred             EcCCCcEEEEEecccC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----c
Q 007429          403 VDENHGLCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----N  472 (604)
Q Consensus       403 ~~~~~~l~LVmEy~~g------GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~  472 (604)
                      .++.. +.+|+|....      .+|.+++. .+.++. .+..   .+-+-..||-+++|+.+||+|.||++....    .
T Consensus        87 eT~~G-~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~  160 (199)
T PF10707_consen   87 ETNLG-LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR  160 (199)
T ss_pred             ecCCc-eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence            88764 8899988653      36888883 444655 3333   334445788899999999999999995433    4


Q ss_pred             EEEEe
Q 007429          473 VCLGD  477 (604)
Q Consensus       473 vKL~D  477 (604)
                      +.|+|
T Consensus       161 lvlID  165 (199)
T PF10707_consen  161 LVLID  165 (199)
T ss_pred             EEEEe
Confidence            67777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.75  E-value=8.6e-05  Score=73.05  Aligned_cols=98  Identities=15%  Similarity=0.149  Sum_probs=78.5

Q ss_pred             HHHHHHHHhCCC-CceeEEEEEEEcCCCcEEEEEecccCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---c
Q 007429          381 RKDLLELMTCGH-KNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLND---H  453 (604)
Q Consensus       381 ~~Ei~~L~~L~H-pnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dl---L~~~~~l~~~~il~ia~qIa~gL~YLHs---~  453 (604)
                      ..|..++..+++ +++++++|+|.     -++|+||.+.+++.+.   +..-...++..+.+++.++++.+++|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357777777766 69999999994     3578999988766532   1122346899999999999999999987   3


Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .+.-.|++++|+-++++|++|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            577789999999999999999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.73  E-value=0.00012  Score=82.41  Aligned_cols=76  Identities=22%  Similarity=0.357  Sum_probs=56.1

Q ss_pred             EEEEEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      -.++|||++|--+.++.. +...++.+.+.....++.  +..+=..|+.|.|..|.||+++.+|++.+.|||+....+.
T Consensus       241 ~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         241 RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            469999999999988742 334566555444333332  2333348999999999999999999999999999876653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.63  E-value=0.00051  Score=69.27  Aligned_cols=129  Identities=16%  Similarity=0.121  Sum_probs=72.2

Q ss_pred             eeccCc-eEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEecccCCCH
Q 007429          348 IGPNSF-KGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSV  421 (604)
Q Consensus       348 LG~G~F-G~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL  421 (604)
                      |-.|.. ..||+.    ..+.+|......     ...+.+|+..+..+ .+--+.+++++....+. -++|||+++|.+|
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGR-AWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc-cEEEEEeeCCccH
Confidence            334444 677873    245555554322     22355677766665 23446677777665443 6799999999877


Q ss_pred             HHHH----------------HhcCCCCH-------H--HHHHHHH--------------------HHHHHHHHHH-----
Q 007429          422 NDLI----------------LKSRKLQT-------K--EIIRIAI--------------------DVAEGIKFLN-----  451 (604)
Q Consensus       422 ~dlL----------------~~~~~l~~-------~--~il~ia~--------------------qIa~gL~YLH-----  451 (604)
                      ....                .+-..++.       .  .......                    .+...+..|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6431                00001110       0  0000000                    0111122221     


Q ss_pred             --hcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          452 --DHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       452 --s~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                        ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              1348999999999999988778899998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.28  E-value=0.0013  Score=64.18  Aligned_cols=130  Identities=17%  Similarity=0.218  Sum_probs=86.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCcee-EEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL-QFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIV-kl~g~~~~~~~~l~LV  412 (604)
                      .....+..+.||+|.+|.||+|.    .+++|.-+....    ...+..|..+|..+.-.++. ++|.+-  .   .++.
T Consensus        20 ~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg--~---~~i~   90 (201)
T COG2112          20 GKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYG--E---DFIR   90 (201)
T ss_pred             cchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEec--h---hhhh
Confidence            33445677899999999999964    677777664332    34567888877776555544 344332  2   2366


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC-CCceEEcCCCcEEEEecCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN-SQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLK-p~NILld~~g~vKL~DFGla~~  483 (604)
                      |||..|-.|.+.-...   +..++.    .+++.-.-|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus        91 me~i~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIGG---DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhcc---cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9999998888765321   333333    35555555667899999886 5555555566999999998763

>PLN02876 acyl-CoA dehydrogenase

Probab=97.24  E-value=0.0029  Score=75.56  Aligned_cols=75  Identities=19%  Similarity=0.332  Sum_probs=49.3

Q ss_pred             eeeeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCce--eEEEEEEEcCC--CcEEE
Q 007429          345 IDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNI--LQFYCVCVDEN--HGLCV  411 (604)
Q Consensus       345 ~~~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnI--Vkl~g~~~~~~--~~l~L  411 (604)
                      +..|+.|.++.+|+-        ..+.+|+...... ......+.+|..++..+. |.+|  .+.+++|.+..  ...|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            567888988888862        2444555432211 112345778998888884 6554  78888887642  23689


Q ss_pred             EEecccCCC
Q 007429          412 VTKLMEGGS  420 (604)
Q Consensus       412 VmEy~~gGS  420 (604)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.16  E-value=0.0023  Score=64.38  Aligned_cols=29  Identities=17%  Similarity=0.115  Sum_probs=24.9

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      +++|+|+.+.||+++.++..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            48999999999999876656799999864

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.02  E-value=0.0017  Score=73.39  Aligned_cols=75  Identities=17%  Similarity=0.265  Sum_probs=53.3

Q ss_pred             EEEEEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC----CCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----HGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~----~g~vKL~DFGla~~  483 (604)
                      -.|+||||+|.-+.|+-. +...++...+...+.++..  +-|=..|++|.|=.|.||++..    ++.+.+.|||+...
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            569999999988776542 3345666655444443322  2233578999999999999984    56799999999765


Q ss_pred             cc
Q 007429          484 CK  485 (604)
Q Consensus       484 ~~  485 (604)
                      ..
T Consensus       355 is  356 (538)
T KOG1235|consen  355 IS  356 (538)
T ss_pred             cc
Confidence            54

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.00  E-value=0.002  Score=71.73  Aligned_cols=158  Identities=21%  Similarity=0.243  Sum_probs=99.3

Q ss_pred             HHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 007429          377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA  456 (604)
Q Consensus       377 ~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIV  456 (604)
                      ..++......++++.|+|...++.+.........+|||++.- ||++++..+. +......              .+++.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc--------------ccccc
Confidence            455677778889999999999998876655458899999955 9999985443 2221111              22222


Q ss_pred             eccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCC
Q 007429          457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA  536 (604)
Q Consensus       457 HrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~  536 (604)
                      |-     ||       ++++| -+...       .           |=.+.         .|+||||+|.++.|+.-|..
T Consensus        90 ~~-----~~-------~~~td-~~~t~-------~-----------~~~~~---------pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   90 HL-----NI-------IYITD-HFLTK-------Y-----------PSPIG---------PKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ee-----hh-------hhccc-ccccc-------C-----------CCCCC---------cchhhhhHHHHHHHHHHhhH
Confidence            21     11       23333 11000       0           10010         15999999999999999987


Q ss_pred             CCCCCChHHHHHHHHHcCCCC----------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 007429          537 AYAACSPVQAAVGIAACGLRP----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS  590 (604)
Q Consensus       537 Pf~~~s~~~~~~~i~~~~~r~----------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~  590 (604)
                      .+......+....+..-...+          .+-..++..+..+..+|+-..|..||.+.++.+
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            777655555444433322111          112245677888999999999999998777654

>PRK10593 hypothetical protein; Provisional

Probab=96.45  E-value=0.042  Score=57.80  Aligned_cols=76  Identities=12%  Similarity=0.062  Sum_probs=49.9

Q ss_pred             eEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC---CceeEEEEEEEcC--CCcEEEE
Q 007429          342 LEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDE--NHGLCVV  412 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H---pnIVkl~g~~~~~--~~~l~LV  412 (604)
                      ..-.+.||.|..+.||.-    ..+.+|..+. ...   ...+..|...|+.+.-   -.+.+++++|...  ...-+||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            345678999999999982    2344455332 111   2346677777776632   4688888887643  2337899


Q ss_pred             EecccCCCH
Q 007429          413 TKLMEGGSV  421 (604)
Q Consensus       413 mEy~~gGSL  421 (604)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.32  E-value=0.00068  Score=82.72  Aligned_cols=150  Identities=13%  Similarity=-0.000  Sum_probs=106.1

Q ss_pred             HHHhCCCCceeEEEEEEEcC-CCcEEEEEecccCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc-----Cc
Q 007429          386 ELMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDH-----GV  455 (604)
Q Consensus       386 ~L~~L~HpnIVkl~g~~~~~-~~~l~LVmEy~~gGSL~dlL~~~~----~l~~~~il~ia~qIa~gL~YLHs~-----gI  455 (604)
                      .++...|++++..+.=.... +...+.+++|+.+|.+.+.|.++-    .++..-+.....+...+..-+|+.     -.
T Consensus      1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred             hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence            34456788888766544332 334689999999999999985432    233333333333336666776654     26


Q ss_pred             eeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCC
Q 007429          456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE  535 (604)
Q Consensus       456 VHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~  535 (604)
                      +|++||+.|.+|..+.++|++++|+.+.............+++-|+.|+....-.++    .++|+|..|+.+|+...|.
T Consensus      1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t----~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT----KRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred             hhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh----hHHHHHHHHHHHHHHhccc
Confidence            999999999999999999999999987433333334445567778999988765443    3489999999999998887


Q ss_pred             CCCC
Q 007429          536 AAYA  539 (604)
Q Consensus       536 ~Pf~  539 (604)
                      .+|-
T Consensus      1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred             HHHH
Confidence            7653

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.14  E-value=0.023  Score=61.40  Aligned_cols=137  Identities=16%  Similarity=0.133  Sum_probs=92.1

Q ss_pred             EEeeeeeccCceEEEE-----eEEEEEEEeecCC----------------------CCc--hHHHHHHHHHHHHHhCCCC
Q 007429          343 EFIDQIGPNSFKGVYK-----GKRVGIEKLKGCD----------------------KGN--AYEFELRKDLLELMTCGHK  393 (604)
Q Consensus       343 ~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~----------------------~~~--~~~~~~~~Ei~~L~~L~Hp  393 (604)
                      ++-.+|..|--.-||.     |..+|||+++..-                      ..+  ......++|++.|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456788888889997     5678999864310                      000  1122356778778776443


Q ss_pred             ceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCCCCceEEcCCCc
Q 007429          394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGN  472 (604)
Q Consensus       394 nIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL-Hs~gIVHrDLKp~NILld~~g~  472 (604)
                      .|.----.. -.+  -.|||+|+.....-.-..+.-.++...+..+-.+++.-|.-| |..++||.||.-=|+|+. +|.
T Consensus       227 GIP~PePIl-Lk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  227 GIPCPEPIL-LKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCCCcee-eec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            332111111 112  359999997544333333455678888889999999999888 567999999999999997 688


Q ss_pred             EEEEecCCccc
Q 007429          473 VCLGDMGIVTA  483 (604)
Q Consensus       473 vKL~DFGla~~  483 (604)
                      +.|+|-+-+..
T Consensus       303 lyiIDVSQSVE  313 (520)
T KOG2270|consen  303 LYIIDVSQSVE  313 (520)
T ss_pred             EEEEEcccccc
Confidence            99999887544

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.13  E-value=0.038  Score=55.17  Aligned_cols=29  Identities=21%  Similarity=0.163  Sum_probs=25.8

Q ss_pred             CceeccCCCCceEEcC-CCcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILld~-~g~vKL~DFGla~  482 (604)
                      +++|+|+.+.|||++. ++.+.|+||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999998 5789999998753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.95  E-value=0.029  Score=57.15  Aligned_cols=29  Identities=14%  Similarity=0.189  Sum_probs=25.4

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .++|+|+.|.||+++.++ +.|+||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            489999999999999877 78999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.68  E-value=0.075  Score=55.00  Aligned_cols=30  Identities=23%  Similarity=0.226  Sum_probs=26.5

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            469999999999999988777899998854

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.68  E-value=0.24  Score=54.55  Aligned_cols=73  Identities=15%  Similarity=0.079  Sum_probs=44.8

Q ss_pred             eeeeeccCceEEEEe------EEEEEEEeecCC----CC-chHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCCcEE
Q 007429          345 IDQIGPNSFKGVYKG------KRVGIEKLKGCD----KG-NAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       345 ~~~LG~G~FG~VykG------k~VAIKklk~~~----~~-~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~~l~  410 (604)
                      .+.||.|.+..||+.      +.+.||.-....    .. .....+...|...|..+   ...++++++.+  ++.. -+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CE
Confidence            467999999999983      367788743111    11 11223345555555553   23567888866  3333 57


Q ss_pred             EEEecccCCC
Q 007429          411 VVTKLMEGGS  420 (604)
Q Consensus       411 LVmEy~~gGS  420 (604)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998743

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.41  E-value=0.013  Score=62.23  Aligned_cols=128  Identities=16%  Similarity=0.154  Sum_probs=81.7

Q ss_pred             eEEeeeeeccCceEEEE-----eEEEEEEEe-----------------ecCCC-Cc--hHHHHHHHHHHHHHhCC-C-Cc
Q 007429          342 LEFIDQIGPNSFKGVYK-----GKRVGIEKL-----------------KGCDK-GN--AYEFELRKDLLELMTCG-H-KN  394 (604)
Q Consensus       342 y~i~~~LG~G~FG~Vyk-----Gk~VAIKkl-----------------k~~~~-~~--~~~~~~~~Ei~~L~~L~-H-pn  394 (604)
                      +.++++||-|.-+.||.     |+..++|.-                 +.... ..  .......+|+..|..|. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45678899999999997     344444431                 00001 11  12233567777777762 2 33


Q ss_pred             eeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEE
Q 007429          395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       395 IVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vK  474 (604)
                      |.+.++++     .-++|||++.|..|...-   ...+...+   ...++.-+--|..+|+||+|.+-=||++.++++++
T Consensus       174 VPkpiD~~-----RH~Vvmelv~g~Pl~~v~---~v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  174 VPKPIDHN-----RHCVVMELVDGYPLRQVR---HVEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCccccc-----ceeeHHHhhcccceeeee---ecCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            55555433     258999999997776542   11233332   23333344567789999999999999999999999


Q ss_pred             EEecCC
Q 007429          475 LGDMGI  480 (604)
Q Consensus       475 L~DFGl  480 (604)
                      ++||--
T Consensus       243 vIDFPQ  248 (465)
T KOG2268|consen  243 VIDFPQ  248 (465)
T ss_pred             EeechH
Confidence            999954

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.01  E-value=0.099  Score=54.42  Aligned_cols=29  Identities=24%  Similarity=0.219  Sum_probs=25.8

Q ss_pred             CceeccCCCCceEEcCC----CcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILLDRH----GNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILld~~----g~vKL~DFGla~  482 (604)
                      .++|+|+.+.|||++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999975    889999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=94.90  E-value=0.49  Score=49.64  Aligned_cols=30  Identities=20%  Similarity=0.204  Sum_probs=25.7

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .++||+|+.|.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999966556899999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.46  E-value=0.14  Score=55.49  Aligned_cols=87  Identities=22%  Similarity=0.242  Sum_probs=62.7

Q ss_pred             CCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcC
Q 007429          391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDR  469 (604)
Q Consensus       391 ~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~  469 (604)
                      .-++..+.+-+-.++..+.|++|++. |++|.-    .......++..|+.+.+.-+.-+..+ .+=|||+.-.||||+ 
T Consensus       283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-  356 (488)
T COG5072         283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-  356 (488)
T ss_pred             cchhhhcceEEecCCceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence            33444444433334444578888876 445532    23346778888888888877777655 689999999999999 


Q ss_pred             CCcEEEEecCCccc
Q 007429          470 HGNVCLGDMGIVTA  483 (604)
Q Consensus       470 ~g~vKL~DFGla~~  483 (604)
                      +|+|.|+||-+++.
T Consensus       357 ~GnvtLIDfklsRl  370 (488)
T COG5072         357 EGNVTLIDFKLSRL  370 (488)
T ss_pred             cCceEEEEeeeeec
Confidence            99999999999874

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.22  E-value=0.33  Score=51.82  Aligned_cols=32  Identities=13%  Similarity=0.106  Sum_probs=28.3

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .++|+|+.+.||+|+.++-+=+.||+++...+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            38999999999999999999999999976543

>PLN02756 S-methyl-5-thioribose kinase

Probab=93.48  E-value=0.99  Score=49.89  Aligned_cols=79  Identities=10%  Similarity=0.014  Sum_probs=45.7

Q ss_pred             EeeeeeccCceEEEEe----EEEEEEEeec----CCCC-chHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCCcEEE
Q 007429          344 FIDQIGPNSFKGVYKG----KRVGIEKLKG----CDKG-NAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       344 i~~~LG~G~FG~VykG----k~VAIKklk~----~~~~-~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..+.||.|.-..||+-    ..+.||.-..    .... .....+...|...|..+   ...++++++.++.+.   -++
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---ALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC---CEE
Confidence            3677899999999983    3566776431    1110 01112223444555443   235788899888633   458


Q ss_pred             EEecccC--CCHHHHH
Q 007429          412 VTKLMEG--GSVNDLI  425 (604)
Q Consensus       412 VmEy~~g--GSL~dlL  425 (604)
                      +||++++  ..+.+-+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            9999977  3454443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=93.01  E-value=1.4  Score=48.01  Aligned_cols=30  Identities=20%  Similarity=0.160  Sum_probs=24.7

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..++|+|+.+.||+++.++ ++++|+.++..
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            4589999999999998655 77999987543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.96  E-value=0.61  Score=48.56  Aligned_cols=30  Identities=23%  Similarity=0.225  Sum_probs=25.1

Q ss_pred             CceeccCCCCceEEcCCCc-EEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGN-VCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~-vKL~DFGla~~  483 (604)
                      .++|+|++|.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.86  E-value=1.5  Score=46.69  Aligned_cols=29  Identities=24%  Similarity=0.316  Sum_probs=25.1

Q ss_pred             ceeccCCCCceEEcC-CCcEEEEecCCccc
Q 007429          455 VAYRDLNSQRILLDR-HGNVCLGDMGIVTA  483 (604)
Q Consensus       455 IVHrDLKp~NILld~-~g~vKL~DFGla~~  483 (604)
                      ++|.|+.+.|||++. ++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=91.13  E-value=0.32  Score=51.00  Aligned_cols=30  Identities=23%  Similarity=0.247  Sum_probs=26.9

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988877899999863

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=90.55  E-value=0.49  Score=49.18  Aligned_cols=28  Identities=25%  Similarity=0.364  Sum_probs=24.9

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .+++|+|+.+.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47899999999999987 67899999864

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=90.11  E-value=1.8  Score=47.69  Aligned_cols=30  Identities=10%  Similarity=0.123  Sum_probs=24.9

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ...+|+||.|.||+++.++ +|++|..++..
T Consensus       227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAfy  256 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAFY  256 (409)
T ss_pred             hhhccCcCCCCCEEecCCc-eEEEccccccc
Confidence            3589999999999999764 89999887643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=89.96  E-value=1  Score=46.02  Aligned_cols=100  Identities=13%  Similarity=0.047  Sum_probs=64.0

Q ss_pred             EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHH
Q 007429          362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI  441 (604)
Q Consensus       362 VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~  441 (604)
                      .-+|+++.....- ...-+..+..++.++  ..|+++.   .+.++...++.|.|-....         .+.    .++.
T Consensus        88 L~lKKi~slp~~~-~~~~y~nky~v~Arm--hGilrL~---NDn~~~yGvIlE~Cy~~~i---------~~~----N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCI-NDALYFNKYRVFARM--HGILRLK---NDNNYKYGVILERCYKIKI---------NFS----NFIT  148 (308)
T ss_pred             hhhhhccCCCccc-chhhhhhhhhHHHHh--hheeEee---cCCCceeEEEEeeccCccc---------chh----HHHH
Confidence            3467776443321 223346667777764  3577777   3455567899999844111         111    1111


Q ss_pred             HHHHHHHHHHh--cCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          442 DVAEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       442 qIa~gL~YLHs--~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      -=+.+|.-.|+  .+.+|+|..|+||+-|..|.+||.|=+.
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            11345677784  4799999999999999999999999875

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=89.89  E-value=0.94  Score=49.97  Aligned_cols=59  Identities=15%  Similarity=0.130  Sum_probs=42.0

Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceeccCCCCceEEc
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLD  468 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL-Hs~gIVHrDLKp~NILld  468 (604)
                      ..++-+|..|.++..++. ....++....+++.--+.|+--+ --.+++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            457778899989988874 33445555556655555555433 346899999999999994

>PTZ00384 choline kinase; Provisional

Probab=88.80  E-value=4.1  Score=44.63  Aligned_cols=29  Identities=17%  Similarity=0.015  Sum_probs=23.8

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ...+|.|+-+.|||.+. +.+.++||..+.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            45799999999999764 559999997753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=88.09  E-value=6.3  Score=41.53  Aligned_cols=72  Identities=8%  Similarity=0.116  Sum_probs=40.4

Q ss_pred             eEEeeeeeccCceEEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCCcEEEEEe
Q 007429          342 LEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       342 y~i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .+-.+.++.|....+|+    ++.+-+|.-.....     ..+..|..-|..|   .--.+++.+++....+. -++|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEE
Confidence            45567889899999997    56788888763222     2245666655555   34567788888776654 589999


Q ss_pred             cccCC
Q 007429          415 LMEGG  419 (604)
Q Consensus       415 y~~gG  419 (604)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK10271 thiK thiamine kinase; Provisional

Probab=86.88  E-value=0.55  Score=46.41  Aligned_cols=29  Identities=14%  Similarity=0.125  Sum_probs=25.3

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      -.+|+|+.|.||+++.+| ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            369999999999998777 89999998754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=84.45  E-value=1.4  Score=46.35  Aligned_cols=29  Identities=10%  Similarity=0.059  Sum_probs=26.7

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      +++|+|+.+.|+|++.++.+-++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=84.03  E-value=1.6  Score=43.01  Aligned_cols=29  Identities=31%  Similarity=0.405  Sum_probs=21.0

Q ss_pred             CceeccCCCCceEE-cCCCcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILL-DRHGNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILl-d~~g~vKL~DFGla~  482 (604)
                      .++|+||.|.|||+ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02236 choline kinase

Probab=82.87  E-value=1.5  Score=47.05  Aligned_cols=29  Identities=21%  Similarity=0.354  Sum_probs=25.5

Q ss_pred             CceeccCCCCceEEcC-CCcEEEEecCCcc
Q 007429          454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVT  482 (604)
Q Consensus       454 gIVHrDLKp~NILld~-~g~vKL~DFGla~  482 (604)
                      .++|+|+++.|||++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            5899999999999986 4679999998864

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=82.43  E-value=2.5  Score=41.49  Aligned_cols=30  Identities=20%  Similarity=0.266  Sum_probs=25.0

Q ss_pred             cCceeccCCCCceEEcCCC-----cEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHG-----NVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g-----~vKL~DFGla~  482 (604)
                      ..++|||+.+.||++..++     .+.|.||..++
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4689999999999997544     58999998854

subfamily of choline kinases

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=81.78  E-value=5.2  Score=43.20  Aligned_cols=93  Identities=15%  Similarity=0.106  Sum_probs=67.5

Q ss_pred             HHHHHHHHHh-----CCCCceeEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-Hhc
Q 007429          380 LRKDLLELMT-----CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDH  453 (604)
Q Consensus       380 ~~~Ei~~L~~-----L~HpnIVkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL-Hs~  453 (604)
                      .++|+..|++     |.+|.+|.+..        -.|||.|+...-+..--.++-.|+.......-.|+...|.-| |+.
T Consensus       332 AEkEmhNL~RMq~~GlpcP~vV~lkk--------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec  403 (531)
T KOG2269|consen  332 AEKEMHNLSRMQKHGLPCPQVVKLKK--------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC  403 (531)
T ss_pred             HHHHHHHHHHHHhcCCCCCceeeeec--------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence            3455555555     46788888762        358999986533332212344688888888888999999877 788


Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      -+||.||.--|+|+..+ .+-++|-.-+
T Consensus       404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQs  430 (531)
T KOG2269|consen  404 LLVHADLSEYNLLWTPG-KVWVIDVSQS  430 (531)
T ss_pred             heeecchhhhhheecCC-ceEEEechhc
Confidence            99999999999999865 8888887654

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=80.56  E-value=2.7  Score=43.76  Aligned_cols=45  Identities=18%  Similarity=0.192  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHHHHhc--CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          439 IAIDVAEGIKFLNDH--GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       439 ia~qIa~gL~YLHs~--gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .+..+-.++.-.+..  -++|.|+.|.|+|.++.+.++|+||.-|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            333333444434333  489999999999999999999999987643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	604
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-20
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-20
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-20
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-20
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-20
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-19
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-04

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 13/266 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           W + +  +    +IG  SF  VYKGK    V ++ LK  D         R ++  L    
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR 90
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F      +N  L +VT+  EG S+   L ++  K Q  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGEATEYETDGYRWLAPEIIAG 508
           +   + +RD+ S  I L     V +GD G+ T     S  +  E  T    W+APE+I  
Sbjct: 149 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIP---KDCP 564
             ++   ++ S+VYS+G+V++E++TGE  Y+  +     + +   G   P++    K+CP
Sbjct: 209 Q-DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
           + +K L+  C      +RP F +I+S
Sbjct: 268 KAMKRLVADCVKKVKEERPLFPQILS 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 341 NLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +L   ++IG  SF  V++    G  V ++ L   D       E  +++  +    H NI+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDH 453
            F    V +   L +VT+ +  GS+  L+ KS    +L  +  + +A DVA+G+ +L++ 
Sbjct: 98  LFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 454 G--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
              + +RDL S  +L+D+   V + D G+     S    ++       W+APE++  +P 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           +      S+VYSFG+++WE+ T +  +   +P Q    +     R EIP++    + +++
Sbjct: 217 NEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 572 IKCWNNSPSKRPQFSEIISLL 592
             CW N P KRP F+ I+ LL
Sbjct: 273 EGCWTNEPWKRPSFATIMDLL 293

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 23/274 (8%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 385
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 446 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
           GI+++ +    + +RDL S  I L   D +  VC       T+ +SV   +      ++W
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-LGNFQW 192
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPE 558
           +APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLRP 
Sbjct: 193 MAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 14/261 (5%)
Query: 341 NLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +L   ++IG  SF  V++    G  V ++ L   D       E  +++  +    H NI+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDH 453
            F    V +   L +VT+ +  GS+  L+ KS    +L  +  + +A DVA+G+ +L++ 
Sbjct: 98  LFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 454 G--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
              + +R+L S  +L+D+   V + D G+     S   +++       W+APE++  +P 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           +      S+VYSFG+++WE+ T +  +   +P Q    +     R EIP++    + +++
Sbjct: 217 NEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 572 IKCWNNSPSKRPQFSEIISLL 592
             CW N P KRP F+ I+ LL
Sbjct: 273 EGCWTNEPWKRPSFATIMDLL 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 138/276 (50%), Gaps = 27/276 (9%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 385
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 446 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVC--LGDMGIVTACKSVGEATEYETDGY 498
           GI+++ +    + +RDL S  I L   D +  VC  + D G+  + +SV   +      +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL--SQQSVHSVSGL-LGNF 190
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLR 556
           +W+APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLR
Sbjct: 191 QWMAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 23/274 (8%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 385
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 446 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
           GI+++ +    + +RDL S  I L   D +  VC        + +SV   +      ++W
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-LGNFQW 192
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPE 558
           +APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLRP 
Sbjct: 193 MAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEF------ELRKDLLELMTCGHKNILQFYCV 401
           IG   F  VY+   +G E      + +  E        +R++        H NI+    V
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA---YR 458
           C+ E + LC+V +   GG +N  +L  +++    ++  A+ +A G+ +L+D  +    +R
Sbjct: 75  CLKEPN-LCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 459 DLNSQRILLDRHGNVCLGDMG-IVTACKSVGEATEYE-------TDGYRWLAPEIIAGDP 510
           DL S  IL+ +   V  GD+   +      G A E+           Y W+APE+I    
Sbjct: 133 DLKSSNILILQ--KVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
            S      S+V+S+G+++WE++TGE  +     +  A G+A   L   IP  CP+    L
Sbjct: 191 FSKG----SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 571 MIKCWNNSPSKRPQFSEIISLL 592
           M  CWN  P  RP F+ I+  L
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQL 268

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 7   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 66
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 67  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 185 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 243
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
           + +K LM +C      +RP F  I++
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILA 269

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 79  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 197 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
           + +K LM +C      +RP F  I++
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 79  HVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 197 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
           + +K LM +C      +RP F  I++
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 342 LEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           + F++++G + F  VYKG           + V I+ LK   +G   E E R + +     
Sbjct: 28  VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARL 86
Query: 391 GHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
            H N++                 YC   D +  L + +   + GS +D       L+  +
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
            + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V  A  Y+ 
Sbjct: 147 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REVYAADYYKL 203
Query: 496 DG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 549
            G      RW+APE I     S+     S+++S+G+V+WE+ + G   Y   S       
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS 599
           I    + P  P DCP  + +LMI+CWN  PS+RP+F +I S L    N+S
Sbjct: 260 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLS 308

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 209 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 16/281 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDL 384
           G +    W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDV 443
             L    H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWL 501
           A+G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIP 560
           APE+I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ 
Sbjct: 179 APEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 237
Query: 561 K---DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           K   +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 30  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 89
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 90  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 148 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 208 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 266
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 267 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 300

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 16/281 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDL 384
           G +    W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDV 443
             L    H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWL 501
           A+G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIP 560
           APE+I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ 
Sbjct: 179 APEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 237
Query: 561 K---DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           K   +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 28  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 80
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 81  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 136
Query: 427 KS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 197 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 252 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 23  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 82
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 83  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 141 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 201 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 259
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 260 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 293

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 5   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 64
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 65  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 183 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 241
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 242 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 209 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 131/268 (48%), Gaps = 17/268 (6%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 390
           G+W+++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M  
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKF 449
            H  ++Q Y VC+ E   +C+VT+ ME G ++D +   R L   E ++ + +DV EG+ +
Sbjct: 61  SHPKLVQLYGVCL-EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEI 505
           L +  V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEV 176
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
            +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+   
Sbjct: 177 FSFSRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAS 231
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +  +M  CW   P  RP FS ++  L
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLR 138
Query: 427 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 373
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 4   QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 53
Query: 374 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 428
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 54  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLRKHD 112
Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 489 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 173 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 228 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 370
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 371 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 427 KS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 486 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 373
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 21  QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 70
Query: 374 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 428
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 71  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLRKHD 129
Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 189
Query: 489 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 190 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 244
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 245 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 373
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 4   QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 53
Query: 374 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 428
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 54  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLRKHD 112
Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 489 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 173 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 228 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 565 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 595
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 32/265 (12%)
Query: 348 IGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHK 393
           IG   F  VYKG            V I+ LK       Y  + R D L     +    H 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-----GYTEKQRVDFLGEAGIMGQFSHH 106
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLND 452
           NI++   V + +   + ++T+ ME G+++  +  K  +    +++ +   +A G+K+L +
Sbjct: 107 NIIRLEGV-ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAG 508
               +RDL ++ IL++ +    + D G+    +   EAT Y T G     RW APE I+ 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAIS- 223
Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
                  T  S+V+SFG+V+WE++T GE  Y   S  +    I   G R   P DCP  +
Sbjct: 224 ---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSAI 279
Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             LM++CW    ++RP+F++I+S+L
Sbjct: 280 YQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 132/283 (46%), Gaps = 41/283 (14%)
Query: 342 LEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           + F++++G + F  VYKG           + V I+ LK   +G   E E R + +     
Sbjct: 11  VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARL 69
Query: 391 GHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
            H N++                 YC   D +  L + +   + GS +D       L+  +
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
            + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V  A  Y+ 
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REVYAADYYKL 186
Query: 496 DG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 549
            G      RW+APE I     S+     S+++S+G+V+WE+ + G   Y   S       
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           I    + P  P DCP  + +LMI+CWN  PS+RP+F +I S L
Sbjct: 243 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 126/247 (51%), Gaps = 25/247 (10%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L E    G   H NI+    V V ++  + +
Sbjct: 47  GKRELPVAIKTLK-----VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGV-VTKSKPVMI 100
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           VT+ ME GS++  + K+  +    +++ +   ++ G+K+L+D G  +RDL ++ IL++ +
Sbjct: 101 VTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSN 160
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 161 LVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAFR----KFTSASDVWSYGI 215
Query: 527 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           V+WE+V+ GE  Y   +  Q  +     G R   P DCP  L  LM+ CW    + RP+F
Sbjct: 216 VMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKF 274
Query: 586 SEIISLL 592
            EI+++L
Sbjct: 275 DEIVNML 281

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 130/268 (48%), Gaps = 17/268 (6%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 390
           G+W+++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M  
Sbjct: 3   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 62
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKF 449
            H  ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +
Sbjct: 63  SHPKLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 121
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEI 505
           L +  V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+
Sbjct: 122 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEV 178
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
            +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+   
Sbjct: 179 FSFSRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAS 233
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +  +M  CW   P  RP FS ++  L
Sbjct: 234 THVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 243
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 359
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 360 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 414
Query: 567 LKSLMIKCWNNSPSKRPQFSEIISLL--LRTNNI 598
           +  +M  CW+   + RP F ++   L  +RT+ +
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 21/262 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 187
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 188 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  +M  CW+   + RP F ++
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQL 264

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 21/262 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 56
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 172
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 173 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 227
Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  +M  CW+   + RP F ++
Sbjct: 228 VYEVMKNCWHLDAAMRPSFLQL 249

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 21/262 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 62
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 178
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
              E+   T  S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 179 ---EAAFST-KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 233
Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  +M  CW+   + RP F ++
Sbjct: 234 VYEVMKNCWHLDAAMRPSFLQL 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLME 417
           V I+ LK       Y    R+D L     +    H NI++   V V       +VT+ ME
Sbjct: 80  VAIKALKA-----GYTERQRRDFLSEASIMGQFDHPNIIRLEGV-VTRGRLAMIVTEYME 133
Query: 418 GGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
            GS+ D  L++   +    +++ +   V  G+++L+D G  +RDL ++ +L+D +    +
Sbjct: 134 NGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 476 GDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
            D G+    +   +A    T G    RW APE IA    S +    S+V+SFG+V+WE++
Sbjct: 193 SDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVL 248
Query: 533 T-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
             GE  Y   +  +  +     G R   P  CP  L  LM+ CW+   ++RP+FS+I+S+
Sbjct: 249 AYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 592 L 592
           L
Sbjct: 308 L 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLME 417
           V I+ LK       Y    R+D L     +    H NI++   V V       +VT+ ME
Sbjct: 80  VAIKALKA-----GYTERQRRDFLSEASIMGQFDHPNIIRLEGV-VTRGRLAMIVTEYME 133
Query: 418 GGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
            GS+ D  L++   +    +++ +   V  G+++L+D G  +RDL ++ +L+D +    +
Sbjct: 134 NGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 476 GDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
            D G+    +   +A    T G    RW APE IA    S +    S+V+SFG+V+WE++
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVL 248
Query: 533 T-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
             GE  Y   +  +  +     G R   P  CP  L  LM+ CW+   ++RP+FS+I+S+
Sbjct: 249 AYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 592 L 592
           L
Sbjct: 308 L 308

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 54  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 107
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 108 ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSN 167
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 168 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 222
Query: 527 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 223 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 281
Query: 586 SEIISLLLRTNNISNSSNR 604
            +I+++L +     NS  R
Sbjct: 282 GQIVNMLDKLIRNPNSLKR 300

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 136/275 (49%), Gaps = 17/275 (6%)
Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 384
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 70
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YR 499
            E +++L      +RDL ++  L++  G V + D G+    + V +  E  + G     R
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEETSSVGSKFPVR 186
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR  
Sbjct: 187 WSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLY 241
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 39  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 92
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 93  ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 152
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 153 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 207
Query: 527 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 208 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 266
Query: 586 SEIISLLLRTNNISNSSNR 604
            +I+++L +     NS  R
Sbjct: 267 GQIVNMLDKLIRNPNSLKR 285

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 66
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 185 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 72
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 191 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 33  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 86
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 87  ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 146
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 526
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 147 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 201
Query: 527 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 202 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 260
Query: 586 SEIISLLLRTNNISNSSNR 604
            +I+++L +     NS  R
Sbjct: 261 GQIVNMLDKLIRNPNSLKR 279

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 66
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 185 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 72
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 191 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 133/269 (49%), Gaps = 26/269 (9%)
Query: 336 LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR    +L    
Sbjct: 5   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELR----QLSRVN 60
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTKEIIRIAIDVAEGIK 448
           H NI++ Y  C++    +C+V +  EGGS+ +++  +  L        +   +  ++G+ 
Sbjct: 61  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 117
Query: 449 FLND---HGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           +L+      + +RDL    +LL   G V  + D G  TAC      T  +     W+APE
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTNNKGSA-AWMAPE 174
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDC 563
           +  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+ 
Sbjct: 175 VFEGS--NYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 230
Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 231 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 133/269 (49%), Gaps = 26/269 (9%)
Query: 336 LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR    +L    
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELR----QLSRVN 59
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTKEIIRIAIDVAEGIK 448
           H NI++ Y  C++    +C+V +  EGGS+ +++  +  L        +   +  ++G+ 
Sbjct: 60  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 449 FLND---HGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           +L+      + +RDL    +LL   G V  + D G  TAC      T  +     W+APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTNNKGSA-AWMAPE 173
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDC 563
           +  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+ 
Sbjct: 174 VFEGS--NYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 384
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 500
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 501 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 21/277 (7%)
Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 384
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 70
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDG 497
            E +++L      +RDL ++  L++  G V + D G+           SVG         
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP----- 184
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            RW  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR
Sbjct: 185 VRWSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLR 239
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
              P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 21/277 (7%)
Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 384
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 2   TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 61
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 443
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 62  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 120
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDG 497
            E +++L      +RDL ++  L++  G V + D G+           SVG         
Sbjct: 121 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP----- 175
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            RW  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR
Sbjct: 176 VRWSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLR 230
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
              P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 231 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 267

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMT 389
           +G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M 
Sbjct: 1   MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
             H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E ++
Sbjct: 61  LSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLA 502
           +L      +RDL ++  L++  G V + D G+           SVG          RW  
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSP 174
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P 
Sbjct: 175 PEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPH 229
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
              + + ++M  CW+    +RP F  ++S +L
Sbjct: 230 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 131/267 (49%), Gaps = 13/267 (4%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 390
           G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M  
Sbjct: 2   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 61
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 449
            H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++
Sbjct: 62  SHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEIIA 507
           L      +RDL ++  L++  G V + D G+        E T      +  RW  PE++ 
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKFPVRWSPPEVLM 179
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + 
Sbjct: 180 YSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEK 234
Query: 567 LKSLMIKCWNNSPSKRPQFSEIISLLL 593
           + ++M  CW+    +RP F  ++S +L
Sbjct: 235 VYTIMYSCWHEKADERPTFKILLSNIL 261

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 131/271 (48%), Gaps = 21/271 (7%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 390
           G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M  
Sbjct: 1   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 60
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 449
            H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++
Sbjct: 61  SHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLAP 503
           L      +RDL ++  L++  G V + D G+           SVG          RW  P
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPP 174
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P  
Sbjct: 175 EVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHL 229
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL 593
             + + ++M  CW+    +RP F  ++S +L
Sbjct: 230 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 260

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 62
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 452
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 63  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 508
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 178
Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 179 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 233
Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             +M  CW   P  RP FS ++  L
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 124/256 (48%), Gaps = 23/256 (8%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK       Y  + R+D L E    G   H N++    V V     + +
Sbjct: 68  GKRDVAVAIKTLK-----VGYTEKQRRDFLCEASIMGQFDHPNVVHLEGV-VTRGKPVMI 121
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           V + ME G+++  + K   +    +++ +   +A G+++L D G  +RDL ++ IL++ +
Sbjct: 122 VIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSN 181
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
               + D G+    +   EA    T G    RW APE I    +    T  S+V+S+G+V
Sbjct: 182 LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI----QYRKFTSASDVWSYGIV 237
Query: 528 IWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
           +WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    ++RP+F 
Sbjct: 238 MWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFE 296
Query: 587 EIISLLLRTNNISNSS 602
           +I+ +L +     NS+
Sbjct: 297 QIVGILDKMIRNPNSA 312

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 54/311 (17%)
Query: 310 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 360
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 361 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 418 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVY 522
                V +GD G+    + + E   Y   G      RW+APE +     + S    S+++
Sbjct: 164 AHDFTVKIGDFGM---TRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMW 216
Query: 523 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 581
           SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW  +P  
Sbjct: 217 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKM 275
Query: 582 RPQFSEIISLL 592
           RP F EI++LL
Sbjct: 276 RPTFLEIVNLL 286

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G+  E +  ++   +M   H 
Sbjct: 23  VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHP 82
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 452
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 83  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 508
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 198
Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 199 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 253
Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             +M  CW   P  RP FS ++  L
Sbjct: 254 YQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 138/316 (43%), Gaps = 64/316 (20%)
Query: 310 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 360
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 361 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 418 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVSETW 517
                V +GD G+            YETD YR          W+APE +     + S   
Sbjct: 164 AHDFTVKIGDFGMTRDI--------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS--- 212
Query: 518 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
            S+++SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW 
Sbjct: 213 -SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQ 270
Query: 577 NSPSKRPQFSEIISLL 592
            +P  RP F EI++LL
Sbjct: 271 FNPKMRPTFLEIVNLL 286

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL--KGCDKGNAYEFELRKDLLELMTC 390
           G   L  + +  + ++G   F  V  GK  G   +  K   +G+  E E  ++   +M  
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL 60
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
            H  +++FY VC  E + + +VT+ +  G  +N L    + L+  +++ +  DV EG+ F
Sbjct: 61  SHPKLVKFYGVCSKE-YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAP 503
           L  H   +RDL ++  L+DR   V + D G+           SVG  T++     +W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG--TKFPV---KWSAP 174
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E+      S      S+V++FG+++WE+ + G+  Y   +  +  + ++  G R   P  
Sbjct: 175 EVFHYFKYSSK----SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHL 229
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIIS 590
               +  +M  CW+  P KRP F +++S
Sbjct: 230 ASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 121/260 (46%), Gaps = 15/260 (5%)
Query: 342 LEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
           L F+ ++  N     +KG ++G  + ++ LK  D       +  ++   L    H N+L 
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 398 FYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLN--D 452
               C         ++T  M  GS+ +++ +         + ++ A+D+A G+ FL+  +
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
             +    LNS+ +++D      +    +  + +S G           W+APE +   PE 
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-----APAWVAPEALQKKPED 186
Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
            +    ++++SF +++WE+VT E  +A  S ++  + +A  GLRP IP      +  LM 
Sbjct: 187 TNRR-SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245
Query: 573 KCWNNSPSKRPQFSEIISLL 592
            C N  P+KRP+F  I+ +L
Sbjct: 246 ICMNEDPAKRPKFDMIVPIL 265

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 62
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 452
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 63  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 508
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 178
Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 179 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 233
Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             +M  CW   P  RP FS ++  L
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 452
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 61  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 508
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 176
Query: 509 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 177 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 231
Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
             +M  CW   P  RP FS ++  L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 71
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 72  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 184
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 185 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 16  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 73
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 74  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 186
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 187 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 241
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 242 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 17  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 74
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 75  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 187
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 188 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 242
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 243 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 75
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 76  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 188
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 189 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 243
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 244 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 10  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 67
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 68  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 180
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 181 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 235
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 236 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 71
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 72  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 184
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 185 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 178
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 178
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 9   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 66
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 67  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 179
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 180 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 234
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 235 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 13  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 70
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 71  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 183
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 184 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 238
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 239 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 60
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 61  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 173
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 174 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 228
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 229 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------- 434
            +++   C H  +++   V V +     V+ +LM  G +   +   R             
Sbjct: 80  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 435 --EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
             ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+            
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------- 188
Query: 493 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGL 244
Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 245 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 69
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------- 434
            +++   C H  +++   V V +     V+ +LM  G +   +   R             
Sbjct: 70  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 435 --EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
             ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+            
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------- 178
Query: 493 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGL 234
Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 235 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 17/266 (6%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGH 392
           W +  ++L+ I ++G   F  V+ G   G  K  +K    G        ++   +    H
Sbjct: 4   WEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKH 63
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFL 450
             ++Q Y V  +E   + +VT+ M  GS+ D +   + R L+   ++ +A  VA G+ ++
Sbjct: 64  DKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 451 NDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGY--RWLAPEIIA 507
                 +RDL S  IL+  +G +C + D G+    +   E T  +   +  +W APE   
Sbjct: 122 ERMNYIHRDLRSANILVG-NGLICKIADFGLARLIED-NEXTARQGAKFPIKWTAPEAAL 179
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P+DCP  
Sbjct: 180 YGRFTIK----SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPIS 234
Query: 567 LKSLMIKCWNNSPSKRPQFSEIISLL 592
           L  LMI CW   P +RP F  + S L
Sbjct: 235 LHELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 80  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 137 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 188
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 189 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 242
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 243 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 73  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 130 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 181
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 182 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 235
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 236 GLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 70
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 71  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 128 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 179
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 180 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 233
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 234 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 73  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 130 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 181
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 182 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 235
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 236 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 67  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 124 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 175
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 176 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 229
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 382
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 72
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 432
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 73  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            +E+I++A ++A+G+ +LN     +R+L ++  ++     V +GD G+            
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-------- 181
Query: 493 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           YETD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGL 237
Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           S  Q    +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 238 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 382
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 432
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 72  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            +E+I++A ++A+G+ +LN     +R+L ++  ++     V +GD G+            
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-------- 180
Query: 493 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           YETD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGL 236
Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           S  Q    +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 237 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 74  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 131 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 182
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 183 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 236
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 237 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 101
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 102 SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 159 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 210
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 211 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 264
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 265 GLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 314

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 54/311 (17%)
Query: 310 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 360
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 361 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 418 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVY 522
                V +GD G+    + + E       G      RW+APE +     + S    S+++
Sbjct: 164 AHDFTVKIGDFGM---TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTS----SDMW 216
Query: 523 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 581
           SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW  +P  
Sbjct: 217 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKM 275
Query: 582 RPQFSEIISLL 592
           RP F EI++LL
Sbjct: 276 RPTFLEIVNLL 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNS----FKGVYKGK-RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G       + G Y G  +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-AEXTAREGAKFPIKWTA 178
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 61
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 444
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 62  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
           EG+ F+ +    +R+L +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 174
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 175 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 229
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 230 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 394
           ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M   H+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDH 453
           ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++L   
Sbjct: 61  LVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLAPEIIA 507
              +RDL ++  L++  G V + D G+           SVG          RW  PE++ 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPPEVLM 174
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + 
Sbjct: 175 YSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEK 229
Query: 567 LKSLMIKCWNNSPSKRPQFSEIISLLL 593
           + ++M  CW+    +RP F  ++S +L
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNIL 256

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEFSF 137
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DXXKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 382
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 432
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 72  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+    + + E   
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIXETDX 185
Query: 493 YETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 546
               G      RW+APE +     + S    S+++SFG+V+WE+ +  E  Y   S  Q 
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSNEQV 241
Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 242 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 382
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 68
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 432
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 69  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+    + + E   
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIXETDX 182
Query: 493 YETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 546
               G      RW+APE +     + S    S+++SFG+V+WE+ +  E  Y   S  Q 
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSNEQV 238
Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 239 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 36/297 (12%)
Query: 335 WLLNSDNLEFIDQIGPNS---FKGVY---KGKRVGIEKLKGCDKGNAYEFELRKDLLELM 388
           W +N D+ E  + IG  +    +  Y   K ++V I+++   +K      EL K++  + 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMS 68
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRIA 440
            C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I 
Sbjct: 69  QCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 499
            +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+     + G+ T  +      
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 500 ----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------- 548
               W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +       
Sbjct: 188 GTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 549 -GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             +       E+ K   +  + ++  C    P KRP  +E    LLR      + N+
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE----LLRHKFFQKAKNK 297

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV-DENHGLCVVTKLME 417
           G++V ++ LK    GN    +L+K++  L    H+NI+++  +C  D  +G+ ++ + + 
Sbjct: 50  GEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 418 GGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
            GS+ + + K++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++    V +G
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168
Query: 477 DMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+  A ++  E    + D      W APE +      ++    S+V+SFG+ + E++T
Sbjct: 169 DFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA----SDVWSFGVTLHELLT 224
Query: 534 ---GEAAYAAC-----SPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSP 579
               +++  A       P    + +         G R   P +CP  +  LM KCW   P
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 580 SKRPQFSEII 589
           S R  F  +I
Sbjct: 285 SNRTSFQNLI 294

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV-DENHGLCVVTKLME 417
           G++V ++ LK    GN    +L+K++  L    H+NI+++  +C  D  +G+ ++ + + 
Sbjct: 38  GEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 418 GGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
            GS+ + + K++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++    V +G
Sbjct: 97  SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 156
Query: 477 DMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+  A ++  E    + D      W APE +      ++    S+V+SFG+ + E++T
Sbjct: 157 DFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA----SDVWSFGVTLHELLT 212
Query: 534 ---GEAAYAAC-----SPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSP 579
               +++  A       P    + +         G R   P +CP  +  LM KCW   P
Sbjct: 213 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 272
Query: 580 SKRPQFSEII 589
           S R  F  +I
Sbjct: 273 SNRTSFQNLI 282

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 53/291 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 67  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++   +     V +GD G+          
Sbjct: 124 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI------ 175
Query: 491 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 176 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 229
Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 GLSNEQVLRFVMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDL 384
           ++ + +  + ++G  SF  VY+G            RV ++ + +        EF     +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQTK 434
           ++  TC H  +++   V V +     VV +LM  G +   +   R              +
Sbjct: 73  MKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 129
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+            YE
Sbjct: 130 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------YE 181
Query: 495 TDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
           TD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   S 
Sbjct: 182 TDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSN 237
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            Q    +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 238 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 11  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 70
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 129
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 130 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 190 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 244
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 245 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 300

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 8   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 67
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 126
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 127 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 187 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 241
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 242 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 297

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 12  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 71
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 130
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 131 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 191 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 245
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 246 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 137
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 40/294 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           RW L  D L     +G  +F  V   + +G++K K            K +A E +L   +
Sbjct: 63  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 122
Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 485 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
             + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 242 HHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 297 V-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 183 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 388
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 238
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 445
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 239 TLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 295
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 503
           G+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W AP
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 354
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++
Sbjct: 355 EAINFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPEN 409
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 137
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 388
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 10  WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 65
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 445
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 66  TLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 122
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 503
           G+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W AP
Sbjct: 123 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 181
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++
Sbjct: 182 EAINFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPEN 236
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 237 CPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 133/284 (46%), Gaps = 18/284 (6%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 388
           + +W +   ++    ++G   F  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 446
              H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 504
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 564 PQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRTNNISNSSNR 604
           P+ +  LM  CW  +PS RP F+EI      + + ++IS+   +
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 279

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 335 WLLNSDNLEFIDQIGPNS---FKGVY---KGKRVGIEKLKGCDKGNAYEFELRKDLLELM 388
           W +N D+ E  + IG  +    +  Y   K ++V I+++   +K      EL K++  + 
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMS 63
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRIA 440
            C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I 
Sbjct: 64  QCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 499
            +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+     + G+ T  +      
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 500 ----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------- 548
               W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +       
Sbjct: 183 GTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 239
Query: 549 -GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
             +       E+ K   +  + ++  C    P KRP  +E++
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---- 386
           +W+LN ++L   +QIG  +F  V+ G+      L   K C +      +L+   L+    
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE--TLPPDLKAKFLQEARI 165
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAE 445
           L    H NI++   VC  +   + +V +L++GG  +  L  +  +L+ K ++++  D A 
Sbjct: 166 LKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----W 500
           G+++L      +RDL ++  L+     + + D G+    +   +     + G R     W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVXAASGGLRQVPVKW 281
Query: 501 LAPEII-AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +  G   S S+ W     SFG+++WE  + G + Y   S  Q    +   G  P 
Sbjct: 282 TAPEALNYGRYSSESDVW-----SFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP- 335
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            P+ CP  +  LM +CW   P +RP FS I
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 43/286 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 64
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 65  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E 
Sbjct: 122 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIXET 176
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
                 G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 233 QVLRFVMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 43/286 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 430
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 74  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E 
Sbjct: 131 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIXET 185
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
                 G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 242 QVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---- 386
           +W+LN ++L   +QIG  +F  V+ G+      L   K C +      +L+   L+    
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE--TLPPDLKAKFLQEARI 165
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAE 445
           L    H NI++   VC  +   + +V +L++GG  +  L  +  +L+ K ++++  D A 
Sbjct: 166 LKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----W 500
           G+++L      +RDL ++  L+     + + D G+    +   +     + G R     W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVYAASGGLRQVPVKW 281
Query: 501 LAPEII-AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
            APE +  G   S S+ W     SFG+++WE  + G + Y   S  Q    +   G  P 
Sbjct: 282 TAPEALNYGRYSSESDVW-----SFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP- 335
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            P+ CP  +  LM +CW   P +RP FS I
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCG---HKNILQFY 399
           IG   F  V +G+     K + C      KG   E + R+ L E    G   H NI++  
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
            V V  +  + ++T+ ME G+++  + L   +    +++ +   +A G+++L +    +R
Sbjct: 84  GV-VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 459 DLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG----YRWLAPEIIAGDPESV 513
           DL ++ IL++ +    + D G+    + +  + TE  + G     RW APE IA      
Sbjct: 143 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR---- 198
Query: 514 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
             T  S+ +S+G+V+WE+++ GE  Y   S  Q  +       R   P DCP  L  LM+
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCPTSLHQLML 257
Query: 573 KCWNNSPSKRPQFSEIISLL 592
            CW    + RP+F +++S L
Sbjct: 258 DCWQKDRNARPRFPQVVSAL 277

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 209 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 263
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 269 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 323
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVS 348

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 215 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 269
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 270 PLYEVMLKCWHPKAEMRPSFSELVS 294

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 211 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 208 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 262
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 135/298 (45%), Gaps = 42/298 (14%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ +  L++R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLRE-YLQAREPPGLEYS 136
Query: 430 ---------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
                    +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+
Sbjct: 137 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 481 VTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEA 536
                 + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G +
Sbjct: 197 ARDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGS 251
Query: 537 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
            Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 252 PYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 228 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 282
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 283 PLYEVMLKCWHPKAEMRPSFSELVS 307

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 211 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 99
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 220 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I +
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRD 322

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 209 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 263
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 202 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 256
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 257 PLYEVMLKCWHPKAEMRPSFSELVS 281

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 229 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 283
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 284 PLYEVMLKCWHPKAEMRPSFSELVS 308

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 208 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 262
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 207 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 261
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVS 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 205 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 259
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 260 PLYEVMLKCWHPKAEMRPSFSELVS 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 506
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 566 ILKSLMIKCWNNSPSKRPQFSEIIS 590
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 73
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 74  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 133
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 134 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 194 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 249
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 250 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 297

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 67
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 68  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 127
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 128 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 188 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 243
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 244 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 291

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 75
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 76  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 135
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 136 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 196 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 251
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 252 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 299

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DXXKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DXXKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 74
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 75  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 134
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 135 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 195 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 250
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 251 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 120/247 (48%), Gaps = 18/247 (7%)
Query: 348 IGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
           +G  ++  VY G+      R+ I+++   ++ + Y   L +++       HKNI+Q Y  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQ-YLG 86
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
              EN  + +  + + GGS++ L L+S+    K   + I      + EG+K+L+D+ + +
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 458 RDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 516
           RD+    +L++ +  V  + D G       +   TE  T   +++APEII   P    + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCW 575
             ++++S G  I EM TG+  +      QAA+  +    + PEIP+      K+ ++KC+
Sbjct: 206 --ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 576 NNSPSKR 582
              P KR
Sbjct: 264 EPDPDKR 270

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 72
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 73  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 132
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 133 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 193 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 248
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 249 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 296

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 66
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 67  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 126
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 127 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 187 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 242
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I +
Sbjct: 243 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRD 289

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 21/260 (8%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCG---HKNILQFY 399
           IG   F  V +G+     K + C      KG   E + R+ L E    G   H NI++  
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
            V V  +  + ++T+ ME G+++  + L   +    +++ +   +A G+++L +    +R
Sbjct: 82  GV-VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESV 513
           DL ++ IL++ +    + D G+    +       Y +        RW APE IA      
Sbjct: 141 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR---- 196
Query: 514 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
             T  S+ +S+G+V+WE+++ GE  Y   S  Q  +       R   P DCP  L  LM+
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCPTSLHQLML 255
Query: 573 KCWNNSPSKRPQFSEIISLL 592
            CW    + RP+F +++S L
Sbjct: 256 DCWQKDRNARPRFPQVVSAL 275

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 86
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 207 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 262
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 263 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 310

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 133/284 (46%), Gaps = 18/284 (6%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 388
           + +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 446
              H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 504
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 564 PQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRTNNISNSSNR 604
           P+ +  LM  CW  +PS RP F+EI      + + ++IS+   +
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 279

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 25/248 (10%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK     + Y  + R+D L     +    H N++    V V ++  + +
Sbjct: 58  GKREIFVAIKTLK-----SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV-VTKSTPVMI 111
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ ME GS++  + ++  +    +++ +   +A G+K+L D    +RDL ++ IL++ +
Sbjct: 112 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 171
Query: 471 GNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESVSETWMSNVYSFG 525
               + D G+    +       Y +        RW APE I    +    T  S+V+S+G
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYRKFTSASDVWSYG 227
Query: 526 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 584
           +V+WE+++ GE  Y   +  Q  +       R   P DCP  L  LM+ CW    + RP+
Sbjct: 228 IVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 286
Query: 585 FSEIISLL 592
           F +I++ L
Sbjct: 287 FGQIVNTL 294

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 120/247 (48%), Gaps = 18/247 (7%)
Query: 348 IGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
           +G  ++  VY G+      R+ I+++   ++ + Y   L +++       HKNI+Q Y  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQ-YLG 72
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
              EN  + +  + + GGS++ L L+S+    K   + I      + EG+K+L+D+ + +
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 458 RDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 516
           RD+    +L++ +  V  + D G       +   TE  T   +++APEII   P    + 
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCW 575
             ++++S G  I EM TG+  +      QAA+  +    + PEIP+      K+ ++KC+
Sbjct: 192 --ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 576 NNSPSKR 582
              P KR
Sbjct: 250 EPDPDKR 256

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 86
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 207 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 262
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 263 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 310

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/317 (24%), Positives = 135/317 (42%), Gaps = 64/317 (20%)
Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 371
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 372 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 427 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178
Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------RWLAPEIIAGDPES 512
           + IL+     + + D G+            YE D Y          +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSYVKRSQGRIPVKWMAIESLF---DH 227
Query: 513 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 572 IKCWNNSPSKRPQFSEI 588
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKNTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 115
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 116 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 174 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 287
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 288 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 323

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+      G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 598 ISNS 601
           ++ +
Sbjct: 319 LTTN 322

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 15/260 (5%)
Query: 342 LEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
           L F+ ++  N     +KG ++G  + ++ LK  D       +  ++   L    H N+L 
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 398 FYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLN--D 452
               C         ++T     GS+ +++ +         + ++ A+D A G  FL+  +
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLE 131
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
             +    LNS+ + +D      +    +  + +S G           W+APE +   PE 
Sbjct: 132 PLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY-----APAWVAPEALQKKPED 186
Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
            +    ++ +SF +++WE+VT E  +A  S  +    +A  GLRP IP      +  L  
Sbjct: 187 TNRR-SADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSKLXK 245
Query: 573 KCWNNSPSKRPQFSEIISLL 592
            C N  P+KRP+F  I+ +L
Sbjct: 246 ICXNEDPAKRPKFDXIVPIL 265

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 13  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLA 191
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 192 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 246
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 247 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 598 ISNS 601
           ++ +
Sbjct: 306 LTTN 309

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 388
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 177 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 232
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 445
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 233 TLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 289
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
           G+ F+      +RDL +  IL+       + D G+                  +W APE 
Sbjct: 290 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFP---------IKWTAPEA 340
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
           I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++CP
Sbjct: 341 INFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCP 395
Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISLL 592
           + L ++M++CW N P +RP F  I S+L
Sbjct: 396 EELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ + + K + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 95
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 96  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 154 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 267
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 268 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 303

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KLNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 105
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 106 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 164 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 277
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 278 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 313

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L   +
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88
Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
            E+    M   HKNI+     C  ++  L V+      G++ + +   R           
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+    
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 485 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
            ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 208 NNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
             PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   ++ 
Sbjct: 263 I-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
Query: 601 S 601
           +
Sbjct: 322 N 322

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +   ++  +
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 106 N--HQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 275
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 103
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 104 KFNHQNIVR--CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 275
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D +   + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGME 131
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 251 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 306 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 598 ISNS 601
           ++ +
Sbjct: 365 LTTN 368

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 15  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 193
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 194 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 248
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 249 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 598 ISNS 601
           ++ +
Sbjct: 308 LTTN 311

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 388
           + +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 446
              H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 504
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 564 PQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ +  LM  CW  +PS RP F+EI
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 381
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 18  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 77
Query: 382 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 429
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 430 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 196
Query: 482 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 537
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 197 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 251
Query: 538 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 597
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 252 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 598 ISNS 601
           ++ +
Sbjct: 311 LTTN 314

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 341 NLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 69
Query: 391 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 70  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 129
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 505
           +L      +R+L ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 130 YLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 555
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 190 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 245
Query: 556 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 246 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 293

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 88
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 89  KFNHQNIVR--CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 260
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 88
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 89  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 260
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 80
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 81  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 139 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 252
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 253 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 288

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+T+  + G+++  +   R             
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 188
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 244
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 129
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 130 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A  Y   G   
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 301
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 24/252 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLME 417
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D     L +V + + 
Sbjct: 60  GEMVAVKALKA-DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
            GS+ D  L    +   +++  A  + EG+ +L+     +RDL ++ +LLD    V +GD
Sbjct: 119 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177
Query: 478 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 178 FGLAKAVPEGHEXYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 233
Query: 535 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 580
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEAS 293
Query: 581 KRPQFSEIISLL 592
            RP F  +I +L
Sbjct: 294 FRPTFENLIPIL 305

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 388
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 106
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 440
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 107 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A  Y   G   
Sbjct: 165 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 498 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 278
Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 279 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 314

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+T+  + G+++  +   R             
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 188
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 244
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 128/275 (46%), Gaps = 35/275 (12%)
Query: 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMT 389
           N+  I  +G  +F  VY+G+           +V ++ L         E +   + L +  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-YSEQDELDFLMEALIISK 104
Query: 390 CGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIAI 441
             H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A 
Sbjct: 105 FNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---- 497
           D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G    
Sbjct: 163 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 498 -YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 554
             +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     G
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTSG 276
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 277 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 411
           GKR   V I+ LK     + Y  + R+D L     +    H N++    V V ++  + +
Sbjct: 32  GKREIFVAIKTLK-----SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV-VTKSTPVMI 85
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +T+ ME GS++  + ++  +    +++ +   +A G+K+L D    +R L ++ IL++ +
Sbjct: 86  ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSN 145
Query: 471 GNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESVSETWMSNVYSFG 525
               + D G+    +       Y +        RW APE I    +    T  S+V+S+G
Sbjct: 146 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYRKFTSASDVWSYG 201
Query: 526 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 584
           +V+WE+++ GE  Y   +  Q  +       R   P DCP  L  LM+ CW    + RP+
Sbjct: 202 IVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 260
Query: 585 FSEIISLL 592
           F +I++ L
Sbjct: 261 FGQIVNTL 268

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 134/317 (42%), Gaps = 64/317 (20%)
Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 371
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 372 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 427 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAA 178
Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----------YRWLAPEIIAGDPES 512
           + IL+     + + D G+            YE D            +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSXVKRSQGRIPVKWMAIESLF---DH 227
Query: 513 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 572 IKCWNNSPSKRPQFSEI 588
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 383
           +W    D L     +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 384 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGL---ARDIYKD 197
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 384
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 442
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 500
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 384
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 14  GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 73
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 442
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 74  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 132
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 500
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 133 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 191
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 192 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 246
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 247 PEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 384
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 442
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 500
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 134/317 (42%), Gaps = 64/317 (20%)
Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 371
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 372 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 426
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 427 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178
Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----------YRWLAPEIIAGDPES 512
           + IL+     + + D G+            YE D            +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSXVKRSQGRIPVKWMAIESLF---DH 227
Query: 513 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 572 IKCWNNSPSKRPQFSEI 588
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMT-CGHKNILQ 397
            E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L     H+NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 398 FYCVCVDEN-----HGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFL 450
           +Y   + +N       L +V +    GSV DLI   K   L+ + I  I  ++  G+  L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 509
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 204
Query: 510 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
             P++  + + S+++S G+   EM  G        P++A   I          K   +  
Sbjct: 205 ENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 263
Query: 568 KSLMIKCWNNSPSKRPQFSEII 589
           +S +  C   + S+RP   +++
Sbjct: 264 QSFIESCLVKNHSQRPATEQLM 285

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESL 189
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 230
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 71  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 129
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 189 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 243
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEI 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 187 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 241
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK        +F    +LL      H++I++FY VCV E   L +V + M+ G +
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLT--NLQHEHIVKFYGVCV-EGDPLIMVFEYMKHGDL 102
Query: 422 N--------DLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           N        D +L +      +L   +++ IA  +A G+ +L      +RDL ++  L+ 
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSNVYS 523
            +  V +GD G+    + V     Y   G+     RW+ PE I     +      S+V+S
Sbjct: 163 ENLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWS 215
Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            G+V+WE+ T G+  +   S  +    I   G   + P+ CPQ +  LM+ CW   P  R
Sbjct: 216 LGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMR 274
Query: 583 PQFSEIISLLLRTNNISNSS 602
                I +LL    N++ +S
Sbjct: 275 KNIKGIHTLL---QNLAKAS 291

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 93
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 94  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 208
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 209 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 258
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 259 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 67  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 185 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 239
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 187 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 241
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 68
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 69  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 183
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 184 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 233
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 234 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 36/261 (13%)
Query: 348 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
           IG   F  V++G           V I+  K C   +  E +  ++ L +    H +I++ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKL 456
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
             V + EN  + ++ +L   G +   + ++   L    +I  A  ++  + +L      +
Sbjct: 457 IGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDP-ES 512
           RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+APE I      S
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLRPEIPKDCPQIL 567
            S+ WM     FG+ +WE++          P Q       +G    G R  +P +CP  L
Sbjct: 572 ASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 568 KSLMIKCWNNSPSKRPQFSEI 588
            SLM KCW   PS+RP+F+E+
Sbjct: 622 YSLMTKCWAYDPSRRPRFTEL 642

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 230
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 117
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 118 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 234
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 290
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 197
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 67
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 68  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 182
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 183 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 232
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 233 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 30/193 (15%)
Query: 411 VVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           V+   M+ G ++  +L SR       L  + ++R  +D+A G+++L+     +RDL ++ 
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVS 514
            +L     VC+ D G+            Y  D YR          WLA E +A +  +V 
Sbjct: 168 CMLAEDMTVCVADFGLSRKI--------YSGDYYRQGCASKLPVKWLALESLADNLYTVH 219
Query: 515 ETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 573
               S+V++FG+ +WE++T G+  YA     +    +   G R + P +C + +  LM +
Sbjct: 220 ----SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-GNRLKQPPECMEEVYDLMYQ 274
Query: 574 CWNNSPSKRPQFS 586
           CW+  P +RP F+
Sbjct: 275 CWSADPKQRPSFT 287

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 63  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 177
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 178 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 227
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 82
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 199
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 255
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 256 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 70
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 71  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 185
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 186 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 235
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 67  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 185 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 239
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 27/260 (10%)
Query: 348 IGPNSFKGVYKGKRV---------GIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
           IG   F  VY G+ +          I+ L    +    E  LR+ LL +    H N+L  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL-MRGLNHPNVLAL 87
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFLNDHGVAY 457
             + +       V+   M  G +   I   ++  T K++I   + VA G+++L +    +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-------WLAPEIIAGDP 510
           RDL ++  +LD    V + D G+    + + +   Y    +R       W A E +    
Sbjct: 148 RDLAARNCMLDESFTVKVADFGL---ARDILDREYYSVQQHRHARLPVKWTALESL---- 200
Query: 511 ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
           ++   T  S+V+SFG+++WE++T G   Y    P      +A  G R   P+ CP  L  
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQ 259
Query: 570 LMIKCWNNSPSKRPQFSEII 589
           +M +CW   P+ RP F  ++
Sbjct: 260 VMQQCWEADPAVRPTFRVLV 279

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 13/262 (4%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 68  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA 507
           +L      +RDL ++  L+  +  V + D G+          A        +W APE +A
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
            +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+ 
Sbjct: 187 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPEK 241
Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  LM  CW  +PS RP F+EI
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 24/252 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME 417
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D+    L +V + + 
Sbjct: 43  GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
            GS+ D  L    +   +++  A  + EG+ +L+     +R+L ++ +LLD    V +GD
Sbjct: 102 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGD 160
Query: 478 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 161 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 216
Query: 535 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 580
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEAS 276
Query: 581 KRPQFSEIISLL 592
            RP F  +I +L
Sbjct: 277 FRPTFENLIPIL 288

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 13/262 (4%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA 507
           +L      +RDL ++  L+  +  V + D G+          A        +W APE +A
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 187
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
            +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+ 
Sbjct: 188 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPEK 242
Query: 567 LKSLMIKCWNNSPSKRPQFSEI 588
           +  LM  CW  +PS RP F+EI
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+T+  + G+++  +   R             
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 188
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 244
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 337 LNSDNLEF--------IDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRK 382
           L ++NL F        + +IG  SF      K    G++  I+++      +    E R+
Sbjct: 13  LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIA 440
           ++  L    H NI+Q Y    +EN  L +V    EGG +   I   K    Q  +I+   
Sbjct: 73  EVAVLANMKHPNIVQ-YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
           + +   +K ++D  + +RD+ SQ I L + G V LGD GI     S  E          +
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           L+PEI    P +      S++++ G V++E+ T + A+ A S     + I + G  P + 
Sbjct: 192 LSPEICENKPYNNK----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVS 246
Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                 L+SL+ + +  +P  RP  + I+
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 274 KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +R+L ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 392 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 446
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEI 469

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 36/261 (13%)
Query: 348 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
           IG   F  V++G           V I+  K C   +  E +  ++ L +    H +I++ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKL 456
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
             V + EN  + ++ +L   G +   + ++   L    +I  A  ++  + +L      +
Sbjct: 457 IGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDP-ES 512
           RD+ ++ +L+     V LGD G+    + + ++T Y+        +W+APE I      S
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLRPEIPKDCPQIL 567
            S+ WM     FG+ +WE++          P Q       +G    G R  +P +CP  L
Sbjct: 572 ASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 568 KSLMIKCWNNSPSKRPQFSEI 588
            SLM KCW   PS+RP+F+E+
Sbjct: 622 YSLMTKCWAYDPSRRPRFTEL 642

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 386
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 34  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 93
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 445
           + +  H ++++   VC+     + +VT+LM  G + + + + +  + ++ ++   + +A+
Sbjct: 94  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 209
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           A E I         T  S+V+S+G+ IWE++T         P +    +   G R   P 
Sbjct: 210 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 265
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEI 588
            C   +  +M+KCW      RP+F E+
Sbjct: 266 ICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 125/273 (45%), Gaps = 15/273 (5%)
Query: 324 TVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-L 380
           TV        +W +   ++    ++G   +  VY+G  K+  +       K +  E E  
Sbjct: 243 TVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 302
Query: 381 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--R 438
            K+   +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 361
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
           +A  ++  +++L      +R+L ++  L+  +  V + D G+ +   +    T +    +
Sbjct: 362 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKF 420
Query: 499 --RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     
Sbjct: 421 PIKWTAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDY 475
Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           R E P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 476 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 385 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 433
           L++M+    H+NI+     C      L +      G  +N L  KSR L+T         
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 434 ----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
               ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMN 216
Query: 490 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
            + Y   G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y     
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 385 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 433
           L++M+    H+NI+     C      L +      G  +N L  KSR L+T         
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 434 ----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
               ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +  
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMN 216
Query: 490 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
            + Y   G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y     
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 386
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 11  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 445
           + +  H ++++   VC+     + +VT+LM  G + + + + +  + ++ ++   + +A+
Sbjct: 71  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 186
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           A E I         T  S+V+S+G+ IWE++T         P +    +   G R   P 
Sbjct: 187 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 242
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEI 588
            C   +  +M+KCW      RP+F E+
Sbjct: 243 ICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 24/252 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME 417
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D+    L +V + + 
Sbjct: 43  GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
            GS+ D  L    +   +++  A  + EG+ +L+     +R+L ++ +LLD    V +GD
Sbjct: 102 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGD 160
Query: 478 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 161 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 216
Query: 535 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 580
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEAS 276
Query: 581 KRPQFSEIISLL 592
            RP F  +I +L
Sbjct: 277 FRPTFENLIPIL 288

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 123/269 (45%), Gaps = 15/269 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 384
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 442
             +    H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 500
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+     V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGER 230
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 123/269 (45%), Gaps = 15/269 (5%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 384
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 442
             +    H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 500
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 383
           +W    D L     +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 384 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL---ARDIYKD 197
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 15/266 (5%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLE 386
           + + +W +   ++    ++G   +  VY G  K+  +       K +  E E   K+   
Sbjct: 22  QSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 81
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVA 444
           +    H N++Q   VC  E     +VT+ M  G++ D + +  + +   ++   +A  ++
Sbjct: 82  MKEIKHPNLVQLLGVCTLEP-PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQIS 140
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
             +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W A
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTA 199
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +   G R E P+
Sbjct: 200 PESLAYNTFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YDLLEKGYRMEQPE 254
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSE 587
            CP  +  LM  CW  SP+ RP F+E
Sbjct: 255 GCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFEL 380
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK    GN      
Sbjct: 171 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEAF 227
Query: 381 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIR 438
            ++   +    H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ 
Sbjct: 228 LQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
           +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIED-NEYTARQGAKF 344
Query: 499 --RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G 
Sbjct: 345 PIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GY 399
Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 400 RMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 436

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L    L  +  +G  +F  VYKG            V I+ L+      A + E+  +  
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            +   G   + +   +C+     L  VT+LM  G + D + ++R +L +++++   + +A
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+        + TEY  DG     +W
Sbjct: 130 KGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKW 187
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           +A E I         T  S+V+S+G+ +WE++T  A      P +    +   G R   P
Sbjct: 188 MALESIL----RRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 243
Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             C   +  +M+KCW      RP+F E++S
Sbjct: 244 PICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 377
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 435
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 496 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 377
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 435
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 496 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 3   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 60
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 61  ----RHEKLVQLYAVVSEEP--IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 114
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 115 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTA 173
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 174 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 228
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 229 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 259

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 68  KHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESL 185
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 186 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 240
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 320
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 321 -----HEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 432
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 433 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 487
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 448
            H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 506
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 6   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 63
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 64  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 117
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 118 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 176
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 177 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 231
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 232 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 59
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 60  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 113
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 114 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 172
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 173 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 227
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 ECPESLHDLMCQCWRKDPEERPTFEYLQAFL 258

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 4   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 61
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 62  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 115
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 116 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 174
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 561
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 175 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 229
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 ECPESLHDLMCQCWRKDPEERPTFEYLQAFL 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 35/238 (14%)
Query: 381 RKDL---LELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND----------LIL 426
           RKD     EL+T   H++I++FY VC D +  L +V + M+ G +N           +++
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 427 KSRKLQTK------EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
             +  Q K      +++ IA  +A G+ +L      +RDL ++  L+  +  V +GD G+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 481 VTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G 534
               + V     Y   G+     RW+ PE I     +      S+V+SFG+++WE+ T G
Sbjct: 180 ---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWSFGVILWEIFTYG 232
Query: 535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +  +   S  +    I   G   E P+ CP+ +  +M+ CW   P +R    EI  +L
Sbjct: 233 KQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 21/278 (7%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFE 379
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK    G      
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEA 59
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEII 437
             ++   +    H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
            +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAK 176
Query: 498 Y--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 554
           +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G
Sbjct: 177 FPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-G 231
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 232 YRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 19/239 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV--DENHGLCVVTK 414
           + GK+V ++K+    K    E  L  +++ +    H N++  Y   +  DE   L VV +
Sbjct: 68  HTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHDNVVDMYSSYLVGDE---LWVVME 122
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
            +EGG++ D++  +R +  ++I  + + V   + +L++ GV +RD+ S  ILL   G + 
Sbjct: 123 FLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 181
Query: 475 LGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           L D G      K V +        Y W+APE+I+  P         +++S G+++ EM+ 
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLVGTPY-WMAPEVISRLPYGTE----VDIWSLGIMVIEMID 236
Query: 534 GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ---ILKSLMIKCWNNSPSKRPQFSEII 589
           GE  Y    P+QA   I    L P + KD  +   +L+  +       PS+R    E++
Sbjct: 237 GEPPYFNEPPLQAMRRIRD-SLPPRV-KDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 188
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 244
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 385 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---------RKLQT 433
           L++M+    H+NI+     C      L +      G  +N L  K+         R L+ 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
           ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +   + Y
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNY 216
Query: 494 ETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 547
              G      +W+APE I         T  S+V+S+G+++WE+ + G   Y         
Sbjct: 217 IVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 272
Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 33/285 (11%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 32  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 385 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---------RKLQT 433
           L++M+    H+NI+     C      L +      G  +N L  K+         R L+ 
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
           ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +   + Y
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNY 208
Query: 494 ETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 547
              G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y         
Sbjct: 209 IVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILVNSKF 264
Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 265 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 38/290 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 383
           +W    D L+    +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 82
Query: 384 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 431 --LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
             L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + 
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL---ARDIX 199
Query: 489 EATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 542
           +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y    
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 130/287 (45%), Gaps = 49/287 (17%)
Query: 339 SDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           +  ++ + QIG   +     G ++G++V ++     ++ + +      ++ + +   H+N
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFR---ETEIYQTVLMRHEN 92
Query: 395 ILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           IL F    +        L ++T   E GS+ D  LKS  L  K ++++A     G+  L+
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 452 DH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE------TDG 497
                      +A+RDL S+ IL+ ++G  C+ D+G+  A K + +  E +         
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVKFISDTNEVDIPPNTRVGT 209
Query: 498 YRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM----VTG------EAAYAACSPVQ 545
            R++ PE++  + +        M+++YSFG+++WE+    V+G      +  Y    P  
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 546 AAVG-----IAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
            +       +    LRP  P      +C + +  LM +CW ++P+ R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 197
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L     +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 22  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 81
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 82  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 431 ---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
              L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDI 198
Query: 488 GEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
            +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y   
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGV 254
Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 377
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 60
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 435
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 61  AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
           ++ ++  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 171
Query: 496 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227
Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELR---KDLLELMTCG 391
           W +  + LE  + IG   F  VY G+  G   ++  D     E +L+   ++++      
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 450
           H+N++ F   C+   H L ++T L +G ++  ++  ++  L   +  +IA ++ +G+ +L
Sbjct: 88  HENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WL---AP 503
           +  G+ ++DL S+ +  D +G V + D G+ +    V +A   E D  R    WL   AP
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFS-ISGVLQAGRRE-DKLRIQNGWLCHLAP 203
Query: 504 EIIAGDPESVSETWM-----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
           EII        E  +     S+V++ G + +E+   E  +    P +A +     G++P 
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPN 262
Query: 559 IPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           + +    + +  +++ CW     +RP F++++ +L
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 387
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 446
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T  +        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTXXKASKGKLPIKWMA 180
Query: 503 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 556
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 230
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAYEFELRKDLLELM 388
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E   +L++  
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEE--ANLMK-- 62
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAE 445
           T  H  +++ Y V   E   + ++T+ M  GS+ D  LKS    K+   ++I  +  +AE
Sbjct: 63  TLQHDKLVRLYAVVTKE-EPIYIITEFMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQIAE 120
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 503
           G+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W AP
Sbjct: 121 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 179
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           E I     ++     SNV+SFG++++E+VT G+  Y   +       ++  G R    ++
Sbjct: 180 EAINFGCFTIK----SNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ-GYRMPRMEN 234
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           CP  L  +M  CW     +RP F  + S+L
Sbjct: 235 CPDELYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAY-----EFELRKDLLELM 388
           +L+ ++++F D IG  +F  V K   K+ G+       +   Y       +   +L  L 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 389 TCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 433
             GH  NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 81  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 434 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 485
              ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  
Sbjct: 199 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 249 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAY-----EFELRKDLLELM 388
           +L+ ++++F D IG  +F  V K   K+ G+       +   Y       +   +L  L 
Sbjct: 11  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 70
Query: 389 TCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 433
             GH  NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 71  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 434 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 485
              ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  
Sbjct: 189 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 238
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 239 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 287

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 377
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 60
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 435
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 61  AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
           ++ ++  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEWTARQG 171
Query: 496 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227
Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 66
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 124
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           EG+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 181
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 182 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 236
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 237 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 386
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 387 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 197
Query: 487 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 540
           + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 253
Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  G + D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 432 IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----N 545
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
               +  S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 604
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 605 MNLCWTYDVENRPGFA-AVELRLRN 628

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 433 IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----N 546
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
               +  S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 605
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 606 MNLCWTYDVENRPGFA-AVELRLRN 629

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 392 HKNILQFYCVCVD-ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAI 441
           H N+++   VC++  + G+    V+   M+ G ++  +L SR       +  + +++  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-- 499
           D+A G+++L++    +RDL ++  +L     VC+ D G+            Y  D YR  
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--------YSGDYYRQG 206
Query: 500 --------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI 550
                   W+A E +A        T  S+V++FG+ +WE+ T G   Y            
Sbjct: 207 RIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDY 261
Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
              G R + P+DC   L  +M  CW   P  RP FS
Sbjct: 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 74  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 192 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 246
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 247 MNLCWTYDVENRPGFA-AVELRLRN 270

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 68  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 186 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 240
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 241 MNLCWTYDVENRPGFA-AVELRLRN 264

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 74  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 192 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 246
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 247 MNLCWTYDVENRPGFA-AVELRLRN 270

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 90  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 208 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 262
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 263 MNLCWTYDVENRPGFA-AVELRLRN 286

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 90  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 208 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 262
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 263 MNLCWTYDVENRPGFA-AVELRLRN 286

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 80  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 198 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 252
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 253 MNLCWTYDVENRPGFA-AVELRLRN 276

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 88  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 206 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 260
Query: 571 MIKCWNNSPSKRPQFSEIISLLLRT 595
           M  CW      RP F+  + L LR 
Sbjct: 261 MNLCWTYDVENRPGFA-AVELRLRN 284

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVCEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 70  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 511
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 512 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 188 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 242
Query: 571 MIKCWNNSPSKRPQFSEI 588
           M  CW      RP F+ +
Sbjct: 243 MNLCWTYDVENRPGFAAV 260

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 377
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 435
            ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKLR------HEKLVQLYAVVSEEP--IYIVGEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 496 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 184
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 75
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 76  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 133
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 190
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 191 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 245
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 246 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E  L K    
Sbjct: 8   WEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---- 63
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDV 443
             T  H  +++ Y V   E   + ++T+ M  GS+ D  LKS    K+   ++I  +  +
Sbjct: 64  --TLQHDKLVRLYAVVTRE-EPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQI 119
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
           AEG+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W 
Sbjct: 120 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 178
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE I     ++     S+V+SFG++++E+VT G+  Y   +       ++     P + 
Sbjct: 179 APEAINFGCFTIK----SDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV- 233
Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           ++CP  L  +M  CW     +RP F  + S+L
Sbjct: 234 ENCPDELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 385 LELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK--EIIRIAI 441
           +++M C  H N+L+F  V   +   L  +T+ ++GG++  +I KS   Q    + +  A 
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKR-LNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAK 115
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------------VTACKSVG 488
           D+A G+ +L+   + +RDLNS   L+  + NV + D G+             + + K   
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 489 EATEYETDGY-RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 547
               Y   G   W+APE+I G   S  E    +V+SFG+V+ E++    A     P    
Sbjct: 176 RKKRYTVVGNPYWMAPEMING--RSYDEK--VDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 548 VGIAACG-LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            G+   G L    P +CP     + ++C +  P KRP F ++
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 192
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 193 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 247
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 187
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 188 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 242
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 94
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 95  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 152
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 210
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 211 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 265
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 130
Query: 422 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 523
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 191 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 245
Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           FG+V+WE+ T G+  +   S  +A   I   G   E P+ CP  + ++M  CW   P +R
Sbjct: 246 FGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQR 304
Query: 583 PQFSEIISLL 592
               ++ + L
Sbjct: 305 HSIKDVHARL 314

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 63
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 178
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 179 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 233
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 101
Query: 422 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 102 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 161
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 523
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 162 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 216
Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           FG+V+WE+ T G+  +   S  +A   I   G   E P+ CP  + ++M  CW   P +R
Sbjct: 217 FGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQR 275
Query: 583 PQFSEIISLL 592
               ++ + L
Sbjct: 276 HSIKDVHARL 285

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAY-----EFELRKDLLELM 388
           +L+ ++++F D IG  +F  V K   K+ G+       +   Y       +   +L  L 
Sbjct: 18  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 77
Query: 389 TCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 433
             GH  NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 78  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 434 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 485
              ++++  A DVA G+ +L+     +R+L ++ IL+  +    + D G+     V   K
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  
Sbjct: 196 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 245
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 246 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 294

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 107
Query: 422 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 108 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 167
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 523
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 168 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 222
Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           FG+V+WE+ T G+  +   S  +A   I   G   E P+ CP  + ++M  CW   P +R
Sbjct: 223 FGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQR 281
Query: 583 PQFSEIISLL 592
               ++ + L
Sbjct: 282 HSIKDVHARL 291

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 45/294 (15%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 385 LELMTC--GHKNILQFYCVCVDENHG--LCVVTKLMEGGSVNDLILKSR----------- 429
           L++M+    H+NI+     C    HG  + V+T+    G + + + + R           
Sbjct: 100 LKIMSHLGQHENIVNLLGACT---HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                +L +++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---A 213
Query: 485 KSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY 538
           + +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G   Y
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGLNPY 269
Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                      +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 270 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I +L+      A + E+  +  
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK-EILDEAY 103
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 161
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 162 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 218
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 219 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 273
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 274 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  +   +C        L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 78  HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 508
             G+ YRDL    ILLD+ G++ + D G+   CK   +G+A   E  G   ++APEI+ G
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              + S  W    +SFG++++EM+ G++ +      +    I      P  P+   +  K
Sbjct: 194 QKYNHSVDW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAK 247
Query: 569 SLMIKCWNNSPSKR 582
            L++K +   P KR
Sbjct: 248 DLLVKLFVREPEKR 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 125/281 (44%), Gaps = 27/281 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 376
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 434
           E ++ K L       H+ ++Q Y V  +E   + +V + M  G + D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 495 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 207 HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 262
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 263 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 321
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 546
            P         +++S G+++ EMV GE  Y    P++A
Sbjct: 322 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLKA 355

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 131/300 (43%), Gaps = 59/300 (19%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGI----------EKLKGCDKGNAYEFELRKDLLELMT 389
           +N+E++  IG  +F  V++ +  G+           K+   +     + + +++   +  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVN-----------------DLILKSR--- 429
             + NI++   VC      +C++ + M  G +N                 DL  ++R   
Sbjct: 107 FDNPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 430 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+    +
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL---SR 222
Query: 486 SVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
           ++  A  Y+ DG      RW+ PE I  +      T  S+V+++G+V+WE+ + G   Y 
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 540 ACSPVQAAV-----GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             +  +         I AC      P++CP  L +LM  CW+  P+ RP F  I  +L R
Sbjct: 279 GMAHEEVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 184
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 191
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 192 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 246
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 70
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 71  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 185
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 186 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 240
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 241 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 87  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 144
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK---QSAYDS-KA 200
Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 259
Query: 580 SKRPQFSEIISLLLRTNNISNSS 602
           S RP   E++       N   +S
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTS 282

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 371 DKGNAYEFELRKD-LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 429
           DK     F+   D +L + +  H +I++   +C      L +VT+ +  GS+ D + + R
Sbjct: 70  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHR 127
Query: 430 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
             L  + ++   + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+        
Sbjct: 128 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 187
Query: 489 EATEYE--TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 546
           +   Y       +W+A E I         T  S+V+S+G+ +WE++T  A   A   +  
Sbjct: 188 KQLLYSEAKTPIKWMALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 243
Query: 547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
              +   G R   P+ C   +  +M+KCW    + RP F E+ +   R
Sbjct: 244 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 291

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 130 HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 185
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 186 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 244
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 566
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 245 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 298
Query: 567 -LKSLMIKCWNNSPSKRPQFSEII 589
            LK  + +     P++R   +E++
Sbjct: 299 SLKGFLDRLLVRDPAQRATAAELL 322

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 72  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK---QSAYDS-KA 185
Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 244
Query: 580 SKRPQFSEIISLLLRTNNISNSS 602
           S RP   E++       N   +S
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTS 267

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 12/223 (5%)
Query: 371 DKGNAYEFELRKD-LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 429
           DK     F+   D +L + +  H +I++   +C   +  L +VT+ +  GS+ D + + R
Sbjct: 52  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR 109
Query: 430 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
             L  + ++   + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+        
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 489 EATEYE--TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 545
           +   Y       +W+A E I         T  S+V+S+G+ +WE++T G   YA     +
Sbjct: 170 KQLLYSEAKTPIKWMALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
               +   G R   P+ C   +  +M+KCW    + RP F E+
Sbjct: 226 VP-DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 87  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 142
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 143 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 201
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 566
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 202 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 255
Query: 567 -LKSLMIKCWNNSPSKRPQFSEII 589
            LK  + +     P++R   +E++
Sbjct: 256 SLKGFLDRLLVRDPAQRATAAELL 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 85  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 140
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 141 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 199
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 566
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 200 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 253
Query: 567 -LKSLMIKCWNNSPSKRPQFSEII 589
            LK  + +     P++R   +E++
Sbjct: 254 SLKGFLDRLLVRDPAQRATAAELL 277

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 73
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 74  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 189
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 190 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 244
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 187
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 188 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 242
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 72  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDS-KA 185
Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 244
Query: 580 SKRPQFSEIISLLLRTNNISNSS 602
           S RP   E++       N   +S
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTS 267

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 70
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  + +LM  G + D + + +  + ++ ++   + +A
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL--IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 186
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 187 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 241
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 76  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 131
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 190
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 566
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 191 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 244
Query: 567 -LKSLMIKCWNNSPSKRPQFSEII 589
            LK  + +     P++R   +E++
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELL 268

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 184
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 79
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 137
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 194
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 195 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 249
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M KCW      RP+F E+I
Sbjct: 250 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  + +LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 30/268 (11%)
Query: 336 LLNSDNLEFID-QIGPNSF----KGVYKGKR----VGIEKLK-GCDKGNAYEFELRKDLL 385
            L  DNL   D ++G  +F    +GVY+ ++    V I+ LK G +K +  E      ++
Sbjct: 5   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVA 444
             +   +  I++   VC  E   L +V ++  GG ++  ++  R+ +    +  +   V+
Sbjct: 65  HQLD--NPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD------GY 498
            G+K+L +    +RDL ++ +LL       + D G+    K++G    Y T         
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL---SKALGADDSYYTARSAGKWPL 177
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           +W APE I     S      S+V+S+G+ +WE ++ G+  Y      +    I   G R 
Sbjct: 178 KWYAPECINFRKFSSR----SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRM 232
Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           E P +CP  L +LM  CW      RP F
Sbjct: 233 ECPPECPPELYALMSDCWIYKWEDRPDF 260

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 80  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 135
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 508
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 136 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 194
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 566
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 195 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 248
Query: 567 -LKSLMIKCWNNSPSKRPQFSEII 589
            LK  + +     P++R   +E++
Sbjct: 249 SLKGFLDRLLVRDPAQRATAAELL 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 191
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 192 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 246
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 124/282 (43%), Gaps = 23/282 (8%)
Query: 337 LNSDNLEF-----------IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFEL 380
           L ++NL F           +++IG  SF  V+KG     ++V   K+   ++      ++
Sbjct: 13  LGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI 72
Query: 381 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
           ++++  L  C    + ++Y   + +   L ++ + + GGS  DL L+   L   +I  I 
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATIL 130
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
            ++ +G+ +L+     +RD+ +  +LL  HG V L D G+                   W
Sbjct: 131 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           +APE+I    +S  ++  ++++S G+   E+  GE  ++   P++    I      P + 
Sbjct: 191 MAPEVIK---QSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLE 245
Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
            +  + LK  +  C N  PS RP   E++       N   +S
Sbjct: 246 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 287

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 384
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 25  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 385 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-------------- 428
           L++M+    H+NI+     C      L +      G  +N L  K+              
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 429 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
                   R L+ ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 481 VTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G 534
               + +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G
Sbjct: 205 ---ARDIMNDSNYIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLG 257
Query: 535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              Y           +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 258 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  +   +C        L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 77  HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 508
             G+ YRDL    ILLD+ G++ + D G+   CK   +G+A      G   ++APEI+ G
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCGTPDYIAPEILLG 192
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              + S  W    +SFG++++EM+ G++ +      +    I      P  P+   +  K
Sbjct: 193 QKYNHSVDW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAK 246
Query: 569 SLMIKCWNNSPSKR 582
            L++K +   P KR
Sbjct: 247 DLLVKLFVREPEKR 260

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 10/191 (5%)
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA 444
           L L    H  I++ +    D    + ++   +EGG +  L+ KS++         A +V 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
             +++L+   + YRDL  + ILLD++G++ + D G     K V + T        ++APE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYXLCGTPDYIAPE 173
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKD 562
           +++  P + S  W    +SFG++I+EM+ G   +   + ++    I    LR  P   +D
Sbjct: 174 VVSTKPYNKSIDW----WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 563 CPQILKSLMIK 573
              +L  L+ +
Sbjct: 230 VKDLLSRLITR 240

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLL---ELMTC-- 390
           L  DN EFI  +G  SF       +V + ++K  + G+ Y  + L+KD++   + + C  
Sbjct: 20  LGIDNFEFIRVLGKGSFG------KVMLARVK--ETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 391 ----------GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
                      H  + Q +C C      L  V + + GG +   I KSR+         A
Sbjct: 72  TEKRILSLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEYETDGY 498
            ++   + FL+D G+ YRDL    +LLD  G+  L D G+     C  V  AT   T  Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
             +APEI+       +  W    ++ G++++EM+ G A + A
Sbjct: 191 --IAPEILQEMLYGPAVDW----WAMGVLLYEMLCGHAPFEA 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 73
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  + +LM  G + D + + +  + ++ ++   + +A
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL--IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 188
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 189 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 243
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 85/157 (54%), Gaps = 10/157 (6%)
Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+++ Y    V E   L V+ + ++GG++ D++ + R L  ++I  +   V + + +L
Sbjct: 101 HFNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYL 157
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGD 509
           +  GV +RD+ S  ILL   G V L D G      K V +        Y W+APE+I+  
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPY-WMAPEVIS-- 214
Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 546
             S+  T + +++S G+++ EMV GE  Y + SPVQA
Sbjct: 215 -RSLYATEV-DIWSLGIMVIEMVDGEPPYFSDSPVQA 249

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 134/298 (44%), Gaps = 39/298 (13%)
Query: 308 MPLPSSSFVVSVDEWQTVQSGGEEIG--RWLLNSDNLEFID-QIGPNSF----KGVYKGK 360
           MP+ +S F       ++  S  EE+   +  L  DNL   D ++G  +F    +GVY+ +
Sbjct: 308 MPMDTSVF-------ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR 360
Query: 361 R----VGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415
           +    V I+ LK G +K +  E      ++  +   +  I++   VC  E   L +V ++
Sbjct: 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQAE--ALMLVMEM 416
Query: 416 MEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
             GG ++  ++  R+ +    +  +   V+ G+K+L +    +R+L ++ +LL       
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476
Query: 475 LGDMGIVTACKSVGEATEYETD------GYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + D G+    K++G    Y T         +W APE I     S      S+V+S+G+ +
Sbjct: 477 ISDFGL---SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR----SDVWSYGVTM 529
Query: 529 WEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 585
           WE ++ G+  Y      +    I   G R E P +CP  L +LM  CW      RP F
Sbjct: 530 WEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDF 586

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 385
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 386 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 79  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 499
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 553
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 196 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 249
Query: 554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 84/168 (50%), Gaps = 13/168 (7%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           +  +++I  +  VA G++FL+     +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKN 252
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     S      S+V+S+G+++WE+ + G + Y      
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTK----SDVWSYGVLLWEIFSLGGSPYPGVQMD 308
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G+R   P+     +  +M+ CW+  P +RP+F+E++  L
Sbjct: 309 EDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 385
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 7   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 66
Query: 386 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 67  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 123
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 499
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 124 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 183
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 553
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 184 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 237
Query: 554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 385
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 3   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 62
Query: 386 ELMTCGHKN-ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 63  KAL---HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 119
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 499
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 120 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 553
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 180 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 233
Query: 554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 234 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 244
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 300
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     L  + +LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL--IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 192
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 193 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 247
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 251
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 307
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 246
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 253
Query: 491 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 309
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 497
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RHIKNDSNYVVKG 228
Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 229 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 285 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 335

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 109/229 (47%), Gaps = 9/229 (3%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAY-EFELRKDLLE-- 386
           E + R L   D  E I ++G  +F  VYK +      L      +   E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 503
           + + +L+D+ + +RDL +  IL    G++ L D G+     +++     +    Y W+AP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAP 204
Query: 504 EIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
           E++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 497
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIKNDSNYVVKG 221
Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 222 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 277
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 278 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 328

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 497
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIKNDSNYVVKG 223
Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 224 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 279
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 280 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 330

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 497
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIKNDSNYVVKG 228
Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 229 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 285 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 335

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 497
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIKNDSNYVVKG 205
Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 206 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 312

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 106/228 (46%), Gaps = 7/228 (3%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAY-EFELRKDLLE-- 386
           E + R L   D  E I ++G  +F  VYK +      L      +   E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 505 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
           ++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 499
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
            P  C   +  +M KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 106/228 (46%), Gaps = 7/228 (3%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAY-EFELRKDLLE-- 386
           E + R L   D  E I ++G  +F  VYK +      L      +   E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 505 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
           ++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 118/256 (46%), Gaps = 17/256 (6%)
Query: 342 LEFIDQIGPNSFKGVYKG--KRVG-IEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
            + ++++G  S+  VYK   K  G I  +K     +  + E+ K++  +  C   +++++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKY 89
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
           Y     +N  L +V +    GSV+D+I L+++ L   EI  I     +G+++L+     +
Sbjct: 90  YGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 517
           RD+ +  ILL+  G+  L D G+                   W+APE+I    + +    
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI----QEIGYNC 204
Query: 518 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA----CGLRPEIPKDCPQILKSLMIK 573
           +++++S G+   EM  G+  YA   P++A   I         +PE+  D        + +
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDN---FTDFVKQ 261
Query: 574 CWNNSPSKRPQFSEII 589
           C   SP +R   ++++
Sbjct: 262 CLVKSPEQRATATQLL 277

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 28/271 (10%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +D+IG  SF  VYKG     K V   K+   ++      ++++++  L  C    I +++
Sbjct: 24  LDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + ++  L ++ + + GGS  DL LK   L+   I  I  ++ +G+ +L+     +RD
Sbjct: 84  GSYL-KSTKLWIIMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL   G+V L D G+                   W+APE+I    +  +  + +
Sbjct: 142 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI----KQSAYDFKA 197
Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL--------KSLM 571
           +++S G+   E+  GE   +   P++             IPK+ P  L        K  +
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQHSKPFKEFV 248
Query: 572 IKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
             C N  P  RP   E++     T     +S
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITRYTKKTS 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 359 GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLM 416
           G+ V ++ LK GC  G       ++++  L T  H++I+++   C D+    + +V + +
Sbjct: 38  GEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
             GS+ D  L    +   +++  A  + EG+ +L+     +R L ++ +LLD    V +G
Sbjct: 96  PLGSLRD-YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIG 154
Query: 477 DMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T
Sbjct: 155 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KECKFYYASDVWSFGVTLYELLT 210
Query: 534 G-EAAYAACSPVQAAVG-------------IAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
             ++  +  +     +G             +   G R   P  CP  +  LM  CW    
Sbjct: 211 YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEA 270
Query: 580 SKRPQFSEIISLL 592
           S RP F  ++ +L
Sbjct: 271 SFRPTFQNLVPIL 283

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 409
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 25  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 461
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 82  WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 462 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 513
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 198
Query: 514 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 558
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 258
Query: 559 IPKDC---PQI--LKSLMIKCWNNSPSKR 582
           IP      P +  L  LM +CW  +PS R
Sbjct: 259 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 359 GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLM 416
           G+ V ++ LK GC  G       ++++  L T  H++I+++   C D+    + +V + +
Sbjct: 37  GEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
             GS+ D  L    +   +++  A  + EG+ +L+     +R L ++ +LLD    V +G
Sbjct: 95  PLGSLRD-YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIG 153
Query: 477 DMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T
Sbjct: 154 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KECKFYYASDVWSFGVTLYELLT 209
Query: 534 G-EAAYAACSPVQAAVG-------------IAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
             ++  +  +     +G             +   G R   P  CP  +  LM  CW    
Sbjct: 210 YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEA 269
Query: 580 SKRPQFSEIISLL 592
           S RP F  ++ +L
Sbjct: 270 SFRPTFQNLVPIL 282

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 409
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 54  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 110
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 461
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 111 WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 169
Query: 462 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 513
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 170 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 227
Query: 514 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 558
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 228 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 287
Query: 559 IPKDC---PQI--LKSLMIKCWNNSPSKR 582
           IP      P +  L  LM +CW  +PS R
Sbjct: 288 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
             H+NI+    V  +E+    +V + +EG ++++ I     L     I     + +GIK 
Sbjct: 68  LSHQNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDGYRWLAPEIIAG 508
            +D  + +RD+  Q IL+D +  + + D GI  A        T +     ++ +PE   G
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-------K 561
             E+  E   +++YS G+V++EM+ GE  +      + AV IA   ++  +P       K
Sbjct: 187 --EATDEC--TDIYSIGIVLYEMLVGEPPFNG----ETAVSIAIKHIQDSVPNVTTDVRK 238
Query: 562 DCPQILKSLMIKCWNNSPSKR 582
           D PQ L +++++      + R
Sbjct: 239 DIPQSLSNVILRATEKDKANR 259

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL   G+ YRDL 
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW---- 525
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++FG++++EM+ G+A +
Sbjct: 526 WAFGVLLYEMLAGQAPF 542

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 409
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 25  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 461
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 82  WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 462 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 513
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 198
Query: 514 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 558
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 258
Query: 559 IPKDC---PQI--LKSLMIKCWNNSPSKR 582
           IP      P +  L  LM +CW  +PS R
Sbjct: 259 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 385
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 6   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 65
Query: 386 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 66  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 122
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 499
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 123 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 182
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 553
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +         
Sbjct: 183 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGSERDVPA 236
Query: 554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/250 (21%), Positives = 118/250 (47%), Gaps = 20/250 (8%)
Query: 353 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 407
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 41  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 97
Query: 408 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 98  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 157
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 522
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 158 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 210
Query: 523 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 211 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 270
Query: 583 PQFSEIISLL 592
           P+F+E++  L
Sbjct: 271 PRFTELVCSL 280

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/250 (21%), Positives = 118/250 (47%), Gaps = 20/250 (8%)
Query: 353 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 407
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 25  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 81
Query: 408 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 82  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 141
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 522
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 142 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 194
Query: 523 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 195 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 254
Query: 583 PQFSEIISLL 592
           P+F+E++  L
Sbjct: 255 PRFTELVCSL 264

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL   G+ YRDL 
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 149 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW---- 204
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++FG++++EM+ G+A +
Sbjct: 205 WAFGVLLYEMLAGQAPF 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/250 (21%), Positives = 118/250 (47%), Gaps = 20/250 (8%)
Query: 353 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 407
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 29  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 85
Query: 408 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 86  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 522
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 146 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 198
Query: 523 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258
Query: 583 PQFSEIISLL 592
           P+F+E++  L
Sbjct: 259 PRFTELVCSL 268

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGI-----EKLKGCDKGN 374
             G  +IG ++L        D +G  +F  V  GK      +V +     +K++  D   
Sbjct: 9   HDGRVKIGHYILG-------DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK 434
               ++R+++  L    H +I++ Y V +     + +V + + GG + D I K+ +L  K
Sbjct: 62  ----KIRREIQNLKLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK 116
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           E  R+   +  G+ + + H V +RDL  + +LLD H N  + D G+ +   S GE     
Sbjct: 117 ESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRXS 175
Query: 495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEV---DIWSSGVILYALLCGTLPF 216

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 47/297 (15%)
Query: 337 LNSDNLEF--------IDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRK 382
           L ++NL F        +  +G  S+  V K      G+ V I+K    D     +    +
Sbjct: 14  LGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 442
           ++  L    H+N++    VC  +     +V + ++   ++DL L    L  + + +    
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWY-LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 502
           +  GI F + H + +RD+  + IL+ + G V L D G      + GE  + E     + A
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--------- 553
           PE++ GD   V      +V++ G ++ EM  GE  +   S +     I  C         
Sbjct: 193 PELLVGD---VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 554 ----------GLR-PEIPKDCP---------QILKSLMIKCWNNSPSKRPQFSEIIS 590
                     G+R PEI +  P         +++  L  KC +  P KRP  +E++ 
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 51/284 (17%)
Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LR 381
             V++G E+      +  + E +  +G  SF     GK   + K+   D G+ Y  + L+
Sbjct: 16  HHVKAGSEKA-----DPSHFELLKVLGQGSF-----GKVFLVRKVTRPDSGHLYAMKVLK 65
Query: 382 KDLLE-------------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 428
           K  L+             L    H  +++ +     E   L ++   + GG +   + K 
Sbjct: 66  KATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKE 124
Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488
                +++     ++A G+  L+  G+ YRDL  + ILLD  G++ L D G+        
Sbjct: 125 VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ 178
Query: 489 EATEYETDGY------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
           EA ++E   Y       ++APE++     S S  W    +S+G++++EM+TG   +    
Sbjct: 179 EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADW----WSYGVLMFEMLTGSLPFQGKD 234
Query: 543 PVQAAVGIAACGLRPEIPKDCPQIL----KSLMIKCWNNSPSKR 582
             +    I    L        PQ L    +SL+   +  +P+ R
Sbjct: 235 RKETMTLILKAKL------GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 386
           E + R L  ++  E + ++G  +F  VYK K      L          E EL   ++E  
Sbjct: 9   EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  +   + 
Sbjct: 69  ILATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 503
           E + FL+   + +RDL +  +L+   G++ L D G+     K++ +   +    Y W+AP
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAP 186
Query: 504 EIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           E++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA         
Sbjct: 187 EVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------- 237
Query: 561 KDCPQIL---------KSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
            D P +L         +  +    + +P  RP  ++++     ++  SN + R
Sbjct: 238 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 386
           E + R L  ++  E + ++G  +F  VYK K      L          E EL   ++E  
Sbjct: 1   EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 60
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  +   + 
Sbjct: 61  ILATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 119
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 503
           E + FL+   + +RDL +  +L+   G++ L D G+     K++ +   +    Y W+AP
Sbjct: 120 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAP 178
Query: 504 EIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           E++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA         
Sbjct: 179 EVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------- 229
Query: 561 KDCPQIL---------KSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
            D P +L         +  +    + +P  RP  ++++     ++  SN + R
Sbjct: 230 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 281

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/263 (21%), Positives = 116/263 (44%), Gaps = 12/263 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
              + +   L ++ + + GGS  DL L++      +I  +  ++ +G+ +L+     +RD
Sbjct: 88  GSYL-KGSKLWIIMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 145
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           + +  +LL   G+V L D G+                   W+APE+I    +S  ++  +
Sbjct: 146 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDS-KA 201
Query: 520 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           +++S G+   E+  GE   +   P++    I      P +  D  +  K  +  C N  P
Sbjct: 202 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLVGDFTKSFKEFIDACLNKDP 260
Query: 580 SKRPQFSEIISLLLRTNNISNSS 602
           S RP   E++       N   +S
Sbjct: 261 SFRPTAKELLKHKFIVKNSKKTS 283

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           SDN    + +G   F  VYKG+      V +++LK  ++    E + + ++  +    H+
Sbjct: 37  SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERXQGGELQFQTEVEMISMAVHR 95
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-----LQTKEIIRIAIDVAEGIK 448
           N+L+    C+     L +V   M  GSV    L+ R      L   +  RIA+  A G+ 
Sbjct: 96  NLLRLRGFCMTPTERL-LVYPYMANGSVAS-CLRERPESQPPLDWPKRQRIALGSARGLA 153
Query: 449 FLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPE 504
           +L+DH    + +RD+ +  ILLD      +GD G+                G    +APE
Sbjct: 154 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE 213
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------------SPV 544
            ++    S      ++V+ +G+++ E++TG+ A+                         +
Sbjct: 214 YLSTGKSSEK----TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +A V +   G   +  ++  Q+++  ++ C  +SP +RP+ SE++ +L
Sbjct: 270 EALVDVDLQGNYKD--EEVEQLIQVALL-CTQSSPMERPKMSEVVRML 314

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   I +  K +  + +  A +++ G+ FL+  G+ YRDL 
Sbjct: 88  CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLK 147
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              ++LD  G++ + D G+       G  T        ++APEIIA  P   S  W    
Sbjct: 148 LDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW---- 203
Query: 522 YSFGMVIWEMVTGEAAY 538
           +++G++++EM+ G+  +
Sbjct: 204 WAYGVLLYEMLAGQPPF 220

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           SDN    + +G   F  VYKG+      V +++LK  ++    E + + ++  +    H+
Sbjct: 29  SDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHR 87
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-----LQTKEIIRIAIDVAEGIK 448
           N+L+    C+     L +V   M  GSV    L+ R      L   +  RIA+  A G+ 
Sbjct: 88  NLLRLRGFCMTPTERL-LVYPYMANGSVAS-CLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 449 FLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPE 504
           +L+DH    + +RD+ +  ILLD      +GD G+                G    +APE
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------------SPV 544
            ++    S      ++V+ +G+++ E++TG+ A+                         +
Sbjct: 206 YLSTGKSSEK----TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +A V +   G   +  ++  Q+++  ++ C  +SP +RP+ SE++ +L
Sbjct: 262 EALVDVDLQGNYKD--EEVEQLIQVALL-CTQSSPMERPKMSEVVRML 306

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 227 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 286
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 287 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 128
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 129 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 188
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 189 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 248
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 249 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 153
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 154 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 213
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 214 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 273
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 274 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 133
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 134 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 193
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 194 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 253
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 254 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 386
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 22  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 498
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 189
Query: 499 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 557
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 190 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243
Query: 558 EIPKDCPQIL----KSLMIKCWNNSPSKR 582
                 PQ L    +SL+   +  +P+ R
Sbjct: 244 ----GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +RD+ S  ILL 
Sbjct: 93  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 151
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 525
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 152 MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 204
Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 583
           ++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +  + +C      KR 
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRG 263
Query: 584 QFSEII 589
              E+I
Sbjct: 264 SAKELI 269

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 346 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 405 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 453
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 130
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 507
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 131 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 190
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 552
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 191 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 250
Query: 553 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 582
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 251 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 386
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 22  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 498
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 189
Query: 499 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 557
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 190 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243
Query: 558 EIPKDCPQIL----KSLMIKCWNNSPSKR 582
                 PQ L    +SL+   +  +P+ R
Sbjct: 244 ----GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 510
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 568
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 569 SLMIKCWNNSPSKRPQFSEII 589
             + +C +    KR    E++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELL 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 386
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 23  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 78  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 136
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 498
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 190
Query: 499 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 557
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 191 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 244
Query: 558 EIPKDCPQIL----KSLMIKCWNNSPSKR 582
                 PQ L    +SL+   +  +P+ R
Sbjct: 245 ----GMPQFLSPEAQSLLRMLFKRNPANR 269

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 510
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 568
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 569 SLMIKCWNNSPSKRPQFSEII 589
             + +C +    KR    E++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELL 268

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 510
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 568
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 569 SLMIKCWNNSPSKRPQFSEII 589
             + +C      KR    E++
Sbjct: 248 DFLNRCLEMDVEKRGSAKELL 268

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 27/163 (16%)
Query: 392 HKNILQFY-------CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA 444
           H+NILQF         V VD    L ++T   E GS++D  LK+  +   E+  IA  +A
Sbjct: 77  HENILQFIGAEKRGTSVDVD----LWLITAFHEKGSLSDF-LKANVVSWNELCHIAETMA 131
Query: 445 EGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCLGDMGIVT---ACKSVGEAT 491
            G+ +L++            +++RD+ S+ +LL  +   C+ D G+     A KS G+ T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD-T 190
Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMS-NVYSFGMVIWEMVT 533
             +    R++APE++ G      + ++  ++Y+ G+V+WE+ +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 431
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 549 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 597
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 431
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490
             K  I +  D  + + F + +G+ +RD+    IL+     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV 173
Query: 491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 XQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 549 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 597
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 148
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 149 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 204
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 205 WALGVLMFEMMAGRSPF 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 137
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 193
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 194 WALGVLMFEMMAGRSPF 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 236
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 237 WALGVLMFEMMAGRSPF 253

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 133
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 521
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 134 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 189
Query: 522 YSFGMVIWEMVTGEAAY 538
           ++ G++++EM+ G + +
Sbjct: 190 WALGVLMFEMMAGRSPF 206

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 97  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 514
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEI---- 211
Query: 515 ETWMSNVYSFGMVIWEMVTGEAA 537
            T  S++YSFG+V+ E++TG  A
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPA 233

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 52/301 (17%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK-----------LKGCDKGNAYEFELRK 382
           +W    +NLEF   +G  +F  V      GI K           LK  +K ++ E E   
Sbjct: 39  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALM 96
Query: 383 DLLELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI---- 436
             L++MT    H+NI+     C        +      G  +N L  K  K    EI    
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 437 ------------------IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
                             +  A  VA+G++FL      +RDL ++ +L+     V + D 
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 479 GIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           G+    + +   + Y   G      +W+APE +     ++     S+V+S+G+++WE+ +
Sbjct: 217 GL---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----SDVWSYGILLWEIFS 269
Query: 534 -GEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
            G   Y    PV A    +   G + + P    + +  +M  CW     KRP F  + S 
Sbjct: 270 LGVNPYPGI-PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 592 L 592
           L
Sbjct: 329 L 329

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +R++ S  ILL 
Sbjct: 93  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLG 151
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 525
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 152 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 204
Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 583
           ++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +  + +C      KR 
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRG 263
Query: 584 QFSEII 589
              E+I
Sbjct: 264 SAKELI 269

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
            LC+V  LM GG +   I    +    E   +  A ++  G++ L+   + YRDL  + I
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
           LLD HG++ + D+G+       G+  +       ++APE++  +  + S  W    ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALG 372
Query: 526 MVIWEMVTGEAAY 538
            +++EM+ G++ +
Sbjct: 373 CLLYEMIAGQSPF 385

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 431
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 549 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 597
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 97  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 514
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEI---- 211
Query: 515 ETWMSNVYSFGMVIWEMVTGEAA 537
            T  S++YSFG+V+ E++TG  A
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPA 233

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/285 (21%), Positives = 125/285 (43%), Gaps = 38/285 (13%)
Query: 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 390
           N     +IG   F  VY+      G  V ++K++  D  +A   + R D ++    L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQL 89
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEG 446
            H N++++Y   +++N  L +V +L + G ++ +I   +K    +  + + +  + +   
Sbjct: 90  NHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           ++ ++   V +RD+    + +   G V LGD+G+     S   A         +++PE I
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAA--------YAACSPVQAAVGIAACGLRPE 558
             +       + S+++S G +++EM   ++         Y+ C  ++       C   P 
Sbjct: 209 HEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDY-PP 257
Query: 559 IPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
           +P D   + L+ L+  C N  P KRP  + +  +  R +  + SS
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
            LC+V  LM GG +   I    +    E   +  A ++  G++ L+   + YRDL  + I
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
           LLD HG++ + D+G+       G+  +       ++APE++  +  + S  W    ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALG 372
Query: 526 MVIWEMVTGEAAY 538
            +++EM+ G++ +
Sbjct: 373 CLLYEMIAGQSPF 385

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 431
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 549 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 597
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 31  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 91  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 514
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI---- 205
Query: 515 ETWMSNVYSFGMVIWEMVTGEAA 537
            T  S++YSFG+V+ E++TG  A
Sbjct: 206 -TPKSDIYSFGVVLLEIITGLPA 227

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 503
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 503
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 503
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 503
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V + ++G ++ D++     +  K  I +  D  + + F + +G+ +RD+    I++   
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 169
Query: 471 GNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
             V + D GI  A    G +   T       ++L+PE   GD    S    S+VYS G V
Sbjct: 170 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCV 225
Query: 528 IWEMVTGEAAYAACSPVQAAVGIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSK 581
           ++E++TGE  +   SPV     +A   +R + IP           L ++++K    +P  
Sbjct: 226 LYEVLTGEPPFTGDSPVS----VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 281
Query: 582 RPQF-SEIISLLLRTNN 597
           R Q  +E+ + L+R +N
Sbjct: 282 RYQTAAEMRADLVRVHN 298

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 66/303 (21%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
           L+ DNL+ ++ IG   +  VYKG    + V ++     ++ N   F   K++  +    H
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEH 66
Query: 393 KNILQFYC----VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII---RIAIDVAE 445
            NI +F      V  D      +V +    GS    + K   L T + +   R+A  V  
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 446 GIKFLN------DH---GVAYRDLNSQRILLDRHGNVCLGDMGI---VTACKSV--GE-- 489
           G+ +L+      DH    +++RDLNS+ +L+   G   + D G+   +T  + V  GE  
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 490 -ATEYETDGYRWLAPEIIAG-----DPESVSETWMSNVYSFGMVIWE-------MVTGEA 536
            A   E    R++APE++ G     D ES  +    ++Y+ G++ WE       +  GE+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ--VDMYALGLIYWEIFMRCTDLFPGES 240
Query: 537 AYAACSPVQAAVG-----------IAACGLRPEIPKD------CPQILKSLMIKCWNNSP 579
                   Q  VG           ++    RP+ P+         + LK  +  CW+   
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 580 SKR 582
             R
Sbjct: 301 EAR 303

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ + + ++++    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 503
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ + + ++++    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 503
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ + + ++++    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 503
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + M GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 111/264 (42%), Gaps = 17/264 (6%)
Query: 348 IGPNSFKGVYKGKRV--GIE-KLKGCDKGNAYEF----ELRKDLLELMTCGHKNILQFYC 400
           +G  SF GVY+ + +  G+E  +K  DK   Y+      ++ ++       H +IL+ Y 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 401 VCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
              D N+ + +V ++   G +N   LK+R       E       +  G+ +L+ HG+ +R
Sbjct: 79  YFEDSNY-VYLVLEMCHNGEMNR-YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWM 518
           DL    +LL R+ N+ + D G+ T  K   E          +++PEI       +     
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE---- 192
Query: 519 SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS 578
           S+V+S G + + ++ G   +   +       +       E+P       K L+ +    +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIHQLLRRN 250
Query: 579 PSKRPQFSEIISLLLRTNNISNSS 602
           P+ R   S ++     + N S  S
Sbjct: 251 PADRLSLSSVLDHPFMSRNSSTKS 274

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLE 386
           +S   + ++++G  ++  VYKG           K V ++  +G       E  L K+L  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-- 60
Query: 387 LMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRI 439
                H+NI++ Y V   EN    V       + K M+  +V +     R L+   +   
Sbjct: 61  ----KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYF 113
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
              + +G+ F +++ + +RDL  Q +L+++ G + LGD G+  A          E     
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 500 WLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYAACS 542
           + AP+++ G     S T+ +  +++S G ++ EM+TG+  +   +
Sbjct: 174 YRAPDVLMG-----SRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 21/236 (8%)
Query: 375 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 431
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SP     
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS--- 226
Query: 549 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 597
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + M GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 336 LLNSDNLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
           ++++ +  FI ++G   F      +G++ G    ++++   ++ +  E +   D+  L  
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 84
Query: 390 CGHKNILQFYCVCVDEN---HGLCVVTKLMEGGS----VNDLILKSRKLQTKEIIRIAID 442
             H NIL+    C+ E    H   ++    + G+    +  L  K   L   +I+ + + 
Sbjct: 85  --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT-ACKSV----------GEAT 491
           +  G++ ++  G A+RDL    ILL   G   L D+G +  AC  V            A 
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
           +  T  YR  APE+ +     V +   ++V+S G V++ M+ GE  Y        +V +A
Sbjct: 203 QRCTISYR--APELFSVQSHCVIDE-RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 552 ACGLR--PEIPKDCP---QILKSLMIKCWNNSPSKRPQFSEIISLL 592
                  P+ P+      Q+L S+M       P +RP    ++S L
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMM----TVDPHQRPHIPLLLSQL 301

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEII 589
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEII 589
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEII 589
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 23/268 (8%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 392
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 393 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 448 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGYRWL 501
           K  +      H V +RDL    + LD   NV LGD G+        + A E+    Y ++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY-YM 183
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           +PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP 
Sbjct: 184 SPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPY 238
Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEII 589
                L  ++ +  N     RP   EI+
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 14/252 (5%)
Query: 345 IDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQ 397
           + +IG  SF  VY  + V       I+K+    K +  +++ + K++  L    H N +Q
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
            Y  C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +
Sbjct: 119 -YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 517
           RD+ +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGK 233
Query: 518 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 577
           + +V+S G+   E+   +      + + A   IA             +  ++ +  C   
Sbjct: 234 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 578 SPSKRPQFSEII 589
            P  RP  SE++
Sbjct: 293 IPQDRPT-SEVL 303

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V +  +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEII 589
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 14/252 (5%)
Query: 345 IDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQ 397
           + +IG  SF  VY  + V       I+K+    K +  +++ + K++  L    H N +Q
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
            Y  C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +
Sbjct: 80  -YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 517
           RD+ +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGK 194
Query: 518 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 577
           + +V+S G+   E+   +      + + A   IA             +  ++ +  C   
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 578 SPSKRPQFSEII 589
            P  RP  SE++
Sbjct: 254 IPQDRPT-SEVL 264

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 116/264 (43%), Gaps = 30/264 (11%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKD---LLELMTCGH---- 392
           +N E +  +G  ++     GK   + K+ G D G  Y  ++ K    + +  T  H    
Sbjct: 54  ENFELLKVLGTGAY-----GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 393 KNILQFY---CVCVDENHGLCVVTKL------MEGGSVNDLILKSRKLQTKEIIRIAIDV 443
           + +L+        V  ++     TKL      + GG +   + +  +    E+     ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---GYRW 500
              ++ L+  G+ YRD+  + ILLD +G+V L D G+  + + V + TE   D      +
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYDFCGTIEY 226
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PE 558
           +AP+I+ G      +    + +S G++++E++TG + +       +   I+   L+  P 
Sbjct: 227 MAPDIVRGGDSGHDKA--VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 559 IPKDCPQILKSLMIKCWNNSPSKR 582
            P++   + K L+ +     P KR
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V +  +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEII 589
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 117/264 (44%), Gaps = 23/264 (8%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 6   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 65
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 66  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + + E          +++PE + G  
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDEMANEFVGTRSYMSPERLQGTH 182
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
            SV     S+++S G+ + EM  G       +  +    I       E P   P  + SL
Sbjct: 183 YSVQ----SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVN-----EPPPKLPSAVFSL 233
Query: 571 MI-----KCWNNSPSKRPQFSEII 589
                  KC   +P++R    +++
Sbjct: 234 EFQDFVNKCLIKNPAERADLKQLM 257

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKD 383
           L++ +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEI 436
           L       H NI++   V   EN    V       + K M+  ++  + L   K    ++
Sbjct: 63  L------NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
           +       +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E  
Sbjct: 117 L-------QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
              + APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 TLWYRAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 23/305 (7%)
Query: 309 PLPSSSFVVSVDEWQTVQSGGEEIGR-WLLNSDNLEFIDQIGPNSFKGVYKGKRVG---I 364
           PLPS+      +E  + Q   E   R W L  ++ E    +G   F  VY  +      I
Sbjct: 4   PLPSAPENNPEEELASKQKNEESKKRQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 365 EKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
             LK   K        E +LR+++       H NIL+ Y    D    + ++ +    G+
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGT 120
Query: 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
           V   + K  K   +       ++A  + + +   V +RD+  + +LL   G + + D G 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 481 VTACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                S    T   T  Y  L PE+I G    E V      +++S G++ +E + G+  +
Sbjct: 181 SVHAPSSRRTTLCGTLDY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPF 232
Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI 598
            A +  +    I+        P    +  + L+ +   ++PS+RP   E++     T N 
Sbjct: 233 EANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 290
Query: 599 SNSSN 603
           S  SN
Sbjct: 291 SKPSN 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 79/160 (49%), Gaps = 5/160 (3%)
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 438
           ++++++  L    H +I++ Y V +       +V + + GG + D I K  +++  E  R
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
           +   +   + + + H V +RDL  + +LLD H N  + D G+ +   S GE         
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRTSCGSP 174
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
            + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 175 NYAAPEVISGRLYAGPEV---DIWSCGVILYALLCGTLPF 211

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGXKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 66
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 67  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 120
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 121 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 177 RAPEILLGXKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 119/263 (45%), Gaps = 17/263 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 22  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 81
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 82  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 198
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---PEIPKDCPQI- 566
            SV     S+++S G+ + EM  G     + S   A   +    +    P++P     + 
Sbjct: 199 YSVQ----SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLE 254
Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
            +  + KC   +P++R    +++
Sbjct: 255 FQDFVNKCLIKNPAERADLKQLM 277

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 392
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 393 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 448 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 502
           K  +      H V +RDL    + LD   NV LGD G+           +       +++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP  
Sbjct: 185 PEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYR 239
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEII 589
               L  ++ +  N     RP   EI+
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 6/184 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  V   + GG +   + + R          A ++A  + +L+   + YRDL  + ILLD
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
             G++ L D G+          T        +LAPE++   P   +  W    +  G V+
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW----WCLGAVL 229
Query: 529 WEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
           +EM+ G   + + +  +    I      L+P I      +L+ L+ K        +  F 
Sbjct: 230 YEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289
Query: 587 EIIS 590
           EI S
Sbjct: 290 EIKS 293

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 496
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 156 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 215
Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 556
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 216 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 269
Query: 557 PEIP--KDCPQILKSLMIKCWNNSPSKR 582
            E+P  K   +  K L+ K     PS R
Sbjct: 270 FELPQWKKVSESAKDLIRKMLTYVPSMR 297

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 392
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 393 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 447
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 448 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 502
           K  +      H V +RDL    + LD   NV LGD G+           +       +++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP  
Sbjct: 185 PEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYR 239
Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEII 589
               L  ++ +  N     RP   EI+
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 496
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 155 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 214
Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 556
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 215 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 268
Query: 557 PEIP--KDCPQILKSLMIKCWNNSPSKR 582
            E+P  K   +  K L+ K     PS R
Sbjct: 269 FELPQWKKVSESAKDLIRKMLTYVPSMR 296

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/201 (21%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  G
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 447 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
           I +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +     Y ++AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAP 197
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 561
           E++ G  +   + W     S G++++ +++G   +   +       +       E+P  K
Sbjct: 198 EVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 562 DCPQILKSLMIKCWNNSPSKR 582
              +  K L+ K     PS R
Sbjct: 253 KVSESAKDLIRKMLTYVPSMR 273

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
           ++ G   F  VYKG      V ++KL         E   +  +++     C H+N+++  
Sbjct: 28  NKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
               D +  LC+V      GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 88  GFSSDGD-DLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 514
           +RD+ S  ILLD      + D G+  A +   +            + APE + G+     
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI---- 202
Query: 515 ETWMSNVYSFGMVIWEMVTGEAA 537
            T  S++YSFG+V+ E++TG  A
Sbjct: 203 -TPKSDIYSFGVVLLEIITGLPA 224

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 137
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 496
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 138 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 197
Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 556
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 198 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 251
Query: 557 PEIP--KDCPQILKSLMIKCWNNSPSKR 582
            E+P  K   +  K L+ K     PS R
Sbjct: 252 FELPQWKKVSESAKDLIRKMLTYVPSMR 279

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 65  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 124
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 125 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 241
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 242 YSVQ----SDIWSMGLSLVEMAVG 261

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 79/160 (49%), Gaps = 5/160 (3%)
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 438
           ++++++  L    H +I++ Y V +       +V + + GG + D I K  +++  E  R
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
           +   +   + + + H V +RDL  + +LLD H N  + D G+ +   S GE         
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRDSCGSP 174
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
            + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 175 NYAAPEVISGRLYAGPEV---DIWSCGVILYALLCGTLPF 211

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 110/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 105
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 165
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V  AT      
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGATWTLCGT 222
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 223 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 279 PSHFSSDLKDLLRNLL 294

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 97  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 215
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 216 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 269
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 270 SLIQKMLQTDPTARPTINELLN 291

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 95  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 154 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 213
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 214 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 267
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 268 SLIQKMLQTDPTARPTINELLN 289

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 73  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 192 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 245
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 246 SLIQKMLQTDPTARPTINELLN 267

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 71  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 190 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 243
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 113/263 (42%), Gaps = 21/263 (7%)
Query: 337 LNSDNLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           L+  N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +   
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVL 63
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
            H NI++ + V ++    L +V +   GG V D ++    ++ KE       +   +++ 
Sbjct: 64  NHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           +   + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G  
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQI 566
               E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +
Sbjct: 182 YDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENL 236
Query: 567 LKSLMIKCWNNSPSKRPQFSEII 589
           LK  +I     +PSKR    +I+
Sbjct: 237 LKKFLIL----NPSKRGTLEQIM 255

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 77  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 136 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 195
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 196 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 249
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 250 SLIQKMLQTDPTARPTINELLN 271

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 170
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 73  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 192 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 245
Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           SL+ K     P+ RP  +E+++
Sbjct: 246 SLIQKMLQTDPTARPTINELLN 267

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 66
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 67  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 120
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 121 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 177 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 215

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 35/226 (15%)
Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLL 385
           + +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L 
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIR 438
                 H NI++   V   EN    V       + K M+  ++  + L   K    +++ 
Sbjct: 61  -----NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL- 114
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
                 +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E    
Sbjct: 115 ------QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            + APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 WYRAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 63
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 64  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 117
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 118 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 173
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 174 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLAGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLXGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 109/258 (42%), Gaps = 21/258 (8%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++       H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ + V ++    L +V +   GG V D ++   + + KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 570
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYXSTDCENLLKKF 247
Query: 571 MIKCWNNSPSKRPQFSEI 588
           +I     +PSKR    +I
Sbjct: 248 LIL----NPSKRGTLEQI 261

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 90  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 206
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 207 YSVQ----SDIWSMGLSLVEMAVG 226

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V + K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V + K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 62  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 230
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 231 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 287 KDLLRNLL 294

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 34  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 202
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 203 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 259 KDLLRNLL 266

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 34  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 202
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 203 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 259 KDLLRNLL 266

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 27  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 139 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEYLAPEI 195
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 196 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 251
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 252 KDLLRNLL 259

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI+    V  D+   + VVT+LM+GG + D IL+ +    +E   +   + + +++L+
Sbjct: 75  HPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 452 DHGVAYRDLNSQRIL-LDRHGN---VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
             GV +RDL    IL +D  GN   + + D G     ++             ++APE++ 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL- 192
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 539
              E        +++S G++++ M+TG   +A
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 28  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 85
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 145
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 202
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 203 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 259 PSHFSSDLKDLLRNLL 274

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/201 (21%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI + Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  G
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 447 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
           I + + + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +     Y ++AP
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAY-YIAP 197
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 561
           E++ G  +   + W     S G++++ +++G   +   +       +       E+P  K
Sbjct: 198 EVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 562 DCPQILKSLMIKCWNNSPSKR 582
              +  K L+ K     PS R
Sbjct: 253 KVSESAKDLIRKXLTYVPSXR 273

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 527
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 528 IWEMVTGEAAY 538
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 266 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 325
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 527
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 326 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 379
Query: 528 IWEMVTGEAAY 538
           +++++ G + +
Sbjct: 380 LFKLLRGHSPF 390

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 527
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 528 IWEMVTGEAAY 538
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 527
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 528 IWEMVTGEAAY 538
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 105
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 165
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 222
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 223 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 279 PSHFSSDLKDLLRNLL 294

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 22  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 79
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 80  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 139
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 140 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 196
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 197 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 252
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 253 PSHFSSDLKDLLRNLL 268

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 94/200 (47%), Gaps = 29/200 (14%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC---VCVDENHGL 409
           ++G++ G+ V ++     D+ + +      ++   +   H NIL F        + +  L
Sbjct: 25  WRGLWHGESVAVKIFSSRDEQSWFR---ETEIYNTVLLRHDNILGFIASDMTSRNSSTQL 81
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 461
            ++T   E GS+ D  L+ + L+    +R+A+  A G+  L+           +A+RD  
Sbjct: 82  WLITHYHEHGSLYDF-LQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFK 140
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-------YRWLAPEIIAGDPES-- 512
           S+ +L+  +   C+ D+G+        + ++Y   G        R++APE++     +  
Sbjct: 141 SRNVLVKSNLQCCIADLGLAVMH---SQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDC 197
Query: 513 -VSETWMSNVYSFGMVIWEM 531
             S  W +++++FG+V+WE+
Sbjct: 198 FESYKW-TDIWAFGLVLWEI 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 127
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 128 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 187
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 188 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 239
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 240 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 211

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G+    K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGL---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G+    K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGL---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTL 171
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 172 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 224 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 23/305 (7%)
Query: 309 PLPSSSFVVSVDEWQTVQSGGEEIGR-WLLNSDNLEFIDQIGPNSFKGVYKGKRVG---I 364
           PLPS+      +E  + Q   E   R W L  ++ E    +G   F  VY  +      I
Sbjct: 4   PLPSAPENNPEEELASKQKNEESKKRQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 365 EKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
             LK   K        E +LR+++       H NIL+ Y    D    + ++ +    G+
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGT 120
Query: 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
           V   + K  K   +       ++A  + + +   V +RD+  + +LL   G + + D G 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 481 VTACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                S        T  Y  L PE+I G    E V      +++S G++ +E + G+  +
Sbjct: 181 SVHAPSSRRDDLCGTLDY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPF 232
Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI 598
            A +  +    I+        P    +  + L+ +   ++PS+RP   E++     T N 
Sbjct: 233 EANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 290
Query: 599 SNSSN 603
           S  SN
Sbjct: 291 SKPSN 295

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDLLE 386
           + +++L F + +G  +F  ++KG R  +            LK  DK +    E   +   
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 387 LMT-CGHKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 442
           +M+   HK+++  Y  CVC DEN    +V + ++ GS++  + K++  +     + +A  
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDEN---ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 499
           +A  + FL ++ + + ++ ++ ILL R  +   G+   +         T    D  +   
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 500 -WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
            W+ PE I  +P++++    ++ +SFG  +WE+ +G       S + +   +     R +
Sbjct: 182 PWVPPECIE-NPKNLN--LATDKWSFGTTLWEICSG--GDKPLSALDSQRKLQFYEDRHQ 236
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           +P      L +L+  C +  P  RP F  II
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 14  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 71
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 72  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 131
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D  G + + D G     K V   T      
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGF---AKRVKGRTWXLCGT 188
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 189 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 244
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 245 PSHFSSDLKDLLRNLL 260

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 44/253 (17%)
Query: 312 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG----------KR 361
           SSS++V  + ++      EE       ++N +    IG   F  VYKG          KR
Sbjct: 17  SSSYLVPFESYRVPLVDLEEA------TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
              E  +G ++       L         C H +++     C DE + + ++ K ME G++
Sbjct: 71  RTPESSQGIEEFETEIETLS-------FCRHPHLVSLIGFC-DERNEMILIYKYMENGNL 122
Query: 422 NDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
              +    L +  +  ++ + I I  A G+ +L+   + +RD+ S  ILLD +    + D
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
Query: 478 MGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWE 530
            GI      +G+         T GY          DPE   +   T  S+VYSFG+V++E
Sbjct: 183 FGISKKGTELGQTHLXXVVKGTLGYI---------DPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 531 MVTGEAAYAACSP 543
           ++   +A     P
Sbjct: 234 VLCARSAIVQSLP 246

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCG 391
           N   +  IG  +F      + +  G+ V I   K  DK       L+K   E   +    
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAI---KIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++ + V ++    L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 70  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
              + +RDL ++ +LLD   N+ + D G      +VG   +       + APE+  G   
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQIL 567
              E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +L
Sbjct: 188 DGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLL 242
Query: 568 KSLMIKCWNNSPSKRPQFSEII 589
           K  ++     +P KR    +I+
Sbjct: 243 KRFLVL----NPIKRGTLEQIM 260

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 341 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCG 391
           N   +  IG  +F      + +  G+ V I   K  DK       L+K   E   +    
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAI---KIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++ + V ++    L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 73  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
              + +RDL ++ +LLD   N+ + D G      +VG   +       + APE+  G   
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQIL 567
              E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +L
Sbjct: 191 DGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLL 245
Query: 568 KSLMIKCWNNSPSKRPQFSEII 589
           K  ++     +P KR    +I+
Sbjct: 246 KRFLVL----NPIKRGTLEQIM 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +++D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIIISKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
           +++  +  L+  G+ YRDL  + I+L+  G+V L D G+       G  T        ++
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEI 559
           APEI+     + +  W    +S G ++++M+TG   +   +  +    I  C L   P +
Sbjct: 189 APEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 560 PKDCPQILKSLM 571
            ++   +LK L+
Sbjct: 245 TQEARDLLKKLL 256

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
           +++  +  L+  G+ YRDL  + I+L+  G+V L D G+       G  T        ++
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEI 559
           APEI+     + +  W    +S G ++++M+TG   +   +  +    I  C L   P +
Sbjct: 189 APEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 560 PKDCPQILKSLM 571
            ++   +LK L+
Sbjct: 245 TQEARDLLKKLL 256

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 394 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 388 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 209

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAPEII     + +  W    ++ G++I++M  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 393
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 394 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 563
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 564 PQILKSLM 571
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 29/253 (11%)
Query: 319 VDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIE----KLKGCDK 372
           ++E +T   G    GR+L      +F  +IG  SFK VYKG      +E    +L+    
Sbjct: 11  IEELETKAVGXSNDGRFL------KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 373 GNAYEFELRKDLLELMTCGHKNILQFYCV---CVDENHGLCVVTKLMEGGSVNDLILKSR 429
             +     +++   L    H NI++FY      V     + +VT+L   G++   + + +
Sbjct: 65  TKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK 124
Query: 430 KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKS 486
             + K +      + +G++FL+     + +RDL    I +    G+V +GD+G+ T  ++
Sbjct: 125 VXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYAACSPV 544
                   T       PE  A  PE   E +    +VY+FG    E  T E  Y+ C   
Sbjct: 185 SFAKAVIGT-------PEFXA--PEXYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNA 235
Query: 545 QAAVGIAACGLRP 557
                    G++P
Sbjct: 236 AQIYRRVTSGVKP 248

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 9/227 (3%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 556
            Y  L PE I G           +++S G++ +E + G+  + A +  +    I+     
Sbjct: 176 DY--LPPEXIEGRXHDEK----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF- 228
Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
              P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 229 -TFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V K +      +   KL   +   A   ++ ++L  L  C 
Sbjct: 13  LKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 72
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              I+ FY     +   + +  + M+GGS++ ++ +++++  + + +++I V  G+ +L 
Sbjct: 73  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           + H + +RD+    IL++  G + L D G+  + + +            ++APE + G  
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMAPERLQGTH 189
Query: 511 ESVSETWMSNVYSFGMVIWEMVTG 534
            SV     S+++S G+ + E+  G
Sbjct: 190 YSVQ----SDIWSMGLSLVELAVG 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTL 175
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R 
Sbjct: 60  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARRF 117
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
              +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +       
Sbjct: 118 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSPN 176
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 177 YAAPEVISGKLYAGPEV---DVWSCGVILYVML 206

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 41/264 (15%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K           G
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----------G 193
Query: 498 YRW--------LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
             W        LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    
Sbjct: 194 RTWXLCGTPEALAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 550 IAACGLR--PEIPKDCPQILKSLM 571
           I +  +R       D   +L++L+
Sbjct: 250 IVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL 171
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 172 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 224 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R 
Sbjct: 61  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARRF 118
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
              +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +       
Sbjct: 119 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSPN 177
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 178 YAAPEVISGKLYAGPEV---DVWSCGVILYVML 207

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 364 IEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVN 422
           IEK  G  +   +     +++  L  C G+KNIL+      D+     V  KL +GGS+ 
Sbjct: 46  IEKQAGHSRSRVF-----REVETLYQCQGNKNILELIEFFEDDTRFYLVFEKL-QGGSIL 99
Query: 423 DLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV-----CLGD 477
             I K +    +E  R+  DVA  + FL+  G+A+RDL  + IL +    V     C  D
Sbjct: 100 AHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFD 159
Query: 478 MG----IVTACKSVGEATEYETDG-YRWLAPEII-AGDPESVSETWMSNVYSFGMVIWEM 531
           +G    +  +C  +         G   ++APE++     ++       +++S G+V++ M
Sbjct: 160 LGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIM 219
Query: 532 VTGEAAYAA 540
           ++G   +  
Sbjct: 220 LSGYPPFVG 228

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 345 IDQIGPNSFKGVYK-----GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTCGHK 393
           ++++G  ++  VYK     G+ V +++++      G       E  L K+L       H 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL------HHP 79
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+    V   E   L +V + ME      L      LQ  +I      +  G+   + H
Sbjct: 80  NIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
            + +RDL  Q +L++  G + L D G+  A      +  +E     + AP+++ G  +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
           +     +++S G +  EM+TG+  +   +       I +    P  P++ PQ+
Sbjct: 199 TSV---DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQV 247

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R 
Sbjct: 51  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARRF 108
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
              +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +       
Sbjct: 109 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSPN 167
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 168 YAAPEVISGKLYAGPEV---DVWSCGVILYVML 197

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 9/169 (5%)
Query: 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           +N  L +V +   GG +   + +  +         A  +    ++L+   + YRDL  + 
Sbjct: 113 DNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 524
           +L+D+ G + + D G     K V   T        +LAPEII     + +  W    ++ 
Sbjct: 173 LLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW----WAL 225
Query: 525 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLM 571
           G++I+EM  G   + A  P+Q    I +  +R       D   +L++L+
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R 
Sbjct: 55  IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARRF 112
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
              +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +       
Sbjct: 113 FQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSPN 171
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 172 YAAPEVISGKLYAGPEV---DVWSCGVILYVML 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 26/163 (15%)
Query: 392 HKNILQFYCVCVDENHG------LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
           H+N+LQF      E  G      L ++T   + GS+ D  LK   +   E+  +A  ++ 
Sbjct: 68  HENLLQFIAA---EKRGSNLEVELWLITAFHDKGSLTDY-LKGNIITWNELCHVAETMSR 123
Query: 446 GIKFLNDH-----------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEAT 491
           G+ +L++             +A+RD  S+ +LL       L D G+       K  G+ T
Sbjct: 124 GLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD-T 182
Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMS-NVYSFGMVIWEMVT 533
             +    R++APE++ G      + ++  ++Y+ G+V+WE+V+
Sbjct: 183 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 345 IDQIGPNSFKGVYK-----GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTCGHK 393
           ++++G  ++  VYK     G+ V +++++      G       E  L K+L       H 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL------HHP 79
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+    V   E   L +V + ME      L      LQ  +I      +  G+   + H
Sbjct: 80  NIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
            + +RDL  Q +L++  G + L D G+  A      +  +E     + AP+++ G  +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
           +     +++S G +  EM+TG+  +   +       I +    P  P++ PQ+
Sbjct: 199 TSV---DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQV 247

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 25/256 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 389
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 390 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +LAP II     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPAIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 557 -PEIPKDCPQILKSLM 571
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 166
Query: 497 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 221 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 170
Query: 497 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 224
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 25/219 (11%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 387
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAE 445
               H NI++   V   EN    V   L +   + D +  S    +    I      + +
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQ--DLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
           G+ F + H V +RDL  + +L++  G + L D G+  A         +E     + APEI
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
           + G     +     +++S G +  EMVT  A +   S +
Sbjct: 175 LLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 165
Query: 497 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 220 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 312 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG----------KR 361
           SSS++V  + ++      EE       ++N +    IG   F  VYKG          KR
Sbjct: 17  SSSYLVPFESYRVPLVDLEEA------TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
              E  +G ++       L         C H +++     C DE + + ++ K ME G++
Sbjct: 71  RTPESSQGIEEFETEIETLS-------FCRHPHLVSLIGFC-DERNEMILIYKYMENGNL 122
Query: 422 NDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
              +    L +  +  ++ + I I  A G+ +L+   + +RD+ S  ILLD +    + D
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
Query: 478 MGIVTACKSVGEATEYETDGYRWLAPEIIAG-DPESVSE---TWMSNVYSFGMVIWEMVT 533
            GI        + TE +      +    +   DPE   +   T  S+VYSFG+V++E++ 
Sbjct: 183 FGISK------KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 534 GEAAYAACSP 543
             +A     P
Sbjct: 237 ARSAIVQSLP 246

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 394
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 455 VAYRDLNSQRIL---LDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 501
           + +RDL  + +L   LD    + + D G          + TAC + G           ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG-----------YV 185
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           APE++A  P S +     + +S G++ + ++ G   +
Sbjct: 186 APEVLAQKPYSKA----VDCWSIGVIAYILLCGYPPF 218

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + + G      S    T   T 
Sbjct: 113 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 172
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 173 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 165
Query: 497 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 220 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+KS+KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+   C+     T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL---CRH----TDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 394
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 455 VAYRDLNSQRIL---LDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 501
           + +RDL  + +L   LD    + + D G          + TAC + G           ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG-----------YV 185
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APE++A  P S +     + +S G++ + ++ G
Sbjct: 186 APEVLAQKPYSKA----VDCWSIGVIAYILLCG 214

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/271 (21%), Positives = 122/271 (45%), Gaps = 26/271 (9%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDLLE 386
           + +++L F + +G  +F  ++KG R  +            LK  DK +    E   +   
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 387 LMT-CGHKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 442
           +M+   HK+++  Y  C C DEN    +V + ++ GS++  + K++  +     + +A  
Sbjct: 65  MMSKLSHKHLVLNYGVCFCGDEN---ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 499
           +A  + FL ++ + + ++ ++ ILL R  +   G+   +         T    D  +   
Sbjct: 122 LAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 500 -WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
            W+ PE I  +P++++    ++ +SFG  +WE+ +G       S + +   +     R +
Sbjct: 182 PWVPPECIE-NPKNLNLA--TDKWSFGTTLWEICSG--GDKPLSALDSQRKLQFYEDRHQ 236
Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           +P      L +L+  C +  P  RP F  II
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 113 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 172
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 173 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 394
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 455 VAYRDLNSQRIL---LDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 501
           + +RDL  + +L   LD    + + D G          + TAC + G           ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG-----------YV 185
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APE++A  P S +     + +S G++ + ++ G
Sbjct: 186 APEVLAQKPYSKA----VDCWSIGVIAYILLCG 214

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH+N+L+      +E+    V  K M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEK-MRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 451 NDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETD-------GYRW 500
           ++ G+A+RDL  + IL +    V    + D G+ +  K  G+ +   T           +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 501 LAPEIIAGDPESVS-ETWMSNVYSFGMVIWEMVTGEAAYAA 540
           +APE++    E  S      +++S G++++ +++G   +  
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + + G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 78/167 (46%), Gaps = 6/167 (3%)
Query: 372 KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL 431
           K +     + +++  L    H +I++ Y V       + V+     GG + D I++ +++
Sbjct: 48  KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE--YAGGELFDYIVEKKRM 105
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
              E  R    +   I++ + H + +RDL  + +LLD + NV + D G+ +   + G   
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL-SNIMTDGNFL 164
Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +       + APE+I G   +  E    +V+S G+V++ M+ G   +
Sbjct: 165 KTSCGSPNYAAPEVINGKLYAGPEV---DVWSCGIVLYVMLVGRLPF 208

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 394
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 455 VAYRDLNSQRIL---LDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 501
           + +RDL  + +L   LD    + + D G          + TAC + G           ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG-----------YV 185
Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APE++A  P S +     + +S G++ + ++ G
Sbjct: 186 APEVLAQKPYSKA----VDCWSIGVIAYILLCG 214

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 51  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 109
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 110 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 169
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 170 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 221
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 222 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 438 RIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
           +I +   + +  L ++  + +RD+    ILLDR GN+ L D GI  + + V    +    
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKTRDA 186
Query: 497 GYR-WLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
           G R ++APE I  DP +  + +   S+V+S G+ ++E+ TG   Y   + V   +     
Sbjct: 187 GCRPYMAPERI--DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 554 GLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEII 589
           G  P++         P  +  + + C     SKRP++ E++
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNL-CLTKDESKRPKYKELL 284

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 114
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 175 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 226
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 227 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 85  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 144
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 145 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 200
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 201 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 22/265 (8%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGN----AYEFELRKDLLE 386
           +W L  ++ E    +G   F  VY  +   R  I  LK   K        E +LR+++  
Sbjct: 1   QWAL--EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI 58
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
                H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  
Sbjct: 59  QSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           + + +   V +RD+  + +LL   G + + D G      S    T   T  Y  L PE+I
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY--LPPEMI 175
Query: 507 AG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
            G    E V      +++S G++ +E + G+  + A +  +    I+        P    
Sbjct: 176 EGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVT 227
Query: 565 QILKSLMIKCWNNSPSKRPQFSEII 589
           +  + L+ +   ++PS+RP   E++
Sbjct: 228 EGARDLISRLLKHNPSQRPMLREVL 252

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/160 (21%), Positives = 76/160 (47%), Gaps = 5/160 (3%)
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 438
           +L +++  +    H NI++ + V ++    L +V +   GG V D ++   +++ KE   
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498
               +   +++ +   + +RDL ++ +LLD   N+ + D G      +VG   +      
Sbjct: 119 KFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNKLDTFCGSP 177
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
            + APE+  G      E    +V+S G++++ +V+G   +
Sbjct: 178 PYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPF 214

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 344 FIDQIGPNSFKGVY--KGKRVG-IEKLKGCDKGNAY-EFELRKDLLELMTCGHKNILQFY 399
           F++ +G  +F  V+  K +  G +  LK   K  A+ +  L  ++  L    H+NI+   
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
            +     H   +V +L+ GG + D IL+      K+   +   V   +K+L+++G+ +RD
Sbjct: 73  DIYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 460 LNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 516
           L  + +L    + +  + + D G+    ++   +T   T GY  +APE++A  P S +  
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY--VAPEVLAQKPYSKA-- 187
Query: 517 WMSNVYSFGMVIWEMVTGEAAY 538
              + +S G++ + ++ G   +
Sbjct: 188 --VDCWSIGVITYILLCGYPPF 207

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 83  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 142
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 143 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 198
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 199 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI+    V  D+   + VVT+L +GG + D IL+ +    +E   +   + + +++L+
Sbjct: 75  HPNIITLKDV-YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 452 DHGVAYRDLNSQRIL-LDRHGN---VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
             GV +RDL    IL +D  GN   + + D G     ++             ++APE++ 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL- 192
Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 539
              E        +++S G++++  +TG   +A
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTXLTGYTPFA 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 7/157 (4%)
Query: 438 RIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
           ++ + + + + +L + HGV +RD+    ILLD  G + L D GI  + + V +  +  + 
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSA 185
Query: 497 G-YRWLAPEII-AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
           G   ++APE I   DP        ++V+S G+ + E+ TG+  Y  C      +      
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 555 LRPEIPKDC--PQILKSLMIKCWNNSPSKRPQFSEII 589
             P +P         +S +  C      KRP++++++
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 111 ATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +       I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/276 (18%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM---TCGHKNI 395
           + + E I  +G  +F  V K +     +     K    E +L   L E+M   +  H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 396 LQFYC------------VCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAI 441
           +++Y               V +   L +  +  E G++ DLI  S  L  Q  E  R+  
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFR 123
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--- 498
            + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++      
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 499 -----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 547
                       ++A E++ G      +    ++YS G++ +EM+   +       +   
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 583
           +   +    P+   +  ++ K ++    ++ P+KRP
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/232 (18%), Positives = 106/232 (45%), Gaps = 13/232 (5%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   +L    +G + E E+ +++  L    H NI+  + +  ++   + ++ +L+
Sbjct: 40  YAAKFIKKRRLSSSRRGVSRE-EIEREVNILREIRHPNIITLHDIFENKT-DVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDR---HGN 472
            GG + D + +   L   E  +    + +G+ +L+   +A+ DL  + I LLD+   +  
Sbjct: 98  SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 157
Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + L D GI    ++ G   +       ++APEI+  +P  +     ++++S G++ + ++
Sbjct: 158 IKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYILL 212
Query: 533 TGEAAYAACSPVQAAVGIAACG--LRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +G + +   +  +    I+A       E   +  ++ K  + +     P +R
Sbjct: 213 SGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 91/215 (42%), Gaps = 13/215 (6%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                P    +  + L+ +   ++PS+RP   E++
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 427 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKXLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIK 448
           ++Q +C   D+ + L +V + M GG + +L+       K  K  T E++ +A+D    + 
Sbjct: 137 VVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDAIHSM- 193
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEI 505
                G+ +RD+    +LLD+HG++ L D G        G     T   T  Y  ++PE+
Sbjct: 194 -----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY--ISPEV 246
Query: 506 I---AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
           +    GD     E    + +S G+ ++EM+ G+  + A S V
Sbjct: 247 LKSQGGDGYYGREC---DWWSVGVFLFEMLVGDTPFYADSLV 285

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSF--------KGV---YKGKRVGIEKLKGCDKG 373
           V  G E +    +  D+ E  +++G   F        KG    Y  K +   +L    +G
Sbjct: 11  VDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 374 NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT 433
            + E E+ +++  L    H NI+  + +  ++   + ++ +L+ GG + D + +   L  
Sbjct: 71  VSRE-EIEREVNILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTE 128
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDR---HGNVCLGDMGIVTACKSVGE 489
            E  +    + +G+ +L+   +A+ DL  + I LLD+   +  + L D GI    ++  E
Sbjct: 129 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 490 ATE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
               + T    ++APEI+  +P  +     ++++S G++ + +++G + +   +  +   
Sbjct: 189 FKNIFGTP--EFVAPEIVNYEPLGLE----ADMWSIGVITYILLSGASPFLGETKQETLT 242
Query: 549 GIAACG--LRPEIPKDCPQILKSLMIKCWNNSPSKR 582
            I+A       E   +  ++ K  + +     P +R
Sbjct: 243 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 278

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 427 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKTLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 24/198 (12%)
Query: 343 EFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLE---LMTCGHK 393
           E +D +G   F  VYK +       V I+K+K   +  A +   R  L E   L    H 
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLN 451
           NI+            + +V   ME     ++I+K  S  L    I    +   +G+++L+
Sbjct: 73  NIIGL-LDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
            H + +RDL    +LLD +G + L D G+  +  S   A  ++     + APE++ G   
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG--- 186
Query: 512 SVSETWMSNVYSFGMVIW 529
                  + +Y  G+ +W
Sbjct: 187 -------ARMYGVGVDMW 197

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/260 (19%), Positives = 116/260 (44%), Gaps = 24/260 (9%)
Query: 340 DNLEFIDQIGPNSF--------KGV---YKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 388
           D+ E  +++G   F        KG    Y  K +   +L    +G + E E+ +++  L 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-EIEREVNILR 63
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H NI+  + +  ++   + ++ +L+ GG + D + +   L   E  +    + +G+ 
Sbjct: 64  EIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 449 FLNDHGVAYRDLNSQRI-LLDR---HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           +L+   +A+ DL  + I LLD+   +  + L D GI    ++ G   +       ++APE
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPE 181
Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPKD 562
           I+  +P  +     ++++S G++ + +++G + +   +  +    I+A       E   +
Sbjct: 182 IVNYEPLGLE----ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237
Query: 563 CPQILKSLMIKCWNNSPSKR 582
             ++ K  + +     P +R
Sbjct: 238 TSELAKDFIRRLLVKDPKRR 257

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 427 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 177
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 178 FDGERKKDLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 233
Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 234 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413
           KG Y      IEK         +  E+  ++  L +  H NI++ + V  D+ +   +VT
Sbjct: 76  KGRYSDDNKNIEK---------FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY-FYLVT 125
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-- 471
           +  EGG + + I+   K    +   I   +  GI +L+ H + +RD+  + ILL+     
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185
Query: 472 -NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
            N+ + D G+ +      +  +     Y ++APE++        + W     S G++++ 
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIAPEVLKKKYNEKCDVW-----SCGVIMYI 239
Query: 531 MVTG 534
           ++ G
Sbjct: 240 LLCG 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
           + ++ +   GG +  L L   +  +   ++IR+   + EG+ +L+ + + + DL  Q IL
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163
Query: 467 LDRHGNVCLGDMGIVT--ACKSVGEATEY-ETDGY-RWLAPEIIAGDPESVSETWMSNVY 522
           L       LGD+ IV     + +G A E  E  G   +LAPEI+  DP + +    ++++
Sbjct: 164 LS--SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA----TDMW 217
Query: 523 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIPKDCPQILKSLMIKCWN 576
           + G++ + ++T  + +      +  + I+   +         + +     ++SL++K   
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVK--- 274
Query: 577 NSPSKRP 583
            +P KRP
Sbjct: 275 -NPEKRP 280

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH+N+L+      +E+    V  K M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEK-MRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 451 NDHGVAYRDLNSQRILLDRHGN------VCLGDMGIVTACKSVGEATEYETD-------G 497
           ++ G+A+RDL  + IL + H N      +C  D+G  +  K  G+ +   T         
Sbjct: 128 HNKGIAHRDLKPENILCE-HPNQVSPVKICDFDLG--SGIKLNGDCSPISTPELLTPCGS 184
Query: 498 YRWLAPEIIAGDPESVS-ETWMSNVYSFGMVIWEMVTGEAAYAA 540
             ++APE++    E  S      +++S G++++ +++G   +  
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 166
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 427 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 545
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKDLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 170
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 24/245 (9%)
Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLC 410
           K + K   V I    GC  G  Y+ E   D LE         KN  +    C      L 
Sbjct: 57  KALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKC------LF 110
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAI--DVAEGIKFLNDHGVAYRDLNSQRILLD 468
           +  +  + G++   I K R  +  +++ + +   + +G+ +++   + +RDL    I L 
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV 170
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 528
               V +GD G+VT+ K+ G+ T  +    R+++PE I+    S       ++Y+ G+++
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQIS----SQDYGKEVDLYALGLIL 225
Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLMIKCWNNSPSKRPQFSE 587
            E++        C             LR  I  D   +  K+L+ K  +  P  RP  SE
Sbjct: 226 AELL------HVCDTAFETSKFFT-DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 278
Query: 588 IISLL 592
           I+  L
Sbjct: 279 ILRTL 283

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 170
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 169
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 169
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 117 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 174
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 175 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 219
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 220 GCIMAELLTGRTLFPGTDHI 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 345 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 520 NVYSFGMVIWEMVTGEAAYAACS 542
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVS 205

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 345 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 520 NVYSFGMVIWEMVTGEAAYAACS 542
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVS 205

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 126 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 183
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 184 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 228
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 229 GCIMAELLTGRTLFPGTDHI 248

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 118 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 175
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 176 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 220
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 221 GCIMAELLTGRTLFPGTDHI 240

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 69  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 127
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 507
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 128 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPSYLAPEIIECS 185
Query: 508 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                P    E    +++S G++++ ++ G   +
Sbjct: 186 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 340 DNLEFIDQIGPNSFKGV------YKGKRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCG 391
           D  E I+ IG  ++  V        G++V I+K+      NA++     ++ L EL    
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKRTLRELKILK 109
Query: 392 H---------KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 442
           H         K+IL+   V   E   + VV  LME   ++ +I  S+ L  + +      
Sbjct: 110 HFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETD--GYR 499
           +  G+K+++   V +RDL    +L++ +  + +GD G+    C S  E   + T+    R
Sbjct: 168 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 500 WL-APEIIAGDPESVSE-TWMSNVYSFGMVIWEMVT 533
           W  APE++     S+ E T   +++S G +  EM+ 
Sbjct: 228 WYRAPELML----SLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 345 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 519
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 520 NVYSFGMVIWEMVTGEAAYAACS 542
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVS 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 6/153 (3%)
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
             GH +I+       + +  + +V  LM  G + D + +   L  KE   I   + E + 
Sbjct: 156 VAGHPHIITL-IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIA 507
           FL+ + + +RDL  + ILLD +  + L D G     +   +  E   T GY  LAPEI+ 
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY--LAPEILK 272
Query: 508 GDPESVSETWMSNV--YSFGMVIWEMVTGEAAY 538
              +     +   V  ++ G++++ ++ G   +
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 82  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 507
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLRSVCGTPSYLAPEIIECS 198
Query: 508 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                P    E    +++S G++++ ++ G   +
Sbjct: 199 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 229

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ Y    D+ +   +V ++  GG + D I+  +K    +   I   V  G
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRN-YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 133
Query: 447 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
             +L+ H + +RDL  + +LL+   R   + + D G+    +  G+  E     Y ++AP
Sbjct: 134 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAP 192
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           E++    +   + W     S G++++ ++ G   +   +  Q  +     G     P D 
Sbjct: 193 EVLRKKYDEKCDVW-----SCGVILYILLCGYPPFGGQTD-QEILKRVEKGKFSFDPPDW 246
Query: 564 PQI---LKSLMIKCWNNSPSKR 582
            Q+    K L+       PSKR
Sbjct: 247 TQVSDEAKQLVKLMLTYEPSKR 268

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 82  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 507
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 508 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                P    E    +++S G++++ ++ G   +
Sbjct: 199 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 229

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 169
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 106 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 163
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 164 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 208
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 209 GCIMAELLTGRTLFPGTDHI 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ Y    D+ +   +V ++  GG + D I+  +K    +   I   V  G
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRN-YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 116
Query: 447 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
             +L+ H + +RDL  + +LL+   R   + + D G+    +  G+  E     Y ++AP
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAP 175
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           E++    +   + W     S G++++ ++ G   +   +  Q  +     G     P D 
Sbjct: 176 EVLRKKYDEKCDVW-----SCGVILYILLCGYPPFGGQTD-QEILKRVEKGKFSFDPPDW 229
Query: 564 PQI---LKSLMIKCWNNSPSKR 582
            Q+    K L+       PSKR
Sbjct: 230 TQVSDEAKQLVKLMLTYEPSKR 251

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 172 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 216
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 217 GCIMAELLTGRTLFPGTDHI 236

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 337 LNSDNLEFIDQIGPNSFKGV---YKGKRVGIEKLKGCDKGNAYEF-ELR---KDLLELMT 389
           +N D+ E +  IG  SF  V    K     +  +K  +K    E  E+R   K+L  +  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
             H  ++  +    DE   + +V  L+ GG +   + ++   + + +     ++   + +
Sbjct: 72  LEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIA- 507
           L +  + +RD+    ILLD HG+V + D  I        + T    T  Y  +APE+ + 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY--MAPEMFSS 188
Query: 508 --GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
             G   S +  W    +S G+  +E++ G   Y   S
Sbjct: 189 RKGAGYSFAVDW----WSLGVTAYELLRGRRPYHIRS 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 474 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 527
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 528 IWEMVTGEAAYAACSPV 544
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 474 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 527
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 528 IWEMVTGEAAYAACSPV 544
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 130 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 187
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 188 KILDFGL-------ARHTDDEMXGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 232
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 233 GCIMAELLTGRTLFPGTDHI 252

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 474 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 527
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 528 IWEMVTGEAAYAACSPV 544
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEK----LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +SD  +F+  IG  +F GV +  R  + K    +K  ++G A +  ++++++   +  H 
Sbjct: 18  DSDRYDFVKDIGSGNF-GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI++F  V +   H L ++ +   GG + + I  + +    E       +  G+ + +  
Sbjct: 77  NIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDPES 512
            + +RDL  +  LLD      L       +  SV  +    T G   ++APE++      
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RQ 192
Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAY 538
             +  +++V+S G+ ++ M+ G   +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPF 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 126 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 183
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 184 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 228
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 229 GCIMAELLTGRTLFPGTDHI 248

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 169
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 118 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 175
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 176 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 220
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 221 GCIMAELLTGRTLFPGTDHI 240

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 173
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                P    +  + L+ +   ++PS+RP   E++
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 130 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 187
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 188 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 232
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 233 GCIMAELLTGRTLFPGTDHI 252

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 104 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 161
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 162 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 206
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 207 GCIMAELLTGRTLFPGTDHI 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 104
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 105 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 162
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 163 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 207
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 208 GCIMAELLTGRTLFPGTDHI 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMSNVYSFGMVIW 529
            + D G+          T+ E  GY   RW  APEI+     ++      +++S G ++ 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN---AMHYNQTVDIWSVGCIMA 214
Query: 530 EMVTGEAAYAACSPV 544
           E++TG   +     +
Sbjct: 215 ELLTGRTLFPGTDHI 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 104 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 161
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 162 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 206
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 207 GCIMAELLTGRTLFPGTDHI 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K  KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 525 GMVIWEMVTGEAAY 538
           G ++ E++TG   +
Sbjct: 206 GCIMAELLTGRTLF 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 340 DNLEFIDQIGPNSFKGV------YKGKRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCG 391
           D  E I+ IG  ++  V        G++V I+K+      NA++     ++ L EL    
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKRTLRELKILK 108
Query: 392 H---------KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 442
           H         K+IL+   V   E   + VV  LME   ++ +I  S+ L  + +      
Sbjct: 109 HFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETD--GYR 499
           +  G+K+++   V +RDL    +L++ +  + +GD G+    C S  E   + T+    R
Sbjct: 167 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 500 WL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           W  APE++    E    T   +++S G +  EM+ 
Sbjct: 227 WYRAPELMLSLHEY---TQAIDLWSVGCIFGEMLA 258

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 28/246 (11%)
Query: 345 IDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +D++G  ++  VYKGK            + +E  +G       E  L KDL       H 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 60
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+  + +   E   L +V + ++      L      +    +      +  G+ + +  
Sbjct: 61  NIVTLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAGDP 510
            V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  YR   P+I+ G  
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLWYR--PPDILLGST 176
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           +  ++    +++  G + +EM TG   +   S V+  +      L     +  P IL + 
Sbjct: 177 DYSTQI---DMWGVGCIFYEMATGRPLFPG-STVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 571 MIKCWN 576
             K +N
Sbjct: 233 EFKTYN 238

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDYGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 17/220 (7%)
Query: 337 LNSDNLEFIDQIGPNSFK--GVYKGKRVG-------IEKLKGCDKGNAYEFELRKDLLEL 387
           L  D+ E +  IG  +F    V K K+ G       + K     +G    F   +D+L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-- 115
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 446
           +    + I Q +    DEN+ L +V +   GG +  L+ K  +    E+ R  + ++   
Sbjct: 116 VNGDRRWITQLHFAFQDENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 505
           I  ++  G  +RD+    ILLDR G++ L D G     ++ G        G   +L+PEI
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 506 IAGDPESVSETWMS---NVYSFGMVIWEMVTGEAAYAACS 542
           +                + ++ G+  +EM  G+  + A S
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDAGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/151 (21%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ Y    D+ +   +V +  +GG + D I+   K    +   I   V  G
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
           + +L+ H + +RDL  + +LL   ++   + + D G+    ++  +  E     Y ++AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY-YIAP 207
Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           E++    +   + W     S G++++ ++ G
Sbjct: 208 EVLRKKYDEKCDVW-----SIGVILFILLAG 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/276 (18%), Positives = 109/276 (39%), Gaps = 35/276 (12%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM---TCGHKNI 395
           + + E I  +G  +F  V K +     +     K    E +L   L E+M   +  H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 396 LQFYC------------VCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAI 441
           +++Y               V +   L +  +  E  ++ DLI  S  L  Q  E  R+  
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI-HSENLNQQRDEYWRLFR 123
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--- 498
            + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++      
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 499 -----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 547
                       ++A E++ G      +    ++YS G++ +EM+   +       +   
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 583
           +   +    P+   +  ++ K ++    ++ P+KRP
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDRGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G+++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGVIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G+++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGVIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------- 489
           + I I +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E       
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 490 ----ATEYETDGYR-WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
               AT     G + +++PE I G+  S       +++S G++++E++   +       V
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHK----VDIFSLGLILFELLYSFS--TQMERV 280
Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIK-CWNNSPSKRPQFSEII 589
           +    +          +  PQ  + +M++   + SP++RP+ ++II
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQ--EHMMVQDMLSPSPTERPEATDII 324

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM G  +N+ I+KS+ L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 114 LM-GADLNN-IVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELR 171
Query: 475 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 528
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 172 ILDFGL--ARQADEEMTGYVATRWYR--APEIML--------NWMHYNQTVDIWSVGCIM 219
Query: 529 WEMVTGEAAY 538
            E++ G+A +
Sbjct: 220 AELLQGKALF 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKIC 168
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 534 GEAAY 538
               +
Sbjct: 226 NRPIF 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAAC 553
           +++G + +   +  +    I A 
Sbjct: 211 LLSGASPFLGDTKQETLANITAV 233

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIX 166
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 534 GEAAY 538
               +
Sbjct: 224 NRPIF 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 356 VYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLC 410
           V  G ++ ++KL    +   +     ++L  L    H+N++    V      ++E + + 
Sbjct: 73  VKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY 132
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +VT LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++  
Sbjct: 133 LVTHLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 190
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NV 521
             + + D G+          T+ E  GY   RW  APEI+          WM      ++
Sbjct: 191 CELKILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNMTVDI 235
Query: 522 YSFGMVIWEMVTGEAAYAACSPV 544
           +S G ++ E++TG   +     +
Sbjct: 236 WSVGCIMAELLTGRTLFPGTDHI 258

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAAC 553
           +++G + +   +  +    I A 
Sbjct: 211 LLSGASPFLGDTKQETLANITAV 233

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDGGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +VT LM
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 128
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
            G  +  L LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 129 -GADLYKL-LKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 186
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 243
Query: 534 GEAAY 538
               +
Sbjct: 244 NRPIF 248

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/204 (19%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G   E E+ +++  L    H NI+  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVCRE-EIEREVSILRQVLHPNIITLHDV-YENRTDVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAACG 554
           +++G + +   +  +    I A  
Sbjct: 211 LLSGASPFLGDTKQETLANITAVS 234

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 15/242 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYE---------FELRKDLLEL 387
           L+ ++ E I  IG  +F  V   K    E++      N +E         F   +D+L  
Sbjct: 87  LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN 146
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 446
             C  + I   +    DENH L +V     GG +  L+ K      +++ R  I ++   
Sbjct: 147 GDC--QWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 505
           I  ++     +RD+    +LLD +G++ L D G        G        G   +++PEI
Sbjct: 204 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 506 IAGDPESVSETWMS-NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
           +    + + +     + +S G+ ++EM+ GE  + A S V+    I     R + P    
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 323
Query: 565 QI 566
            +
Sbjct: 324 DV 325

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 534 GEAAY 538
               +
Sbjct: 224 NRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 534 GEAAY 538
               +
Sbjct: 224 NRPIF 228

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 15/242 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYE---------FELRKDLLEL 387
           L+ ++ E I  IG  +F  V   K    E++      N +E         F   +D+L  
Sbjct: 71  LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 446
             C  + I   +    DENH L +V     GG +  L+ K      +++ R  I ++   
Sbjct: 131 GDC--QWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 505
           I  ++     +RD+    +LLD +G++ L D G        G        G   +++PEI
Sbjct: 188 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 506 IAGDPESVSETWMS-NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
           +    + + +     + +S G+ ++EM+ GE  + A S V+    I     R + P    
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 307
Query: 565 QI 566
            +
Sbjct: 308 DV 309

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 83  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 142
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 143 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 198
Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 199 MYEMMCGRLPF 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 85  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 144
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 145 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 200
Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 201 MYEMMCGRLPF 211

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 534 GEAAY 538
               +
Sbjct: 226 NRPIF 230

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 84  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 143
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 144 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 199
Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 200 MYEMMCGRLPF 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D  +          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFYL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 114 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 172 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 228
Query: 534 GEAAY 538
               +
Sbjct: 229 NRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 56  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 115 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 172
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 173 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 229
Query: 534 GEAAY 538
               +
Sbjct: 230 NRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 47  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 106 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 163
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 164 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 220
Query: 534 GEAAY 538
               +
Sbjct: 221 NRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ ++     + D I +   LQ +        V E ++  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 181
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 237
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 238 LIRW----CLALRPSDRPTFEEI 256

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 534 GEAAY 538
               +
Sbjct: 224 NRPIF 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 283 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 338
Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 339 MYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 467
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 226 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 285
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 286 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 341
Query: 528 IWEMVTGEAAY 538
           ++EM+ G   +
Sbjct: 342 MYEMMCGRLPF 352

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAAC 553
           +++G + +   +  +    I + 
Sbjct: 211 LLSGASPFLGDTKQETLANITSV 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/269 (20%), Positives = 110/269 (40%), Gaps = 16/269 (5%)
Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKR------VGIEKL-KGCDKGNAYEFE 379
           SG  +I       D+ E    +G   F  VY  +       V ++ L K   +    E +
Sbjct: 10  SGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ 69
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
           LR+++       H NIL+ Y    D    + ++ +    G +   + KS     +    I
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRR-IYLILEYAPRGELYKELQKSCTFDEQRTATI 128
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
             ++A+ + + +   V +RD+  + +LL   G + + D G      S+   T   T  Y 
Sbjct: 129 MEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDY- 187
Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
            L PE+I G   +       +++  G++ +E++ G   + + S  +    I    L+   
Sbjct: 188 -LPPEMIEGRMHNEK----VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLK--F 240
Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
           P   P   + L+ K   ++PS+R   +++
Sbjct: 241 PASVPTGAQDLISKLLRHNPSERLPLAQV 269

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 534 GEAAY 538
               +
Sbjct: 226 NRPIF 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 107 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 221
Query: 534 GEAAY 538
               +
Sbjct: 222 NRPIF 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 107 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 221
Query: 534 GEAAY 538
               +
Sbjct: 222 NRPIF 226

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 384 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 438
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 497
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 556
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 557 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 582
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 128
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 129 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 186
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 243
Query: 534 GEAAY 538
               +
Sbjct: 244 NRPIF 248

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAAC 553
           +++G + +   +  +    I + 
Sbjct: 211 LLSGASPFLGDTKQETLANITSV 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 25/235 (10%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA---NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 533 TGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     + Q    I   G        CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIEQLG------TPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 58  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 116
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 117 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 174
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 175 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 231
Query: 534 GEAAY 538
               +
Sbjct: 232 NRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 534 GEAAY 538
               +
Sbjct: 224 NRPIF 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 472
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 473 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 530
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 531 MVTGEAAYAACSPVQAAVGIAAC 553
           +++G + +   +  +    I + 
Sbjct: 211 LLSGASPFLGDTKQETLANITSV 233

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 382 KDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
           K  +E+M +  H NI++ Y    ++N  + +V +L  GG + + ++  R  +  +  RI 
Sbjct: 71  KQEIEIMKSLDHPNIIRLY-ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 129
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDG 497
            DV   + + +   VA+RDL  +  L         + L D G+    K  G+    +   
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKVGT 188
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +++P+++ G      + W     S G++++ ++ G   ++A +  +  + I       
Sbjct: 189 PYYVSPQVLEGLYGPECDEW-----SAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTF 243
Query: 557 PEIPKD----CPQILKSLMIKCWNNSPSKR 582
           PE  KD     PQ  +SL+ +    SP +R
Sbjct: 244 PE--KDWLNVSPQA-ESLIRRLLTKSPKQR 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEII 437
           E++ ++  +    H N++Q Y     +N  + +V + ++GG + D I+ +S  L   + I
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRIL-LDRHG-NVCLGDMGIVTACKSVGEATEYET 495
                + EGI+ ++   + + DL  + IL ++R    + + D G+    K   E  +   
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF 249
Query: 496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 555
               +LAPE++  D  S    + ++++S G++ + +++G + +   +  +    I AC  
Sbjct: 250 GTPEFLAPEVVNYDFVS----FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
Query: 556 RPE------IPKDCPQILKSLMI--KCWNNSPS---KRPQFSE 587
             E      I ++  + +  L+I  K W  S S   K P  S+
Sbjct: 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  G    RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMXGXVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 384 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 438
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 497
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 556
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 557 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 582
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 382 KDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
           K  +E+M +  H NI++ Y    ++N  + +V +L  GG + + ++  R  +  +  RI 
Sbjct: 54  KQEIEIMKSLDHPNIIRLY-ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 112
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDG 497
            DV   + + +   VA+RDL  +  L         + L D G+    K  G+    +   
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKVGT 171
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 556
             +++P+++ G      + W     S G++++ ++ G   ++A +  +  + I       
Sbjct: 172 PYYVSPQVLEGLYGPECDEW-----SAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTF 226
Query: 557 PEIPKD----CPQILKSLMIKCWNNSPSKR 582
           PE  KD     PQ  +SL+ +    SP +R
Sbjct: 227 PE--KDWLNVSPQA-ESLIRRLLTKSPKQR 253

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 384 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 438
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 497
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 556
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 557 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 582
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            +   G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILGFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 391
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGAGNF-GVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 452 DHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAG 508
              VA+RDL  +  LLD      + + D G   A  SV  +      G   ++APE++  
Sbjct: 133 AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA--SVLHSQPKSAVGTPAYIAPEVLL- 189
Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 543
             +   +  +++V+S G+ ++ M+ G  AY    P
Sbjct: 190 --KKEYDGKVADVWSCGVTLYVMLVG--AYPFEDP 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 233
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 477 DMGIVTACKSVGEATEY--ETDGYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T +  E    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM G  +N+ I+K + L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 114 LM-GADLNN-IVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELR 171
Query: 475 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 528
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 172 ILDFGL--ARQADEEMTGYVATRWYR--APEIML--------NWMHYNQTVDIWSVGCIM 219
Query: 529 WEMVTGEAAY 538
            E++ G+A +
Sbjct: 220 AELLQGKALF 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 114 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 477 DMGIVTACKSVGEATEY--ETDGYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T +  E    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 172 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 228
Query: 534 GEAAY 538
               +
Sbjct: 229 NRPIF 233

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 87/190 (45%), Gaps = 17/190 (8%)
Query: 358 KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVT 413
           +  RV I+K+   +     +  LR ++  L+   H+N++    +     ++    + +V 
Sbjct: 67  RKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQ 125
Query: 414 KLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
            LME     DL  +LKS++L    I      +  G+K+++   V +RDL    +L++   
Sbjct: 126 DLME----TDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTC 181
Query: 472 NVCLGDMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVI 528
           ++ + D G+        + T + T+    RW  APEI+     S   T   +++S G ++
Sbjct: 182 DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCIL 238
Query: 529 WEMVTGEAAY 538
            EM++    +
Sbjct: 239 AEMLSNRPIF 248

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 474 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 524
            + D G+          T+ E  G    RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGXVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 525 GMVIWEMVTGEAAYAACSPV 544
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 25/235 (10%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA---NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 533 TGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     + Q    I   G        CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIEQLG------TPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET- 495
           + I + +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E     T 
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 496 -DGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
              Y           +++PE I G+    S +   +++S G++++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGN----SYSHKVDIFSLGLILFELL 224

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 399 YCVCV-----DENHG---LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIK 448
           + VC+     + +HG   L ++ + MEGG +   I +   +    +E   I  D+   I+
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 449 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
           FL+ H +A+RD+  + +L    ++   + L D G           T   T  Y  +APE+
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY--VAPEV 200
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-----AACSP-VQAAVGIAACGLR--- 556
           +   PE   ++   +++S G++++ ++ G   +      A SP ++  + +   G     
Sbjct: 201 LG--PEKYDKS--CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 557 -PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             E+ +D  Q+++ L+       P++R   ++ ++
Sbjct: 257 WSEVSEDAKQLIRLLL----KTDPTERLTITQFMN 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/175 (18%), Positives = 82/175 (46%), Gaps = 8/175 (4%)
Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIA 440
           K+ + +M   H   L       ++ + + ++ + + GG + D I  +  K+   E+I   
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGY 498
               EG+K +++H + + D+  + I+ +  +  +V + D G+ T      E  +  T   
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATA 214
Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
            + APEI+  +P      + +++++ G++ + +++G + +A    ++    +  C
Sbjct: 215 EFAAPEIVDREPVG----FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 399 YCVCV-----DENHG---LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIK 448
           + VC+     + +HG   L ++ + MEGG +   I +   +    +E   I  D+   I+
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 449 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
           FL+ H +A+RD+  + +L    ++   + L D G           T   T  Y  +APE+
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY--VAPEV 181
Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-----AACSP-VQAAVGIAACGLR--- 556
           +   PE   ++   +++S G++++ ++ G   +      A SP ++  + +   G     
Sbjct: 182 LG--PEKYDKS--CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 557 -PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             E+ +D  Q+++ L+       P++R   ++ ++
Sbjct: 238 WSEVSEDAKQLIRLLL----KTDPTERLTITQFMN 268

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 103 LMDA---NLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 159
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 212
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 213 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 260

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 416
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           E       +LK + L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 477 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 534 GEAAY 538
               +
Sbjct: 228 NRPIF 232

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
           +LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 109 ELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 474 CLGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
            + D G+  TAC +        T  YR  APE+I G   + +     +++S G ++ E+V
Sbjct: 166 KILDFGLARTACTNFMMTPYVVTRYYR--APEVILGMGYAAN----VDIWSVGCIMGELV 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 329
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 330 LGVILFICLSGYPPFS 345

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 90  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 149
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 150 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 203
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 204 LGVILFICLSGYPPFS 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 97  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 156
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 157 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 210
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 211 LGVILFICLSGYPPFS 226

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI--DVAEGIKFLNDHGVAYRDLNSQRIL 466
           L +  +  + G++   I K R  +  +++ + +   + +G+ +++   +  RDL    I 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 526
           L     V +GD G+VT+ K+ G+    +    R+++PE I+            ++Y+ G+
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKG-TLRYMSPEQISSQDYGKE----VDLYALGL 209
Query: 527 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLMIKCWNNSPSKRPQF 585
           ++ E++        C             LR  I  D   +  K+L+ K  +  P  RP  
Sbjct: 210 ILAELL------HVCDTAFETSKFFT-DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 586 SEIISLL 592
           SEI+  L
Sbjct: 263 SEILRTL 269

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 289
Query: 471 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 523
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 290 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 343
Query: 524 FGMVIWEMVTGEAAYA 539
            G++++  ++G   ++
Sbjct: 344 LGVILFICLSGYPPFS 359

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 210
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 266
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 267 LIRW----CLALRPSDRPTFEEI 285

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 233
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 475 LGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 533
           + D G+  TA  S     E  T  YR  APE+I G    +      +++S G ++ EM+ 
Sbjct: 167 ILDFGLARTAGTSFMMTPEVVTRYYR--APEVILG----MGYKENVDIWSVGCIMGEMIK 220
Query: 534 GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
           G   +     +     +       ++   CP+ +K L
Sbjct: 221 GGVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 252

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 210
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 266
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 267 LIRW----CLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 209
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 266 LIRW----CLALRPSDRPTFEEI 284

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 181
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 237
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 238 LIRW----CLALRPSDRPTFEEI 256

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 102/263 (38%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 510 PESVSETWMSN----VYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +           V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 209
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 266 LIRW----CLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 210
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSXECQH 266
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 267 LIRW----CLALRPSDRPTFEEI 285

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 233
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCVVT 413
           G++V I+KL    +   +     ++LL L    H+N++    V    +     +   +V 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
             M+      + LK      ++I  +   + +G+K+++  GV +RDL    + ++    +
Sbjct: 109 PFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165
Query: 474 CLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPESVSETWMS-----NVYSFGMV 527
            + D G+  A  +  E T Y     RW  APE+I         +WM      +++S G +
Sbjct: 166 KILDFGL--ARHADAEMTGYVVT--RWYRAPEVIL--------SWMHYNQTVDIWSVGCI 213
Query: 528 IWEMVTGEAAY 538
           + EM+TG+  +
Sbjct: 214 MAEMLTGKTLF 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 210
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSXECQH 266
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 267 LIRW----CLALRPSDRPTFEEI 285

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 224
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 280
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 281 LIRW----CLALRPSDRPTFEEI 299

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 46  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM G  +N+ I+K + L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 106 LM-GADLNN-IVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR 163
Query: 475 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 528
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 164 ILDFGL--ARQADEEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCIM 211
Query: 529 WEMVTGEAAY 538
            E++ G+A +
Sbjct: 212 AELLQGKALF 221

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 209
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSXECQH 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 266 LIRW----CLALRPSDRPTFEEI 284

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 104/229 (45%), Gaps = 19/229 (8%)
Query: 369 GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK 427
           GC +      ++ +++  L    H N+++   V  D N   L +V +L+  G V ++   
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--P 129
Query: 428 SRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
           + K  +++  R    D+ +GI++L+   + +RD+    +L+   G++ + D G+    K 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 487 VGEATEYETDGYRWLAPEIIAGDPESVSETW------MSNVYSFGMVIWEMVTGEAAYAA 540
             +A    T G     P  +A  PES+SET         +V++ G+ ++  V G+  +  
Sbjct: 190 -SDALLSNTVG----TPAFMA--PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 541 CSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
              +     I +  L  P+ P D  + LK L+ +  + +P  R    EI
Sbjct: 243 ERIMCLHSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 10  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 129
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 180
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 236
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 237 LIRW----CLALRPSDRPTFEEI 255

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 94/208 (45%), Gaps = 10/208 (4%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 391
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 510
              V +RDL  +  LLD      L       +  SV  +   +T G   ++APE++    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL--- 189
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA---NLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 209
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 265
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 266 LIRW----CLALRPSDRPTFEEI 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 196
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 252
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 253 LIRW----CLALRPSDRPTFEEI 271

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 34  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 153
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 204
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 260
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 261 LIRW----CLALRPSDRPTFEEI 279

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 196
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 252
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 253 LIRW----CLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 197
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 253
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 254 LIRW----CLALRPSDRPTFEEI 272

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 197
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 253
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 254 LIRW----CLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 216
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 272
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 273 LIRW----CLALRPSDRPTFEEI 291

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 224
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 280
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 281 LIRW----CLALRPSDRPTFEEI 299

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 347 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 390
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 59  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 118
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 119 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 178
Query: 451 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 229
Query: 510 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 565
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 285
Query: 566 ILKSLMIKCWNNSPSKRPQFSEI 588
           +++     C    PS RP F EI
Sbjct: 286 LIRW----CLALRPSDRPTFEEI 304

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
            G   +     +     +       ++   CP+ +K L
Sbjct: 220 KGGVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/216 (19%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 111 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           + D G+     +    T Y    Y + APE+I G    +      +++S G ++ EM+ G
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG----MGYKENVDIWSVGCIMGEMIKG 222
Query: 535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
              +     +     +       ++   CP+ +K L
Sbjct: 223 GVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 253

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 82/187 (43%), Gaps = 17/187 (9%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 413
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
           +LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 107 ELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 163
Query: 474 CLGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM 531
            + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ E+
Sbjct: 164 KILDFGLARTASTNFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEL 216
Query: 532 VTGEAAY 538
           V G   +
Sbjct: 217 VKGSVIF 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 391
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 510
              V +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 189
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/192 (22%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCVVT 413
           G++V I+KL    +   +     ++LL L    H+N++    V    +     +   +V 
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126
Query: 414 KLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
             M+     DL  +   +   ++I  +   + +G+K+++  GV +RDL    + ++    
Sbjct: 127 PFMQ----TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182
Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPESVSETWMS-----NVYSFGM 526
           + + D G+  A  +  E T Y     RW  APE+I         +WM      +++S G 
Sbjct: 183 LKILDFGL--ARHADAEMTGYVVT--RWYRAPEVIL--------SWMHYNQTVDIWSVGC 230
Query: 527 VIWEMVTGEAAY 538
           ++ EM+TG+  +
Sbjct: 231 IMAEMLTGKTLF 242

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  +   +  
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
                ++A  + + +   V +RD+  + +LL  +G + + D G      S    T   T 
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 497 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
            Y  L PE+I G    E V      +++S G++ +E + G   + A +  +    I+   
Sbjct: 175 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVE 226
Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                P    +  + L+ +   ++ S+R   +E++
Sbjct: 227 F--TFPDFVTEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 392 HKNILQFYCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
           H NIL    + V       H L +VT+LM       +  +   +  + I      +  G+
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEII 506
             L++ GV +RDL+   ILL  + ++ + D  +     +    T Y T  +RW  APE++
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELV 205
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
               +    T + +++S G V+ EM   +A +
Sbjct: 206 M---QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 392 HKNILQFYCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
           H NIL    + V       H L +VT+LM       +  +   +  + I      +  G+
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEII 506
             L++ GV +RDL+   ILL  + ++ + D  +     +    T Y T  +RW  APE++
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELV 205
Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
               +    T + +++S G V+ EM   +A +
Sbjct: 206 M---QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 533 TG 534
            G
Sbjct: 220 KG 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 391
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 14  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 73  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 510
              V +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 132 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 188
Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAY 538
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 86/211 (40%), Gaps = 10/211 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +  E I +IG  S+  V+K      G+ V I+K    +     +    +++  L    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           N++    V       L +V +  +   +++L    R +    +  I     + + F + H
Sbjct: 63  NLVNLLEV-FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
              +RD+  + IL+ +H  + L D G         +  + E     + +PE++ GD +  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
                 +V++ G V  E+++G   +   S V
Sbjct: 182 PPV---DVWAIGCVFAELLSGVPLWPGKSDV 209

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 108
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 109 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 165
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 166 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 218
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 219 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 266

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 104 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 160
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 161 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 213
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 214 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 261

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 414
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 532
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	604
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-48
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-24
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-15
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-14
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-12
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-12
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-07
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-07
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-07
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-07
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-06
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-06
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-06
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-06
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-05
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-04

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  214 bits (548), Expect = 1e-65
 Identities = 62/271 (22%), Positives = 123/271 (45%), Gaps = 23/271 (8%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
             ++   L F+ ++  N      KG ++G  + ++ LK  D       +  ++   L   
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 391 GHKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 447
            H N+L     C         ++T  M  GS+ +++ +  +  +   + ++ A+D+A G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 448 KFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
            FL   +  +    LNS+ +++D      +    +            +++ G      W+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV---------KFSFQSPGRMYAPAWV 175

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           APE +   PE  +    ++++SF +++WE+VT E  +A  S ++  + +A  GLRP IP 
Sbjct: 176 APEALQKKPED-TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                +  LM  C N  P+KRP+F  I+ +L
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  215 bits (549), Expect = 3e-65
 Identities = 70/271 (25%), Positives = 131/271 (48%), Gaps = 14/271 (5%)

Query: 331 EIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE 386
           +     +   +L   ++IG  SF    +  + G  V ++ L   D       E  +++  
Sbjct: 28  DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
           +    H NI+ F        + L +VT+ +  GS+  L+ KS    +L  +  + +A DV
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 444 AEGIKFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
           A+G+ +L   +  + +R+L S  +L+D+   V + D G+     S   +++       W+
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           APE++  +P   +E   S+VYSFG+++WE+ T +  +   +P Q    +     R EIP+
Sbjct: 207 APEVLRDEP--SNE--KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +    + +++  CW N P KRP F+ I+ LL
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  209 bits (534), Expect = 1e-63
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 25/275 (9%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEF--ELRKDLLELM 388
             ++   L   + IG   F    +  + G  V ++  +     +  +    +R++     
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H NI+    VC+ E + LC+V +   GG +N + L  +++    ++  A+ +A G+ 
Sbjct: 62  MLKHPNIIALRGVCLKEPN-LCLVMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMN 119

Query: 449 FL---NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDG-- 497
           +L       + +RDL S  IL+ +          I+       A       T   +    
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGA 177

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 557
           Y W+APE+I       S+   S+V+S+G+++WE++TGE  +     +  A G+A   L  
Sbjct: 178 YAWMAPEVIRASM--FSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            IP  CP+    LM  CWN  P  RP F+ I+  L
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  205 bits (524), Expect = 1e-61
 Identities = 68/270 (25%), Positives = 130/270 (48%), Gaps = 26/270 (9%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
            +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR+    L   
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRV 58

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 447
            H NI++ Y  C++    +C+V +  EGGS+ +++  +           +   +  ++G+
Sbjct: 59  NHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 448 KFL---NDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAP 503
            +L       + +RDL    +LL   G V  + D G  TAC      T        W+AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTN-NKGSAAWMAP 172

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKD 562
           E+  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+
Sbjct: 173 EVFEG--SNYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228

Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (517), Expect = 8e-61
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 386
             L  + +E+  QIG   F  V+KG+       V I+ L  G  +G     E  ++    
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73

Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAID 442
              +    H NI++ Y +  +      +V + +  G +   +L K+  ++    +R+ +D
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 443 VAEGIKFLNDHGVAY--RDLNSQRILLD---RHGNVCL--GDMGIVTACKSVGEATEYET 495
           +A GI+++ +       RDL S  I L     +  VC    D G   + +SV   +    
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--LSQQSVHSVSG-LL 187

Query: 496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-- 553
             ++W+APE I  + ES +E   ++ YSF M+++ ++TGE  +   S  +          
Sbjct: 188 GNFQWMAPETIGAEEESYTE--KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           GLRP IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (503), Expect = 8e-59
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 15/278 (5%)

Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRK 382
               +    W +    +    +IG  SF  VYKGK    V ++ L             + 
Sbjct: 10  HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKN 69

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAI 441
           ++  L    H NIL F          L +VT+  EG S+   +  S  K + K++I IA 
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YR 499
             A G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E       
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 500 WLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-- 556
           W+APE+I     +  S    S+VY+FG+V++E++TG+  Y+  +     + +   G    
Sbjct: 188 WMAPEVIRMQDSNPYSF--QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245

Query: 557 --PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              ++  +CP+ +K LM +C      +RP F  I++ +
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (500), Expect = 4e-58
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 37/284 (13%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLL--- 385
            +    +L   + +G   F    K  ++  G+ + +++L   D+      E ++  L   
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLKEV 58

Query: 386 ELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDV 443
           ++M C  H N+L+F  V   +   L  +T+ ++GG++  +I     +    + +  A D+
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKR-LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--------------VTACKSVGE 489
           A G+ +L+   + +RDLNS   L+  + NV + D G+               +  K   +
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
                     W+APE+I G           +V+SFG+V+ E++    A     P     G
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEK----VDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233

Query: 550 IAAC-GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +     L    P +CP     + ++C +  P KRP F ++   L
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  193 bits (492), Expect = 8e-57
 Identities = 62/309 (20%), Positives = 132/309 (42%), Gaps = 31/309 (10%)

Query: 299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
           N +L      P  +S   + + EW        +I       + LE  + IG   F  VY 
Sbjct: 5   NLSLLSARSFPRKASQTSIFLQEW--------DI-----PFEQLEIGELIGKGRFGQVYH 51

Query: 359 GK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415
           G+    V I  +             +++++      H+N++ F   C+   H L ++T L
Sbjct: 52  GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-LAIITSL 110

Query: 416 MEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
            +G ++  ++  ++  L   +  +IA ++ +G+ +L+  G+ ++DL S+ +  D +G V 
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169

Query: 475 LGDMGI-----VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWM-----SNVYSF 524
           + D G+     V       +    +      LAPEII        E  +     S+V++ 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229

Query: 525 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRP 583
           G + +E+   E  +      +A +     G++P + +    + +  +++ CW     +RP
Sbjct: 230 GTIWYELHAREWPFKTQPA-EAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288

Query: 584 QFSEIISLL 592
            F++++ +L
Sbjct: 289 TFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  189 bits (481), Expect = 5e-55
 Identities = 69/335 (20%), Positives = 137/335 (40%), Gaps = 49/335 (14%)

Query: 311 PSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIE 365
           P  S    +++ Q+  SG G  +      +  ++ + QIG   +     G ++G++V ++
Sbjct: 7   PGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVK 66

Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVN 422
                ++     +    ++ + +   H+NIL F    +        L ++T   E GS+ 
Sbjct: 67  VFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123

Query: 423 DLILKSRKLQTKEIIRIAIDVAEGIKFL--------NDHGVAYRDLNSQRILLDRHGNVC 474
           D  LKS  L  K ++++A     G+  L            +A+RDL S+ IL+ ++G  C
Sbjct: 124 DY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182

Query: 475 LGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE--TWMSNVYSFGMVI 528
           + D+G+     S     +   +      R++ PE++             M+++YSFG+++
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

Query: 529 WEMVTGEAA----------YAACSPVQAAVG-----IAACGLRPEIPK-----DCPQILK 568
           WE+     +          Y    P   +       +    LRP  P      +C + + 
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302

Query: 569 SLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 603
            LM +CW ++P+ R     +   L     +S S +
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTL---AKMSESQD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  183 bits (466), Expect = 3e-53
 Identities = 64/296 (21%), Positives = 121/296 (40%), Gaps = 45/296 (15%)

Query: 338 NSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
            + ++  ++ +G   +    +G ++G+ V ++     D+  ++  E   +L   +   H+
Sbjct: 6   VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-KSWFRE--TELYNTVMLRHE 62

Query: 394 NILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           NIL F    +   H    L ++T   E GS+ D  L+   L T   +RI + +A G+  L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHL 121

Query: 451 --------NDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTACKSVGEATEYETDG-Y 498
                       +A+RDL S+ IL+ ++G  C+ D+G   + +   +  +       G  
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 499 RWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTG----------EAAYAACSPVQA 546
           R++APE++    +          ++++FG+V+WE+             +  +    P   
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 547 AVGI---AAC--GLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +        C    RP IP           L  LM +CW  +PS R     I   L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 4e-50
 Identities = 59/301 (19%), Positives = 121/301 (40%), Gaps = 49/301 (16%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
               +  +   + IG   F    +G ++G+ V ++     ++  ++  E   ++ + +  
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFRE--AEIYQTVML 93

Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
            H+NIL F      +N     L +V+   E GS+ D  L    +  + +I++A+  A G+
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGL 152

Query: 448 KFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
             L+           +A+RDL S+ IL+ ++G  C+ D+G+     S  +  +   +   
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 498 --YRWLAPEIIAGDPESVSETWMSN----VYSFGMVIWEMVTGEAAYAACSPVQAA---- 547
              R++APE++        + + S     +Y+ G+V WE+    +        Q      
Sbjct: 213 GTKRYMAPEVLDD--SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 548 -----------VGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
                        +    LRP IP      +  +++  +M +CW  + + R     I   
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 592 L 592
           L
Sbjct: 331 L 331

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  170 bits (433), Expect = 2e-48
 Identities = 64/312 (20%), Positives = 124/312 (39%), Gaps = 51/312 (16%)

Query: 326 QSGGEEIG--RWLLNSDNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFE 379
            S G ++G       S  L+ ++      F  V+K     + V ++     DK  +++ E
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNE 66

Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEI 436
              ++  L    H+NILQF             L ++T   E GS++D  LK+  +   E+
Sbjct: 67  --YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-LKANVVSWNEL 123

Query: 437 IRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
             IA  +A G+ +L++            +++RD+ S+ +LL  +   C+ D G+  A K 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--ALKF 181

Query: 487 VGEATEYETDG----YRWLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAAC 541
               +  +T G     R++APE++ G      +     ++Y+ G+V+WE+ +   A    
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 542 S-----PVQAAVGIAAC-----------GLRPEIPKDCP-----QILKSLMIKCWNNSPS 580
                 P +  +G                 RP +           +L   + +CW++   
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 581 KRPQFSEIISLL 592
            R     +   +
Sbjct: 302 ARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  162 bits (412), Expect = 3e-45
 Identities = 57/312 (18%), Positives = 105/312 (33%), Gaps = 60/312 (19%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
             L+ DNL+ ++ IG   +    KG    + V ++     ++     F   K++  +   
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNIYRVPLM 64

Query: 391 GHKNILQFYCVC----VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
            H NI +F         D      +V +    GS+    L           R+A  V  G
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRG 123

Query: 447 IKFL---------NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
           + +L             +++RDLNS+ +L+   G   + D G+             E D 
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 498 --------YRWLAPEIIAGD---PESVSETWMSNVYSFGMVIWEMVTG------------ 534
                    R++APE++ G     +  S     ++Y+ G++ WE+               
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243

Query: 535 -EAAYAACSP-------VQAAVGIAACGLRPEIPKDC------PQILKSLMIKCWNNSPS 580
            + A+            +Q  V       RP+ P+         + LK  +  CW+    
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301

Query: 581 KRPQFSEIISLL 592
            R         +
Sbjct: 302 ARLTAQXAEERM 313

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (379), Expect = 3e-40
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 33/276 (11%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 386
           W+LN ++L   +QIG  +F  V+ G+       V ++  +         +F     L E 
Sbjct: 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF-----LQEA 163

Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 442
             L    H NI++   VC  +   + +V +L++GG      L++    L+ K ++++  D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTF-LRTEGARLRVKTLLQMVGD 221

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 497
            A G+++L      +RDL ++  L+     + + D G+    +   +     + G     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVYAASGGLRQVP 278

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            +W APE +         +  S+V+SFG+++WE  + G + Y   S  Q    +   G R
Sbjct: 279 VKWTAPEALN---YGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGR 333

Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              P+ CP  +  LM +CW   P +RP FS I   L
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  145 bits (368), Expect = 3e-39
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 74/322 (22%)

Query: 312 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD 371
           S++ V   DEW        E+ R     + +    ++G  SF  VY+G   G+ K +   
Sbjct: 10  SAADVYVPDEW--------EVAR-----EKITMSRELGQGSFGMVYEGVAKGVVKDEPET 56

Query: 372 -------KGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
                     A   E R + L    +M      ++++   V         V+ +LM  G 
Sbjct: 57  RVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGD 114

Query: 421 VNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
           +   +   R               ++I++A ++A+G+ +LN +   +RDL ++  ++   
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174

Query: 471 GNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPEIIAGDPESVSE- 515
             V +GD G    I            YETD Y          RW++PE       S+ + 
Sbjct: 175 FTVKIGDFGMTRDI------------YETDYYRKGGKGLLPVRWMSPE-------SLKDG 215

Query: 516 --TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
             T  S+V+SFG+V+WE+ T  E  Y   S  Q    +   G   + P +CP +L  LM 
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-GGLLDKPDNCPDMLFELMR 274

Query: 573 KCWNNSPSKRPQFSEIISLLLR 594
            CW  +P  RP F EIIS +  
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKE 296

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (374), Expect = 6e-39
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 39/276 (14%)

Query: 334 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
            W LN   L+ +  IG   F     G Y+G +V ++ +K             +  L    
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 238

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
            +    H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++D
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 297

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---- 498
           V E +++L  +   +RDL ++ +L+       + D G+    +         T       
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL--TKE------ASSTQDTGKLP 349

Query: 499 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            +W APE +     S      S+V+SFG+++WE+ + G   Y           +   G +
Sbjct: 350 VKWTAPEALREKKFST----KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYK 404

Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            + P  CP  +  +M  CW+   + RP F ++   L
Sbjct: 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  143 bits (362), Expect = 2e-38
 Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 72/323 (22%)

Query: 308 MPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL 367
           +P  S      +++          I R     + L     +G   F  V +G     +  
Sbjct: 15  VPRGSEELQNKLEDV--------VIDR-----NLLILGKILGEGEFGSVMEGNLKQEDGT 61

Query: 368 ------KGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDEN----HGLCVVT 413
                 K     N+ + E  ++ L     M    H N+++   VC++ +        V+ 
Sbjct: 62  SLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120

Query: 414 KLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
             M+ G ++  +L SR       +  + +++  +D+A G+++L++    +RDL ++  +L
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180

Query: 468 DRHGNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPEIIAGDPESV 513
                VC+ D G    I            Y  D Y          +W+A E       S+
Sbjct: 181 RDDMTVCVADFGLSKKI------------YSGDYYRQGRIAKMPVKWIAIE-------SL 221

Query: 514 SE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
           ++   T  S+V++FG+ +WE+ T G   Y      +    +   G R + P+DC   L  
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-GHRLKQPEDCLDELYE 280

Query: 570 LMIKCWNNSPSKRPQFSEIISLL 592
           +M  CW   P  RP FS +   L
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQL 303

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (360), Expect = 2e-38
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 33/280 (11%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDL 384
             L+   +L  ++++G  SF  V +G+          V ++ LK        + E   D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDF 68

Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
           +     + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
           A+ VAEG+ +L      +RDL ++ +LL     V +GD G++ A         Y      
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHR 184

Query: 498 ---YRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
              + W APE +        S+TW      FG+ +WEM T G+  +   +  Q    I  
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTW-----MFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P+DCPQ + ++M++CW + P  RP F  +   L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (359), Expect = 2e-38
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)

Query: 334 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
            W LN   L+ +  IG   F     G Y+G +V ++ +K             +  L    
Sbjct: 15  GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 66

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
            +    H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++D
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 125

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDG---- 497
           V E +++L  +   +RDL ++ +L+       + D G+               T      
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---------TKEASSTQDTGKL 176

Query: 498 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W APE +    E    +  S+V+SFG+++WE+ + G   Y           +   G 
Sbjct: 177 PVKWTAPEALR---EKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GY 231

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           + + P  CP  +  +M  CW+   + RP F ++   L
Sbjct: 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (361), Expect = 3e-38
 Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 60/302 (19%)

Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK------LKGCDKGNAYEFELRKD 383
           E++   L+          +G   F  V + +    +       +K   K +       ++
Sbjct: 13  EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEE 71

Query: 384 LL---ELMT-CGHKNILQFYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSR----- 429
            L     M    H ++ +   V +            V+   M+ G ++  +L SR     
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131

Query: 430 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTAC 484
             L  + ++R  +D+A G+++L+     +RDL ++  +L     VC+ D G    I    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI---- 187

Query: 485 KSVGEATEYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEM 531
                   Y  D Y          +WLA E       S+++   T  S+V++FG+ +WE+
Sbjct: 188 --------YSGDYYRQGCASKLPVKWLALE-------SLADNLYTVHSDVWAFGVTMWEI 232

Query: 532 VT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           +T G+  YA     +    +   G R + P +C + +  LM +CW+  P +RP F+ +  
Sbjct: 233 MTRGQTPYAGIENAEIYNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291

Query: 591 LL 592
            L
Sbjct: 292 EL 293

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  140 bits (356), Expect = 1e-37
 Identities = 70/325 (21%), Positives = 127/325 (39%), Gaps = 61/325 (18%)

Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 364
           +L +            +W        E  R     D L+    +G  +F  V +    GI
Sbjct: 5   ELPLDEHCERLPYDASKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGI 51

Query: 365 EKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVV 412
           +K   C        K  A   E  + L+   +++     H N++     C      L V+
Sbjct: 52  DKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110

Query: 413 TKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVA 456
            +  + G+++  +   R                 L  + +I  +  VA+G++FL      
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170

Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPE 511
           +RDL ++ ILL     V + D G+    + + +  +Y   G      +W+APE       
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGL---ARDIYKDPDYVRKGDARLPLKWMAPE------- 220

Query: 512 SVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
           ++ +   T  S+V+SFG+++WE+ + G + Y      +        G R   P      +
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 280

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL 592
              M+ CW+  PS+RP FSE++  L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (365), Expect = 2e-37
 Identities = 63/294 (21%), Positives = 124/294 (42%), Gaps = 47/294 (15%)

Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK--RVGIEKLKGCDKGNAY 376
            T+        +W +   ++    ++G   +    +GV+K     V ++ LK        
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----- 257

Query: 377 EFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--- 429
                ++ L+    +    H N++Q   VC  E     ++T+ M  G++ D  L+     
Sbjct: 258 --MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDY-LRECNRQ 313

Query: 430 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
           ++    ++ +A  ++  +++L      +R+L ++  L+  +  V + D G+         
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL--------- 364

Query: 490 ATEYETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY 538
           +     D Y          +W APE +A +  S+     S+V++FG+++WE+ T G + Y
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPY 420

Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 Q    +     R E P+ CP+ +  LM  CW  +PS RP F+EI    
Sbjct: 421 PGIDLSQVYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  140 bits (354), Expect = 3e-37
 Identities = 64/288 (22%), Positives = 128/288 (44%), Gaps = 43/288 (14%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
             +   N+  I  +G  +F  VY+G+  G+                   E +   D L  
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 83

Query: 386 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 436
             +++   H+NI++   V +       ++ +LM GG +   + ++R        L   ++
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 493
           + +A D+A G ++L ++   +RD+ ++  LL   G      +GD G+    + +  A+ Y
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRASYY 199

Query: 494 ETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
              G      +W+ PE       +  E   T  ++ +SFG+++WE+ + G   Y + S  
Sbjct: 200 RKGGCAMLPVKWMPPE-------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +    + + G R + PK+CP  +  +M +CW + P  RP F+ I+  +
Sbjct: 253 EVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  140 bits (356), Expect = 4e-37
 Identities = 64/288 (22%), Positives = 127/288 (44%), Gaps = 43/288 (14%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
             +   N+  I  +G  +F  VY+G+  G+                   E +   D L  
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 124

Query: 386 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 436
             +++   H+NI++   V +       ++ +LM GG +   + ++R        L   ++
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 493
           + +A D+A G ++L ++   +RD+ ++  LL   G      +GD G+    + +  A  Y
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAGYY 240

Query: 494 ETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPV 544
              G      +W+ PE       +  E   T  ++ +SFG+++WE+ + G   Y + S  
Sbjct: 241 RKGGCAMLPVKWMPPE-------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293

Query: 545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           +    + + G R + PK+CP  +  +M +CW + P  RP F+ I+  +
Sbjct: 294 EVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  139 bits (353), Expect = 5e-37
 Identities = 69/312 (22%), Positives = 129/312 (41%), Gaps = 65/312 (20%)

Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------- 371
            +W        E  R     D L     +G  +F  V   + VGI+K K  +        
Sbjct: 28  PKW--------EFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74

Query: 372 -KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI 425
            K +A E +   DL+   E+M     HKNI+     C  +   L V+ +    G++ + +
Sbjct: 75  LKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYL 132

Query: 426 LKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
              R                 +  K+++     +A G+++L      +RDL ++ +L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192

Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---TWMSNV 521
           +  + + D G+    + +     Y+         +W+APE       ++ +   T  S+V
Sbjct: 193 NNVMKIADFGL---ARDINNIDYYKKTTNGRLPVKWMAPE-------ALFDRVYTHQSDV 242

Query: 522 YSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS 580
           +SFG+++WE+ T G + Y      +    +   G R + P +C   L  +M  CW+  PS
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPS 301

Query: 581 KRPQFSEIISLL 592
           +RP F +++  L
Sbjct: 302 QRPTFKQLVEDL 313

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (348), Expect = 5e-37
 Identities = 68/275 (24%), Positives = 131/275 (47%), Gaps = 31/275 (11%)

Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 386
           G+W+++   L F+ +IG   F  V+ G      +V I+ ++             +D +E 
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEE 53

Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
              +M   H  ++Q Y VC+++   +C+VT+ ME G ++D +   R     + ++ + +D
Sbjct: 54  AEVMMKLSHPKLVQLYGVCLEQAP-ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
           V EG+ +L +  V +RDL ++  L+  +  + + D G+    + V +     + G     
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM---TRFVLDDQYTSSTGTKFPV 169

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           +W +PE+ +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R 
Sbjct: 170 KWASPEVFSFSRYSS----KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRL 224

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             P+     +  +M  CW   P  RP FS ++  L
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (351), Expect = 8e-37
 Identities = 61/277 (22%), Positives = 126/277 (45%), Gaps = 34/277 (12%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A   +  K++L
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65

Query: 386 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 440
           +    + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
           + +A+G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G   
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181

Query: 498 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W+A E I     +      S+V+S+G+ +WE++T G   Y      + +  +   G 
Sbjct: 182 PIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GE 236

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           R   P  C   +  +M KCW      RP+F E+I   
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (349), Expect = 9e-37
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 41/280 (14%)

Query: 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL--- 385
           +S  + F + IG   F  VY G             ++ L         +       L   
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEG 77

Query: 386 ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDV 443
            +M    H N+L    +C+       VV   M+ G + + +  ++     K++I   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 498
           A+G+K+L      +RDL ++  +LD    V + D G+    + + +   Y          
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEYYSVHNKTGAKL 194

Query: 499 --RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
             +W+A E       S+     T  S+V+SFG+++WE++T G   Y   +     V +  
Sbjct: 195 PVKWMALE-------SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P+ CP  L  +M+KCW+     RP FSE++S +
Sbjct: 248 -GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (346), Expect = 1e-36
 Identities = 63/275 (22%), Positives = 123/275 (44%), Gaps = 31/275 (11%)

Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 386
           G   L  + +  + ++G   F  V  GK      V ++ +K              +  + 
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-------EDEFFQE 53

Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAID 442
              +M   H  +++FY VC  E   + +VT+ +  G + + L    + L+  +++ +  D
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYP-IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
           V EG+ FL  H   +RDL ++  L+DR   V + D G+    + V +     + G     
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM---TRYVLDDQYVSSVGTKFPV 169

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           +W APE+          +  S+V++FG+++WE+ + G+  Y   +  +  + ++  G R 
Sbjct: 170 KWSAPEVFH---YFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRL 224

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             P      +  +M  CW+  P KRP F +++S +
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (346), Expect = 1e-36
 Identities = 57/279 (20%), Positives = 118/279 (42%), Gaps = 34/279 (12%)

Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRK 382
            ++ +  +++     +G   F  VY+G           V ++  K  C   N  +F    
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF---- 60

Query: 383 DLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 438
            + E   +    H +I++   +  +E     ++ +L   G +   L      L+   ++ 
Sbjct: 61  -MSEAVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVL 117

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG- 497
            ++ + + + +L      +RD+  + IL+     V LGD G+    + + +   Y+    
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVT 174

Query: 498 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
               +W++PE I         T  S+V+ F + +WE+++ G+  +           +   
Sbjct: 175 RLPIKWMSPESIN----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK- 229

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           G R   P  CP +L +LM +CW+  PS RP+F+E++  L
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  136 bits (346), Expect = 1e-36
 Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 34/277 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 384
           + +  + +E    IG   F  V++G           V I+  K         +F     L
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF-----L 64

Query: 385 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
            E   +    H +I++   V  +    + ++ +L   G +   L ++   L    +I  A
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
             ++  + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+      
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKL 179

Query: 498 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W+APE I     + +    S+V+ FG+ +WE++  G   +           I   G 
Sbjct: 180 PIKWMAPESINFRRFTSA----SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 234

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           R  +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  139 bits (352), Expect = 2e-36
 Identities = 76/340 (22%), Positives = 137/340 (40%), Gaps = 69/340 (20%)

Query: 296 GVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKG 355
                NL  Q  +   S   +     W        E+ R     D L     +G  +F  
Sbjct: 38  IPTTENLYFQGMLAGVSEYELPEDPRW--------ELPR-----DRLVLGKPLGEGAFGQ 84

Query: 356 VYKGKRVGIEKLKGCD---------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCV 401
           V   + +G++K K            K +A E +   DL+   E+M     HKNI+     
Sbjct: 85  VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGA 143

Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAE 445
           C  +   L V+ +    G++ + +   R                 L +K+++  A  VA 
Sbjct: 144 CTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------- 498
           G+++L      +RDL ++ +L+     + + D G+    + +     +  D Y       
Sbjct: 203 GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDI-----HHIDYYKKTTNGR 254

Query: 499 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 554
              +W+APE +    + +  T  S+V+SFG+++WE+ T G + Y      +    +   G
Sbjct: 255 LPVKWMAPEALF---DRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-G 309

Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
            R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (345), Expect = 3e-36
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 43/287 (14%)

Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELR 381
           G     +W +   ++    ++G   +  VY+G        V ++ LK  D     EF   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--- 56

Query: 382 KDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEI 436
             L E   +    H N++Q   VC  E     ++T+ M  G++ D + +  +  +    +
Sbjct: 57  --LKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVL 113

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
           + +A  ++  +++L      +RDL ++  L+  +  V + D G+         +     D
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------SRLMTGD 164

Query: 497 GY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 545
            Y          +W APE +A +  S+     S+V++FG+++WE+ T G + Y      Q
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

Query: 546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +     R E P+ CP+ +  LM  CW  +PS RP F+EI    
Sbjct: 221 VYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  136 bits (344), Expect = 3e-36
 Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 26/275 (9%)

Query: 334 RWLLNSDNLEFIDQ-IGPNSF----KGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLE- 386
              L+   L   D+ +G  +F    KG Y+ K+V     +K   K  A +  L+ +LL  
Sbjct: 10  EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 68

Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
              +    +  I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----Y 498
           + G+K+L +    +RDL ++ +LL       + D G+  A ++  +   Y+         
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPV 184

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           +W APE I         +  S+V+SFG+++WE  + G+  Y      +    +   G R 
Sbjct: 185 KWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERM 239

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             P  CP+ +  LM  CW      RP F+ +   L
Sbjct: 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  135 bits (343), Expect = 4e-36
 Identities = 55/282 (19%), Positives = 111/282 (39%), Gaps = 38/282 (13%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDL 384
             + +++L F + +G  +F  ++KG R  +            LK  DK +       +  
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESF 59

Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 439
            E    +    HK+++  Y VCV  +    +V + ++ GS++  L      +     + +
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--------EAT 491
           A  +A  + FL ++ + + ++ ++ ILL R  +   G+       K +            
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF---IK-LSDPGISITVLPK 174

Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI 550
           +   +   W+ PE I       +    ++ +SFG  +WE+ + G+   +A    +     
Sbjct: 175 DILQERIPWVPPECIE---NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                +   PK     L +L+  C +  P  RP F  II  L
Sbjct: 232 ED-RHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDL 270

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 5e-36
 Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 35/293 (11%)

Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK-RVGIEKLKGCD 371
            +V      Q+ G     W +  ++L    ++G   F     G + G  RV I+ LK   
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220

Query: 372 KGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
                     +  L+    +    H+ ++Q Y V  +E   + +VT+ M  GS+ D  LK
Sbjct: 221 -------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LK 270

Query: 428 SRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                 L+  +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA--- 327

Query: 485 KSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
           + + +       G     +W APE       ++     S+V+SFG+++ E+ T G   Y 
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYP 383

Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                +    +   G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 384 GMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  137 bits (347), Expect = 7e-36
 Identities = 68/303 (22%), Positives = 126/303 (41%), Gaps = 62/303 (20%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           +W    D L     +G   F  V   + VGI+K K  +         K +A E +   DL
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDL 133

Query: 385 L---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 430
           +   E+M     HKNI+     C  +   L V+ +    G++ + +   R          
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 431 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
                  +  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+   
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL--- 249

Query: 484 CKSVGEATEYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWE 530
            + +        D Y          +W+APE       ++ +   T  S+V+SFG+++WE
Sbjct: 250 ARDI-----NNIDYYKKTTNGRLPVKWMAPE-------ALFDRVYTHQSDVWSFGVLMWE 297

Query: 531 MVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           + T G + Y      +    +   G R + P +C   L  +M  CW+  PS+RP F +++
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 590 SLL 592
             L
Sbjct: 357 EDL 359

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  135 bits (341), Expect = 8e-36
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE-- 386
            W +  + L+ ++++G   F  V+ G      +V ++ LK                L   
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-------MSPDAFLAEA 59

Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAI 441
             +    H+ +++ Y V   E   + ++T+ ME GS+ D  LK+     L   +++ +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDF-LKTPSGIKLTINKLLDMAA 116

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTACKSVGEATEYETDG- 497
            +AEG+ F+ +    +RDL +  IL+    +  + D G   ++       E  EY     
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREG 169

Query: 498 ----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 552
                +W APE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +  
Sbjct: 170 AKFPIKWTAPEAINYGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

Query: 553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            G R   P +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 226 -GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (346), Expect = 9e-36
 Identities = 74/316 (23%), Positives = 123/316 (38%), Gaps = 40/316 (12%)

Query: 299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
           + NL  Q    +      ++ +  Q VQ               + F + IG   F  VY 
Sbjct: 53  SENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS-----LIVHFNEVIGRGHFGCVYH 107

Query: 359 GK---------RVGIEKLKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDE 405
           G             ++ L         +       L    +M    H N+L    +C+  
Sbjct: 108 GTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 406 NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
                VV   M+ G + + I         K++I   + VA+G+KFL      +RDL ++ 
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE---TW 517
            +LD    V + D G+          + +   G     +W+A E       S+     T 
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-------SLQTQKFTT 275

Query: 518 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
            S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP  L  +M+KCW+
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWH 334

Query: 577 NSPSKRPQFSEIISLL 592
                RP FSE++S +
Sbjct: 335 PKAEMRPSFSELVSRI 350

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 9e-36
 Identities = 80/318 (25%), Positives = 135/318 (42%), Gaps = 34/318 (10%)

Query: 294 RNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF 353
            +     NL  Q ++P P   +       +  ++G        + +  +     IG    
Sbjct: 6   HHSSGRENLYFQGKLPEPQF-YAEPHTYEEPGRAGRSF--TREIEASRIHIEKIIGSGDS 62

Query: 354 KGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 400
             V  G+          V I+ LK G  +    +F     L E   +    H NI++   
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF-----LSEASIMGQFDHPNIIRLEG 117

Query: 401 VCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
           V         +VT+ ME GS++  L     +    +++ +   V  G+++L+D G  +RD
Sbjct: 118 VVTRGRL-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176

Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE 515
           L ++ +L+D +    + D G+    +       Y T G     RW APE IA    S   
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAFRTFSS-- 233

Query: 516 TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 574
              S+V+SFG+V+WE++  GE  Y   +       +   G R   P  CP  L  LM+ C
Sbjct: 234 --ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAPMGCPHALHQLMLDC 290

Query: 575 WNNSPSKRPQFSEIISLL 592
           W+   ++RP+FS+I+S+L
Sbjct: 291 WHKDRAQRPRFSQIVSVL 308

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (338), Expect = 2e-35
 Identities = 66/283 (23%), Positives = 132/283 (46%), Gaps = 33/283 (11%)

Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFEL 380
            + G   G W ++  +L F+ ++G   F  V  GK      V I+ +K            
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-------MS 62

Query: 381 RKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTK 434
             + +E    +M   H+ ++Q Y VC  +   + ++T+ M  G + +  L+    + QT+
Sbjct: 63  EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFIITEYMANGCLLNY-LREMRHRFQTQ 120

Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
           +++ +  DV E +++L      +RDL ++  L++  G V + D G+    + V +     
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEYTS 177

Query: 495 TDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 549
           + G     RW  PE++     S   +  S++++FG+++WE+ + G+  Y   +  + A  
Sbjct: 178 SVGSKFPVRWSPPEVLM---YSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

Query: 550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           IA  GLR   P    + + ++M  CW+    +RP F  ++S +
Sbjct: 234 IAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (351), Expect = 2e-35
 Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 35/275 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
           W +  ++L    ++G   F  V+ G      RV I+ LK             +  L+   
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-------MSPEAFLQEAQ 314

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
            +    H+ ++Q Y V  +E   + +VT+ M  GS+ D  LK      L+  +++ +A  
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQ 371

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
           +A G+ ++      +RDL +  IL+  +    + D G+    + + +       G     
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPI 428

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R 
Sbjct: 429 KWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRM 483

Query: 558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  134 bits (339), Expect = 3e-35
 Identities = 69/313 (22%), Positives = 126/313 (40%), Gaps = 66/313 (21%)

Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
            +W        E  R     + L F   +G  +F  V +    G+ K            K
Sbjct: 16  HKW--------EFPR-----NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 373 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
            +A+  E R+ L+   ++++    H NI+     C        V+T+    G + + + +
Sbjct: 63  PSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRR 120

Query: 428 SRK------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
            R                   L  ++++  +  VA+G+ FL      +RDL ++ ILL  
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT- 179

Query: 470 HGNVC-LGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---TWMSN 520
           HG +  + D G+    + +   + Y   G      +W+APE       S+     T+ S+
Sbjct: 180 HGRITKICDFGL---ARDIKNDSNYVVKGNARLPVKWMAPE-------SIFNCVYTFESD 229

Query: 521 VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 579
           V+S+G+ +WE+ + G + Y           +   G R   P+  P  +  +M  CW+  P
Sbjct: 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 580 SKRPQFSEIISLL 592
            KRP F +I+ L+
Sbjct: 290 LKRPTFKQIVQLI 302

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  134 bits (339), Expect = 3e-35
 Identities = 74/317 (23%), Positives = 130/317 (41%), Gaps = 70/317 (22%)

Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
            +W        E  R      NL     +G   F  V K     ++   G         K
Sbjct: 16  PKW--------EFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62

Query: 373 GNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 428
            NA   E  +DLL    ++    H ++++ Y  C  +   L ++ +  + GS+   + +S
Sbjct: 63  ENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRES 120

Query: 429 RK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
           RK                        L   ++I  A  +++G+++L +  + +RDL ++ 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---T 516
           IL+     + + D G+    + V E   Y          +W+A E       S+ +   T
Sbjct: 181 ILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGRIPVKWMAIE-------SLFDHIYT 230

Query: 517 WMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 575
             S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM++CW
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCW 289

Query: 576 NNSPSKRPQFSEIISLL 592
              P KRP F++I   L
Sbjct: 290 KQEPDKRPVFADISKDL 306

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (347), Expect = 3e-35
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
           W +  ++L+   ++G   F  V+        +V ++ +K             +  L    
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEAN 235

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
            + T  H  +++ + V   E   + ++T+ M  GS+ D  LKS +       ++I  +  
Sbjct: 236 VMKTLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQ 292

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 497
           +AEG+ F+      +RDL +  IL+       + D G+      V E  EY         
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL----ARVIEDNEYTAREGAKFP 348

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            +W APE I     ++     S+V+SFG+++ E+VT G   Y   S  +    +   G R
Sbjct: 349 IKWTAPEAINFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYR 403

Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              P++CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  134 bits (340), Expect = 3e-35
 Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 32/278 (11%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 383
             ++   +     IG   F  VYKG            V I+ LK G  +    +F     
Sbjct: 39  TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----- 93

Query: 384 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 439
           L E   +    H NI++   V       + ++T+ ME G+++  L  K  +    +++ +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGM 152

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
              +A G+K+L +    +RDL ++ IL++ +    + D G+    +   E   Y T G  
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGK 211

Query: 498 --YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 554
              RW APE I+    + +    S+V+SFG+V+WE++T GE  Y   S  +    I   G
Sbjct: 212 IPIRWTAPEAISYRKFTSA----SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-G 266

Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            R   P DCP  +  LM++CW    ++RP+F++I+S+L
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  134 bits (340), Expect = 3e-35
 Identities = 67/297 (22%), Positives = 123/297 (41%), Gaps = 57/297 (19%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKD 383
             +   ++    ++G  +F  V+  +            V ++ LK   +        R+D
Sbjct: 36  HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQD 89

Query: 384 LL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---------- 429
                EL+T   H++I++F+ VC +    L +V + M  G +N  +              
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148

Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                 L   +++ +A  VA G+ +L      +RDL ++  L+ +   V +GD G+    
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--- 205

Query: 485 KSVGEATEYETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GE 535
           + +     Y   G      RW+ PE       S+     T  S+V+SFG+V+WE+ T G+
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPE-------SILYRKFTTESDVWSFGVVLWEIFTYGK 258

Query: 536 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +   S  +A   I   G   E P+ CP  + ++M  CW   P +R    ++ + L
Sbjct: 259 QPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 4e-35
 Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 34/277 (12%)

Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE 386
           GR+L      +F  +IG  SFK VYK         V   +L+      +     +++   
Sbjct: 25  GRFL------KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 78

Query: 387 LMTCGHKNILQFY---CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
           L    H NI++FY      V     + +VT+LM  G++   + + + ++ K +      +
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 444 AEGIKFLNDHG--VAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDG--Y 498
            +G++FL+     + +RDL    I +    G+V +GD+G+         +      G   
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASFAKAVIGTPE 195

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
            ++APE+     E   E    +VY+FGM + EM T E  Y+ C            G++P 
Sbjct: 196 -FMAPEMYE---EKYDE--SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249

Query: 559 -IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
              K     +K ++  C   +  +R    +    LL 
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKD----LLN 282

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (336), Expect = 5e-35
 Identities = 68/316 (21%), Positives = 114/316 (36%), Gaps = 70/316 (22%)

Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------R 361
             S+ +  V +          I               IG   F  VY G+         +
Sbjct: 3   LDSALLAEVKDV--------LIPH---ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQ 51

Query: 362 VGIEKLKGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLME 417
             I+ L         E +  +  L    LM    H N+L    + +       V+   M 
Sbjct: 52  CAIKSLS-----RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106

Query: 418 GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
            G +   I   ++    K++I   + VA G+++L +    +RDL ++  +LD    V + 
Sbjct: 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVA 166

Query: 477 DMG----IVTACKSVGEATEYETDGY------------RWLAPEIIAGDPESVSE---TW 517
           D G    I             + + Y            +W A E       S+     T 
Sbjct: 167 DFGLARDI------------LDREYYSVQQHRHARLPVKWTALE-------SLQTYRFTT 207

Query: 518 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 576
            S+V+SFG+++WE++T G   Y    P      +A  G R   P+ CP  L  +M +CW 
Sbjct: 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQVMQQCWE 266

Query: 577 NSPSKRPQFSEIISLL 592
             P+ RP F  ++  +
Sbjct: 267 ADPAVRPTFRVLVGEV 282

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  134 bits (339), Expect = 6e-35
 Identities = 73/365 (20%), Positives = 131/365 (35%), Gaps = 88/365 (24%)

Query: 281 GEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSD 340
           G +E       +  + +    L                +           E  R     +
Sbjct: 1   GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSL--------EYPR-----N 47

Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT- 389
           N+E++  IG  +F  V++ +  G+   +          K  A   +++ D      LM  
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAE 106

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------------- 429
             + NI++   VC      +C++ + M  G +N+ +                        
Sbjct: 107 FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 430 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IV 481
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G    I 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI- 224

Query: 482 TACKSVGEATEYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVI 528
                      Y  D Y          RW+ PE       S+     T  S+V+++G+V+
Sbjct: 225 -----------YSADYYKADGNDAIPIRWMPPE-------SIFYNRYTTESDVWAYGVVL 266

Query: 529 WEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSE 587
           WE+ + G   Y   +  +    +   G     P++CP  L +LM  CW+  P+ RP F  
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325

Query: 588 IISLL 592
           I  +L
Sbjct: 326 IHRIL 330

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (351), Expect = 6e-35
 Identities = 66/277 (23%), Positives = 121/277 (43%), Gaps = 34/277 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL 385
           + +  + +E    IG   F  V++G           V I+  K     N     +R+  L
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFL 439

Query: 386 E---LM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
           +    M    H +I++   V  +    + ++ +L   G +   L ++   L    +I  A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
             ++  + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+      
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKL 554

Query: 498 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W+APE I         T  S+V+ FG+ +WE++  G   +           I   G 
Sbjct: 555 PIKWMAPESINFR----RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 609

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           R  +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (334), Expect = 7e-35
 Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 34/279 (12%)

Query: 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 383
           +  L  DNL   D ++G  +F  V +G          V I+ LK G +K +  E      
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----- 57

Query: 384 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
           + E   +    +  I++   VC  E   L +V ++  GG ++  ++  R ++    +  +
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
              V+ G+K+L +    +RDL ++ +LL       + D G+  A  +  + + Y      
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAG 173

Query: 498 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
               +W APE I         +  S+V+S+G+ +WE ++ G+  Y      +    I   
Sbjct: 174 KWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 228

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           G R E P +CP  L +LM  CW      RP F  +   +
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (335), Expect = 1e-34
 Identities = 57/279 (20%), Positives = 119/279 (42%), Gaps = 36/279 (12%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
            +     L  +  +G   F  V+KG            V I+ ++     +    +  + +
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-----DKSGRQSFQAV 62

Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
            +    + +  H +I++   +C      L +VT+ +  GS+ D + + R  L  + ++  
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
            + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+      +    +       
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA---DLLPPDDKQLLYSEA 177

Query: 498 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 553
               +W+A E I     +      S+V+S+G+ +WE++T G   YA     +    +   
Sbjct: 178 KTPIKWMALESIHFGKYTHQ----SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK- 232

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           G R   P+ C   +  +M+KCW    + RP F E+ +  
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (337), Expect = 2e-34
 Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 29/276 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 384
             L++ N+     +G   F  V  G+          V I+ LK G  +    +F     L
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF-----L 94

Query: 385 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
            E   +    H NI++   V       + +VT+ ME GS++  L     +    +++ + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
             +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   EA      G   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 556
            RW +PE IA    +      S+V+S+G+V+WE+++ GE  Y   S       +   G R
Sbjct: 214 IRWTSPEAIAYRKFTS----ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYR 268

Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  131 bits (332), Expect = 2e-34
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 54/296 (18%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
            + +   L+ I  +G   F  V               V ++ LK            R   
Sbjct: 26  TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-----RSGW 80

Query: 385 LE----LMTCGHKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
            +    L T  H++I+++   C D     L +V + +  GS+ D  L    +   +++  
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLF 139

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ETD 496
           A  + EG+ +L+     +RDL ++ +LLD    V +GD G+    K+V E  EY     D
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA---KAVPEGHEYYRVRED 196

Query: 497 G---YRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV- 548
           G     W APE        + E    + S+V+SFG+ ++E++T  +++ +  +     + 
Sbjct: 197 GDSPVFWYAPE-------CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 549 ----GIAAC--------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                +           G R   P  CP  +  LM  CW    S RP F  +I +L
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (333), Expect = 3e-34
 Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 56/306 (18%)

Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
           ++W        E  R     +NL+F   +G  +F  V +    G+ K            K
Sbjct: 39  EKW--------EFPR-----NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85

Query: 373 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
             A+  E ++ L+   ++M+    H+NI+     C      + V+T+    G + + + +
Sbjct: 86  STAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRR 143

Query: 428 SRK--------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
             +                T++++  +  VA+G+ FL      +RD+ ++ +LL  +G+V
Sbjct: 144 KSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHV 202

Query: 474 C-LGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMV 527
             +GD G+    + +   + Y   G      +W+APE I    + V  T  S+V+S+G++
Sbjct: 203 AKIGDFGL---ARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVY-TVQSDVWSYGIL 255

Query: 528 IWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 586
           +WE+ + G   Y           +   G +   P   P+ + S+M  CW   P+ RP F 
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315

Query: 587 EIISLL 592
           +I S L
Sbjct: 316 QICSFL 321

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 3e-34
 Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 52/293 (17%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLL- 385
            +L+ ++++F D IG  +F  V K +           I+++K      A + +  +D   
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDD-HRDFAG 74

Query: 386 --ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------ 429
             E++     H NI+     C    + L +  +    G++ D + KSR            
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 430 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
                L +++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190

Query: 486 SVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 539
                  Y          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y 
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIESLN---YSVY-TTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +  +    +   G R E P +C   +  LM +CW   P +RP F++I+  L
Sbjct: 244 GMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  132 bits (333), Expect = 4e-34
 Identities = 70/341 (20%), Positives = 130/341 (38%), Gaps = 55/341 (16%)

Query: 293 FRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNS 352
           ++      +    +Q+   S +    VD  +      E   +W    +NLEF   +G  +
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREY-----EYDLKWEFPRENLEFGKVLGSGA 57

Query: 353 FKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYC 400
           F  V      GI K            K  A   E R+ L+   ++MT    H+NI+    
Sbjct: 58  FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHENIVNLLG 116

Query: 401 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEII 437
            C      + ++ +    G + + +   R                        L  ++++
Sbjct: 117 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175

Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
             A  VA+G++FL      +RDL ++ +L+     V + D G+    + +   + Y   G
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---ARDIMSDSNYVVRG 232

Query: 498 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
                 +W+APE +    E +  T  S+V+S+G+++WE+ + G   Y           + 
Sbjct: 233 NARLPVKWMAPESLF---EGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288

Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G + + P    + +  +M  CW     KRP F  + S L
Sbjct: 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (331), Expect = 4e-34
 Identities = 61/277 (22%), Positives = 127/277 (45%), Gaps = 34/277 (12%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A   +  K++L
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65

Query: 386 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 440
           +    + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
           + +A+G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G   
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181

Query: 498 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 555
             +W+A E I     +      S+V+S+G+ +WE++T G   Y      + +  +   G 
Sbjct: 182 PIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GE 236

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           R   P  C   +  +M+KCW      RP+F E+I   
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  130 bits (328), Expect = 5e-34
 Identities = 67/294 (22%), Positives = 126/294 (42%), Gaps = 49/294 (16%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
             ++   + F++++G + F  VYKG   G    +          K  A     R++    
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHE 62

Query: 386 -ELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------- 429
             L     H N++    V   +   L ++      G +++ ++                 
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 430 --KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
              L+  + + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REV 178

Query: 488 GEATEYETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAY 538
             A  Y+  G      RW+APE       ++     +  S+++S+G+V+WE+ + G   Y
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPE-------AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              S       I         P DCP  + +LMI+CWN  PS+RP+F +I S L
Sbjct: 232 CGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  130 bits (328), Expect = 6e-34
 Identities = 73/315 (23%), Positives = 128/315 (40%), Gaps = 71/315 (22%)

Query: 318 SVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEK 366
            +            I R      ++    ++G  +F  V+  +            V ++ 
Sbjct: 6   GIHVQ--------HIKR-----RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA 52

Query: 367 LKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVN 422
           LK            RKD     EL+T   H++I++FY VC D +  L +V + M+ G +N
Sbjct: 53  LKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-LIMVFEYMKHGDLN 105

Query: 423 DLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
             +                    +L   +++ IA  +A G+ +L      +RDL ++  L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165

Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSE---TWM 518
           +  +  V +GD G+    + V     Y   G+     RW+ PE       S+     T  
Sbjct: 166 VGANLLVKIGDFGMS---RDVYSTDYYRVGGHTMLPIRWMPPE-------SIMYRKFTTE 215

Query: 519 SNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 577
           S+V+SFG+++WE+ T G+  +   S  +    I   G   E P+ CP+ +  +M+ CW  
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDVMLGCWQR 274

Query: 578 SPSKRPQFSEIISLL 592
            P +R    EI  +L
Sbjct: 275 EPQQRLNIKEIYKIL 289

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (331), Expect = 2e-32
 Identities = 68/310 (21%), Positives = 127/310 (40%), Gaps = 36/310 (11%)

Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGR--WLLNSDNLEFID-QIGPNSFKGVYKGK- 360
           ++  P       +    +++  S  EE+      L  DNL   D ++G  +F  V +G  
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY 357

Query: 361 -------RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGL 409
                   V I+ LK        E    ++++     +    +  I++   VC  E   L
Sbjct: 358 RMRKKQIDVAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--L 410

Query: 410 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
            +V ++  GG ++  ++  R ++    +  +   V+ G+K+L +    +R+L ++ +LL 
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYS 523
                 + D G+  A  +  + + Y          +W APE I     S      S+V+S
Sbjct: 471 NRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS----RSDVWS 524

Query: 524 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 582
           +G+ +WE ++ G+  Y      +    I   G R E P +CP  L +LM  CW      R
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDR 583

Query: 583 PQFSEIISLL 592
           P F  +   +
Sbjct: 584 PDFLTVEQRM 593

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  126 bits (318), Expect = 2e-32
 Identities = 62/297 (20%), Positives = 121/297 (40%), Gaps = 54/297 (18%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
                  L+ I  +G   F  V   +          +V ++ LK              DL
Sbjct: 16  THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADL 70

Query: 385 LE----LMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 438
            +    L    H+NI+++  +C ++  +G+ ++ + +  GS+ + L     K+  K+ ++
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 495
            A+ + +G+ +L      +RDL ++ +L++    V +GD G+    K++    EY   + 
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT---KAIETDKEYYTVKD 187

Query: 496 DG---YRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV 548
           D      W APE        + +      S+V+SFG+ + E++T  ++  +  +     +
Sbjct: 188 DRDSPVFWYAPE-------CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

Query: 549 -----GIAAC--------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 +           G R   P +CP  +  LM KCW   PS R  F  +I   
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  126 bits (319), Expect = 2e-32
 Identities = 60/294 (20%), Positives = 118/294 (40%), Gaps = 49/294 (16%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
            +    +L++I Q+G  +F  V   +           V +++L+          + ++D 
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDF 71

Query: 385 LE----LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIR 438
                 L       I+++  V        L +V + +  G + D + + R +L    ++ 
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 495
            +  + +G+++L      +RDL ++ IL++   +V + D G+    K +    +Y     
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA---KLLPLDKDYYVVRE 188

Query: 496 DG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 551
            G     W APE ++ +  S      S+V+SFG+V++E+ T  + + +  +     +G  
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQ----SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 552 ACGL-------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                            R   P  CP  +  LM  CW  SP  RP FS +   L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  124 bits (312), Expect = 1e-31
 Identities = 67/311 (21%), Positives = 129/311 (41%), Gaps = 60/311 (19%)

Query: 324 TVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDK 372
            + S  E+         +L+F+ Q+G  +F  V   +           V ++KL+   ++
Sbjct: 25  AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84

Query: 373 GNAYEFELRKDLLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LIL 426
                    +D       L +  H NI+++  VC       L ++ + +  GS+ D L  
Sbjct: 85  H-------LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 137

Query: 427 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
              ++   ++++    + +G+++L      +RDL ++ IL++    V +GD G+    K 
Sbjct: 138 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KV 194

Query: 487 VGEATEY---ETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
           + +  EY   +  G     W APE +     SV+    S+V+SFG+V++E+ T    Y  
Sbjct: 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA----SDVWSFGVVLYELFT----YIE 246

Query: 541 CSPVQAAVGIAACGLRP-------------------EIPKDCPQILKSLMIKCWNNSPSK 581
            S    A  +   G                        P  CP  +  +M +CWNN+ ++
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306

Query: 582 RPQFSEIISLL 592
           RP F ++   +
Sbjct: 307 RPSFRDLALRV 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  122 bits (308), Expect = 3e-31
 Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 60/300 (20%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 383
                 +L+F+ Q+G  +F  V   +           V ++KL+   ++         +D
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-------LRD 57

Query: 384 LLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LILKSRKLQTKEII 437
                  L +  H NI+++  VC       L ++ + +  GS+ D L     ++   +++
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117

Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---E 494
           +    + +G+++L      +RDL ++ IL++    V +GD G+    K + +  E+   +
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KVLPQDKEFFKVK 174

Query: 495 TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
             G     W APE +     SV+    S+V+SFG+V++E+ T    Y   S    A  + 
Sbjct: 175 EPGESPIFWYAPESLTESKFSVA----SDVWSFGVVLYELFT----YIEKSKSPPAEFMR 226

Query: 552 ACGLRP-------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             G                        P  CP  +  +M +CWNN+ ++RP F ++   +
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  123 bits (311), Expect = 3e-31
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 30/267 (11%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
           +    + +IG  SF      K     +   +K  +       E  +   E   L    H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLN 451
           NI+Q+     +    L +V    EGG +   I   +    Q  +I+   + +   +K ++
Sbjct: 84  NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRWLAP 503
           D  + +RD+ SQ I L + G V LGD GI     S        +G  T Y      +L+P
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG--TPY------YLSP 194

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           EI    P +      S++++ G V++E+ T + A+ A S     + I + G  P +    
Sbjct: 195 EICENKPYN----NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHY 249

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIIS 590
              L+SL+ + +  +P  RP  + I+ 
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILE 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  121 bits (306), Expect = 7e-31
 Identities = 44/262 (16%), Positives = 86/262 (32%), Gaps = 31/262 (11%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 391
           + + ++G  S+  V+K +     K  G                +  + L E         
Sbjct: 60  QRLSRLGHGSYGEVFKVRS----KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 392 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIK 448
           H   ++      +    L +     E  G S+          L   ++     D    + 
Sbjct: 116 HPCCVRLEQAWEEGGI-LYLQ---TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
            L+  G+ + D+    I L   G   LGD G++    + G     E D   ++APE++ G
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQG 230

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              + ++ +     S G+ I E+             Q    +    L PE        L+
Sbjct: 231 SYGTAADVF-----SLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELR 282

Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
           S+++      P  R     +++
Sbjct: 283 SVLVMMLEPDPKLRATAEALLA 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (286), Expect = 4e-28
 Identities = 57/284 (20%), Positives = 121/284 (42%), Gaps = 34/284 (11%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
            N     +IG   F  VY+   +       LK     +  + + R D ++    L    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 448
            N++++Y   +++N  L +V +L + G ++ +I   +K +     + + +  + +   ++
Sbjct: 92  PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRW 500
            ++   V +RD+    + +   G V LGD+G+     S        VG  T Y      +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG--TPY------Y 202

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEI 559
           ++PE I  +  +    + S+++S G +++EM   ++ +      + +          P +
Sbjct: 203 MSPERIHENGYN----FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258

Query: 560 PKDC-PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 602
           P D   + L+ L+  C N  P KRP  + +  +  R +  + SS
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (283), Expect = 5e-28
 Identities = 46/280 (16%), Positives = 105/280 (37%), Gaps = 50/280 (17%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 391
             +++IG   F  V+K  +    +L GC        K  A   + +  L E     +   
Sbjct: 14  HELEKIGSGEFGSVFKCVK----RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGI 447
           H ++++++    +++H + +  +   GGS+ D I ++ ++ +     E+  + + V  G+
Sbjct: 70  HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-------------------LGDMGIVTACKSVG 488
           ++++   + + D+    I + R                        +GD+G VT    + 
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RIS 185

Query: 489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
                E D   +LA E++  +    +    +++++  + +      E             
Sbjct: 186 SPQVEEGDSR-FLANEVLQENY---THLPKADIFALALTVVCAAGAEPLPRNGDQWHE-- 239

Query: 549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 588
            I   G  P IP+   Q    L+    +  P +RP    +
Sbjct: 240 -IRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  109 bits (274), Expect = 2e-26
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 38/283 (13%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAY-EFELRKDLLE 386
           +++ +  FI ++G   F  V   + +          I   +  D+  A  E ++ +    
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-- 83

Query: 387 LMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRI 439
                H NIL+    C+ E        ++    + G++ + I     K   L   +I+ +
Sbjct: 84  ----NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV-----------G 488
            + +  G++ ++  G A+RDL    ILL   G   L D+G +                  
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
            A +  T  YR  APE+ +     V     ++V+S G V++ M+ GE  Y        +V
Sbjct: 200 WAAQRCTISYR--APELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 549 GIAACG-LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
            +A    L           L  L+       P +RP    ++S
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  107 bits (269), Expect = 5e-26
 Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 36/283 (12%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           + I+ IG   F  V+K K     K   +K     N    +  +++  L    H NI+ + 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYN 70

Query: 400 CVCVDENHG---------------LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 442
                 ++                L +  +  + G++   I K R   L     + +   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWL 501
           + +G+ +++   +  RDL    I L     V +GD G+VT+ K+ G+ T   + G  R++
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--RSKGTLRYM 188

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 561
           +PE I+            ++Y+ G+++ E++        C                 I  
Sbjct: 189 SPEQISSQDYG----KEVDLYALGLILAELLHV------CDTAFETSKFFTDLRDGIISD 238

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 604
              +  K+L+ K  +  P  RP  SEI+  L         + R
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  106 bits (266), Expect = 9e-26
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 31/273 (11%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
           ++ E +  IG  S+    K +R    K    K  D G+  E E +  + E   L    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 394 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 448
           NI+++Y   +D  +  L +V +  EGG +  +I K  K +     + ++R+   +   +K
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 449 FL-----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-----ETDGY 498
                    H V +RDL    + LD   NV LGD G+    + +   T +      T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL---ARILNHDTSFAKTFVGTPYY 182

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
             ++PE +     +      S+++S G +++E+      + A S  + A  I   G    
Sbjct: 183 --MSPEQMNRMSYN----EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRR 235

Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 591
           IP      L  ++ +  N     RP   EI+  
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  106 bits (267), Expect = 1e-25
 Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 43/289 (14%)

Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--- 386
           GR+L    + E I  +G   F  V++ K    +    +K     N  E    K + E   
Sbjct: 1   GRYL---TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKA 56

Query: 387 LMTCGHKNILQFYCVCVDENHG-----------LCVVTKLMEGGSVNDLILKSRKLQTKE 435
           L    H  I++++   +++N             L +  +L    ++ D +     ++ +E
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 436 ---IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
               + I + +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E   
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 493 YETDGYR------------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 540
             T                +++PE I G+  S       +++S G++++E++        
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS----HKVDIFSLGLILFELLY--PFSTQ 230

Query: 541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
              V+    +      P +          ++    + SP +RP+   II
Sbjct: 231 MERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (262), Expect = 7e-25
 Identities = 47/276 (17%), Positives = 96/276 (34%), Gaps = 42/276 (15%)

Query: 343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
             + QIG      V++           K V +E+       ++Y  E+    L  +    
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL-DSYRNEI--AYLNKLQQHS 87

Query: 393 KNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
             I++ Y   + + + + +V   ME     +N  + K + +   E      ++ E +  +
Sbjct: 88  DKIIRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLA 502
           + HG+ + DL     L+   G + L D GI      +   T   T   +        ++ 
Sbjct: 144 HQHGIVHSDLKPANFLIVD-GMLKLIDFGI---ANQMQPDT---TSVVKDSQVGTVNYMP 196

Query: 503 PEIIAGDPESVSETWMSNVY-------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACG 554
           PE I     S       +         S G +++ M  G+  +    + +     I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

Query: 555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
              E P    + L+ ++  C    P +R    E+++
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (262), Expect = 7e-25
 Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 48/314 (15%)

Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGP 350
           S      + + K+Q   P    +  V + E          E   W+          ++G 
Sbjct: 15  SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM------THQPRVGR 68

Query: 351 NSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
            SF  V++            K+V +E  +        E                 I+  Y
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVA------CAGLSSPRIVPLY 116

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
               +    + +  +L+EGGS+  LI +   L     +       EG+++L+   + + D
Sbjct: 117 GAVREGPW-VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175

Query: 460 LNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYR--------WLAPEIIAGDP 510
           + +  +LL   G+   L D G       +      ++             +APE++ G P
Sbjct: 176 VKADNVLLSSDGSRAALCDFGH---ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKS 569
                    +++S   ++  M+ G   +         + IA+      EIP  C  +   
Sbjct: 233 CDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 570 LMIKCWNNSPSKRP 583
            + +     P  R 
Sbjct: 289 AIQEGLRKEPVHRA 302

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  102 bits (257), Expect = 7e-24
 Identities = 51/319 (15%), Positives = 105/319 (32%), Gaps = 40/319 (12%)

Query: 295 NGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFK 354
           +G++ +      +  + S       D+  +  S  E I    +       + QIG     
Sbjct: 15  SGMKETAAAKFERQHMDSPDLGTDDDDKAS-SSANECIS---VKGRIYSILKQIGSGGSS 70

Query: 355 GVYKGKRVGIEK--LKGCDKGNAYEFELRK-----DLLELMTCGHKNILQFYCVCVDENH 407
            V++      +   +K  +   A    L         L  +      I++ Y   + + +
Sbjct: 71  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130

Query: 408 GLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
            + +V   ME     +N  + K + +   E      ++ E +  ++ HG+ + DL     
Sbjct: 131 -IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186

Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEIIAGDPESVSETW 517
           L+   G + L D GI      +   T   T   +        ++ PE I     S     
Sbjct: 187 LIVD-GMLKLIDFGI---ANQMQPDT---TSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239

Query: 518 MSNVY-------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQILKS 569
             +         S G +++ M  G+  +    + +     I       E P    + L+ 
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299

Query: 570 LMIKCWNNSPSKRPQFSEI 588
           ++  C    P +R    E+
Sbjct: 300 VLKCCLKRDPKQRISIPEL 318

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (255), Expect = 8e-24
 Identities = 46/268 (17%), Positives = 95/268 (35%), Gaps = 30/268 (11%)

Query: 343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
             + QIG      V++           K V +E+       ++Y  E+    L  +    
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL-DSYRNEI--AYLNKLQQHS 68

Query: 393 KNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
             I++ Y   + + + + +V   ME     +N  + K + +   E      ++ E +  +
Sbjct: 69  DKIIRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-G-YRWLAPEIIAG 508
           + HG+ + DL     L+   G + L D GI    +    +   ++  G   ++ PE I  
Sbjct: 125 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 509 DPESVSETWMSNVY-------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIP 560
              S       +         S G +++ M  G+  +    + +     I       E P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEI 588
               + L+ ++  C    P +R    E+
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  101 bits (252), Expect = 2e-23
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 13/177 (7%)

Query: 422 NDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
               L    L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+ 
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL- 239

Query: 482 TACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 535
              + + +  +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G 
Sbjct: 240 --ARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVY-TIQSDVWSFGVLLWEIFSLGA 293

Query: 536 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           + Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 27/151 (17%), Positives = 51/151 (33%), Gaps = 27/151 (17%)

Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
            +W        E  R     D L+    +G  +F  V +    GI+K   C        K
Sbjct: 15  SKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 61

Query: 373 GNAYEFELRKDL---LELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
             A   E  + L   L+++     H N++     C      L V+ +  + G+++  +  
Sbjct: 62  EGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120

Query: 428 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
            R        + A    +G  ++    V  +
Sbjct: 121 KRNEFVPYKTKGA-RFRQGKDYVGAIPVDLK 150

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  101 bits (253), Expect = 2e-23
 Identities = 47/242 (19%), Positives = 82/242 (33%), Gaps = 36/242 (14%)

Query: 330 EEIGRWLLNSDNLEFIDQIG--PNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELR 381
           + +  +L      E +  IG        V        G+ V + ++      N     L+
Sbjct: 15  QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74

Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRI 439
            +L       H NI+ +    + +N  L VVT  M  GS  DLI       +    I  I
Sbjct: 75  GELHVSKLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---------------VTAC 484
              V + + +++  G  +R + +  IL+   G V L  +                     
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 544
            SV            WL+PE++  + +       S++YS G+   E+  G   +      
Sbjct: 194 YSVK--VLP------WLSPEVLQQNLQGYDAK--SDIYSVGITACELANGHVPFKDMPAT 243

Query: 545 QA 546
           Q 
Sbjct: 244 QM 245

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 38/280 (13%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLEL 387
            W +N D+ E  + IG  +   V         ++V I K    +K      EL K++  +
Sbjct: 9   PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAI-KRINLEKCQTSMDELLKEIQAM 67

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRI 439
             C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I
Sbjct: 68  SQCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
             +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+      +    +   +  R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV---SAFLATGGDITRNKVR 183

Query: 500 --------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                   W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +   
Sbjct: 184 KTFVGTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 552 --------ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 583
                         E+ K   +  + ++  C    P KRP
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 62/260 (23%), Positives = 111/260 (42%), Gaps = 31/260 (11%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 394
                  ++IG  +   VY    V   +    +  +     + EL   ++L +    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+ +    +  +  L VV + + GGS+ D++     +   +I  +  +  + ++FL+ + 
Sbjct: 79  IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEII 506
           V +RD+ S  ILL   G+V L D G    +T  +S     VG  T Y      W+APE++
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPY------WMAPEVV 188

Query: 507 AGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDC 563
                    + W     S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+  
Sbjct: 189 TRKAYGPKVDIW-----SLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKL 242

Query: 564 PQILKSLMIKCWNNSPSKRP 583
             I +  + +C      KR 
Sbjct: 243 SAIFRDFLNRCLEMDVEKRG 262

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 34/257 (13%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +++IG  SF  V+K       K V I K+   ++      ++++++  L  C    + 
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAI-KIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
           ++Y     ++  L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKI 141

Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKS---------VGEATEYETDGYRWLAPEIIA 507
           +RD+ +  +LL  HG V L D G V    +         VG  T +      W+APE+I 
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFG-VAGQLTDTQIKRNTFVG--TPF------WMAPEVIK 192

Query: 508 GDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
               +S ++ W     S G+   E+  GE  ++   P++    I      P +  +  + 
Sbjct: 193 QSAYDSKADIW-----SLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKP 246

Query: 567 LKSLMIKCWNNSPSKRP 583
           LK  +  C N  PS RP
Sbjct: 247 LKEFVEACLNKEPSFRP 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 62/260 (23%), Positives = 110/260 (42%), Gaps = 31/260 (11%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 394
              L+   +IG  S   V   +     +    K  D       EL   +++ +    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           +++ Y   +     L V+ + ++GG++ D I+   +L  ++I  +   V + + +L+  G
Sbjct: 104 VVEMYKSYLVGEE-LWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEII 506
           V +RD+ S  ILL   G V L D G    ++         VG  T Y      W+APE+I
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG--TPY------WMAPEVI 213

Query: 507 AGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDC 563
           +     +  + W     S G+++ EMV GE  Y + SPVQA   +      P++      
Sbjct: 214 SRSLYATEVDIW-----SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKV 267

Query: 564 PQILKSLMIKCWNNSPSKRP 583
             +L+  + +     P +R 
Sbjct: 268 SPVLRDFLERMLVRDPQERA 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 34/256 (13%)

Query: 348 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +G  ++  VY G           K +     +          E+   L +     HKNI+
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEI--ALHK--HLKHKNIV 82

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGIKFLND 452
           Q+     +    + +  + + GGS++ L L+S+   L+  E  I      + EG+K+L+D
Sbjct: 83  QYLGSFSENGF-IKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 453 HGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYET-DG--YRWLAPEIIAG 508
           + + +RD+    +L++ + G + + D G   + +  G     ET  G    ++APEII  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGT--SKRLAGINPCTETFTGTLQ-YMAPEIIDK 197

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQIL 567
            P    +   ++++S G  I EM TG+  +     P  A   +    + PEIP+      
Sbjct: 198 GPRGYGK--AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255

Query: 568 KSLMIKCWNNSPSKRP 583
           K+ ++KC+   P KR 
Sbjct: 256 KAFILKCFEPDPDKRA 271

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 54/277 (19%), Positives = 103/277 (37%), Gaps = 28/277 (10%)

Query: 326 QSGGEEIG--RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEF 378
           Q+G   IG  R+    ++LE + ++G  +   V+K        V   K            
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68

Query: 379 ELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
            +  DL  ++ +     I+Q +   +     + +  +LM   +          +  + + 
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPIPERILG 127

Query: 438 RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGE 489
           ++ + + + + +L   HGV +RD+    ILLD  G + L D GI           +S G 
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG- 186

Query: 490 ATEYETDGYRWLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
                     ++APE I     +  +    ++V+S G+ + E+ TG+  Y  C      +
Sbjct: 187 -CAA------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

Query: 549 GIAACGLRPEIPKDC--PQILKSLMIKCWNNSPSKRP 583
                   P +P         +S +  C      KRP
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 45/282 (15%), Positives = 111/282 (39%), Gaps = 33/282 (11%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGHKNI 395
           + + E I  +G  +F  V K +     +    K           +  +++ L +  H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 396 LQFYCVCVDENHG------------LCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 442
           +++Y   ++  +             L +  +  E G++ DLI   +   Q  E  R+   
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 499
           + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++       
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 500 -----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 548
                      ++A E++ G      +    ++YS G++ +EM+   +       +   +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEK---IDMYSLGIIFFEMIYPFSTGMERVNILKKL 241

Query: 549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
              +    P+   +  ++ K ++    ++ P+KRP    +++
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 52/267 (19%), Positives = 107/267 (40%), Gaps = 25/267 (9%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELMTCG 391
           L  D+ E I ++G  +   V+K   K  G+    KL   +   A   ++ ++L  L  C 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL- 450
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 90  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS-VGEATEYETDGYRWLAPE 504
             H + +RD+    IL++  G + L D G+      +   S VG  T        +++PE
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG--TRS------YMSPE 200

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
            + G   SV     S+++S G+ + EM  G          +  +                
Sbjct: 201 RLQGTHYSVQ----SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISL 591
                  +  +           E++  
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDY 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 46/202 (22%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H+NI+    V  +++    +V + +EG ++++ I     L     I     + +GIK  +
Sbjct: 70  HQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPEI 505
           D  + +RD+  Q IL+D +  + + D GI  A   + E +  +T+       Y   +PE 
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQY--FSPEQ 183

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA---VGIAACGLRPEIPKD 562
             G+         +++YS G+V++EM+ GE  +   + V  A   +  +   +  ++ KD
Sbjct: 184 AKGEATDEC----TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 563 CPQILKSLMIKCWNNSPSKRPQ 584
            PQ L +++++      + R +
Sbjct: 240 IPQSLSNVILRATEKDKANRYK 261

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 37/295 (12%)

Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCD 371
           +S++    ++   E+   W   +++L+ + +IG  ++  V K   K  G     K     
Sbjct: 1   MSIESSGKLKISPEQH--WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 372 KGNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 430
                + +L  DL  +M +     I+QFY     E     +  +LM      D   K   
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CWICMELMSTSF--DKFYKYVY 115

Query: 431 LQTKEII------RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 480
               ++I      +I +   + +  L  +  + +RD+    ILLDR GN+ L D GI   
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 481 ----VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
               +   +  G           ++APE I            S+V+S G+ ++E+ TG  
Sbjct: 176 LVDSIAKTRDAG--CRP------YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

Query: 537 AYAACSPV----QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSE 587
            Y   + V       V      L     ++      + +  C     SKRP++ E
Sbjct: 228 PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 56/257 (21%), Positives = 112/257 (43%), Gaps = 26/257 (10%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE-LRKDLLELMTCGHKNILQF 398
           E + ++G  +F  VYK K      L   K  +  +  E E    ++  L TC H  I++ 
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAY 457
                 +   L ++ +   GG+V+ ++L+  + L   +I  +   + E + FL+   + +
Sbjct: 82  LGAYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140

Query: 458 RDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAPEIIAGD 509
           RDL +  +L+   G++ L D G+      T  K    +G  T Y      W+APE++  +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG--TPY------WMAPEVVMCE 192

Query: 510 PESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQI 566
               +   + ++++S G+ + EM   E  +   +P++  + IA     P +  P      
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWSVE 251

Query: 567 LKSLMIKCWNNSPSKRP 583
            +  +    + +P  RP
Sbjct: 252 FRDFLKIALDKNPETRP 268

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 47/260 (18%), Positives = 95/260 (36%), Gaps = 39/260 (15%)

Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 364
            L  P+ S     +  EWQ      +    + L S  +     +G  +F  VY+  +  +
Sbjct: 33  GLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89

Query: 365 EK--------LKGCDKGNAYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVVTKL 415
                     LK     N +EF +   L+E L        ++FY   + +N    +V +L
Sbjct: 90  NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-SVLVGEL 148

Query: 416 MEGGSVNDLILKSRKLQTK-----EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--- 467
              G++ + I   +    K      +I  A+ +   I+ ++D  + + D+     +L   
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208

Query: 468 --------DRHGNVCLGDMGIVTACKSVGEATEY----ETDGYRWLAPEIIAGDPESVSE 515
                   D    + L D+G     K   + T +    ET G++    E+++  P     
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ--CVEMLSNKP----W 262

Query: 516 TWMSNVYSFGMVIWEMVTGE 535
            +  + +     ++ M+ G 
Sbjct: 263 NYQIDYFGVAATVYCMLFGT 282

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 392 HKNILQFYCVCVDENHGLCV---VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           H  I+  Y     E     +   V + ++G ++ D++     +  K  I +  D  + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLA 502
           F + +G+ +RD+    I++     V + D GI  A    G  +  +T        Y  L+
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQTAAVIGTAQY--LS 187

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-- 560
           PE   G  +SV     S+VYS G V++E++TGE  +   SPV     +A   +R +    
Sbjct: 188 PEQARG--DSVDAR--SDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQHVREDPIPP 239

Query: 561 ----KDCPQILKSLMIKCWNNSPSKRPQ 584
               +     L ++++K    +P  R Q
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQ 267

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 27/269 (10%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELM-TC 390
           + +D+LE I ++G  ++  V K      G     K       +  +  L  DL   M T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGI 447
                + FY     E   + +  +LM+            K QT     + +IA+ + + +
Sbjct: 64  DCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 448 KFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGEATEYETDGYR 499
           + L +   V +RD+    +L++  G V + D GI       V      G   +       
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG--CKP------ 174

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           ++APE I  +      +  S+++S G+ + E+      Y +       +        P++
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234

Query: 560 PKD-CPQILKSLMIKCWNNSPSKRPQFSE 587
           P D           +C   +  +RP + E
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 34/264 (12%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMT-CGHKNILQF 398
           E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L     H+NI  +
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 399 Y-----CVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLN 451
           Y           +  L +V +    GSV DLI   K   L+ + I  I  ++  G+  L+
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAP 503
            H V +RD+  Q +LL  +  V L D G+      T  +    +G  T Y      W+AP
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG--TPY------WMAP 198

Query: 504 EIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG---LRPEI 559
           E+IA D    +   + S+++S G+   EM  G        P++A   I       L+   
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK--- 255

Query: 560 PKDCPQILKSLMIKCWNNSPSKRP 583
            K   +  +S +  C   + S+RP
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRP 279

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 37/263 (14%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
            +  + ++++G  S+  VYK      G+ V I+++           E+ K++  +  C  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLN 451
            +++++Y         L +V +    GSV+D+I L+++ L   EI  I     +G+++L+
Sbjct: 84  PHVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS---VGEATEYETDGYRWLAP 503
                +RD+ +  ILL+  G+  L D G+      T  K    +G  T +      W+AP
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG--TPF------WMAP 194

Query: 504 EIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--P 560
           E+I       V++ W     S G+   EM  G+  YA   P++A   I      P    P
Sbjct: 195 EVIQEIGYNCVADIW-----SLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRKP 248

Query: 561 KDCPQILKSLMIKCWNNSPSKRP 583
           +         + +C   SP +R 
Sbjct: 249 ELWSDNFTDFVKQCLVKSPEQRA 271

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 85.2 bits (211), Expect = 8e-18
 Identities = 57/281 (20%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSF-----KGVYKG-----KRVGIEKLKGCDKGNAY 376
            G EE    ++   +    D +G  +      +G++       KR+  E     D+    
Sbjct: 11  DGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---- 66

Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KE 435
           E +L ++  E     H N+++++C   D      +  +L    ++ + + +        E
Sbjct: 67  EVQLLRESDE-----HPNVIRYFCTEKDRQF-QYIAIELC-AATLQEYVEQKDFAHLGLE 119

Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTACK--SVG 488
            I +      G+  L+   + +RDL    IL+            + D G+   CK  +VG
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL---CKKLAVG 176

Query: 489 EATEYETDGYR----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 543
             +     G      W+APE+++ D +  + T+  +++S G V + +++ G   +     
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKE-NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

Query: 544 VQAAVGIAACGL-RPEIPKDCPQILKSLMIKCWNNSPSKRP 583
            QA + + AC L      K    I + L+ K     P KRP
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 56/299 (18%), Positives = 98/299 (32%), Gaps = 47/299 (15%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMT--CG 391
           L    L     +    F  VY+ + VG  +   LK        +       +  M    G
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84

Query: 392 HKNILQFYCVCVDENHGLCVVTK----LME--GGSVNDLILKSR---KLQTKEIIRIAID 442
           H NI+QF                    L E   G + + + K      L    +++I   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 443 VAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG------------ 488
               ++ ++     + +RDL  + +LL   G + L D G  T                  
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 489 --EATEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVTGEAAYAACSP 543
             E T   T  YR   PEII  D  S   + E    ++++ G +++ +   +       P
Sbjct: 205 EEEITRNTTPMYR--TPEII--DLYSNFPIGEK--QDIWALGCILYLLCFRQ------HP 252

Query: 544 VQAAVGIAACGLRPEIPKDCPQ--ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 600
            +    +     +  IP    Q  +  SL+      +P +R   +E++  L       N
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 28/214 (13%), Positives = 64/214 (29%), Gaps = 26/214 (12%)

Query: 392 HKNILQFYCVCVDENHG----LCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAI 441
                +   V +DE          +   M+         +       + L     +++ +
Sbjct: 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 218

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
            V   +  L+ +G+ +  L    I+LD+ G V L            G +      G  + 
Sbjct: 219 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH---LVRDGASAVSPI-GRGFA 274

Query: 502 APEIIAG------DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 555
            PE  A              T+  + ++ G+ I+ +   +      + +  +  I     
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--S 332

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
              IP+    +L+  +          R    + +
Sbjct: 333 CKNIPQPVRALLEGFLRY----PKEDRLLPLQAM 362

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.1 bits (200), Expect = 8e-17
 Identities = 40/213 (18%), Positives = 79/213 (37%), Gaps = 34/213 (15%)

Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFLNDHG 454
                      L +  +L    ++ D + +   L+ +E    + I I +AE ++FL+  G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR------------WLA 502
           + +RDL    I       V +GD G+VTA     E     T                +++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA------VGIAACGLR 556
           PE I G+  S       +++S G++++E+                      +        
Sbjct: 245 PEQIHGNNYSHK----VDIFSLGLILFEL---------LYSFSTQMERVRIITDVRNLKF 291

Query: 557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
           P +          ++    + SP++RP+ ++II
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 13/200 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  + + +
Sbjct: 68  HPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP- 510
              V +RD+  + +LL   G + + D G      S        T  Y  L PE+I G   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY--LPPEMIEGRMH 184

Query: 511 -ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
            E V      +++S G++ +E + G+  + A +  +    I+        P    +  + 
Sbjct: 185 DEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARD 236

Query: 570 LMIKCWNNSPSKRPQFSEII 589
           L+ +   ++PS+RP   E++
Sbjct: 237 LISRLLKHNPSQRPMLREVL 256

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 59/258 (22%), Positives = 105/258 (40%), Gaps = 33/258 (12%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNI 395
             + +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           +Q+    + E+    +V +   G + + L +  + LQ  EI  +     +G+ +L+ H +
Sbjct: 117 IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKS-----VGEATEYETDGYRWLAPEIIAGDP 510
            +RD+ +  ILL   G V LGD G   +  +     VG  T Y      W+APE+I    
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANSFVG--TPY------WMAPEVILAMD 226

Query: 511 ES----VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PKDCPQ 565
           E       + W     S G+   E+   +      + + A   IA     P +      +
Sbjct: 227 EGQYDGKVDVW-----SLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSE 280

Query: 566 ILKSLMIKCWNNSPSKRP 583
             ++ +  C    P  RP
Sbjct: 281 YFRNFVDSCLQKIPQDRP 298

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 31/227 (13%), Positives = 72/227 (31%), Gaps = 26/227 (11%)

Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME------GGSVNDLILKSRK 430
           F    DL++      K +++      D        +   M+      G  +       + 
Sbjct: 145 FIFPFDLVKDP--QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202

Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
           L     +++ + V   +  L+ +G+ +  L    I+LD+ G V L         +     
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRDGARV 260

Query: 491 TEYETDGYRWLAPEIIA-------GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 543
               + G+    PE+ A               T+  + ++ G+VI+ +   +      + 
Sbjct: 261 VSSVSRGF--EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318

Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           +  +  I        IP+    +L+  +          R    + + 
Sbjct: 319 LGGSEWIFRS--CKNIPQPVRALLEGFLRY----PKEDRLLPLQAME 359

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 46/211 (21%), Positives = 91/211 (43%), Gaps = 31/211 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H++++ F+    D +  + VV +L    S+ +L  + + L   E       +  G ++L+
Sbjct: 74  HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 502
            + V +RDL    + L+    V +GD G+         AT+ E DG R         ++A
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 183

Query: 503 PEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           PE+++      E   + W     S G +++ ++ G+  +      +  + I        I
Sbjct: 184 PEVLSKKGHSFE--VDVW-----SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 234

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           PK    +  SL+ K     P+ RP  +E+++
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 46/211 (21%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H++++ F+    D +  + VV +L    S+ +L  + + L   E       +  G ++L+
Sbjct: 100 HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 502
            + V +RDL    + L+    V +GD G+         AT+ E DG R         ++A
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 209

Query: 503 PEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           PE+++      E        +V+S G +++ ++ G+  +      +  + I        I
Sbjct: 210 PEVLSKKGHSFE-------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 260

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           PK    +  SL+ K     P+ RP  +E+++
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTINELLN 291

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 55/264 (20%), Positives = 103/264 (39%), Gaps = 45/264 (17%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--------LM 388
           D  + I  +G  SF  V   K         +K  DK    +  ++   +E        L 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----QKVVKLKQIEHTLNEKRILQ 96

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGI 447
                 +++      D ++ L +V + + GG +   + +  +  ++   R  A  +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTF 154

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYETDGYRW 500
           ++L+   + YRDL  + +L+D+ G + + D G     K V   T       E        
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEA------- 204

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PE 558
           LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R    
Sbjct: 205 LAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

Query: 559 IPKDCPQILKSLMIKCWNNSPSKR 582
              D   +L++L+        +KR
Sbjct: 261 FSSDLKDLLRNLLQV----DLTKR 280

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 34/205 (16%), Positives = 71/205 (34%), Gaps = 27/205 (13%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
             +++  +     +   L V  +L+ G  +  ++ +   L     + I   +   +   +
Sbjct: 93  EPHVVPIHDFGEIDGQ-LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPEI 505
             G  +RD+  + IL+       L D GI +A     +    +         Y  +APE 
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA---TTDEKLTQLGNTVGTLYY--MAPER 206

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG------IAACGLRPEI 559
            +    +      +++Y+   V++E +TG   Y     +                +RP I
Sbjct: 207 FSESHATYR----ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGI 261

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQ 584
           P     ++   M K    +P  R  
Sbjct: 262 PVAFDAVIARGMAK----NPEDRYV 282

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.8 bits (189), Expect = 8e-15
 Identities = 65/299 (21%), Positives = 112/299 (37%), Gaps = 51/299 (17%)

Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 370
           P + ++ S+   + +Q    E     +  +       +G   F  V   +     K+  C
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQP--VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYAC 214

Query: 371 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 415
            K       L K  +     E M    K IL+           Y     +   LC+V  L
Sbjct: 215 KK-------LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--LCLVLTL 265

Query: 416 MEGGSVNDL---ILKSRKLQTKEIIRIAIDVAE---GIKFLNDHGVAYRDLNSQRILLDR 469
           M GG   DL   I    +    E  R     AE   G++ L+   + YRDL  + ILLD 
Sbjct: 266 MNGG---DLKFHIYHMGQAGFPEA-RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321

Query: 470 HGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
           HG++ + D+G+      V E    +    T GY  +APE++  +  + S  W    ++ G
Sbjct: 322 HGHIRISDLGL---AVHVPEGQTIKGRVGTVGY--MAPEVVKNERYTFSPDW----WALG 372

Query: 526 MVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
            +++EM+ G++ +           +         E  +      +SL  +     P++R
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 39/199 (19%), Positives = 78/199 (39%), Gaps = 13/199 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NIL+ Y    D    + ++ +    G +   + K  +   +       ++A+ + + +
Sbjct: 73  HPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP- 510
           +  V +RD+  + +L+   G + + D G      S+   T   T  Y  L PE+I G   
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY--LPPEMIEGKTH 189

Query: 511 -ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
            E V      +++  G++ +E + G   + + S  +    I    L+   P       K 
Sbjct: 190 DEKV------DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKD 241

Query: 570 LMIKCWNNSPSKRPQFSEI 588
           L+ K     P +R     +
Sbjct: 242 LISKLLRYHPPQRLPLKGV 260

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 53/278 (19%), Positives = 105/278 (37%), Gaps = 48/278 (17%)

Query: 281 GEIEEEEACDESFRNGVE--NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLN 338
           G + +++   + F+  +E    NL+  +      S       +W+ V+          L 
Sbjct: 134 GHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIH------LT 187

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLL-----ELMTCGHK 393
            ++      IG   F  VY  ++    K+            L K  +     E +    +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC-------LDKKRIKMKQGETLALNER 240

Query: 394 NILQ-------------FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
            +L               Y     +   L  +  LM GG ++  + +       ++   A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE---TDG 497
            ++  G++ +++  V YRDL    ILLD HG+V + D+G+        +   +    T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHG 355

Query: 498 YRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTG 534
           Y  +APE++  G     S  W    +S G ++++++ G
Sbjct: 356 Y--MAPEVLQKGVAYDSSADW----FSLGCMLFKLLRG 387

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 24/228 (10%), Positives = 60/228 (26%), Gaps = 19/228 (8%)

Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLMEG------GSVNDLILKSR 429
              L      +         Q      D       ++             +++ + +   
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 430 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
                 +  +   +      L   G+ +       + +   G + LGD+  +    + G 
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249

Query: 490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
           A+      Y     E +     + +     N +  G+ I+ +      +   +P      
Sbjct: 250 ASS-VPVTY--APREFLNASTATFTHA--LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 550 IAACGLRPEIP----KDCPQI---LKSLMIKCWNNSPSKRPQFSEIIS 590
                  P         C  +   +K+L+ +  N    +R    E + 
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 27/149 (18%)

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYET 495
           V   +++L+   + YRDL  + ILLD++G++ + D G     K V + T       +Y  
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDY-- 169

Query: 496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 555
                +APE+++  P + S  W    +SFG++I+EM+ G   +   + ++    I    L
Sbjct: 170 -----IAPEVVSTKPYNKSIDW----WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

Query: 556 R--PEIPKDCPQILKSLMIKCWNNSPSKR 582
           R  P   +D   +L  L+ +      S+R
Sbjct: 221 RFPPFFNEDVKDLLSRLITR----DLSQR 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 25/173 (14%)

Query: 416 ME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
           ME   G S+       +KL   E I   +++   + +L+  G+ Y DL  + I+L     
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ- 219

Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 532
           + L D+G V+   S G    Y T G+   APEI+   P     T  +++Y+ G  +  + 
Sbjct: 220 LKLIDLGAVSRINSFGYL--YGTPGF--QAPEIVRTGP-----TVATDIYTVGRTLAALT 270

Query: 533 TGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQ 584
                           G    GL  + P          L+ +  +  P +R  
Sbjct: 271 LDLPTRN---------GRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.8 bits (177), Expect = 7e-14
 Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 42/268 (15%)

Query: 353 FKGVYKGKRVGIEKLKGCDKGNAY----EFELRKDLLELMTCG---HKNILQFYCVCVDE 405
           +KG      V ++KL             +F       E+       H+N+++      D 
Sbjct: 48  YKGYVNNTTVAVKKLAAMVDITTEELKQQF-----DQEIKVMAKCQHENLVELLGFSSDG 102

Query: 406 NHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
           +  LC+V   M  GS+ D +               +IA   A GI FL+++   +RD+ S
Sbjct: 103 DD-LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWLAPEIIAGDPESVSETW 517
             ILLD      + D G+  A       T        T  Y  +APE + G+      T 
Sbjct: 162 ANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAY--MAPEALRGEI-----TP 213

Query: 518 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----PEI--PK----DCPQI 566
            S++YSFG+V+ E++TG  A       Q  + I            +    K    D   +
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273

Query: 567 LKSLMI--KCWNNSPSKRPQFSEIISLL 592
                +  +C +   +KRP   ++  LL
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 61/308 (19%), Positives = 103/308 (33%), Gaps = 66/308 (21%)

Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 370
           P   F+ S+   + +Q    E     +  D       +G   F  V+  +     KL  C
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQP--MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215

Query: 371 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 415
            K       L K  L            K IL            Y      +  LC+V  +
Sbjct: 216 KK-------LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD--LCLVMTI 266

Query: 416 MEGGSVNDLILKSRKLQTKEII----RIAIDVAE---GIKFLNDHGVAYRDLNSQRILLD 468
           M GG   D+      +          R     A+   G++ L+   + YRDL  + +LLD
Sbjct: 267 MNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323

Query: 469 RHGNVCLGDMGIVTACKSVGEATEYE--------TDGYRWLAPEIIAGDPESVSETWMSN 520
             GNV + D+G+        E    +        T G+  +APE++ G+    S  +   
Sbjct: 324 DDGNVRISDLGL---AV---ELKAGQTKTKGYAGTPGF--MAPELLLGEEYDFSVDY--- 372

Query: 521 VYSFGMVIWEMVTG------EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 574
            ++ G+ ++EM+                 ++  V   A     +         ++L+ K 
Sbjct: 373 -FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQK- 430

Query: 575 WNNSPSKR 582
               P KR
Sbjct: 431 ---DPEKR 435

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 36/189 (19%)

Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
           L  V + + GG   DL   I KSR+         A ++   + FL+D G+ YRDL    +
Sbjct: 99  LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 515
           LLD  G+  L D G+   CK     G  T       +Y       +APEI+       + 
Sbjct: 156 LLDHEGHCKLADFGM---CKEGICNGVTTATFCGTPDY-------IAPEILQEMLYGPAV 205

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 573
            W    ++ G++++EM+ G A + A +       I    +     + +D   ILKS M K
Sbjct: 206 DW----WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261

Query: 574 CWNNSPSKR 582
                P+ R
Sbjct: 262 N----PTMR 266

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 46/274 (16%), Positives = 104/274 (37%), Gaps = 51/274 (18%)

Query: 353 FKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410
           F+G ++G+ V + K  L         E +L  +  +     H N++++YC    +   L 
Sbjct: 33  FQGSFQGRPVAV-KRMLIDFCDIALMEIKLLTESDD-----HPNVIRYYCSETTDRF-LY 85

Query: 411 VVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463
           +  +L    ++ DL+          +  +    I +   +A G+  L+   + +RDL  Q
Sbjct: 86  IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144

Query: 464 RILLD-------------RHGNVCLGDMGIVTACKSVGEATEYE---------TDGYRWL 501
            IL+               +  + + D G+   CK +                T G+R  
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGL---CKKLDSGQSSFRTNLNNPSGTSGWR-- 199

Query: 502 APEIIAGDPESVSETWMSN---VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 557
           APE++       ++  ++    ++S G V + +++ G+  +      ++ +      L  
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE 259

Query: 558 EIPKDCPQIL---KSLMIKCWNNSPSKRPQFSEI 588
                   ++     L+ +  ++ P KRP   ++
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 36/189 (19%)

Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
           L  V + + GG   DL   I    K         A ++  G++FL+  G+ YRDL    I
Sbjct: 93  LFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149

Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 515
           LLD+ G++ + D G+   CK        T       +Y       +APEI+ G   + S 
Sbjct: 150 LLDKDGHIKIADFGM---CKENMLGDAKTNTFCGTPDY-------IAPEILLGQKYNHSV 199

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 573
            W    +SFG++++EM+ G++ +      +    I          + K+   +L  L ++
Sbjct: 200 DW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255

Query: 574 CWNNSPSKR 582
                P KR
Sbjct: 256 E----PEKR 260

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 36/189 (19%)

Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
           L  V + + GG   DL   I +  + +    +  A ++A G+ FL   G+ YRDL    +
Sbjct: 417 LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473

Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 515
           +LD  G++ + D G+   CK     G  T       +Y       +APEIIA  P   S 
Sbjct: 474 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEIIAYQPYGKSV 523

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 573
            W    ++FG++++EM+ G+A +      +    I    +     + K+   I K LM K
Sbjct: 524 DW----WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579

Query: 574 CWNNSPSKR 582
                P KR
Sbjct: 580 H----PGKR 584

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 30/152 (19%)

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
           +A  + +L+   + YRDL  + ILLD  G++ L D G+   CK        T       E
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPE 204

Query: 493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA 552
           Y       LAPE++   P   +  W    +  G V++EM+ G   + + +  +    I  
Sbjct: 205 Y-------LAPEVLHKQPYDRTVDW----WCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

Query: 553 CGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
             L+  P I      +L+ L+ K      +KR
Sbjct: 254 KPLQLKPNITNSARHLLEGLLQKD----RTKR 281

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 36/189 (19%)

Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
           L  V + + GG   DL   I +  + +    +  A ++A G+ FL   G+ YRDL    +
Sbjct: 96  LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152

Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 515
           +LD  G++ + D G+   CK     G  T       +Y       +APEIIA  P   S 
Sbjct: 153 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEIIAYQPYGKSV 202

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 573
            W    ++FG++++EM+ G+A +      +    I    +     + K+   I K LM K
Sbjct: 203 DW----WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258

Query: 574 CWNNSPSKR 582
                P KR
Sbjct: 259 H----PGKR 263

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 43/270 (15%), Positives = 98/270 (36%), Gaps = 52/270 (19%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--------LM 388
           ++ +F   +G  SF  V   + +   +   +K  +K       ++++ +         + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK----RHIIKENKVPYVTRERDVMS 85

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTK----EIIRIAI 441
              H   ++ Y    D+   L       + G +   I K        T+    EI+  A+
Sbjct: 86  RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV-SAL 143

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE------- 494
           +      +L+  G+ +RDL  + ILL+   ++ + D G     K +   ++         
Sbjct: 144 E------YLHGKGIIHRDLKPENILLNEDMHIQITDFGT---AKVLSPESKQARANSFVG 194

Query: 495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
           T  Y  ++PE++       S       ++ G +I+++V G   + A +       I    
Sbjct: 195 TAQY--VSPELLTEKSACKSSDL----WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

Query: 555 LR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
                +       +++ L++       +KR
Sbjct: 249 YDFPEKFFPKARDLVEKLLVL----DATKR 274

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 39/161 (24%)

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
           ++  + +L++ G+ YRDL    +LLD  G++ L D G+   CK     G+ T        
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 175

Query: 493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--- 549
           Y       +APEI+ G+    S  W    ++ G++++EM+ G + +              
Sbjct: 176 Y-------IAPEILRGEDYGFSVDW----WALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 224

Query: 550 ------IAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
                 I    +R    +      +LKS + K     P +R
Sbjct: 225 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD----PKER 261

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 30/152 (19%)

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
           +   +++L+   V YRD+  + ++LD+ G++ + D G+   CK   S G          E
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFCGTPE 170

Query: 493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA 552
           Y       LAPE++  +    +  W    +  G+V++EM+ G   +      +    I  
Sbjct: 171 Y-------LAPEVLEDNDYGRAVDW----WGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

Query: 553 CGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
             +R    +  +   +L  L+ K     P +R
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKD----PKQR 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 71/300 (23%)

Query: 338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG 391
           ++ N+     +G   F  VYKG       V +++LK    +G   +F       E+    
Sbjct: 33  SNKNI-----LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF-----QTEVEMIS 82

Query: 392 ---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK---EI-IRIAIDVA 444
              H+N+L+    C+       +V   M  GSV   + +  + Q         RIA+  A
Sbjct: 83  MAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141

Query: 445 EGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMG-----------IVTACKSVGEA 490
            G+ +L+DH    + +RD+ +  ILLD      +GD G           + TA +     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---- 197

Query: 491 TEYETDGYRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 549
               T G+  +APE +  G     SE   ++V+ +G+++ E++TG+ A+           
Sbjct: 198 ----TIGH--IAPEYLSTG---KSSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 550 IA---ACGLR----------PEIPKDCPQILKSLMIK----CWNNSPSKRPQFSEIISLL 592
           +      GL            ++  +        +I+    C  +SP +RP+ SE++ +L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.3 bits (168), Expect = 1e-12
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 33/154 (21%)

Query: 444 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT------ 491
           AE    +  L+  G+ YRDL  + I+L+  G+V L D G+   CK     G  T      
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL---CKESIHDGTVTHTFCGT 184

Query: 492 -EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 550
            EY       +APEI+     + +  W    +S G ++++M+TG   +   +  +    I
Sbjct: 185 IEY-------MAPEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKI 233

Query: 551 AACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
             C L   P + ++   +LK L+ +    + + R
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKR----NAASR 263

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 39/161 (24%)

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
           ++  + +L++ G+ YRDL    +LLD  G++ L D G+   CK     G+ T        
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 218

Query: 493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--- 549
           Y       +APEI+ G+    S  W    ++ G++++EM+ G + +              
Sbjct: 219 Y-------IAPEILRGEDYGFSVDW----WALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267

Query: 550 ------IAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
                 I    +R    +      +LKS + K     P +R
Sbjct: 268 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD----PKER 304

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 62/298 (20%), Positives = 114/298 (38%), Gaps = 70/298 (23%)

Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSF-------KGVYKGKRVGIEKLKGCDKGNAYE 377
           ++   +EI    +     E  ++  P+ F       +G + GK   ++K+ G D    Y 
Sbjct: 1   MEGSIKEIA---ITHHVKEGHEKADPSQFELLKVLGQGSF-GKVFLVKKISGSDARQLYA 56

Query: 378 FE-LRKDLL----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKLMEGGSVN 422
            + L+K  L     + T   ++IL            Y    +    L ++   + GG   
Sbjct: 57  MKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK--LYLILDFLRGG--- 111

Query: 423 DL---ILKSRKLQTKEIIRIAIDVAE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
           DL   + K      +    +   +AE    +  L+  G+ YRDL  + ILLD  G++ L 
Sbjct: 112 DLFTRLSKEVMFTEE---DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLT 168

Query: 477 DMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 526
           D G+    K      +         EY       +APE++     + S  W    +SFG+
Sbjct: 169 DFGL---SKESIDHEKKAYSFCGTVEY-------MAPEVVNRRGHTQSADW----WSFGV 214

Query: 527 VIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
           +++EM+TG   +      +    I    L     +  +   +L+ L  +    +P+ R
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKR----NPANR 268

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 26/209 (12%), Positives = 62/209 (29%), Gaps = 42/209 (20%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
              + +   V V    G  VV + + GGS+ ++            IR    +A      +
Sbjct: 90  KPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAH 146

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
             GVA    +  R+ +   G+V L                         +       +P+
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------------MPDA----NPQ 182

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP------KDCPQ 565
                   ++   G  ++ ++            ++ +  A      +        +D P 
Sbjct: 183 -------DDIRGIGASLYALLVNRWPLPEAGV-RSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 566 ILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
            + ++  +        R   S +++L+ +
Sbjct: 235 QISAVAARSVQGDGGIRSA-STLLNLMQQ 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 40/262 (15%), Positives = 85/262 (32%), Gaps = 51/262 (19%)

Query: 309 PLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVY----KGKRVGI 364
           PL S   ++S        +   +     +N  +   I  +    F  +       K   +
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYIN--DYRIIRTLNQGKFNKIILCEKDNKFYAL 59

Query: 365 --------EKLKGCDKGNAYEFELRKDL------LELMT-CGHKNILQFYCVCVDENHGL 409
                   EK +   K N  +  ++         L+++T   ++  L    +  + +  +
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE-V 118

Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA--------EGIKFLNDH-GVAYRDL 460
            ++ + ME  S+         L       I I V             ++++   + +RD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178

Query: 461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW--------LAPEIIAGDPES 512
               IL+D++G V L D G      S      Y  D            + PE  + +   
Sbjct: 179 KPSNILMDKNGRVKLSDFGE-----SE-----YMVDKKIKGSRGTYEFMPPEFFSNESSY 228

Query: 513 VSETWMSNVYSFGMVIWEMVTG 534
                  +++S G+ ++ M   
Sbjct: 229 NGAK--VDIWSLGICLYVMFYN 248

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 36/216 (16%), Positives = 78/216 (36%), Gaps = 32/216 (14%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 394
              D +G  +   V++      G    I   K  +  +         ++   L    HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 395 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 450
           I++ + +  +       ++ +    GS+  ++ +   +  L   E + +  DV  G+  L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 451 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 502
            ++G+ +R++    I+     D      L D G   A + + +     + Y T+ Y  L 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183

Query: 503 PEIIAGDPESVSETWMSN----VYSFGMVIWEMVTG 534
           P++                   ++S G+  +   TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 36/216 (16%), Positives = 78/216 (36%), Gaps = 32/216 (14%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 394
              D +G  +   V++      G    I   K  +  +         ++   L    HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 395 ILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 450
           I++ + +  +       ++ +    GS+  ++ +   +  L   E + +  DV  G+  L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 451 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 502
            ++G+ +R++    I+     D      L D G   A + + +     + Y T+ Y  L 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183

Query: 503 PEIIAGDPESVSETWMSN----VYSFGMVIWEMVTG 534
           P++                   ++S G+  +   TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 52/306 (16%), Positives = 104/306 (33%), Gaps = 62/306 (20%)

Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE 379
               +  G W       E  +++G   F  V +      G++V I   K C +      E
Sbjct: 7   SLPTQTCGPW-------EMKERLGTGGFGYVLRWIHQDTGEQVAI---KQCRQ------E 50

Query: 380 LRKDLLE--------LMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLIL 426
           L     E        +    H N++    V      +  N    +  +  EGG +   + 
Sbjct: 51  LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN 110

Query: 427 KSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGI 480
           +      L+   I  +  D++  +++L+++ + +RDL  + I+L          + D+G 
Sbjct: 111 QFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG- 169

Query: 481 VTACKSVGE----ATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTG 534
               K + +         T  Y  LAPE++       +V      + +SFG + +E +TG
Sbjct: 170 --YAKELDQGELCTEFVGTLQY--LAPELLEQKKYTVTV------DYWSFGTLAFECITG 219

Query: 535 EAAYAACSPVQAAVGIAACGLRPEIP---KDCPQILKSLMIKCWNN-SPSKRPQFSEIIS 590
              +          G         I         +  S ++   N+ S     +    + 
Sbjct: 220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279

Query: 591 LLLRTN 596
            +L  +
Sbjct: 280 CMLMWH 285

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 67/363 (18%), Positives = 128/363 (35%), Gaps = 69/363 (19%)

Query: 253 IKKPKPTSVKLPFGLCGCQEENTKGRDFG-EIEEEEACDESFRNGVEN--SNLKIQLQMP 309
            ++P+P      F +   Q      R F  E  EE    E +   ++     LK Q    
Sbjct: 65  TERPRPN----TFIIRCLQWTTVIERTFHVETPEE---REEWTTAIQTVADGLKKQAAAE 117

Query: 310 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL-- 367
           +   S   S +             +  +  +  E++  +G  +F  V   K     +   
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 177

Query: 368 -KGCDKGNAYEFELRKDLLELMTCGHKNILQ----------FYCVCVDENHGLCVVTKLM 416
            K   K        + ++   +T     +LQ           Y     +   LC V +  
Sbjct: 178 MKILKKEVIVA---KDEVAHTLT--ENRVLQNSRHPFLTALKYSFQTHDR--LCFVMEYA 230

Query: 417 EGGSVNDL---ILKSRKLQTKEIIRI-AIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHG 471
            GG   +L   + + R   +++  R    ++   + +L ++  V YRDL  + ++LD+ G
Sbjct: 231 NGG---ELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286

Query: 472 NVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSETWMSNV 521
           ++ + D G+   CK     G          EY       LAPE++  +    +  W    
Sbjct: 287 HIKITDFGL---CKEGIKDGATMKTFCGTPEY-------LAPEVLEDNDYGRAVDW---- 332

Query: 522 YSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSP 579
           +  G+V++EM+ G   +      +    I    +R    +  +   +L  L+ K     P
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD----P 388

Query: 580 SKR 582
            +R
Sbjct: 389 KQR 391

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 38/190 (20%), Positives = 79/190 (41%), Gaps = 33/190 (17%)

Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQR 464
           + +V  L+ GG   DL   + ++     +E +++   ++   + +L +  + +RD+    
Sbjct: 90  MFMVVDLLLGG---DLRYHLQQNVHF-KEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPE---SVSETW 517
           ILLD HG+V + D  I      +   T+      T  Y  +APE+ +       S +  W
Sbjct: 146 ILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKPY--MAPEMFSSRKGAGYSFAVDW 200

Query: 518 MSNVYSFGMVIWEMVTGEAAY---AACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMI 572
               +S G+  +E++ G   Y   ++ S  +         +       ++   +LK L+ 
Sbjct: 201 ----WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256

Query: 573 KCWNNSPSKR 582
                +P +R
Sbjct: 257 P----NPDQR 262

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 40/161 (24%)

Query: 444 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK----SVGEAT----- 491
            E    ++ L+  G+ YRD+  + ILLD +G+V L D G+    K       E       
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFVADETERAYDFCG 222

Query: 492 --EYETDGYRWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTG----EAAYAACSP 543
             EY       +AP+I+ G      +   W    +S G++++E++TG           S 
Sbjct: 223 TIEY-------MAPDIVRGGDSGHDKAVDW----WSLGVLMYELLTGASPFTVDGEKNSQ 271

Query: 544 VQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 582
            + +  I         E+      +++ L++K     P KR
Sbjct: 272 AEISRRILKSEPPYPQEMSALAKDLIQRLLMK----DPKKR 308

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 63.3 bits (155), Expect = 3e-11
 Identities = 40/212 (18%), Positives = 84/212 (39%), Gaps = 32/212 (15%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFL 450
           H +IL+ Y    D N+ + +V ++   G +N  +  + +     E       +  G+ +L
Sbjct: 70  HPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WL 501
           + HG+ +RDL    +LL R+ N+ + D G+         AT+ +    +         ++
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPHEKHYTLCGTPNYI 179

Query: 502 APEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 558
           +PEI        E       S+V+S G + + ++ G   +   +       +        
Sbjct: 180 SPEIATRSAHGLE-------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-- 230

Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           +P       K L+ +    +P+ R   S ++ 
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 40/214 (18%), Positives = 81/214 (37%), Gaps = 36/214 (16%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVA 444
           +       ++Q +    D+ + L +V + M GG   DL  ++ +  +  K       +V 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRY-LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVV 178

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---Y 498
             +  ++  G  +RD+    +LLD+ G++ L D G    C  + +      D   G   Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT---CMKMNKEGMVRCDTAVGTPDY 235

Query: 499 RWLAPEIIAGDPESVSET----WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 554
             ++PE++              W    +S G+ ++EM+ G+  + A S V     I    
Sbjct: 236 --ISPEVLKSQGGDGYYGRECDW----WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289

Query: 555 LR------PEIPKDCPQILKSLMIKCWNNSPSKR 582
                    +I K+   ++ + +          R
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFL-----TDREVR 318

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 45/277 (16%)

Query: 348 IGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402
           IG   F  VYKG      +V +++          EFE   + L    C H +++     C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRHPHLVSLIGFC 104

Query: 403 VDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYR 458
            + N  + ++ K ME G++   +  S         ++ + I I  A G+ +L+   + +R
Sbjct: 105 DERNE-MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR 163

Query: 459 DLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETD-----GYRWLAPE-IIAGDP 510
           D+ S  ILLD +    + D GI    K     + T   T      GY  + PE  I G  
Sbjct: 164 DVKSINILLDENFVPKITDFGI---SKKGTELDQTHLSTVVKGTLGY--IDPEYFIKGRL 218

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP------VQAAVGIAACG---------L 555
                T  S+VYSFG+V++E++   +A     P       + AV     G         L
Sbjct: 219 -----TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273

Query: 556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             +I  +  +      +KC   S   RP   +++  L
Sbjct: 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 41/211 (19%), Positives = 87/211 (41%), Gaps = 31/211 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++ + V   E   L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 73  HPNIVKLFEVIETEKT-LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 501
              + +RDL ++ +LLD   N+ + D G          +   C +             + 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGA-----------PPYA 180

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEI 559
           APE+  G      E    +V+S G++++ +V+G   +   +  +    +     R    +
Sbjct: 181 APELFQGKKYDGPE---VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             DC  +LK  ++     +P KR    +I+ 
Sbjct: 238 STDCENLLKRFLVL----NPIKRGTLEQIMK 264

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 43/200 (21%), Positives = 80/200 (40%), Gaps = 36/200 (18%)

Query: 404 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNS 462
           DEN+ L +V +   GG +  L+ K  +    E+ R    ++   I  ++  G  +RD+  
Sbjct: 132 DENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEIIAGDPESVSET 516
             ILLDR G++ L D G    C  +       +    G   Y  L+PEI+    ++V   
Sbjct: 191 DNILLDRCGHIRLADFGS---CLKLRADGTVRSLVAVGTPDY--LSPEIL----QAVGGG 241

Query: 517 WMSNVY-------SFGMVIWEMVTGEAAYAACSPVQ-------AAVGIAACGLRPEIPKD 562
             +  Y       + G+  +EM  G+  + A S  +           ++   +   +P++
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301

Query: 563 CPQILKSLMIKCWNNSPSKR 582
               ++ L+       P  R
Sbjct: 302 ARDFIQRLL-----CPPETR 316

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 25/189 (13%)

Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQRILL 467
           L +V     GG +  L+ K      +E+ R    ++   I  ++     +RD+    IL+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208

Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEIIAGDPESVSE-----T 516
           D +G++ L D G    C  + E    ++    G   Y  ++PEI+               
Sbjct: 209 DMNGHIRLADFGS---CLKLMEDGTVQSSVAVGTPDY--ISPEILQAMEGGKGRYGPECD 263

Query: 517 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI---LKSLMIK 573
           W    +S G+ ++EM+ GE  + A S V+    I     R + P     +    K L I+
Sbjct: 264 W----WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL-IR 318

Query: 574 CWNNSPSKR 582
               S   R
Sbjct: 319 RLICSREHR 327

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 43/164 (26%), Positives = 61/164 (37%), Gaps = 21/164 (12%)

Query: 364 IEKLKGCDKGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEG 418
           I+   G         ELR+  L   +++    GH NI+Q             +V  LM+ 
Sbjct: 50  IDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKK 108

Query: 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
           G + D + +   L  KE  +I   + E I  L+   + +RDL  + ILLD   N+ L D 
Sbjct: 109 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168

Query: 479 GIVTACK-------SVGEATEYETDGYRWLAPEIIAGDPESVSE 515
           G               G      T  Y  LAPEII         
Sbjct: 169 GFSCQLDPGEKLREVCG------TPSY--LAPEIIECSMNDNHP 204

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.8 bits (149), Expect = 5e-10
 Identities = 67/477 (14%), Positives = 126/477 (26%), Gaps = 164/477 (34%)

Query: 9   SSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRF---QRLS-RNV 64
           S +    +  VE+VL R N +        E    S   + Y     + +   Q  +  NV
Sbjct: 73  SKQEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131

Query: 65  S--EAIASLKNTL-NLDSAPT----GGVGVG----ARDQPTASSNSKIET--SRKVVWGS 111
           S  +    L+  L  L  A      G +G G    A D      + K++     K+ W +
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD---VCLSYKVQCKMDFKIFWLN 188

Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
           +    +        PE ++  ++K    +  ++         + L I        + R  
Sbjct: 189 LKNCNS--------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---HSIQAELRRL 237

Query: 172 IMIQE------VSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFT 225
           +  +       V  +     V       N+   W A +       + CK           
Sbjct: 238 LKSKPYENCLLVLLN-----V------QNAKA-WNAFN-------LSCK----------- 267

Query: 226 LGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKG--RDFGEI 283
               IL        +   Q+ + L +A      +       L     +  K     + + 
Sbjct: 268 ----ILLT------TRFKQVTDFLSAATTT-HISLDHHSMTL---TPDEVKSLLLKYLDC 313

Query: 284 EE----EEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDE----WQTVQSGGEEIGRW 335
                  E    +                P   S    S+ +    W            W
Sbjct: 314 RPQDLPREVLTTN----------------PRRLSIIAESIRDGLATWD----------NW 347

Query: 336 L-LNSDNLE-----FIDQIGPNSFKGVYKG-----KRVGI-------------------- 364
             +N D L       ++ + P  ++ ++           I                    
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407

Query: 365 -EKL--KGCDKGNAYE---------FELRKDLLELMTCGHKNILQFYCV--CVDENH 407
             KL      +    E          EL+  L       H++I+  Y +    D + 
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDD 463

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 7e-09
 Identities = 63/438 (14%), Positives = 123/438 (28%), Gaps = 152/438 (34%)

Query: 271 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 330
           ++      D  ++++        ++ +    +   +      S  +       T+ S  E
Sbjct: 26  EDAFVDNFDCKDVQDMP------KSILSKEEIDHIIMSKDAVSGTLRLFW---TLLSKQE 76

Query: 331 EIGRWLLNS---DNLEFI------DQIGPNSFKGVYKGKRVGIEKLKG----CDKGNAYE 377
           E+ +  +      N +F+      +Q  P+    +Y  +R   ++L        K N   
Sbjct: 77  EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR---DRLYNDNQVFAKYNVSR 133

Query: 378 FE----LRKDLLEL----------MT-CGHKNIL--QFYCVCVDENHGLCVVTKLMEGG- 419
            +    LR+ LLEL          +   G K  +      VC+        V   M+   
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSG-KTWVALD---VCLSYK-----VQCKMDFKI 184

Query: 420 ---------SVNDLILKSRKL--QTKEIIRIAIDVAEGIKF-LNDHGVAYRDLNSQR--- 464
                    S   ++   +KL  Q         D +  IK  ++      R L   +   
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 465 ---ILLDRHGNVCLGDMGIVTA----CK--------SVGEA------------------T 491
              ++L    NV   +     A    CK         V +                   T
Sbjct: 245 NCLLVLL---NVQ--NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 492 EYETDGY--RW-------LAPEIIAGDP-------ESVSE---TW----MSNVYSFGMVI 528
             E      ++       L  E++  +P       ES+ +   TW      N      +I
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 529 WEMVTGEAAYAACSPVQAAVGIAACGLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQF 585
                 E++     P +         + P    IP     +L  +    W +        
Sbjct: 360 ------ESSLNVLEPAEYRKMFDRLSVFPPSAHIP---TILLSLI----WFDVIKSDVM- 405

Query: 586 SEII------SLLLRTNN 597
             ++      SL+ +   
Sbjct: 406 -VVVNKLHKYSLVEKQPK 422

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 34/133 (25%), Positives = 54/133 (40%), Gaps = 16/133 (12%)

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
            GH +I+         +  + +V  LM  G + D + +   L  KE   I   + E + F
Sbjct: 157 AGHPHIITLIDSYESSSF-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-------SVGEATEYETDGYRWLA 502
           L+ + + +RDL  + ILLD +  + L D G     +         G      T GY  LA
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG------TPGY--LA 267

Query: 503 PEIIAGDPESVSE 515
           PEI+    +    
Sbjct: 268 PEILKCSMDETHP 280

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 46/228 (20%), Positives = 80/228 (35%), Gaps = 46/228 (20%)

Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEF---ELR--KDLL 385
            +   E + +IG  ++  VYK      G  V ++ ++     G         +R    L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 386 ELMTCGHKNILQFYCVCVDENHG----LCVVTKLMEGGSVNDL--ILKSRK---LQTKEI 436
            L    H N+++   VC          + +V + ++     DL   L       L  + I
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETI 122

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-EYET 495
             +      G+ FL+ + + +RDL  + IL+   G V L D G+          T    T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 496 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             YR  APE++               Y+  + +W       EM   + 
Sbjct: 183 LWYR--APEVLLQST-----------YATPVDMWSVGCIFAEMFRRKP 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 44/272 (16%), Positives = 93/272 (34%), Gaps = 48/272 (17%)

Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE---LMTC 390
             +  +G  +F  V+               I+K K  +     + +L K  LE   L   
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
            H NI++   +  ++     V+ K   G  +   I +  +L       I   +   + +L
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRW 500
               + +RD+  + I++     + L D G            T C ++             
Sbjct: 147 RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC---------- 196

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PE 558
            APE++ G+P    E     ++S G+ ++ +V  E       P           +     
Sbjct: 197 -APEVLMGNPYRGPEL---EMWSLGVTLYTLVFEEN------PFCELEETVEAAIHPPYL 246

Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           + K+   ++  L+       P +R    ++++
Sbjct: 247 VSKELMSLVSGLLQP----VPERRTTLEKLVT 274

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 9/130 (6%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI+    V  D  + + VVT+LM+GG + D IL+ +    +E   +   + + 
Sbjct: 70  LRYGQHPNIITLKDVYDDGKY-VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128

Query: 447 IKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRW 500
           +++L+  GV +RDL    IL         ++ + D G     ++      T   T  +  
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF-- 186

Query: 501 LAPEIIAGDP 510
           +APE++    
Sbjct: 187 VAPEVLERQG 196

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 30/129 (23%), Positives = 61/129 (47%), Gaps = 14/129 (10%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H  I++       E++ +  V +LMEGG + D ++ +++L+          +   
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251

Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD----GYR 499
           +++L+++G+ +RDL  + +LL   +    + + D G     K +GE +   T      Y 
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 307

Query: 500 WLAPEIIAG 508
            LAPE++  
Sbjct: 308 -LAPEVLVS 315

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 22/123 (17%), Positives = 49/123 (39%), Gaps = 7/123 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFL 450
           H  ++  +    D+N  + ++ + M GG + + +       +  E +     V +G+  +
Sbjct: 213 HPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 451 NDHGVAYRDLNSQRILL-DRHGN-VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 507
           +++   + DL  + I+   +  N + L D G+               T  +   APE+  
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF--AAPEVAE 329

Query: 508 GDP 510
           G P
Sbjct: 330 GKP 332

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 15/134 (11%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH+N+L+      +E+    +V + M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127

Query: 451 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD---------GY 498
           ++ G+A+RDL  + IL    ++   V + D  + +  K  G+ +   T           Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 499 RWLAPEIIAGDPES 512
             +APE++    E 
Sbjct: 188 --MAPEVVEAFSEE 199

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 53.7 bits (130), Expect = 5e-08
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 25/153 (16%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H +I++ Y V         +V + + GG + D I K  +++  E  R+   +   + + +
Sbjct: 70  HPHIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRWL 501
            H V +RDL  + +LLD H N  + D G+           T+C S   A           
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA----------- 177

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APE+I+G   +  E    +++S G++++ ++ G
Sbjct: 178 APEVISGRLYAGPE---VDIWSCGVILYALLCG 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 8/125 (6%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           GH NI++ + V  D+ H   +V +L+ GG + + I K +     E   I   +   +  +
Sbjct: 64  GHPNIVKLHEVFHDQLH-TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 451 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEI 505
           +D GV +RDL  + +L    + +  + + D G         +   T   T  Y   APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY--AAPEL 180

Query: 506 IAGDP 510
           +  + 
Sbjct: 181 LNQNG 185

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 38/198 (19%), Positives = 79/198 (39%), Gaps = 36/198 (18%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE--- 386
            ++   + ++G  ++  V   K            I+K +      + + +  +   E   
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 387 -----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI 441
                L +  H NI++ + V  D+ +   +VT+  EGG + + I+   K    +   I  
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEAT 491
            +  GI +L+ H + +RD+  + ILL   +   N+ + D G+ +           +G   
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG--- 210

Query: 492 EYETDGYRWLAPEIIAGD 509
              T  Y  +APE++   
Sbjct: 211 ---TAYY--IAPEVLKKK 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 53.0 bits (128), Expect = 9e-08
 Identities = 33/156 (21%), Positives = 73/156 (46%), Gaps = 9/156 (5%)

Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419
           K +   +L    +G + E E+ +++  L    H NI+  + +  ++   + ++ +L+ GG
Sbjct: 36  KFIKKRRLSSSRRGVSRE-EIEREVNILREIRHPNIITLHDIFENKTD-VVLILELVSGG 93

Query: 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCL 475
            + D + +   L   E  +    + +G+ +L+   +A+ DL  + I+L      +  + L
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153

Query: 476 GDMGIVTACKSVGEATE-YETDGYRWLAPEIIAGDP 510
            D GI    ++  E    + T  +  +APEI+  +P
Sbjct: 154 IDFGIAHKIEAGNEFKNIFGTPEF--VAPEIVNYEP 187

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 39/213 (18%), Positives = 90/213 (42%), Gaps = 30/213 (14%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
           S+  + + ++G  ++  V             I+ ++      +   +L +++  L    H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
            NI++ Y    D+ +   +V +  +GG + D I+   K    +   I   V  G+ +L+ 
Sbjct: 96  PNIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 453 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLA 502
           H + +RDL  + +LL   ++   + + D G+    ++       +G      T  Y  +A
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG------TAYY--IA 206

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
           PE++    +   + W     S G++++ ++ G 
Sbjct: 207 PEVLRKKYDEKCDVW-----SIGVILFILLAGY 234

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 24/124 (19%), Positives = 50/124 (40%), Gaps = 7/124 (5%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKF 449
            H+NIL  +         L ++ + + G  + + I   + +L  +EI+     V E ++F
Sbjct: 59  RHRNILHLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 450 LNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 506
           L+ H + + D+  + I+     +  + + + G     K        +    Y   APE+ 
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY--YAPEVH 175

Query: 507 AGDP 510
             D 
Sbjct: 176 QHDV 179

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 25/123 (20%), Positives = 53/123 (43%), Gaps = 7/123 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H  ++  +    D+   + ++ + + GG + D I  +  K+   E+I       EG+K +
Sbjct: 107 HPKLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 451 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 507
           ++H + + D+  + I+ +      V + D G+ T             T  +   APEI+ 
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF--AAPEIVD 223

Query: 508 GDP 510
            +P
Sbjct: 224 REP 226

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 32/156 (20%), Positives = 70/156 (44%), Gaps = 9/156 (5%)

Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419
           K +   + +   +G   E E+ +++  L    H NI+  + V  +    + ++ +L+ GG
Sbjct: 43  KFIKKRQSRASRRGVCRE-EIEREVSILRQVLHPNIITLHDVYENRTD-VVLILELVSGG 100

Query: 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCL 475
            + D + +   L  +E       + +G+ +L+   +A+ DL  + I+L        ++ L
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 476 GDMGIVTACKSVGEATE-YETDGYRWLAPEIIAGDP 510
            D G+    +   E    + T  +  +APEI+  +P
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEF--VAPEIVNYEP 194

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 26/124 (20%), Positives = 57/124 (45%), Gaps = 8/124 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H N++  + V  +    + ++ +L+ GG + D + +   L  +E       + +G+ +L+
Sbjct: 74  HHNVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 452 DHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 506
              +A+ DL  + I+L        ++ L D G+    +   E    + T  +  +APEI+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF--VAPEIV 190

Query: 507 AGDP 510
             +P
Sbjct: 191 NYEP 194

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 33/159 (20%), Positives = 75/159 (47%), Gaps = 24/159 (15%)

Query: 391 GHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVA 444
           G  +IL+    F     +  H + +V +++ G ++  LI K   R +    + +I+  + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVH-VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 445 EGIKFLNDH-GVAYRDLNSQRILLDR------HGNVCLGDMGIVTACKSVGEATEY-ETD 496
            G+ +++   G+ + D+  + +L++          + + D+G   AC      T   +T 
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTR 199

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 535
            YR  +PE++ G P        ++++S   +I+E++TG+
Sbjct: 200 EYR--SPEVLLGAPWGCG----ADIWSTACLIFELITGD 232

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 7/125 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
           H N++Q Y     +N  + +V + ++GG + D I+ +S  L   + I     + EGI+ +
Sbjct: 145 HANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203

Query: 451 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 507
           +   + + DL  + IL        + + D G+    K   +    + T  +  LAPE++ 
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF--LAPEVVN 261

Query: 508 GDPES 512
            D  S
Sbjct: 262 YDFVS 266

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 339 SDNLEFIDQIGPNSFKGVYKG--KRVGIEK-LKGCDKGNAYEFELRKDLLE----LMTCG 391
           SD  +    +G  SF  V     K  G E  +K   K    +   ++ LL     L    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  GI +++
Sbjct: 85  HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143

Query: 452 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIA 507
            + + +RDL  + +LL    +  N+ + D G+ T  ++  +  +   T  Y  +APE++ 
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY--IAPEVLH 201

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGE 535
           G  +   + W     S G++++ +++G 
Sbjct: 202 GTYDEKCDVW-----STGVILYILLSGC 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 14/129 (10%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H  I++       E++ +  V +LMEGG + D ++ +++L+          +   
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYETD----GYR 499
           +++L+++G+ +RDL  + +LL        + + D G     K +GE +   T      Y 
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 182

Query: 500 WLAPEIIAG 508
            LAPE++  
Sbjct: 183 -LAPEVLVS 190

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 52.2 bits (126), Expect = 2e-07
 Identities = 43/224 (19%), Positives = 84/224 (37%), Gaps = 52/224 (23%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 385
           +  E I +IG  S+  V+K      G+ V I+K        + +        LR  + L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-----ESEDDPVIKKIALREIRMLK 57

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
           +L    H N++    V   +   L +V +  +    + +   L   +  +    +  I  
Sbjct: 58  QL---KHPNLVNLLEVFRRKRR-LHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITW 109

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 499
              + + F + H   +RD+  + IL+ +H  + L D G         +   +   T  YR
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             +PE++ GD +          Y   + +W       E+++G  
Sbjct: 170 --SPELLVGDTQ----------YGPPVDVWAIGCVFAELLSGVP 201

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 37/187 (19%), Positives = 77/187 (41%), Gaps = 22/187 (11%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC---------DKGNAYEFE-LRKDLLELM 388
           ++  +  +++G  +F  V +     ++ L G           K +A + + L ++     
Sbjct: 10  TEEYQLFEELGKGAFSVVRRC----VKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H NI++ +    +E H   ++  L+ GG + + I+        +       + E + 
Sbjct: 66  LLKHPNIVRLHDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124

Query: 449 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAP 503
             +  GV +R+L  + +LL    +   V L D G+    +   +A      T GY  L+P
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY--LSP 182

Query: 504 EIIAGDP 510
           E++  DP
Sbjct: 183 EVLRKDP 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 64/234 (27%)

Query: 340 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFE--------LR--K 382
              E + +IG  ++  V+K       G+ V +++++        +          +R   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVA 63

Query: 383 DLLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-----ILKSRKLQT 433
            L  L T  H N+++ + VC     D    L +V + ++     DL      +    + T
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPT 119

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
           + I  +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+    +        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMAL 176

Query: 494 ----ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
                T  YR  APE++               Y+  + +W       EM   + 
Sbjct: 177 TSVVVTLWYR--APEVLLQSS-----------YATPVDLWSVGCIFAEMFRRKP 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 64/236 (27%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
              E + +IG  +F  V+K      G++V ++K+           E  K+      L E 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALREI 67

Query: 387 --LMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDL--ILKSR--KLQT 433
             L    H+N++    +C  +             V    E    +DL  +L +   K   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
            EI R+   +  G+ +++ + + +RD+ +  +L+ R G + L D G+  A      +   
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 494 E------TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
                  T  YR   PE++ G+ +          Y   + +W       EM T   
Sbjct: 184 RYTNRVVTLWYR--PPELLLGERD----------YGPPIDLWGAGCIMAEMWTRSP 227

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 25/124 (20%), Positives = 55/124 (44%), Gaps = 8/124 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H N++  + V  ++   + ++ +L+ GG + D + +   L  +E       +  G+ +L+
Sbjct: 73  HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 452 DHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 506
              +A+ DL  + I+L         + + D G+        E    + T  +  +APEI+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF--VAPEIV 189

Query: 507 AGDP 510
             +P
Sbjct: 190 NYEP 193

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 37/173 (21%)

Query: 379 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL 431
           ELR  LL+ M   H+N++    V      ++E + + +VT LM      DL  I+K +KL
Sbjct: 78  ELR--LLKHMK--HENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKL 129

Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
               +  +   +  G+K+++   + +RDL    + ++    + + D G+  A  +  E T
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL--ARHTADEMT 187

Query: 492 EY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
            Y  T  YR  APEI+          WM   Y+  + IW       E++TG  
Sbjct: 188 GYVATRWYR--APEIMLN--------WMH--YNQTVDIWSVGCIMAELLTGRT 228

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 25/153 (16%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H +I++ Y V    +  + +V + + GG + D I K+ +L  KE  R+   +  G+ + +
Sbjct: 75  HPHIIKLYQVISTPSD-IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRWL 501
            H V +RDL  + +LLD H N  + D G+           T+C S   A           
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA----------- 182

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
           APE+I+G   +  E    +++S G++++ ++ G
Sbjct: 183 APEVISGRLYAGPE---VDIWSSGVILYALLCG 212

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 30/155 (19%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           H +I++ Y V       + +V   +E  GG + D I++ +++   E  R    +   I++
Sbjct: 68  HPHIIKLYDVITTPTD-IVMV---IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYR 499
            + H + +RDL  + +LLD + NV + D G+           T+C S   A         
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA--------- 174

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 534
             APE+I G   +  E    +V+S G+V++ M+ G
Sbjct: 175 --APEVINGKLYAGPE---VDVWSCGIVLYVMLVG 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 34/132 (25%), Positives = 63/132 (47%), Gaps = 19/132 (14%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           L    H NI++ + +  D +    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
           I +++ H + +RDL  + ILL   ++  ++ + D G+ T  +        +G      T 
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG------TA 187

Query: 497 GYRWLAPEIIAG 508
            Y  +APE++ G
Sbjct: 188 YY--IAPEVLRG 197

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 51.0 bits (123), Expect = 4e-07
 Identities = 26/121 (21%), Positives = 52/121 (42%), Gaps = 7/121 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H+N+++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+
Sbjct: 64  HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD----GYRWLAPEIIA 507
             G+ +RD+  + +LLD   N+ + D G+ T  +                Y  +APE++ 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY--VAPELLK 180

Query: 508 G 508
            
Sbjct: 181 R 181

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 51.0 bits (123), Expect = 4e-07
 Identities = 29/134 (21%), Positives = 54/134 (40%), Gaps = 19/134 (14%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
                H NI++ +    +E+    +V  L+ GG + + I+        +       + E 
Sbjct: 59  CRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
           I + + +G+ +R+L  + +LL    +   V L D G+              G      T 
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TP 171

Query: 497 GYRWLAPEIIAGDP 510
           GY  L+PE++  DP
Sbjct: 172 GY--LSPEVLKKDP 183

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 33/147 (22%), Positives = 68/147 (46%), Gaps = 9/147 (6%)

Query: 392 HKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           H N+++   V  D N   L +V +L+  G V ++      L   +      D+ +GI++L
Sbjct: 95  HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYL 153

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIA 507
           +   + +RD+    +L+   G++ + D G V+      +A    T G   +  +APE ++
Sbjct: 154 HYQKIIHRDIKPSNLLVGEDGHIKIADFG-VSNEFKGSDALLSNTVGTPAF--MAPESLS 210

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTG 534
              +  S     +V++ G+ ++  V G
Sbjct: 211 ETRKIFSGK-ALDVWAMGVTLYCFVFG 236

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 44/237 (18%), Positives = 74/237 (31%), Gaps = 72/237 (30%)

Query: 343 EFIDQIGPNSFKGVY---------KGKRVGIEKLKGCDKGNAYE--FELRKD-------- 383
                I      G Y         +G  V I+++                          
Sbjct: 25  TVQRFIS----SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 384 -LLELMTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKE- 435
            LL      H NIL     F        H L +VT+LM      DL  ++  +++     
Sbjct: 81  RLLNHFH--HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQ 134

Query: 436 --------IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
                   I+        G+  L++ GV +RDL+   ILL  + ++ + D  +     + 
Sbjct: 135 HIQYFMYHILL-------GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 488 GEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
              T Y     YR  APE++               ++  + +W       EM   +A
Sbjct: 188 ANKTHYVTHRWYR--APELVMQ----------FKGFTKLVDMWSAGCVMAEMFNRKA 232

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 40/182 (21%), Positives = 78/182 (42%), Gaps = 17/182 (9%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC---DKGNAYEFELRKDLLELMTCGHKNI 395
           SD  E   ++G  +   VY+ K+ G +K        K    +  +R ++  L+   H NI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-IVRTEIGVLLRLSHPNI 110

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           ++   +       + +V +L+ GG + D I++      ++       + E + +L+++G+
Sbjct: 111 IKLKEIFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 456 AYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAG 508
            +RDL  + +L         + + D G+    K V      +    T GY   APEI+ G
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGL---SKIVEHQVLMKTVCGTPGY--CAPEILRG 224

Query: 509 DP 510
             
Sbjct: 225 CA 226

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 50.3 bits (121), Expect = 8e-07
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 51/227 (22%)

Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--K 382
            +   E +D +G   F  VYK       + V I+K+K    G+  E +       LR  K
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIK 64

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIR 438
            L EL    H NI+        ++  + +V   ME     DL  I+K     L    I  
Sbjct: 65  LLQEL---SHPNIIGLLDAFGHKS-NISLVFDFME----TDLEVIIKDNSLVLTPSHIKA 116

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETD 496
             +   +G+++L+ H + +RDL    +LLD +G + L D G+  +  S   A   +  T 
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
            YR  APE++ G          + +Y  G+ +W       E++    
Sbjct: 177 WYR--APELLFG----------ARMYGVGVDMWAVGCILAELLLRVP 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 50.3 bits (121), Expect = 9e-07
 Identities = 31/129 (24%), Positives = 59/129 (45%), Gaps = 15/129 (11%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
               ++  + V  + +  + ++ +   GG +  L L      +   ++IR+   + EG+ 
Sbjct: 87  SCPRVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 449 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWL 501
           +L+ + + + DL  Q ILL      G++ + D G+    + +G A E      T  Y  L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM---SRKIGHACELREIMGTPEY--L 200

Query: 502 APEIIAGDP 510
           APEI+  DP
Sbjct: 201 APEILNYDP 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 57/266 (21%), Positives = 100/266 (37%), Gaps = 36/266 (13%)

Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRK---DLLELMTC 390
           +    +G   F  VY G RV          +EK +  D G             LL+ ++ 
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
           G   +++        +    ++ +  E    + D I +   LQ +        V E ++ 
Sbjct: 106 GFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 450 LNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYET-DG---YRWLAPE 504
            ++ GV +RD+  + IL+D   G + L D G      ++ + T Y   DG   Y    PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVY--SPPE 218

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
            I            + V+S G+++++MV G+       P +    I    +     +   
Sbjct: 219 WIRYHRYHGRS---AAVWSLGILLYDMVCGDI------PFEHDEEIIRGQVF--FRQRVS 267

Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
              + L+  C    PS RP F EI +
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQN 293

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 49.9 bits (120), Expect = 9e-07
 Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 19/132 (14%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
           + +  H NI++ Y    D    + +V +L  GG + + ++  R  +  +  RI  DV   
Sbjct: 60  MKSLDHPNIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
           + + +   VA+RDL  +  L         + L D G+    K        VG      T 
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG------TP 172

Query: 497 GYRWLAPEIIAG 508
            Y  ++P+++ G
Sbjct: 173 YY--VSPQVLEG 182

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 41/185 (22%), Positives = 78/185 (42%), Gaps = 30/185 (16%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVG---IEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
            F++ +G  +F  V+       GK      I+K       +     L  ++  L    H+
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHE 66

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+    +     H   +V +L+ GG + D IL+      K+   +   V   +K+L+++
Sbjct: 67  NIVTLEDIYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 454 GVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEI 505
           G+ +RDL  + +L    + +  + + D G+     S  E     +      GY  +APE+
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL-----SKMEQNGIMSTACGTPGY--VAPEV 178

Query: 506 IAGDP 510
           +A  P
Sbjct: 179 LAQKP 183

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 19/129 (14%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++ +    +E+    +V  L+ GG + + I+        +       + E I + +
Sbjct: 87  HPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145

Query: 452 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWL 501
            +G+ +R+L  + +LL    +   V L D G+              G      T GY  L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TPGY--L 197

Query: 502 APEIIAGDP 510
           +PE++  DP
Sbjct: 198 SPEVLKKDP 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 57/226 (25%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KDL 384
           +    +D++G  ++  VYK         V +++++        E E       +R    L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54

Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 440
            +L    H NI+  + +   E   L +V + ++     DL   L      +    +    
Sbjct: 55  KDL---KHANIVTLHDIIHTEKS-LTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFL 106

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDG 497
             +  G+ + +   V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLW 165

Query: 498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
           YR   P+I+ G          S  YS  + +W       EM TG  
Sbjct: 166 YR--PPDILLG----------STDYSTQIDMWGVGCIFYEMATGRP 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 52/266 (19%), Positives = 92/266 (34%), Gaps = 44/266 (16%)

Query: 348 IGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELM-----TCGHK 393
           +G   F  V+ G R+          I + +        +       + L+       GH 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
            +++       +   + V+ + +    + D I +   L           V   I+  +  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158

Query: 454 GVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYET-DG---YRWLAPEIIAG 508
           GV +RD+  + IL+D R G   L D G      ++     Y   DG   Y    PE I+ 
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYTDFDGTRVY--SPPEWISR 212

Query: 509 D----PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
                         + V+S G+++++MV G+       P +    I    L    P    
Sbjct: 213 HQYHALP-------ATVWSLGILLYDMVCGDI------PFERDQEILEAELH--FPAHVS 257

Query: 565 QILKSLMIKCWNNSPSKRPQFSEIIS 590
               +L+ +C    PS RP   EI+ 
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILL 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 52/224 (23%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 385
           +  E +  +G  S+  V K      G+ V I+K        + + +      +R  K L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-----ESDDDKMVKKIAMREIKLLK 79

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
           +L    H+N++    VC  +     +V + ++    + +   L+     L  + + +   
Sbjct: 80  QL---RHENLVNLLEVCKKKKR-WYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 499
            +  GI F + H + +RD+  + IL+ + G V L D G      + GE   +   T  YR
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             APE++ GD +          Y   + +W       EM  GE 
Sbjct: 192 --APELLVGDVK----------YGKAVDVWAIGCLVTEMFMGEP 223

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 27/121 (22%), Positives = 53/121 (43%), Gaps = 7/121 (5%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H+N+++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+
Sbjct: 64  HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-G---YRWLAPEIIA 507
             G+ +RD+  + +LLD   N+ + D G+ T  +            G   Y  +APE++ 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY--VAPELLK 180

Query: 508 G 508
            
Sbjct: 181 R 181

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 57/224 (25%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
             +  +G  ++  V        G +V I+KL        ++          ELR  LL+ 
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELR--LLKH 80

Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
           M   H+N++    V      +D+     +V   M      DL  ++K  KL    I  + 
Sbjct: 81  MR--HENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLV 134

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
             + +G+++++  G+ +RDL    + ++    + + D G+  A ++  E T Y  T  YR
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL--ARQADSEMTGYVVTRWYR 192

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             APE+I          WM   Y+  + IW       EM+TG+ 
Sbjct: 193 --APEVILN--------WMR--YTQTVDIWSVGCIMAEMITGKT 224

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 49.0 bits (118), Expect = 1e-06
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 53/224 (23%)

Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 386
           +    +++IG  ++  VYK     G+   ++K++          E   +      + E  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---------LEKEDEGIPSTTIREIS 52

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
            L    H NI++ Y V   +   L +V + ++     DL  +L   +  L++       +
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKR-LVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLL 107

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGYR 499
            +  GI + +D  V +RDL  Q +L++R G + + D G+  A    V + T E  T  YR
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             AP+++ G          S  YS  + IW       EMV G  
Sbjct: 168 --APDVLMG----------SKKYSTTIDIWSVGCIFAEMVNGTP 199

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 53/224 (23%)

Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 386
           +  + ++++G  ++  VYK     G+ V +++++          +   +      + E  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---------LDAEDEGIPSTAIREIS 71

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
            L    H NI+    V   E   L +V + ME     DL  +L   K  LQ  +I     
Sbjct: 72  LLKELHHPNIVSLIDVIHSERC-LTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLY 126

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGYR 499
            +  G+   + H + +RDL  Q +L++  G + L D G+  A    V   T E  T  YR
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             AP+++ G          S  YS  + IW       EM+TG+ 
Sbjct: 187 --APDVLMG----------SKKYSTSVDIWSIGCIFAEMITGKP 218

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 43/210 (20%), Positives = 89/210 (42%), Gaps = 28/210 (13%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK-GNAYEFELRKDLLELM----TCG 391
           E +  IG  SF  V K       + V ++ ++   +       E+R  +LE +       
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR--ILEHLRKQDKDN 157

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKF 449
             N++         NH +C+  +L+   ++ +LI K+  +      + + A  + + +  
Sbjct: 158 TMNVIHMLENFTFRNH-ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 450 LNDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 506
           L+ + + + DL  + ILL       + + D G  ++C        Y ++  YR  APE+I
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYR--APEVI 271

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
            G    +      +++S G ++ E++TG  
Sbjct: 272 LGARYGMP----IDMWSLGCILAELLTGYP 297

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 31/190 (16%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELMT 389
           ++    +  +G  SF  V K K            I K       N     + +++  L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---AKNKDTSTILREVELLKK 77

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
             H NI++ + +  D +    +V +L  GG + D I+K ++    +  RI   V  GI +
Sbjct: 78  LDHPNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 450 LNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYR 499
           ++ H + +RDL  + ILL   ++  ++ + D G+ T  +        +G      T  Y 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG------TAYY- 189

Query: 500 WLAPEIIAGD 509
            +APE++ G 
Sbjct: 190 -IAPEVLRGT 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 12/135 (8%)

Query: 385 LELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIR 438
                 G  +I+    V  + +HG   L ++ + MEGG +   I + R  Q    +E   
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAE 132

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYET 495
           I  D+   I+FL+ H +A+RD+  + +L    ++   + L D G           T   T
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

Query: 496 DGYRWLAPEIIAGDP 510
             Y  +APE++  + 
Sbjct: 193 PYY--VAPEVLGPEK 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 26/156 (16%), Positives = 58/156 (37%), Gaps = 12/156 (7%)

Query: 364 IEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND 423
           ++  K          +L+++        H +I++       +   L +V + M+G  +  
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-LYMVFEFMDGADLCF 115

Query: 424 LILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLG 476
            I+K                   + E +++ +D+ + +RD+    +LL   +    V LG
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175

Query: 477 DMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDP 510
             G+       G        T  +  +APE++  +P
Sbjct: 176 GFGVAIQLGESGLVAGGRVGTPHF--MAPEVVKREP 209

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 59/227 (25%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
             +  IG  ++  V          RV I+K+      + +E          E++  +L  
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIK--ILLR 81

Query: 388 MTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAI 441
               H+NI+          +++   + +V  LME     DL  +LK++ L    I     
Sbjct: 82  FR--HENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLY 135

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETD 496
            +  G+K+++   V +RDL    +LL+   ++ + D G            G  TEY  T 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
            YR  APEI+            S  Y+  + IW       EM++   
Sbjct: 196 WYR--APEIMLN----------SKGYTKSIDIWSVGCILAEMLSNRP 230

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 34/221 (15%), Positives = 78/221 (35%), Gaps = 51/221 (23%)

Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           N D+ + + ++G   +  V++       ++V ++ LK   K      E++  +LE +  G
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-EIK--ILENL-RG 89

Query: 392 HKNILQFYCVCVDENHGLC--VVTKLMEGGSVNDL-----ILKSRKLQ--TKEIIRIAID 442
             NI+    +  D        V   +       D       L    ++    EI++    
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEILK---- 141

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEY-ETDGYRW 500
               + + +  G+ +RD+    +++D  H  + L D G+        E      +  ++ 
Sbjct: 142 ---ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK- 197

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTG 534
             PE++              +Y + + +W        M+  
Sbjct: 198 -GPELLVD----------YQMYDYSLDMWSLGCMLASMIFR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 58/224 (25%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
                +G  ++  V        G++V I+KL        ++          EL   LL+ 
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELL--LLKH 79

Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
           M   H+N++    V      +   +   +V   M+     DL  I+   K   ++I  + 
Sbjct: 80  MQ--HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL-KFSEEKIQYLV 132

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
             + +G+K+++  GV +RDL    + ++    + + D G+  A  +  E T Y  T  YR
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL--ARHADAEMTGYVVTRWYR 190

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             APE+I          WM   Y+  + IW       EM+TG+ 
Sbjct: 191 --APEVILS--------WMH--YNQTVDIWSVGCIMAEMLTGKT 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
           + +  IG  +   V         + V I+KL        ++          EL   L++ 
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELV--LMKC 80

Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
           +   HKNI+    V      ++E   + +V +LM+     +L  +++  +L  + +  + 
Sbjct: 81  V--NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM-ELDHERMSYLL 133

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
             +  GIK L+  G+ +RDL    I++     + + D G+     +    T Y  T  YR
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
             APE+I           +   Y   + IW       EM+ G  
Sbjct: 194 --APEVI-----------LGMGYKENVDIWSVGCIMGEMIKGGV 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 27/155 (17%), Positives = 62/155 (40%), Gaps = 22/155 (14%)

Query: 392 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVN--DLILKSRKLQTKEIIRIAIDVAEGIK 448
           HKN++Q   V  +E    + +V +    G     D + + ++    +       + +G++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD----GYRWLAPE 504
           +L+  G+ ++D+    +LL   G + +  +G+  A           T      +    PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF--QPPE 181

Query: 505 IIAGD-----PESVSETWMSNVYSFGMVIWEMVTG 534
           I  G       +        +++S G+ ++ + TG
Sbjct: 182 IANGLDTFSGFK-------VDIWSAGVTLYNITTG 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 28/137 (20%), Positives = 56/137 (40%), Gaps = 23/137 (16%)

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAID 442
           L +  H NI++ + V  D ++ + +V +  EGG + + I+ ++          +  +   
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATE 492
           +   + + +   V ++DL  + IL      H  + + D G+    KS        G    
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG---- 188

Query: 493 YETDGYRWLAPEIIAGD 509
             T  Y  +APE+   D
Sbjct: 189 --TALY--MAPEVFKRD 201

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 44/222 (19%), Positives = 88/222 (39%), Gaps = 54/222 (24%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
              E +++IG  ++  V+K       + V +++++          +   +      L E 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALREI 52

Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 440
             L    HKNI++ + V   +   L +V +  +     DL     S    L  + +    
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKK-LTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFL 107

Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGY 498
             + +G+ F +   V +RDL  Q +L++R+G + L + G+  A    V   + E  T  Y
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 499 RWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 533
           R   P+++ G          + +YS  + +W       E+  
Sbjct: 168 R--PPDVLFG----------AKLYSTSIDMWSAGCIFAELAN 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 58/230 (25%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KD 383
           S   + ++++G  ++  VYK      G  V ++++K        + E       +R    
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-------LDSEEGTPSTAIREISL 56

Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKE 435
           + EL    H+NI++ Y V   EN  L +V         K M+  +V +     R L+   
Sbjct: 57  MKEL---KHENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNL 109

Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EY 493
           +      + +G+ F +++ + +RDL  Q +L+++ G + LGD G+  A    V   + E 
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169

Query: 494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
            T  YR  AP+++ G             YS  + IW       EM+TG+ 
Sbjct: 170 VTLWYR--APDVLMGSRT----------YSTSIDIWSCGCILAEMITGKP 207

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 41/249 (16%), Positives = 80/249 (32%), Gaps = 62/249 (24%)

Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
                IG  S+  V                + K K           ++ ++  +    H 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-------------------- 433
           NI + Y V  DE + +C+V +L  GG + D +       T                    
Sbjct: 89  NIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 434 --------------------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHG 471
                               K I  I   +   + +L++ G+ +RD+  +  L   ++  
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207

Query: 472 NVCLGDMGIVTACKSVGEATEYE------TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 525
            + L D G+      +     Y       T  +  +APE++    ES       + +S G
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF--VAPEVLNTTNESYGP--KCDAWSAG 263

Query: 526 MVIWEMVTG 534
           +++  ++ G
Sbjct: 264 VLLHLLLMG 272

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 35/172 (20%)

Query: 379 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLILKSRKLQT 433
           EL   L++ +   HKNI+    V      ++E   + +V +LM+     +L    +    
Sbjct: 111 ELV--LMKCV--NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELD 162

Query: 434 KEIIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
            E +  +   +  GIK L+  G+ +RDL    I++     + + D G+     +    T 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 493 Y-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
           Y  T  YR  APE+I           +   Y   + IW       EMV  + 
Sbjct: 223 YVVTRYYR--APEVI-----------LGMGYKENVDIWSVGCIMGEMVRHKI 261

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 58/229 (25%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
           D    I ++G  ++  VYK       + V I++++          E  ++      + E 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIREV 84

Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAI 441
             L    H+NI++   V    +  L ++ +  E    NDL   + K+  +  + I     
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHR-LHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLY 139

Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMGIVTACKS-VGEAT-EYE 494
            +  G+ F +     +RDL  Q +LL          + +GD G+  A    + + T E  
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
           T  YR   PEI+ G          S  YS  + IW       EM+    
Sbjct: 200 TLWYR--PPEILLG----------SRHYSTSVDIWSIACIWAEMLMKTP 236

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 44/220 (20%), Positives = 83/220 (37%), Gaps = 52/220 (23%)

Query: 345 IDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRK-DLLELMTCGHKNILQF 398
              IG  SF  V++ K      V I+K+   DK     F+ R+  ++ ++   H N++  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-DK----RFKNRELQIMRIVK--HPNVVDL 97

Query: 399 YCV------CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDV-----AE 445
                      DE   L +V + +       +    +      + +  + I +       
Sbjct: 98  KAFFYSNGDKKDEVF-LNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAP 503
            + +++  G+ +RD+  Q +LLD   G + L D G      +      Y  +  YR  AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
           E+I G          +  Y+  + IW       E++ G+ 
Sbjct: 211 ELIFG----------ATNYTTNIDIWSTGCVMAELMQGQP 240

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 21/150 (14%)

Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +IG  +F  +  GK +         +E +K        E+   K L          I 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL-----GSGDGIP 68

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           Q Y       +   V+  L  G S+ DL  L  R    K ++ IAI +   +++++   +
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 456 AYRDLNSQRILLDRHGN-----VCLGDMGI 480
            YRD+  +  L+ R GN     + + D  +
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 54/233 (23%)

Query: 340 DNLEFID-QIGPNSFKGVYK--------GKRVGIEKLK--GCDKGNAYEFELRKDLLELM 388
           D  E+   ++G  ++  VYK         K   +++++  G       E  L   L EL 
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL---LRELK 76

Query: 389 TCGHKNILQFYCVCVD-ENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKEIIRI 439
              H N++    V +   +  + ++          +++    +    K  +L    +  +
Sbjct: 77  ---HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKS-VGEATEYE 494
              + +GI +L+ + V +RDL    IL+       G V + DMG      S +    + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 495 ----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 536
               T  YR  APE++ G          +  Y+  + IW       E++T E 
Sbjct: 194 PVVVTFWYR--APELLLG----------ARHYTKAIDIWAIGCIFAELLTSEP 234

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK-GNAYEFELR--KDLLELMTCGHK 393
           E    IG  SF  V K       + V I+ +K      N  + E+R  + + +  T    
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFL- 450
            I+      +  NH LC+V +++   ++ DL+  +    +      + A  +   + FL 
Sbjct: 117 YIVHLKRHFMFRNH-LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 451 -NDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 506
             +  + + DL  + ILL   +   + + D G  ++C+      +Y ++  YR  +PE++
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRFYR--SPEVL 230

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
            G P  ++     +++S G ++ EM TGE 
Sbjct: 231 LGMPYDLA----IDMWSLGCILVEMHTGEP 256

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 25/136 (18%)

Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVA 444
              +I++   V  +   G   L +V + ++GG +   I   R  Q    +E   I   + 
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIG 171

Query: 445 EGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYE 494
           E I++L+   +A+RD+  + +L      +  + L D G      S               
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------ 225

Query: 495 TDGYRWLAPEIIAGDP 510
           T  Y  +APE++  + 
Sbjct: 226 TPYY--VAPEVLGPEK 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 44.3 bits (105), Expect = 8e-05
 Identities = 44/222 (19%), Positives = 83/222 (37%), Gaps = 53/222 (23%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRK-DLLELMTCGHKNI 395
                IG  SF  VY+      G+ V I+K+   DK     F+ R+  ++  +   H NI
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DK----RFKNRELQIMRKLD--HCNI 109

Query: 396 LQFYCV------CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAID----- 442
           ++            DE + L +V   +       +  + +      + +  I +      
Sbjct: 110 VRLRYFFYSSGEKKDEVY-LNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEY-ETDGYRW 500
           +   + +++  G+ +RD+  Q +LLD     + L D G             Y  +  YR 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGE 535
            APE+I G          +  Y+  + +W       E++ G+
Sbjct: 224 -APELIFG----------ATDYTSSIDVWSAGCVLAELLLGQ 254

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 30/148 (20%), Positives = 57/148 (38%), Gaps = 19/148 (12%)

Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +IG  SF  +Y G  +         +E +K        E ++ K +      G   I 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----GGVGIP 68

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
                  + ++ + V+  L  G S+ DL    SRK   K ++ +A  +   I++++    
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126

Query: 456 AYRDLNSQRILLDRHGN---VCLGDMGI 480
            +RD+     L+        V + D G+
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGL 154

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 25/121 (20%), Positives = 50/121 (41%), Gaps = 8/121 (6%)

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H NI++F  V +   H L ++ +   GG + + I  + +    E       +  G+ + +
Sbjct: 75  HPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 452 DHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIA 507
              + +RDL  +  LLD      + + D G  +    +     +   T  Y  +APE++ 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY--IAPEVLL 190

Query: 508 G 508
            
Sbjct: 191 R 191

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 33/148 (22%), Positives = 60/148 (40%), Gaps = 19/148 (12%)

Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +IG  SF  +Y G  +         +E +K       YE ++ + L      G   I 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----GGTGIP 66

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
                 V+ ++ + V+  L  G S+ DL    SRKL  K ++ +A  +   ++F++    
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124

Query: 456 AYRDLNSQRILLDRHGN---VCLGDMGI 480
            +RD+     L+        V + D G+
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGL 152

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 49/313 (15%), Positives = 101/313 (32%), Gaps = 92/313 (29%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD----LLELM 388
            D  E    IG  S+  V +       + V I+K+          FE   D    L E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 389 ---TCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR- 438
                 H ++++   + +    ++   L VV ++ +    +D   + ++    T+  I+ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKT 160

Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG------------------- 479
           +  ++  G+K+++  G+ +RDL     L+++  +V + D G                   
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 480 ---------IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW 529
                             + T +  T  YR  APE+I               Y+  + +W
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELILL----------QENYTEAIDVW 268

Query: 530 -------EMVTGEAAYAACSPVQAAVGIAACGLRPEIP-KDCPQILKSLMIKCWNNSPSK 581
                  E++       A    +           P  P   C  +             ++
Sbjct: 269 SIGCIFAELLNMIKENVAYHADR----------GPLFPGSSCFPLSPDQKAGNDFKFHTR 318

Query: 582 RP--QFSEIISLL 592
               Q + I ++L
Sbjct: 319 GNRDQLNVIFNIL 331

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 21/151 (13%)

Query: 344 FIDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
              +IG  SF  +++G  +          E  +        E+   K L      G   I
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL-----AGCTGI 68

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
              Y    +  H + V+  L  G S+ DL+ L  RK   K +   A  +   ++ +++  
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 455 VAYRDLNSQRILLDRHGN-----VCLGDMGI 480
           + YRD+     L+ R  +     + + D G+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 48/184 (26%)

Query: 379 ELRKDLLELMTCGHKNILQFY-------------CVCVDENHGLCVVTKLMEGGSVNDL- 424
           E++  ++  +   H NI++ +                + E + + +V + ME     DL 
Sbjct: 58  EIK--IIRRL--DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLA 109

Query: 425 -ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMG--- 479
            +L+   L  +        +  G+K+++   V +RDL    + ++     + +GD G   
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 480 -IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------E 530
            +       G  +E   T  YR  +P ++             N Y+  + +W       E
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLS----------PNNYTKAIDMWAAGCIFAE 217

Query: 531 MVTG 534
           M+TG
Sbjct: 218 MLTG 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 20/101 (19%), Positives = 43/101 (42%), Gaps = 14/101 (13%)

Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL-----QTKEIIRIAID 442
              +I++   V  +   G   L +V + ++GG +   I           +  EI++    
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---S 125

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGI 480
           + E I++L+   +A+RD+  + +L      +  + L D G 
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 36/170 (21%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
                +Q         H +C+V +L+ G S  D I ++     +   I ++A  + + + 
Sbjct: 75  STFRCVQMLEWFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132

Query: 449 FLNDHGVAYRDL---NSQRILLDRHGNVCLGDMGIVTACKSV----------GEATEYET 495
           FL+ + + + DL   N   IL  +       +  I    +++          G AT Y+ 
Sbjct: 133 FLHSNKLTHTDLKPEN---ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT-YDD 188

Query: 496 DG---------YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
           +          YR  APE+I     S       +V+S G ++ E   G  
Sbjct: 189 EHHSTLVSTRHYR--APEVILALGWSQP----CDVWSIGCILIEYYLGFT 232

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 28/167 (16%), Positives = 60/167 (35%), Gaps = 30/167 (17%)

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
                +          H +C+  +L+ G +  + + ++         +  +A  +   ++
Sbjct: 80  NKFLCVLMSDWFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV----------GEATEYETDG- 497
           FL+++ + + DL  + IL        L +       KSV          G AT ++ +  
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHH 196

Query: 498 --------YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 536
                   YR   PE+I     +       +V+S G +++E   G  
Sbjct: 197 TTIVATRHYR--PPEVILELGWAQP----CDVWSIGCILFEYYRGFT 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 33/183 (18%), Positives = 65/183 (35%), Gaps = 45/183 (24%)

Query: 379 ELRKDLLELMTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQ 432
           E++  +L+     H+NI+           +  + + ++ +LM+     DL  ++ ++ L 
Sbjct: 59  EIK--ILKHFK--HENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLS 110

Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG-----------IV 481
              I          +K L+   V +RDL    +L++ + ++ + D G             
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 482 TACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 533
                     E+  T  YR  APE++            S  YS  M +W       E+  
Sbjct: 171 EPTGQQSGMVEFVATRWYR--APEVMLT----------SAKYSRAMDVWSCGCILAELFL 218

Query: 534 GEA 536
              
Sbjct: 219 RRP 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	604
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.55
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.74
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.2
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.92
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.89
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.62
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.56
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.39
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.36
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.1
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.62
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.43
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	93.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	88.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	81.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	81.32

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-56  Score=461.75  Aligned_cols=268  Identities=28%  Similarity=0.478  Sum_probs=224.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk---~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..|+++.+++++.++||+|+||.||+|+   .||||.++...........+.+|+.++.+++|||||+++|+|.++ . +
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~-~  106 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-N-L  106 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S-C
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-e-E
Confidence            4799999999999999999999999985   699999986655555566789999999999999999999998643 3 8


Q ss_pred             EEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||||||+||+|.++|... .++++..++.++.||+.||+|||+++||||||||+||||++++++||+|||+|+......
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999999999654 579999999999999999999999999999999999999999999999999997654322


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----CCCCC
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKD  562 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----~~p~~  562 (604)
                        .......||+.|||||++.+.... .++.++|||||||++|||+||+.||.+.++...+..++..+...    ..+.+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~-~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNN-PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             cceeecccccCCCccCHHHhhccCCC-CCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence              223455799999999999765322 35678999999999999999999999887777666666655432    35678


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCCCC
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN  603 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~~~  603 (604)
                      +|+.+.+||.+||+.||++||||.||+++|+.+....-.-+
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~~  306 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKIN  306 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC--
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCCC
Confidence            99999999999999999999999999999988765443333

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.2e-55  Score=454.59  Aligned_cols=257  Identities=25%  Similarity=0.484  Sum_probs=220.2

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      +++..++++++++||+|+||.||+|+           .||||.++... ......++.+|+.++.+++|||||+++|+|.
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            34666889999999999999999975           59999997443 3334567899999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL  467 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl  467 (604)
                      +++. ++||||||++|+|.++|...                ..+++..++.++.||+.||+|||+++||||||||+||||
T Consensus       100 ~~~~-~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          100 KDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSSS-CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ECCE-EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            8765 89999999999999999532                258999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChH
Q 007429          468 DRHGNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV  544 (604)
Q Consensus       468 d~~g~vKL~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~  544 (604)
                      ++++++||+|||+++......  .......||+.|||||++.+..+    +.++|||||||++|||+| |..||.+.+..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~----s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF----SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC----CccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999997654332  22334578999999999987754    456999999999999999 89999998877


Q ss_pred             HHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          545 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       545 ~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +.... +..+.+++.|.+||+.+.+||.+||+.||++||||.||+++|+...|.
T Consensus       255 ~~~~~-i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          255 DVVEM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             HHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             HHHHH-HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence            66554 455677788999999999999999999999999999999999876553

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.7e-55  Score=452.24  Aligned_cols=255  Identities=26%  Similarity=0.466  Sum_probs=219.1

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .|..++|.+.++||+|+||.||+|+           .||||+++..  ......++.+|+.+|.+++|||||+++|+|.+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            4666899999999999999999974           5999999743  33445678999999999999999999999998


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS-------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~-------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      ++. +|||||||++|+|.++|.+.             ..+++..++.++.||+.||.|||+++||||||||+||||+.++
T Consensus        87 ~~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             CCE-EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            775 99999999999999999653             3699999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .+||+|||+++.......  ......||+.|||||++.+..+    +.++|||||||++|||+| |+.||.+.+..+...
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~----~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  241 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF----TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  241 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC----CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999976543322  1223458999999999987754    456999999999999999 899999988877665


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .+. .+.++..|..+|+++.+||.+||+.||++||||.+|...|+++.+.
T Consensus       242 ~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          242 CIT-QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            554 4567788999999999999999999999999999999999887553

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.7e-55  Score=463.46  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=227.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g  400 (604)
                      .+|+|..++|++++.||+|+||.||+|           +.||||.++... .......+.+|+.+|.+++| ||||+++|
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            579999999999999999999999997           469999997432 33345568899999999965 89999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      +|.+++..+|||||||++|+|.++|.+.                ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9987665589999999999999999642                248899999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  541 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~  541 (604)
                      ||++.++.+||+|||+++.......  ......||+.|||||++.+..+    +.++|||||||++|||+| |..||.+.
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y----~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY----TIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC----CCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999986644332  2234468999999999987754    456999999999999998 99999988


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +..+.+...+..+.++..|..+++++.++|.+||+.||++||||.||+++|.++.+.
T Consensus       292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            776777777888889999999999999999999999999999999999999988653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.1e-54  Score=450.93  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=215.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      +.+..++|.+.++||+|+||.||+|+           .||||+++..  ......++.+|+.+|.+++|||||+++|+|.
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45667899999999999999999974           5999999743  3334567899999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKS---------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD  468 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~---------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld  468 (604)
                      +.+. +|||||||++|+|.+++.+.               .++++..++.++.||+.||.|||+++||||||||+||||+
T Consensus       114 ~~~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          114 EGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSSS-EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             ECCE-EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            8775 99999999999999998643               2589999999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 007429          469 RHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ  545 (604)
Q Consensus       469 ~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~  545 (604)
                      .++++||+|||+++.......  ......||+.|||||++.+..+    +.++|||||||++|||+| |+.||...+..+
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~----~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF----TTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC----CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC----CccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999986543322  2234568999999999987754    456999999999999999 899999988877


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       546 ~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ....+ ..+.+++.|..+|+++.+||.+||+.||++||||.||+++|+.+...
T Consensus       269 ~~~~i-~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          269 AIDCI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHH-HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHH-HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            66554 45667889999999999999999999999999999999999988654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.8e-54  Score=455.04  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=214.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++++.||+|+||.||++      +.||||++............+.+|+.+|++++|||||++++++.+++. +|||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS-LYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEEE
Confidence            478999999999999999995      579999998665555556678999999999999999999999998775 9999


Q ss_pred             EecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+||+|.++|...  ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++........
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            9999999999999643  35799999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....+||+.|||||++.+..++    .++|||||||++|||++|+.||.+.+..+.+..+.... .+..+..+++++.+|
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~----~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYN----NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCC----HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHH
Confidence            3445799999999999887654    46999999999999999999999988888777777654 446778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      |.+||+.||.+|||+.|+++|-|..
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhh
Confidence            9999999999999999999885543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.3e-54  Score=446.45  Aligned_cols=251  Identities=20%  Similarity=0.318  Sum_probs=211.9

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ++.++|++++.||+|+||.||+++         .||+|.++...........+.+|+.+|.+++|||||++++++.+++.
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            445789999999999999999864         59999987543222223357789999999999999999999998876


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|||||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+++.....
T Consensus       101 -~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 -LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             -EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             -EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999876554


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      .......+||+.|||||++.+..++.    ++|||||||++|||+||..||.+.+..+....+...  .+.+|..+++++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~----~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~  253 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQ----SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEA  253 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCT----HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred             CccccccccCcccCCHHHhccCCCCC----CCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHH
Confidence            44455668999999999998876554    599999999999999999999998888877777765  456788999999


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQ-----FSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT-----~~ELL~~L~~  594 (604)
                      .+||.+||+.||++|||     ++|+++|=|.
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence            99999999999999998     5788887553

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-52  Score=445.45  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=216.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|+++++||+|+||.||+|      +.||||++.......  ...+.+|+.+|+.++|||||+++++|.+++. +||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            57999999999999999995      579999997543332  3347899999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||+||+|.+++.+ ..+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+++...........
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999999854 57999999999999999999999999999999999999999999999999999877665555566


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      .+||+.|||||++.+..|+    .++|||||||++|||++|.+||.+.+..+....+..... ....+..+++++.+||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~----~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYG----PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            7899999999999877654    459999999999999999999999888777666554322 22344578999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +||+.||++|||+.|+++|=|...
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcC
Confidence            999999999999999999866543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7e-53  Score=445.09  Aligned_cols=250  Identities=18%  Similarity=0.267  Sum_probs=214.0

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ...+.|++.++||+|+||.||+|      +.||||+++....       ..+|+.++..++|||||++++++.+++. +|
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~-~~  126 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPW-VN  126 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTE-EE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence            34567899999999999999995      5799999975322       2468999999999999999999998775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~  489 (604)
                      ||||||+||+|.++|.+.+.+++..+..++.||+.||+|||++|||||||||+||||+.+| ++||+|||+++.......
T Consensus       127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999999998888999999999999999999999999999999999999999988 699999999987654322


Q ss_pred             c-----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCc
Q 007429          490 A-----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDC  563 (604)
Q Consensus       490 ~-----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~  563 (604)
                      .     ....+||+.|||||++.+..++    .++|||||||++|||+||..||.+.+..+....+.....+ ..+|..+
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~----~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCD----AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             ccceecCCccccCccccCHHHHCCCCCC----cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence            1     2334799999999999987654    4599999999999999999999987776666666665433 2468899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++++.++|.+||+.||.+|||+.||+++|......
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999999887543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.4e-52  Score=426.47  Aligned_cols=250  Identities=19%  Similarity=0.283  Sum_probs=203.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|.+...... ......+.+|+.+++.++|||||++++++.+++. +|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-IIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EEEE
Confidence            57899999999999999995      58999999754322 2234568899999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+ +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...... ...
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~  169 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLK  169 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-ccC
Confidence            9999 67999999888899999999999999999999999999999999999999999999999999997654432 234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|||||++.+..+.   +.++||||+||++|||++|+.||.+.+.......+...  ...+|..+++++++||.
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~---~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYA---GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             -----CTTSCHHHHSSSSCC---CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHH
T ss_pred             CeeECcccCChhhhcCCCCC---CChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence            45799999999999887653   34699999999999999999999987777666655554  45578889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +||+.||++|||+.|+++|=|.-.+
T Consensus       245 ~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHccCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999998776443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-52  Score=430.36  Aligned_cols=245  Identities=24%  Similarity=0.411  Sum_probs=209.8

Q ss_pred             eEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---CCcEEEE
Q 007429          342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVV  412 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---~~~l~LV  412 (604)
                      |++.++||+|+||.||+|      +.||+|++............+.+|+.++++++|||||+++++|.+.   +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            578889999999999996      4799999986555555556789999999999999999999998752   2348999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcC-CCcEEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~-~g~vKL~DFGla~~~~~~~~  489 (604)
                      ||||+||+|.+++.+.+.+++..+..++.||+.||+|||+++  ||||||||+||||+. +|.+||+|||+|+....  .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence            999999999999988889999999999999999999999998  999999999999984 79999999999975432  2


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCCCCccHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILK  568 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p~~~s~~l~  568 (604)
                      .....+||+.|||||++.+ .    ++.++|||||||++|||+||+.||.+.+....+...+..+.++ .++..+++++.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~----y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-K----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-C----CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccCCcccCccccCHHHcCC-C----CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence            2345579999999999864 2    4557999999999999999999998877666666656555443 45667889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +||.+||+.||++|||+.|+++|=|
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcc
Confidence            9999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.5e-53  Score=440.42  Aligned_cols=245  Identities=16%  Similarity=0.251  Sum_probs=214.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.+|+.++|||||++++++.+++. +||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEE
Confidence            478999999999999999995      5799999974321 11224568899999999999999999999998876 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  489 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--  489 (604)
                      |||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+++.......  
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      .....+||+.|||||++.+..++    .++||||+||++|||++|.+||.+.+..+....+....  ..+|..+++++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~----~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~d  263 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSAC----KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARD  263 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBC----HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCC----cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHH
Confidence            33455899999999999887654    45999999999999999999999988888777777653  4578899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIIS  590 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~  590 (604)
                      ||.+||+.||.+|||+.|++.
T Consensus       264 li~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTC
T ss_pred             HHHHHccCCHhHCcChHHHcC
Confidence            999999999999999998643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=447.65  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=216.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|+++++||+|+||.||+|      +.||||++.......  ...+.+|+.+|+.++|||||+++++|.+++. +||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCE-EEEEE
Confidence            67999999999999999995      579999997554332  3457899999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||+||+|.+++. ...+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+++...........
T Consensus       228 Ey~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            9999999999985 457999999999999999999999999999999999999999999999999999877655555566


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      .+||+.|||||++.+..|+    .++|||||||++|||++|.+||.+.+..+.+..+..... ....+..+++++++||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~----~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYG----PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            7899999999999877654    459999999999999999999999888877766655432 23445678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||+.||++|||+.|+++|=|..
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhc
Confidence            99999999999999999986544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-50  Score=420.29  Aligned_cols=255  Identities=22%  Similarity=0.425  Sum_probs=203.1

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC---cEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~---~l~LV  412 (604)
                      ++|.+.++||+|+||.||+|    +.||||++...   .......+.|+..+..++|||||+++|+|.+++.   .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            56899999999999999996    68999999642   2233344567777778999999999999987642   47999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~--------gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ||||++|+|.++|.+ ..+++..+.+++.|++.||+|||++        +||||||||+||||+.++++||+|||+++..
T Consensus        80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999954 5689999999999999999999987        9999999999999999999999999998776


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCC--CCCCcchhHHHHHHHHHHHHcCCCCCCC----------C-----Ch
Q 007429          485 KSVGEA----TEYETDGYRWLAPEIIAGDPES--VSETWMSNVYSFGMVIWEMVTGEAAYAA----------C-----SP  543 (604)
Q Consensus       485 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s--~~~t~kSDVWSlGvvLyELlTG~~Pf~~----------~-----s~  543 (604)
                      ......    .....||+.|||||++.+....  ..++.++|||||||++|||+||.+||..          .     ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322    2234699999999999765321  1345679999999999999999776532          1     11


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          544 VQAAVGIAACGLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       544 ~~~~~~i~~~~~r~~~p~~-----~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ......+...+.+|.+|..     +++.+.+||.+||+.||++||||.||++.|.++...
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            2333334455667777654     346789999999999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-49  Score=413.84  Aligned_cols=246  Identities=19%  Similarity=0.306  Sum_probs=188.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~------  407 (604)
                      ++|++++.||+|+||.||+|      +.||||+++... .......+.+|+.+|.+++|||||++++++.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46999999999999999985      589999997543 23344568899999999999999999999976542      


Q ss_pred             -----cEEEEEecccCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecC
Q 007429          408 -----GLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       408 -----~l~LVmEy~~gGSL~dlL~~~~~---l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                           .+|||||||++|+|.+++.....   .++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 27999999999999999976543   4556788999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc------------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 007429          480 IVTACKSVGEA------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  547 (604)
Q Consensus       480 la~~~~~~~~~------------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~  547 (604)
                      +|+........            ....+||+.|||||++.+..++    .++|||||||++|||++   ||.........
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~----~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS----HKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCC----THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC----CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            99876543221            1224699999999999887654    46999999999999996   78653322222


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .........++.+...++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            2222222223333345677889999999999999999999998744

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=418.86  Aligned_cols=252  Identities=19%  Similarity=0.237  Sum_probs=210.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CCc
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-----~~~  408 (604)
                      ++|++++.||+|+||.||+|      +.||||+++...........+.+|+.+|+.++|||||++++++...     ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            68999999999999999995      5899999976555444556788999999999999999999998643     234


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|||||||+ |+|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++......
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            899999996 5899999888899999999999999999999999999999999999999999999999999998654321


Q ss_pred             ----CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC------
Q 007429          489 ----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE------  558 (604)
Q Consensus       489 ----~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~------  558 (604)
                          ......+||+.|||||++.+..+   ++.++||||+||++|||++|.+||.+.+..+.+..+......+.      
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~---~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSLHE---YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTCSC---CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cccccccccceeChHhcCHHHhcCCCC---CCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence                22344579999999999887543   34569999999999999999999999888777766654322211      


Q ss_pred             -----------------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          559 -----------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       559 -----------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                             ....+++++.+||.+||..||.+|||+.|+++|=|..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence                                   1134688999999999999999999999999986643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-45  Score=381.10  Aligned_cols=261  Identities=26%  Similarity=0.461  Sum_probs=218.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      ..|.+..++|++.+.||+|+||.||++    +.||+|.+............+.+|+.++.+++||||+++++++.+... 
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC-
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc-
Confidence            456677789999999999999999996    589999997655444455678899999999999999999999987775 


Q ss_pred             EEEEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      +++||||+++|+|.+++.+..   .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            899999999999999996544   3999999999999999999999999  99999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      ............||+.|+|||.+.+..++.    ++|||||||++|||++|..||...+..+....+.....+..+|..+
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNE----KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL  264 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCT----THHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCc----hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            544333344557899999999998776544    5999999999999999999999988888777777777788889999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++.+.++|.+||+.||.+|||+.++++.|..+.+.
T Consensus       265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999988764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.3e-46  Score=393.99  Aligned_cols=244  Identities=18%  Similarity=0.325  Sum_probs=195.6

Q ss_pred             CCeEEeeeeeccCceEEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++++.||+|+||.||++         +.||+|++....    ...++.+|+.+|..+ +|||||++++++.++++ +
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~-~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH-V   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE-E
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE-E
Confidence            67999999999999999986         469999986432    244578899999988 79999999999988776 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~~~~~~  488 (604)
                      |+|||||+||+|.+++   +.+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            9999999999999998   358999999999999999999999999999999999999877 799999999997554321


Q ss_pred             C----------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 007429          489 E----------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  540 (604)
Q Consensus       489 ~----------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~  540 (604)
                      .                            .....+||+.|||||++.+..   .++.++||||+||++|||++|+.||..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP---NQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCS---CCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC---CCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            1                            112336999999999998754   234569999999999999999999965


Q ss_pred             CC-hHHHHHHHHHc------------------------------------CC----------------CCCCCCCccHHH
Q 007429          541 CS-PVQAAVGIAAC------------------------------------GL----------------RPEIPKDCPQIL  567 (604)
Q Consensus       541 ~s-~~~~~~~i~~~------------------------------------~~----------------r~~~p~~~s~~l  567 (604)
                      .+ ..+.+..+...                                    ..                .......+++++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            43 33333222210                                    00                001123578899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+||.+||+.||.+|||++|+++|=|.
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            999999999999999999999988553

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.5e-46  Score=418.08  Aligned_cols=247  Identities=15%  Similarity=0.292  Sum_probs=214.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|.+....  ......+.+|+.+|..++|||||+++++|.+++. +||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEE
Confidence            68999999999999999985      589999997532  2334568899999999999999999999998775 99999


Q ss_pred             ecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC--CcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~--g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+||+|.++|.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++...... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-~  312 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-S  312 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-E
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-c
Confidence            99999999999853 4579999999999999999999999999999999999999854  899999999998765432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~s~~l~  568 (604)
                      ....+||+.|||||++.+..++    .++|||||||++|||++|..||.+.+..+.+..+.......  ..+..++++++
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~----~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVG----YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBC----HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3455799999999999987654    45999999999999999999999988888887777655443  23467899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||.+||+.||.+|||+.|+++|=|.
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCc
Confidence            99999999999999999999998553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.1e-46  Score=421.70  Aligned_cols=249  Identities=19%  Similarity=0.298  Sum_probs=205.3

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCC----CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~----~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||++      +.||+|++....    .........+.++.++..++|||||+++++|.+++
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            34578999999999999999985      589999996422    11111112233355566789999999999999887


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +|||||||+||+|.++|.+.+.+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus       266 ~-lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 K-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             E-EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             E-EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            6 999999999999999998888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccCCCCcccccccccC-CCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHcCCCCCCCCC
Q 007429          487 VGEATEYETDGYRWLAPEIIAG-DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s---~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .  .....+||+.|||||++.+ ..|    +.++|+|||||++|||++|.+||.+.+   ..+....+..  ....+|..
T Consensus       345 ~--~~~t~~GTp~YmAPEvl~~~~~y----~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~  416 (689)
T 3v5w_A          345 K--KPHASVGTHGYMAPEVLQKGVAY----DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDS  416 (689)
T ss_dssp             C--CCCSCCSCGGGCCHHHHSTTCCC----CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTT
T ss_pred             C--CCCCccCCcCccCHHHHhCCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCcc
Confidence            3  2345689999999999964 344    445999999999999999999997532   2223333333  35568889


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQ-----FSEIISLLLR  594 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT-----~~ELL~~L~~  594 (604)
                      +++++++||.+||+.||.+|++     +.||++|-+.
T Consensus       417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF  453 (689)
T 3v5w_A          417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  453 (689)
T ss_dssp             SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred             CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence            9999999999999999999998     7999988664

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-45  Score=383.51  Aligned_cols=260  Identities=25%  Similarity=0.438  Sum_probs=223.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||+|           +.||+|.++.. ........+.+|+.++..+ +|||||++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            578888999999999999999999997           47999999743 2333445688999999999 8899999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcCC--------------------------------------------------
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSRK--------------------------------------------------  430 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~--------------------------------------------------  430 (604)
                      ++.+.+..+++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998876558999999999999999965432                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--ccc
Q 007429          431 ----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATE  492 (604)
Q Consensus       431 ----------------l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~  492 (604)
                                      +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ...
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            88999999999999999999999999999999999999999999999999876543322  223


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ...+|+.|+|||++.+..+    +.++|||||||++|||++ |..||...............+.....|..+++++.++|
T Consensus       254 ~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVY----TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             ccCCCceeEChhhhcCCCC----CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            3457889999999986644    456999999999999998 99999987766666667777778888999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+||+.||.+|||+.+++++|..+.+
T Consensus       330 ~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHHHHHHHH
Confidence            99999999999999999999998865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.6e-45  Score=385.06  Aligned_cols=261  Identities=23%  Similarity=0.469  Sum_probs=221.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      ..|.+..++|++.+.||+|+||.||+|+             .||+|.++... .......+.+|+.++..+ +|||||++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3567778999999999999999999875             49999997442 233345688999999999 89999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      +++|.+.+. +|+||||+++|+|.+++...+                .+++..++.++.||+.||+|||++||+||||||
T Consensus       153 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp  231 (370)
T 2psq_A          153 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  231 (370)
T ss_dssp             EEEECSSSS-CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             EEEEccCCC-EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence            999987775 999999999999999996543                478999999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+    +.++|||||||++|||++ |..||.
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY----THQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC----CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC----CcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999876544322  2233456789999999987654    456999999999999999 999998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .....+.. ..+..+.++..|..+++.+.++|.+||+.||.+||++.|++++|.++.....
T Consensus       308 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          308 GIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             TCCGGGHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            87665543 4455667778899999999999999999999999999999999999876544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-44  Score=377.94  Aligned_cols=249  Identities=18%  Similarity=0.297  Sum_probs=218.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~   93 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-LYLIM   93 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEEE
Confidence            68999999999999999985      579999998655444455668899999999999999999999987775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-GGGT
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-cccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987654432 3345


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..||+.|+|||.+.+..+.   +.++|||||||++|||++|..||.+.+..+....+....  ..+|..+++++.+++.+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCC---SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred             ccCCcceeCcccccCCCcC---CchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence            5799999999999876543   346999999999999999999999988877776666653  34677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ||..||.+|||+.|+++|-|..
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTT
T ss_pred             HCCCChhHCcCHHHHhcCHhhc
Confidence            9999999999999999986643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-44  Score=360.62  Aligned_cols=257  Identities=23%  Similarity=0.441  Sum_probs=224.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  409 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l  409 (604)
                      +.+..++|++.+.||+|+||.||+|    +.+|+|.++...........+.+|+..+..++||||+++++++.+.. ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            4566688999999999999999996    57999999866555555567889999999999999999999998762 348


Q ss_pred             EEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ++||||+++|+|.+++....  .+++..++.++.||+.||.|||+++  ++||||||+|||++.++.++|+|||+.....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999997654  5899999999999999999999999  9999999999999999999999999865432


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                           .....+|+.|+|||.+.+..+.. ++.++||||||+++|||++|..||...+.......+...+.++..|..+++
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDT-NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGS-CHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             -----ccCccCCccccChhhhccCCCCC-CCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                 22346789999999998764432 234699999999999999999999998888888888888888899999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+.+++.+||+.||.+|||+.++++.|.++.+
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            99999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=373.69  Aligned_cols=260  Identities=26%  Similarity=0.436  Sum_probs=218.6

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeEE---------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk~---------VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      +.+..++|++.+.||+|+||.||+|+.         ||+|.++... .......+.+|+.++..++||||+++++++.+.
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            456678999999999999999999753         9999997432 333456688999999999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      +. .++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       123 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          123 RL-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GC-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             Cc-cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            65 89999999999999999644 57999999999999999999999999999999999999999999999999998766


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          485 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       485 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ......   .....+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||......+.... +..+.+...+
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~  276 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF----SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAP  276 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCCCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCC----CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCCCCCC
Confidence            543221   222345778999999986644    446999999999999999 9999998777665544 4455677788


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      ..+++.+.++|.+||+.||.+|||+.+|++.|..+....+.
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            89999999999999999999999999999999998766543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-44  Score=359.81  Aligned_cols=256  Identities=24%  Similarity=0.523  Sum_probs=218.7

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +.|.+..++|++++.||+|+||.||++     +.||+|++.....   ....+.+|+.++..++||||+++++++.+.+.
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            578899999999999999999999996     4699999975432   24568899999999999999999999987775


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           80 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             -EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             -eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence             99999999999999999643 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          487 VGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       487 ~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ... ......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+....+ ..+.++..|..++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRY----SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLAS  233 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTSC
T ss_pred             cccccccCcccccccCCHHHhcCCCC----CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hcCccCCCCCcCC
Confidence            221 2233346778999999986654    446999999999999999 99999987776655444 4456667788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+.+++.+||+.||.+||++.+++++|.++..
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999999998865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.3e-44  Score=376.56  Aligned_cols=250  Identities=16%  Similarity=0.284  Sum_probs=215.8

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..++|++++.||+|+||.||++      +.||+|.++.... .......+.+|+.++..++||||+++++++.+.+. +|
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~   81 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-EE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE-EE
Confidence            3478999999999999999985      5799999974311 11123457789999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++........
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998765444444


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....||+.|+|||++.+..++.    ++|||||||++|||++|..||...+.......+...  ...+|..+++++.++
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  235 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGR----AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCT----THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCc----hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence            55567999999999998776544    599999999999999999999988777766666654  345788899999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHHHHHH
Q 007429          571 MIKCWNNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       571 I~kCL~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      |.+||+.||.+||     ++.+|++|-+.
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence            9999999999999     99999988654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.3e-44  Score=368.49  Aligned_cols=248  Identities=21%  Similarity=0.378  Sum_probs=214.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|++.......  ...+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   96 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE-EEEEE
Confidence            57899999999999999996      479999997544332  4457899999999999999999999998775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            99999999999854 46999999999999999999999999999999999999999999999999998776655444555


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      ..||+.|+|||.+.+..++    .++|||||||++|||++|..||...++......+..... ....+..+++.+.++|.
T Consensus       176 ~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYG----PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCC----cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            6799999999999877544    469999999999999999999998888776665555443 34557788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHh
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||+.||.+|||+.|++++-+..
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHccCChhHCcCHHHHhhChhhc
Confidence            99999999999999999876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-44  Score=373.82  Aligned_cols=261  Identities=22%  Similarity=0.385  Sum_probs=220.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||+|+           .||+|.+.... .......+.+|+.++..+ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3688888999999999999999999976           49999997432 222345688999999999 9999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  457 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~-----------------------~l~~~~il~ia~qIa~gL~YLHs~gIVH  457 (604)
                      ++.+.+. +++||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+|
T Consensus       117 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          117 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEeeCCc-cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9988765 899999999999999996542                       2789999999999999999999999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-C
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  534 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G  534 (604)
                      |||||+|||++.++.+||+|||++........  ......+|+.|+|||.+.+..+    +.++|||||||++|||+| |
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY----TIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC----ChhHhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999876543322  1223346788999999976654    456999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       535 ~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..||...............+.++..|..+++.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            99999877666666777777788888899999999999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.6e-44  Score=365.76  Aligned_cols=262  Identities=24%  Similarity=0.435  Sum_probs=224.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||+|+           .||+|.++... .......+.+|+.++..+ +||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            4677888999999999999999999874           79999997432 233456688999999999 9999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~------------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++.+.+. .++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||
T Consensus        95 ~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           95 ACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEecCCC-cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            9988775 899999999999999996543                  489999999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||++.........  .....+++.|+|||.+.+..+    +.++||||||+++|||++ |..||.
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY----TFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC----ChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998766543221  223346788999999976643    456999999999999999 999999


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ................+...+..+++.+.++|.+||+.||.+|||+.+++++|.++.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            8776666666677777777788899999999999999999999999999999999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-43  Score=356.40  Aligned_cols=257  Identities=24%  Similarity=0.466  Sum_probs=218.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      .|.+..++|++++.||+|+||.||+++     .||+|.++....   ...++.+|+..+..++||||+++++++.+... 
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   77 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-   77 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc-
Confidence            456778999999999999999999964     799999975432   24568899999999999999999999987765 


Q ss_pred             EEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999999999654 46999999999999999999999999999999999999999999999999998765443


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          488 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       488 ~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .. ......+|+.|+|||.+.+..++.    ++||||||+++|||++ |..||...........+ ..+.....|..+++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSS----KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASD  232 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEET----THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTSCH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCch----hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-HcCCCCCCCCcChH
Confidence            22 122334567899999998765443    5999999999999999 99999987776655444 44556667788899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .+.+++.+||+.||.+|||+.+++++|..+.+..
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            9999999999999999999999999999887643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=377.37  Aligned_cols=261  Identities=25%  Similarity=0.488  Sum_probs=223.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      .+|.+..++|++.+.||+|+||.||+++             .||+|+++.. ........+.+|+.++..+ +|||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            5788888999999999999999999975             5999999754 2333446688999999999 99999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++++.+.+. +++||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||
T Consensus       141 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          141 LGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEECSSSS-CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             eeeeccCCc-eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            999987775 899999999999999996543                489999999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..+    +.++|||||||++|||++ |..||.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY----THQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC----CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC----CchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999876543321  2233456788999999987654    456999999999999999 999998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .....+. ...+..+.++..+..+++++.++|.+||+.||.+|||+.+++++|.++.....
T Consensus       296 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          296 GVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             TCCHHHH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            8766554 44555666778888999999999999999999999999999999999876544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-44  Score=364.87  Aligned_cols=259  Identities=25%  Similarity=0.475  Sum_probs=220.2

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ..|.+..++|++.+.||+|+||.||++           +.||+|.++... .......+.+|+.++..++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            467778899999999999999999997           569999987432 33344568899999999999999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  457 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~~------------------------~l~~~~il~ia~qIa~gL~YLHs~gIVH  457 (604)
                      +.+.+. .++||||+++|+|.+++....                        .+++..++.++.||+.||.|||++||+|
T Consensus        95 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           95 CSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EecCCc-eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            987765 899999999999999996543                        3889999999999999999999999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-C
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  534 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G  534 (604)
                      |||||+|||++.++.+||+|||++........  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY----TTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc----CchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999876543322  1233456788999999986543    456999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       535 ~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..||......... ..+..+..+..+..+++.+.+++.+||+.||.+||++.+++++|.++...
T Consensus       250 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          250 GNPYPGIPPERLF-NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CCSSTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCHHHHH-HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            9999887665543 44555667778889999999999999999999999999999999988653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.2e-44  Score=388.08  Aligned_cols=253  Identities=24%  Similarity=0.482  Sum_probs=218.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      ..|.+..++|++.+.||+|+||.||+|    +.||||.++...    ....+.+|+.++..++|||||++++++.+....
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            468899999999999999999999995    579999997533    234678999999999999999999999877645


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      +|+||||+++|+|.+++.+.+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999997554  379999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .   .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+... .+..+.++..|..+++
T Consensus       342 ~---~~~~~~~~~y~aPE~~~~~~~----~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-~i~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          342 T---QDTGKLPVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGCPP  413 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCC----CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-HHHTTCCCCCCTTCCH
T ss_pred             c---ccCCCCCcceeCHHHhcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCcCCH
Confidence            2   223357889999999987654    456999999999999998 999999876655443 3456778888999999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+.+||.+||+.||.+|||+.+|++.|..+..
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-44  Score=383.69  Aligned_cols=259  Identities=25%  Similarity=0.479  Sum_probs=219.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..|.+..++|++.+.||+|+||.||+|+      .||+|.++.. ........+.+|+.++..++|||||++++++.+.+
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            4688888999999999999999999964      6999998743 22233345789999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . +|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          186 P-IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             C-cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            5 89999999999999999654 469999999999999999999999999999999999999999999999999987543


Q ss_pred             cCCCcc--cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ......  ....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+.. ..+..+.+++.|..
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRY----SSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EFVEKGGRLPCPEL  339 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HHHHTTCCCCCCTT
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCCC
Confidence            321111  11234678999999986543    456999999999999998 99999987766544 44556677788999


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +++.+.++|.+||+.||.+|||+.+|++.|..+.+.
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            999999999999999999999999999999988654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-44  Score=370.00  Aligned_cols=261  Identities=25%  Similarity=0.452  Sum_probs=219.1

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ..+.+..++|++++.||+|+||.||+|           +.||+|.++... .......+.+|+.++..++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            456677789999999999999999996           468999987432 33345668899999999999999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAY  457 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~------------------------~~l~~~~il~ia~qIa~gL~YLHs~gIVH  457 (604)
                      +.+.+. .++||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+|
T Consensus       119 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          119 CAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EccCCc-eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            987765 89999999999999999653                        46899999999999999999999999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-C
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  534 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G  534 (604)
                      |||||+|||++.++.+||+|||++.......  .......+|+.|+|||.+.+..+    +.++||||||+++|||++ |
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY----TTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc----CcccccHHHHHHHHHHHhcC
Confidence            9999999999999999999999987654322  12234457889999999986654    456999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       535 ~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ..||...+..+....+ ..+..+..|..+++.+.++|.+||+.||.+||++.+++++|.++....+
T Consensus       274 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             CCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCcCCCCChHHHHHHH-hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            9999987776655444 4455567788999999999999999999999999999999999877654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-43  Score=358.94  Aligned_cols=258  Identities=24%  Similarity=0.494  Sum_probs=218.5

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+.|.+..++|++++.||+|+||.||+++     .||+|+++....   ....+.+|+.++..++||||+++++++.+.+
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   92 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   92 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence            36788999999999999999999999964     799999975432   2456889999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           93 P-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             S-EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             C-eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            5 9999999999999999965 4579999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......+|+.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+.......+ ..+.+...|..+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKF----SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLA  246 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCC----SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCCCCCTTC
T ss_pred             ccccccccCCccCcccCCHHHhccCCC----CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-hcccCCCCCCcC
Confidence            3221 1223346788999999986654    456999999999999998 99999988776655444 445666778888


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++.+.+++.+||+.||.+|||+.+++++|..+.+.
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-43  Score=359.80  Aligned_cols=256  Identities=20%  Similarity=0.352  Sum_probs=213.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|.+........ ....+.+|+..+..++||||+++++++.+.+. .|+|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   89 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC-YYLV   89 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE-EEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe-EEEE
Confidence            78999999999999999986      4799999875443332 34568899999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-cc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-AT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~~  491 (604)
                      |||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  169 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT  169 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999876543321 23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---CCCCCccHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EIPKDCPQILK  568 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~~p~~~s~~l~  568 (604)
                      ....||+.|+|||.+.+..++.    ++||||||+++|||++|..||...+...............   ..+..+|+.+.
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~----~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          170 NHVLGTVQYFSPEQAKGEATDE----CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             -----CCSSCCHHHHHTCCCCT----THHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             CccccCccccCHhHhcCCCCCc----hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            3446899999999998876544    4999999999999999999999988777665555443322   24567899999


Q ss_pred             HHHHHhhhcCCCCCC-CHHHHHHHHHHhhCccC
Q 007429          569 SLMIKCWNNSPSKRP-QFSEIISLLLRTNNISN  600 (604)
Q Consensus       569 ~LI~kCL~~dP~kRP-T~~ELL~~L~~~~~~~~  600 (604)
                      ++|.+||+.||.+|| ++.++.+.|..+....+
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            999999999999998 89999999988766543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-44  Score=365.02  Aligned_cols=262  Identities=24%  Similarity=0.435  Sum_probs=222.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||++           +.||+|.++... .......+.+|+.++..+ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            467788899999999999999999997           479999997432 333445688999999998 7899999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCc
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  464 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~----------------l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~N  464 (604)
                      ++...+..+++||||+++|+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            998776558999999999999999965443                8899999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q 007429          465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  541 (604)
Q Consensus       465 ILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~  541 (604)
                      ||++.++.+||+|||++........  ......+|+.|+|||.+.+..+    +.++||||||+++|||++ |..||...
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY----TIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc----cchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999999876543322  1223456889999999986654    456999999999999998 99999887


Q ss_pred             ChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       542 s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ............+.+...+..+++.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            6655555666666777788889999999999999999999999999999999887643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=360.83  Aligned_cols=255  Identities=18%  Similarity=0.238  Sum_probs=208.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc------------------------hHHHHHHHHHHHH
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------------------------AYEFELRKDLLEL  387 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~------------------------~~~~~~~~Ei~~L  387 (604)
                      ..++|++.+.||+|+||.||++      +.||+|.+.......                        .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3478999999999999999996      579999987543211                        1123578999999


Q ss_pred             HhCCCCceeEEEEEEEcC-CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceE
Q 007429          388 MTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL  466 (604)
Q Consensus       388 ~~L~HpnIVkl~g~~~~~-~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NIL  466 (604)
                      ..++||||+++++++.+. ...+++||||+++++|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            999999999999999874 34589999999999998865 4457999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 007429          467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA  546 (604)
Q Consensus       467 ld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~  546 (604)
                      ++.++.+||+|||++..............||+.|+|||.+.+.... ..+.++|||||||++|||++|..||........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKI-FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCC-EESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCC-CCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999987765444334455789999999999765421 124568999999999999999999998777666


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       547 ~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ...+.......+.+..+++.+.++|.+||+.||.+|||+.|+++|-+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            666665555544456789999999999999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=378.17  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=209.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +..++|++++.||+|+||.||++      +.||+|+++.... .......+.+|..++..+ +||||+++++++.+.+. 
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-   98 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-   98 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE-
Confidence            45689999999999999999985      5799999974311 111234467888888887 79999999999988775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987654444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      .......||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++.+.
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~  252 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYG----PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDAT  252 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCT----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcC----CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence            445566799999999999876544    4599999999999999999999998888777777664  4457788999999


Q ss_pred             HHHHHhhhcCCCCCCCH------HHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQF------SEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~------~ELL~~L~~  594 (604)
                      ++|.+||+.||.+||++      .+|++|-+.
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f  284 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF  284 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence            99999999999999998      888887654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-43  Score=358.36  Aligned_cols=258  Identities=24%  Similarity=0.450  Sum_probs=206.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      ..|.+..++|++.+.||+|+||.||+|.         .|++|.++... .......+.+|+..+..++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            4577788999999999999999999874         48888886432 2334556889999999999999999999985


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      + + ..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~-~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           87 E-N-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             S-S-SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-C-ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4 3 3789999999999999996544 79999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          483 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       483 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ....... ......+++.|+|||.+.+..+    +.++||||||+++|||++ |..||......+....+ ..+.+...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~~~~  239 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRF----TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMP  239 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCC----SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCC----CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCCCCC
Confidence            6543322 1233356788999999986644    456999999999999997 99999987766554443 345566788


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..+++.+.++|.+||+.||.+|||+.+++++|.++.+.
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999988654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=383.23  Aligned_cols=250  Identities=17%  Similarity=0.235  Sum_probs=214.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+............+.+|+.++..++|||||++++++.+.+. .|+||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH-HYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE-EEEEE
Confidence            67899999999999999985      679999998654444445568899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc---CCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld---~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9999999999998888899999999999999999999999999999999999998   4678999999999776654444


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~  568 (604)
                      .....||+.|+|||++.+..++    .++||||+||++|+|++|.+||.+.+.......+.........+  ..+++++.
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~----~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYG----KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             eecccCCcccCCHHHhcCCCCC----CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            4456799999999999876554    45999999999999999999999988877777777665543333  46899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|.+||+.||.+|||+.|+++|-+.
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccc
Confidence            99999999999999999999987553

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=376.29  Aligned_cols=257  Identities=24%  Similarity=0.478  Sum_probs=216.7

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      +.+..++|++++.||+|+||.||+|+           .||+|+++.. ........+.+|+.++..++|||||++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            34566889999999999999999976           6999999743 23344556889999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NV  473 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~-------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~v  473 (604)
                      +... .++||||+++|+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       145 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          145 QSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSSS-CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCC-CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            7765 899999999999999996542       489999999999999999999999999999999999999555   59


Q ss_pred             EEEecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          474 CLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       474 KL~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      ||+|||+++......  .......+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+... .
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~-~  298 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF----TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-F  298 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-H
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-H
Confidence            999999987543322  22334467889999999987654    456999999999999998 999999877666544 4


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +..+.++..+..+++.+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus       299 i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            445566777889999999999999999999999999999999988654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=365.86  Aligned_cols=253  Identities=22%  Similarity=0.388  Sum_probs=209.7

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      .+.+..++|++.+.||+|+||.||++      +.|++|++...  .......+.+|+.++..++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            45677899999999999999999995      46999988542  34445668899999999999999999999998775


Q ss_pred             cEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           82 -LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             -EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             -eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence             9999999999999999976 45799999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcc--------------cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-----HH
Q 007429          487 VGEAT--------------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-----AA  547 (604)
Q Consensus       487 ~~~~~--------------~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~-----~~  547 (604)
                      .....              ....||+.|+|||.+.+..++    .++||||||+++|||++|..||....+..     ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD----EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCC----cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            22211              134689999999999876544    46999999999999999999987533211     01


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          548 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       548 ~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ....    ....|..+++.+.++|.+||+.||.+|||+.++++.|..+..
T Consensus       237 ~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111    123467788899999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=384.75  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=221.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|.+..++|++.+.||+|+||.||+|+     .||||+++...   .....+.+|+.++..++|||||++++++.. + 
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~-  255 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-  255 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C-
Confidence            4688999999999999999999999974     69999997533   235568899999999999999999999863 3 


Q ss_pred             cEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .+++||||+++|+|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            389999999999999999643  378999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+.+..+....+ ..+.+++.|..+
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~  410 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSF----TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENC  410 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HHTCCCCCCTTS
T ss_pred             CCceeccCCCcccccccCHHHhccCCC----CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCC
Confidence            3211 1223346788999999986644    456999999999999999 99999988776665544 456777888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      ++.+.+||.+||+.||.+|||+.+|++.|..+....+.
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999998765543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-43  Score=364.89  Aligned_cols=263  Identities=23%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      +..+.+..++|++++.||+|+||.||+|+         .||+|.++...........+.+|+.++..++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            45667788999999999999999999963         689999976544455566788999999999999999999999


Q ss_pred             EcCCCc-----EEEEEecccCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          403 VDENHG-----LCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       403 ~~~~~~-----l~LVmEy~~gGSL~dlL~~~~------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      ......     .++||||+++|+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            876531     389999999999999985432      589999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .+||+|||++........  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+...
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY----TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCC----CCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999876543321  1223346788999999987654    456999999999999999 999999877666554


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .+ ..+.....+..+++.+.+++.+||+.||.+|||+.++++.|.++....
T Consensus       251 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 YL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HH-hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            44 445566778889999999999999999999999999999999886654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-43  Score=365.70  Aligned_cols=252  Identities=17%  Similarity=0.298  Sum_probs=206.4

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe---------EEEEEEEeecCCCC--chHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~~--~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .+..++|++++.||+|+||.||++         +.+|+|.++.....  ......+.+|+.++..++||||+++++++.+
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            355688999999999999999975         46999999754321  1223456789999999999999999999988


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      .+. +|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSC-EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCE-EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            776 9999999999999999988788999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ...........||+.|+|||.+.+..++    .++|||||||++|||++|..||...+.......+...  ...+|..++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~  245 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHN----RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLT  245 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCC----THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSC
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCC----CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCC
Confidence            4443344456789999999999876543    4699999999999999999999988877776666654  345778899


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      +.+.++|.+||+.||.+||     ++.++++|-+.
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            9999999999999999999     88999987664

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-43  Score=353.26  Aligned_cols=251  Identities=27%  Similarity=0.560  Sum_probs=207.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCc--hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGN--AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~--~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++|++.+.||+|+||.||+|    +.+|+|.++......  .....+.+|+..+..++||||+++++++.+.+. .+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~   82 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN-LC   82 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-eE
Confidence            45689999999999999999996    689999987543222  223567899999999999999999999987765 89


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---ceeccCCCCceEEcC--------CCcEEEEecC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDR--------HGNVCLGDMG  479 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g---IVHrDLKp~NILld~--------~g~vKL~DFG  479 (604)
                      +||||+++++|.+++ ..+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999988 4567999999999999999999999999   899999999999986        7789999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ++.......  .....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...+.......+.........
T Consensus       162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          162 LAREWHRTT--KMSAAGAYAWMAPEVIRASMF----SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             C---------------CCGGGSCHHHHHHCCC----SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccccc--ccCCCCccceeCHHHhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            987654322  224468999999999986644    45699999999999999999999998888887777877778888


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +..+++.+.++|.+||+.||.+|||+.+++++|.++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            999999999999999999999999999999999753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-43  Score=366.03  Aligned_cols=260  Identities=23%  Similarity=0.429  Sum_probs=222.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      ..|.+..++|++.+.||+|+||.||+|.           .||+|.+.... .......+.+|+.++..+ +||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3577888999999999999999999975           69999997543 233455688999999999 8999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceE
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKS--------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL  466 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~--------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NIL  466 (604)
                      ++.+.+. +++||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       118 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          118 ACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EECSSSS-CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEecCCc-eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9987765 89999999999999998542              35799999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCh
Q 007429          467 LDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP  543 (604)
Q Consensus       467 ld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~  543 (604)
                      ++.++.+||+|||++.........  .....+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||.....
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY----TVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC----ChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            999999999999998765433221  223346788999999986644    456999999999999998 9999998776


Q ss_pred             HHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       544 ~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..........+.++..|..+++.+.++|.+||+.||.+|||+.+++++|..+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            6666677777777788888999999999999999999999999999999987643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.9e-43  Score=355.44  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=216.0

Q ss_pred             ceeecCCCeEEee-eeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~-~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .+.++.++|++.+ .||+|+||.||+|        +.|++|.++...........+.+|+.++..++||||+++++++. 
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-
Confidence            4566778899998 9999999999986        57999999765544445667899999999999999999999994 


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      .+. .++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           89 AES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             SSS-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCC-cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            343 8999999999999999988788999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          485 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       485 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ......   .....+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+.. ..+..+.++..|
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~  242 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKF----SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGCP  242 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCC----ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCCCCC
Confidence            443221   122346788999999976543    446999999999999999 99999987766544 444556677788


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..+++.+.++|.+||+.||.+||++.++++.|..+...
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999987643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-43  Score=366.55  Aligned_cols=263  Identities=20%  Similarity=0.344  Sum_probs=211.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-  407 (604)
                      ..|.+..++|++++.||+|+||.||+|    +.||+|++...   ........+|+..+..++|||||++++++.+... 
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            467889999999999999999999996    57999999642   2334456678888999999999999999987542 


Q ss_pred             --cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CceeccCCCCceEEcCCCcEEE
Q 007429          408 --GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCL  475 (604)
Q Consensus       408 --~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~----------gIVHrDLKp~NILld~~g~vKL  475 (604)
                        .+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++          ||+||||||+|||++.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence              37999999999999999854 4699999999999999999999999          9999999999999999999999


Q ss_pred             EecCCccccccCCCc--ccccCCCCcccccccccCCCCC-CCCCcchhHHHHHHHHHHHHcCCCCCCCCC----------
Q 007429          476 GDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACS----------  542 (604)
Q Consensus       476 ~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s-~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s----------  542 (604)
                      +|||+++........  .....||+.|+|||++.+.... ..++.++|||||||++|||++|..||.+..          
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999998765543221  2334689999999999864322 233457899999999999999999997532          


Q ss_pred             ------hHHHHHHHHHcCCCCCCCC-----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          543 ------PVQAAVGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       543 ------~~~~~~~i~~~~~r~~~p~-----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                            .......+.....++..+.     .+++++.+||.+||+.||.+|||+.++++.|.++....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  1122222233333444333     23567999999999999999999999999999886543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-43  Score=359.21  Aligned_cols=257  Identities=22%  Similarity=0.430  Sum_probs=209.5

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+..++|++++.||+|+||.||+++          .||+|++...  .......+.+|+.++..++||||+++++++...
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3456889999999999999999864          7999998743  233345688999999999999999999999654


Q ss_pred             C-CcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 N-HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 ~-~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      + ..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            2 33899999999999999996644 599999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---------------H
Q 007429          484 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------------Q  545 (604)
Q Consensus       484 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---------------~  545 (604)
                      ......   ......+++.|+|||.+.+..+    +.++||||||+++|||++|..||......               .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKF----SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCC----ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            543321   1223346677999999987654    45699999999999999999988642211               1


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          546 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       546 ~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ........+.+...|..+++++.++|.+||+.||.+|||+.++++.|.++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            22334455667778899999999999999999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.6e-43  Score=350.35  Aligned_cols=256  Identities=24%  Similarity=0.530  Sum_probs=218.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ++|.++.++|++.+.||+|+||.||++     +.|++|.+......   ...+.+|+..+..++||||+++++++.+.+.
T Consensus         1 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             --CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            368899999999999999999999996     47999999754332   3568899999999999999999999987765


Q ss_pred             cEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       .++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        78 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           78 -ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             -CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             -eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence             89999999999999999654 4689999999999999999999999999999999999999999999999999876533


Q ss_pred             CC-CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          487 VG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       487 ~~-~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .. .......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+.... +..+.++..|..++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~  231 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRY----SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLAS  231 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSC
T ss_pred             ccccccccccccccccChhhhcCCCc----cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-HhcCCcCCCCccCc
Confidence            21 11223456788999999986644    456999999999999999 8999998777665544 44456667788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+.+++.+||+.||.+||++.+++++|..+..
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-43  Score=371.02  Aligned_cols=249  Identities=18%  Similarity=0.245  Sum_probs=213.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+............+.+|+.++..++|||||++++++.+.+. .|+||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence            57899999999999999985      579999998655444445668899999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....... .
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-A  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-S
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-c
Confidence            9999999999997777899999999999999999999999999999999999998654   59999999987665332 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~  568 (604)
                      .....||+.|+|||++.+..++    .++|||||||++|+|++|..||...+.......+.......+.+  ..+++++.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYS----KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             cccCCCCccccCHHHHccCCCC----chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3345789999999999876544    46999999999999999999999888777766666655443332  36789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|.+||+.||.+||++.+++++-|.
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccc
Confidence            99999999999999999999998664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8e-43  Score=355.12  Aligned_cols=250  Identities=16%  Similarity=0.228  Sum_probs=205.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+.++..++||||+++++++.+++. +++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE-EEEEE
Confidence            68999999999999999996      469999998666555556678899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL-~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++ +|.+.+ ...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            99987 555555 4456899999999999999999999999999999999999999999999999999987655444455


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHcCCC---------------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPVQAAVGIAACGLR---------------  556 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf-~~~s~~~~~~~i~~~~~r---------------  556 (604)
                      ...+|+.|+|||.+.+..   .++.++|||||||++|||++|..|| ...+.......+......               
T Consensus       160 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCS---CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CCccccCCcChHHHcCCC---CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            567899999999997654   2345699999999999999887774 454554444444321111               


Q ss_pred             ------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          557 ------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       557 ------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                  ......+++.+.+||.+||+.||.+|||+.|+++|-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence                        01223578999999999999999999999999987554

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-43  Score=355.80  Aligned_cols=262  Identities=27%  Similarity=0.494  Sum_probs=207.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk---~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..+++..++|++.+.||+|+||.||+|+   .+|+|.++...........+.+|+.++..++||||+++++++.. .. .
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~-~   94 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ-L   94 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-C
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-Cc-c
Confidence            4677888999999999999999999974   69999998665555555678899999999999999999997643 33 7


Q ss_pred             EEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            899999999999999854 4579999999999999999999999999999999999999999999999999987544221


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-C---CCCCC
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-P---EIPKD  562 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~---~~p~~  562 (604)
                        .......||+.|+|||.+..... ..++.++||||||+++|||++|..||...............+.. +   ..+..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDS-NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN  253 (289)
T ss_dssp             ---------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred             ccccccccCCCccccCchhhcccCC-CCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence              12233468999999999873321 23456799999999999999999999987766655555544332 2   23457


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +++.+.++|.+||+.||.+|||+.++++.|.++..
T Consensus       254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            89999999999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.8e-43  Score=363.74  Aligned_cols=260  Identities=23%  Similarity=0.471  Sum_probs=220.1

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl  398 (604)
                      ..|.+..++|++.+.||+|+||.||+|+             .||+|.++... .......+.+|+.++..+ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            4677888999999999999999999975             49999987432 333445688999999999 99999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCC
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  462 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp  462 (604)
                      ++++.+.+. +++||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||
T Consensus       107 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          107 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEECSSSC-CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEccCCc-eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            999987765 899999999999999996543                388999999999999999999999999999999


Q ss_pred             CceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCC
Q 007429          463 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  539 (604)
Q Consensus       463 ~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~  539 (604)
                      +|||++.++.+||+|||++........  ......+++.|+|||.+.+..+    +.++||||||+++|||++ |..||.
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY----THQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc----ChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999876554322  1233356788999999976543    456999999999999999 999998


Q ss_pred             CCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          540 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       540 ~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..+..+.. ..+..+.++..+..++..+.++|.+||+.||.+||++.+++++|.++....
T Consensus       262 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          262 GIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             TCCHHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCHHHHH-HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            87665544 344455667788899999999999999999999999999999999986543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.9e-43  Score=370.93  Aligned_cols=249  Identities=18%  Similarity=0.282  Sum_probs=212.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++++.||+|+||.||++      +.+|+|.++......    .....+.+|+.++..++||||+++++++.+... +
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~   90 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD-V   90 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-E
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE-E
Confidence            67999999999999999985      579999997543321    134568899999999999999999999988765 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~~  485 (604)
                      ++||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998777899999999999999999999999999999999999998877    79999999987765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~  563 (604)
                      ... ......||+.|+|||++.+..++    .++|||||||++|+|++|..||.+.+..+....+.......  ..+..+
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          171 DGV-EFKNIFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCC-ccccCCCCccEECchHHcCCCCC----ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            432 23345799999999999876544    45999999999999999999999988877776666543332  223578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+.++|.+||..||.+|||+.|+++|-|.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  276 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence            8999999999999999999999999987553

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-42  Score=366.64  Aligned_cols=250  Identities=18%  Similarity=0.306  Sum_probs=209.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..++|++++.||+|+||.||++      +.+|+|.++....... ....+.+|+.++..+ +|||||++++++.+... +
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-~   85 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-L   85 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-E
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE-E
Confidence            3478999999999999999985      5799999986543332 334577888888887 89999999999988775 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHHHHcCCCCCCC
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC---------SPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~---------s~~~~~~~i~~~~~r~~~p  560 (604)
                      ......||+.|+|||++.+..++    .++|||||||++|||++|..||...         ........+..  ....+|
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p  239 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYG----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIP  239 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCC
T ss_pred             cccccCCCccccCccccCCCCCC----hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCC
Confidence            45556899999999999876544    4599999999999999999999752         11222223333  345678


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQF------SEIISLLLR  594 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~------~ELL~~L~~  594 (604)
                      ..+++.+.++|.+||+.||.+||++      .++++|-+.
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            8899999999999999999999995      788877554

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.4e-43  Score=370.66  Aligned_cols=251  Identities=20%  Similarity=0.272  Sum_probs=213.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +..++|++++.||+|+||.||++      +.||+|.++.... .......+..|..++..+ +||||+++++++.+.+. 
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-   95 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-   95 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE-
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE-
Confidence            45689999999999999999984      5799999974321 111234467788888776 89999999999988775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999877889999999999999999999999999999999999999999999999999987654444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      .......||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++++.
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  249 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAV  249 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBS----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             cccccccCCccccChhhhcCCCcC----CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence            445566799999999999876544    4599999999999999999999988887777766664  4457888999999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQ-----FSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT-----~~ELL~~L~~  594 (604)
                      +||.+||..||.+||+     +.+|++|-+.
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence            9999999999999995     6888887553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-43  Score=372.75  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=211.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +..++|++.+.||+|+||.||++      +.||+|.++.... .......+..|..++..+ +||||+++++++.+.+. 
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~-   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE-
Confidence            45689999999999999999985      5799999974321 011233466777777765 99999999999988775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                      .......||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  .+.+|..+++++.
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  246 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYN----HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAK  246 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCC----ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHH
Confidence            445566799999999999876544    4599999999999999999999988877776666554  4567888999999


Q ss_pred             HHHHHhhhcCCCCCCCHH-HHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFS-EIISLLL  593 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~-ELL~~L~  593 (604)
                      ++|.+||..||.+||++. +|++|-+
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCcc
Confidence            999999999999999997 7776644

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-43  Score=364.65  Aligned_cols=246  Identities=20%  Similarity=0.308  Sum_probs=213.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++++.||+|+||.||++      +.||+|.++..... ......+.+|+.++..++||||+++++++.+... +|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE-EEE
Confidence            478999999999999999984      57999999743211 1123456789999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||++||+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....   ..
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---cc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999876543   23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....||+.|+|||++.+..++.    ++|||||||++|||++|..||...+.......+....  ..+|..+++++.++|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  234 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNK----SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLL  234 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCT----THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCc----ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            3457899999999998776554    4999999999999999999999888877777766653  457788999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHHHHHH
Q 007429          572 IKCWNNSPSKRP-----QFSEIISLLLR  594 (604)
Q Consensus       572 ~kCL~~dP~kRP-----T~~ELL~~L~~  594 (604)
                      .+||..||.+||     +++++++|-+.
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence            999999999999     89999987654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.3e-43  Score=362.82  Aligned_cols=253  Identities=23%  Similarity=0.454  Sum_probs=210.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|+          .|++|.+.... .......+.+|+.++..++||||++++++|.+..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            456889999999999999999975          36888876432 2233456889999999999999999999998754


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             --EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             --eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence              7899999999999999965 4579999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  .....+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||...+.... ...+..+.+...+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  243 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY----THQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI  243 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTT
T ss_pred             CCcccccccCCCccccccChHHhccCCC----CchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHHcCCCCCCCcc
Confidence            33221  223356789999999987654    456999999999999999 9999988766544 345555667778888


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++..+.+++.+||+.||.+||++.+++++|..+..
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999988754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-42  Score=347.63  Aligned_cols=253  Identities=18%  Similarity=0.234  Sum_probs=216.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||+|+||.||++      +.||+|.+............+.+|+.++..++||||+++++++.+.+. .++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE-EEEE
Confidence            378999999999999999985      589999998655444455668899999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~~~~~~~  489 (604)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            999999999999988788999999999999999999999999999999999999987665   9999999987655432 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQIL  567 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l  567 (604)
                      ......+++.|+|||.+.+..++    .++||||||+++|+|++|..||...........+.........  ...+++.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYS----KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             cccCCCCCcCCcCchhhcCCCCC----cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            23345789999999999876543    4699999999999999999999988877777666665544333  34789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+++.+||+.||.+|||+.+++++-+....
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            999999999999999999999998776543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.8e-43  Score=379.70  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=216.3

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|.+..++|++.+.||+|+||.||+|     ..||||.++....   ....+.+|+.++..++||||+++++++.+ + 
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~-  251 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-  251 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C-
Confidence            468888999999999999999999997     4699999975432   24568899999999999999999999876 3 


Q ss_pred             cEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .+++||||+++|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            38999999999999999954  3469999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+....+.... +..+.+++.|..+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~  406 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRF----TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPEC  406 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTS
T ss_pred             CCceecccCCcccccccCHhHHhcCCC----CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            3221 1223346788999999986644    456999999999999999 9999998877665544 4566778888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ++.+.++|.+||+.||++|||+.+|++.|..+....+
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            9999999999999999999999999999999876544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-43  Score=353.48  Aligned_cols=260  Identities=23%  Similarity=0.441  Sum_probs=221.6

Q ss_pred             ccccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       330 ~~i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      +.+..|.+..++|++.+.||+|+||.||+|      +.||+|.+...   ......+.+|+.++..++||||+++++++.
T Consensus         3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A            3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            344678889999999999999999999995      57999999742   233556889999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      +.+. .++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~-~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           80 REPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSS-EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             cCCC-EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            7765 99999999999999999653  35899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          482 TACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       482 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ........ ......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||......... .......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~~~~~~~~~~  233 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKF----SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMER  233 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhccCCCCC
Confidence            76553322 2223346788999999987654    456999999999999999 99999886655443 34555667778


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +..+++.+.+++.+||+.||.+|||+.++++.|..+...
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            889999999999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-42  Score=373.90  Aligned_cols=252  Identities=18%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  408 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~  408 (604)
                      +..++|++++.||+|+||.||++      +.+|+|+++....... ....+.+|..++..+ +|||||++++++.+.+. 
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-  127 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-  127 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE-
Confidence            45578999999999999999985      5799999975432221 123466788888776 89999999999988775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999987644444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHHHHcCCCCCCC
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--------PVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s--------~~~~~~~i~~~~~r~~~p  560 (604)
                      .......||+.|+|||++.+..++    .++|||||||++|||++|..||....        ........+. .....+|
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~----~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p  282 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYG----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIP  282 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH-HCCCCCC
T ss_pred             CccccccCCcccCCchhhcCCCCC----hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh-ccccCCC
Confidence            445566899999999999887554    45999999999999999999996421        1222222222 2355688


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQF------SEIISLLLR  594 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~------~ELL~~L~~  594 (604)
                      ..+++++.+||.+||+.||.+||++      .+|++|-+.
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            8999999999999999999999984      788887654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-43  Score=355.53  Aligned_cols=250  Identities=19%  Similarity=0.294  Sum_probs=203.3

Q ss_pred             CCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      ++|++++.||+|+||.||++     +.+|+|++............+.+|+.++..++||||+++++++.+.+. +++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-EEEEEE
Confidence            67999999999999999996     579999997544333333567899999999999999999999988775 999999


Q ss_pred             cccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       415 y~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            9986 999988654 57999999999999999999999999999999999999999999999999998766543333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------------C
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------------P  557 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------------~  557 (604)
                      ..+|+.|+|||.+.+..   .++.++|||||||++|||++|..||...+..+....+......                +
T Consensus       160 ~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             --CCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccCchheeCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            56899999999997542   2345699999999999999999999988776665554432100                0


Q ss_pred             -----------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -----------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                 .....+++.+.++|.+||+.||.+|||+.|+++|-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                       1124578999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=360.99  Aligned_cols=249  Identities=16%  Similarity=0.273  Sum_probs=211.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+.......    .....+.+|+.++..++||||+++++++.+... .
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-E
Confidence            56899999999999999995      579999987543321    134568899999999999999999999988765 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~~  485 (604)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998777899999999999999999999999999999999999999888    79999999987664


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~  563 (604)
                      ... ......||+.|+|||++.+..++    .++|||||||++|+|++|..||...+..+....+........  .+..+
T Consensus       170 ~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          170 FGN-EFKNIFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             TTS-CCCCCCSCTTTCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CCC-ccccccCCcCcCCceeecCCCCC----cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            332 23345689999999999876544    459999999999999999999998877776666555433321  23578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+.++|.+||+.||.+|||+.++++|-+.
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  275 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  275 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence            8999999999999999999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=361.04  Aligned_cols=249  Identities=16%  Similarity=0.217  Sum_probs=213.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.+|+|.+...   ......+.+|+.++..++||||+++++++.+.+. +++||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~   80 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE-EEEEE
Confidence            78999999999999999985      57999998632   3344568899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--CCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....... .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~  159 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-N  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-E
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-c
Confidence            999999999999654 37999999999999999999999999999999999999987  7899999999987664332 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s~~l~  568 (604)
                      .....+|+.|+|||++.+..+    +.++|||||||++|+|++|..||...+..+....+........  ....+++++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVV----STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEE----CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cccccCChhhcCcHHhcCCCC----CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            344568999999999987643    4569999999999999999999999888777776666544322  1246889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++|.+||..||.+|||+.|+++|-+....
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999887654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-42  Score=358.67  Aligned_cols=251  Identities=20%  Similarity=0.278  Sum_probs=202.6

Q ss_pred             CCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .++|++++.||+|+||.||+++     .||+|++............+.+|+.++..++||||+++++++.+++. +++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-LTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC-EEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE-EEEEE
Confidence            3789999999999999999964     69999997554444445668899999999999999999999987775 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            99986 888887654 4699999999999999999999999999999999999999999999999999987654444445


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---C-----------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---E-----------  558 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~-----------  558 (604)
                      ...+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||...+..+....+......+   .           
T Consensus       178 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             CCcccCCcCCHHHhcCCC---CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            557899999999987642   23456999999999999999999998766555444433211110   0           


Q ss_pred             --------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          559 --------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       559 --------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                    ....+++++.+||.+||+.||.+|||+.|+++|-+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                          123467899999999999999999999999987554

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=351.49  Aligned_cols=259  Identities=24%  Similarity=0.413  Sum_probs=217.9

Q ss_pred             ceeecCCCeEEee-eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~-~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .|.+..++|.+.+ .||+|+||.||+|.        .||+|.++... .......+.+|+.++..++||||+++++++..
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   81 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   81 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC
Confidence            4667778899987 99999999999863        59999997542 33345668899999999999999999999943


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                       +. .++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        82 -~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           82 -EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             -SS-EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CC-cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence             33 89999999999999998543 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          484 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      .......   .....+|+.|+|||.+.+..+    +.++||||||+++|||++ |..||......+... .+..+.++..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~i~~~~~~~~  234 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKF----SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMEC  234 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCC----CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHhcCCcCCC
Confidence            6433221   223346789999999976543    456999999999999998 999999877665544 3445666778


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      |..+++.+.++|.+||+.||.+||++.+++++|+.+....+
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            88999999999999999999999999999999999865443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.7e-43  Score=370.22  Aligned_cols=259  Identities=20%  Similarity=0.322  Sum_probs=208.3

Q ss_pred             cceeecCCCeEEeeeeecc--CceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          333 GRWLLNSDNLEFIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G--~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      +.+....++|++++.||+|  +||.||++      +.||+|++............+.+|+.+++.++|||||++++++.+
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4556667899999999999  99999985      579999998655444455668899999999999999999999998


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .+. +|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           98 DNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             TTE-EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCE-EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            775 99999999999999999654  579999999999999999999999999999999999999999999999999976


Q ss_pred             ccccCC-------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC
Q 007429          483 ACKSVG-------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       483 ~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      ......       .......||+.|+|||++.+..  ..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL--QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eeccccccccccccccccccccccccCHHHHhccC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            543221       1223346889999999998631  1244569999999999999999999987655443332221110


Q ss_pred             --------------------------------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          556 --------------------------------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       556 --------------------------------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                                                                  ....+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                        112345678899999999999999999999999987


Q ss_pred             HHH
Q 007429          592 LLR  594 (604)
Q Consensus       592 L~~  594 (604)
                      -+.
T Consensus       335 p~f  337 (389)
T 3gni_B          335 SFF  337 (389)
T ss_dssp             GGG
T ss_pred             HHH
Confidence            443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=358.27  Aligned_cols=258  Identities=27%  Similarity=0.459  Sum_probs=212.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      +.+..++|.+.+.||+|+||.||+|.          .||+|.++... .......+.+|+.++..++||||+++++++.+
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            45777899999999999999999964          38999987432 33344568899999999999999999999987


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .+. .++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          118 YKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSS-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CCC-cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            665 99999999999999999654 5799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          484 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      .......   .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+.... +..+.++..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~  271 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKF----TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPT  271 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCC
T ss_pred             hccccccccccCCCCccccccCchhcccCCC----CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHCCCcCCC
Confidence            5433221   122345778999999986654    446999999999999999 9999988777655443 445566677


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +..+++.+.++|.+||+.||.+||++.+++++|.++....
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            8889999999999999999999999999999999886543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-42  Score=350.78  Aligned_cols=261  Identities=17%  Similarity=0.274  Sum_probs=198.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      |.+..++|++++.||+|+||.||++      +.||+|+++...........+.++...+..++||||+++++++.+.+. 
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~-   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS-
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC-
Confidence            3456689999999999999999995      469999997543222222233344444667899999999999998776 


Q ss_pred             EEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .++||||+++ +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999975 88887743    45799999999999999999999998 999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHcCCCCCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~-s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ..... ......+|+.|+|||.+........++.++|||||||++|+|++|..||... .+................+..
T Consensus       160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred             ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence            54332 2334468999999999854433344566799999999999999999999874 444555555555444444567


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +++.+.+++.+||+.||.+|||+.++++|-+.....
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            899999999999999999999999999987765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-42  Score=352.26  Aligned_cols=257  Identities=24%  Similarity=0.436  Sum_probs=211.5

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+..++|++++.||+|+||.||++          +.||+|.+..... ......+.+|+.++..++||||+++++++.+.
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            345577999999999999999975          4799999975432 22345688999999999999999999999876


Q ss_pred             C-CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 N-HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 ~-~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      . ..+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            3 348999999999999999954 45799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC--------------CChHHH
Q 007429          484 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA--------------CSPVQA  546 (604)
Q Consensus       484 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~--------------~s~~~~  546 (604)
                      ......   ......+|+.|+|||.+.+..++    .++||||||+++|+|++|..|+..              ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFY----IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE----HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCC----cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            654332   22334578889999999776443    469999999999999999987642              122334


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       547 ~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .......+.+...+..+++.+.++|.+||+.||.+|||+.++++.|..+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            445556667778889999999999999999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-42  Score=365.70  Aligned_cols=253  Identities=17%  Similarity=0.264  Sum_probs=201.2

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ...++|++++.||+|+||.||++      +.||+|++......   ...+.+|+..++.++||||+++++++.+... ++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-LA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE-EE
Confidence            45688999999999999999985      57999999754332   3457799999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc--EEEEecCCccccccCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVG  488 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~--vKL~DFGla~~~~~~~  488 (604)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999987788999999999999999999999999999999999999987765  999999998743322 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHHcCCCCCCCCCcc
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~----~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .......||+.|+|||++.+..+.   +.++|||||||++|+|++|..||.....    ......+.......+....++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCC---HHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCC---CCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            223345689999999999876543   2348999999999999999999986433    333333444433433444689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+.+||.+||+.||.+|||+.|+++|-+...+
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999887544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-42  Score=349.15  Aligned_cols=251  Identities=29%  Similarity=0.530  Sum_probs=210.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHH-----HHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYE-----FELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~-----~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      +..++|++.+.||+|+||.||+++      .||+|.+..........     ..+.+|+.++..++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            455889999999999999999864      69999987544333222     5678999999999999999999998654


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCc-----EEEEe
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGN-----VCLGD  477 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~-----vKL~D  477 (604)
                      .   ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +||+|
T Consensus        96 ~---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 P---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             T---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             C---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            3   6999999999999888543 47999999999999999999999999  999999999999988876     99999


Q ss_pred             cCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHcCC
Q 007429          478 MGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGL  555 (604)
Q Consensus       478 FGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~--~~~~~i~~~~~  555 (604)
                      ||+++....   ......+|+.|+|||.+.+...  .++.++|||||||++|||++|..||...+..  .....+.....
T Consensus       173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEEE--SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS---CEECCCCCCTTSCGGGSSCSSC--EECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc---cccccCCCccccCchhhccCCC--CcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999865432   2344578999999999854322  2355799999999999999999999875433  33455566777


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++.++..+++.+.++|.+||+.||.+|||+.++++.|.++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8888999999999999999999999999999999999753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-42  Score=356.19  Aligned_cols=264  Identities=22%  Similarity=0.418  Sum_probs=211.8

Q ss_pred             cccceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       331 ~i~~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      .+..+.+..++|.+.+.||+|+||.||+|.         .||+|.++...........+.+|+..+..++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            345677888999999999999999999863         69999987654444445668899999999999999999999


Q ss_pred             EEcCCC----cEEEEEecccCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          402 CVDENH----GLCVVTKLMEGGSVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       402 ~~~~~~----~l~LVmEy~~gGSL~dlL~~------~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      +.+...    ..++||||+++|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            987542    25999999999999999842      34699999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .+||+|||++.......  .......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||..........
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY----TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCC----CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc----cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            99999999987654322  12233456788999999987654    456999999999999999 999998877655544


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      . ...+.++..+..+++.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       261 ~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 Y-LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             H-HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             H-HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            3 4445567788899999999999999999999999999999999986543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-42  Score=348.43  Aligned_cols=257  Identities=26%  Similarity=0.480  Sum_probs=218.2

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|.+..++|++++.||+|+||.||+|     ..|++|.+.....   ....+.+|+.++..++||||+++++++.++ .
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC-C
Confidence            468888899999999999999999996     4799999975432   245688999999999999999999998643 3


Q ss_pred             cEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       .++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             -cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence             789999999999999996433  79999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......+++.|+|||.+.+..+    +.++||||||+++|||++ |..||...+..+.... +..+.+...+..+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTF----TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNC  235 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             CcccccccCCCCccCccChhhhccCCC----CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-HhcccCCCCcccc
Confidence            4322 1223346788999999976543    456999999999999999 9999998777655443 4455667778899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ++.+.+++.+||+.||.+|||+.++++.|..+....
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999999886544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.6e-43  Score=380.43  Aligned_cols=253  Identities=17%  Similarity=0.272  Sum_probs=208.0

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      .+..++|++++.||+|+||.||++      +.||+|.++.... .......+.+|+.++..++||||+++++++.+.+. 
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-  222 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-  222 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE-
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE-
Confidence            345578999999999999999985      5899999974321 11223446788888889999999999999998775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      +|+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++.....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999999888899999999999999999999998 99999999999999999999999999998765444


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  567 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l  567 (604)
                      ........||+.|+|||++.+..++    .++|||||||++|||++|..||...+.......+....  ..+|..+++++
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~  376 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEA  376 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred             CcccccccCCccccCHhhcCCCCCC----CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHH
Confidence            4445556799999999999876554    46999999999999999999999888777766666543  45788899999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHHHHHHh
Q 007429          568 KSLMIKCWNNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      .+||.+||+.||.+||     ++.|+++|-+..
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence            9999999999999999     999999876654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=349.97  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             ceeecCC--CeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          334 RWLLNSD--NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       334 ~~~i~~~--~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      .+.+..+  .|.+.+.||+|+||.||+|+         .+|+|.+.... .......+.+|+.++..++||||+++++++
T Consensus        13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   91 (298)
T 3pls_A           13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIM   91 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3444444  35567999999999999975         68999987432 233445678999999999999999999999


Q ss_pred             EcCCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          403 VDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       403 ~~~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .+.+...++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           92 LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             CCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             ecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            8776545899999999999999965 457899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC----CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHcCCC
Q 007429          482 TACKSVG----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGLR  556 (604)
Q Consensus       482 ~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~~s~~~~~~~i~~~~~r  556 (604)
                      .......    .......+++.|+|||.+.+..+    +.++||||||+++|+|++| .+||...+... .......+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~  246 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRF----TTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRR  246 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC----CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCC
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCC----ChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCC
Confidence            7554321    12233457789999999987654    4469999999999999995 45555544444 3444555666


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ...+..+++.+.+++.+||+.||.+|||+.++++.|.++.....
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            77788899999999999999999999999999999999876553

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.9e-43  Score=362.29  Aligned_cols=253  Identities=23%  Similarity=0.425  Sum_probs=209.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|+          .|++|.+...... .....+.+|+..+..++||||+++++++.+. 
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   87 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-   87 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-
Confidence            566899999999999999999975          3888887543221 1223456888899999999999999998643 


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       ..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        88 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 -SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             -SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             -ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence             389999999999999999654 479999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ....  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||......... ..+..+.+...|..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  241 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKY----THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEKGERLAQPQI  241 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHHTTCBCCCCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCC----ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCCCCCCc
Confidence            4322  2233457789999999987654    456999999999999999 99999986655443 34455667777888


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++..+.++|.+||+.||.+||++.+++++|.++..
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999998854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.4e-43  Score=384.15  Aligned_cols=259  Identities=24%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ...|.+..++|++.+.||+|+||.||+|      ..||||.++....   ....+.+|+.++..++|||||+++++|.+.
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3578899999999999999999999996      5799999975332   245688999999999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .. +++||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       289 ~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          289 PP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             Cc-EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            65 89999999999999999653  3689999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          484 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       484 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      ...... ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+.. ..+..+.++..|.
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~  442 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNKF----SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPE  442 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCCT
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCCC----CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCC
Confidence            543221 1223345778999999986644    456999999999999999 99999987665443 4456677888899


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .+++.+.+||.+||+.||.+|||+.+|++.|..+....
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999876543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-42  Score=367.61  Aligned_cols=248  Identities=19%  Similarity=0.249  Sum_probs=214.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.++..++||||+++++++.+... +|
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~  117 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LY  117 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE-EE
Confidence            3478999999999999999985      5799999864321 11123457789999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....   
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            99999999999999988788999999999999999999999999999999999999999999999999998765432   


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...+|..+++.+.++
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYN----KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDL  268 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHH
T ss_pred             cccccCCccccCHHHhcCCCCC----CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence            3345789999999999876544    4699999999999999999999988887777666664  455788899999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHHHHHHh
Q 007429          571 MIKCWNNSPSKRPQ-----FSEIISLLLRT  595 (604)
Q Consensus       571 I~kCL~~dP~kRPT-----~~ELL~~L~~~  595 (604)
                      |.+||+.||.+||+     +.+|++|-+..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            99999999999998     99999886643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-42  Score=354.49  Aligned_cols=258  Identities=25%  Similarity=0.444  Sum_probs=216.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ..|.+..++|++.+.||+|+||.||+|           +.||+|.+... ........+.+|+.++..++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            467788899999999999999999985           45889988743 233344568899999999999999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~----------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      +.+.+. .++||||+++|+|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        97 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           97 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EccCCc-cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            987765 89999999999999998542          3568999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~  548 (604)
                      .+||+|||++........  ......+++.|+|||.+.+..+    +.++||||||+++|||++ |..||...+..+...
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCC----CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            999999999876543321  1223346788999999986654    456999999999999999 899999877766554


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+. .+..+..+..+++.+.++|.+||+.||.+|||+.+++++|.+...
T Consensus       252 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            444 444556788899999999999999999999999999999988744

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=354.22  Aligned_cols=251  Identities=19%  Similarity=0.271  Sum_probs=203.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-LHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe-EEEEE
Confidence            67999999999999999985      579999997655444455668899999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            99999999999877778999999999999999999999999999999999999999999999999998776544444445


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-------------------C
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-------------------G  554 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-------------------~  554 (604)
                      ..+|+.|+|||.+.+..   .++.++||||||+++|+|++|..||.+.+..+....+...                   +
T Consensus       162 ~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          162 EVATRWYRSPELLVGDT---QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             ----GGGCCHHHHHTCS---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             CcCCccccChHHHhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            57899999999997632   2345699999999999999999999988776655443321                   0


Q ss_pred             CCCCC----------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          555 LRPEI----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       555 ~r~~~----------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .....          ...+++.+.++|.+||+.||.+|||+.++++|-+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  288 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF  288 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence            01111          13578889999999999999999999999988554

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.1e-43  Score=370.93  Aligned_cols=256  Identities=28%  Similarity=0.470  Sum_probs=206.0

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+..++|++.+.||+|+||.||+|+         .||+|.++... .......+.+|+.++..++||||+++++++.+.+
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            4566789999999999999999863         49999997432 3334556889999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . .++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 P-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             S-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             c-eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            5 899999999999999996543 79999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          486 SVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       486 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      .....   .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+... .+..+.+...+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~-~i~~~~~~~~~~  273 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKF----TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK-AVDEGYRLPPPM  273 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH-HHHTTEECCCCT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCc----CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCc
Confidence            43221   112235678999999987654    456999999999999998 999999877765544 344555666788


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .++..+.++|.+||+.||.+||++.++++.|.++...
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999999988654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.4e-43  Score=352.59  Aligned_cols=250  Identities=22%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe-------------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG-------------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG-------------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      +..++|++.+.||+|+||.||+|             ..|++|.+....  ......+.+|+.++..++||||+++++++.
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            45578999999999999999996             358899886432  234456889999999999999999999998


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc--------EE
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VC  474 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~--------vK  474 (604)
                      +.+. .++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        83 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTC-CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCC-CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            8775 899999999999999997654 4999999999999999999999999999999999999998887        99


Q ss_pred             EEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHc
Q 007429          475 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       475 L~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~~s~~~~~~~i~~~  553 (604)
                      |+|||++.....    .....+++.|+|||.+.+..   .++.++|||||||++|||++| .+||......... .....
T Consensus       162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~  233 (289)
T 4fvq_A          162 LSDPGISITVLP----KDILQERIPWVPPECIENPK---NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED  233 (289)
T ss_dssp             ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGG---GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred             eccCcccccccC----ccccCCcCcccCHHHhCCCC---CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence            999999765432    22345788899999998622   245579999999999999995 5555555444333 33332


Q ss_pred             CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       554 ~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                        ....|..+++.+.++|.+||+.||.+|||+.+++++|.++.+..
T Consensus       234 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          234 --RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             --TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence              44566777888999999999999999999999999999887643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-43  Score=363.80  Aligned_cols=252  Identities=17%  Similarity=0.247  Sum_probs=206.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|.+..... ......+.+|+.++..++||||+++++++.+.+. .|+||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEEEE
Confidence            68999999999999999985      5799999874332 2223457899999999999999999999988775 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC--Ccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~--~~~  491 (604)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999999999999777789999999999999999999999999999999999999999999999999987654322  123


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~-~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....||+.|+|||++.+..+   .+.++|||||||++|+|++|..||.......... ..............+++.+.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSB---CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            34578999999999986543   2446999999999999999999998765532222 2233323333345688999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      |.+||+.||.+|||+.|++++-|...
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcc
Confidence            99999999999999999999877654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-42  Score=348.54  Aligned_cols=254  Identities=20%  Similarity=0.323  Sum_probs=212.9

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..++|++.+.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++||||+++++++.+... .+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE-EE
Confidence            4478999999999999999996      36999998642211 1123457889999999999999999999988765 89


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--c
Confidence            99999999999999988788999999999999999999999999999999999999999999999999997554332  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      .....+++.|+|||.+.+..++.    ++||||||+++|+|++|..||...+..+....+...  ...+|..+++.+.++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDE----KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDL  237 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCT----THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCc----cchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHH
Confidence            23446899999999998765543    599999999999999999999987777666555443  445778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      |.+||+.||.+|||+.|+++|-+......+
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            999999999999999999999887655443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.3e-42  Score=348.19  Aligned_cols=257  Identities=20%  Similarity=0.385  Sum_probs=212.9

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .|.+..++|++.+.||+|+||.||+|.         .|++|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            456677899999999999999999974         48999987432 33345668899999999999999999999865


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..  .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           85 EP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS--CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC--CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            43  68999999999999999654 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          484 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       484 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      ...... ......+++.|+|||.+.+..+    +.++||||||+++|||++ |..||........... ...+.+...+.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~  237 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRF----TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRLPKPD  237 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCCCCCT
T ss_pred             cccccccccccCCCCcceeCchhhccCCC----CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCCCCCC
Confidence            543221 2233456788999999976654    446999999999999998 9999987665554433 34455667788


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .+++.+.+++.+||+.||.+||++.+++++|..+.+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            8999999999999999999999999999999988653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-42  Score=350.36  Aligned_cols=253  Identities=24%  Similarity=0.481  Sum_probs=209.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      ..|.+..++|++.+.||+|+||.||++    +.|++|.++...    ....+.+|+..+..++||||+++++++.+....
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            467788899999999999999999995    679999987432    245678999999999999999999998766545


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      .++||||+++|+|.+++.+..  .+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            899999999999999996544  389999999999999999999999999999999999999999999999999865443


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .   .....+++.|+|||.+.+..+    +.++||||||+++|||++ |..||...+..+.. ..+..+.++..+..+++
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          170 T---QDTGKLPVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTTCCCCCCTTCCH
T ss_pred             c---ccCCCccccccCHHHhCCCCC----CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCCcccCCH
Confidence            2   223457888999999976544    456999999999999998 99999887655443 33445567778889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+.++|.+||+.||.+||++.++++.|..+..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-42  Score=365.19  Aligned_cols=250  Identities=16%  Similarity=0.247  Sum_probs=205.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCC---CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~---~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+....   ........+.+|+.++..++||||+++++++.+.+. +|
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-LY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-EE
Confidence            67999999999999999995      579999986321   111234568899999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCccc
Q 007429          411 VVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTA  483 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~  483 (604)
                      +||||+++|+|.+++.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999999887532    25899999999999999999999999999999999999987665   99999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPK  561 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~  561 (604)
                      ............||+.|+|||++.+..++    .++|||||||++|+|++|..||... .......+........  ...
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYG----KPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCC----chHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            66544444456799999999999876543    4699999999999999999999874 3344444444433221  124


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+++.+.++|.+||+.||.+|||+.++++|-+..
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            6789999999999999999999999999876643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.4e-42  Score=350.47  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=210.8

Q ss_pred             CCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      .+|++.+.||+|+||.||+|.         .+++|.+... ........+.+|+.++..++||||+++++++.+.+...+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            457899999999999999875         4788888743 233344568899999999999999999999876665589


Q ss_pred             EEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            99999999999999965 34689999999999999999999999999999999999999999999999999876543221


Q ss_pred             ----cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          490 ----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       490 ----~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                          ......+|+.|+|||.+.+..+    +.++||||||+++|+|++ |.+||...+....... ...+.+...|..++
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  258 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCP  258 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-HHTTCCCCCCTTCC
T ss_pred             hccccccCCCCCccccChHHhcCCCC----ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhcCCCCCCCccCC
Confidence                1223356788999999987654    446999999999999999 6777776655544433 34455666788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      +.+.+++.+||+.||.+|||+.++++.|..+.....
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            999999999999999999999999999999877554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=359.86  Aligned_cols=257  Identities=16%  Similarity=0.249  Sum_probs=211.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H--pnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++++.||+|+||.||++     +.||+|++............+.+|+.++..++|  |||+++++++.+... +
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~-~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-I   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-E
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE-E
Confidence            45678999999999999999985     579999998655555455678899999999976  999999999988775 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      ++||| +.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            99999 45779999998888899999999999999999999999999999999999997 68899999999876543322


Q ss_pred             --cccccCCCCcccccccccCCCC-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCCCCC
Q 007429          490 --ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEI  559 (604)
Q Consensus       490 --~~~~~~gt~~Y~APE~l~~~~~-------s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r~~~  559 (604)
                        ......||+.|+|||.+.+...       ...++.++|||||||++|||++|..||..... ......+........+
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  242 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence              1234568999999999864211       12356679999999999999999999987543 3445555555666778


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      |..++..+.++|.+||+.||.+|||+.++++|.+...
T Consensus       243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            8888999999999999999999999999999987653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-42  Score=350.31  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=211.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.|++|.+............+.+|+..+..++||||+++++++.+. +..+++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            68899999999999999995      5699999986554444556788999999999999999999988653 3458999


Q ss_pred             EecccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          413 TKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~g-----IVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      |||+++|+|.+++...    ..+++..++.++.||+.||.|||+++     |+||||||+|||++.++.+||+|||++..
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            9999999999999643    24999999999999999999999999     99999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      ............+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...+.......+. .+..+.+|..+
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~  240 (279)
T 2w5a_A          166 LNHDTSFAKTFVGTPYYMSPEQMNRMSY----NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRY  240 (279)
T ss_dssp             C---CHHHHHHHSCCTTCCHHHHHCC-C----CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTS
T ss_pred             eccccccccccCCCccccChHHhccCCC----CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCccc
Confidence            5543322334468999999999987644    456999999999999999999999877665554444 44556778889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++.+.++|.+||+.||.+||++.+|+++++...+
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            9999999999999999999999999998875543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-42  Score=349.41  Aligned_cols=259  Identities=27%  Similarity=0.487  Sum_probs=210.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      ..+..++|++++.||+|+||.||+|+         .|++|.++.... .......+.+|+..+..++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            44566899999999999999999975         489998875432 22345568899999999999999999999976


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..  .++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus        93 ~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           93 PP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             SS--CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CC--ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            54  78999999999999999654 5799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          484 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      .......   .....+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+....+.....+...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF----SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  246 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCC----CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence            6443221   223356778999999976543    456999999999999999 99999998888877777777777778


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +..+++.+.++|.+||+.||.+|||+.+++++|.++....
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            8899999999999999999999999999999999887643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.6e-43  Score=370.38  Aligned_cols=257  Identities=11%  Similarity=0.171  Sum_probs=199.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHH---------HHHHHHHHHhCCCCceeE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFE---------LRKDLLELMTCGHKNILQ  397 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~---------~~~Ei~~L~~L~HpnIVk  397 (604)
                      ..++|++++.||+|+||.||+|           +.||+|.+.........+..         +..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4578999999999999999997           45899998754321111111         223444566778999999


Q ss_pred             EEEEEEcCC---CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc--CCC
Q 007429          398 FYCVCVDEN---HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHG  471 (604)
Q Consensus       398 l~g~~~~~~---~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld--~~g  471 (604)
                      +++++....   ...|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999997642   3379999999 99999999765 5899999999999999999999999999999999999999  889


Q ss_pred             cEEEEecCCccccccCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 007429          472 NVCLGDMGIVTACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  544 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~  544 (604)
                      .+||+|||+++........       .....||+.|+|||.+.+..+    +.++|||||||++|||++|..||......
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP----SRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC----CchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            9999999999765433221       123348999999999987654    45699999999999999999999853322


Q ss_pred             HHHHHHHHcCCCC--------C-CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          545 QAAVGIAACGLRP--------E-IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       545 ~~~~~i~~~~~r~--------~-~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ...........+.        . .+..+++++.++|..||+.||.+||++.+|++.|.++....
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            2221111111111        1 12567899999999999999999999999999999886644

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-42  Score=350.90  Aligned_cols=252  Identities=23%  Similarity=0.443  Sum_probs=198.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHh--CCCCceeEEEEEEEcC---CCcE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDE---NHGL  409 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~--L~HpnIVkl~g~~~~~---~~~l  409 (604)
                      .++|++++.||+|+||.||+|    +.||+|++...     ....+.+|..++..  ++||||+++++++.+.   ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            378899999999999999996    57999998632     12333445444444  8999999999997653   2348


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLH--------s~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      ++||||+++|+|.+++ +...+++..++.++.||+.||.|||        +++|+||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHH-TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHH-hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999999999998 4457999999999999999999999        999999999999999999999999999998


Q ss_pred             cccccCCCc----ccccCCCCcccccccccCCCCCC--CCCcchhHHHHHHHHHHHHcC----------CCCCCCCC---
Q 007429          482 TACKSVGEA----TEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTG----------EAAYAACS---  542 (604)
Q Consensus       482 ~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~--~~t~kSDVWSlGvvLyELlTG----------~~Pf~~~s---  542 (604)
                      .........    .....||+.|+|||.+.+.....  .++.++|||||||++|||++|          ..||....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            765443222    22336899999999998764322  233579999999999999999          88886532   


Q ss_pred             -hHHHHHHH-HHcCCCCCCCC-----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          543 -PVQAAVGI-AACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       543 -~~~~~~~i-~~~~~r~~~p~-----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                       ........ .....++..|.     .+++.+.++|.+||+.||.+|||+.++++.|.++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence             22222222 22334444443     35688999999999999999999999999998763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-42  Score=369.84  Aligned_cols=249  Identities=19%  Similarity=0.277  Sum_probs=205.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCCcE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~-L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ..++|++++.||+|+||.||++      +.+|+|.++...... .....+.+|..+ +..++|||||++++++.+.+. +
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~-~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-L  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE-E
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE-E
Confidence            4578999999999999999986      479999997543222 123345566655 456799999999999988775 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      ......||+.|+|||++.+..++    .++|||||||++|||++|..||...+..+....+...  ...++..++..+.+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYD----RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARH  268 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCC----chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHH
Confidence            45566899999999999876554    4599999999999999999999988887777766664  34577889999999


Q ss_pred             HHHHhhhcCCCCCCCH----HHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQF----SEIISLLL  593 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~----~ELL~~L~  593 (604)
                      ||.+||+.||.+||++    .+|++|-+
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~  296 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVF  296 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence            9999999999999997    46665543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9e-42  Score=354.45  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=209.2

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .|...+.||+|+||.||+|      +.||||.+......  ....+.+|+.++..++||||+++++++...+. .++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence            4678889999999999985      57999999754432  24457899999999999999999999988775 999999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+++|+|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus       123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999884 4579999999999999999999999999999999999999999999999999987765544344456


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCccHHHHHHHHH
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIK  573 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s~~l~~LI~k  573 (604)
                      .||+.|+|||.+.+..++    .++|||||||++|||++|..||...+..+....+...... ...+..+++.+.++|.+
T Consensus       202 ~gt~~y~aPE~~~~~~~~----~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYA----TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCHhhhcCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            799999999999876543    4699999999999999999999988777666555443221 12334678999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ||+.||.+|||+.+++++-+..
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGG
T ss_pred             HccCChhhCcCHHHHhcChhhc
Confidence            9999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3e-43  Score=380.44  Aligned_cols=262  Identities=18%  Similarity=0.256  Sum_probs=217.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ..+.+..++|++++.||+|+||.||++      +.+|+|.++..... ......+.+|+.++..++|||||+++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345567789999999999999999985      47999998642110 00112366888999999999999999999987


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .. +|+||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus       142 ~~-~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          142 RY-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             SE-EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CE-EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            75 9999999999999999854 579999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CC
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  562 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~  562 (604)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||...+.......+........+|  ..
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  299 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  299 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence            4332 23355799999999999876533335567999999999999999999999988887777766543233333  46


Q ss_pred             ccHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHhh
Q 007429          563 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLRTN  596 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~k--RPT~~ELL~~L~~~~  596 (604)
                      +++++++||.+||..+|.+  ||++.||++|-+...
T Consensus       300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            8999999999999999988  999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.3e-42  Score=365.23  Aligned_cols=257  Identities=16%  Similarity=0.250  Sum_probs=211.4

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEcCCCc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDENHG  408 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~--HpnIVkl~g~~~~~~~~  408 (604)
                      .+..++|++++.||+|+||.||++     +.||||++............+.+|+.++..++  |||||++++++...+. 
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~-  130 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-  130 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE-
Confidence            344567999999999999999985     57999999865554445567889999999986  5999999999988776 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||| +.+++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 56789999998878899999999999999999999999999999999999996 6899999999987664332


Q ss_pred             C--cccccCCCCcccccccccCCCC-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCCCC
Q 007429          489 E--ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPE  558 (604)
Q Consensus       489 ~--~~~~~~gt~~Y~APE~l~~~~~-------s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r~~  558 (604)
                      .  ......||+.|+|||++.+...       ...++.++|||||||++|||++|..||..... ...+..+........
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence            2  1234569999999999976321       12456779999999999999999999987543 345555555556667


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +|...+..+.+||.+||+.||.+||++.|++++-+..
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            7888899999999999999999999999999987764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.9e-42  Score=347.26  Aligned_cols=251  Identities=18%  Similarity=0.276  Sum_probs=216.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|.+.+.||+|+||.||++      +.+++|.+...... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv   93 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFVV   93 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE-EEEE
Confidence            67899999999999999995      47999998754322 2344567899999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  173 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  173 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999877654444445


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+..+    +.++||||||+++|+|++|..||......+....+...  ...+|..+++.+.++|.
T Consensus       174 ~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          174 VLCGTPNYIAPEVLSKKGH----SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CCCSCCSSCCHHHHTTSCB----CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHH
T ss_pred             cccCCCCcCCcchhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHH
Confidence            5678999999999987654    34699999999999999999999987776665554433  44577889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +||+.||.+|||+.+++++-+....
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHcccChhhCcCHHHHhhChheecC
Confidence            9999999999999999998776543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-41  Score=345.70  Aligned_cols=254  Identities=18%  Similarity=0.257  Sum_probs=208.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+..+..+ +|+||+++++++.+... .
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-N   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-E
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce-e
Confidence            34578999999999999999996      58999998744322    2366888888888 89999999999987765 8


Q ss_pred             EEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc-----EEEEecCCccc
Q 007429          410 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTA  483 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~-----vKL~DFGla~~  483 (604)
                      ++||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 89999999754 46999999999999999999999999999999999999988776     99999999876


Q ss_pred             cccCCC-------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHc
Q 007429          484 CKSVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAAC  553 (604)
Q Consensus       484 ~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s---~~~~~~~i~~~  553 (604)
                      ......       ......||+.|+|||.+.+..+    +.++|||||||++|||++|..||....   .......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ----SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCC----ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            654322       1234468999999999987654    456999999999999999999998743   33333333222


Q ss_pred             C---CCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          554 G---LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       554 ~---~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .   ..+..+..+++.+.+++.+||+.||.+||++.+|++.|.++.+..+
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            1   1222345789999999999999999999999999999999876544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-42  Score=355.61  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC---c
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENH---G  408 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~---~  408 (604)
                      .++|++.+.||+|+||.||++      +.||+|.++...... .....+.+|+..+..++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            478999999999999999985      579999997643332 234567899999999999999999999876543   2


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  170 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence            48999999999999999877889999999999999999999999999999999999999999999999999987654332


Q ss_pred             C---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCc
Q 007429          489 E---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDC  563 (604)
Q Consensus       489 ~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~  563 (604)
                      .   ......||+.|+|||.+.+..+    +.++|||||||++|||++|..||...+..............+.  .+..+
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARGDSV----DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             -----------CCTTCCHHHHHTCCC----CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccCcCcccCCHHHhcCCCC----CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            2   1223458999999999987654    4569999999999999999999999888777766666544332  24568


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++++.++|.+||+.||.+||+..+++.+-+.
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            9999999999999999999976666654443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=356.43  Aligned_cols=254  Identities=23%  Similarity=0.442  Sum_probs=209.2

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|+          .|++|.+.... .......+.+|+.++..++||||+++++++.+..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            566899999999999999999975          36888876433 2334566889999999999999999999998754


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        91 --~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             --EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             --ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence              7899999999999999965 4579999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ....  ......+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||......... ..+..+.+...+..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  243 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY----THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPI  243 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTT
T ss_pred             CccccccccCCCccccccCHHHHcCCCC----ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcc
Confidence            3322  1223346778999999987654    446999999999999999 99999887665543 44555667778888


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++..+.++|.+||+.||.+||++.|+++.|.++...
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999999999999988653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-42  Score=382.98  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=220.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|++..++|++.+.||+|+||.||+|     ..||||+++....   ....+.+|+.+|..++|||||++++++.+ + 
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~-  334 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-  334 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c-
Confidence            578999999999999999999999997     4699999975432   24568899999999999999999999876 3 


Q ss_pred             cEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .+||||||+.+|+|.+++..  ...+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            38999999999999999954  3469999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||......+.... +..+.+...+..+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~~~~  489 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRF----TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPEC  489 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTC
T ss_pred             CCceecccCCcCcccccCHHHhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCC
Confidence            3211 1223346788999999986643    456999999999999999 9999998877665544 4566777888999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ++.+.+||.+||+.||++|||+.+|++.|..+....+
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            9999999999999999999999999999998876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.5e-42  Score=343.17  Aligned_cols=244  Identities=18%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+..+..+ +||||+++++++.+.+. .++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~-~~lv   89 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH-MLIQ   89 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE-EEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence            67899999999999999995      5799999987655566667788999999998 99999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC------------------
Q 007429          413 TKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------------------  470 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~------------------  470 (604)
                      |||+++|+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999654    569999999999999999999999999999999999999844                  


Q ss_pred             -CcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 007429          471 -GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG  549 (604)
Q Consensus       471 -g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~  549 (604)
                       ..+||+|||++......    ....+|+.|+|||.+.+..   .++.++|||||||++|+|++|.+|+......    .
T Consensus       170 ~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~  238 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENY---THLPKADIFALALTVVCAAGAEPLPRNGDQW----H  238 (289)
T ss_dssp             CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCC---TTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----H
T ss_pred             ceEEEEcccccccccCCc----cccCCCccccChhHhcCCC---CCCchhhHHHHHHHHHHHhcCCCCCcchhHH----H
Confidence             47999999998765432    2345899999999997642   2345799999999999999999877554322    2


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       550 i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ....+..+.+|..+++.+.++|.+||+.||.+|||+.+++++-+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence            2344556778889999999999999999999999999999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-41  Score=346.76  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=216.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+.|++++.||+|+||.||+|      +.|++|.+...... .....+.+|+.++..++||||+++++++.+... .++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEE
Confidence            367999999999999999996      47999999754332 334568899999999999999999999988775 8999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999984 45799999999999999999999999999999999999999999999999999877655443444


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...+++.|+|||.+.+..++    .++||||||+++|+|++|..||...........+. ....+.++..++..+.++|.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYD----SKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHH
T ss_pred             ccCCCcCccCHHHHhcCCCC----chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHH
Confidence            55789999999999876544    46999999999999999999999877766555444 34566678889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +||+.||.+|||+.+++++.+...+.
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999988766543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-41  Score=346.87  Aligned_cols=254  Identities=20%  Similarity=0.384  Sum_probs=198.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||+|      +.||+|++...... ......+.+|+..+..++||||+++++++.+.+. .++|
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv  110 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIV  110 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc-EEEE
Confidence            57899999999999999985      57999999754333 2344568899999999999999999999998775 9999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            999999999999853    3468999999999999999999999999999999999999999999999999987655443


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHcCCCCCCCCCccHH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s--~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||....  .......+.....++..+..++++
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGY----NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             --------CCSSCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             ccccccCCCeeEeChHHhCCCCC----CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            33344568999999999987644    456999999999999999999997542  233333333333343344678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +.++|.+||+.||.+||++.++++.|.++...
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999988653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8e-42  Score=388.37  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=216.6

Q ss_pred             cceeecCCCeEEee-eeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          333 GRWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       333 ~~~~i~~~~y~i~~-~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      ..|.++...+.+.. .||+|+||.||+|        +.||||+++..........++.+|+.++..++|||||++++++.
T Consensus       361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  440 (635)
T 4fl3_A          361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE  440 (635)
T ss_dssp             SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34566666676654 8999999999986        56999999865444445677899999999999999999999996


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ++ . +++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       441 ~~-~-~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          441 AE-S-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             SS-S-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             cC-C-EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            44 3 889999999999999998888899999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          484 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ......   ......+|+.|+|||++.+..+    +.++|||||||++|||++ |..||.+.+..+.. ..+..+.++..
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~----~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~~~~~~~~  593 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKF----SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC  593 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCC
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence            643321   1223346788999999987654    456999999999999998 99999987776554 44556677888


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      |..+++++.+||.+||+.||++||++.+|++.|.....
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=366.62  Aligned_cols=254  Identities=19%  Similarity=0.302  Sum_probs=209.5

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      .+..++|++++.||+|+||.||++      +.+|+|.+..... .......+.+|+.++..++|||||++++++.+... 
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-   89 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED-   89 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-
Confidence            355688999999999999999985      5799999864321 11123457899999999999999999999998775 


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... 
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999999988788999999999999999999999999999999999999999999999999998765433 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHcCCCCCCCCCccH
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s---~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      .......||+.|+|||++.+... ..++.++|||||||++|||++|..||...+   .......+..  ....+|..+++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~  245 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKG-AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQ  245 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSS-CCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCH
T ss_pred             CceeccCCCccccCCeeeccCCC-CCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCH
Confidence            23345679999999999975321 124456999999999999999999997532   2232222222  34567888999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-HHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQ-FSEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT-~~ELL~~L~~  594 (604)
                      .+.+||.+||+.||.+||+ +.++++|-+.
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f  275 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM  275 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence            9999999999999999999 8888775443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.9e-42  Score=354.69  Aligned_cols=255  Identities=26%  Similarity=0.460  Sum_probs=210.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      +..++|++.+.||+|+||.||+++        .+++|.++... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            344789999999999999999964        35888887432 222344578999999999 99999999999988775


Q ss_pred             cEEEEEecccCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~----------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                       .++||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          101 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             -eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence             999999999999999996543                689999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  550 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i  550 (604)
                      .+||+|||+++..... .......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...+..+... .
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-~  253 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY----TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-K  253 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-H
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccC----CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-H
Confidence            9999999998643321 12233456788999999976543    446999999999999998 999999877665443 3


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +..+.+...+..+++.+.++|.+||+.||.+|||+.+++++|.++....
T Consensus       254 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            4455667778889999999999999999999999999999999986654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-41  Score=341.73  Aligned_cols=249  Identities=17%  Similarity=0.248  Sum_probs=211.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||+|      ..+++|++.......  ...+.+|+.++..++||||+++++++.+... .++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD-IYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-EEEEE
Confidence            57899999999999999996      378999987543332  4567899999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-M  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-C
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-c
Confidence            999999999999888889999999999999999999999999999999999999   888999999999987655332 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--CCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p~~~s~~l~  568 (604)
                      .....+|+.|+|||.+.+.     ++.++||||||+++|||++|..||...+..+....+.........  ...+++.+.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-----YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-----BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             hhccCCCCCccChHHhccc-----CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            3445689999999998754     344699999999999999999999988887777666655433221  126789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ++|.+||+.||.+|||+.+++++-+....
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999998765443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.8e-42  Score=354.55  Aligned_cols=251  Identities=19%  Similarity=0.307  Sum_probs=192.9

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++++.||+|+||.||+|      +.||+|.++..... .....+.+|+.++..++||||+++++++.+++. +++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENK-LTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE-EEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe-EEEE
Confidence            368899999999999999985      57999999754322 223457789999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          413 TKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      |||++ |+|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            99998 5999998543      3589999999999999999999999999999999999999999999999999877654


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC----------
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  556 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r----------  556 (604)
                      .........+|+.|+|||++.+..   .++.++|||||||++|||++|..||...+..+....+......          
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSR---TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CcccCCCCcccccccCchHhhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            433344557899999999997642   2345699999999999999999999988776665554432110          


Q ss_pred             ----------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 ----------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 ----------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                            +..+..+++++.++|.+||+.||.+|||+.|++++-+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                                  011235788999999999999999999999999886544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=349.50  Aligned_cols=249  Identities=23%  Similarity=0.507  Sum_probs=203.9

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++.++|++.+.||+|+||.||++    +.||+|.+...    .....+.+|+..+.+++||||+++++++.+   ..++|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv   77 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLV   77 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEE
Confidence            45678999999999999999996    57999998632    234568899999999999999999998863   27899


Q ss_pred             EecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCceeccCCCCceEEcCCCc-EEEEecCCccccc
Q 007429          413 TKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLND---HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACK  485 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs---~gIVHrDLKp~NILld~~g~-vKL~DFGla~~~~  485 (604)
                      |||+++|+|.+++....   .++...++.++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999999996544   47889999999999999999999   89999999999999998887 7999999986543


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCCCCCCCCcc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      ..   .....||+.|+|||.+.+..+    +.++||||||+++|||++|..||..... ..........+.++..+..++
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (307)
T 2eva_A          158 TH---MTNNKGSAAWMAPEVFEGSNY----SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP  230 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCC----CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred             cc---cccCCCCCceEChhhhCCCCC----CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence            22   233468999999999987654    4469999999999999999999986432 222333445566777888899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999886544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=358.10  Aligned_cols=266  Identities=19%  Similarity=0.397  Sum_probs=213.6

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk---~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      +..|.+..++|++.+.||+|+||.||+|+   .+++|.++...........+.+|+..+..++||||+++++++.+.+. 
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC-
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc-
Confidence            45788889999999999999999999975   58999987543333333346788889999999999999999998776 


Q ss_pred             EEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      +++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999996544 799999999999999999999999999999999999998 789999999997654321


Q ss_pred             -----CCcccccCCCCcccccccccCCCC-----CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC
Q 007429          488 -----GEATEYETDGYRWLAPEIIAGDPE-----SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP  557 (604)
Q Consensus       488 -----~~~~~~~~gt~~Y~APE~l~~~~~-----s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~  557 (604)
                           ........|++.|+|||.+.+...     ...++.++||||||+++|||++|..||...........+.......
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 112334458899999999875321     2234667999999999999999999999887776665555443333


Q ss_pred             CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          558 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       558 ~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..+..++..+.++|.+||+.||.+|||+.++++.|..+....
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            334578899999999999999999999999999999886643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-41  Score=355.02  Aligned_cols=251  Identities=18%  Similarity=0.276  Sum_probs=216.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|.+.+.||+|+||.||++      +.+++|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEE
Confidence            367899999999999999995      47999998754322 2344568899999999999999999999988765 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            99999999999999877889999999999999999999999999999999999999999999999999988765444445


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+..++    .++||||||+++|+|++|..||......+....+...  ...+|..+++.+.++|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHS----FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLI  272 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBC----THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHH
T ss_pred             cccCCCccccCHHHhccCCCC----chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHH
Confidence            556789999999999876543    4599999999999999999999987776666555544  3456788999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+||+.||.+||++.+++++-+...
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999877654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=384.91  Aligned_cols=259  Identities=24%  Similarity=0.420  Sum_probs=215.4

Q ss_pred             cceeecCCCeEEee-eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          333 GRWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       333 ~~~~i~~~~y~i~~-~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      ..|.+..+++.+.+ .||+|+||.||+|.        .||||.++... .......+.+|+.++..++|||||+++++|.
T Consensus       328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            35677788888888 89999999999863        48999997543 2334566889999999999999999999997


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ++  .+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus       407 ~~--~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          407 AE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             SS--SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             cC--CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            63  389999999999999998644 469999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCC
Q 007429          483 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  558 (604)
Q Consensus       483 ~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~  558 (604)
                      .......   ......+++.|+|||++.+..+    +.++|||||||++|||++ |..||...+..+... .+..+.++.
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~----~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-~i~~~~~~~  559 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKF----SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRME  559 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-HHHTTCCCC
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCC----CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCC
Confidence            6543221   1122345688999999986644    456999999999999998 999999887766544 445567788


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .|..+++.+.+||.+||+.||.+||++.+|++.|.......
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            89999999999999999999999999999999998875443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.2e-42  Score=354.05  Aligned_cols=255  Identities=23%  Similarity=0.472  Sum_probs=211.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      +..++|++++.||+|+||.||+|+           .||+|.+... ........+.+|+.++..++||||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            455889999999999999999986           6999999643 2334455688999999999999999999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEE
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCL  475 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~-------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL  475 (604)
                      .. .|+||||+++|+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.   +..+||
T Consensus       106 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 LP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SS-CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CC-cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            65 899999999999999996542       4889999999999999999999999999999999999984   446999


Q ss_pred             EecCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 007429          476 GDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA  552 (604)
Q Consensus       476 ~DFGla~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~  552 (604)
                      +|||++.......  .......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||......+... .+.
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~~  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF----TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-FVT  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCC----CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH-HHh
Confidence            9999987543322  12234457889999999976644    456999999999999998 999998876655443 444


Q ss_pred             cCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          553 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       553 ~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .+.++..+..+++.+.++|.+||+.||.+||++.+++++|+.+...
T Consensus       260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            5556677888999999999999999999999999999999988653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4e-42  Score=357.57  Aligned_cols=253  Identities=18%  Similarity=0.235  Sum_probs=200.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|+++...........+.+|+.++..++||||+++++++.+... +++||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~  112 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-LHLIF  112 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE-EEEEE
Confidence            67899999999999999996      579999997554444344557799999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-----CCCcEEEEecCCccccccCC
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-----~~g~vKL~DFGla~~~~~~~  488 (604)
                      ||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++     ..+.+||+|||++.......
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99985 9999998888899999999999999999999999999999999999994     55569999999987765444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC----------
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE----------  558 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~----------  558 (604)
                      .......+|+.|+|||++.+..   .++.++|||||||++|||++|..||...+..+....+......+.          
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSR---HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             --------CCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccCCCcCCccccCHHHhcCCC---CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            4444556899999999997643   234569999999999999999999998888776666554311111          


Q ss_pred             ------C------------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          559 ------I------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       559 ------~------------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                            +            +..+++++.+||.+||+.||.+|||+.|+++|-+.-..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                  0            11267899999999999999999999999998765443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-41  Score=356.56  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=213.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.|++++.||+|+||.||+|      +.||+|++........ ....+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe-EEEE
Confidence            45899999999999999985      5799999975443322 23458899999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....    .
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence            99997 58888875 345799999999999999999999999999999999999999999999999999876543    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....||+.|+|||++.+... ..++.++|||||||++|||++|..||...+.......+.....+...+..+++.+.++|
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  286 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  286 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSS-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            34578999999999864211 12455799999999999999999999988887777777766655556678899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .+||+.||.+|||+.+++++.+.....
T Consensus       287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          287 DSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHcccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999998876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.6e-42  Score=353.46  Aligned_cols=258  Identities=22%  Similarity=0.416  Sum_probs=214.3

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .+..++|++++.||+|+||.||+++          .||+|++...  .......+.+|+.++..++||||+++++++...
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            4677899999999999999999864          6999998743  233445688999999999999999999998753


Q ss_pred             -CCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 -NHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 -~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                       ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence             3448999999999999999965 34699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--------------HHH
Q 007429          484 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--------------VQA  546 (604)
Q Consensus       484 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--------------~~~  546 (604)
                      ......   ......+|+.|+|||.+.+..+    +.++||||||+++|+|++|..||.....              ...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIF----SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCC----ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            543322   1233457888999999976643    4569999999999999999999864322              233


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       547 ~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .......+.+...+..+++.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            44555666777888899999999999999999999999999999999875543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-41  Score=351.37  Aligned_cols=248  Identities=17%  Similarity=0.280  Sum_probs=210.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+.......    .....+.+|+.++..++||||+++++++.+... .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   90 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD-V   90 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE-E
Confidence            57899999999999999995      479999987543322    134568899999999999999999999987765 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~~  485 (604)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999998777899999999999999999999999999999999999999888    79999999987665


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~  563 (604)
                      ... ......||+.|+|||.+.+..+    +.++||||||+++|+|++|..||...+..+....+.......  ..+..+
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          171 DGV-EFKNIFGTPEFVAPEIVNYEPL----GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTCCC----CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ccc-cccccCCCCCccCcccccCCCC----CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            432 2334468999999999987654    346999999999999999999999887776666555433221  223578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ++.+.++|.+||+.||.+|||+.++++|-+
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            899999999999999999999999998755

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9e-42  Score=352.83  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=213.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEE----------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~Vyk----------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..+.|++++.||+|+||.||+          |+.||+|+++.. ........+.+|+.++..++||||+++++++.+.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            4445679999999999999975          357999999753 33344566889999999999999999999998753


Q ss_pred             -CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 -HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 -~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       ..+++||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence             458999999999999999854 459999999999999999999999999999999999999999999999999987765


Q ss_pred             cCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH--------------HHHH
Q 007429          486 SVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--------------QAAV  548 (604)
Q Consensus       486 ~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~--------------~~~~  548 (604)
                      ....   ......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||......              ....
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKF----YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCC----CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            4322   1233457888999999986644    35699999999999999999999753211              1233


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .....+.+...+..+++.+.++|.+||+.||.+|||+.++++.|..+.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            4455666777888999999999999999999999999999999999876543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-42  Score=362.99  Aligned_cols=249  Identities=20%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC-CcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~-~~l~L  411 (604)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.++..+. ||||+++++++..++ ..+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            68999999999999999985      57999999755444555666889999999996 999999999998654 34899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC---
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---  488 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~---  488 (604)
                      ||||++ |+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            999997 499998854 579999999999999999999999999999999999999999999999999987653211   


Q ss_pred             ------------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 007429          489 ------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI  550 (604)
Q Consensus       489 ------------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i  550 (604)
                                        .......||+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+....+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST---KYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                              1122346899999999997632   2445699999999999999999999988877666554


Q ss_pred             HHcCCCCC---------------------------------------------CCCCccHHHHHHHHHhhhcCCCCCCCH
Q 007429          551 AACGLRPE---------------------------------------------IPKDCPQILKSLMIKCWNNSPSKRPQF  585 (604)
Q Consensus       551 ~~~~~r~~---------------------------------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~  585 (604)
                      ......+.                                             .+..+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            42211110                                             122678899999999999999999999


Q ss_pred             HHHHHHHH
Q 007429          586 SEIISLLL  593 (604)
Q Consensus       586 ~ELL~~L~  593 (604)
                      .|+++|-+
T Consensus       324 ~e~l~Hp~  331 (388)
T 3oz6_A          324 NDALKHPF  331 (388)
T ss_dssp             HHHTTSTT
T ss_pred             HHHhCCHH
Confidence            99999854

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-42  Score=365.53  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=203.9

Q ss_pred             CeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .|++.+.||+|+||.||+|+         .||+|.++.. ........+.+|+.++..++||||+++++++.+.+...++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            47889999999999999874         4788888643 2334456688999999999999999999998766545899


Q ss_pred             EEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-
Q 007429          412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  489 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-  489 (604)
                      ||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999999654 4688999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          490 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       490 ---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                         ......+|+.|+|||.+.+..+    +.++|||||||++|||++ |.+||...+..+.... ...+.++..|..+++
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPD  323 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-HHTTCCCCCCTTCCH
T ss_pred             cccccCCCCCcccccChHHhcCCCC----CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCH
Confidence               1123346788999999986654    456999999999999999 7888887665544433 344556677888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      .+.++|.+||+.||.+||++.++++.|..+......
T Consensus       324 ~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            999999999999999999999999999998765543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-41  Score=353.20  Aligned_cols=250  Identities=16%  Similarity=0.225  Sum_probs=203.9

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..+ +||||+++++++.+.+. .++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY-NAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE-EEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc-cEE
Confidence            478999999999999999986      57999998754322    2467899999999 99999999999988765 899


Q ss_pred             EEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc-----EEEEecCCccccc
Q 007429          412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTACK  485 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~-----vKL~DFGla~~~~  485 (604)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++...
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 8999999965 468999999999999999999999999999999999999999887     9999999987654


Q ss_pred             cCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCC
Q 007429          486 SVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGL  555 (604)
Q Consensus       486 ~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~  555 (604)
                      .....       .....||+.|+|||++.+..+    +.++|||||||++|||++|..||...+.   .+....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQ----SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCC----CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            43221       234578999999999987654    4569999999999999999999987432   232322222111


Q ss_pred             CC---CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          556 RP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       556 r~---~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..   .....+| ++.+++..||+.||.+||++++|.+.|.++.+..
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            11   1223456 9999999999999999999999999999886543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-41  Score=343.97  Aligned_cols=252  Identities=17%  Similarity=0.309  Sum_probs=214.3

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++.+.||+|+||.||++      +.|++|.+..... .......+.+|+.++..++||||+++++++.+.+. .
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR-I   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-E
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE-E
Confidence            44578999999999999999996      4699999864211 11123567899999999999999999999988765 8


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      ++||||+++|+|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            999999999999999988788999999999999999999999999999999999999999999999999998654432  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      ......+++.|+|||.+.+..++    .++||||||+++|+|++|..||...+.......+..  ....+|..++..+.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  241 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHD----EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKD  241 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC----TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCC----cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHH
Confidence            23345689999999999876554    359999999999999999999998777666555544  344577889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +|.+||+.||.+||++.++++|-+....
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            9999999999999999999998776543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=349.69  Aligned_cols=259  Identities=14%  Similarity=0.202  Sum_probs=205.5

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~  410 (604)
                      ..++|++.+.||+|+||.||+|      +.||+|.+....... ....+.+|+.++..++||||+++++++.... ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            3467899999999999999985      579999997533222 2345679999999999999999999998765 2489


Q ss_pred             EEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----cCCCcEEEEecCCccc
Q 007429          411 VVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTA  483 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----d~~g~vKL~DFGla~~  483 (604)
                      +||||+++|+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999999996543   39999999999999999999999999999999999999    8888899999999877


Q ss_pred             cccCCCcccccCCCCcccccccccCC----CCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHcCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGD----PESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGL  555 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s----~~~~~~~i~~~~~  555 (604)
                      ...... .....||+.|+|||++...    .....++.++|||||||++|||++|..||....    ..+....+.....
T Consensus       166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             cCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            654332 2345689999999988621    111234456999999999999999999997433    2334444443322


Q ss_pred             CC-----------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          556 RP-----------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       556 r~-----------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..                       .++..++..+.+++.+||+.||++|||+.|++++..+..-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            11                       12234567899999999999999999999999999887553

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-41  Score=372.17  Aligned_cols=250  Identities=19%  Similarity=0.346  Sum_probs=213.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+.++..++|||||++++++.+... +|+||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE-EEEEE
Confidence            67899999999999999985      579999986433222335668899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc---CCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld---~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... .
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-K  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-c
Confidence            9999999999998888899999999999999999999999999999999999995   45679999999987654432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~  568 (604)
                      .....||+.|+|||++.+.     ++.++||||+||++|+|++|..||.+.+..+....+.........|  ..+++.+.
T Consensus       180 ~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             --CCTTGGGGCCGGGGGSC-----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             cCCCcCCCCCCCHHHhCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence            3345689999999999753     4557999999999999999999999988888777777665554443  46789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ++|.+||+.||.+|||+.++++|-|...
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            9999999999999999999999977654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7e-42  Score=351.30  Aligned_cols=246  Identities=19%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~------  407 (604)
                      ++|++++.||+|+||.||++      +.||+|+++... .......+.+|+.++..++|||||+++++|.+...      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            57899999999999999985      479999997543 33345668999999999999999999999865432      


Q ss_pred             --------------------------------------------------cEEEEEecccCCCHHHHHHhcC---CCCHH
Q 007429          408 --------------------------------------------------GLCVVTKLMEGGSVNDLILKSR---KLQTK  434 (604)
Q Consensus       408 --------------------------------------------------~l~LVmEy~~gGSL~dlL~~~~---~l~~~  434 (604)
                                                                        .+++||||+++|+|.+++.+..   ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999997543   35666


Q ss_pred             HHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC------------cccccCCCCcccc
Q 007429          435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------------ATEYETDGYRWLA  502 (604)
Q Consensus       435 ~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~------------~~~~~~gt~~Y~A  502 (604)
                      .++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......            ......||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            7899999999999999999999999999999999999999999999877654321            1223468999999


Q ss_pred             cccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCC
Q 007429          503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR  582 (604)
Q Consensus       503 PE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kR  582 (604)
                      ||.+.+..++    .++|||||||++|||++|..|+..   .............+..+...++.+.++|.+||+.||.+|
T Consensus       245 PE~~~~~~~~----~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          245 PEQIHGNNYS----HKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             HHHHHCCCCC----THHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             hHHhcCCCCc----chhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            9999876544    469999999999999998665422   112222222222222334567889999999999999999


Q ss_pred             CCHHHHHHHHH
Q 007429          583 PQFSEIISLLL  593 (604)
Q Consensus       583 PT~~ELL~~L~  593 (604)
                      ||+.|++++-+
T Consensus       318 ps~~~~l~~~~  328 (332)
T 3qd2_B          318 PEATDIIENAI  328 (332)
T ss_dssp             CCHHHHHHSTT
T ss_pred             CCHHHHhhchh
Confidence            99999998643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-42  Score=378.54  Aligned_cols=261  Identities=20%  Similarity=0.243  Sum_probs=213.6

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+.+..++|++++.||+|+||.||++      +.||+|++....... .....+.+|+.++..++|||||+++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            44566789999999999999999996      579999986421100 01122678888999999999999999999877


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . +|+||||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+++...
T Consensus       148 ~-~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          148 N-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             E-EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             E-EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            5 9999999999999999976 4689999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCCc-ccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC---
Q 007429          486 SVGEA-TEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP---  560 (604)
Q Consensus       486 ~~~~~-~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p---  560 (604)
                      ..... .....||+.|+|||++.... ....++.++|||||||++|||++|..||...+..+....+.....+..+|   
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            43322 23457999999999987210 01123456999999999999999999999988887777666443233333   


Q ss_pred             CCccHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSK--RPQFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~k--RPT~~ELL~~L~~~  595 (604)
                      ..+++++.+||.+||..+|.+  ||+++|+++|-+..
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            458999999999999888888  99999999987664

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=351.02  Aligned_cols=257  Identities=22%  Similarity=0.479  Sum_probs=199.7

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~---~~l~LV  412 (604)
                      ++|++++.||+|+||.||+|    +.||+|.+....   ......+.++.....++||||+++++++.+..   ..+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            67899999999999999995    589999986321   12222233333333459999999999998763   348999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~--------gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      |||+++|+|.+++.. ..+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+|||++...
T Consensus       114 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             ECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            999999999999954 4799999999999999999999999        9999999999999999999999999998765


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCCCCCC--cchhHHHHHHHHHHHHcC----------CCCCCCCC----hH
Q 007429          485 KSVGEA----TEYETDGYRWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTG----------EAAYAACS----PV  544 (604)
Q Consensus       485 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~~~t--~kSDVWSlGvvLyELlTG----------~~Pf~~~s----~~  544 (604)
                      ......    .....||+.|+|||.+.+........  .++|||||||++|||++|          ..||....    ..
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            433222    12346899999999998765443221  248999999999999999          77776432    12


Q ss_pred             HHHH-HHHHcCCCCCCCC-----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          545 QAAV-GIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       545 ~~~~-~i~~~~~r~~~p~-----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .... .......++.+|.     .+++.+.++|.+||+.||.+|||+.+++++|..+....+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            2222 2233344555554     567889999999999999999999999999999877543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=346.42  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC----
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE----  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~----  405 (604)
                      ...++|++++.||+|+||.||+|+      .|++|.+.....   ....+.+|+..+..+ +||||+++++++...    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            345889999999999999999964      699999874432   235678899999998 899999999999864    


Q ss_pred             -CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          406 -NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       406 -~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                       ...+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             23489999999999999999653  479999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      .............+++.|+|||.+.+... ...++.++|||||||++|+|++|..||...+.......+.........+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            65543333344568999999999873211 12344569999999999999999999998887777666666555555567


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+++.+.++|.+||..||.+||++.+++++-+..
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            7899999999999999999999999999976644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.4e-42  Score=342.83  Aligned_cols=258  Identities=17%  Similarity=0.244  Sum_probs=209.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.|++|.+..... ......+.+|+..+..++||||+++++++.+.+. .++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE-EEEEE
Confidence            57899999999999999985      5799999874432 2344568899999999999999999999988765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC--Ccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~--~~~  491 (604)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            999999999998777789999999999999999999999999999999999999999999999999987654322  123


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHcCCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~-~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....+++.|+|||.+.+..+   .+.++||||||+++|||++|..||........ ...+............+++.+.++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSB---CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            34568999999999976543   24469999999999999999999987554322 222232222223335688999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHhhCccCCC
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRTNNISNSS  602 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~~  602 (604)
                      |.+||+.||.+|||+.+++++-+......+..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  273 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKKGA  273 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC---
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhhccC
Confidence            99999999999999999999877655444433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=374.28  Aligned_cols=261  Identities=20%  Similarity=0.257  Sum_probs=211.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      .++.+..++|++++.||+|+||.||++      +.||+|+++...... .....+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345567789999999999999999985      579999997421111 1112367888899999999999999999987


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      +. +|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..
T Consensus       134 ~~-~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          134 NY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             SE-EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CE-EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            75 99999999999999999764 47999999999999999999999999999999999999999999999999998776


Q ss_pred             ccCCCc-ccccCCCCcccccccccCC---CCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC---CC
Q 007429          485 KSVGEA-TEYETDGYRWLAPEIIAGD---PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL---RP  557 (604)
Q Consensus       485 ~~~~~~-~~~~~gt~~Y~APE~l~~~---~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~---r~  557 (604)
                      ...... .....||+.|+|||++...   .....++.++|||||||++|||++|..||...+..+....+.....   .+
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  292 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP  292 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence            543322 2345799999999998731   1112345579999999999999999999999888777666654322   22


Q ss_pred             CCCCCccHHHHHHHHHhhhcCCCCC---CCHHHHHHHHHHh
Q 007429          558 EIPKDCPQILKSLMIKCWNNSPSKR---PQFSEIISLLLRT  595 (604)
Q Consensus       558 ~~p~~~s~~l~~LI~kCL~~dP~kR---PT~~ELL~~L~~~  595 (604)
                      ..+..+++++++||.+||. +|.+|   |+++||++|-+..
T Consensus       293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            3346789999999999999 99998   6999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=346.22  Aligned_cols=251  Identities=18%  Similarity=0.264  Sum_probs=200.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTC---GHKNILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~---~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~  406 (604)
                      .++|++++.||+|+||.||++      +.||+|.+......   ......+.+|+.++..+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            478999999999999999996      47999998743211   11123455666666554   5999999999998754


Q ss_pred             C----cEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          407 H----GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       407 ~----~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                      .    .+++||||+.+ +|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            2    37999999974 9999997654  399999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---  557 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---  557 (604)
                      ++...... ......+|+.|+|||++.+..++.    ++|||||||++|||++|..||...+.......+......+   
T Consensus       167 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          167 ARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYAT----PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             TTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCS----THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccCCCc-ccCCccccccccCchHHcCCCCCc----hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            87654322 234457899999999998776544    5999999999999999999999888777666554321111   


Q ss_pred             C----------------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 E----------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ~----------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .                      ....+++.+.++|.+||+.||.+|||+.|+++|-+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~  301 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  301 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence            0                      1235788999999999999999999999999886544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8e-42  Score=359.44  Aligned_cols=245  Identities=20%  Similarity=0.320  Sum_probs=204.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.+|+|.+......      ..+|+.++.++ +||||+++++++.+.+. +|+|
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv   94 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKY-VYVV   94 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE-EEEE
Confidence            67899999999999999985      57999999754432      23566777776 79999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC----CcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~----g~vKL~DFGla~~~~~~~  488 (604)
                      |||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+...    +.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            9999999999999888889999999999999999999999999999999999998543    359999999998765544


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC---CChHHHHHHHHHcCCCC--CCCCCc
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA---CSPVQAAVGIAACGLRP--EIPKDC  563 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~---~s~~~~~~~i~~~~~r~--~~p~~~  563 (604)
                      .......+|+.|+|||++.+..+    +.++|||||||++|||++|..||..   .+..+....+.......  ..+..+
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGY----DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHH----HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CceeccCCCccccCHHHhcCCCC----CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            44455678999999999976543    4469999999999999999999985   33444444555443332  234578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++++.+||.+||..||.+||++.++++|-|..
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            99999999999999999999999999988764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-41  Score=353.05  Aligned_cols=255  Identities=16%  Similarity=0.241  Sum_probs=207.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCC---CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~---~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+....   ........+.+|+.++..++||||+++++++.+.+. .+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~  104 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY-IC  104 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe-EE
Confidence            67899999999999999996      469999986431   122334568899999999999999999999988765 99


Q ss_pred             EEEecccCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 007429          411 VVTKLMEGGSVNDLILK----------------------------------------SRKLQTKEIIRIAIDVAEGIKFL  450 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~----------------------------------------~~~l~~~~il~ia~qIa~gL~YL  450 (604)
                      +||||+++|+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999999841                                        11235778889999999999999


Q ss_pred             HhcCceeccCCCCceEEcCCC--cEEEEecCCccccccCCC----cccccCCCCcccccccccCCCCCCCCCcchhHHHH
Q 007429          451 NDHGVAYRDLNSQRILLDRHG--NVCLGDMGIVTACKSVGE----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF  524 (604)
Q Consensus       451 Hs~gIVHrDLKp~NILld~~g--~vKL~DFGla~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSl  524 (604)
                      |++||+||||||+|||++.++  .+||+|||++........    ......||+.|+|||.+.+..  ..++.++|||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Diwsl  262 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--ESYGPKCDAWSA  262 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS--SCCCTHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC--CCCCcHHHHHHH
Confidence            999999999999999998776  899999999876543221    123456899999999997532  234557999999


Q ss_pred             HHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          525 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       525 GvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~--~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ||++|||++|..||...+..+....+.........+.  .+++.+.++|.+||+.||.+||++.+++++-+...-
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            9999999999999999888887777777655443332  478999999999999999999999999998776543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-41  Score=342.22  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=210.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---CCc
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHG  408 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---~~~  408 (604)
                      ..+.|++.+.||+|+||.||+|      ..|++|.+............+.+|+.++..++||||+++++++...   ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3456899999999999999996      4699999986555555566788999999999999999999998753   334


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEc-CCCcEEEEecCCccccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACK  485 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld-~~g~vKL~DFGla~~~~  485 (604)
                      +++||||+++|+|.+++.+...+++..++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            8999999999999999987788999999999999999999999999  99999999999997 78999999999986543


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCcc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCP  564 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s  564 (604)
                      ..  ......+++.|+|||.+.+.     ++.++||||||+++|+|++|..||...............+.. ...+..++
T Consensus       184 ~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (290)
T 1t4h_A          184 AS--FAKAVIGTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             TT--SBEESCSSCCCCCGGGGGTC-----CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             cc--ccccccCCcCcCCHHHHhcc-----CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence            32  23345689999999988743     345699999999999999999999986666555555544433 34566678


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +.+.++|.+||+.||.+|||+.++++|-+.
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            999999999999999999999999987553

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.2e-42  Score=355.57  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+.+. .++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-WYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE-EEE
Confidence            4478999999999999999985      579999997665555555667899999999999999999999988775 899


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            99999999999987767789999999999999999999999999999999999999999999999999987665544444


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------  555 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----------------  555 (604)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||...+..+....+.....                
T Consensus       182 ~~~~~t~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDV---KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCT---TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             CCCcCCccccCcccccCCC---CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            5567899999999997642   234569999999999999999999998877665554432110                


Q ss_pred             ---C-CC---------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 ---R-PE---------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 ---r-~~---------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                         . +.         ....+++.+.+||.+||+.||.+|||+.|++++-+.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~  311 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ  311 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence               0 00         1135789999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=356.83  Aligned_cols=248  Identities=19%  Similarity=0.254  Sum_probs=194.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.++...    ....+.+|+.++..++||||+++++++.+... .++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE-ISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe-EEEE
Confidence            367999999999999999996      469999997432    23457789999999999999999999988765 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~~~~~~~  489 (604)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..... .
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~  205 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V  205 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence            999999999999987778999999999999999999999999999999999999976   889999999998765432 2


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHcCCCC--CCCCCccHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRP--EIPKDCPQI  566 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~-~i~~~~~r~--~~p~~~s~~  566 (604)
                      ......||+.|+|||.+.+..+    +.++|||||||++|||++|..||.......... .+.......  .....++..
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAY----GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -------CGGGSCHHHHTTCCC----CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ccccccCCCCccCHHHhcCCCC----CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            2334568999999999987654    446999999999999999999998766655333 333333222  233578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +.++|.+||+.||.+|||+.+++++-+...
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999866543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=347.85  Aligned_cols=251  Identities=20%  Similarity=0.343  Sum_probs=186.7

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||+|+      .|++|.+...... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY-VYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE-EEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe-EEEE
Confidence            578999999999999999964      7999998642111 1123557899999999999999999999988765 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            9999999999999654 579999999999999999999999999999999999999999999999999987665433333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+..++    .++||||||+++|||++|..||...........+..  .....|..++.++.++|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHG----LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCTTSCHHHHHHH
T ss_pred             eeccCCCCcCCcchhcCCCCC----chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCccccCHHHHHHH
Confidence            445689999999999876544    359999999999999999999987654443332222  23346777899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+||+.||.+|||+.+++++-+....
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999987665443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=361.43  Aligned_cols=248  Identities=15%  Similarity=0.315  Sum_probs=210.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.+|+|.+....  ......+.+|+.++..++||||+++++++.+... +++||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv~  127 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLIL  127 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE-EEEEE
Confidence            67999999999999999995      579999987432  2334568899999999999999999999988765 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--CCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  .+.+||+|||++....... .
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-I  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-C
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-c
Confidence            999999999998654 37999999999999999999999999999999999999974  4779999999987765432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--CCCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--~~~p~~~s~~l~  568 (604)
                      .....||+.|+|||++.+..+    +.++|||||||++|||++|..||...+..+....+......  ......+++++.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPV----GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCB----CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeeccCCCccCchhccCCCC----CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            334578999999999987654    45699999999999999999999998877777666665433  234457899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++|.+||+.||.+|||+.+++++-+..
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCcccc
Confidence            999999999999999999999986543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-41  Score=341.85  Aligned_cols=246  Identities=17%  Similarity=0.284  Sum_probs=200.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|.+.+.||+|+||.||++      +.+++|++..... ......+.+|+.++..++||||+++++++.+... .++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN-MYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe-EEEEE
Confidence            57899999999999999985      5799999875432 2234568899999999999999999999987765 99999


Q ss_pred             ecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCcccccc
Q 007429          414 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       414 Ey~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~  486 (604)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            99999999998843    3579999999999999999999999999999999999999   5568899999999876543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC-CCCCccH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE-IPKDCPQ  565 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~-~p~~~s~  565 (604)
                      .. ......+++.|+|||.+.+.     ++.++||||||+++|||++|..||...+..+....+........ ....+++
T Consensus       180 ~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          180 DE-HSTNAAGTALYMAPEVFKRD-----VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             --------CTTGGGCCHHHHTTC-----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred             cc-cCcCcccccCcCChHHhccC-----CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence            22 23445689999999998642     35679999999999999999999998877666555554433322 2234789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .+.++|.+||+.||.+|||+.|++++-+
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            9999999999999999999999998644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.4e-41  Score=344.24  Aligned_cols=248  Identities=18%  Similarity=0.311  Sum_probs=209.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||++      +.||+|.++....  .....+.+|+.++..++||||+++++++.+... .++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH-YYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE-EEEEE
Confidence            57899999999999999985      5799999985432  223457899999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......  .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~  163 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--I  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--T
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--c
Confidence            999999999999877889999999999999999999999999999999999999   78899999999998654322  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--CCCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--~~~p~~~s~~l~  568 (604)
                      .....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...+.......+......  ...+..+++.+.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPY----SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSC----CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             cccccCCCCccChHHhccCCC----CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            233468999999999987644    45699999999999999999999988777666666655433  234567899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ++|.+||+.||.+||++.+++++-+...
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999877654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-42  Score=362.92  Aligned_cols=250  Identities=19%  Similarity=0.260  Sum_probs=207.6

Q ss_pred             CCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||+|.      .||+|.+...... ......+.+|+.++..++||||+++++++.+... +++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD-IVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEE
Confidence            678999999999999999964      7999998642111 1112457899999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~  165 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLK  165 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTC
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cccc
Confidence            9999 6799999988888999999999999999999999999999999999999999999999999998765433 2234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|+|||.+.+..+.   +.++|||||||++|+|++|..||...........+  ......+|..+++.+.++|.
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYA---GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGG---CHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred             cccCCcCcCCHHHHcCCCCC---CCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence            45789999999999876432   34699999999999999999999875433221111  11234567788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          573 KCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +||+.||.+|||+.|++++-|...+
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999886543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-41  Score=346.41  Aligned_cols=255  Identities=13%  Similarity=0.221  Sum_probs=203.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++.+.||+|+||.||++      +.|++|.+...... ......+.+|+..+..++||||+++++++.+.+. +++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ-LYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe-EEE
Confidence            378999999999999999996      57999998754322 2234568899999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-Cc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-~~  490 (604)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            99999999999999877889999999999999999999999999999999999999999999999999987654322 12


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--CCCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--~~~p~~~s~~l~  568 (604)
                      .....+++.|+|||.+.+..++.    ++||||||+++|||++|..||....... ..........  ...+..+++.+.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~----~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATY----RADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             -----CCGGGCCGGGTCC----C----CCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCc----hHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccccCCCCCHHHH
Confidence            23446889999999998765443    5999999999999999999998865543 3333333222  235677899999


Q ss_pred             HHHHHhhhcCCCCCC-CHHHHHHHHHHhhCcc
Q 007429          569 SLMIKCWNNSPSKRP-QFSEIISLLLRTNNIS  599 (604)
Q Consensus       569 ~LI~kCL~~dP~kRP-T~~ELL~~L~~~~~~~  599 (604)
                      ++|.+||+.||.+|| ++.++++.|.......
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            999999999999999 9999999999886644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.3e-41  Score=339.41  Aligned_cols=249  Identities=18%  Similarity=0.313  Sum_probs=206.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++++.||+|+||.||++      +.+++|.++......    .....+.+|+.++..++||||+++++++.+... .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD-V   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe-E
Confidence            56899999999999999985      579999987543221    135668899999999999999999999988765 8


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~~  485 (604)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998778899999999999999999999999999999999999998877    89999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~  563 (604)
                      .... .....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...+..+....+.......  ..+..+
T Consensus       164 ~~~~-~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          164 AGNE-FKNIFGTPEFVAPEIVNYEPL----GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCC----CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             CCCc-ccccCCCcCccCcceecCCCC----CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            3322 234468999999999987654    446999999999999999999999887766655554433221  223567


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++.+.+++.+||..||.+||++.+++++-+.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence            8999999999999999999999999997554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-41  Score=370.42  Aligned_cols=248  Identities=16%  Similarity=0.288  Sum_probs=207.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      ..+|+|++............+.+|+.++..++|||||++++++.+... +|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN-YYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence            46899999999999999986      479999997654333345568899999999999999999999988775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC---CcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~---g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++....... .
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~  194 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-K  194 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-C
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-c
Confidence            999999999999877889999999999999999999999999999999999999764   459999999987665432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~  568 (604)
                      .....||+.|+|||++.+.     ++.++||||+||++|+|++|..||...+..+....+.........+  ..+++.+.
T Consensus       195 ~~~~~gt~~y~aPE~l~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             ccccCCCcCeeCHHHHccc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            3445799999999998642     4457999999999999999999999988888777777665544333  46899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ++|.+||+.||.+|||+.++++|-|-
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~  295 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWI  295 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCccc
Confidence            99999999999999999999987554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.3e-42  Score=355.70  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ..++|++.+.||+|+||.||+|     +.||+|++.....  .....+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  113 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILI  113 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-CEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence            4578999999999999999995     5899998875432  234567899999999999999999999987765 8999


Q ss_pred             EecccCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~----~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+++|+|.+++....    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999985432    58999999999999999999999999999999999999999999999999987644322


Q ss_pred             C--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH------HHHHHHHcC------
Q 007429          489 E--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ------AAVGIAACG------  554 (604)
Q Consensus       489 ~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~------~~~~i~~~~------  554 (604)
                      .  ......||+.|+|||.+.+..+    +.++|||||||++|||++|+.||....+..      ........+      
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRL----TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBC----CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccCCCccccCHHHhcCCCC----CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            1  1233457899999999976654    446999999999999999999997643321      111111111      


Q ss_pred             ---CCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          555 ---LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       555 ---~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                         .....+..++..+.+++.+||+.||++|||+.+++++|+.+....++
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence               11223345678899999999999999999999999999998765543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=357.99  Aligned_cols=255  Identities=14%  Similarity=0.187  Sum_probs=195.1

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHH---------HHHHHHHHHHHhCCCCceeEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYE---------FELRKDLLELMTCGHKNILQFY  399 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~---------~~~~~Ei~~L~~L~HpnIVkl~  399 (604)
                      ..++|++.+.||+|+||.||+|.         .+++|.+.........+         ..+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            34789999999999999999974         48899887543221111         1245667778889999999999


Q ss_pred             EEEEcC---CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC--cEE
Q 007429          400 CVCVDE---NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG--NVC  474 (604)
Q Consensus       400 g~~~~~---~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g--~vK  474 (604)
                      +++.+.   ....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            999872   33489999999 899999997777899999999999999999999999999999999999999887  999


Q ss_pred             EEecCCccccccCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 007429          475 LGDMGIVTACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  547 (604)
Q Consensus       475 L~DFGla~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~  547 (604)
                      |+|||+++........       .....||+.|+|||.+.+..+    +.++|||||||++|||++|..||.........
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL----SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC----CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC----CchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            9999998765432211       134468999999999987644    45699999999999999999999653221111


Q ss_pred             HHHHHcCCCCCCC---------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          548 VGIAACGLRPEIP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       548 ~~i~~~~~r~~~p---------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ...........+|         ..+++.+.++|.+||+.||.+||++.+|++.|.+...
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111222         2788999999999999999999999999999988654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=348.74  Aligned_cols=243  Identities=18%  Similarity=0.267  Sum_probs=195.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|+++++||+|+||.||+|      +.||||++...............|+..+..+ +||||++++++|.+.+. +|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~-~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE-EEEE
Confidence            67999999999999999995      5799999876544444445556666666554 99999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+ +++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  213 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AG  213 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CC
Confidence            9999 66999988654 469999999999999999999999999999999999999999999999999987654332 23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....||+.|+|||++.+ .    ++.++|||||||++|||++|..|+......   ..+.....++.++..+++.+.++|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-S----YGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-C----CSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             cccCCCccccCHhHhcC-C----CCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHHHHHH
Confidence            44568999999999875 2    345699999999999999997666543222   222223333345667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHH
Q 007429          572 IKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      .+||+.||.+|||+.|++++-+
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHcCCChhhCcCHHHHHhCcc
Confidence            9999999999999999998644

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.5e-41  Score=337.38  Aligned_cols=252  Identities=19%  Similarity=0.295  Sum_probs=205.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++.+.||+|+||.||+|      +.|++|.+..... .......+.+|+..+..++||||+++++++.+.+. .++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-FFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe-EEE
Confidence            478999999999999999985      5799999864321 11123467899999999999999999999988765 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  167 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FL  167 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-ce
Confidence            99999999999999877889999999999999999999999999999999999999999999999999987654322 22


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....+++.|+|||.+.+..+   .+.++||||||+++|+|++|..||...........+...  ....|..++..+.++|
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLY---AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLL  242 (276)
T ss_dssp             ---------CCTGGGTTSCC---CHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCC---CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHH
Confidence            34468899999999986543   235699999999999999999999887766655544443  3456778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+||+.||.+|||+.+++++-+....
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999998765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-41  Score=371.81  Aligned_cols=251  Identities=21%  Similarity=0.301  Sum_probs=214.5

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|.+.+.||+|+||.||+|      +.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+. +|+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD-IFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEE
Confidence            378999999999999999985      57999999743211 1123467899999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++|+|.+++.+++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus        94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~  172 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL  172 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccc
Confidence            9999999999999987788999999999999999999999999999999999999999999999999998765432 223


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....||+.|+|||.+.+..+.   +.++|||||||++|||++|..||...+.......+...  ....|..+++++.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~---~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYA---GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLL  247 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBC---SHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCC---CCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHH
Confidence            445799999999999876432   34699999999999999999999987776666555543  3456778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+||+.||.+|||+.++++|-+...
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhh
Confidence            9999999999999999999877643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.8e-41  Score=353.16  Aligned_cols=252  Identities=18%  Similarity=0.344  Sum_probs=207.6

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++|++++.||+|+||.||++      +.||+|.+... ........+.+|+.++..++||||+++++++.+.+. .+
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE-EE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE-EE
Confidence            44578999999999999999995      57999999754 233445668899999999999999999999988775 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......  
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999999998878899999999999999999999996 9999999999999999999999999998654332  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH---------------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---------------------  548 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~---------------------  548 (604)
                      ......||+.|+|||.+.+..+    +.++|||||||++|+|++|..||...+......                     
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHY----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCC----SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1234478999999999987644    456999999999999999999998755433211                     


Q ss_pred             --------------------HHHHcCCCCCC-CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          549 --------------------GIAACGLRPEI-PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       549 --------------------~i~~~~~r~~~-p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                          ........+.. +..++.++.+||.+||+.||.+|||+.++++|-+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                                11111222223 3457899999999999999999999999999887654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-41  Score=370.60  Aligned_cols=250  Identities=19%  Similarity=0.320  Sum_probs=215.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++|||||++++++.+.+. .++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-EEEE
Confidence            67899999999999999985      57999999754332 2345668899999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccCCC
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-  183 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-  183 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence            9999999999999888889999999999999999999999999999999999999   567899999999987655432 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQIL  567 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l  567 (604)
                      ......||+.|+|||++.+.     ++.++||||+||++|+|++|.+||...+..+....+.........|  ..+++.+
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHGT-----YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHTC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             ccccCCCCccccCceeecCC-----CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            23345689999999999762     3456999999999999999999999988888777777766554444  4689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          568 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       568 ~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .++|.+||+.||.+|||+.++++|-|...
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            99999999999999999999999877653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-40  Score=367.71  Aligned_cols=250  Identities=18%  Similarity=0.288  Sum_probs=210.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-----------hHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-----------AYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-----------~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      ++|++++.||+|+||.||++      +.+|+|.+.......           .....+.+|+.++..++|||||++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            67999999999999999985      479999987543221           2345688999999999999999999999


Q ss_pred             EcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEEecC
Q 007429          403 VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMG  479 (604)
Q Consensus       403 ~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~DFG  479 (604)
                      .+... +|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       116 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          116 EDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             ECSSE-EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EcCCE-EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            88775 999999999999999998888899999999999999999999999999999999999998876   69999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ++....... ......||+.|+|||++.+.     ++.++||||+||++|+|++|..||.+.+..+....+.........
T Consensus       195 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          195 LSSFFSKDY-KLRDRLGTAYYIAPEVLKKK-----YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             TCEECCTTS-CBCCCCSCTTTCCHHHHTTC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             CCEEcCCCC-ccccccCCcCCCCHHHhccC-----CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            987665432 23445789999999998642     345699999999999999999999998888777777765544332


Q ss_pred             C--CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 P--KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p--~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +  ..+++++.++|.+||+.||.+|||+.|+++|-|...
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            2  578999999999999999999999999999877654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=341.24  Aligned_cols=249  Identities=21%  Similarity=0.394  Sum_probs=206.0

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ..++|++++.||+|+||.||+|      +.|++|.+.....    ...+.+|+..+..++||||+++++++.+.+. .++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD-LWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEE
Confidence            3478999999999999999985      5799999975332    2457789999999999999999999988765 899


Q ss_pred             EEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+++|+|.+++. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999986 4568999999999999999999999999999999999999999999999999998766544334


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKS  569 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~  569 (604)
                      .....+++.|+|||.+.+..++    .++||||||+++|+|++|..||...........+..... ....+..++..+.+
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYN----CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBC----TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCC----ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence            4455789999999999876544    459999999999999999999998877666554444322 22335667899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +|.+||+.||.+|||+.+++++-+..
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHh
Confidence            99999999999999999999876654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.4e-41  Score=339.76  Aligned_cols=253  Identities=18%  Similarity=0.210  Sum_probs=204.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..++|++++..++++.......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            378999999999999999996      57999998754332    24678999999999988777777776655558999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccCC
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~~  488 (604)
                      |||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999 8899999963 4579999999999999999999999999999999999999   588999999999987665432


Q ss_pred             C-------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHc---CC
Q 007429          489 E-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAAC---GL  555 (604)
Q Consensus       489 ~-------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~---~~  555 (604)
                      .       ......||+.|+|||.+.+..+    +.++|||||||++|||++|+.||.....   .+....+...   ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQ----SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccCChhhhcCCCC----CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            2       1234568999999999987654    4569999999999999999999986432   1122222211   11


Q ss_pred             CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          556 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       556 r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .+..+..+|+.+.+++.+||+.||.+|||+.++++.|.++....+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            122346789999999999999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.5e-41  Score=344.41  Aligned_cols=251  Identities=20%  Similarity=0.317  Sum_probs=197.4

Q ss_pred             CCeEEe-eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~-~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      +.|++. +.||+|+||.||++      +.||+|.+.....  .....+.+|+.++.++ +||||+++++++.+.+. +|+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~-~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE-EEE
Confidence            678885 78999999999995      5899999975432  2345678999999884 79999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCccccccCC
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVG  488 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~~~~~~  488 (604)
                      ||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999999988788999999999999999999999999999999999999998776   9999999987553221


Q ss_pred             C-------cccccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---------------HH
Q 007429          489 E-------ATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------------VQ  545 (604)
Q Consensus       489 ~-------~~~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---------------~~  545 (604)
                      .       ......||+.|+|||.+.+... ...++.++|||||||++|||++|..||.....               ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1       1123358999999999864210 01123459999999999999999999986532               12


Q ss_pred             HHHHHHHcCCCCCCC----CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          546 AAVGIAACGLRPEIP----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       546 ~~~~i~~~~~r~~~p----~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ....+....  ..+|    ..+++.+.+||.+||+.||.+|||+.|+++|-+..
T Consensus       249 ~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          249 LFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             HHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            222333322  2233    46789999999999999999999999999986543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=351.09  Aligned_cols=265  Identities=21%  Similarity=0.353  Sum_probs=200.9

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CC
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD----EN  406 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~----~~  406 (604)
                      +.+..++|++++.||+|+||.||+|    +.||+|++....   ......+.++..+..++||||+++++.+..    ..
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            4466789999999999999999996    579999997432   222333445555556899999999986543    22


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeccCCCCceEEcCCCcEEEEe
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---------GVAYRDLNSQRILLDRHGNVCLGD  477 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~---------gIVHrDLKp~NILld~~g~vKL~D  477 (604)
                      ..+++||||+++|+|.+++... .+++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            3478999999999999998544 458999999999999999999999         999999999999999999999999


Q ss_pred             cCCccccccCC--------CcccccCCCCcccccccccCCCCC---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---
Q 007429          478 MGIVTACKSVG--------EATEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVTGEAAYAACSP---  543 (604)
Q Consensus       478 FGla~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~s---~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---  543 (604)
                      ||++.......        .......||+.|+|||++.+....   ..++.++|||||||++|||++|..||.....   
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99987654321        112234689999999999864221   1233569999999999999999776542111   


Q ss_pred             ---------------HHHHHHHHHcCCCCCCCCC------ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCCC
Q 007429          544 ---------------VQAAVGIAACGLRPEIPKD------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS  602 (604)
Q Consensus       544 ---------------~~~~~~i~~~~~r~~~p~~------~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~~  602 (604)
                                     ............++.+|..      +++.+.++|.+||+.||.+|||+.|+++.|..+...++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence                           1111122233445555554      4568999999999999999999999999999998776544


Q ss_pred             C
Q 007429          603 N  603 (604)
Q Consensus       603 ~  603 (604)
                      +
T Consensus       324 ~  324 (336)
T 3g2f_A          324 K  324 (336)
T ss_dssp             -
T ss_pred             c
Confidence            3

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.2e-41  Score=339.35  Aligned_cols=252  Identities=18%  Similarity=0.213  Sum_probs=201.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..++|++++..++.+.......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            68999999999999999996      47999987644322    236688888999999888887777766555589999


Q ss_pred             ecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccCCC
Q 007429          414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       414 Ey~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~~~  489 (604)
                      ||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 8899999864 4579999999999999999999999999999999999999   7899999999999876654322


Q ss_pred             -------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHcC---CC
Q 007429          490 -------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACG---LR  556 (604)
Q Consensus       490 -------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---~~~~~i~~~~---~r  556 (604)
                             ......+|+.|+|||.+.+..+    +.++|||||||++|||++|..||...+..   .....+....   ..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQ----SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCC----CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence                   1234568999999999987654    45699999999999999999999864321   1222222111   11


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      ......+++.+.++|.+||+.||.+|||+.++++.|.++....+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            12336788999999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.2e-41  Score=387.28  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=214.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE  405 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~  405 (604)
                      +..+..++|++++.||+|+||.||+++      .||+|+++.... .......+..|..++..+ +||||+++++++.+.
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            344567899999999999999999864      699999974211 111223466777778776 799999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      +. +||||||++||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++...
T Consensus       415 ~~-~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          415 DR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             SE-EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CE-EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            65 99999999999999999887889999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ..........||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+..+....+...  ...+|..+++
T Consensus       494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~----~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  567 (674)
T 3pfq_A          494 WDGVTTKTFCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSK  567 (674)
T ss_dssp             CTTCCBCCCCSCSSSCCHHHHTCCCBS----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCCTTSCH
T ss_pred             cCCcccccccCCCcccCHhhhcCCCCC----ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCccCCH
Confidence            444455566899999999999877654    4599999999999999999999998888777766654  4567889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCH-----HHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQF-----SEIISLLLR  594 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~-----~ELL~~L~~  594 (604)
                      ++.+||.+||+.||.+||++     .+|++|-+.
T Consensus       568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence            99999999999999999997     888877544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-41  Score=354.07  Aligned_cols=245  Identities=20%  Similarity=0.303  Sum_probs=181.8

Q ss_pred             CeEEe---eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEE
Q 007429          341 NLEFI---DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       341 ~y~i~---~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~  410 (604)
                      +|++.   +.||+|+||.||++      +.||+|.+...     ....+.+|+..+..+. ||||+++++++.+... .|
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-~~   82 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-TF   82 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-EE
Confidence            45554   78999999999995      57999999642     2456778999999986 9999999999988775 89


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEEecCCccccccC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSV  487 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~DFGla~~~~~~  487 (604)
                      +||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999999998888899999999999999999999999999999999999998766   8999999998766544


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-------HHHHHHHHHcCCCCCC-
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-------VQAAVGIAACGLRPEI-  559 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-------~~~~~~i~~~~~r~~~-  559 (604)
                      ........+|+.|+|||.+.+..+    +.++|||||||++|+|++|..||.....       .+....+......... 
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~----~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGY----DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             ---------------------CCC----CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCcccccCCCcCccCHHHhcCCCC----CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            444455578999999999987654    4569999999999999999999986432       2233333322221111 


Q ss_pred             -CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          560 -PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       560 -p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                       ...+++++.+||.+||+.||.+|||+.+++++-|..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence             135789999999999999999999999999886654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-40  Score=347.43  Aligned_cols=245  Identities=19%  Similarity=0.294  Sum_probs=200.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-----CCceeEEEEEEEcC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----HKNILQFYCVCVDE  405 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-----HpnIVkl~g~~~~~  405 (604)
                      +-.++|++++.||+|+||.||++      +.||+|.++.   ..........|+.++..+.     |||||++++++...
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            44689999999999999999986      4699999963   2333455678888888875     99999999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--------------
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--------------  469 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--------------  469 (604)
                      +. +++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus       109 ~~-~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          109 DH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TE-EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             Ce-eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            75 99999999 889999996544  5999999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 007429          470 -----------HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY  538 (604)
Q Consensus       470 -----------~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf  538 (604)
                                 ++.+||+|||++......   .....||+.|+|||++.+..++.    ++|||||||++|||++|..||
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~----~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDV----SSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCT----THHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCC----ccchHHHHHHHHHHHHCCCCC
Confidence                       789999999998754332   33457899999999998776554    599999999999999999999


Q ss_pred             CCCChHHHHHHHHHcCCCC------------------------CCCC--------------------CccHHHHHHHHHh
Q 007429          539 AACSPVQAAVGIAACGLRP------------------------EIPK--------------------DCPQILKSLMIKC  574 (604)
Q Consensus       539 ~~~s~~~~~~~i~~~~~r~------------------------~~p~--------------------~~s~~l~~LI~kC  574 (604)
                      ...+..+....+.......                        .+|.                    ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            9877666554433321111                        0111                    1236788999999


Q ss_pred             hhcCCCCCCCHHHHHHHHH
Q 007429          575 WNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       575 L~~dP~kRPT~~ELL~~L~  593 (604)
                      |+.||.+|||+.|+++|-+
T Consensus       340 L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGG
T ss_pred             hcCChhhCCCHHHHhcCcc
Confidence            9999999999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4e-41  Score=342.73  Aligned_cols=253  Identities=18%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .++|++++.||+|+||.||+|      +.+++|.+......  ....+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-LWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C-EEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe-EEEE
Confidence            478999999999999999996      46999998654322  24567889999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999999865 4579999999999999999999999999999999999999999999999999975433222223


Q ss_pred             cccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-CCCCCccHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILKS  569 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-~~p~~~s~~l~~  569 (604)
                      ....+++.|+|||.+.... ....++.++||||||+++|+|++|..||...+.......+....... ..+..++..+.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            3456899999999984210 01123456999999999999999999999888777666665544332 345678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +|.+||+.||.+|||+.+++++-+.
T Consensus       255 li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             HHHHHcccChhhCCCHHHHhcChHH
Confidence            9999999999999999999987543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-41  Score=354.87  Aligned_cols=248  Identities=18%  Similarity=0.268  Sum_probs=200.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++++.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            378999999999999999985      57999999765444445567889999999999999999999997653     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  181 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  181 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence            369999999 7799999854 67999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                         .....+|+.|+|||++.+..   .++.++||||+||++|||++|+.||.+.+....+..+......+          
T Consensus       182 ---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          182 ---MTGYVVTRWYRAPEVILNWM---RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTT---CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ---cCcCcCCCCcCCHHHHhCCC---CCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence               33456899999999988632   23446999999999999999999999887766555444321111          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                         .....+++.+.+|+.+||..||.+|||+.++++|-+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f  311 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  311 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence                               1234678999999999999999999999999998554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-41  Score=363.97  Aligned_cols=252  Identities=18%  Similarity=0.226  Sum_probs=189.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----CcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~l  409 (604)
                      ++|++++.||+|+||.||++      +.||||++............+.+|+.+|..++|||||++++++....    ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            78999999999999999985      57999999765444455567889999999999999999999996442    348


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      |+||||+. |+|.+++.....+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            99999985 69999998777899999999999999999999999999999999999999999999999999976543211


Q ss_pred             ---------------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc---------
Q 007429          490 ---------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT---------  533 (604)
Q Consensus       490 ---------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT---------  533 (604)
                                                 ......||+.|+|||++....   .++.++|||||||++|||++         
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE---NYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCC---CCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence                                       122335799999999875332   24456999999999999998         


Q ss_pred             --CCCCCCCCCh--------------------HHHHHHHHHc-C---------------------CCC-------CCCCC
Q 007429          534 --GEAAYAACSP--------------------VQAAVGIAAC-G---------------------LRP-------EIPKD  562 (604)
Q Consensus       534 --G~~Pf~~~s~--------------------~~~~~~i~~~-~---------------------~r~-------~~p~~  562 (604)
                        |.++|.+.+.                    ...+..+... +                     ...       .....
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              6777765431                    1111111100 0                     000       11235


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +++++.+||.+||..||.+|||+.|+++|-+..
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~  401 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFK  401 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence            689999999999999999999999999986654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=346.33  Aligned_cols=264  Identities=19%  Similarity=0.267  Sum_probs=208.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-  405 (604)
                      .-+.+..++|++++.||+|+||.||++      +.||+|.+...  .......+.+|+.++..++||||+++++++... 
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            456778889999999999999999985      57999998643  233455688999999999999999999999732 


Q ss_pred             --CCcEEEEEecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecC
Q 007429          406 --NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       406 --~~~l~LVmEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                        ....++||||+++|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence              2348999999999999999864    3579999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc---------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHH
Q 007429          480 IVTACKSVGEA---------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVG  549 (604)
Q Consensus       480 la~~~~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~  549 (604)
                      ++.........         .....||+.|+|||.+.+.... .++.++||||||+++|||++|..||..... ......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEE-EECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCc-CCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            97654321110         1123468999999998765321 234579999999999999999999963111 001122


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          550 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       550 i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ........+.+..+++.+.++|.+||+.||.+||++.+++++|..+....
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            23334444556678999999999999999999999999999999886544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.5e-41  Score=336.73  Aligned_cols=248  Identities=21%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE--------  405 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~--------  405 (604)
                      ++|++++.||+|+||.||++      +.|++|.+....      ..+.+|+.++..++||||+++++++...        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            57899999999999999985      579999997532      2356899999999999999999988641        


Q ss_pred             -------CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEE
Q 007429          406 -------NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG  476 (604)
Q Consensus       406 -------~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~  476 (604)
                             ...+++||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                   22379999999999999999643  579999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC
Q 007429          477 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR  556 (604)
Q Consensus       477 DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r  556 (604)
                      |||++........ .....+++.|+|||.+.+..++    .++||||||+++|||++|..||...  .. ......   .
T Consensus       165 Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~~~~~~~~~--~~-~~~~~~---~  233 (284)
T 2a19_B          165 DFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYG----KEVDLYALGLILAELLHVCDTAFET--SK-FFTDLR---D  233 (284)
T ss_dssp             CCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCC----THHHHHHHHHHHHHHHSCCSSHHHH--HH-HHHHHH---T
T ss_pred             cchhheecccccc-ccccCCcccccChhhhccCCCc----chhhhHHHHHHHHHHHhcCCcchhH--HH-HHHHhh---c
Confidence            9999876654322 3344689999999999876543    4699999999999999999887532  11 111222   2


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCCCCC
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR  604 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~~~R  604 (604)
                      ..++..+++.+.++|.+||+.||.+|||+.+++++|+.+.+..+...|
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~  281 (284)
T 2a19_B          234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER  281 (284)
T ss_dssp             TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence            335677889999999999999999999999999999999887665443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-42  Score=359.08  Aligned_cols=257  Identities=23%  Similarity=0.397  Sum_probs=202.6

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  408 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~  408 (604)
                      .+.+..++|++.+.||+|+||.||+|     +.||+|++...... .....+.+|+.++..++||||+++++++.+.+. 
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  101 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-  101 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC-
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc-
Confidence            34456688999999999999999995     56999998754322 122357899999999999999999999987775 


Q ss_pred             EEEEEecccCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~----~l~~~~il~ia~qIa~gL~YLHs~---gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .++||||+++|+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            899999999999999996433    489999999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHHc---
Q 007429          482 TACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC----SPVQAAVGIAAC---  553 (604)
Q Consensus       482 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~----s~~~~~~~i~~~---  553 (604)
                      ........ ......||+.|+|||.+.+..+    +.++|||||||++|||++|..||...    ............   
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSEE----CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             cccCcccccccccccCCcCccCHHHhccCCC----CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            76643322 2333458999999999976644    45699999999999999999999521    000001111111   


Q ss_pred             ----------CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          554 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       554 ----------~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                ......+...++.+.+++.+||+.||.+|||+.+++++|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                      1111233345578999999999999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=356.16  Aligned_cols=245  Identities=19%  Similarity=0.281  Sum_probs=202.4

Q ss_pred             EEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      ...+.||+|+||.||+|      +.||+|.++...  ......+.+|+.++..++|||||++++++.+.+. +++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEEeCC
Confidence            34678999999999985      479999997532  2344568899999999999999999999988775 99999999


Q ss_pred             cCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE--cCCCcEEEEecCCccccccCCCcccc
Q 007429          417 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       417 ~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl--d~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      ++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...... ....
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~  247 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKV  247 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccc
Confidence            999999988544 479999999999999999999999999999999999999  567889999999987765432 2334


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCccHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILKSLM  571 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s~~l~~LI  571 (604)
                      ..||+.|+|||++.+..+    +.++|||||||++|||++|..||...+..+....+........  ....+++++.+||
T Consensus       248 ~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFV----SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBC----CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccCCCcEeChhhccCCCC----CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            468999999999976543    4569999999999999999999999888877777776654432  2356899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          572 IKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+||+.||.+|||+.|++++-+..
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcC
Confidence            999999999999999999976643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-40  Score=350.80  Aligned_cols=252  Identities=18%  Similarity=0.245  Sum_probs=210.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc------hHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------AYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~------~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      ++|++.+.||+|+||.||++      +.||||.+.......      .....+.+|+.++..+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57899999999999999985      579999987543221      1134577899999998 8999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . .++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       174 ~-~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 F-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             E-EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             E-EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            5 999999999999999998777899999999999999999999999999999999999999999999999999876654


Q ss_pred             CCCcccccCCCCcccccccccCCCC--CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CC
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  562 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~--s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~  562 (604)
                      .. ......||+.|+|||++.+...  ...++.++|||||||++|||++|..||...+.......+.........|  ..
T Consensus       253 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          253 GE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             Cc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            32 2344578999999999864321  1234557999999999999999999999877776666666554443322  46


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +++.+.++|.+||+.||.+|||+.+++++-+
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            7899999999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-40  Score=358.57  Aligned_cols=262  Identities=19%  Similarity=0.206  Sum_probs=202.6

Q ss_pred             CccccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 007429          329 GEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  402 (604)
Q Consensus       329 ~~~i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~  402 (604)
                      ++.+..|.+ .++|++++.||+|+||.||++      +.||||++............+.+|+.++..++||||+++++++
T Consensus        16 ~Q~~~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~   94 (432)
T 3n9x_A           16 FQGIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI   94 (432)
T ss_dssp             TTCGGGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             hcCCCccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            344455555 488999999999999999996      5799999986554445566789999999999999999999999


Q ss_pred             EcCC----CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          403 VDEN----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       403 ~~~~----~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      ....    ..+|+||||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           95 IPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             CCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence            7663    348999999975 99999987778999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCC----------------------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC--
Q 007429          479 GIVTACKSVGE----------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG--  534 (604)
Q Consensus       479 Gla~~~~~~~~----------------------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG--  534 (604)
                      |+++.......                      ......||+.|+|||++....   .++.++|||||||++|||++|  
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE---NYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCS---CCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC---CCCcccccchHHHHHHHHHhccc
Confidence            99976643221                      124457899999999875432   245569999999999999984  


Q ss_pred             ---------CCCCCCCCh-----------------HHHHHHHHH------------------------cCCCCCC-----
Q 007429          535 ---------EAAYAACSP-----------------VQAAVGIAA------------------------CGLRPEI-----  559 (604)
Q Consensus       535 ---------~~Pf~~~s~-----------------~~~~~~i~~------------------------~~~r~~~-----  559 (604)
                               .++|.+.+.                 ...+..+..                        .......     
T Consensus       251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (432)
T 3n9x_A          251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK  330 (432)
T ss_dssp             TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred             ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence                     444433221                 111111111                        0111111     


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ...+++++.+||.+||..||.+|||+.|+++|-+..
T Consensus       331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            145789999999999999999999999999986644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-40  Score=339.94  Aligned_cols=261  Identities=16%  Similarity=0.240  Sum_probs=211.5

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~--HpnIVkl~g~~~~~~  406 (604)
                      ...+..++|++++.||+|+||.||++     +.||+|.+............+.+|+.++..++  ||||+++++++.+..
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            45566788999999999999999985     57999999865544445567889999999986  599999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus       102 ~-~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          102 Y-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             E-EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             E-EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            5 999999 56789999998888899999999999999999999999999999999999997 48999999999876543


Q ss_pred             CCC--cccccCCCCcccccccccCCCC-------CCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCC
Q 007429          487 VGE--ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLR  556 (604)
Q Consensus       487 ~~~--~~~~~~gt~~Y~APE~l~~~~~-------s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r  556 (604)
                      ...  ......|++.|+|||.+.+...       ...++.++||||||+++|||++|..||..... ......+......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            322  1233468999999999876321       12456679999999999999999999987543 3444445555566


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ..++..+++.+.++|.+||+.||.+||++.+++++-+....
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            67788889999999999999999999999999998876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-40  Score=335.61  Aligned_cols=255  Identities=21%  Similarity=0.233  Sum_probs=211.5

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-------hHHHHHHHHHHHHHhCC-CCceeEEEEEEEc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-------AYEFELRKDLLELMTCG-HKNILQFYCVCVD  404 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-------~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~  404 (604)
                      .++|++.+.||+|+||.||++      +.||+|.+.......       .....+.+|+.++.++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            378999999999999999985      579999997543211       12345778999999985 9999999999987


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      .+. .++||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCe-EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            765 9999999999999999987788999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCC--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--  560 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--  560 (604)
                      .... ......+++.|+|||.+.+..  ....++.++||||||+++|+|++|..||...+.......+.........+  
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          175 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             CCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            4332 233456899999999985211  11234557999999999999999999999887777666666655443333  


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ..++..+.++|.+||+.||.+|||+.+++++-+..
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence            46889999999999999999999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=351.31  Aligned_cols=251  Identities=16%  Similarity=0.250  Sum_probs=197.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.||+|++...... .....+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC-EEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE-EEEEe
Confidence            67999999999999999996      46999998643321 111124578899999999999999999988776 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            99975 999988654 4699999999999999999999999999999999999999999999999999876554433344


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---C-----------
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---E-----------  558 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~-----------  558 (604)
                      ...+|+.|+|||.+.+..   .++.++|||||||++|||++|..||.+.+..+....+......+   .           
T Consensus       159 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ----CGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccCcccccChhhhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            557899999999987632   23456999999999999999999999888776655544321111   1           


Q ss_pred             --------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          559 --------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       559 --------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                    .+..+++++.+||.+||+.||.+|||+.|+++|-+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence                          11346788999999999999999999999999877653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-40  Score=337.49  Aligned_cols=249  Identities=19%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.|++|.+............+.+|+.++..++||||+++++++.+.+. .++||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe-EEEEE
Confidence            57899999999999999985      479999997654444445678899999999999999999999987765 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC---CcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~---g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+|||++........ 
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence            999999999999877889999999999999999999999999999999999999764   4699999999876543322 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--CCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~~~s~~l~  568 (604)
                      .....+++.|+|||.+.+.     ++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             cccccCcccccChHHhcCC-----CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            2233578889999998753     3456999999999999999999999888777666666554444333  56899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ++|.+||+.||.+|||+.+++++-+..
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHh
Confidence            999999999999999999999976543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=338.66  Aligned_cols=257  Identities=23%  Similarity=0.404  Sum_probs=208.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      .+.+..++|.....||+|+||.||+|+      .|++|.+....  ......+.+|+..+..++||||+++++++.+.+.
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            444555666667789999999999964      79999997543  2334567899999999999999999999988775


Q ss_pred             cEEEEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTA  483 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~  483 (604)
                       .++||||+++++|.+++....   .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus        94 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           94 -IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             -EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             -EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence             899999999999999996542   5678899999999999999999999999999999999988 89999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcCCCCCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~~r~~~p~~  562 (604)
                      ............+++.|+|||.+.+...  .++.++||||||+++|+|++|..||..... .............+.+|..
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPR--GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES  250 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGG--GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTT
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCC--CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccccc
Confidence            6543333445578999999999875421  234579999999999999999999976433 3333333444566778889


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +++++.++|.+||+.||.+||++.+++.+-+..
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            999999999999999999999999999875543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-41  Score=344.43  Aligned_cols=257  Identities=26%  Similarity=0.456  Sum_probs=191.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..|.+..++|++.+.||+|+||.||++      +.||+|.+..... ......+.+|+..+..++||||+++++++...+
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            357788899999999999999999986      4799998864322 223345778898899999999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          407 HGLCVVTKLMEGGSVNDLILK--------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~--------~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      . .++||||+++++|.+++..        ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+||
T Consensus        87 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           87 E-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             C-EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             C-cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence            6 9999999999999999853        346899999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCC-----cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc
Q 007429          479 GIVTACKSVGE-----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC  553 (604)
Q Consensus       479 Gla~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~  553 (604)
                      |++........     ......+|+.|+|||.+.+..   .++.++||||||+++|||++|..||...............
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR---GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHH---CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhcccc---CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            99866543221     123346899999999986421   1345699999999999999999999987766555444433


Q ss_pred             CCC--------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          554 GLR--------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       554 ~~r--------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ...        ......+++.+.++|.+||+.||.+||++.+++++-+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            221        12345678999999999999999999999999987543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=345.62  Aligned_cols=256  Identities=23%  Similarity=0.436  Sum_probs=210.8

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+++          .||+|++...  .......+.+|+.++..++||||+++++++...+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            455789999999999999999864          7999999753  2334556889999999999999999999987654


Q ss_pred             -CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 -HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 -~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                       ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence             2489999999999999999765 46999999999999999999999999999999999999999999999999998766


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---------------HHH
Q 007429          485 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------------VQA  546 (604)
Q Consensus       485 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---------------~~~  546 (604)
                      ......   .....++..|+|||.+.+..+    +.++||||||+++|||++|..||.....               ...
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKF----SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCC----CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            543221   223356778999999986543    4569999999999999999998864211               112


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          547 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       547 ~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      +...+..+.++..+..+++.+.++|.+||+.||.+|||+.++++.|..+...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2334455566677889999999999999999999999999999999988653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-41  Score=350.50  Aligned_cols=252  Identities=20%  Similarity=0.268  Sum_probs=203.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch---HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~---~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ++|++++.||+|+||.||++      +.||+|.+........   ....+.+|+.++..++||||+++++++.+... .+
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   88 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-IS   88 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-CE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc-eE
Confidence            67899999999999999985      5799999874322211   12357789999999999999999999987765 89


Q ss_pred             EEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999986 898888654 4689999999999999999999999999999999999999999999999999887655444


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---CC-------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EI-------  559 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~~-------  559 (604)
                      ......+|+.|+|||.+.+..   .++.++|||||||++|||++|.+||.+.+..+....+......+   .+       
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cCCcccccccccCchHhhCCC---CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            445567899999999997543   24556999999999999999999999888777666655431111   00       


Q ss_pred             ----------------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 ----------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 ----------------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                                      ...+++++.++|.+||+.||.+|||+.|+++|-+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence                            1456789999999999999999999999999877643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-41  Score=354.79  Aligned_cols=253  Identities=19%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             cCCCeEEeeeeeccCceEEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE  405 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~  405 (604)
                      ..++|++++.||+|+||.||++         +.||+|.++....  .......+.+|+.++..+ +||||+++++++.+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            4478999999999999999975         4599999864321  111123355788888888 799999999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      +. +++||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          132 TK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TE-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ce-EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            75 99999999999999999877889999999999999999999999999999999999999999999999999987654


Q ss_pred             cCC-CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHcCCCCCCC
Q 007429          486 SVG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       486 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s----~~~~~~~i~~~~~r~~~p  560 (604)
                      ... .......||+.|+|||++.+...  .++.++|||||||++|||++|..||....    .......+..  ..+.+|
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDS--GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCC--CCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence            322 22333468999999999986422  23457999999999999999999997432    2222222222  355678


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHHh
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      ..++..+.+||.+||+.||.+||     ++.+++++.+..
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            88999999999999999999999     999999988764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-40  Score=344.91  Aligned_cols=256  Identities=23%  Similarity=0.430  Sum_probs=206.4

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHh--CCCCceeEEEEEEEcCC---CcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDEN---HGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~--L~HpnIVkl~g~~~~~~---~~l~  410 (604)
                      ++|++.+.||+|+||.||+|    +.||+|.+...     ....+.+|+.++..  ++||||+++++++....   ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            67899999999999999995    68999998632     23456677777766  79999999999998775   2489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLH--------s~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      +||||+++|+|.+++.+ ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|||++.
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999999999954 46899999999999999999999        8999999999999999999999999999987


Q ss_pred             ccccCCC----cccccCCCCcccccccccCCCCCC--CCCcchhHHHHHHHHHHHHcC----------CCCCCCCC----
Q 007429          483 ACKSVGE----ATEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTG----------EAAYAACS----  542 (604)
Q Consensus       483 ~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~--~~t~kSDVWSlGvvLyELlTG----------~~Pf~~~s----  542 (604)
                      .......    ......||+.|+|||.+.+.....  .++.++|||||||++|||++|          ..||....    
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            6554332    123446899999999998653322  122569999999999999999          78887542    


Q ss_pred             -hHHHHHHHHHcCCCCCCCC-----CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          543 -PVQAAVGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       543 -~~~~~~~i~~~~~r~~~p~-----~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                       .......+.....++.+|.     .++..+.+||.+||+.||.+|||+.+++++|.++.+..+.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence             2222233334445555554     3557899999999999999999999999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-40  Score=364.85  Aligned_cols=248  Identities=19%  Similarity=0.248  Sum_probs=198.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++++.||+|+||.||++      +.||||++............+.+|+.++..++|||||++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            378999999999999999985      68999999865444445667889999999999999999999997553     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             eEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            47999999987 5666663  34899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                       .......||+.|+|||++.+..++.    ++|||||||++|||++|+.||.+.+..+.+..+......+          
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~----~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          218 -FMMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             -CCC----CCCTTCCHHHHTTCCCCT----THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             -cccCCCcccccccCHHHHcCCCCCH----HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence             2234457899999999998876554    5999999999999999999999888776665554321111          


Q ss_pred             ----------C---------CCCC-----------ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 ----------E---------IPKD-----------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 ----------~---------~p~~-----------~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                .         +|..           .++++.+||.+||..||.+|||+.|+++|-+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence                      0         0100           15679999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-40  Score=356.46  Aligned_cols=245  Identities=16%  Similarity=0.261  Sum_probs=192.4

Q ss_pred             CCeEEe-eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHH-hCCCCceeEEEEEEEc---CCCc
Q 007429          340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELM-TCGHKNILQFYCVCVD---ENHG  408 (604)
Q Consensus       340 ~~y~i~-~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~-~L~HpnIVkl~g~~~~---~~~~  408 (604)
                      ++|.+. +.||+|+||.||++      +.||+|++...       ..+.+|+.++. ..+||||+++++++..   ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            567776 78999999999985      47999999632       23567777764 4589999999999865   2334


Q ss_pred             EEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~  483 (604)
                      +|+||||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            89999999999999999654  36999999999999999999999999999999999999998   78999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHcCCCCCC
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ----AAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~----~~~~i~~~~~r~~~  559 (604)
                      ..... ......||+.|+|||++.+..++    .++|||||||++|||++|..||.......    ....+.........
T Consensus       214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          214 TTSHN-SLTTPCYTPYYVAPEVLGPEKYD----KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             CC------------CTTCCGGGSCCCCSS----SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             cCCCC-ccccCCCCCCccCHhhcCCCCCC----CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            54322 23345789999999999776544    46999999999999999999998654321    22333433333222


Q ss_pred             --CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 --PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 --p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                        ...+++++.+||.+||+.||.+|||+.++++|-+...
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence              2568999999999999999999999999999988654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=352.49  Aligned_cols=242  Identities=15%  Similarity=0.202  Sum_probs=203.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~------~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ++|++++.||+|+||.||++      +.||+|.+........      ....+.+|+.++..++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            67899999999999999996      5799999986532211      12246679999999999999999999988775


Q ss_pred             cEEEEEecccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          408 GLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       408 ~l~LVmEy~~gG-SL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                       +++||||+.+| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       104 -~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          104 -FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             -EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             -EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence             89999999777 9999998888899999999999999999999999999999999999999999999999999876554


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .. ......||+.|+|||++.+..+   .+.++|||||||++|||++|..||......        .......|..++++
T Consensus       183 ~~-~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~  250 (335)
T 3dls_A          183 GK-LFYTFCGTIEYCAPEVLMGNPY---RGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKE  250 (335)
T ss_dssp             TC-CBCEECSCGGGCCHHHHTTCCB---CSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHH
T ss_pred             CC-ceeccCCCccccChhhhcCCCC---CCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHH
Confidence            32 2334568999999999987643   245689999999999999999999763221        12233456678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +.++|.+||+.||.+|||+.+++++-+.
T Consensus       251 l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          251 LMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            9999999999999999999999998664

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-40  Score=341.03  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=200.1

Q ss_pred             EEeeeeeccCceEEEEe----EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEecc
Q 007429          343 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  416 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG----k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmEy~  416 (604)
                      ...+.||+|+||.||+|    +.||+|++.....  .......+.+|+.++..++||||+++++++.+.+. .++||||+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~  112 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYM  112 (307)
T ss_dssp             TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEECC
T ss_pred             ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc-eEEEEEec
Confidence            34578999999999996    5899999875322  22345668899999999999999999999987765 89999999


Q ss_pred             cCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--cc
Q 007429          417 EGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  491 (604)
Q Consensus       417 ~gGSL~dlL~~---~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~  491 (604)
                      ++|+|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ..
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            99999999853   34699999999999999999999999999999999999999999999999999876543322  12


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHc----------CCCCC
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA---AVGIAAC----------GLRPE  558 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~---~~~i~~~----------~~r~~  558 (604)
                      ....|++.|+|||.+.+.     ++.++||||||+++|+|++|..||........   +......          .....
T Consensus       193 ~~~~g~~~y~aPE~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGE-----ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTE-----ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccCCCcCcCChHHhcCC-----CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence            334689999999998753     34569999999999999999999986443211   1111111          11122


Q ss_pred             CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       559 ~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .+..++..+.+++.+||+.||.+|||+.+++++|.++.
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            34456788999999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=351.10  Aligned_cols=250  Identities=10%  Similarity=0.137  Sum_probs=203.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe--------------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeE-------
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG--------------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ-------  397 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG--------------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVk-------  397 (604)
                      .++|++.+.||+|+||.||+|              +.||+|.+...       ..+.+|+.++..++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            478999999999999999986              35899998743       24678899999999999887       


Q ss_pred             --------EEEEEEcCCCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE
Q 007429          398 --------FYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL  467 (604)
Q Consensus       398 --------l~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl  467 (604)
                              +++++...+...++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6788877555589999999 99999999765  689999999999999999999999999999999999999


Q ss_pred             cCCC--cEEEEecCCccccccCCCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 007429          468 DRHG--NVCLGDMGIVTACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY  538 (604)
Q Consensus       468 d~~g--~vKL~DFGla~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf  538 (604)
                      +.++  .+||+|||+++........       .....||+.|+|||.+.+..+    +.++|||||||++|||++|..||
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP----SRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC----CchhhHHHHHHHHHHHHhCCCCc
Confidence            9998  8999999998765433221       123468999999999987644    45699999999999999999999


Q ss_pred             CCCC-hHHHHHHHHH--cCCCCCCC------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccC
Q 007429          539 AACS-PVQAAVGIAA--CGLRPEIP------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  600 (604)
Q Consensus       539 ~~~s-~~~~~~~i~~--~~~r~~~p------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~  600 (604)
                      .... ..........  ......++      ..+++.+.++|.+||+.||.+||++.+|++.|.++.+..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            8754 2222222111  11122222      2468999999999999999999999999999999876554

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=341.36  Aligned_cols=258  Identities=15%  Similarity=0.247  Sum_probs=190.8

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEE---
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCV---  403 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~---  403 (604)
                      .+.+...+|++.+.||+|+||.||+++      .||+|++...  .......+.+|+..+.++. ||||+++++++.   
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~   99 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK   99 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence            566777899999999999999999964      6999998643  2334456789999999985 999999999995   


Q ss_pred             ----cCCCcEEEEEecccCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEcCCCcEE
Q 007429          404 ----DENHGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVC  474 (604)
Q Consensus       404 ----~~~~~l~LVmEy~~gGSL~dlL~~---~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld~~g~vK  474 (604)
                          .....+++||||+. |+|.+++..   ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence                22334899999996 699998854   457999999999999999999999999  99999999999999999999


Q ss_pred             EEecCCccccccCCCc------------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 007429          475 LGDMGIVTACKSVGEA------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS  542 (604)
Q Consensus       475 L~DFGla~~~~~~~~~------------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s  542 (604)
                      |+|||++.........            .....+|+.|+|||++.... ...++.++|||||||++|||++|..||....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCT-TSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc-cCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            9999998765432211            11335889999999984221 2234567999999999999999999997654


Q ss_pred             hHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       543 ~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ...    +.........+..++..+.++|.+||+.||.+||++.+++++|+.+....
T Consensus       258 ~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          258 KLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            433    23333444455667888999999999999999999999999999886543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-40  Score=351.84  Aligned_cols=248  Identities=18%  Similarity=0.248  Sum_probs=199.9

Q ss_pred             eecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---  406 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~---  406 (604)
                      ....++|++++.||+|+||.||++      +.||+|++......      ..+|+.+++.++|||||++++++....   
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            345688999999999999999996      57999998754322      236889999999999999999985432   


Q ss_pred             ----------------------------------CcEEEEEecccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 007429          407 ----------------------------------HGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIK  448 (604)
Q Consensus       407 ----------------------------------~~l~LVmEy~~gGSL~dlL~----~~~~l~~~~il~ia~qIa~gL~  448 (604)
                                                        ..+++||||+++ +|.+.+.    ....+++..+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              238899999985 8877764    3467999999999999999999


Q ss_pred             HHHhcCceeccCCCCceEEc-CCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHH
Q 007429          449 FLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV  527 (604)
Q Consensus       449 YLHs~gIVHrDLKp~NILld-~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvv  527 (604)
                      |||++||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+..   .++.++||||+||+
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~i  231 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGAT---EYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCS---SCCTHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCC---CCCcchhhhhHHHH
Confidence            99999999999999999998 68899999999997654432 233446789999999987643   23456999999999


Q ss_pred             HHHHHcCCCCCCCCChHHHHHHHHHcCCCC---------------------------CCCCCccHHHHHHHHHhhhcCCC
Q 007429          528 IWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------------------EIPKDCPQILKSLMIKCWNNSPS  580 (604)
Q Consensus       528 LyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---------------------------~~p~~~s~~l~~LI~kCL~~dP~  580 (604)
                      +|||++|..||.+.+..+.+..++.....+                           .++..+++++.+||.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            999999999999988877666655321111                           14566889999999999999999


Q ss_pred             CCCCHHHHHHHHHH
Q 007429          581 KRPQFSEIISLLLR  594 (604)
Q Consensus       581 kRPT~~ELL~~L~~  594 (604)
                      +|||+.|+++|-+.
T Consensus       312 ~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          312 LRINPYEAMAHPFF  325 (383)
T ss_dssp             GSCCHHHHHTSGGG
T ss_pred             hCCCHHHHhcCHHH
Confidence            99999999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-40  Score=346.36  Aligned_cols=253  Identities=17%  Similarity=0.276  Sum_probs=204.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  406 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-------  406 (604)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+..       
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67899999999999999996      47999998755544444456779999999999999999999998742       


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      ..+|+||||+++ +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            248999999986 77777754 3579999999999999999999999999999999999999999999999999987654


Q ss_pred             cCC----CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc--CCCCCC
Q 007429          486 SVG----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--GLRPEI  559 (604)
Q Consensus       486 ~~~----~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~--~~r~~~  559 (604)
                      ...    .......||+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+...  ...+..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCC---CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            221    1223446799999999987643   2345699999999999999999999988776655544432  112211


Q ss_pred             CCC----------------------------ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 PKD----------------------------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p~~----------------------------~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      ...                            .++.+.+||.+||+.||.+|||+.|+++|-+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            111                            2677999999999999999999999999877654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.2e-41  Score=345.68  Aligned_cols=260  Identities=21%  Similarity=0.359  Sum_probs=185.8

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHH-HHHhCCCCceeEEEEEEEcC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ..|.+..++|++++.||+|+||.||++      +.||+|.+.... ......++..|+. .+..++||||+++++++.+.
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            468888899999999999999999985      579999997543 2333445556666 55567999999999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecC
Q 007429          406 NHGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMG  479 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~-----~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFG  479 (604)
                      +. .++||||+++ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        94 ~~-~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           94 GD-CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SE-EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             Cc-eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            75 8999999986 88888753     45789999999999999999999999 99999999999999999999999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          480 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       480 la~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ++....... ......|++.|+|||.+........++.++|||||||++|+|++|..||...............+..+.+
T Consensus       172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            987654322 2233468999999999854322334556799999999999999999999875433222111122222222


Q ss_pred             C----CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 P----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p----~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +    ..+++.+.++|.+||+.||.+||++.+++++-+...
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            2    468899999999999999999999999999876654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-40  Score=346.19  Aligned_cols=249  Identities=18%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             CCeEEe-eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~-~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ++|.+. +.||+|+||.||++      +.||+|.+............+.+|+.++..+ +||||+++++++.+.+. +++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~-~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE-IIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe-EEE
Confidence            456676 89999999999985      5899999986555444566788999999988 56999999999987765 999


Q ss_pred             EEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCcccccc
Q 007429          412 VTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKS  486 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~~~~  486 (604)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998543  57999999999999999999999999999999999999998   78999999999876643


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC--CCCCCCCcc
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--RPEIPKDCP  564 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~--r~~~p~~~s  564 (604)
                      ... .....||+.|+|||.+.+..++    .++|||||||++|+|++|..||...+..+....+.....  ....+..++
T Consensus       187 ~~~-~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          187 ACE-LREIMGTPEYLAPEILNYDPIT----TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             ccc-cccccCCcCccCCeeecCCCCC----chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            322 2345689999999999876544    459999999999999999999998887776666555433  334456789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +.+.++|.+||+.||.+|||+.+++++-+.
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            999999999999999999999999998664

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-40  Score=372.04  Aligned_cols=251  Identities=20%  Similarity=0.307  Sum_probs=208.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~-~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++++.||+|+||.||++      +.||+|++...... ......+.+|+.++..++||||+++++++.+... +
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-L  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE-E
Confidence            34578999999999999999985      57999999643211 1123457789999999999999999999988765 9


Q ss_pred             EEEEecccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~----~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998643    369999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHHHHcCCCCCCCC
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s----~~~~~~~i~~~~~r~~~p~  561 (604)
                      ..........||+.|+|||++.+..++    .++|||||||++|||++|..||...+    .......+...  ...+|.
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~----~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~  414 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYD----FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPD  414 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCT
T ss_pred             CCCcccccccCCccccChhhhcCCCCC----hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCc
Confidence            544334445899999999999876544    45999999999999999999998653    23333334432  456788


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHH
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQF-----SEIISLLLR  594 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~-----~ELL~~L~~  594 (604)
                      .+++.+.++|.+||+.||.+||++     .+|++|-+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff  452 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF  452 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence            899999999999999999999965     788876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-40  Score=359.64  Aligned_cols=252  Identities=16%  Similarity=0.226  Sum_probs=195.8

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC------chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~------~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .++|.+.+.||+|+||.||+|      +.||+|.+......      ......+.+|+.++..++|||||++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            378999999999999999996      58999998753211      11122477999999999999999999998644 


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---cEEEEecCCccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTA  483 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---~vKL~DFGla~~  483 (604)
                       ..++||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             -EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             -ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence             3799999999999999987778899999999999999999999999999999999999997554   599999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC---C
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---P  560 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~---p  560 (604)
                      ..... ......||+.|+|||++.+... ..++.++|||||||++|+|++|..||...............+.....   .
T Consensus       292 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          292 LGETS-LMRTLCGTPTYLAPEVLVSVGT-AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             CC------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             cCCCc-cccccCCCCCccCceeeecCCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            54322 2334578999999999864321 23456799999999999999999999875443333333333322222   2


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ..+++.+.++|.+||+.||.+|||+.++++|-|.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            4678999999999999999999999999998654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4e-40  Score=375.69  Aligned_cols=258  Identities=24%  Similarity=0.450  Sum_probs=215.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      ..|.+..++|++.+.||+|+||.||+|.         .||+|.++... .......+.+|+.++..++|||||++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4566777899999999999999999974         48888886432 3334456889999999999999999999985


Q ss_pred             cCCCcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       404 ~~~~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      + +. .++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       462 ~-~~-~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          462 E-NP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             S-SS-CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             c-Cc-eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            4 33 899999999999999996544 78999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCC
Q 007429          483 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  560 (604)
Q Consensus       483 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p  560 (604)
                      ....... ......+|+.|+|||.+.+..+    +.++|||||||++|||++ |..||.+....+....+. .+.++..|
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~  614 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRF----TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMP  614 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCC----CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence            6543321 1223356789999999986644    456999999999999997 999999887776655444 45566788


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ..+++.+.++|.+||+.||.+|||+.+|++.|..+...
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999988643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=335.36  Aligned_cols=253  Identities=18%  Similarity=0.288  Sum_probs=208.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~  410 (604)
                      ++|++++.||+|+||.||++      +.+++|.++....  .......+.+|+..+..++||||+++++++.... ...+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            67899999999999999985      5799999864321  1223456889999999999999999999986432 3489


Q ss_pred             EEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC-
Q 007429          411 VVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV-  487 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~-  487 (604)
                      +||||++++ |.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999886 7777754  457999999999999999999999999999999999999999999999999998765432 


Q ss_pred             -CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          488 -GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       488 -~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                       ........+++.|+|||.+.+...  ..+.++||||||+++|||++|..||...+.......+...  ...++..+++.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~  239 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDT--FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPP  239 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSC--EESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHH
T ss_pred             cccccccCCCCCCCcChhhccCccc--CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHH
Confidence             122334568999999999976432  2245799999999999999999999987776665555543  34577889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.++|.+||+.||.+|||+.+++++-+....
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999999998776544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-41  Score=375.31  Aligned_cols=252  Identities=18%  Similarity=0.304  Sum_probs=209.2

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      +..++|++++.||+|+||.||++      +.||+|++..... .......+.+|+.++..++|||||++++++.+.+. +
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-L  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE-E
Confidence            45678999999999999999985      5799999864321 11123457789999999999999999999988775 9


Q ss_pred             EEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      |+||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999986544  4999999999999999999999999999999999999999999999999998766433


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHcCCCCCCCCCcc
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      . ......||+.|+|||++.+..++    .++|||||||++|||++|..||.....   ...+...+. ..+..+|..++
T Consensus       340 ~-~~~~~~GT~~Y~APEvl~~~~~~----~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~~s  413 (576)
T 2acx_A          340 Q-TIKGRVGTVGYMAPEVVKNERYT----FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFS  413 (576)
T ss_dssp             C-CEECCCSCGGGCCHHHHTTCEES----SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTTSC
T ss_pred             c-cccccCCCccccCHHHHcCCCCC----ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCccCC
Confidence            2 23345799999999999876544    459999999999999999999987532   222322222 23556788899


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHHh
Q 007429          565 QILKSLMIKCWNNSPSKRP-----QFSEIISLLLRT  595 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~~~  595 (604)
                      +++.+||.+||+.||.+||     ++.|+++|-+..
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence            9999999999999999999     789999886543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=335.86  Aligned_cols=260  Identities=18%  Similarity=0.336  Sum_probs=189.7

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+|.+..++|++++.||+|+||.||++      +.||+|.+............+..+...+..++||||+++++++.+.+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            357777899999999999999999995      57999999854332222222334444567789999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      . .++||||+ ++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        98 ~-~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           98 D-VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             E-EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             c-EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            5 99999999 5566666543 46799999999999999999999995 9999999999999999999999999998665


Q ss_pred             ccCCCcccccCCCCcccccccccCCC-CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCC--C
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K  561 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p--~  561 (604)
                      .... ......+++.|+|||.+.+.. ....++.++|||||||++|||++|..||..................+..+  .
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            4322 233446899999999996421 12234567999999999999999999998754433333333334444444  4


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+++.+.++|.+||+.||.+||++.+++++-+..
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            5799999999999999999999999999876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-40  Score=338.80  Aligned_cols=250  Identities=20%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEc----
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVD----  404 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~----  404 (604)
                      .++|++++.||+|+||.||++       +.||+|.++...........+.+|+.++..+   +||||+++++++..    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            378999999999999999986       4689999864332222122345666655554   89999999999872    


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ....+++||||++ |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            2334899999998 59999986543  49999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC------
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------  556 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r------  556 (604)
                      ...... ......+++.|+|||.+.+..+    +.++|||||||++|+|++|..||...+.......+......      
T Consensus       169 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          169 IYSFQM-ALTSVVVTLWYRAPEVLLQSSY----ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCGGG-GGCCCCCCCTTCCHHHHTTCCC----CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccCCC-CccccccccceeCHHHHhcCCC----CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            654322 2334568999999999987654    44699999999999999999999988877666555432110      


Q ss_pred             -------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          557 -------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       557 -------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                         ..++..+++.+.++|.+||+.||.+|||+.++++|-+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence                               01335688999999999999999999999999987544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-39  Score=345.60  Aligned_cols=249  Identities=19%  Similarity=0.241  Sum_probs=196.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----C
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  407 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~  407 (604)
                      .++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            378999999999999999985      57999999865444445566889999999999999999999997654     2


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      .+|+||||+++ +|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            48999999975 7888874  45899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                      . ......||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+.......+......+          
T Consensus       181 ~-~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          181 F-MMTPYVVTRYYRAPEVILGMGYK----ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCC----TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             c-ccCCceecCCccCHHHhcCCCCC----chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1 22345689999999999876554    45999999999999999999999887766655554321111          


Q ss_pred             ----------CC--------------CC------CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ----------EI--------------PK------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ----------~~--------------p~------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                .+              |.      ..++.+.+||.+||+.||.+|||+.|+++|-+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                      00              11      1256799999999999999999999999987754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.5e-42  Score=361.58  Aligned_cols=248  Identities=11%  Similarity=0.076  Sum_probs=191.4

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHH---HHHHhCCCCceeEEE-----
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDL---LELMTCGHKNILQFY-----  399 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei---~~L~~L~HpnIVkl~-----  399 (604)
                      |....++|++.+.||+|+||.||+|      +.||||.+..... .......+.+|+   ..+..++|||||+++     
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            3344578999999999999999985      5799999975432 223445688998   455566899999998     


Q ss_pred             --EEEEcCCC----------------cEEEEEecccCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcC
Q 007429          400 --CVCVDENH----------------GLCVVTKLMEGGSVNDLILKSRKLQT-------KEIIRIAIDVAEGIKFLNDHG  454 (604)
Q Consensus       400 --g~~~~~~~----------------~l~LVmEy~~gGSL~dlL~~~~~l~~-------~~il~ia~qIa~gL~YLHs~g  454 (604)
                        +++.+.+.                ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence              77665432                278999999 5799999976555555       788889999999999999999


Q ss_pred             ceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCC-------CCCCCCCcchhHHHHHHH
Q 007429          455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD-------PESVSETWMSNVYSFGMV  527 (604)
Q Consensus       455 IVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~s~~~t~kSDVWSlGvv  527 (604)
                      |+||||||+|||++.++.+||+|||+++....   ......| +.|+|||++.+.       .....++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999999999999999999875332   2334456 999999999865       000123456999999999


Q ss_pred             HHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          528 IWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       528 LyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +|||++|..||...+.......+      ...+..+++.+.++|.+||+.||.+|||+.+++++-+
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  362 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  362 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred             HHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence            99999999999765433221111      1233678899999999999999999999999998654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.3e-40  Score=346.69  Aligned_cols=253  Identities=17%  Similarity=0.257  Sum_probs=205.0

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ..|.+. ++|.+.+.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++...+
T Consensus        36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            356654 79999999999999999985      68999999865555555667889999999999999999999998765


Q ss_pred             C-----cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          407 H-----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       407 ~-----~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .     ..|+||||+. ++|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            3     1399999997 58988763  35999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----
Q 007429          482 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----  557 (604)
Q Consensus       482 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----  557 (604)
                      +.....   .....+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+..+....+......+    
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVILSWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCS---CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccC---cCCcccCccccCHHHhcCCC---CCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            755432   33456899999999997632   23445999999999999999999999887766655544321111    


Q ss_pred             -------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 -------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 -------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                               ..+..+++.+.+||.+||+.||.+|||+.|+++|-+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                                     11245789999999999999999999999999987653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.2e-40  Score=345.68  Aligned_cols=251  Identities=18%  Similarity=0.264  Sum_probs=204.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----Cc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG  408 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~  408 (604)
                      .++|++++.||+|+||.||++      +.||+|++... ........+.+|+.++..++||||+++++++....    ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            368999999999999999996      57999999743 23334466889999999999999999999997553    34


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .|+||||+.+ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999975 99998854 569999999999999999999999999999999999999999999999999987655332


Q ss_pred             Cc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------
Q 007429          489 EA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------  557 (604)
Q Consensus       489 ~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------  557 (604)
                      ..   .....||+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+..+....+......+        
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBC---SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CccccccccccccCCCCCHHhcCCC---CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            21   23347899999999876543   23456999999999999999999998877655544433211110        


Q ss_pred             ----------------C-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ----------------E-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ----------------~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                      .     ....+++.+.+||.+||+.||.+|||+.|+++|-+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                            0     1246788999999999999999999999999986654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-40  Score=342.43  Aligned_cols=249  Identities=16%  Similarity=0.251  Sum_probs=197.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC------chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~------~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ++|++.+.||+|+||.||++      +.||+|.+......      ......+.+|+.++..++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            57899999999999999996      57999998643211      111234789999999999999999999987553 


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCcccc
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTAC  484 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~~~  484 (604)
                       .|+||||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999987788999999999999999999999999999999999999987665   999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC---CCCC
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EIPK  561 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~---~~p~  561 (604)
                      .... ......||+.|+|||.+.+... ..++.++|||||||++|+|++|..||............+..+...   ..+.
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          168 GETS-LMRTLCGTPTYLAPEVLVSVGT-AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             CCCH-HHHHHHSCCTTCCHHHHHHTTT-TTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             cccc-ccccccCCcCccCchhhccCCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            4321 1233468999999999753211 134557999999999999999999998654432222223222222   2235


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .+++.+.++|.+||+.||.+||++.+++++-
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence            6789999999999999999999999999763

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-40  Score=351.44  Aligned_cols=253  Identities=17%  Similarity=0.254  Sum_probs=190.5

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-  406 (604)
                      .|.+. ++|++++.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++.... 
T Consensus        24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            35444 78999999999999999996      58999999755444445567889999999999999999999997541 


Q ss_pred             ----CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          407 ----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       407 ----~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                          ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                3379999999 6799998854 679999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  557 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----  557 (604)
                      .....   .....+|+.|+|||.+.+..   .++.++|||||||++|||++|..||.+.+....+..+......+     
T Consensus       181 ~~~~~---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTADE---MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCC---SCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccc---CCCcCcCcCccChHHHcCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65432   33457899999999987632   23446999999999999999999999887766555443311110     


Q ss_pred             ----------------C--------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 ----------------E--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 ----------------~--------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                      .        ....+++.+.+||.+||..||.+|||+.++++|-+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                            0        1135678899999999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-40  Score=346.32  Aligned_cols=248  Identities=15%  Similarity=0.220  Sum_probs=205.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCch---------------HHHHHHHHHHHHHhCCCCceeEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA---------------YEFELRKDLLELMTCGHKNILQFY  399 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~---------------~~~~~~~Ei~~L~~L~HpnIVkl~  399 (604)
                      .++|++++.||+|+||.||++    +.||+|.+........               ....+.+|+.++..++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            478999999999999999995    6899999864322111               115688999999999999999999


Q ss_pred             EEEEcCCCcEEEEEecccCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCC
Q 007429          400 CVCVDENHGLCVVTKLMEGGSVNDL------ILK--SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRH  470 (604)
Q Consensus       400 g~~~~~~~~l~LVmEy~~gGSL~dl------L~~--~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~  470 (604)
                      +++.+.+. .++||||+++|+|.++      +.+  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus       110 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          110 GIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEEESSSE-EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEeeCCe-EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            99988775 9999999999999998      654  4679999999999999999999999 999999999999999999


Q ss_pred             CcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCh-HHHHH
Q 007429          471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW-MSNVYSFGMVIWEMVTGEAAYAACSP-VQAAV  548 (604)
Q Consensus       471 g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~-kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~  548 (604)
                      +.+||+|||++......  ......+++.|+|||.+.+..   .++. ++||||||+++|||++|..||..... .+...
T Consensus       189 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNES---SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             SCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCC---CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CcEEEeccccccccccc--cccCCCCCcCccCchhhcCCC---CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            99999999998765432  234457899999999998652   1222 69999999999999999999998766 44433


Q ss_pred             HHHHcCCCCCCC-------------------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          549 GIAACGLRPEIP-------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       549 ~i~~~~~r~~~p-------------------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .+...  ...+|                   ..+++.+.++|.+||+.||.+||++.+++++-+.
T Consensus       264 ~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f  326 (348)
T 2pml_X          264 NIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL  326 (348)
T ss_dssp             HHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            33322  22333                   5688999999999999999999999999987554

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-39  Score=351.00  Aligned_cols=246  Identities=17%  Similarity=0.240  Sum_probs=200.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC------CCCceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L------~HpnIVkl~g~~~~~~  406 (604)
                      ..+|++++.||+|+||.||+|      +.||+|+++..   ......+.+|+.++..+      +|+||+++++++...+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            467999999999999999996      68999999742   23345567777777765      6789999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc--EEEEecCCcc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVT  482 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~--vKL~DFGla~  482 (604)
                      . +++||||+. ++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.
T Consensus       173 ~-~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          173 H-ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             E-EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             e-EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            5 999999996 59999986543  5999999999999999999999999999999999999999987  9999999986


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  557 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----  557 (604)
                      ....   ......+|+.|+|||++.+..++    .++|||||||++|||++|.+||...+..+.+..+......+     
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          251 YEHQ---RVYTYIQSRFYRAPEVILGARYG----MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             ETTC---CCCSSCSCGGGCCHHHHHTBCCC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecCC---cccccCCCCCccChHHHhCCCCC----chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            5432   23345789999999999877544    46999999999999999999999887766655443211000     


Q ss_pred             ----------------------------------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCH
Q 007429          558 ----------------------------------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQF  585 (604)
Q Consensus       558 ----------------------------------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~  585 (604)
                                                                          .++...++.+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                                0112347889999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 007429          586 SEIISLLLRTN  596 (604)
Q Consensus       586 ~ELL~~L~~~~  596 (604)
                      .|+++|-|...
T Consensus       404 ~e~L~Hpw~~~  414 (429)
T 3kvw_A          404 GQALRHPWLRR  414 (429)
T ss_dssp             HHHHTSTTTC-
T ss_pred             HHHhCChhhcc
Confidence            99999866543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-39  Score=335.26  Aligned_cols=244  Identities=19%  Similarity=0.262  Sum_probs=197.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC------ceeEEEEEEEcC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK------NILQFYCVCVDE  405 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hp------nIVkl~g~~~~~  405 (604)
                      .++|++++.||+|+||.||++       +.||+|.++..   ......+.+|+.++..++|+      +|+++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            478999999999999999985       47999999632   23345677888888877554      599999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--------------
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--------------  469 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--------------  469 (604)
                      +. .++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus        90 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           90 GH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             Cc-EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            75 99999999 889999996654  6899999999999999999999999999999999999987              


Q ss_pred             -----CCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 007429          470 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  544 (604)
Q Consensus       470 -----~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~  544 (604)
                           ++.+||+|||++.....   ......||+.|+|||.+.+..+    +.++|||||||++|||++|..||...+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGW----SQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCC----CTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCC----CcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                 67899999999876432   2334578999999999987654    44699999999999999999999987765


Q ss_pred             HHHHHHHHcCCC------------------------------------------CCCCCCccHHHHHHHHHhhhcCCCCC
Q 007429          545 QAAVGIAACGLR------------------------------------------PEIPKDCPQILKSLMIKCWNNSPSKR  582 (604)
Q Consensus       545 ~~~~~i~~~~~r------------------------------------------~~~p~~~s~~l~~LI~kCL~~dP~kR  582 (604)
                      +....+......                                          ...+..+++.+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            544322211000                                          01122346789999999999999999


Q ss_pred             CCHHHHHHHHHH
Q 007429          583 PQFSEIISLLLR  594 (604)
Q Consensus       583 PT~~ELL~~L~~  594 (604)
                      ||+.|++++-+.
T Consensus       321 pt~~ell~hp~f  332 (339)
T 1z57_A          321 ITLREALKHPFF  332 (339)
T ss_dssp             CCHHHHTTSGGG
T ss_pred             cCHHHHhcCHHH
Confidence            999999987443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=343.13  Aligned_cols=249  Identities=13%  Similarity=0.181  Sum_probs=201.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQF  398 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~---HpnIVkl  398 (604)
                      ..+.+..++|.+.+.||+|+||.||+|           +.||+|.+....     ..++.+|+.++..++   |+||+++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            467788899999999999999999998           268999986432     345667777777776   8999999


Q ss_pred             EEEEEcCCCcEEEEEecccCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC----
Q 007429          399 YCVCVDENHGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----  469 (604)
Q Consensus       399 ~g~~~~~~~~l~LVmEy~~gGSL~dlL~~-----~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~----  469 (604)
                      ++++...+. .|+||||+++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.    
T Consensus       133 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          133 YSAHLFQNG-SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEECSSC-EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             heeeecCCC-cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            999988776 8999999999999999963     457999999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEEecCCccccccC--CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 007429          470 -------HGNVCLGDMGIVTACKSV--GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  540 (604)
Q Consensus       470 -------~g~vKL~DFGla~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~  540 (604)
                             ++.+||+|||+++.....  ........||+.|+|||++.+..+    +.++|||||||++|||++|+.||..
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW----NYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB----STHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC----CccccHHHHHHHHHHHHhCCCcccc
Confidence                   899999999999754422  222344579999999999987654    4569999999999999999999965


Q ss_pred             CChHHHHHHHHHcCCCCCCC-CCccHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHhhCc
Q 007429          541 CSPVQAAVGIAACGLRPEIP-KDCPQILKSLMIKCWNNSPSKR-PQFSEIISLLLRTNNI  598 (604)
Q Consensus       541 ~s~~~~~~~i~~~~~r~~~p-~~~s~~l~~LI~kCL~~dP~kR-PT~~ELL~~L~~~~~~  598 (604)
                      ......       .....+. ...++.+.+++..|++.+|.+| |++.++.+.|......
T Consensus       288 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          288 NEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            322110       0011111 1246789999999999999998 6788888888776543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=352.61  Aligned_cols=258  Identities=14%  Similarity=0.192  Sum_probs=205.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-CcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-~~l~L  411 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.+...... .....+.+|+.++..++||||+++++++.+.. ...++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            467899999999999999995      57999999753322 22345678999999999999999999998765 24899


Q ss_pred             EEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----cCCCcEEEEecCCcccc
Q 007429          412 VTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----d~~g~vKL~DFGla~~~  484 (604)
                      ||||+++|+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++..
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999999996543   39999999999999999999999999999999999999    77888999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCC----CCCCcchhHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHHcCCC
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPES----VSETWMSNVYSFGMVIWEMVTGEAAYAAC----SPVQAAVGIAACGLR  556 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s----~~~t~kSDVWSlGvvLyELlTG~~Pf~~~----s~~~~~~~i~~~~~r  556 (604)
                      .... ......||+.|+|||.+.+....    ..++.++|||||||++|||++|..||...    ...+....+......
T Consensus       167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             cCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            5432 22345689999999998642111    12345699999999999999999999742    234444444443221


Q ss_pred             C-----------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          557 P-----------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       557 ~-----------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      .                       .++..++..+.+++.+||+.||++||++.++++.+.++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1                       11234567899999999999999999999999999988663

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-39  Score=338.87  Aligned_cols=251  Identities=15%  Similarity=0.226  Sum_probs=201.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC----Cc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG  408 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~----~~  408 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.+... ........+.+|+.++..++||||+++++++....    ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            378999999999999999985      57999999643 23334556789999999999999999999987541    34


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      .++||||+. |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            899999997 599998854 579999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc----------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-
Q 007429          489 EA----------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-  557 (604)
Q Consensus       489 ~~----------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-  557 (604)
                      ..          .....||+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+......+ 
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA---KYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCC---CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCC---CccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            11          12236799999999876432   24557999999999999999999999877655444333211110 


Q ss_pred             -----------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          558 -----------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       558 -----------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                                   ..+..+++.+.++|.+||+.||.+|||+.++++|-+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                                         01246789999999999999999999999999986654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-39  Score=329.78  Aligned_cols=246  Identities=19%  Similarity=0.351  Sum_probs=192.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE--------  405 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~--------  405 (604)
                      ++|++++.||+|+||.||+|      +.||+|.+...   ......+.+|+.++..++||||+++++++.+.        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            57899999999999999996      47999999632   23345678999999999999999999998653        


Q ss_pred             ----CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCC
Q 007429          406 ----NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  480 (604)
Q Consensus       406 ----~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGl  480 (604)
                          ....|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                23489999999999999999644 3688899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--------------CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 007429          481 VTACKSVG--------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA  546 (604)
Q Consensus       481 a~~~~~~~--------------~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~  546 (604)
                      +.......              .......+++.|+|||.+.+..   .++.++|||||||++|||++   ||........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG---HYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCS---CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCC---CCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            87654221              1123345889999999997542   23456999999999999998   5654322222


Q ss_pred             HHHHHHc---CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          547 AVGIAAC---GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       547 ~~~i~~~---~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .......   ..++.++..+++.+.++|.+||+.||.+|||+.+++++-+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence            2222222   23344566778899999999999999999999999987554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-39  Score=333.90  Aligned_cols=245  Identities=13%  Similarity=0.222  Sum_probs=196.9

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC-CCcEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE-NHGLC  410 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~-~~~l~  410 (604)
                      .++|++++.||+|+||.||++      +.||+|.++...     ...+.+|+.++..++ ||||+++++++.+. ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            478999999999999999996      579999987322     356789999999996 99999999999874 23489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+++++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus       110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-  185 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  185 (330)
T ss_dssp             EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence            9999999999999874   489999999999999999999999999999999999999777 89999999987654332 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHH-------------cCC
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAA-------------CGL  555 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s-~~~~~~~i~~-------------~~~  555 (604)
                      ......+++.|+|||.+.+..   .++.++|||||||++|||++|..||.... ..+.+..+..             ...
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ccccccccccccChhhhcCCC---cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            234457889999999987632   23456999999999999999999996433 2222221111             000


Q ss_pred             ----------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          556 ----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       556 ----------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                            ....+..+++++.+||.+||+.||.+|||+.|+++|-+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence                                  0111223789999999999999999999999999986543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=339.48  Aligned_cols=252  Identities=17%  Similarity=0.263  Sum_probs=202.9

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      .|.+. ++|.+.+.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++.....
T Consensus        19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            45443 78999999999999999985      589999997654444455678899999999999999999999987643


Q ss_pred             -----cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          408 -----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       408 -----~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                           ..|+||||+. |+|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence                 2599999997 58888763  359999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--------
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--------  554 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--------  554 (604)
                      .....   .....+|+.|+|||.+.+..   .++.++|||||||++|||++|..||.+.+..+....+....        
T Consensus       175 ~~~~~---~~~~~~t~~y~aPE~~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE---MTGYVVTRWYRAPEVILSWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C-----------CCSBCCSCHHHHSCCS---CCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCCC---ccccccCcCcCCHHHHhCcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            64422   23446799999999987632   23446999999999999999999999877665554443210        


Q ss_pred             ------------------CC---CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          555 ------------------LR---PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       555 ------------------~r---~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                        .+   ...+..+++.+.++|.+||+.||.+|||+.++++|-+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                              01   123346789999999999999999999999999886643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-39  Score=350.05  Aligned_cols=245  Identities=20%  Similarity=0.196  Sum_probs=196.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----Cc
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-----~~  408 (604)
                      .+|++++.||+|+||.||+|      +.||||++......      ..+|+.++..++|||||+++++|....     ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46899999999999999996      46999998743221      236889999999999999999986421     23


Q ss_pred             EEEEEecccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-CcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~----~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-g~vKL~DFGla~~  483 (604)
                      +++||||+++ +|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            6799999986 7776653    24579999999999999999999999999999999999999965 5689999999986


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-------
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------  556 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-------  556 (604)
                      ...... .....+|+.|+|||++.+..   .++.++|||||||++|||++|+.||.+.+..+.+..++.....       
T Consensus       207 ~~~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          207 LVRGEP-NVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CCTTCC-CCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cccCCC-ceeeeeCCCcCCHHHHcCCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543322 23456899999999997642   2345699999999999999999999988877666555432100       


Q ss_pred             --------CC------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 --------PE------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 --------~~------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                              ..            ++..+++++.+||.+||+.||.+||++.|+++|-+..
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence                    01            2346789999999999999999999999999987653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=330.73  Aligned_cols=251  Identities=16%  Similarity=0.203  Sum_probs=196.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-------
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-------  405 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-------  405 (604)
                      .++|++++.||+|+||.||+|      +.||+|++....  ......+.+|+.++..++||||+++++++...       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            378999999999999999985      689999987432  33445678999999999999999999998432       


Q ss_pred             ------CCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-CCCcEEEEec
Q 007429          406 ------NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDM  478 (604)
Q Consensus       406 ------~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-~~g~vKL~DF  478 (604)
                            ....++||||++ |+|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             cccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                  234899999998 59999984 45789999999999999999999999999999999999997 5679999999


Q ss_pred             CCccccccCC---CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC
Q 007429          479 GIVTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  555 (604)
Q Consensus       479 Gla~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~  555 (604)
                      |++.......   .......+++.|+|||.+.+..   .++.++|||||||++|||++|..||...+..+....+.....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcc---cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9987654321   1123345788999999886532   245579999999999999999999998877665554443211


Q ss_pred             C-----------------------C-----CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          556 R-----------------------P-----EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       556 r-----------------------~-----~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      .                       +     ..+..+++++.++|.+||+.||.+|||+.++++|-+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            0                       0     123467899999999999999999999999999876553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-39  Score=345.87  Aligned_cols=245  Identities=19%  Similarity=0.205  Sum_probs=197.1

Q ss_pred             CCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-----cE
Q 007429          340 DNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----GL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-----~l  409 (604)
                      .+|++++.||+|+||.||+++     .+|+|++......      ..+|+.+++.++|||||++++++.....     .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            579999999999999999964     5899988643322      2368899999999999999999965432     27


Q ss_pred             EEEEecccCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-CCCcEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~---~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-~~g~vKL~DFGla~~~~  485 (604)
                      ++||||++++.+..+..   ....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            89999998754433321   245799999999999999999999999999999999999999 79999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------  557 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------  557 (604)
                      .... .....+|+.|+|||.+.+..   .++.++|||||||++|||++|..||.+.+..+.+..+......+        
T Consensus       194 ~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          194 AGEP-NVSYICSRYYRAPELIFGAT---NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TTCC-CCSSCSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCC-CcccccCcCccCHHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            3322 33456799999999997643   24456999999999999999999999988777666554421110        


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                         .++..+++++.+||.+||+.||.+|||+.|+++|-+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence                               1234578999999999999999999999999998554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.9e-40  Score=348.07  Aligned_cols=248  Identities=10%  Similarity=0.059  Sum_probs=181.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHH---HHHhCCCCceeEEE-------EEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLL---ELMTCGHKNILQFY-------CVC  402 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~---~L~~L~HpnIVkl~-------g~~  402 (604)
                      .+|++.+.||+|+||.||+|      +.||+|++........ ....+.+|+.   .|.. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            46899999999999999996      5799999986544232 3345667744   4555 799988865       455


Q ss_pred             EcCC----------------CcEEEEEecccCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCceecc
Q 007429          403 VDEN----------------HGLCVVTKLMEGGSVNDLILKS-RKLQTKEI------IRIAIDVAEGIKFLNDHGVAYRD  459 (604)
Q Consensus       403 ~~~~----------------~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~i------l~ia~qIa~gL~YLHs~gIVHrD  459 (604)
                      ..++                ..+|+||||++ |+|.+++... ..+.+..+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            4332                23799999999 7999999653 34555555      67789999999999999999999


Q ss_pred             CCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 007429          460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA  539 (604)
Q Consensus       460 LKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~  539 (604)
                      |||+|||++.++.+||+|||+++.....   .....+|+.|+|||.+.+..  ..++.++|||||||++|||++|..||.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNAST--ATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSE--EECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCC--CCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999998765432   22445679999999997621  123557999999999999999999998


Q ss_pred             CCChHHHHH-H----HHH--cCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          540 ACSPVQAAV-G----IAA--CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       540 ~~s~~~~~~-~----i~~--~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ...+..... .    ...  .......+..+++.+.+||.+||+.||++|||+.++++|-+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            764321100 0    000  111222335789999999999999999999999999987654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-39  Score=342.86  Aligned_cols=244  Identities=17%  Similarity=0.256  Sum_probs=192.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--------CCceeEEEEEEEc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--------HKNILQFYCVCVD  404 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~--------HpnIVkl~g~~~~  404 (604)
                      .++|++++.||+|+||.||++      +.||+|.++..   ......+.+|+.++..++        |+||+++++++..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            478999999999999999996      57999999632   334456788999888874        7889999999873


Q ss_pred             ---CCCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEcCCC-------
Q 007429          405 ---ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHG-------  471 (604)
Q Consensus       405 ---~~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld~~g-------  471 (604)
                         ....+|+||||+ +++|.+.+.+.  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence               223489999999 55666666443  4699999999999999999999998 999999999999999776       


Q ss_pred             ------------------------------------------cEEEEecCCccccccCCCcccccCCCCcccccccccCC
Q 007429          472 ------------------------------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD  509 (604)
Q Consensus       472 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~  509 (604)
                                                                .+||+|||++......   .....||+.|+|||++.+.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence                                                      7999999998765432   3345689999999999877


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh------HHHHHHHHHc-CCC--------------------------
Q 007429          510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP------VQAAVGIAAC-GLR--------------------------  556 (604)
Q Consensus       510 ~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~------~~~~~~i~~~-~~r--------------------------  556 (604)
                      .++    .++|||||||++|||++|..||...+.      ......+... +..                          
T Consensus       269 ~~~----~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          269 GYN----TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             CCC----THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             CCC----cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            544    459999999999999999999976442      2222211110 100                          


Q ss_pred             -------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          557 -------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       557 -------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                                   ...+...++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence                         0123345677899999999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-39  Score=340.30  Aligned_cols=252  Identities=19%  Similarity=0.223  Sum_probs=196.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCc---------hHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN---------AYEFELRKDLLELMTCGHKNILQFYCVCV  403 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~---------~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~  403 (604)
                      ..++|++.+.||+|+||.||+|     +.||+|++.......         .....+.+|+.++..++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3478999999999999999996     579999986432221         12356889999999999999999999986


Q ss_pred             cCC----CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEec
Q 007429          404 DEN----HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  478 (604)
Q Consensus       404 ~~~----~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DF  478 (604)
                      ...    ..+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            432    24899999998 5888887544 47999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-
Q 007429          479 GIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-  557 (604)
Q Consensus       479 Gla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-  557 (604)
                      |++....... ......+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||...+.......+......+ 
T Consensus       179 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          179 NLAREDTADA-NKTHYVTHRWYRAPELVMQFK---GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             TC----------------CGGGCCHHHHTTCT---TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             Cccccccccc-ccceecccceecCcHHhcCCC---CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9987543322 233456889999999987632   23456999999999999999999999887766555443321111 


Q ss_pred             -----------------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 -----------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 -----------------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                                   ..+..+++.+.+||.+||+.||.+|||+.|+++|-+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  320 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF  320 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence                                         1124567889999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.3e-39  Score=337.09  Aligned_cols=250  Identities=18%  Similarity=0.163  Sum_probs=188.8

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC----
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----  407 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~----  407 (604)
                      ..++|++.+.||+|+||.||+|      +.||+|++.......   ....+++..+..++||||+++++++.....    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3478999999999999999985      479999987543322   234566777788899999999999975331    


Q ss_pred             --cEEEEEecccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCceEEcC-CCcEEEEec
Q 007429          408 --GLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLDR-HGNVCLGDM  478 (604)
Q Consensus       408 --~l~LVmEy~~gGSL~dlL~----~~~~l~~~~il~ia~qIa~gL~YLH--s~gIVHrDLKp~NILld~-~g~vKL~DF  478 (604)
                        .+++||||+++ +|.+.+.    ....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence              27899999987 5554442    4457899999999999999999999  999999999999999997 899999999


Q ss_pred             CCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--
Q 007429          479 GIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--  556 (604)
Q Consensus       479 Gla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--  556 (604)
                      |++........ .....+|+.|+|||.+.+..   .++.++|||||||++|||++|..||...+.......+......  
T Consensus       177 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          177 GSAKKLSPSEP-NVAYICSRYYRAPELIFGNQ---HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             TTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCceecCCCCC-cccccCCcceeCHHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99876654322 33446899999999986543   2345699999999999999999999988877666555432111  


Q ss_pred             ----------------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          557 ----------------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       557 ----------------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                                  +..+..+++++.+||.+||+.||.+|||+.|+++|-+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  319 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD  319 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence                                        112233678999999999999999999999999986654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-38  Score=330.84  Aligned_cols=245  Identities=16%  Similarity=0.244  Sum_probs=196.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc------eeEEEEEEEcC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN------ILQFYCVCVDE  405 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hpn------IVkl~g~~~~~  405 (604)
                      .++|++++.||+|+||.||++       +.||+|.++..   ......+.+|+.++..++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            479999999999999999985       57999999632   334456778888888876655      99999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----------------
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----------------  467 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----------------  467 (604)
                      +. .++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+                
T Consensus        95 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           95 GH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             Ce-EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            75 99999999 55777777544  369999999999999999999999999999999999999                


Q ss_pred             ---cCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH
Q 007429          468 ---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  544 (604)
Q Consensus       468 ---d~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~  544 (604)
                         +.++.+||+|||+++....   ......||+.|+|||++.+..++    .++|||||||++|||++|..||......
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWA----QPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCC----CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence               6788999999999875432   23345789999999999876544    4699999999999999999999987765


Q ss_pred             HHHHHHHHcCCC-C-----------------------------------------CCCCCccHHHHHHHHHhhhcCCCCC
Q 007429          545 QAAVGIAACGLR-P-----------------------------------------EIPKDCPQILKSLMIKCWNNSPSKR  582 (604)
Q Consensus       545 ~~~~~i~~~~~r-~-----------------------------------------~~p~~~s~~l~~LI~kCL~~dP~kR  582 (604)
                      +....+...... +                                         ......+..+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            544332221100 0                                         0111235689999999999999999


Q ss_pred             CCHHHHHHHHHHh
Q 007429          583 PQFSEIISLLLRT  595 (604)
Q Consensus       583 PT~~ELL~~L~~~  595 (604)
                      ||+.|+++|-+..
T Consensus       326 pt~~e~l~hp~f~  338 (355)
T 2eu9_A          326 ITLAEALLHPFFA  338 (355)
T ss_dssp             CCHHHHTTSGGGG
T ss_pred             cCHHHHhcChhhc
Confidence            9999999875543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=333.39  Aligned_cols=244  Identities=19%  Similarity=0.253  Sum_probs=195.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch----HHHHHHHHHHHHHhC----CCCceeEEEEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA----YEFELRKDLLELMTC----GHKNILQFYCVCV  403 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~----~~~~~~~Ei~~L~~L----~HpnIVkl~g~~~  403 (604)
                      -.++|++.+.||+|+||.||+|      +.||+|.+........    ....+.+|+..+..+    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3578999999999999999996      4799999975432211    122355788888887    8999999999998


Q ss_pred             cCCCcEEEEEec-ccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-CCCcEEEEecCCc
Q 007429          404 DENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIV  481 (604)
Q Consensus       404 ~~~~~l~LVmEy-~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-~~g~vKL~DFGla  481 (604)
                      +.+. .++|||| +.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus       109 ~~~~-~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          109 TQEG-FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             cCCe-EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            7765 8899999 78999999998778899999999999999999999999999999999999999 8899999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          482 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       482 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      ......  ......+++.|+|||.+.+..+.   +.++||||||+++|||++|..||.....      +..  ....++.
T Consensus       188 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~---~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--~~~~~~~  254 (312)
T 2iwi_A          188 ALLHDE--PYTDFDGTRVYSPPEWISRHQYH---ALPATVWSLGILLYDMVCGDIPFERDQE------ILE--AELHFPA  254 (312)
T ss_dssp             EECCSS--CBCCCCSCTTTSCHHHHHHSCBC---HHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--TCCCCCT
T ss_pred             hhcccC--cccccCCcccccCceeeecCCCC---CccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--hccCCcc
Confidence            765532  23345689999999998765432   3369999999999999999999976321      122  2445778


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .++..+.++|.+||+.||.+||++.+++++-+..
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            8999999999999999999999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.2e-39  Score=352.81  Aligned_cols=251  Identities=19%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++++.||+|+||.||+|      +.||||++.......    ++.+|+.++..++| ++|+.+..++.+.. ..+|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~-~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGD-YNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETT-EEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCC-EEEE
Confidence            378999999999999999996      479999887543322    36688888999977 45555555555444 4899


Q ss_pred             EEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE---cCCCcEEEEecCCccccccC
Q 007429          412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl---d~~g~vKL~DFGla~~~~~~  487 (604)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.....
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999 8899999964 5589999999999999999999999999999999999999   68899999999999876543


Q ss_pred             CCc-------ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHc---C
Q 007429          488 GEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAAC---G  554 (604)
Q Consensus       488 ~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~---~~~~~~i~~~---~  554 (604)
                      ...       .....||+.|+|||.+.+..+    +.++|||||||++|||++|..||.....   .+.+..+...   .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~----s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQ----SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCC----ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            321       124568999999999987654    4569999999999999999999987443   2222222221   1


Q ss_pred             CCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          555 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       555 ~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ....++..+++++.+||..||+.||.+||++.+|++.|..+....
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            122334678999999999999999999999999999999886543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-39  Score=335.04  Aligned_cols=244  Identities=19%  Similarity=0.254  Sum_probs=201.5

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCC--CCceeEEEEEEEc
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCG--HKNILQFYCVCVD  404 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~----~~~~~~~~Ei~~L~~L~--HpnIVkl~g~~~~  404 (604)
                      .-.++|++.+.||+|+||.||+|      +.||+|.+.......    .....+.+|+.++..++  |+||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999996      569999997543221    11123567888888885  5999999999988


Q ss_pred             CCCcEEEEEecccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc-CCCcEEEEecCCcc
Q 007429          405 ENHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT  482 (604)
Q Consensus       405 ~~~~l~LVmEy~~g-GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld-~~g~vKL~DFGla~  482 (604)
                      .+. .++|||++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       120 ~~~-~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          120 PDS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             SSE-EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCc-EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            775 8999999986 89999998878899999999999999999999999999999999999999 78999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  ......||+.|+|||.+.+..+   .+.++||||||+++|||++|..||.....      +..  ....++..
T Consensus       199 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~~~~~~  265 (320)
T 3a99_A          199 LLKDT--VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQVFFRQR  265 (320)
T ss_dssp             ECCSS--CBCCCCSCGGGSCHHHHHHSCB---CHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCCCCSSC
T ss_pred             ccccc--cccCCCCCccCCChHHhccCCC---CCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cccccccc
Confidence            65532  2234568999999999876543   23468999999999999999999976321      122  23446778


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +++++.++|.+||+.||.+|||+.+++++-+.
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence            89999999999999999999999999987553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.9e-39  Score=335.80  Aligned_cols=251  Identities=15%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-----------CCceeE
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----------HKNILQ  397 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-----------HpnIVk  397 (604)
                      ..+..++|++++.||+|+||.||++      +.||+|.+..   .......+.+|+.++..++           ||||++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            3456689999999999999999996      4799999863   2334455778888887765           899999


Q ss_pred             EEEEEEcCC---CcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CceeccCCCCceEEc---
Q 007429          398 FYCVCVDEN---HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLD---  468 (604)
Q Consensus       398 l~g~~~~~~---~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~-gIVHrDLKp~NILld---  468 (604)
                      +++++...+   ..+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+|||++   
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999997643   2489999999 88999999653  4699999999999999999999998 999999999999994   


Q ss_pred             ---CCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh--
Q 007429          469 ---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--  543 (604)
Q Consensus       469 ---~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~--  543 (604)
                         ..+.+||+|||++......   .....+|+.|+|||++.+..++    .++|||||||++|||++|..||...+.  
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~----~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWG----CGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCC----THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCC----chHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence               3447999999998765432   3344789999999999876544    469999999999999999999986442  


Q ss_pred             ----HHHHHHHHHc-CC---------------------------------------CCCCCCCccHHHHHHHHHhhhcCC
Q 007429          544 ----VQAAVGIAAC-GL---------------------------------------RPEIPKDCPQILKSLMIKCWNNSP  579 (604)
Q Consensus       544 ----~~~~~~i~~~-~~---------------------------------------r~~~p~~~s~~l~~LI~kCL~~dP  579 (604)
                          ......+... +.                                       ...++..+++++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                2222222110 00                                       112345567889999999999999


Q ss_pred             CCCCCHHHHHHHHHHhh
Q 007429          580 SKRPQFSEIISLLLRTN  596 (604)
Q Consensus       580 ~kRPT~~ELL~~L~~~~  596 (604)
                      .+|||+.|+++|-+...
T Consensus       323 ~~Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKD  339 (373)
T ss_dssp             TTCBCHHHHHTCGGGTT
T ss_pred             cccCCHHHHhhChhhhc
Confidence            99999999999876543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-38  Score=331.05  Aligned_cols=251  Identities=16%  Similarity=0.279  Sum_probs=174.2

Q ss_pred             cceeecCCCeEEee-eeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHH-HHHhCCCCceeEEEEEEEc
Q 007429          333 GRWLLNSDNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       333 ~~~~i~~~~y~i~~-~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~-~L~~L~HpnIVkl~g~~~~  404 (604)
                      .++.+ .++|++++ .||+|+||.||++      +.||+|++...   .    ...+|+. .+..++||||+++++++..
T Consensus        22 ~~~~~-~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~----~~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           22 KKYAV-TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P----KARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             BCSCG-GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCccc-cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            34443 36788865 6999999999985      58999999642   1    1223333 3556799999999999875


Q ss_pred             C---CCcEEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEE
Q 007429          405 E---NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLG  476 (604)
Q Consensus       405 ~---~~~l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~  476 (604)
                      .   ...+++||||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence            2   233899999999999999996543  6999999999999999999999999999999999999976   4559999


Q ss_pred             ecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH----HHHH
Q 007429          477 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV----GIAA  552 (604)
Q Consensus       477 DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~----~i~~  552 (604)
                      |||++......  ......+|+.|+|||.+.+..+    +.++|||||||++|+|++|..||..........    .+..
T Consensus       174 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          174 DFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             CCTTCEEC------------------------CHH----HHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             ccccceecccc--ccccCCCCcCccChhhhCCCCC----CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            99998765432  2334567999999999876543    456999999999999999999998655433211    1111


Q ss_pred             c--CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          553 C--GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       553 ~--~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .  .........+++.+.++|.+||+.||.+|||+.+++++-+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            1  11222335789999999999999999999999999998876543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-38  Score=333.09  Aligned_cols=244  Identities=22%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CC-----ceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HK-----NILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-Hp-----nIVkl~g~~~~~~  406 (604)
                      .++|++.+.||+|+||.||+|      +.||+|+++..   .....++..|+.++..++ |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            478999999999999999996      57999999732   233445667777777663 44     5999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCceeccCCCCceEEc--CCCcEEEEecCC
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLD--RHGNVCLGDMGI  480 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLH--s~gIVHrDLKp~NILld--~~g~vKL~DFGl  480 (604)
                      . +|+||||+++ +|.+++...  +.+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||+
T Consensus       130 ~-~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 H-LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             E-EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             c-eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            5 9999999965 999998654  46999999999999999999999  57999999999999994  478899999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--
Q 007429          481 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--  558 (604)
Q Consensus       481 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--  558 (604)
                      +......   .....+|+.|+|||++.+..++    .++|||||||++|||++|..||.+.+..+....+......++  
T Consensus       208 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~----~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          208 SCQLGQR---IYQYIQSRFYRSPEVLLGMPYD----LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CEETTCC---CCSSCSCGGGCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ceecccc---cccccCCccccChHHHcCCCCC----cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            8765432   3345789999999999877544    469999999999999999999998887766655543211100  


Q ss_pred             --------------CCC----------------------------------------------CccHHHHHHHHHhhhcC
Q 007429          559 --------------IPK----------------------------------------------DCPQILKSLMIKCWNNS  578 (604)
Q Consensus       559 --------------~p~----------------------------------------------~~s~~l~~LI~kCL~~d  578 (604)
                                    +|.                                              ...+.+.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                          000                                              01147899999999999


Q ss_pred             CCCCCCHHHHHHHHHH
Q 007429          579 PSKRPQFSEIISLLLR  594 (604)
Q Consensus       579 P~kRPT~~ELL~~L~~  594 (604)
                      |.+|||+.|+++|-+.
T Consensus       361 P~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFF  376 (382)
T ss_dssp             TTTSCCHHHHTTSGGG
T ss_pred             hhhCCCHHHHhcCccc
Confidence            9999999999987554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=339.51  Aligned_cols=249  Identities=18%  Similarity=0.263  Sum_probs=181.9

Q ss_pred             CCeEE-eeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcE
Q 007429          340 DNLEF-IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGL  409 (604)
Q Consensus       340 ~~y~i-~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l  409 (604)
                      +.|++ .++||+|+||.||+++        .||+|++.....    ...+.+|+.++..++|||||++++++... ...+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34666 4579999999999975        589999874332    23567899999999999999999999753 3458


Q ss_pred             EEEEecccCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEE----cCCCcEEEE
Q 007429          410 CVVTKLMEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLG  476 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~---------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILl----d~~g~vKL~  476 (604)
                      |+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 888887422         148999999999999999999999999999999999999    778899999


Q ss_pred             ecCCccccccCC---CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH---------
Q 007429          477 DMGIVTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------  544 (604)
Q Consensus       477 DFGla~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~---------  544 (604)
                      |||+++......   .......||+.|+|||++.+..   .++.++|||||||++|||++|..||......         
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCC---SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCC---cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999987654322   1223346899999999998643   2455799999999999999999999754431         


Q ss_pred             HHHHHHHHc-CCCCC-----------------------------------CCCCccHHHHHHHHHhhhcCCCCCCCHHHH
Q 007429          545 QAAVGIAAC-GLRPE-----------------------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEI  588 (604)
Q Consensus       545 ~~~~~i~~~-~~r~~-----------------------------------~p~~~s~~l~~LI~kCL~~dP~kRPT~~EL  588 (604)
                      +.+..+... +.+..                                   .....++.+.+||.+||+.||.+|||+.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            222222221 11110                                   001125678999999999999999999999


Q ss_pred             HHHHHHhh
Q 007429          589 ISLLLRTN  596 (604)
Q Consensus       589 L~~L~~~~  596 (604)
                      ++|-|...
T Consensus       332 L~hp~f~~  339 (405)
T 3rgf_A          332 MQDPYFLE  339 (405)
T ss_dssp             HTSGGGTS
T ss_pred             hcChhhcc
Confidence            99988754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=341.50  Aligned_cols=251  Identities=16%  Similarity=0.265  Sum_probs=190.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  406 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~  406 (604)
                      +.+.+...+|.+.+.||+|+||.||.     |+.||||++......     .+.+|+.++..+ +|||||++++++.+..
T Consensus        17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            45677778899999999999999654     568999999643221     245788899988 8999999999998877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-----CCcEEEEecCC
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-----HGNVCLGDMGI  480 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-----~g~vKL~DFGl  480 (604)
                      . .|+||||+. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.     ...+||+|||+
T Consensus        92 ~-~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           92 F-QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             E-EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             E-EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            5 899999997 49999986543 4566667899999999999999999999999999999953     23588999999


Q ss_pred             ccccccCC---CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCC
Q 007429          481 VTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR  556 (604)
Q Consensus       481 a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r  556 (604)
                      ++......   .......||+.|+|||++.+... ..++.++|||||||++|||++ |..||..........  ......
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~  246 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK-ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACS  246 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCC
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccc-cCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCC
Confidence            87664332   12234568999999999975322 234557999999999999999 999997655444322  222211


Q ss_pred             CC--C-CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          557 PE--I-PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       557 ~~--~-p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ..  . +...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus       247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~  286 (432)
T 3p23_A          247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF  286 (432)
T ss_dssp             CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred             ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence            11  1 2234667899999999999999999999997643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-37  Score=336.09  Aligned_cols=245  Identities=18%  Similarity=0.269  Sum_probs=184.4

Q ss_pred             CCeEEeeeeeccCceEEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|.+.+.||+|+||+||.     |+.||||++...     ....+.+|+.++..+ +|||||++++++.+.+. +|+||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF-LYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe-EEEEE
Confidence            3456678999999999975     578999998742     133467899988875 89999999999987765 99999


Q ss_pred             ecccCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC-------------CcE
Q 007429          414 KLMEGGSVNDLILKSRKL-------QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-------------GNV  473 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l-------~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~-------------g~v  473 (604)
                      ||++ |+|.+++......       ++..++.++.||+.||.|||++||+||||||+|||++.+             +.+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9996 5999999654322       233457899999999999999999999999999999754             489


Q ss_pred             EEEecCCccccccCCCc----ccccCCCCcccccccccCCC---CCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 007429          474 CLGDMGIVTACKSVGEA----TEYETDGYRWLAPEIIAGDP---ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ  545 (604)
Q Consensus       474 KL~DFGla~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~---~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~  545 (604)
                      ||+|||+++........    .....||+.|+|||++.+..   ....++.++|||||||++|||++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999998876543221    22346899999999997632   12345667999999999999999 999998755443


Q ss_pred             HHHHHHHcCCCCCC-----CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          546 AAVGIAACGLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       546 ~~~~i~~~~~r~~~-----p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                        ..+.........     +..+++++.++|.+||+.||.+|||+.++++|-+
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence              223333222211     1235688999999999999999999999998644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-37  Score=316.25  Aligned_cols=226  Identities=13%  Similarity=0.134  Sum_probs=183.2

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++.+.||+|+||.||+|      +.||+|.+....... .....+.+|+..+..++||||+++++++.+.+. .|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG-GLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc-EEE
Confidence            478999999999999999985      689999997554332 234568899999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.           
T Consensus       109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-----------  175 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----------  175 (286)
T ss_dssp             EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred             EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence            9999999999999844 3 45667889999999999999999999999999999999999999985542           


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHcCCCC--CCCCCccHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---GIAACGLRP--EIPKDCPQI  566 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~---~i~~~~~r~--~~p~~~s~~  566 (604)
                               ++|           ++.++|||||||++|||++|+.||...+......   ........+  ..+..+++.
T Consensus       176 ---------~~~-----------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          176 ---------MPD-----------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ---------CTT-----------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ---------cCC-----------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                     332           3456999999999999999999998755432110   001111111  234578999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +.++|.+||+.||.+| |+.|+++.|.++....
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999999 9999999999987643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.7e-37  Score=312.06  Aligned_cols=225  Identities=16%  Similarity=0.288  Sum_probs=176.8

Q ss_pred             CCeEEe-eeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHH-HhCCCCceeEEEEEEEc---CCCc
Q 007429          340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLEL-MTCGHKNILQFYCVCVD---ENHG  408 (604)
Q Consensus       340 ~~y~i~-~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L-~~L~HpnIVkl~g~~~~---~~~~  408 (604)
                      ++|.++ +.||+|+||.||++      +.||+|.+...       ....+|+..+ ..++||||+++++++..   ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            556776 78999999999986      57999999632       2356777776 55699999999999876   2234


Q ss_pred             EEEEEecccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~--~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~  483 (604)
                      +++||||+++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            899999999999999997543  6999999999999999999999999999999999999998   78899999999754


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc--CCCCCCC-
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--GLRPEIP-  560 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~--~~r~~~p-  560 (604)
                      ...                          ..++.++|||||||++|||++|..||...............  ......+ 
T Consensus       170 ~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          170 TTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            321                          12344699999999999999999999875543321111111  0111222 


Q ss_pred             ---CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          561 ---KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       561 ---~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                         ..+++++.++|.+||+.||.+|||+.|+++|-+....
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence               5678999999999999999999999999998776543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.3e-36  Score=341.11  Aligned_cols=235  Identities=19%  Similarity=0.244  Sum_probs=187.1

Q ss_pred             CCCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCc---
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---  408 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~---  408 (604)
                      .++|++.+.||+|+||.||++       +.|+||.+... ........+.+|+.++..++|||||++++++.+.+..   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            478999999999999999985       57999988643 2233445678999999999999999999999876532   


Q ss_pred             -EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          409 -LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       409 -l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       .||||||++|++|.+++..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence             6999999999999998744  79999999999999999999999999999999999999975 8999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC-CCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~-p~~~s~~  566 (604)
                          ....||+.|+|||++.+..     +.++|||||||++|+|++|..||......         ...... ...+++.
T Consensus       235 ----~~~~gt~~y~aPE~~~~~~-----~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~  296 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTGP-----TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDS  296 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHCS-----CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHH
T ss_pred             ----CccCCCccccCHHHHcCCC-----CCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHH
Confidence                4456899999999987642     45799999999999999999888652110         001000 1123578


Q ss_pred             HHHHHHHhhhcCCCCCCC-HHHHHHHHHHh
Q 007429          567 LKSLMIKCWNNSPSKRPQ-FSEIISLLLRT  595 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT-~~ELL~~L~~~  595 (604)
                      +.++|.+||+.||.+||+ ++++.+.|...
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            999999999999999996 55555555543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6e-36  Score=340.91  Aligned_cols=244  Identities=16%  Similarity=0.180  Sum_probs=189.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc-----CCCc
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD-----ENHG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~-----~~~~  408 (604)
                      ++|++.+.||+|+||.||++      +.||+|.++.. ........+.+|+.++..++||||+++++++..     .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            67899999999999999984      57999998743 233445668899999999999999999998755     1334


Q ss_pred             EEEEEecccCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCc---EEEEecCCcc
Q 007429          409 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVT  482 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~---~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~---vKL~DFGla~  482 (604)
                      .++||||+++|+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            789999999999999996543   6899999999999999999999999999999999999997765   9999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHH---------HH-H
Q 007429          483 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG---------IA-A  552 (604)
Q Consensus       483 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~---------i~-~  552 (604)
                      ...... ......||+.|+|||.+.+..++.    ++|||||||++|+|++|..||...........         +. .
T Consensus       173 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~----ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          173 ELDQGE-LCTEFVGTLQYLAPELLEQKKYTV----TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             BTTSCC-CCCCCCSCCTTCSSCSSCCSCCST----THHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccc-ccccccCCcccCChHHhccCCCCc----hhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            665432 234457899999999998765544    59999999999999999999976433221100         00 0


Q ss_pred             c--------CC----CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHH
Q 007429          553 C--------GL----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII  589 (604)
Q Consensus       553 ~--------~~----r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL  589 (604)
                      .        ..    +..++..+++.+.++|.+||+.||.+|||+.+++
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            0        00    0112334678999999999999999999998844

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-36  Score=325.99  Aligned_cols=243  Identities=14%  Similarity=0.122  Sum_probs=177.7

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCC-Cce--------------
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGH-KNI--------------  395 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~H-pnI--------------  395 (604)
                      ..++|.+.+.||+|+||.||+|      +.||||+++...... .....+.+|+.++..++| +|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456889999999999999996      479999987433222 223457889888888876 211              


Q ss_pred             -------eEEEEEEEcC----CCcEEEEEecccCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 007429          396 -------LQFYCVCVDE----NHGLCVVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAY  457 (604)
Q Consensus       396 -------Vkl~g~~~~~----~~~l~LVmEy~~gGSL~dlL~~-------~~~l~~~~il~ia~qIa~gL~YLHs~gIVH  457 (604)
                             ..+..++...    ....+++|+++ +++|.+++..       ...+++..++.++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                   1111111111    12367788876 5699998841       235778889999999999999999999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCCCcccccccccCCC------CCCCCCcchhHHHHHHHHHHH
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP------ESVSETWMSNVYSFGMVIWEM  531 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~------~s~~~t~kSDVWSlGvvLyEL  531 (604)
                      |||||+||||+.++.+||+|||+++.....   .....| +.|+|||++.+..      ....++.++|||||||++|||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999998765432   334456 9999999994221      222345679999999999999


Q ss_pred             HcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          532 VTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       532 lTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ++|+.||...+.......+.      .....+|+.+.+||.+||+.||.+||++.+++++
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999998765433221111      1224678999999999999999999997777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.7e-36  Score=309.58  Aligned_cols=238  Identities=12%  Similarity=0.114  Sum_probs=182.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCC------CchHHHHHHHHHHHHHhCC---------CCceeEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK------GNAYEFELRKDLLELMTCG---------HKNILQFY  399 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~------~~~~~~~~~~Ei~~L~~L~---------HpnIVkl~  399 (604)
                      .++|++++.||+|+||.||+|    +.||+|++.....      .......+.+|+.+++.++         |||||++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            467888999999999999995    6899999986532      1222355778888877764         88888888


Q ss_pred             EEEEc-----------------------------CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 007429          400 CVCVD-----------------------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL  450 (604)
Q Consensus       400 g~~~~-----------------------------~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YL  450 (604)
                      +++..                             ....+|+||||+++|++.+.+.+ +.+++..+..++.||+.||.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            77531                             13349999999999977666633 5789999999999999999999


Q ss_pred             H-hcCceeccCCCCceEEcCCC--------------------cEEEEecCCccccccCCCcccccCCCCcccccccccCC
Q 007429          451 N-DHGVAYRDLNSQRILLDRHG--------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD  509 (604)
Q Consensus       451 H-s~gIVHrDLKp~NILld~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~  509 (604)
                      | ++||+||||||+|||++.++                    .+||+|||+++....     ....||+.|+|||++.+.
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCCC
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcCC
Confidence            9 99999999999999999887                    899999999976543     234789999999999865


Q ss_pred             CCCCCCCcchhHHHHHHH-HHHHHcCCCCCCCCChHHHHH-HHHHc-CCCCC----CCCCccHHHHHHHHHhhhcCCCCC
Q 007429          510 PESVSETWMSNVYSFGMV-IWEMVTGEAAYAACSPVQAAV-GIAAC-GLRPE----IPKDCPQILKSLMIKCWNNSPSKR  582 (604)
Q Consensus       510 ~~s~~~t~kSDVWSlGvv-LyELlTG~~Pf~~~s~~~~~~-~i~~~-~~r~~----~p~~~s~~l~~LI~kCL~~dP~kR  582 (604)
                      .     +.++||||+|++ .+++++|..||.......... .+... .....    .+..+++++.+||.+||+.|    
T Consensus       253 ~-----~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          253 G-----DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             S-----SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             C-----ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            4     456999998776 778888999985432211122 22211 11111    12357889999999999976    


Q ss_pred             CCHHHHH-HHH
Q 007429          583 PQFSEII-SLL  592 (604)
Q Consensus       583 PT~~ELL-~~L  592 (604)
                       |+.|++ +|=
T Consensus       324 -sa~e~l~~Hp  333 (336)
T 2vuw_A          324 -SATDLLCQHS  333 (336)
T ss_dssp             -SHHHHHHHCG
T ss_pred             -CHHHHHhcCC
Confidence             999998 653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=7e-30  Score=286.87  Aligned_cols=180  Identities=11%  Similarity=0.089  Sum_probs=128.3

Q ss_pred             eeeccCceEE------EEeEEEEEEEeecCCCC--------chHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEE
Q 007429          347 QIGPNSFKGV------YKGKRVGIEKLKGCDKG--------NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       347 ~LG~G~FG~V------ykGk~VAIKklk~~~~~--------~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++.|++|.+      |.|+.+++|.+......        .....++.+|+.+|.++ .|+||+++++++.+++. +||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~-~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS-GWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE-EEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE-EEE
Confidence            4455555433      34778999998754211        11234588999999999 79999999999988776 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||++|++|.++|.+.+++++.   +|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999888888765   478899999999999999999999999999999999999999998776554445


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCC
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE  535 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~  535 (604)
                      ...+||+.|||||++.+..     ...+|+||+|++++++.++.
T Consensus       397 ~t~vGTp~YmAPE~l~g~~-----~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAENK-----SWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHHC----------------------CCCCTTH
T ss_pred             cCceechhhccHHHhCCCC-----CCcccccccccchhhhcccc
Confidence            5567999999999998652     23489999999988776543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=4.3e-26  Score=254.55  Aligned_cols=183  Identities=15%  Similarity=0.111  Sum_probs=137.0

Q ss_pred             EeeeeeccCceEEEE----eEEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          344 FIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       344 i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~------~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ..+.||+|+||.||+    ++.+++|+.........      ....+.+|+.++.+++||||+++..++...+. .|+||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KRIMM  418 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cEEEE
Confidence            356899999999996    56789998764322211      12347899999999999999955555555554 79999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc---
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~---  490 (604)
                      ||+++++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++........   
T Consensus       419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            99999999999854        5689999999999999999999999999999998  9999999999876543221   


Q ss_pred             ----ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 007429          491 ----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA  539 (604)
Q Consensus       491 ----~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~  539 (604)
                          .....||+.|||||++.....  .|+..+|+|+...-..+.+.++.+|.
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~--~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLE--GYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHH--HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHH--HHHHHHhHHHHHHHHHHHHHhccccC
Confidence                124468999999999975211  12334799999998888888777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=6.8e-22  Score=202.79  Aligned_cols=143  Identities=12%  Similarity=0.041  Sum_probs=111.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCc----------------hHHHHHHHHHHHHHhCCCCceeE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN----------------AYEFELRKDLLELMTCGHKNILQ  397 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~----------------~~~~~~~~Ei~~L~~L~HpnIVk  397 (604)
                      ...|.+.+.||+|+||.||+|     +.||+|.++......                .....+.+|+.++..++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            345677899999999999985     589999986432111                12445789999999998  4 55


Q ss_pred             EEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEe
Q 007429          398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD  477 (604)
Q Consensus       398 l~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~D  477 (604)
                      +.+++.. +. .|+||||++||+|.+ +..      .....++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus       166 v~~~~~~-~~-~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          166 VPKVYAW-EG-NAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             SCCEEEE-ET-TEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             cCeEEec-cc-eEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            5554433 33 689999999999988 421      23457999999999999999999999999999999 99999999


Q ss_pred             cCCccccccCCCcccccCCCCccccccccc
Q 007429          478 MGIVTACKSVGEATEYETDGYRWLAPEIIA  507 (604)
Q Consensus       478 FGla~~~~~~~~~~~~~~gt~~Y~APE~l~  507 (604)
                      ||+++..             ..++|||.+.
T Consensus       236 FG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             CTTCEET-------------TSTTHHHHHH
T ss_pred             CCCCeEC-------------CCCCHHHHHH
Confidence            9997532             2368899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=2.2e-18  Score=173.86  Aligned_cols=133  Identities=16%  Similarity=0.133  Sum_probs=101.0

Q ss_pred             eEEeeeeeccCceEEEEeE------E--EEEEEeecCCCCc----------------------hHHHHHHHHHHHHHhCC
Q 007429          342 LEFIDQIGPNSFKGVYKGK------R--VGIEKLKGCDKGN----------------------AYEFELRKDLLELMTCG  391 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykGk------~--VAIKklk~~~~~~----------------------~~~~~~~~Ei~~L~~L~  391 (604)
                      |++.+.||+|+||.||+|.      .  ||||.++......                      .....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            6889999999999999864      5  9999875431110                      11235788999999887


Q ss_pred             CCc--eeEEEEEEEcCCCcEEEEEecccC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCC
Q 007429          392 HKN--ILQFYCVCVDENHGLCVVTKLMEG-G----SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQ  463 (604)
Q Consensus       392 Hpn--IVkl~g~~~~~~~~l~LVmEy~~g-G----SL~dlL~~~~~l~~~~il~ia~qIa~gL~YLH-s~gIVHrDLKp~  463 (604)
                      |++  ++..++.    . ..+|||||+.+ |    +|.++...   .++..+..++.||+.||.||| ++||+||||||+
T Consensus       129 ~~~i~~p~~~~~----~-~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----M-KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----E-TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----C-CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            765  3444432    1 26899999943 4    77776532   235567889999999999999 999999999999


Q ss_pred             ceEEcCCCcEEEEecCCcccc
Q 007429          464 RILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       464 NILld~~g~vKL~DFGla~~~  484 (604)
                      |||++.  .++|+|||++...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999998  9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.55  E-value=3e-15  Score=160.62  Aligned_cols=132  Identities=11%  Similarity=0.070  Sum_probs=94.4

Q ss_pred             eEEeeeeeccCceEEEEe-----EEEEEEEeecCCCC--------------ch------HHHHHHHHHHHHHhCCCCce-
Q 007429          342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG--------------NA------YEFELRKDLLELMTCGHKNI-  395 (604)
Q Consensus       342 y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~--------------~~------~~~~~~~Ei~~L~~L~HpnI-  395 (604)
                      |++.+.||.|+||.||+|     +.||||+++.....              ..      ......+|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            799999999999999984     68999987532100              00      00112456666666644433 


Q ss_pred             -eEEEEEEEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC---
Q 007429          396 -LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---  471 (604)
Q Consensus       396 -Vkl~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g---  471 (604)
                       ...++.   ..  .+|||||++|++|..+..      ......++.||+.+|.|||++|||||||||.|||++.+|   
T Consensus       177 vp~p~~~---~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ---SR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE---ET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec---cC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence             233322   12  369999999988865431      123456789999999999999999999999999998877   


Q ss_pred             -------cEEEEecCCcccc
Q 007429          472 -------NVCLGDMGIVTAC  484 (604)
Q Consensus       472 -------~vKL~DFGla~~~  484 (604)
                             .+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.14  E-value=1.5e-10  Score=115.19  Aligned_cols=135  Identities=13%  Similarity=0.116  Sum_probs=103.5

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEe
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      +.|++...+|.|+++.||+.    ..+++|.........  ...+.+|+..+..+ .+.++.++++++.+.+. .|+|||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-~~lv~e   90 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMS   90 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc-eEEEEE
Confidence            45788888899999999984    588999886421111  12367888888877 36778889988877654 899999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND------------------------------------------  452 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs------------------------------------------  452 (604)
                      |++|.+|.+.+.     +......++.+++.+|..||+                                          
T Consensus        91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            999999987631     122234678899999999998                                          


Q ss_pred             -----------------cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 -----------------HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 -----------------~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                                       ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             458999999999999876666799999753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.93  E-value=2.3e-09  Score=105.32  Aligned_cols=128  Identities=13%  Similarity=0.033  Sum_probs=88.8

Q ss_pred             CeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc--eeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN--ILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hpn--IVkl~g~~~~~~~~l~LVm  413 (604)
                      .+.+....+.|..+.||+.     ..+++|......     ...+.+|+..+..+.+.+  +.+++++..+.+. .++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-DWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-EEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-CEEEE
Confidence            3444433346667999984     458888875431     123567777777764433  5668888776654 88999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG---------------------------------------  454 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g---------------------------------------  454 (604)
                      ||++|.+|.  ..   ..+   ...++.+++..|..||+..                                       
T Consensus        95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998884  21   112   1255667777788887643                                       


Q ss_pred             -------------------ceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          455 -------------------VAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       455 -------------------IVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                                         ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               9999999999999877667799999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.86  E-value=5.7e-09  Score=109.14  Aligned_cols=138  Identities=10%  Similarity=0.128  Sum_probs=99.8

Q ss_pred             EeeeeeccCceEEEEe----EEEEEEEee--cCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEcCC--CcEEEEE
Q 007429          344 FIDQIGPNSFKGVYKG----KRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDEN--HGLCVVT  413 (604)
Q Consensus       344 i~~~LG~G~FG~VykG----k~VAIKklk--~~~~~~~~~~~~~~Ei~~L~~L~--HpnIVkl~g~~~~~~--~~l~LVm  413 (604)
                      -++.|+.|.++.||+.    ..+.+|+..  .... ......+.+|..++..+.  +..++++++++.+..  ...|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4677899999999984    456666654  2111 112335678888888775  456888998887652  2268999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-----------------------------------------  452 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-----------------------------------------  452 (604)
                      ||++|..+.+..  -..++......++.+++..|..||+                                         
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999998875421  2346788888999999999999997                                         


Q ss_pred             -----------------cCceeccCCCCceEEcCCCc--EEEEecCCcccc
Q 007429          453 -----------------HGVAYRDLNSQRILLDRHGN--VCLGDMGIVTAC  484 (604)
Q Consensus       453 -----------------~gIVHrDLKp~NILld~~g~--vKL~DFGla~~~  484 (604)
                                       ..++|+|+++.|||++.++.  +.|+||+.+...
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             35899999999999997753  689999997643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.74  E-value=5.5e-09  Score=106.85  Aligned_cols=187  Identities=15%  Similarity=0.107  Sum_probs=117.5

Q ss_pred             eeeeeccCceEEEEe-EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCc--eeEEEEEEEcCC--CcEEEEEecccC
Q 007429          345 IDQIGPNSFKGVYKG-KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKN--ILQFYCVCVDEN--HGLCVVTKLMEG  418 (604)
Q Consensus       345 ~~~LG~G~FG~VykG-k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~Hpn--IVkl~g~~~~~~--~~l~LVmEy~~g  418 (604)
                      ++.++.|....||+. ..+.+|....    ......+.+|...+..+ .+..  +.+.+.......  ..-|+||++++|
T Consensus        25 i~~~~~G~~n~v~~v~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEINRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEESTTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEECCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            345899999999984 4566776542    13345678888888776 3322  445555443332  113789999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 007429          419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND----------------------------------------------  452 (604)
Q Consensus       419 GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs----------------------------------------------  452 (604)
                      .+|.+...  ..++......++.+++..|..||+                                              
T Consensus       101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A          101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            88875432  346777778888888888888885                                              


Q ss_pred             ------------cCceeccCCCCceEEcC--CCcEEEEecCCccccccCCCcccccCCCCcccccccccC--CCCCCC--
Q 007429          453 ------------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG--DPESVS--  514 (604)
Q Consensus       453 ------------~gIVHrDLKp~NILld~--~g~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~~--  514 (604)
                                  ..++|+|++|.||+++.  .+.+.|+||+.+.......+.......... ..|+....  ..|...  
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~-~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEE-YGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTS-CCHHHHHHHHHHHTCSCH
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccc-cCHHHHHHHHHHcCCCCc
Confidence                        13799999999999998  456889999997654321111111000000 12221110  000000  


Q ss_pred             ------CCcchhHHHHHHHHHHHHcCCCCC
Q 007429          515 ------ETWMSNVYSFGMVIWEMVTGEAAY  538 (604)
Q Consensus       515 ------~t~kSDVWSlGvvLyELlTG~~Pf  538 (604)
                            .....+.|++|.++|.+.+|..+|
T Consensus       258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                  012258999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.20  E-value=1.2e-05  Score=82.43  Aligned_cols=134  Identities=16%  Similarity=0.098  Sum_probs=89.0

Q ss_pred             eeeeeccCceEEEE-eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC---ceeEEEEEEEcCCCcEEEEEecccCCC
Q 007429          345 IDQIGPNSFKGVYK-GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK---NILQFYCVCVDENHGLCVVTKLMEGGS  420 (604)
Q Consensus       345 ~~~LG~G~FG~Vyk-Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~Hp---nIVkl~g~~~~~~~~l~LVmEy~~gGS  420 (604)
                      ++.++.|....||+ |..+.+|.-.    .......+.+|...|..+.+.   .|.+.+.++......-++|||+++|.+
T Consensus        24 v~~l~~G~~n~v~~vg~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILVNGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEETTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEECCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            34578888888987 5666677642    122345678999998887542   366777776533333689999999988


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 007429          421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-----------------------------------------------  453 (604)
Q Consensus       421 L~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~-----------------------------------------------  453 (604)
                      |.+...  ..++......++.++...|..||+.                                               
T Consensus       100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A          100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            876321  1234444444555555555555431                                               


Q ss_pred             -------------CceeccCCCCceEEcC---CCc-EEEEecCCcccc
Q 007429          454 -------------GVAYRDLNSQRILLDR---HGN-VCLGDMGIVTAC  484 (604)
Q Consensus       454 -------------gIVHrDLKp~NILld~---~g~-vKL~DFGla~~~  484 (604)
                                   .++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                         3599999999999987   455 489999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.92  E-value=9.8e-05  Score=73.21  Aligned_cols=125  Identities=12%  Similarity=0.100  Sum_probs=83.3

Q ss_pred             eeccCce-EEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcEEEEEecccCC
Q 007429          348 IGPNSFK-GVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGG  419 (604)
Q Consensus       348 LG~G~FG-~Vyk------Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l~LVmEy~~gG  419 (604)
                      +..|..| .||+      +..+.+|.-...     ....+.+|...|..+. +-.|.++++++.+.+. -++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~-~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD-AWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-EEEEEEeeCCc
Confidence            3444444 5786      345677765421     2345678888877662 3347778888887765 78999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 007429          420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH----------------------------------------------  453 (604)
Q Consensus       420 SL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~----------------------------------------------  453 (604)
                      ++.+.....    ......+..++...|.-||+.                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765321    112234445555555555531                                              


Q ss_pred             ------------CceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          454 ------------GVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       454 ------------gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                                  .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        17999999999999987777799999864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.56  E-value=9.5e-05  Score=76.63  Aligned_cols=31  Identities=16%  Similarity=0.168  Sum_probs=25.9

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4689999999999999644578999998643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.39  E-value=0.00099  Score=67.71  Aligned_cols=30  Identities=17%  Similarity=0.303  Sum_probs=27.1

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.36  E-value=0.0005  Score=72.49  Aligned_cols=73  Identities=14%  Similarity=0.096  Sum_probs=43.3

Q ss_pred             EeeeeeccCceEEEEe------EEEEEEEeecCCC----C-chHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCCcE
Q 007429          344 FIDQIGPNSFKGVYKG------KRVGIEKLKGCDK----G-NAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGL  409 (604)
Q Consensus       344 i~~~LG~G~FG~VykG------k~VAIKklk~~~~----~-~~~~~~~~~Ei~~L~~L~---HpnIVkl~g~~~~~~~~l  409 (604)
                      -++.||.|.++.||++      +.+.+|.......    . ......+..|...+..+.   ...+.+++.+  +... .
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~  110 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-A  110 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-T
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-c
Confidence            3567999999999986      3578887542111    0 011123456666666552   2345566654  2333 5


Q ss_pred             EEEEecccCC
Q 007429          410 CVVTKLMEGG  419 (604)
Q Consensus       410 ~LVmEy~~gG  419 (604)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.12  E-value=0.0053  Score=60.65  Aligned_cols=141  Identities=11%  Similarity=0.113  Sum_probs=94.5

Q ss_pred             CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH-hcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccccCCC
Q 007429          420 SVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  497 (604)
Q Consensus       420 SL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLH-s~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~gt  497 (604)
                      ||.++|. .+.++++++++.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|.+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            7999985 4669999999999999999987762 11212344457899999999988764 2110            112


Q ss_pred             CcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhc
Q 007429          498 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  577 (604)
Q Consensus       498 ~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~  577 (604)
                      ..+.|||...     ...+.+.=|||||+++|..+--..                   .+..+..+++.+.+||..|...
T Consensus       101 ~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSS-----SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHHhc
Confidence            2356888753     122345789999999999887332                   3344556788888888888755


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHHhhC
Q 007429          578 -------------------------SPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       578 -------------------------dP~kRPT~~ELL~~L~~~~~  597 (604)
                                               .+..|+++.+|++....-..
T Consensus       157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             CC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             ccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence                                     34688999999988766544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.10  E-value=0.002  Score=68.67  Aligned_cols=82  Identities=9%  Similarity=0.055  Sum_probs=48.3

Q ss_pred             HhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc-CCCCcccccccccCCCCCCCCCcchhHHHHHHHHH
Q 007429          451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  529 (604)
Q Consensus       451 Hs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLy  529 (604)
                      +...++|+|++|.|||++.++ +.|+||+.+.......+..... .-...|++|+........ ......++......+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQEND-RKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCC-SHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccc-hHHHHHHHHHHHHHHH
Confidence            346799999999999998777 9999999876543211111100 011346666655321111 1112345557777888


Q ss_pred             HHHcC
Q 007429          530 EMVTG  534 (604)
Q Consensus       530 ELlTG  534 (604)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.85  E-value=0.0061  Score=61.70  Aligned_cols=29  Identities=14%  Similarity=0.063  Sum_probs=24.7

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3899999999999 5677789999998654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.62  E-value=0.012  Score=60.85  Aligned_cols=73  Identities=10%  Similarity=0.132  Sum_probs=52.3

Q ss_pred             EEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCCcEEEEEec
Q 007429          343 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTKL  415 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L---~HpnIVkl~g~~~~~~~~l~LVmEy  415 (604)
                      .-++.|+.|....+|+.    ..+.+|.....     ....+..|...|..|   ....+++.++++...+. .++||||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~-~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH-SFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE-EEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc-eEEEEEe
Confidence            34577899999999983    46777776532     134467777776665   23678888888776654 7899999


Q ss_pred             ccCCCH
Q 007429          416 MEGGSV  421 (604)
Q Consensus       416 ~~gGSL  421 (604)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.63  E-value=0.066  Score=54.62  Aligned_cols=32  Identities=19%  Similarity=0.103  Sum_probs=27.4

Q ss_pred             cCceeccCCCCceEEcCC----CcEEEEecCCcccc
Q 007429          453 HGVAYRDLNSQRILLDRH----GNVCLGDMGIVTAC  484 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~----g~vKL~DFGla~~~  484 (604)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    67999999987654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.33  E-value=0.14  Score=51.14  Aligned_cols=75  Identities=12%  Similarity=0.093  Sum_probs=49.3

Q ss_pred             CCeEEeeeeeccCceEEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC---CceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk-----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H---pnIVkl~g~~~~~~~~l~L  411 (604)
                      ..+.-++.+|.|..+.||+     |+.+.+|+........  ...+..|...|..|.-   -.+++.+++.  .   -++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~---~~l   87 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D---RTL   87 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T---TEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc--C---ceE
Confidence            4456688999999999998     6788888765332221  2235677777776622   2355566542  2   368


Q ss_pred             EEecccCCCH
Q 007429          412 VTKLMEGGSV  421 (604)
Q Consensus       412 VmEy~~gGSL  421 (604)
                      ||||+.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.02  E-value=0.083  Score=53.50  Aligned_cols=29  Identities=14%  Similarity=-0.007  Sum_probs=24.9

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999999 4 899999988654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.43  E-value=0.13  Score=55.11  Aligned_cols=68  Identities=9%  Similarity=0.025  Sum_probs=40.0

Q ss_pred             EeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCCcE
Q 007429          344 FIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGL  409 (604)
Q Consensus       344 i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~~~l  409 (604)
                      -++.|+.|....||+..             .+.+|+....  ..  ...+..|...+..+. +.-.+++++.+.  +   
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G---  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---
Confidence            35678888889999843             4556665321  11  123446777666652 222356776552  2   


Q ss_pred             EEEEecccCCC
Q 007429          410 CVVTKLMEGGS  420 (604)
Q Consensus       410 ~LVmEy~~gGS  420 (604)
                      .+|+||++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            27999998644

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=93.88  E-value=0.064  Score=56.90  Aligned_cols=30  Identities=20%  Similarity=0.191  Sum_probs=26.4

Q ss_pred             CceeccCCCCceEEcCC----CcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRH----GNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~----g~vKL~DFGla~~  483 (604)
                      .++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            58999999999999876    7899999998643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=88.35  E-value=0.18  Score=50.76  Aligned_cols=40  Identities=20%  Similarity=0.209  Sum_probs=30.6

Q ss_pred             HHHHHHHHHh-------cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          443 VAEGIKFLND-------HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       443 Ia~gL~YLHs-------~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      +...++++++       .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3445555552       369999999999999977666899998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=81.56  E-value=0.85  Score=46.92  Aligned_cols=32  Identities=9%  Similarity=0.129  Sum_probs=27.7

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36999999999999998888999999886543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=81.32  E-value=1.1  Score=46.10  Aligned_cols=29  Identities=17%  Similarity=0.096  Sum_probs=24.2

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999998655 89999988653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	604
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-41
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-41
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-39
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-37
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-24
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-52
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 13/268 (4%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
           W +    +    +IG  SF  VYKGK    V ++ L             + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 450
           H NIL F          L +VT+  EG S+   +     K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEIIAG 508
           +   + +RDL S  I L     V +GD G+ T       + ++E       W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----PEIPKDCP 564
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G       ++  +CP
Sbjct: 181 QDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISLL 592
           + +K LM +C      +RP F +I++ +
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASI 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-49
 Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 19/272 (6%)

Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           W LN   L+ +  IG   F     G Y+G +V ++ +K      A+  E       +   
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASV----MTQL 57

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
            H N++Q   V V+E  GL +VT+ M  GS+ D +    +  L    +++ ++DV E ++
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +L  +   +RDL ++ +L+       + D G+    K      +      +W APE +  
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALRE 174

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              S      S+V+SFG+++WE+ +         P++  V     G + + P  CP  + 
Sbjct: 175 KKFSTK----SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230

Query: 569 SLMIKCWNNSPSKRPQFSEIISLL--LRTNNI 598
            +M  CW+   + RP F ++   L  ++T+ +
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-48
 Identities = 63/264 (23%), Positives = 115/264 (43%), Gaps = 11/264 (4%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCG 391
            W +  + L+ ++++G   F  V+ G   G  K  +K   +G+        +   +    
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKF 449
           H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +AEG+ F
Sbjct: 67  HQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAG 508
           + +    +RDL +  IL+    +  + D G+    +              +W APE I  
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 568
              ++     S+V+SFG+++ E+VT              +     G R   P +CP+ L 
Sbjct: 185 GTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240

Query: 569 SLMIKCWNNSPSKRPQFSEIISLL 592
            LM  CW   P  RP F  + S+L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 9/261 (3%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFLND 452
            ++Q Y VC+++   +C+V + ME G ++D +   R L   + ++ + +DV EG+ +L +
Sbjct: 61  KLVQLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPE 511
             V +RDL ++  L+  +  + + D G+          +   T    +W +PE+ +    
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           S      S+V+SFG+++WE+ +              V   + G R   P+     +  +M
Sbjct: 180 SSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235

Query: 572 IKCWNNSPSKRPQFSEIISLL 592
             CW   P  RP FS ++  L
Sbjct: 236 NHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-46
 Identities = 62/262 (23%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 394
           ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M   H+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           ++Q Y VC  +   + ++T+ M  G + + +     + QT++++ +  DV E +++L   
Sbjct: 61  LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPES 512
              +RDL ++  L++  G V + D G+          +   +    RW  PE++     S
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 513 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
                 S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + + ++M
Sbjct: 180 SK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 234

Query: 572 IKCWNNSPSKRPQFSEIISLLL 593
             CW+    +RP F  ++S +L
Sbjct: 235 YSCWHEKADERPTFKILLSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-46
 Identities = 56/297 (18%), Positives = 108/297 (36%), Gaps = 44/297 (14%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL------------KGCDKGNAYEFELR 381
           +W    +NLEF   +G  +F  V      GI K             +  D          
Sbjct: 31  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90

Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------- 430
             ++  +   H+NI+     C      + ++ +    G + + +   R+           
Sbjct: 91  LKMMTQLG-SHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 431 ------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
                       L  ++++  A  VA+G++FL      +RDL ++ +L+     V + D 
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208

Query: 479 GIVTACKSVGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 535
           G+     S              +W+APE +     ++     S+V+S+G+++WE+ + G 
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----SDVWSYGILLWEIFSLGV 264

Query: 536 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
             Y           +   G + + P    + +  +M  CW     KRP F  + S L
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 7e-46
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 8/268 (2%)

Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFE-LRKDLL 385
           E + R L   D  E I ++G  +F  VYK +          K  D  +  E E    ++ 
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 62  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 505 IIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKD 562
           ++  +        + ++V+S G+ + EM   E  +   +P++  + IA         P  
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240

Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                K  + KC   +   R   S+++ 
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-45
 Identities = 52/264 (19%), Positives = 101/264 (38%), Gaps = 18/264 (6%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---- 386
           +W L  ++ E    +G   F  VY  +    +    LK   K    +  +   L      
Sbjct: 2   QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
                H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  
Sbjct: 60  QSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           + + +   V +RD+  + +LL   G + + D G      S    T   T  Y  L PE+I
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY--LPPEMI 176

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 566
            G           +++S G++ +E + G+  + A +  +    I+        P    + 
Sbjct: 177 EGRMHDEK----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEG 230

Query: 567 LKSLMIKCWNNSPSKRPQFSEIIS 590
            + L+ +   ++PS+RP   E++ 
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLE 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-45
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 24/274 (8%)

Query: 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 383
           +  L  DNL   D ++G  +F  V +G          V I+ LK G +K +  E      
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 442
           ++      +  I++   VC  +   L +V ++  GG ++  ++  R+ +    +  +   
Sbjct: 62  IM--HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YR 499
           V+ G+K+L +    +RDL ++ +LL       + D G+  A  +        + G    +
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 558
           W APE I     S      S+V+S+G+ +WE ++ G+  Y      +    I   G R E
Sbjct: 178 WYAPECINFRKFSSR----SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRME 232

Query: 559 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            P +CP  L +LM  CW      RP F  +   +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 21/266 (7%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
           ++ E +  IG  S+    K +R    K    K  D G+  E E +  + E   L    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 394 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIK 448
           NI+++Y   +D  +  L +V +  EGG +  +I K  K    L  + ++R+   +   +K
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 449 FL-----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
                    H V +RDL    + LD   NV LGD G+           +       +++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           E +     +      S+++S G +++E+      + A S  + A  I   G    IP   
Sbjct: 184 EQMNRMSYNEK----SDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRY 238

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEII 589
              L  ++ +  N     RP   EI+
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEIL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-44
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 23/273 (8%)

Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKD 383
           + R LL  ++ E    +G  +F  V KG        K V ++ LK      A + EL  +
Sbjct: 3   LDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58

Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
              +    +  I++   +C  E+    +V ++ E G +N  + ++R ++ K II +   V
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116

Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRW 500
           + G+K+L +    +RDL ++ +LL       + D G+  A ++     + +T G    +W
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 559
            APE I     S      S+V+SFG+++WE  + G+  Y      +    +   G R   
Sbjct: 177 YAPECINYYKFSSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGC 231

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P  CP+ +  LM  CW      RP F+ +   L
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 8e-44
 Identities = 54/255 (21%), Positives = 99/255 (38%), Gaps = 13/255 (5%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 395
             + +IG  SF  VY  + V   +   +K          E  +D+++    L    H N 
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
           +Q+    + E+    +V +   G + + L +  + LQ  EI  +     +G+ +L+ H +
Sbjct: 78  IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE 515
            +RD+ +  ILL   G V LGD G       +  A  +      W+APE+I    E    
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANSFVGT-PYWMAPEVILAMDEGQY- 191

Query: 516 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 575
               +V+S G+   E+   +      + + A   IA             +  ++ +  C 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 576 NNSPSKRPQFSEIIS 590
              P  RP    ++ 
Sbjct: 252 QKIPQDRPTSEVLLK 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 9e-44
 Identities = 55/263 (20%), Positives = 106/263 (40%), Gaps = 11/263 (4%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGH 392
           W +  ++L    ++G   F  V+ G   G  +  +K    G        ++   +    H
Sbjct: 12  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 71

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--KEIIRIAIDVAEGIKFL 450
           + ++Q Y V       + +VT+ M  GS+ D +           +++ +A  +A G+ ++
Sbjct: 72  EKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGD 509
                 +RDL +  IL+  +    + D G+    +              +W APE     
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
             ++     S+V+SFG+++ E+ T           +  +     G R   P +CP+ L  
Sbjct: 190 RFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 570 LMIKCWNNSPSKRPQFSEIISLL 592
           LM +CW   P +RP F  + + L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFL 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-43
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 39/302 (12%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKD 383
           +W    + L F   +G  +F  V +    G+ K                       L  +
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 384 LLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------- 429
           L  L   G H NI+     C        V+T+    G + + + + R             
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                 L  ++++  +  VA+G+ FL      +RDL ++ ILL       + D G+    
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 485 KSVGEATEYETDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 541
           K+              +W+APE I         T+ S+V+S+G+ +WE+ + G + Y   
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVY----TFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 542 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 601
                   +   G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISES 309

Query: 602 SN 603
           +N
Sbjct: 310 TN 311

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 21/274 (7%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
           L+   +L  ++++G  SF  V +G+      +     +K        + E   D +    
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
            + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ VA
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWL 501
           EG+ +L      +RDL ++ +LL     V +GD G++ A     +    +      + W 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 502 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 560
           APE +     S +    S+ + FG+ +WEM T G+  +   +  Q    I   G R   P
Sbjct: 182 APESLKTRTFSHA----SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
           +DCPQ + ++M++CW + P  RP F  +   LL 
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 58/276 (21%), Positives = 119/276 (43%), Gaps = 14/276 (5%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTC 390
           +W +   ++    ++G   +  VY+G          +K   +      E  K+   +   
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
            H N++Q   VC  E     ++T+ M  G++ D + +  +  +    ++ +A  ++  ++
Sbjct: 71  KHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIA 507
           +L      +RDL ++  L+  +  V + D G+                   +W APE +A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 567
            +  S+     S+V++FG+++WE+ T   +      +     +     R E P+ CP+ +
Sbjct: 190 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245

Query: 568 KSLMIKCWNNSPSKRPQFSEIISLL---LRTNNISN 600
             LM  CW  +PS RP F+EI        + ++IS+
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 3e-41
 Identities = 61/274 (22%), Positives = 122/274 (44%), Gaps = 24/274 (8%)

Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLL 385
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 63

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVA 444
            + +  + ++ +   +C+     + ++T+LM  G + D + + +     + ++   + +A
Sbjct: 64  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
           +G+ +L D  + +RDL ++ +L+    +V + D G+  A     E  EY  +G     +W
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL--AKLLGAEEKEYHAEGGKVPIKW 179

Query: 501 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 560
           +A E I     +      S+V+S+G+ +WE++T  +      P      I   G R   P
Sbjct: 180 MALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             C   +  +M+KCW      RP+F E+I    +
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-41
 Identities = 48/259 (18%), Positives = 99/259 (38%), Gaps = 12/259 (4%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEF--ELRKDLLELMTCGHKN 394
           ++ + +  +G  ++  V        E+   +K  D   A +    ++K++       H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           +++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+  G
Sbjct: 65  VVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEIIAGDPES 512
           + +RD+  + +LLD   N+ + D G+ T  +                ++APE++      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKDCPQILKSLM 571
                  +V+S G+V+  M+ GE  +   S   Q               K       +L+
Sbjct: 184 ---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 572 IKCWNNSPSKRPQFSEIIS 590
            K    +PS R    +I  
Sbjct: 241 HKILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 6e-41
 Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 34/289 (11%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYK-----------GKRVGIEKLKGCDKGNAYEFELRK 382
           +W    D L+    +G  +F  V +            + V ++ LK     + +   + +
Sbjct: 7   KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
             + +    H N++     C      L V+ +  + G+++  +   R             
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+      
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 487 VGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA-YAACSP 543
             +           +W+APE I     ++     S+V+SFG+++WE+ +  A+ Y     
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 544 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
            +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-41
 Identities = 54/257 (21%), Positives = 108/257 (42%), Gaps = 11/257 (4%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELM-TCGHKN 394
                  ++IG  +   VY    V   +   ++  +     + EL  + + +M    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I+ +    +  +  L VV + + GGS+ D++ ++      +I  +  +  + ++FL+ + 
Sbjct: 79  IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ 136

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           V +RD+ S  ILL   G+V L D G                    W+APE++        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKSLMIK 573
                +++S G++  EM+ GE  Y   +P++A   IA  G    + P+    I +  + +
Sbjct: 197 ----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 574 CWNNSPSKRPQFSEIIS 590
           C +    KR    E++ 
Sbjct: 253 CLDMDVEKRGSAKELLQ 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 9e-41
 Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 21/279 (7%)

Query: 330 EEIGRWLLNSDNLE--FIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF 378
           + +   ++   +L   F + IG   F  VY G             ++ L           
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS- 73

Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEII 437
           +   + + +    H N+L    +C+       VV   M+ G + + I  ++     K++I
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133

Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
              + VA+G+KFL      +RDL ++  +LD    V + D G+          + +   G
Sbjct: 134 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 498 YR----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
            +    W+A E +     +      S+V+SFG+++WE++T  A                 
Sbjct: 194 AKLPVKWMALESLQTQKFTTK----SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           G R   P+ CP  L  +M+KCW+     RP FSE++S +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 40/260 (15%), Positives = 95/260 (36%), Gaps = 16/260 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
           ++ +F   +G  SF  V   + +   +   +K  +K +  +      +      +    H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
              ++ Y    D+   L       + G +   I K              ++   +++L+ 
Sbjct: 68  PFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDP 510
            G+ +RDL  + ILL+   ++ + D G         +     +     ++++PE++    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 570
              S    S++++ G +I+++V G   + A +       I       + P+      + L
Sbjct: 187 ACKS----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDL 240

Query: 571 MIKCWNNSPSKRPQFSEIIS 590
           + K      +KR    E+  
Sbjct: 241 VEKLLVLDATKRLGCEEMEG 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-40
 Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 39/292 (13%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
           +  +   + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL 
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 398 FYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL---- 450
           F      +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L    
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 451 ----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLA 502
                   +A+RDL S+ IL+ ++G  C+ D+G+     S  +  +   +      R++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 503 PEIIAGDPESVSE--TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------------ 548
           PE++              +++Y+ G+V WE+    +        Q               
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 549 ---GIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
               +    LRP IP      +  +++  +M +CW  + + R     I   L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  147 bits (372), Expect = 5e-40
 Identities = 40/262 (15%), Positives = 106/262 (40%), Gaps = 19/262 (7%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           D  + ++++G  +F  V++      G+    + +      + Y  +    ++      H 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN--QLHHP 86

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 452
            ++  +    D+   + ++ + + GG + D I     K+   E+I       EG+K +++
Sbjct: 87  KLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 453 HGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 510
           H + + D+  + I+ +  +  +V + D G+ T      E  +  T    + APEI+  +P
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREP 204

Query: 511 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK 568
                 + +++++ G++ + +++G + +A    ++    +  C      +         K
Sbjct: 205 ----VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
             +       P KR    + + 
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALE 282

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-40
 Identities = 64/283 (22%), Positives = 122/283 (43%), Gaps = 32/283 (11%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLK-GCDKGNAYEFELRKDLLEL 387
           L+ ++++F D IG  +F  V K +           I+++K    K +  +F    ++L  
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKL 431
           +   H NI+     C    + L +  +    G++ D + KS                  L
Sbjct: 67  L-GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
            +++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+    +   + T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 551
                  RW+A E +     + +    S+V+S+G+++WE+V+                  
Sbjct: 185 MGRL-PVRWMAIESLNYSVYTTN----SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239

Query: 552 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 594
             G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-40
 Identities = 55/258 (21%), Positives = 104/258 (40%), Gaps = 15/258 (5%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG 391
           ++      +G  SF  V+        +   I+ LK       +  E  + +  +  +   
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
           H  +   +C    + + L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 62  HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
             G+ YRDL    ILLD+ G++ + D G+          T        ++APEI+ G   
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
           + S     + +SFG++++EM+ G++ +      +    I      P  P+   +  K L+
Sbjct: 181 NHS----VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 234

Query: 572 IKCWNNSPSKRPQFSEII 589
           +K +   P KR      I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 20/270 (7%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLE 386
           ++   +     IG   F  VYKG            V I+ LK          +   +   
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGI 62

Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAE 445
           +    H NI++   V       + ++T+ ME G+++  + +        +++ +   +A 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLA 502
           G+K+L +    +RDL ++ IL++ +    + D G+    +   EAT   + G    RW A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 503 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 562
           PE I+        T  S+V+SFG+V+WE++T              +     G R   P D
Sbjct: 182 PEAISYRKF----TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           CP  +  LM++CW    ++RP+F++I+S+L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  143 bits (361), Expect = 2e-39
 Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 20/269 (7%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT---- 389
           +N E  + +G      V +       K   ++ +     G+    E+++     +     
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 390 ----CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
                GH NI+Q             +V  LM+ G + D + +   L  KE  +I   + E
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 505
            I  L+   + +RDL  + ILLD   N+ L D G         +  E       +LAPEI
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEI 180

Query: 506 IAGDPESVSE--TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 561
           I               +++S G++++ ++ G   +     +     I +   +   P   
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
           D    +K L+ +     P KR    E ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 37/264 (14%), Positives = 101/264 (38%), Gaps = 23/264 (8%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           D+ +  +++G  +F  V++      G     + +    + +      RK++  +    H 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMSVLRHP 83

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 452
            ++  +    D+N  + ++ + M GG + + +     K+   E +     V +G+  +++
Sbjct: 84  TLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 453 HGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEIIAG 508
           +   + DL  + I+    R   + L D G+      +      +       + APE+  G
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQI 566
            P        ++++S G++ + +++G + +   +  +    + +C             + 
Sbjct: 200 KPVGYY----TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 567 LKSLMIKCWNNSPSKRPQFSEIIS 590
            K  + K     P+ R    + + 
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-39
 Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 18/269 (6%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLL 385
           + +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60

Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVA 444
            +    H +I++   V  +  + + ++ +L   G +   +      L    +I  A  ++
Sbjct: 61  TMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 503
             + +L      +RD+ ++ +L+  +  V LGD G+    +        +     +W+AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 504 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 563
           E I         T  S+V+ FG+ +WE++               +G    G R  +P +C
Sbjct: 179 ESINFRRF----TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

Query: 564 PQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           P  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (360), Expect = 4e-39
 Identities = 57/275 (20%), Positives = 108/275 (39%), Gaps = 20/275 (7%)

Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCG 391
           SD  E  + +G      V+  + + + +   +K      A +                  
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 392 HKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           H  I+  Y     E        +V + ++G ++ D++     +  K  I +  D  + + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEI 505
           F + +G+ +RD+    I++     V + D GI  A    G +           ++L+PE 
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC 563
             GD         S+VYS G V++E++TGE  +   SPV  A         P     +  
Sbjct: 186 ARGDSV----DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 564 PQILKSLMIKCWNNSPSKRPQ-FSEIISLLLRTNN 597
              L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 15/268 (5%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
           ++   ++    IG   F  V  G           V I+ LK          +   +   +
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIM 81

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEG 446
               H N++    V       + ++T+ ME GS++  + ++    T  +++ +   +A G
Sbjct: 82  GQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 506
           +K+L D    +RDL ++ IL++ +    + D G+    +       Y +     +     
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 507 AGDPESVSETW-MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 564
           A +     +    S+V+S+G+V+WE+++ GE  Y   +       I     R   P DCP
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCP 259

Query: 565 QILKSLMIKCWNNSPSKRPQFSEIISLL 592
             L  LM+ CW    + RP+F +I++ L
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 31/282 (10%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKD 383
           W +  + +    ++G  SF  VY+G            RV I+ +           E   +
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNE 73

Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQT 433
              +      ++++   V         V+ +LM  G +   +   R              
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
            ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+           + 
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 494 ETD--GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGI 550
                  RW++PE +         T  S+V+SFG+V+WE+ T  E  Y   S  Q    +
Sbjct: 193 GKGLLPVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
              G   + P +CP +L  LM  CW  +P  RP F EIIS +
Sbjct: 249 ME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (355), Expect = 3e-38
 Identities = 58/294 (19%), Positives = 116/294 (39%), Gaps = 41/294 (13%)

Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKDL 384
                +N+E++  IG  +F  V++ +  G+   +            +     + + +++ 
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67

Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------- 430
             +    + NI++   VC      +C++ + M  G +N+ +                   
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 431 ----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
                     L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 481 VTACKSVGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 538
                S         D    RW+ PE I  +  +      S+V+++G+V+WE+ +     
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE----SDVWAYGVVLWEIFSYGLQP 242

Query: 539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
                 +  +     G     P++CP  L +LM  CW+  P+ RP F  I  +L
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 36/290 (12%)

Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
           RW L  D L     +G  +F  V   + +G++K K            K +A E +L   +
Sbjct: 7   RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
            E+    M   HKNI+     C  +   L V+ +    G++ + +   R           
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
                +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 485 KSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 542
             +     T       +W+APE +     +      S+V+SFG+++WE+ T   +     
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ----SDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 543 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-37
 Identities = 60/262 (22%), Positives = 113/262 (43%), Gaps = 20/262 (7%)

Query: 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
           L+F  +IG  SFK VYKG        V   +L+      +     +++   L    H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 396 LQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
           ++FY        G   + +VT+LM  G++   + + + ++ K +      + +G++FL+ 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 453 HG--VAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
               + +RDL    I +    G+V +GD+G+ T  ++        T    ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT--PEFMAPEMYEEK 188

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILK 568
                     +VY+FGM + EM T E  Y+ C            G++P    K     +K
Sbjct: 189 Y-----DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 569 SLMIKCWNNSPSKRPQFSEIIS 590
            ++  C   +  +R    ++++
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLN 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 6e-36
 Identities = 54/304 (17%), Positives = 117/304 (38%), Gaps = 59/304 (19%)

Query: 337 LNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
           L  D+ E I ++G  +   V+K      G  +  + +   +   A   ++ ++L  L  C
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHEC 61

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
               I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L
Sbjct: 62  NSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 451 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-WLAPEIIAG 508
              H + +RD+    IL++  G + L D G+      + ++      G R +++PE + G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG 177

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDC--- 563
              SV     S+++S G+ + EM  G           ++   G    G   E P      
Sbjct: 178 THYSVQ----SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 564 -------------------------------------PQILKSLMIKCWNNSPSKRPQFS 586
                                                    +  + KC   +P++R    
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 587 EIIS 590
           +++ 
Sbjct: 294 QLMV 297

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-36
 Identities = 43/268 (16%), Positives = 107/268 (39%), Gaps = 22/268 (8%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LM 388
            D  +  +++G   F  V K      G +   + +K     ++     R+D+      L 
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
              H N++  + V  ++   + ++ +L+ GG + D + +   L  +E       +  G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127

Query: 449 FLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
           +L+   +A+ DL  + I+L         + + D G+       G   +       ++APE
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPE 186

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPKD 562
           I+  +P  +     ++++S G++ + +++G + +   +  +    ++A       E   +
Sbjct: 187 IVNYEPLGL----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 563 CPQILKSLMIKCWNNSPSKRPQFSEIIS 590
              + K  + +     P KR    + + 
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (336), Expect = 1e-35
 Identities = 51/263 (19%), Positives = 101/263 (38%), Gaps = 18/263 (6%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
            D  +F D +G  +F  V         K V I+ +         E  +  ++  L    H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKH 66

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
            NI+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D
Sbjct: 67  PNIVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 453 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
            G+ +RDL  + +L    D    + + D G+       G           ++APE++A  
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQK 184

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQIL 567
           P S +     + +S G++ + ++ G   +   +  +    I       + P   D     
Sbjct: 185 PYSKA----VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 568 KSLMIKCWNNSPSKRPQFSEIIS 590
           K  +       P KR    + + 
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 45/257 (17%), Positives = 96/257 (37%), Gaps = 14/257 (5%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +     + +G   F  V++      +K    K        +  ++K++  L    H+NIL
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGV 455
             +         L ++ + + G  + + I  S  +L  +EI+     V E ++FL+ H +
Sbjct: 65  HLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 456 AYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
            + D+  + I+    R   + + + G     K         T    + APE+   D  S 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT-APEYYAPEVHQHDVVST 182

Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILKSLM 571
           +    ++++S G +++ +++G   + A +  Q    I         E  K+        +
Sbjct: 183 A----TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 572 IKCWNNSPSKRPQFSEI 588
            +        R   SE 
Sbjct: 239 DRLLVKERKSRMTASEA 255

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-34
 Identities = 48/261 (18%), Positives = 94/261 (36%), Gaps = 26/261 (9%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTC 390
           +    +G   F  VY          V I+ ++        +  N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 451 NDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           ++ GV +RD+  + IL+D + G + L D G     K         T  Y    PE I   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY--SPPEWIRYH 184

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 569
                    + V+S G+++++MV G+  +     +           +    +      + 
Sbjct: 185 R---YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQH 233

Query: 570 LMIKCWNNSPSKRPQFSEIIS 590
           L+  C    PS RP F EI +
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (327), Expect = 3e-34
 Identities = 51/252 (20%), Positives = 107/252 (42%), Gaps = 17/252 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
            + + +  +G  SF  V+  +     +   +K   K      +  +   +    L    H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
             I++ +    D    + ++   +EGG +  L+ KS++         A +V   +++L+ 
Sbjct: 64  PFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
             + YRDL  + ILLD++G++ + D G     K V + T        ++APE+++  P +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
            S     + +SFG++I+EM+ G   +   + ++    I         P    + +K L+ 
Sbjct: 180 KS----IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 233

Query: 573 KCWNNSPSKRPQ 584
           +      S+R  
Sbjct: 234 RLITRDLSQRLG 245

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  131 bits (330), Expect = 3e-34
 Identities = 46/255 (18%), Positives = 101/255 (39%), Gaps = 17/255 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELM-T 389
           ++      IG   F  VY  ++           ++K +   K         + +L L+ T
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
                I+         +  L  +  LM GG ++  + +       ++   A ++  G++ 
Sbjct: 64  GDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 509
           +++  V YRDL    ILLD HG+V + D+G+  AC    +        + ++APE++   
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 510 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILK 568
                    ++ +S G ++++++ G + +       +  +      +  E+P      L+
Sbjct: 181 VAY---DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237

Query: 569 SLMIKCWNNSPSKRP 583
           SL+        ++R 
Sbjct: 238 SLLEGLLQRDVNRRL 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (315), Expect = 8e-33
 Identities = 36/272 (13%), Positives = 80/272 (29%), Gaps = 24/272 (8%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           +      +IG  SF  +Y G  +   +   +K       +  +L  +            +
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGI 65

Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
                C  E     +V +L+     +     SRK   K ++ +A  +   I++++     
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 457 YRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGEATEYETDG-------YRWLAPEII 506
           +RD+     L     +   V + D G+    +                    R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIP 560
            G  +    +   ++ S G V+     G   +                 +        + 
Sbjct: 186 LGIEQ----SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 592
           K  P    + +  C +     +P +S +  L 
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 40/283 (14%), Positives = 86/283 (30%), Gaps = 29/283 (10%)

Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
           +   +IG  SF  +++G  +   +   +K   + +    +LR +            +   
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNV 66

Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
                E     +V  L+     + L L  RK   K +   A  +   ++ +++  + YRD
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126

Query: 460 LNSQRILLDR-----HGNVCLGDMGIVTACKSVGEATEYETDGY-------RWLAPEIIA 507
           +     L+ R        + + D G+V   +                    R+++     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIPK 561
           G  +S       ++ + G V    + G   +               G +       E+  
Sbjct: 187 GREQSRR----DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL---LRTNNISNS 601
             P+     M    N +    P +  +  L    L   N +  
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 42/271 (15%), Positives = 103/271 (38%), Gaps = 30/271 (11%)

Query: 340 DNLEFIDQ-IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
           D+ +   Q +G      V +       ++  ++ L+ C K    E EL     +      
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQ-----C 64

Query: 393 KNILQFYCVCVD---ENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 447
            +I++   V  +       L +V + ++GG +   I     +    +E   I   + E I
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEI 505
           ++L+   +A+RD+  + +L        +  +      K         T  Y   ++APE+
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184

Query: 506 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI------ 559
           +  +    S     +++S G++++ ++ G   + +   +  + G+       +       
Sbjct: 185 LGPEKYDKS----CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
             +  + +K L+       P++R   +E ++
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 6e-32
 Identities = 42/251 (16%), Positives = 91/251 (36%), Gaps = 14/251 (5%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
           ++ +++  +G  +F  V   +     +   +K   K      +     +     L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
             +          +  LC V +   GG +   + + R    +       ++   +++L+ 
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
             V YRD+  + ++LD+ G++ + D G+     S G   +       +LAPE++  +   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
            +  W       G+V++EM+ G   +      +    I         P+      KSL+ 
Sbjct: 184 RAVDWW----GLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLA 237

Query: 573 KCWNNSPSKRP 583
                 P +R 
Sbjct: 238 GLLKKDPKQRL 248

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-31
 Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 38/285 (13%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
           +N + +++IG  ++  VYK      G+ V ++K++   +         +++  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLND 452
           NI++   V   EN  L +V + +       +   +   +    I      + +G+ F + 
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
           H V +RDL  Q +L++  G + L D G+  A         +E     + APEI+ G    
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY- 179

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------- 557
              +   +++S G +  EMVT  A +   S +     I      P               
Sbjct: 180 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 558 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                       ++     +  +SL+ +  +  P+KR      ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 46/259 (17%), Positives = 106/259 (40%), Gaps = 18/259 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVG------------IEKLKGCDKGNAYEFELRKDLLEL 387
           +N E +  +G  ++  V+  +++             ++K     K    E    +  +  
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
                  ++  +     E   L ++   + GG +   + +  +    E+     ++   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEII 506
           + L+  G+ YRD+  + ILLD +G+V L D G+     +      Y+  G   ++AP+I+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 507 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCP 564
            G      +    + +S G++++E++TG + +       +   I+   L+  P  P++  
Sbjct: 203 RGGDSGHDKA--VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 565 QILKSLMIKCWNNSPSKRP 583
            + K L+ +     P KR 
Sbjct: 261 ALAKDLIQRLLMKDPKKRL 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-30
 Identities = 54/282 (19%), Positives = 101/282 (35%), Gaps = 39/282 (13%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCGHK 393
           E +D +G   F  VYK       + V I+K+K   +  A +   R  L E   L    H 
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI+        +++ + +V   ME      +   S  L    I    +   +G+++L+ H
Sbjct: 61  NIIGLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
            + +RDL    +LLD +G + L D G+  +  S   A  ++     + APE++ G     
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM-- 177

Query: 514 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------- 557
                 ++++ G ++ E++         S +     I      P                
Sbjct: 178 -YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 558 ----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 589
                      I       L  L+   +  +P  R   ++ +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (290), Expect = 2e-29
 Identities = 49/283 (17%), Positives = 104/283 (36%), Gaps = 36/283 (12%)

Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
           +    +++IG  ++  VYK     G+   ++K++   +         +++  L    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
           I++ Y V   +   L +V + ++      L +    L++       + +  GI + +D  
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 514
           V +RDL  Q +L++R G + + D G+  A         +E     + AP+++ G  +   
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK--- 177

Query: 515 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------------- 557
            +   +++S G +  EMV G   +   S     + I      P                 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 558 ----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                        K   +    L+ K     P++R    + + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 8e-28
 Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 17/252 (6%)

Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
           D  + I  +G  SF  V   K         +K  DK    + +  +  L     L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
             +++      D ++ L +V + + GG +   + +  +         A  +    ++L+ 
Sbjct: 101 PFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
             + YRDL  + +L+D+ G + + D G     K               LAPEII     +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILSKGYN 216

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
            +     + ++ G++I+EM  G   + A  P+Q    I +   +   P      LK L+ 
Sbjct: 217 KA----VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR 270

Query: 573 KCWNNSPSKRPQ 584
                  +KR  
Sbjct: 271 NLLQVDLTKRFG 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-26
 Identities = 44/288 (15%), Positives = 97/288 (33%), Gaps = 44/288 (15%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
             +  IG  ++  V          RV I+K+   +     +    +++  L+   H+NI+
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENII 69

Query: 397 QFYCVCVDENHGLCVVTKLMEG--GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
               +             L+    G+    +LK++ L    I      +  G+K+++   
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPE 511
           V +RDL    +LL+   ++ + D G+        + T + T+      + APEI+     
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------------- 557
                   +++S G ++ EM++    +     +     I      P              
Sbjct: 190 YTKSI---DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 558 ---------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                           +  +       L+ K    +P KR +  + ++
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 8e-26
 Identities = 45/308 (14%), Positives = 106/308 (34%), Gaps = 59/308 (19%)

Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDL 384
           E+ ++       E + +IG  +F  V+K      G++V ++K+   ++   +     +++
Sbjct: 8   EVSKY-------EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 385 LELMTCGHKNILQFYCVCVDENHG-------LCVVTKLMEGGSVNDLILKSRKLQTKEII 437
             L    H+N++    +C  +          + +V    E      L     K    EI 
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
           R+   +  G+ +++ + + +RD+ +  +L+ R G + L D G+  A      +       
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 498 Y----RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 553
                 +  PE++ G+ +        +++  G ++ EM T        +       I+  
Sbjct: 181 RVVTLWYRPPELLLGERDY---GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 554 GLRPEIPKDCPQI-------------------------------LKSLMIKCWNNSPSKR 582
                 P+  P +                                  L+ K     P++R
Sbjct: 238 CGSIT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296

Query: 583 PQFSEIIS 590
               + ++
Sbjct: 297 IDSDDALN 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 8e-26
 Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 45/291 (15%)

Query: 340 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKD---LLELMT 389
              E + +IG  ++  V+K       G+ V +++++             ++   L  L T
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 390 CGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVA 444
             H N+++ + VC     D    L +V + ++      L  +    + T+ I  +   + 
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
            G+ FL+ H V +RDL  Q IL+   G + L D G+          T        + APE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-LWYRAPE 185

Query: 505 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------- 557
           ++     +       +++S G +  EM   +  +   S V     I      P       
Sbjct: 186 VLLQSSYATP----VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 558 ------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                             +   D  ++ K L++KC   +P+KR      +S
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 9e-25
 Identities = 46/303 (15%), Positives = 103/303 (33%), Gaps = 51/303 (16%)

Query: 330 EEIGR--WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELR 381
           +E+ +  W +       +  +G  ++  V        G +V I+KL    +   +     
Sbjct: 7   QEVTKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65

Query: 382 KDLLELMTCGHKNILQFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKLQTKEI 436
           ++L  L    H+N++    V   +          +V   M  G+    ++K  KL    I
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123

Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
             +   + +G+++++  G+ +RDL    + ++    + + D G+    +           
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL---ARQADSEMTGYVV 180

Query: 497 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 556
              + APE+I         T   +++S G ++ EM+TG+  +     +     I      
Sbjct: 181 TRWYRAPEVILNWMRY---TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 557 P-----------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSE 587
           P                              I  +   +  +L+ K       +R    E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 588 IIS 590
            ++
Sbjct: 298 ALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 5e-24
 Identities = 40/285 (14%), Positives = 94/285 (32%), Gaps = 38/285 (13%)

Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
              E +++IG  ++  V+K       + V +++++  D          +++  L    HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           NI++ + V   +     +V +  +          +  L  + +      + +G+ F +  
Sbjct: 62  NIVRLHDVLHSDKKL-TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 513
            V +RDL  Q +L++R+G + L + G+  A          E     +  P+++ G     
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY- 179

Query: 514 SETWMSNVYSFGMVIWEMVTGEAA-YAACSPVQAAVGIAACGLRP--------------- 557
             +   +++S G +  E+       +           I      P               
Sbjct: 180 --STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 558 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                        +        + L+      +P +R    E + 
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 2e-22
 Identities = 54/290 (18%), Positives = 91/290 (31%), Gaps = 52/290 (17%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
                IG  SF  VY+      G+ V I+K+    +    E ++      +    H NI+
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI------MRKLDHCNIV 76

Query: 397 QFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIK 448
           +                L +V   +           SR    L    +      +   + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 507
           +++  G+ +RD+  Q +LLD    V  L D G        GE          + APE+I 
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPELIF 195

Query: 508 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------- 557
           G  +    T   +V+S G V+ E++ G+  +   S V   V I      P          
Sbjct: 196 GATDY---TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 558 -----------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                                  P    +L  +    +P+ R    E  +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 92.6 bits (229), Expect = 3e-21
 Identities = 33/252 (13%), Positives = 88/252 (34%), Gaps = 13/252 (5%)

Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKN 394
           N D+ + + ++G   +  V++   +   +   +K        + +    +LE +     N
Sbjct: 33  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG-GPN 91

Query: 395 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
           I+    +  D       +V + +       L    + L   +I     ++ + + + +  
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
           G+ +RD+    +++D  H  + L D G+       G+          +  PE++      
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMY 207

Query: 513 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 572
               +  +++S G ++  M+  +  +         +   A  L  E   D        + 
Sbjct: 208 ---DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 573 KCWNNSPSKRPQ 584
             +N+   +  +
Sbjct: 265 PRFNDILGRHSR 276

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 3e-20
 Identities = 39/291 (13%), Positives = 96/291 (32%), Gaps = 46/291 (15%)

Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
            +  + +  +G  ++  V        G RV ++KL    +   +     ++L  L    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 393 KNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
           +N++    V              +   + G  +N+++ K +KL    +  +   +  G+K
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLK 135

Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 508
           +++   + +RDL    + ++    + + D G+    +   +          + APEI+  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDEMTGYVATRWYRAPEIMLN 192

Query: 509 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------- 557
                      +++S G ++ E++TG   +     +     I      P           
Sbjct: 193 WMHY---NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 558 ------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 590
                              +      +   L+ K       KR   ++ ++
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 2e-17
 Identities = 44/258 (17%), Positives = 94/258 (36%), Gaps = 20/258 (7%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
           + +  IG  +   V         + V I+KL    +   +     ++L+ +    HKNI+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 397 QFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
               V   +        + +V +LM+      +     +L  + +  +   +  GIK L+
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH 136

Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 511
             G+ +RDL    I++     + + D G+     +    T Y      + APE+I G   
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGY 195

Query: 512 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 571
                   +++S G ++ EMV  +  +     +     +      P  P+   ++  ++ 
Sbjct: 196 ----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-CPEFMKKLQPTVR 250

Query: 572 IKCWNNSPSKRPQFSEII 589
               N        F ++ 
Sbjct: 251 NYVENRPKYAGLTFPKLF 268

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 68.1 bits (165), Expect = 7e-13
 Identities = 42/268 (15%), Positives = 94/268 (35%), Gaps = 35/268 (13%)

Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---------L 387
             + ++G   F  V+          V ++ ++G DK      E    LL+          
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDV 443
            + G  +IL+       +      V  + E    N L L  +          + +I+  +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 444 AEGIKFLN-DHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG--YR 499
             G+ +++   G+ + D+  + +L++   +   L  + I     +      Y        
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 500 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 559
           + +PE++ G P        ++++S   +I+E++TG+         +   G +       I
Sbjct: 195 YRSPEVLLGAPWGCG----ADIWSTACLIFELITGD------FLFEPDEGHSYTKDDDHI 244

Query: 560 PKDCPQILKSLMIKCWNNSPSKRPQFSE 587
            +   ++L  L      N    R  F+ 
Sbjct: 245 AQII-ELLGELPSYLLRNGKYTRTFFNS 271

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 46.7 bits (110), Expect = 2e-06
 Identities = 23/198 (11%), Positives = 58/198 (29%), Gaps = 32/198 (16%)

Query: 346 DQIGPNSFKGVYK-----GKRVGIEKLK--------GCDKGNAYEFELRKDLLELMTCGH 392
             +G      V+           ++  K          +K +  +       +       
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
           + + +   + V + +       LME     +      +++ +    +   + E +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMILEEVAKFYH 121

Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 512
            G+ + DL+   +L+   G + + D            + E   +G      EI+  D  +
Sbjct: 122 RGIVHGDLSQYNVLVSEEG-IWIIDFPQ---------SVEVGEEG----WREILERDVRN 167

Query: 513 VSETWMSNVYSFGMVIWE 530
           +   + S  Y     I  
Sbjct: 168 IIT-YFSRTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	604
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	89.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	81.98

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=439.15  Aligned_cols=261  Identities=26%  Similarity=0.468  Sum_probs=221.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk---~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      .|+++.++|++.+.||+|+||.||+|+   .||||+++...........+.+|+.++.+++|||||+++|++.++  .++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~--~~~   79 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP--QLA   79 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SCE
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--EEE
Confidence            689999999999999999999999985   699999976555555566789999999999999999999998643  389


Q ss_pred             EEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +|||||++|+|.+++... ..+++..++.++.||+.||+|||+++||||||||+||||+.++++||+|||+++.......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999654 5799999999999999999999999999999999999999999999999999876543222


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----CCCCCc
Q 007429          490 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKDC  563 (604)
Q Consensus       490 --~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----~~p~~~  563 (604)
                        ......||+.|||||++.+.... .++.++|||||||++|||+||+.||.+.++.......+..+...    ..+.++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~-~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             cccccccccCcccCCHHHHhcccCC-CCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              23345789999999999765332 35678999999999999999999999887776666666555433    356789


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      |+++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-53  Score=431.52  Aligned_cols=260  Identities=22%  Similarity=0.408  Sum_probs=225.3

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ..+|+++.++|++.+.||+|+||.||+|      +.||||+++....   ...++.+|+.+|.+++|||||+++|+|.++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            3579999999999999999999999996      4799999874332   245688999999999999999999999877


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      +. +++|||||++|+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~~-~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          86 PP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             Ce-eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            75 89999999999999998653  4789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc-ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          484 CKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       484 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      ....... .....|++.|+|||++.+..+    +.++|||||||++|||++|..||........+...+..+.++..|..
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~----~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKF----SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCC----SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             cCCCCceeeccccccccccChHHHcCCCC----CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence            6543322 233357889999999987654    45699999999999999977766655555666677778888999999


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +|+++.+||.+||+.||.+|||+.+|++.|..+.+..
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999998876654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=438.13  Aligned_cols=255  Identities=23%  Similarity=0.402  Sum_probs=220.6

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  400 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g  400 (604)
                      .+|+++.++|++++.||+|+||.||+|+           .||+|.+.... .......+.+|+.++.++ +|||||+++|
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4799999999999999999999999975           48999886432 222345678999999988 8999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  457 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~-----------------------~l~~~~il~ia~qIa~gL~YLHs~gIVH  457 (604)
                      +|.+.+. +|+|||||++|+|.++|...+                       .+++..++.++.||+.||.|||+++|||
T Consensus       109 ~~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH  187 (325)
T d1rjba_         109 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  187 (325)
T ss_dssp             EECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEeeCCe-EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            9998876 999999999999999996432                       4789999999999999999999999999


Q ss_pred             ccCCCCceEEcCCCcEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-C
Q 007429          458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  534 (604)
Q Consensus       458 rDLKp~NILld~~g~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G  534 (604)
                      |||||+|||++.++++||+|||+++........  .....||+.|||||++.+..+    +.++|||||||++|||+| |
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~----~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY----TIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHTTTS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC----CcceeccchhHHHHHHHhCC
Confidence            999999999999999999999999766543332  223457999999999987654    456999999999999998 8


Q ss_pred             CCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          535 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       535 ~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ..||.+.+..+.+..++..+.+++.|..+|+++.+||.+||+.||++|||++||+++|.
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            99999888777778888889999999999999999999999999999999999999995

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=420.08  Aligned_cols=252  Identities=23%  Similarity=0.489  Sum_probs=207.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ++.++|++++.||+|+||.||+|     +.||||+++...   ....++.+|+..+.+++|||||+++|+|.+++. +++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~l   77 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICL   77 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCc-eEE
Confidence            56789999999999999999996     469999987432   234568899999999999999999999988775 899


Q ss_pred             EEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      ||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999998654 57899999999999999999999999999999999999999999999999998766543322


Q ss_pred             -ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          491 -TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       491 -~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                       .....||+.|+|||++.+..+    +.++|||||||++|||+| |.+||...+..+.. ..+..+.++..|..+++++.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~----~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~  232 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRY----SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLASTHVY  232 (263)
T ss_dssp             -------CTTSCCHHHHTTCCC----CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHHHHTCCCCCCTTSCHHHH
T ss_pred             eecceecCcccCChHHhcCCCC----CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHHHhcCCCCCccccCHHHH
Confidence             233468899999999987654    456999999999999999 56666665555544 44555778888999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +||.+||+.||++|||+++|+++|+++..
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-52  Score=428.07  Aligned_cols=259  Identities=24%  Similarity=0.424  Sum_probs=211.7

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      .+..++|++.+.||+|+||.||+|+         .||||.+.... .......+.+|+.+|++++|||||+++|+|.+++
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            4566889999999999999999975         38888876432 3334456899999999999999999999998776


Q ss_pred             CcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      . +++|||||++|+|.+++... +.+++..++.++.||+.||.|||+++|+||||||+||||+.++++||+|||+++...
T Consensus       101 ~-~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 P-VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             S-CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             E-EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            5 99999999999999988654 479999999999999999999999999999999999999999999999999997665


Q ss_pred             cCCCcc-----cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          486 SVGEAT-----EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       486 ~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ......     ....+|+.|||||.+.+..+    +.++|||||||++|||+| |..||.+.+..+.... +..+.+++.
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~----~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~  254 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKF----TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPP  254 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCC----CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCC
Confidence            432211     12347889999999987654    446999999999999998 8999998887765544 455677888


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCccCC
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  601 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~~~  601 (604)
                      |.++++.+.+||.+||+.||.+|||+.||++.|.++...+++
T Consensus       255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s  296 (299)
T d1jpaa_         255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS  296 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence            999999999999999999999999999999999988765543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=422.40  Aligned_cols=256  Identities=26%  Similarity=0.466  Sum_probs=217.4

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..|+++.++|++++.||+|+||.||+|     +.||||+++....   ....+.+|+.++.+++|||||+++|++.++  
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--   80 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE--   80 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeeccC--
Confidence            579999999999999999999999996     4799999974332   245688999999999999999999988654  


Q ss_pred             cEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                      .+++||||+++|+|.+++..  ..++++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence            37899999999999998743  3369999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE-AAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~-~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      .... ......||+.|||||++.+..+    +.++|||||||++|||+||. +||...+..+ ....+..+.++..|..+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~----~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTF----TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTC
T ss_pred             CCccccccccCCcccccChHHHhCCCC----CchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCCCCcccC
Confidence            4322 2334568899999999986654    45699999999999999955 5555544444 44555667888899999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++++.+||.+||+.||++|||+++|++.|......
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999999999999999876543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=422.05  Aligned_cols=253  Identities=20%  Similarity=0.351  Sum_probs=218.6

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +|.+  ++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.++..++|||||++++++.+++
T Consensus         2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            4544  68999999999999999995      5799999864321 1223456789999999999999999999999877


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +|+|||||++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~-~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          80 R-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             E-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             E-EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            5 999999999999999998888999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          487 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       487 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                      .  ......||+.|||||++.+..++.    ++|||||||++|||++|..||.+.+..+....+...  .+.+|..++++
T Consensus       159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~----~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~  230 (263)
T d2j4za1         159 S--RRTTLCGTLDYLPPEMIEGRMHDE----KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEG  230 (263)
T ss_dssp             C--CCEETTEEGGGCCHHHHTTCCCCT----THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHH
T ss_pred             C--cccccCCCCcccCHHHHcCCCCCc----hhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHH
Confidence            2  234457999999999999876554    599999999999999999999988877766655543  45678889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +.+||.+||+.||.+|||+.|+++|=+...+
T Consensus       231 ~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999998765443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=421.82  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=202.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-CCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-~~~l~LV  412 (604)
                      ++|++++.||+|+||.||+|      +.||+|.+............+.+|+.++++++|||||++++++.+. +..+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            78999999999999999996      4799999986655544556688999999999999999999999764 3348999


Q ss_pred             EecccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       413 mEy~~gGSL~dlL~~----~~~l~~~~il~ia~qIa~gL~YLHs~g-----IVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      ||||++|+|.+++.+    +..+++..++.++.||+.||.|||+++     ||||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999853    347999999999999999999999976     99999999999999999999999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCc
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  563 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~  563 (604)
                      ............||+.|||||++.+..+    +.++|||||||++|||+||..||...+..+....+.. +..+.+|..+
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~----~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~  238 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSY----NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRY  238 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTS
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCC----ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCccc
Confidence            7654444455679999999999987654    4569999999999999999999998887776665554 4445678899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                      ++++.+||.+||+.||.+|||+.||++|
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            9999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=423.80  Aligned_cols=247  Identities=21%  Similarity=0.381  Sum_probs=216.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|+++++||+|+||.||+|      +.||+|+++......  ...+.+|+.+++.++|||||++++++.+++. +|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCE-EEEEE
Confidence            57899999999999999995      589999997543322  4568899999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||+||+|.+++.+ +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...........
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999998754 57999999999999999999999999999999999999999999999999999877655555566


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  572 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~LI~  572 (604)
                      ..||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+..+....+..... ....|..+++++++||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~----~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYG----PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBC----THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCC----chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            6899999999999887554    459999999999999999999999888777766665543 34567789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHH
Q 007429          573 KCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       573 kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||+.||.+|||+.|+++|=+.
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGG
T ss_pred             HHccCChhHCcCHHHHhcCHhh
Confidence            9999999999999999987543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=420.41  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=218.1

Q ss_pred             ceeecCCCeEEee-eeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~-~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      +|.+..++|.+.+ +||+|+||.||+|.        .||||.++.. .......++.+|+.+|.+++|||||+++|+|.+
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            4667778999998 59999999999973        5999999743 233345678999999999999999999999975


Q ss_pred             CCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      +  .+|+|||||++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~--~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          81 E--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             S--SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             C--eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            4  38999999999999999854 35799999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCC
Q 007429          484 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  559 (604)
Q Consensus       484 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~  559 (604)
                      ......   ......||+.|||||++.+..+    +.++|||||||++|||+| |..||.+.+..+.. ..+..+.++..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-~~i~~~~~~~~  233 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKF----SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMEC  233 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCCCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCC----CccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence            654322   1233468899999999987654    456999999999999998 99999987766554 44556778889


Q ss_pred             CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          560 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       560 p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      |..+|+++.+||.+||+.||++||||.+|++.|....
T Consensus       234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999999998887653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-51  Score=416.10  Aligned_cols=258  Identities=25%  Similarity=0.423  Sum_probs=212.6

Q ss_pred             eecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 007429          336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  405 (604)
Q Consensus       336 ~i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~  405 (604)
                      ++..+.|++.+.||+|+||.||+|.          .||||+++.. .......++.+|+.++.+++|||||+++|++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            4667889999999999999999974          5899999643 3333455688999999999999999999999887


Q ss_pred             CCcEEEEEecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      +. +++||||+.+|++.+++... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..
T Consensus        82 ~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SS-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             Cc-eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            75 99999999999999988544 57999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          485 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       485 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      ......   .....||+.|||||++.+..+    +.++|||||||++|||++|..||........+...+..+.+++.|.
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~----~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKF----TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCC----CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            443222   223357899999999987654    4569999999999999996555554444455556677788889999


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +++..+.+||.+||+.||++|||+.||++.|.++...+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            99999999999999999999999999999998875543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=416.79  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=208.7

Q ss_pred             eEEe-eeeeccCceEEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          342 LEFI-DQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       342 y~i~-~~LG~G~FG~VykG--------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.+. ++||+|+||.||+|        +.||||+++..........++.+|+.++++++|||||+++|+|.++  ..+||
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--~~~lv   85 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--SWMLV   85 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS--SEEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC--CEEEE
Confidence            3443 47999999999996        3699999976544455566789999999999999999999999654  37899


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc--
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~--  490 (604)
                      |||+++|+|.+++.+...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+++........  
T Consensus        86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999765443221  


Q ss_pred             -ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          491 -TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       491 -~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                       .....||+.|||||.+.+..+    +.++|||||||++|||+| |..||.+.+..+.. ..+..+.++..|..+|+++.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~----~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~~~~  240 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKF----SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGCPAGCPREMY  240 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccCCCceecCchhhcCCCC----CchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHHH
Confidence             233468899999999987654    456999999999999998 89999988776544 44556778889999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      +||.+||+.||++|||+.+|++.|...
T Consensus       241 ~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         241 DLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            999999999999999999998887664

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=423.01  Aligned_cols=252  Identities=21%  Similarity=0.368  Sum_probs=215.6

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      .+.|++++.||+|+||.||+|      +.||+|++.....  .....+.+|+.+|++++|||||++++++.+++. +|+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lv   87 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWIL   87 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe-EEEE
Confidence            367999999999999999996      4799999975432  223457899999999999999999999998876 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.........
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999999999999754 4579999999999999999999999999999999999999999999999999987654433334


Q ss_pred             cccCCCCcccccccccCCCC-CCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC-CCCCCCCccHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKS  569 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~-s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~-r~~~p~~~s~~l~~  569 (604)
                      ....||+.|||||++.+... ...++.++|||||||++|||++|+.||.+.++.+....+..... ....|..+++++.+
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence            45679999999999865432 33456789999999999999999999999888887777776543 23456788999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ||.+||+.||.+|||+.|+++|=+
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~  271 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPF  271 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCcc
Confidence            999999999999999999998744

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-50  Score=420.92  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=216.8

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .|+++++||+|+||.||+|      +.||||++........ ....+.+|+.++++++|||||++++++.+++. +|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE-EEEEE
Confidence            5899999999999999995      5799999976544333 33458899999999999999999999998775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      |||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++.....    ...
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS  170 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCc
Confidence            9999999988777778899999999999999999999999999999999999999999999999999876543    334


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  573 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~k  573 (604)
                      ..||+.|||||++.+.... .++.++|||||||++|||++|..||.+.+..+....+.....+...+..+++++.+||.+
T Consensus       171 ~~GT~~Y~APE~~~~~~~~-~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  249 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  249 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCC-CcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            5799999999999754322 356679999999999999999999999888888888777766666677899999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHh
Q 007429          574 CWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       574 CL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      ||+.||.+|||+.|+++|-+-.
T Consensus       250 ~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         250 CLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHH
T ss_pred             HCcCChhHCcCHHHHHhCHHhc
Confidence            9999999999999999875443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=420.08  Aligned_cols=251  Identities=18%  Similarity=0.239  Sum_probs=208.4

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.||+|.+..... ......+.+|+.++++++|||||++++++.+++. +||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~-~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce-eEEEE
Confidence            68999999999999999985      5799999975432 2233458899999999999999999999998875 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--cc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~  491 (604)
                      |||++|+|.+++.++..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999997777899999999999999999999999999999999999999999999999999987654322  23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHc-CCCCCCCCCccHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GLRPEIPKDCPQILKSL  570 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~-~~r~~~p~~~s~~l~~L  570 (604)
                      ....||+.|||||++.+..+.   +.++||||+||++|||++|+.||...+........... .........+++++.+|
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~---~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBC---HHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCC---CCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            445799999999999876542   34689999999999999999999876544333333333 23333345789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          571 MIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       571 I~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      |.+||+.||.+|||+.|+++|=|.-
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhC
Confidence            9999999999999999999886543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=420.28  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=215.9

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEE
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY  399 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykG-----------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~  399 (604)
                      ..+|++..++|++++.||+|+||.||+|           +.||||+++... .......+.+|+..+.++ +|+|||.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            4689999999999999999999999996           469999987432 233345567777777776 789999999


Q ss_pred             EEEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q 007429          400 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  463 (604)
Q Consensus       400 g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~  463 (604)
                      +++.+++..+++|||||++|+|.+++...                ..+++..++.++.||+.||.|||+++||||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            99987766689999999999999999542                24889999999999999999999999999999999


Q ss_pred             ceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCC
Q 007429          464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAA  540 (604)
Q Consensus       464 NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~  540 (604)
                      ||||+.++++||+|||+++.......  ......||+.|||||++.+..+    +.++|||||||++|||+|| .+||..
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY----TIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC----CcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999976544332  2334568999999999987654    4569999999999999986 578988


Q ss_pred             CChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       541 ~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ....+.+...+..+.++..|..+++++.++|.+||+.||++|||+.||+++|.++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            777677777778888899999999999999999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=410.68  Aligned_cols=248  Identities=25%  Similarity=0.491  Sum_probs=216.6

Q ss_pred             cCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      +.++|+++++||+|+||.||+|+     .||||+++....   .+.++.+|+..+.+++|||||+++|+|.+++. +++|
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~-~~iv   77 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFII   77 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS-EEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-eEEE
Confidence            56899999999999999999964     799999985433   24568899999999999999999999987765 9999


Q ss_pred             EecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-c
Q 007429          413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  490 (604)
Q Consensus       413 mEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-~  490 (604)
                      |||+++|+|.+++.. ...+++..+++++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999999754 45799999999999999999999999999999999999999999999999999876554332 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      .....+|+.|+|||.+.+..+    +.++|||||||++|||+| |+.||...+..+....+ ..+.++..|..+++++.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~----~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~  232 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKF----SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYT  232 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCC----CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHH
Confidence            233568899999999987654    456999999999999998 89999998877665544 557788899999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      ||.+||+.||++|||+.+|+++|.+
T Consensus       233 li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         233 IMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHccCCHhHCcCHHHHHHHhhC
Confidence            9999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=414.41  Aligned_cols=257  Identities=23%  Similarity=0.440  Sum_probs=209.9

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  404 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~  404 (604)
                      .|+|..++|++++.||+|+||.||+|+         .||||.++... .......+.+|+.++++++|||||+++|++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            488899999999999999999999974         47888876432 33344568899999999999999999999964


Q ss_pred             CCCcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                       + .+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus        80 -~-~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          80 -N-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             -S-SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -C-eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence             3 38999999999999998754 44799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          484 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       484 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      ...... ......||+.|+|||.+.+..++    .++|||||||++|||++ |.+||...+..+.... +..+.++++|.
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~----~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~~~~~~~  232 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFT----SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLPMPP  232 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCS----HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCT
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCC----CccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCC
Confidence            543322 23345678999999999876544    46999999999999998 8999998877666554 44567778899


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCc
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  598 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~  598 (604)
                      ++|+.+.+||.+||+.||.+|||+.||+++|.++.+.
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999987654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=408.95  Aligned_cols=246  Identities=23%  Similarity=0.392  Sum_probs=208.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---CCcEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~---~~~l~  410 (604)
                      +.|++.++||+|+||.||+|      +.||+|++............+.+|+.+|++++|||||++++++.+.   +..+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            34578889999999999996      4799999986554444556688999999999999999999998752   33489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeccCCCCceEEc-CCCcEEEEecCCccccccC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~g--IVHrDLKp~NILld-~~g~vKL~DFGla~~~~~~  487 (604)
                      +||||+++|+|.+++.+...+++..+..++.||+.||+|||+++  |+||||||+||||+ .++.+||+|||+++.....
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999999988889999999999999999999999998  99999999999996 5789999999998754332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-CCCCCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-~~~p~~~s~~  566 (604)
                        ......||+.|||||++.+.     ++.++|||||||++|||++|+.||........+...+..+.. +.++..++++
T Consensus       169 --~~~~~~GT~~Y~aPE~~~~~-----~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         169 --FAKAVIGTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             --SBEESCSSCCCCCGGGGGTC-----CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             --ccCCcccCccccCHHHhCCC-----CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence              23455799999999998752     455799999999999999999999887766666555555444 3456678899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      +.+||.+||+.||++|||+.|+++|=
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCc
Confidence            99999999999999999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=419.05  Aligned_cols=251  Identities=20%  Similarity=0.366  Sum_probs=207.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      +..++|++++.||+|+||.||+|      +.||+|+++... .......+.+|+.+|+.++|||||+++++|.+++. +|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE-EE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence            45689999999999999999995      679999997543 33445678899999999999999999999998876 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCcEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~  489 (604)
                      +||||++||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+...... 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            999999999999999888899999999999999999999997 599999999999999999999999999998654322 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH----------------------
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA----------------------  547 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~----------------------  547 (604)
                       .....||+.|+|||++.+..++.    ++||||+||++|||++|+.||...+.....                      
T Consensus       160 -~~~~~GT~~Y~APEvl~~~~y~~----~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         160 -ANSFVGTRSYMSPERLQGTHYSV----QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             -C---CCSSCCCCHHHHHCSCCCT----THHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             -cccccCCccccCchHHcCCCCCc----HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence             23457999999999999876654    499999999999999999999764432110                      


Q ss_pred             -------------------HHHHHcCCCCCCCC-CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          548 -------------------VGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       548 -------------------~~i~~~~~r~~~p~-~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                                         .........+..+. .++.++.+||.+||..||.+|||++|+++|=+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                               00111112222332 3678999999999999999999999999985443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=417.72  Aligned_cols=247  Identities=16%  Similarity=0.245  Sum_probs=211.0

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      .++|++++.||+|+||.||+|      +.||||.+..... .......+.+|+.++.+++|||||++++++.+++. +|+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE-EEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE-EEE
Confidence            478999999999999999985      5799999864221 11123458899999999999999999999988775 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC--
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  489 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--  489 (604)
                      ||||++||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.......  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999987653322  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHH
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  569 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~  569 (604)
                      ......||+.|||||++.+..++    .++|||||||++|||++|..||.+.+..+....+...  ...+|..+++++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~----~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~  239 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSAC----KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARD  239 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCC----HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHH
T ss_pred             ccccccCCccccCceeeccCCCC----cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHH
Confidence            23345799999999999887554    4699999999999999999999998887777666654  45678899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 007429          570 LMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       570 LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      ||.+||+.||.+|||++|++.+-
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             HHHHHccCCHhHCcCHHHHcCCH
Confidence            99999999999999999976543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-50  Score=409.64  Aligned_cols=258  Identities=23%  Similarity=0.411  Sum_probs=213.5

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      +.|+|+.++|++.+.||+|+||.||+|+     .||||+++....   ....+.+|+.++.+++|||||+++|+|.++ .
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~   85 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-P   85 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEecC-C
Confidence            6799999999999999999999999974     799999974432   245688999999999999999999998653 3


Q ss_pred             cEEEEEecccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~--~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       +++||||+++|+|..++..  ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        86 -~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             -eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence             7899999999999998843  3479999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCcc
Q 007429          486 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  564 (604)
Q Consensus       486 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s  564 (604)
                      .... ......+|+.|+|||.+....++    .++|||||||++|||++|..||............+..+.+++.+..++
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFT----IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCC----HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             CCCceeeccccccccccChHHHhCCCCC----cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            3322 23345689999999999876554    469999999999999996555554444444455566677888999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          565 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +++.++|.+||+.||++||++++|++.|.......
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999999999999998876544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=409.80  Aligned_cols=253  Identities=27%  Similarity=0.495  Sum_probs=211.1

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE---------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      ++.++|++++.||+|+||.||+|+         .||||+++.... .......+.+|+.++.+++|||||+++|+|.++ 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            566889999999999999999974         589999875433 223345689999999999999999999999754 


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                       .+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        84 -~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence             37899999999999998754 4579999999999999999999999999999999999999999999999999988765


Q ss_pred             cCCCc---ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCC
Q 007429          486 SVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  561 (604)
Q Consensus       486 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~  561 (604)
                      .....   .....+++.|+|||.+.+..+    +.++|||||||++|||+| |..||.+.+..+....+...+.+++.+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTF----SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE  238 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCC----CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence            44322   233457889999999987654    456999999999999998 8999999999988888888888889999


Q ss_pred             CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          562 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       562 ~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                      .+|+.+.+||.+||+.||++|||+.+|++.|.++
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            9999999999999999999999999999998875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-50  Score=411.94  Aligned_cols=258  Identities=24%  Similarity=0.443  Sum_probs=219.3

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEE
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC  400 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g  400 (604)
                      +..|++..++|++++.||+|+||.||+|+           .||||+++.. .......++.+|+.++++++||||+++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            34577888999999999999999999984           6899998743 33344567899999999999999999999


Q ss_pred             EEEcCCCcEEEEEecccCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCce
Q 007429          401 VCVDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVA  456 (604)
Q Consensus       401 ~~~~~~~~l~LVmEy~~gGSL~dlL~~~~------------------------~l~~~~il~ia~qIa~gL~YLHs~gIV  456 (604)
                      +|.+.+. +++||||+++|+|.+++....                        .+++..++.++.||+.||+|||+++||
T Consensus        84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv  162 (301)
T d1lufa_          84 VCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  162 (301)
T ss_dssp             EECSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             eeccCCc-eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence            9987765 899999999999999985322                        378899999999999999999999999


Q ss_pred             eccCCCCceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC
Q 007429          457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG  534 (604)
Q Consensus       457 HrDLKp~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG  534 (604)
                      ||||||+|||++.++++||+|||+++.......  ......+++.|+|||.+.+..++    .++|||||||++|||++|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t----~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT----TESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC----HHHHHHHHHHHHHHHHTT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC----hhhhhccchhhHHHHHcc
Confidence            999999999999999999999999876544322  22344688999999999876544    569999999999999998


Q ss_pred             C-CCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          535 E-AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       535 ~-~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      . +||...+..+.... +..+.++..|..+++++.+||.+||+.||++||||.||++.|+++.
T Consensus       239 ~~~p~~~~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         239 GLQPYYGMAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TCCTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5 67888777766554 5556678889999999999999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-50  Score=415.24  Aligned_cols=248  Identities=19%  Similarity=0.301  Sum_probs=199.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      +.|++++.||+|+||.||++      +.||+|.+...... .....+.+|+.+|..++|||||++++++.+++. +||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH-LYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            56999999999999999995      57999999754322 223457899999999999999999999998775 99999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc---CCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld---~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+++...... .
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-V  165 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-e
Confidence            9999999999998888999999999999999999999999999999999999995   57899999999987654332 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~s~~l~  568 (604)
                      .....||+.|||||++.+..++    .++|||||||++|||++|..||.+.+..+....+.......  +.+.++|+++.
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~----~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYS----KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -------CTTSCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             eeeeeeCccccCcHHHcCCCCC----cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            3345799999999999887554    46999999999999999999999988877777777665443  34467899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||.+||+.||++|||+.|+++|-+.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            99999999999999999999997443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-50  Score=418.63  Aligned_cols=249  Identities=16%  Similarity=0.287  Sum_probs=218.5

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEE
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  410 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~  410 (604)
                      ..++|++++.||+|+||.||++      +.||+|+++.... .......+.+|+.+|+.++|||||++++++.+++. +|
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~   81 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-EE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc-cc
Confidence            4578999999999999999985      5899999974321 11224567899999999999999999999998876 99


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++........
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999876655555


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  570 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~L  570 (604)
                      ....+||+.|+|||++.+..++.    ++||||+||++|||++|.+||.+.+..+....+...  .+.+|..+++++.+|
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~----~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  235 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGR----AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCT----THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCCh----hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHH
Confidence            55678999999999999876654    499999999999999999999998887776666654  456889999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHHHHH
Q 007429          571 MIKCWNNSPSKRPQ-----FSEIISLLL  593 (604)
Q Consensus       571 I~kCL~~dP~kRPT-----~~ELL~~L~  593 (604)
                      |.+||+.||.+||+     +.|+++|-+
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcc
Confidence            99999999999994     899998744

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=412.04  Aligned_cols=252  Identities=23%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  406 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~  406 (604)
                      +..++|++++.||+|+||.||+|+          .||+|+++... ......++.+|+.++.+++|||||+++|+|.+++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~   84 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   84 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            455789999999999999999974          48999887433 2233567899999999999999999999998753


Q ss_pred             CcEEEEEecccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  485 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~-~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~  485 (604)
                        .++++||+.+|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+++...
T Consensus        85 --~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             --eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence              6889999999999998865 4579999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCC
Q 007429          486 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  562 (604)
Q Consensus       486 ~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~  562 (604)
                      .....  .....||+.|||||.+.+..+    +.++|||||||++|||+| |.+||.+.+..+. ...+..+.+++.|..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~  237 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIY----THQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI  237 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTT
T ss_pred             cccccccccccccCccccChHHHhcCCC----ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcc
Confidence            43322  233458999999999987654    456999999999999998 8999988766554 455666788889999


Q ss_pred             ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          563 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       563 ~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +++.+.+||.+||+.||.+|||+.||+.+|.++.
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=406.97  Aligned_cols=252  Identities=24%  Similarity=0.483  Sum_probs=212.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      .|++..++|++++.||+|+||.||+|    +.||||+++...    ....+.+|+.++++++|||||+++|+|.++...+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            49999999999999999999999985    689999997432    2356889999999999999999999997665458


Q ss_pred             EEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                      |+||||+++|+|.+++.+.  ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999999999643  35999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHcCCCCCCCCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~  566 (604)
                         .....+++.|+|||++.+..+    +.++|||||||++|||+| |++||...+..+... .+..+.++++|..++++
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~----t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-HHTTTCCCCCCTTCCHH
T ss_pred             ---CccccccccCCChHHHhCCCC----ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHH
Confidence               334467889999999987654    456999999999999998 788888776665544 45567888999999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          567 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      +++||.+||+.||.+|||+.+|+++|+++.+
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=409.65  Aligned_cols=260  Identities=25%  Similarity=0.443  Sum_probs=226.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  401 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~  401 (604)
                      .|++..++|++.+.||+|+||.||+|+           .||||+++... .......+.+|+.++..+ +|||||+++|+
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            688999999999999999999999974           69999997543 334455688999999998 79999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCC
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  463 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~~------------------~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~  463 (604)
                      |.+.+. +++|||||++|+|.+++.+..                  .+++..++.++.||+.||+|||++++|||||||+
T Consensus        96 ~~~~~~-~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          96 CTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             ECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EeeCCE-EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            988775 899999999999999986432                  5889999999999999999999999999999999


Q ss_pred             ceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 007429          464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA  540 (604)
Q Consensus       464 NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf~~  540 (604)
                      |||++.++.+||+|||+++.......  ......||+.|+|||.+.+..    ++.++|||||||++|||+| |.+||..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DIwS~G~~l~ellt~g~p~~~~  250 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV----YTFESDVWSYGIFLWELFSLGSSPYPG  250 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC----CCCcccccchHHHHHHHHhCCCCCCCC
Confidence            99999999999999999886654332  223446899999999998664    3456999999999999998 6777777


Q ss_pred             CChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          541 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       541 ~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .+..+.+..++..+.++..|..+++.+.+||.+||+.||.+|||+.+|+++|++....+
T Consensus       251 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             CCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            77777777888889999999999999999999999999999999999999998865443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=404.55  Aligned_cols=248  Identities=16%  Similarity=0.277  Sum_probs=213.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCC----chHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG----NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~----~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l  409 (604)
                      ++|++++.||+|+||.||+|      +.||+|.++.....    ......+.+|+.+|++++|||||++++++.+++. +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-E
Confidence            67999999999999999995      57999998754322    1235668899999999999999999999998875 9


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC----cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g----~vKL~DFGla~~~~  485 (604)
                      |||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999998888999999999999999999999999999999999999998877    49999999987765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCc
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  563 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~  563 (604)
                      ... ......+|+.|+|||++.+..++    .++|||||||++|||++|..||.+.+..+....+.......  ..+.++
T Consensus       169 ~~~-~~~~~~~t~~y~APE~~~~~~~~----~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         169 FGN-EFKNIFGTPEFVAPEIVNYEPLG----LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             TSC-BCSCCCCCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCc-cccccCCCCcccCHHHHcCCCCC----CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            432 23445789999999999876544    46999999999999999999999988888777766654432  234678


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      |+.+.+||.+||+.||++|||+.|+++|=+
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            999999999999999999999999998744

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=405.52  Aligned_cols=259  Identities=25%  Similarity=0.475  Sum_probs=217.7

Q ss_pred             ccceeecCCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeE
Q 007429          332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQ  397 (604)
Q Consensus       332 i~~~~i~~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVk  397 (604)
                      ..+|.++.++|++++.||+|+||.||+|+             .||||+++.. .......++.+|+..+.++ +|||||+
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~   83 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN   83 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence            35799999999999999999999999974             5899998743 3333446678888888887 8999999


Q ss_pred             EEEEEEcCCCcEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCC
Q 007429          398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN  461 (604)
Q Consensus       398 l~g~~~~~~~~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLK  461 (604)
                      ++++|.+++. +++||||+++|+|.++|...                ..+++..++.++.||+.||+|||+++|||||||
T Consensus        84 ~~~~~~~~~~-~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          84 LLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             EEEEECSSSS-CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cccccccCCe-EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence            9999998775 99999999999999999643                248999999999999999999999999999999


Q ss_pred             CCceEEcCCCcEEEEecCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 007429          462 SQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY  538 (604)
Q Consensus       462 p~NILld~~g~vKL~DFGla~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlT-G~~Pf  538 (604)
                      |+|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |.+||
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y----~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY----THQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC----CchhhhHHhHHHHHHhccCCCCCC
Confidence            9999999999999999999876654332  2334568889999999987654    456999999999999998 78999


Q ss_pred             CCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          539 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       539 ~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      ...+..+. ...+..+.++..|..+++++.+||.+||+.||.+|||+.||++.|+++.-
T Consensus       239 ~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         239 PGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             TTCCHHHH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHH-HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            87766554 45566788889999999999999999999999999999999999988753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.5e-48  Score=394.83  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=212.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC---cE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GL  409 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~---~l  409 (604)
                      ++|++.+.||+|+||.||++      +.||+|.++...... .....+.+|+.+++.++|||||++++++...+.   .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            67999999999999999995      589999997654433 344568899999999999999999999986542   37


Q ss_pred             EEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC-
Q 007429          410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  488 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~-  488 (604)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            8999999999999999888899999999999999999999999999999999999999999999999999976543322 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCcc
Q 007429          489 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCP  564 (604)
Q Consensus       489 --~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~s  564 (604)
                        .......||+.|+|||++.+..+    +.++|||||||++|||+||.+||...++.+....+......+  ....++|
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~----~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSV----DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ------------TTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             cccccccccCcccccCHHHHcCCCC----CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence              12334468999999999987654    456999999999999999999999988888887777765544  2356789


Q ss_pred             HHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhhC
Q 007429          565 QILKSLMIKCWNNSPSKRP-QFSEIISLLLRTNN  597 (604)
Q Consensus       565 ~~l~~LI~kCL~~dP~kRP-T~~ELL~~L~~~~~  597 (604)
                      +++.++|.+||+.||.+|| |++++++.|.++.+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            9999999999999999999 89999999998865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-48  Score=398.76  Aligned_cols=252  Identities=21%  Similarity=0.218  Sum_probs=216.3

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch-------HHHHHHHHHHHHHhCC-CCceeEEEEEEEc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCG-HKNILQFYCVCVD  404 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~-------~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~  404 (604)
                      .++|++++.||+|+||+||++      +.+|||++........       ....+.+|+.++.+++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            378999999999999999995      5899999976543321       1234778999999996 9999999999998


Q ss_pred             CCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ++. +||||||+++|+|.++|..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~-~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             Ccc-eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            775 9999999999999999988889999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCcccccccccCCC--CCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCC--C
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--P  560 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~--p  560 (604)
                      .... ......||+.|+|||.+.+..  ....++.++||||+||++|||++|+.||.+.++......+.........  +
T Consensus       161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (277)
T d1phka_         161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  239 (277)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            5433 234457999999999987432  2234567899999999999999999999998888777777766554333  3


Q ss_pred             CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          561 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       561 ~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                      .++|+++++||.+||+.||.+|||+.|+++|=
T Consensus       240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            47899999999999999999999999998873

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-48  Score=406.72  Aligned_cols=244  Identities=20%  Similarity=0.327  Sum_probs=213.8

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|+++.... .......+.+|+.++..++|||||++++++.+++. +|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe-eeeE
Confidence            68999999999999999995      5799999864221 11123567899999999999999999999998775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      ||||+||+|..++.....+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.....   ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---cc
Confidence            999999999999988888999999999999999999999999999999999999999999999999999776432   34


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|||||++.+..++.    ++|||||||++|||++|+.||.+.+..+....+...  ...+|..+++++.+++.
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~----~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  233 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNK----SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS  233 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCT----THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred             cccCcccccCHHHHcCCCCCc----hhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence            467999999999998876654    499999999999999999999998888877777665  34578889999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHHHHH
Q 007429          573 KCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       573 kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +||..||.+||     |+++|++|=+
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~  259 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPW  259 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcc
Confidence            99999999996     8999998743

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=405.52  Aligned_cols=255  Identities=25%  Similarity=0.435  Sum_probs=212.4

Q ss_pred             ecCCCeEEeeeeeccCceEEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCC
Q 007429          337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  407 (604)
Q Consensus       337 i~~~~y~i~~~LG~G~FG~VykGk--------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~  407 (604)
                      ++.++|++.+.||+|+||.||+|+        .||||+++..... .....+.+|+.+|.++ +|||||+++|+|.+++.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            455899999999999999999974        4788888643322 2344588999999998 79999999999998775


Q ss_pred             cEEEEEecccCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          408 GLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~----------------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                       +++||||+++|+|.++|.+.                ..+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus        86 -~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          86 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             -eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence             99999999999999998543                4689999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE-AAYAACSPVQAAVGI  550 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~-~Pf~~~s~~~~~~~i  550 (604)
                      .+||+|||+++...... ......||+.|+|||.+.+..+    +.++|||||||++|||++|. +||...+..+... .
T Consensus       165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~----~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~-~  238 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY----TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-K  238 (309)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEE----CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-H
T ss_pred             ceEEccccccccccccc-cccceecCCcccchHHhccCCC----CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH-H
Confidence            99999999987554322 2334468999999999987654    45699999999999999965 6787766665544 4


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          551 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       551 ~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +..+.++..|..+++++.+||.+||+.||++|||++||+++|.++....
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            5567788899999999999999999999999999999999999886543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-48  Score=412.07  Aligned_cols=246  Identities=15%  Similarity=0.300  Sum_probs=212.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|++....  ......+.+|+.+|.+++|||||++++++.+++. +||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            57999999999999999995      589999996432  3344568899999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC--CCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~--~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+||+|.+++. ..+.+++..+..++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+++...... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~  181 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-S  181 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-C
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-c
Confidence            9999999999985 4457999999999999999999999999999999999999964  6789999999998765432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s~~l~  568 (604)
                      .....||+.|||||++.+..++    .++|||||||++|||++|+.||.+.+..+....+........  .+..+++++.
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~----~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVG----YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBC----HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cceecCcccccCHHHHcCCCCC----hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3445789999999999887554    469999999999999999999999888888777776655432  3356889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +||.+||..||++|||+.|+++|=+
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcc
Confidence            9999999999999999999999743

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-48  Score=412.40  Aligned_cols=246  Identities=15%  Similarity=0.322  Sum_probs=213.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||++      +.||+|.+....  ......+.+|+.+|++++|||||++++++.+++. +||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            67999999999999999995      579999997532  2334567899999999999999999999998775 99999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEc--CCCcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld--~~g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+||+|.+++.+. .++++..++.++.||+.||.|||++|||||||||+||||+  .++.+||+|||+++...... .
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-~  184 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-I  184 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-C
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-c
Confidence            999999999987544 4799999999999999999999999999999999999998  57899999999998765432 3


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--CCCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--~~p~~~s~~l~  568 (604)
                      .....||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+..+....+.......  ..+..+++++.
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVG----FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBC----HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCC----CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3455789999999999877554    56999999999999999999999988888877777765443  34567899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      +||.+||+.||.+|||+.|+++|=+
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHh
Confidence            9999999999999999999998744

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=407.65  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=211.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHH-hCCCCceeEEEEEEEcCCCcEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCV  411 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~-~L~HpnIVkl~g~~~~~~~~l~L  411 (604)
                      ++|++++.||+|+||+||+|      +.||||+++.... .......+..|+.++. .++|||||++++++.+++. +|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~-~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-EEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc-eeE
Confidence            68999999999999999995      6799999974211 1111233456666554 6899999999999998876 999


Q ss_pred             EEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       412 VmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999998766555555


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  571 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI  571 (604)
                      ....||+.|+|||++.+..++    .++|||||||++|||++|+.||.+.+..+....+...  .+.+|..+++++.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYN----HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             cccCCCCCcCCHHHHcCCCCC----chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence            666899999999999887654    4599999999999999999999998888777666654  4578889999999999


Q ss_pred             HHhhhcCCCCCCCHH-HHHHH
Q 007429          572 IKCWNNSPSKRPQFS-EIISL  591 (604)
Q Consensus       572 ~kCL~~dP~kRPT~~-ELL~~  591 (604)
                      .+||+.||.+||++. ++++|
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHhcccCCCCCcCHHHHHHhC
Confidence            999999999999995 78654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=399.85  Aligned_cols=258  Identities=24%  Similarity=0.431  Sum_probs=219.9

Q ss_pred             cceeecCCCeEEeeeeeccCceEEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       333 ~~~~i~~~~y~i~~~LG~G~FG~VykGk-----------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      ..|+|+.++|++.+.||+|+||.||+|.           .||||+++.. ........+.+|+.++++++|||||+++|+
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            4699999999999999999999999863           5899999743 233344568899999999999999999999


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  471 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~----------~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g  471 (604)
                      |..++. .++||||+++|+|.+++...          ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        92 ~~~~~~-~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          92 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EecCCc-eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            987765 89999999999999998532          1468899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcC-CCCCCCCChHHHHH
Q 007429          472 NVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAV  548 (604)
Q Consensus       472 ~vKL~DFGla~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG-~~Pf~~~s~~~~~~  548 (604)
                      ++||+|||+++........  .....+|+.|+|||.+.+..++    .++|||||||++|||+|| .+||.+.+..+...
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~----~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT----TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC----HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC----cccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999998766543322  2333578999999999877544    469999999999999997 58888877776665


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhC
Q 007429          549 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  597 (604)
Q Consensus       549 ~i~~~~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~  597 (604)
                      .+ ..+.++..|..+++.+.++|.+||+.||.+|||+.+|+++|.+...
T Consensus       247 ~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HH-HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            44 4566788899999999999999999999999999999999987643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=398.55  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=209.3

Q ss_pred             EEeeeeeccCceEEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          343 EFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykGk---------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      .+.+.||+|+||+||+|+         .||||+++.. .......++.+|+.++.+++|||||+++|++.+.+...++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            446789999999999975         4899999743 233345678999999999999999999999987665589999


Q ss_pred             ecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCc--
Q 007429          414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~--  490 (604)
                      |||++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++........  
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999998643 46788899999999999999999999999999999999999999999999998765543221  


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHH
Q 007429          491 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  568 (604)
Q Consensus       491 --~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~  568 (604)
                        .....||+.|+|||.+....+    +.++||||||+++|||+||..||............+..+.++..|..+++++.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~----~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCC----CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             eecccccccccccChHHHhcCCC----CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence              223468899999999987644    55699999999999999977777654444444445566778889999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      +||.+||+.||++||++.||+++|.++.+..
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-48  Score=408.16  Aligned_cols=244  Identities=20%  Similarity=0.258  Sum_probs=213.2

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~-~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||++      +.||+|++..... .......+.+|+.+|+.++|||||++++++.+... +++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc-cccc
Confidence            68999999999999999995      5799999864221 11123457899999999999999999999988775 9999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  492 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~  492 (604)
                      |||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.....   ..
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~  196 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TW  196 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---cc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876532   33


Q ss_pred             ccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 007429          493 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  572 (604)
Q Consensus       493 ~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~~l~~LI~  572 (604)
                      ...||+.|||||++.+..++    .++|||||||++|||+||..||.+.+.......+...  .+..|..+++++.++|.
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~----~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYN----KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBC----THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCC----ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHH
Confidence            45799999999999887654    4599999999999999999999998888777777665  34567889999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHHHHH
Q 007429          573 KCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       573 kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      +||+.||.+|+     |+++|++|=+
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHhhhCHHhccccccccHHHHHcCcc
Confidence            99999999994     8999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-47  Score=405.80  Aligned_cols=250  Identities=18%  Similarity=0.266  Sum_probs=204.2

Q ss_pred             cCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCc-hHHHHHH---HHHHHHHhCCCCceeEEEEEEEcCCC
Q 007429          338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELR---KDLLELMTCGHKNILQFYCVCVDENH  407 (604)
Q Consensus       338 ~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~-~~~~~~~---~Ei~~L~~L~HpnIVkl~g~~~~~~~  407 (604)
                      ..++|++++.||+|+||.||+|      +.||+|.+....... .....+.   .++.++..++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            3578999999999999999985      579999986322110 1112223   34556667799999999999998775


Q ss_pred             cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccC
Q 007429          408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  487 (604)
Q Consensus       408 ~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~  487 (604)
                       +|+|||||+||+|.+++.+...+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus        82 -~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             -EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999866543


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHcCCCCCCCCCccHH
Q 007429          488 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-VGIAACGLRPEIPKDCPQI  566 (604)
Q Consensus       488 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~-~~i~~~~~r~~~p~~~s~~  566 (604)
                        ......||+.|+|||++....   .++.++|||||||++|||+||+.||...+..... ...........+|..++++
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~---~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTC---CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             --cccccccccccchhHHhhcCC---CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence              234557999999999996432   2345699999999999999999999875433221 1122334456678899999


Q ss_pred             HHHHHHHhhhcCCCCCCC-----HHHHHHHHH
Q 007429          567 LKSLMIKCWNNSPSKRPQ-----FSEIISLLL  593 (604)
Q Consensus       567 l~~LI~kCL~~dP~kRPT-----~~ELL~~L~  593 (604)
                      +.+||.+||+.||.+|||     ++|+++|=+
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence            999999999999999999     799998754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=394.28  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=202.4

Q ss_pred             EeeeeeccCceEEEEe------EEEEEEEeecCCCCch---HHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          344 FIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       344 i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~---~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      .++.||+|+||+||+|      +.||||+++.......   ....+.+|+.++..++|||||++++++.+++. +|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~-~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-ISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-CEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc-eeehhh
Confidence            4688999999999985      5799999865432221   12357899999999999999999999998876 999999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+.++++..++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99998888777666789999999999999999999999999999999999999999999999999998766554445556


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----------------
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----------------  557 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----------------  557 (604)
                      .||+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+..+.+..+......+                 
T Consensus       161 ~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         161 VVTRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCCCTTCCHHHHTTCS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             ecChhhccHHHHccCC---CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            7999999999987543   24567999999999999999999999988877766655321110                 


Q ss_pred             ----C-----CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          558 ----E-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       558 ----~-----~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                          .     ....+++++.+||.+||+.||++|||+.|+++|=+
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence                0     01356789999999999999999999999998744

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=397.28  Aligned_cols=246  Identities=17%  Similarity=0.227  Sum_probs=211.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.||+|.++..   ......+.+|+.+|..++|||||++++++.+++. +|+||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~lvm   80 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEE
Confidence            78999999999999999995      57999999743   2334567899999999999999999999998776 99999


Q ss_pred             ecccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCC--CcEEEEecCCccccccCCCc
Q 007429          414 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA  490 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~-~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~--g~vKL~DFGla~~~~~~~~~  490 (604)
                      |||+||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++..... ..
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~  159 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence            9999999999997654 79999999999999999999999999999999999999854  47999999998765432 23


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCC--CCCCccHHHH
Q 007429          491 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  568 (604)
Q Consensus       491 ~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~--~p~~~s~~l~  568 (604)
                      .....+|+.|+|||.+.+..++    .++||||+||++|+|++|..||...+..+....+........  .+..+++++.
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~----~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVS----TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEEC----HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccchhccCCCCC----chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            3445789999999999876544    469999999999999999999999888888777776554432  2246899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          569 SLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       569 ~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      +||.+||..||.+|||+.|+++|=|.
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhh
Confidence            99999999999999999999998654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=390.62  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=204.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.||+|+++...........+.+|+.++++++|||||++++++.+++. +|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~-~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc-eeEEE
Confidence            78999999999999999996      579999997544333334568899999999999999999999998876 99999


Q ss_pred             ecccCCCHHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcc
Q 007429          414 KLMEGGSVNDLI-L-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  491 (604)
Q Consensus       414 Ey~~gGSL~dlL-~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~  491 (604)
                      ||+.++ +.+++ . ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.........
T Consensus        81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999764 44444 3 34579999999999999999999999999999999999999999999999999998776655556


Q ss_pred             cccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC--------------
Q 007429          492 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------  557 (604)
Q Consensus       492 ~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~--------------  557 (604)
                      ....||+.|+|||.+....+   .+.++||||+||++|+|++|+.||.+.+..+....+......+              
T Consensus       160 ~~~~gt~~y~apE~~~~~~~---~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSS---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             eeecccceeeehhhhccccC---CCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            66789999999999876643   3457999999999999999999999888777666554321110              


Q ss_pred             --CC-----------CCCccHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 007429          558 --EI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  591 (604)
Q Consensus       558 --~~-----------p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~  591 (604)
                        ..           ...+++++.+||.+||..||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              11           12457889999999999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-47  Score=386.36  Aligned_cols=249  Identities=19%  Similarity=0.274  Sum_probs=206.0

Q ss_pred             CCeEEeeeeeccCceEEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEEe
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      ++|+++++||+|+||+||+|     +.||||+++...........+.+|+.+|++++|||||++++++.+++. .+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-eeEEEE
Confidence            68999999999999999996     479999997654333334668899999999999999999999998876 999999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCccccc
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  494 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~~  494 (604)
                      |+.++.+..+....+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++.............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            99988777777667789999999999999999999999999999999999999999999999999988766554445556


Q ss_pred             CCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC------------------
Q 007429          495 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------------------  556 (604)
Q Consensus       495 ~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r------------------  556 (604)
                      .+++.|+|||.+.+..+   ++.++|||||||++|||++|+.||.+.+..+....+......                  
T Consensus       161 ~~~~~y~~pE~~~~~~~---~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKK---YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             -CCCTTCCHHHHTTCCS---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             cccchhhhHHHHhCCCC---CCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            78999999999976542   345799999999999999999999988877666554321111                  


Q ss_pred             ---------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          557 ---------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       557 ---------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                               ...+..+++.+.++|.+||+.||++|||+.|+++|=
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                     112356788999999999999999999999999763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=381.05  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=200.1

Q ss_pred             CCeEEeeeeeccCceEEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHh---CCCCceeEEEEEEEcC----
Q 007429          340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE----  405 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG-------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~---L~HpnIVkl~g~~~~~----  405 (604)
                      ++|++++.||+|+||.||++       +.||||+++...........+.+|+.+++.   ++|||||+++++|...    
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            68999999999999999995       468999986533222222234566666554   4899999999998632    


Q ss_pred             CCcEEEEEecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          406 NHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       406 ~~~l~LVmEy~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      ...++++|||+.++++..... ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            234899999999877765543 3457899999999999999999999999999999999999999999999999998754


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC--------
Q 007429          485 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--------  556 (604)
Q Consensus       485 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r--------  556 (604)
                      ... .......||+.|+|||++.+..++    .++||||+||++|||++|.+||.+.++.+.+..+......        
T Consensus       167 ~~~-~~~~~~~gT~~Y~APE~~~~~~y~----~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         167 SFQ-MALTSVVVTLWYRAPEVLLQSSYA----TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CGG-GGGCCCCCCCTTCCHHHHTTCCCC----THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccc-ccCCCcccChhhcCcchhcCCCCC----hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            432 234556799999999999877654    4699999999999999999999998887766655432110        


Q ss_pred             -----------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          557 -----------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       557 -----------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                                       ..++..+++.+.+||.+||+.||++|||+.|+++|=+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                             1234567899999999999999999999999999844

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=389.94  Aligned_cols=244  Identities=16%  Similarity=0.288  Sum_probs=196.0

Q ss_pred             CCeEEee-eeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEcC---CCc
Q 007429          340 DNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDE---NHG  408 (604)
Q Consensus       340 ~~y~i~~-~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~-L~HpnIVkl~g~~~~~---~~~  408 (604)
                      ++|++++ .||+|+||.||+|      +.||||+++..       ..+.+|+.++.+ ++|||||++++++.+.   +..
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            6788886 5999999999996      58999999732       346688887655 5899999999998752   334


Q ss_pred             EEEEEecccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccc
Q 007429          409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  483 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~--~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~  483 (604)
                      +|+|||||+||+|.++|.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.   .+.+||+|||+++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            89999999999999999653  47999999999999999999999999999999999999985   56799999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC--CCCCC-
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--RPEIP-  560 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~--r~~~p-  560 (604)
                      ..... ......||+.|||||++.+..+    +.++|||||||++|+|+||.+||.+.+.......+.....  ...+| 
T Consensus       164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~y----~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         164 TTSHN-SLTTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CCCCC-CCCCCSCCCSSCCCCCCCGGGG----SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ccCCC-ccccccCCcccCCcHHHcCCCC----CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            65433 3445679999999999987654    4569999999999999999999987655443333322211  12233 


Q ss_pred             ---CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 007429          561 ---KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  595 (604)
Q Consensus       561 ---~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~  595 (604)
                         ..+++++.+||.+||+.||++|||+.|+++|=|..
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence               25789999999999999999999999999985543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=383.55  Aligned_cols=256  Identities=22%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             CCeEEeeeeeccCceEEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---CcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG----k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~---~~l~LV  412 (604)
                      ++|.+.+.||+|+||.||+|    +.||||+++..   .......+.|+..+..++|||||+++|+|.+++   ..+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            57889999999999999996    58999998632   222333455666667789999999999998764   247999


Q ss_pred             EecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND--------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs--------~gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      |||+++|+|.+++.+ ..+++..++.++.|++.||.|||+        +|||||||||+||||+.++.+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999965 468999999999999999999996        59999999999999999999999999998876


Q ss_pred             ccCCC----cccccCCCCcccccccccCCCCCC--CCCcchhHHHHHHHHHHHHcCCCCCCCC---------------Ch
Q 007429          485 KSVGE----ATEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTGEAAYAAC---------------SP  543 (604)
Q Consensus       485 ~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~--~~t~kSDVWSlGvvLyELlTG~~Pf~~~---------------s~  543 (604)
                      .....    ......||+.|+|||++.+.....  .++.++|||||||++|||+||..||...               +.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            54332    223456899999999987653322  2456799999999999999998877421               12


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----ccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          544 VQAAVGIAACGLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       544 ~~~~~~i~~~~~r~~~p~~-----~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      ..........+.++.+|..     ++..+.+||.+||+.||.+|||+.||+++|.++....
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            2233333444566666553     3356999999999999999999999999999887543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=381.92  Aligned_cols=240  Identities=19%  Similarity=0.261  Sum_probs=199.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCch----HHHHHHHHHHHHHhCC--CCceeEEEEEEEcCCC
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA----YEFELRKDLLELMTCG--HKNILQFYCVCVDENH  407 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~----~~~~~~~Ei~~L~~L~--HpnIVkl~g~~~~~~~  407 (604)
                      ++|++.+.||+|+||.||+|      +.||||++........    ...++.+|+.+++.++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            67999999999999999985      5799999875332211    1123568888888875  8999999999988775


Q ss_pred             cEEEEEecccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-CCcEEEEecCCccccc
Q 007429          408 GLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACK  485 (604)
Q Consensus       408 ~l~LVmEy~~g-GSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-~g~vKL~DFGla~~~~  485 (604)
                       +++||||+.+ +++.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus        84 -~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 -FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             -EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             -EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence             9999999976 688888888889999999999999999999999999999999999999985 4799999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCCCCCCCccH
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  565 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~~~p~~~s~  565 (604)
                      ..  ......||+.|+|||++.+..+.   +.++|||||||++|||++|..||...+      .+...  ...++..+|+
T Consensus       163 ~~--~~~~~~GT~~y~aPE~~~~~~~~---~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~  229 (273)
T d1xwsa_         163 DT--VYTDFDGTRVYSPPEWIRYHRYH---GRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSS  229 (273)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCBC---HHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCH
T ss_pred             cc--cccccccCCCcCCHHHHcCCCCC---CcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCH
Confidence            32  23345799999999999866432   346899999999999999999997632      12332  3457788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          566 ILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       566 ~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                      ++.+||.+||+.||++|||+.|+++|=+
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            9999999999999999999999998744

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=366.98  Aligned_cols=250  Identities=16%  Similarity=0.214  Sum_probs=209.9

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||+||+|      +.||||+++..........++.+|+.+++.++|||||++++++.+... .++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-eeEEe
Confidence            68999999999999999996      469999998665555566778999999999999999999999998876 89999


Q ss_pred             ecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCCcccc
Q 007429          414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  493 (604)
Q Consensus       414 Ey~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~~~~~  493 (604)
                      +++.+++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            99999999998888889999999999999999999999999999999999999999999999999999877665555556


Q ss_pred             cCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHcC------------------
Q 007429          494 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACG------------------  554 (604)
Q Consensus       494 ~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~-~~~~~~i~~~~------------------  554 (604)
                      ..+++.|+|||.+.+..+   ++.++||||+||++|||++|..||..... .+....+....                  
T Consensus       161 ~~~~~~~~~pe~~~~~~~---~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSC---CCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eccccchhhhhHhccCCC---CCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            667888999999876543   34569999999999999999998755443 33333322110                  


Q ss_pred             ---------CCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          555 ---------LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       555 ---------~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                               .....+..+++.+.+||.+||+.||.+|||++|+++|=|
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence                     011233466889999999999999999999999998743

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=379.58  Aligned_cols=249  Identities=18%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             eeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC-
Q 007429          335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-  407 (604)
Q Consensus       335 ~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~-  407 (604)
                      |.+ .++|++++.||+|+||.||+|      +.||||+++...........+.+|+.+|+.++|||||+++++|...+. 
T Consensus        14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            555 478999999999999999995      579999998655444555678899999999999999999999976542 


Q ss_pred             ----cEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          408 ----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       408 ----~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                          .+|+||||+ +++|..++ ++..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence                379999999 55788776 456799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCC-------
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------  556 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r-------  556 (604)
                      ....   .....+|+.|+|||++.+..+   ++.++||||+||++|||++|++||.+.+.......+......       
T Consensus       171 ~~~~---~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE---MTGYVVTRWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS---CCSSCSCGGGCCTHHHHTTTC---CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc---cccccccccccCHHHHcCCCC---CCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            5432   345678999999999976532   244699999999999999999999987766554433221111       


Q ss_pred             ----------------------CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          557 ----------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       557 ----------------------~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                            ......+++++.+||.+||..||.+|||+.|+++|=
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence                                  113356789999999999999999999999999983

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-44  Score=365.76  Aligned_cols=248  Identities=17%  Similarity=0.198  Sum_probs=193.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCCcEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  413 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~~l~LVm  413 (604)
                      ++|++++.||+|+||.||+|      +.||||.+......    .++..|+.++..++|+|+|..++.+.......++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            57999999999999999996      58999998754322    236788999999988776666555555554589999


Q ss_pred             ecccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC---CCcEEEEecCCccccccCCC
Q 007429          414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       414 Ey~~gGSL~dlL~-~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~---~g~vKL~DFGla~~~~~~~~  489 (604)
                      ||+++ +|.+.+. ..+.+++..+..++.||+.||+|||++|||||||||+|||++.   +..+||+|||+++.......
T Consensus        83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            99954 6666654 4568999999999999999999999999999999999999864   45799999999987654322


Q ss_pred             -------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH---HH---cCCC
Q 007429          490 -------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI---AA---CGLR  556 (604)
Q Consensus       490 -------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i---~~---~~~r  556 (604)
                             ......||+.|||||.+.+..++    .++|||||||++|||++|..||............   ..   ....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQS----RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCC----HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCC----ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence                   12344699999999999876544    5699999999999999999999876544322211   11   1112


Q ss_pred             CCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 007429          557 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  596 (604)
Q Consensus       557 ~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~  596 (604)
                      +..+.++|+++.++|.+||+.||++||++.+|.+.|..+.
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            2345688999999999999999999999999888777654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=367.78  Aligned_cols=252  Identities=17%  Similarity=0.250  Sum_probs=199.0

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-------
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  406 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-------  406 (604)
                      ++|++++.||+|+||+||+|      +.||||++............+.+|+.+|..++||||+++++++....       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67899999999999999996      47999998755444444566789999999999999999999986532       


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      ..+|+||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            23899999998877766555566899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC----CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcC--CCCCCC
Q 007429          487 VG----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIP  560 (604)
Q Consensus       487 ~~----~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~--~r~~~p  560 (604)
                      ..    .......||+.|+|||.+.+..   .++.++||||+||++|||++|+.||.+.+.......+....  ..+...
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~---~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccceecCHHHhhHHHHcCCC---CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            22    1123346899999999987653   24557999999999999999999999877766554443321  111100


Q ss_pred             C----------------------------CccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          561 K----------------------------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       561 ~----------------------------~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                      .                            ..++.+.+||.+||+.||++|||++|+++|=+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            0                            125677899999999999999999999998654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=377.96  Aligned_cols=252  Identities=19%  Similarity=0.341  Sum_probs=206.4

Q ss_pred             CCCeEEeeeeeccCceEEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCC
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDEN  406 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG---------k~VAIKklk~~~~--~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g~~~~~~  406 (604)
                      .++|++++.||+|+||.||++         +.||+|.++....  .......+.+|+.++.+++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            478999999999999999996         4699999854321  11123446789999999966 89999999998887


Q ss_pred             CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCcccccc
Q 007429          407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  486 (604)
Q Consensus       407 ~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~  486 (604)
                      . +++||||+.+|+|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~-~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 K-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             E-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             c-eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            5 999999999999999998888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH--cCCCCCCCCCc
Q 007429          487 VG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CGLRPEIPKDC  563 (604)
Q Consensus       487 ~~-~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~--~~~r~~~p~~~  563 (604)
                      .. .......|++.|+|||.+.+....  ++.++|||||||++|||++|..||...+.......+..  ....+.+|..+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~--~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccchhHHhhcCCcC--CCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            32 233445789999999999765432  34579999999999999999999986543322222221  13356678899


Q ss_pred             cHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 007429          564 PQILKSLMIKCWNNSPSKRP-----QFSEIISLLL  593 (604)
Q Consensus       564 s~~l~~LI~kCL~~dP~kRP-----T~~ELL~~L~  593 (604)
                      ++++.++|.+||+.||.+||     |++|+++|-+
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence            99999999999999999999     5899998644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=371.83  Aligned_cols=248  Identities=17%  Similarity=0.242  Sum_probs=195.5

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCC---cEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLC  410 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~~---~l~  410 (604)
                      ++|++++.||+|+||+||+|      +.||||++.... .......+.+|+.+|..++|||||++++++..+..   ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            56999999999999999995      579999997433 33445568899999999999999999999976531   123


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCCC-
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~~-  489 (604)
                      ++++|+.+|+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....... 
T Consensus        87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            44556678999999854 5799999999999999999999999999999999999999999999999999876543322 


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC----------
Q 007429          490 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  557 (604)
Q Consensus       490 --~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~----------  557 (604)
                        ......||+.|+|||.+....   .++.++||||+||++|||++|..||...+..............+          
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBC---SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             ceeeccccccceechHHHhhcCC---CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence              234456899999999986543   23456999999999999999999998877654443322110000          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 007429          558 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  592 (604)
Q Consensus       558 -------------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L  592 (604)
                                         .....+++++.+|+.+||+.||.+|||+.|+++|=
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                               11235678899999999999999999999999873

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=370.05  Aligned_cols=243  Identities=19%  Similarity=0.183  Sum_probs=195.5

Q ss_pred             CeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CCcE
Q 007429          341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHGL  409 (604)
Q Consensus       341 ~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-----~~~l  409 (604)
                      +|..++.||+|+||+||+|      +.||||++......      ..+|+.+|++++|||||+++++|...     ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            6899999999999999995      57999999754322      23788999999999999999998643     2237


Q ss_pred             EEEEecccCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccc
Q 007429          410 CVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACK  485 (604)
Q Consensus       410 ~LVmEy~~gGSL~dlL---~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~  485 (604)
                      |+|||||+++.+..+.   .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            9999999876444433   2345799999999999999999999999999999999999999875 89999999987665


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCC----------
Q 007429          486 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------  555 (604)
Q Consensus       486 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~----------  555 (604)
                      ... ......|++.|+|||.+.+..   .++.++||||+||++|||++|+.||...+..+.+..+.....          
T Consensus       175 ~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         175 RGE-PNVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             TTS-CCCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCc-ccccccccccccChHHhhccc---CCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            432 234457899999999987543   244579999999999999999999998877766655442100          


Q ss_pred             -----CC------------CCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 007429          556 -----RP------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  593 (604)
Q Consensus       556 -----r~------------~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~  593 (604)
                           ..            .....+++++.+||.+||..||.+|||+.|+++|=+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                 00            112357889999999999999999999999998743

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=369.57  Aligned_cols=253  Identities=15%  Similarity=0.232  Sum_probs=203.0

Q ss_pred             ceeecCCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 007429          334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-  406 (604)
Q Consensus       334 ~~~i~~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~~-  406 (604)
                      -|.+ .++|++++.||+|+||+||+|      +.||||++...........++.+|+.+|..++|||||++++++.... 
T Consensus        13 ~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          13 IWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            3666 478999999999999999995      58999999865555555567889999999999999999999986432 


Q ss_pred             ---CcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          407 ---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       407 ---~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                         ...+++|+|+.+|+|.+++. .+++++..+..++.||+.||.|||++||+||||||+|||++.+|.+|++|||++..
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             cccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence               12456677788999999984 45799999999999999999999999999999999999999999999999999865


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC------
Q 007429          484 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------  557 (604)
Q Consensus       484 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~------  557 (604)
                      ...   ......|++.|+|||.+.+..+   .+.++|||||||++|+|++|.+||.+.+.......+......+      
T Consensus       171 ~~~---~~~~~~g~~~y~apE~~~~~~~---~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDD---EMTGYVATRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTG---GGSSSCHHHHTSCHHHHTTCSC---CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cCc---ccccccccccccCchhhcCCcc---CCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            432   2344568889999999876543   2346999999999999999999999877766555443321111      


Q ss_pred             ---------------C--------CCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 ---------------E--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 ---------------~--------~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                     .        ....+++++.+||.+||..||.+|||+.|+++|=+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence                           0        113578899999999999999999999999997443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-42  Score=355.45  Aligned_cols=250  Identities=17%  Similarity=0.248  Sum_probs=201.3

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCCcEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCVV  412 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~H-pnIVkl~g~~~~~~~~l~LV  412 (604)
                      ++|++++.||+|+||.||+|      +.||||.+......    ..+.+|+..+..+.| +||+.+++++.+... .++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-NVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-EEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc-cEEE
Confidence            68999999999999999996      57999988643322    235678888888865 899999999887765 8999


Q ss_pred             EecccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcC-----CCcEEEEecCCcccccc
Q 007429          413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-----HGNVCLGDMGIVTACKS  486 (604)
Q Consensus       413 mEy~~gGSL~dlL~~~-~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~-----~g~vKL~DFGla~~~~~  486 (604)
                      |||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.     .+.+||+|||+++....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 67999988654 47999999999999999999999999999999999999974     57899999999987543


Q ss_pred             CCC-------cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHH---c
Q 007429          487 VGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAA---C  553 (604)
Q Consensus       487 ~~~-------~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s---~~~~~~~i~~---~  553 (604)
                      ...       ......||+.|||||++.+..+    +.++|||||||++|||++|..||.+..   .......+..   .
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~----~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQ----SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC----CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCC----ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            221       1233469999999999987654    456999999999999999999998543   2222222221   1


Q ss_pred             CCCCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhCcc
Q 007429          554 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  599 (604)
Q Consensus       554 ~~r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~~~~~~  599 (604)
                      .....++.++|+++.+++..||..+|++||++..+.+.|.++.+..
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            2222345678999999999999999999999999999888875543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-42  Score=359.93  Aligned_cols=244  Identities=14%  Similarity=0.219  Sum_probs=195.5

Q ss_pred             CCCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC-CcEE
Q 007429          339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGLC  410 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~~~-~~l~  410 (604)
                      .++|+++++||+|+||+||+|      +.||||+++...     ..++.+|+.+|..++ ||||+++++++.... ..++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            368999999999999999995      579999997432     356789999999985 999999999997543 3489


Q ss_pred             EEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCC-cEEEEecCCccccccCCC
Q 007429          411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  489 (604)
Q Consensus       411 LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g-~vKL~DFGla~~~~~~~~  489 (604)
                      +||||+.+++|..+.   +.+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++...... 
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  184 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence            999999999997653   4699999999999999999999999999999999999998765 59999999987665432 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHH-------------cCC
Q 007429          490 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAA-------------CGL  555 (604)
Q Consensus       490 ~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~-~~~~i~~-------------~~~  555 (604)
                      ......+|+.|+|||.+.+...   ++.++||||+||++|||++|+.||....... ....+..             ...
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQM---YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCC---CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             cccccccCccccCcccccCCCC---CCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            2345578999999999876542   3456999999999999999999998654322 2111110             000


Q ss_pred             ----------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          556 ----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       556 ----------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                                            .......+++++.+||.+||..||.+|||++|+++|=+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                                  001123467899999999999999999999999987544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=363.18  Aligned_cols=247  Identities=19%  Similarity=0.243  Sum_probs=190.7

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CCc
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHG  408 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~HpnIVkl~g~~~~~-----~~~  408 (604)
                      ++|++++.||+|+||+||+|      +.||||++............+.+|+.++..++|||||+++++|...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999995      6899999986655544556688999999999999999999999744     235


Q ss_pred             EEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCccccccCC
Q 007429          409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  488 (604)
Q Consensus       409 l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla~~~~~~~  488 (604)
                      +|+||||+.++.+ +.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++..... 
T Consensus        97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-  172 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  172 (355)
T ss_dssp             EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence            8999999977544 443  356899999999999999999999999999999999999999999999999997665433 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHcCCCC-----------
Q 007429          489 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----------  557 (604)
Q Consensus       489 ~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~~~~~~i~~~~~r~-----------  557 (604)
                      .......+|+.|+|||++.+..++.    ++||||+||++|||++|++||.+.+.......+......+           
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~----~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCT----THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccccccccccccChhhhcCCCCCC----CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            2334557899999999998865544    4999999999999999999998877665544332211000           


Q ss_pred             ---------C--------------CC------CCccHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 007429          558 ---------E--------------IP------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  594 (604)
Q Consensus       558 ---------~--------------~p------~~~s~~l~~LI~kCL~~dP~kRPT~~ELL~~L~~  594 (604)
                               .              .+      ...++++.+||.+||..||++|||++|+++|=|.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence                     0              00      1235678999999999999999999999988544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-36  Score=317.19  Aligned_cols=245  Identities=16%  Similarity=0.275  Sum_probs=182.1

Q ss_pred             CCeEEeeeeeccCceEEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-----------CCCceeEEEEEE
Q 007429          340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-----------GHKNILQFYCVC  402 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~VykG------k~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-----------~HpnIVkl~g~~  402 (604)
                      ++|+++++||+|+||+||+|      +.||||+++..   ......+.+|+.+++.+           .|+|||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            56999999999999999995      57999999732   23344567787777665           468899999998


Q ss_pred             EcCC-CcEEEEEecccCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceeccCCCCceEEcCCCc-----
Q 007429          403 VDEN-HGLCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGN-----  472 (604)
Q Consensus       403 ~~~~-~~l~LVmEy~~gGSL~dlL---~~~~~l~~~~il~ia~qIa~gL~YLHs-~gIVHrDLKp~NILld~~g~-----  472 (604)
                      .... ...+++++++..+......   .....+++..+..++.||+.||+|||+ +||+||||||+||||+.++.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            6542 3366777776655433322   234578999999999999999999998 89999999999999987664     


Q ss_pred             -EEEEecCCccccccCCCcccccCCCCcccccccccCCCCCCCCCcchhHHHHHHHHHHHHcCCCCCCCCChH------H
Q 007429          473 -VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV------Q  545 (604)
Q Consensus       473 -vKL~DFGla~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~t~kSDVWSlGvvLyELlTG~~Pf~~~s~~------~  545 (604)
                       ++++|||.+.....   ......||+.|+|||++.+..++    .++||||+||++++|++|+.||......      .
T Consensus       170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG----CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC----THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             eeeEeeccccccccc---ccccccccccccChhhccccCCC----ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence             99999999875543   23455789999999999877554    4599999999999999999999753321      1


Q ss_pred             HHHHHHH-cCC---------------------------------------CCCCCCCccHHHHHHHHHhhhcCCCCCCCH
Q 007429          546 AAVGIAA-CGL---------------------------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQF  585 (604)
Q Consensus       546 ~~~~i~~-~~~---------------------------------------r~~~p~~~s~~l~~LI~kCL~~dP~kRPT~  585 (604)
                      ....... .+.                                       ....+...++++.+|+.+||..||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            1111100 000                                       111223456789999999999999999999


Q ss_pred             HHHHHHHHH
Q 007429          586 SEIISLLLR  594 (604)
Q Consensus       586 ~ELL~~L~~  594 (604)
                      +|+++|=+.
T Consensus       323 ~e~L~Hp~f  331 (362)
T d1q8ya_         323 GGLVNHPWL  331 (362)
T ss_dssp             HHHHTCGGG
T ss_pred             HHHhcCccc
Confidence            999998443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=3.8e-22  Score=190.15  Aligned_cols=130  Identities=12%  Similarity=0.126  Sum_probs=100.7

Q ss_pred             EEeeeeeccCceEEEEe-----EEEEEEEeecCCCC----------------chHHHHHHHHHHHHHhCCCCceeEEEEE
Q 007429          343 EFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG----------------NAYEFELRKDLLELMTCGHKNILQFYCV  401 (604)
Q Consensus       343 ~i~~~LG~G~FG~VykG-----k~VAIKklk~~~~~----------------~~~~~~~~~Ei~~L~~L~HpnIVkl~g~  401 (604)
                      .+.++||+|+||.||+|     +.||||.++.....                ........+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            57899999999999995     68999987532110                0011234567788889999999998865


Q ss_pred             EEcCCCcEEEEEecccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceeccCCCCceEEcCCCcEEEEecCCc
Q 007429          402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  481 (604)
Q Consensus       402 ~~~~~~~l~LVmEy~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs~gIVHrDLKp~NILld~~g~vKL~DFGla  481 (604)
                      .   .  .+++|||++++.+.       .++......++.|++.+|.|||++||+||||||+|||+++++ ++|+|||++
T Consensus        83 ~---~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a  149 (191)
T d1zara2          83 E---G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS  149 (191)
T ss_dssp             E---T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred             c---C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence            3   2  36999999886543       245555678999999999999999999999999999999654 899999998


Q ss_pred             cccc
Q 007429          482 TACK  485 (604)
Q Consensus       482 ~~~~  485 (604)
                      ....
T Consensus       150 ~~~~  153 (191)
T d1zara2         150 VEVG  153 (191)
T ss_dssp             EETT
T ss_pred             ccCC
Confidence            6654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.90  E-value=2.6e-05  Score=74.60  Aligned_cols=135  Identities=13%  Similarity=0.127  Sum_probs=83.0

Q ss_pred             CCeEEeeeeeccCceEEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCCcEEEEEe
Q 007429          340 DNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTK  414 (604)
Q Consensus       340 ~~y~i~~~LG~G~FG~Vyk----Gk~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L-~HpnIVkl~g~~~~~~~~l~LVmE  414 (604)
                      ..|++.+..+.++.+.||+    +..+.+|+........  ...+.+|...+..+ .+--+.+++.++.+++. .++||+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~-~~lv~~   90 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMS   90 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc-eEEEEE
Confidence            3456666655555578887    3567777775432222  12345666666554 23345677777766654 789999


Q ss_pred             cccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 007429          415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND------------------------------------------  452 (604)
Q Consensus       415 y~~gGSL~dlL~~~~~l~~~~il~ia~qIa~gL~YLHs------------------------------------------  452 (604)
                      +++|.++.+.....     .....++.++...|..||+                                          
T Consensus        91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            99998876543211     1112223334444444442                                          


Q ss_pred             -----------------cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 -----------------HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 -----------------~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                                       ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                             127999999999999977666799998854

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.99  E-value=0.0016  Score=61.39  Aligned_cols=28  Identities=18%  Similarity=0.119  Sum_probs=24.6

Q ss_pred             ceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          455 VAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       455 IVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      ++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.94  E-value=0.0013  Score=67.39  Aligned_cols=30  Identities=17%  Similarity=0.097  Sum_probs=25.6

Q ss_pred             CceeccCCCCceEEcCCCcEEEEecCCcccc
Q 007429          454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  484 (604)
Q Consensus       454 gIVHrDLKp~NILld~~g~vKL~DFGla~~~  484 (604)
                      .++|+|+.|.|||++.++ ++|+||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            589999999999998765 899999887543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.97  E-value=0.09  Score=52.88  Aligned_cols=73  Identities=8%  Similarity=0.062  Sum_probs=42.7

Q ss_pred             CCCeEEeeeeeccCceEEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEc
Q 007429          339 SDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVD  404 (604)
Q Consensus       339 ~~~y~i~~~LG~G~FG~VykGk-------------~VAIKklk~~~~~~~~~~~~~~Ei~~L~~L~-HpnIVkl~g~~~~  404 (604)
                      .+++++ +.|+.|-.-.+|+..             .|-++..- . ...  .....+|..+++.+. +.-..++++++. 
T Consensus        42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~-  115 (395)
T d1nw1a_          42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PET--ESHLVAESVIFTLLSERHLGPKLYGIFS-  115 (395)
T ss_dssp             GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred             ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcC-
Confidence            344554 567778888899743             23333332 2 222  233557777766652 333457787763 


Q ss_pred             CCCcEEEEEecccCCCH
Q 007429          405 ENHGLCVVTKLMEGGSV  421 (604)
Q Consensus       405 ~~~~l~LVmEy~~gGSL  421 (604)
                       +   ++|+||++|.+|
T Consensus       116 -~---g~I~efi~g~~l  128 (395)
T d1nw1a_         116 -G---GRLEEYIPSRPL  128 (395)
T ss_dssp             -T---EEEECCCCEEEC
T ss_pred             -C---ceEEEEeccccC
Confidence             2   478999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=89.04  E-value=0.049  Score=52.68  Aligned_cols=30  Identities=20%  Similarity=0.121  Sum_probs=26.5

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCcc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  482 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~  482 (604)
                      .|+||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            579999999999999988777899999863

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=81.98  E-value=0.63  Score=45.07  Aligned_cols=29  Identities=17%  Similarity=0.056  Sum_probs=23.1

Q ss_pred             cCceeccCCCCceEEcCCCcEEEEecCCccc
Q 007429          453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  483 (604)
Q Consensus       453 ~gIVHrDLKp~NILld~~g~vKL~DFGla~~  483 (604)
                      .++||+|+.+.|||++. + ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            36899999999999974 4 45889998643